Citrus Sinensis ID: 016115
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 395 | 2.2.26 [Sep-21-2011] | |||||||
| Q39012 | 407 | Shaggy-related protein ki | yes | no | 0.962 | 0.933 | 0.910 | 0.0 | |
| Q39010 | 412 | Shaggy-related protein ki | no | no | 0.964 | 0.924 | 0.905 | 0.0 | |
| Q39011 | 380 | Shaggy-related protein ki | no | no | 0.886 | 0.921 | 0.931 | 0.0 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.939 | 0.907 | 0.798 | 0.0 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.878 | 0.846 | 0.847 | 0.0 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.951 | 0.928 | 0.777 | 1e-180 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.878 | 0.848 | 0.824 | 1e-178 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.903 | 0.868 | 0.810 | 1e-178 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.870 | 0.836 | 0.828 | 1e-176 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.878 | 0.844 | 0.815 | 1e-175 |
| >sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 729 bits (1883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/389 (91%), Positives = 367/389 (94%), Gaps = 9/389 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLGPQP A APP Q D D LKR RP++DSDKEMSAAVI+GNDAVTGH
Sbjct: 1 MASLPLGPQPH------ALAPPLQL--HDGDALKR-RPELDSDKEMSAAVIEGNDAVTGH 51
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 52 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 111
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 112 LQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 171
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE NISYI
Sbjct: 172 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYI 231
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPT
Sbjct: 232 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPT 291
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH
Sbjct: 292 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 351
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQEV 389
PFF+ELREPNARLPNGRP PPLFNFKQE+
Sbjct: 352 PFFNELREPNARLPNGRPLPPLFNFKQEL 380
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q39010|KSG6_ARATH Shaggy-related protein kinase zeta OS=Arabidopsis thaliana GN=ASK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 723 bits (1867), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/390 (90%), Positives = 369/390 (94%), Gaps = 9/390 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLGP PQPP + AP Q PH D LKR RPD+D+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLGP-PQPP----SLAP--QPPHLHGGDSLKR-RPDIDNDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDFGSAKVLVKGEANISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
ICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTP
Sbjct: 233 ICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTP 292
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA
Sbjct: 293 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 352
Query: 360 HPFFDELREPNARLPNGRPFPPLFNFKQEV 389
HPFF+ELREPNARLPNGRP PPLFNFKQE+
Sbjct: 353 HPFFNELREPNARLPNGRPLPPLFNFKQEL 382
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39011|KSG7_ARATH Shaggy-related protein kinase eta OS=Arabidopsis thaliana GN=ASK7 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 691 bits (1783), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 326/350 (93%), Positives = 338/350 (96%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
M DKEM AAV+ G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQDRRYKNRELQLMR+MDHPNV+ LKHCFFSTTSKDELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
++YRVLKHYSS NQRMPL+YVKLY YQIFRGLAYIH V GVCHRD+KPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
K+CDFGSAK LVKGEANISYICSR+YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDF 300
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEV 389
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEV
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEV 350
|
Negative regulator in brassinosteroid signal transduction pathway important for plant growth. May be also involved in auxin signaling pathway. Phosphorylates and increases the degradation of BZR1 and BZR2/BES1 by the proteasome. Phosphorylates BHLH150, beet curly top virus C4 and tomato golden mosaic virus AC4 on threonine and serine residues. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 634 bits (1635), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 298/373 (79%), Positives = 328/373 (87%), Gaps = 2/373 (0%)
Query: 16 PQAQAPPSQQPHFDNDLLKRHRPDM--DSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEP 73
P A S D D L DM DKEM A ++ GN TGHII TTIGG+NG+P
Sbjct: 8 PSAAVRESTGNVTDADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTIGGRNGQP 67
Query: 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVI 133
KQTISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MRL+DHPNV+
Sbjct: 68 KQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVV 127
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
SLKHCFFSTT KDEL+LNLV+EYVPET++RV+KHY+ +NQRMPL+YVKLYTYQIFR L+Y
Sbjct: 128 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSY 187
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
IH GVCHRD+KPQNLLV+P THQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFG
Sbjct: 188 IHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
ATEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+
Sbjct: 248 ATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 373
F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LRC AL++ HPFFDELR+PNARL
Sbjct: 308 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDELRDPNARL 367
Query: 374 PNGRPFPPLFNFK 386
PNGR PPLFNFK
Sbjct: 368 PNGRFLPPLFNFK 380
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 633 bits (1633), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 294/347 (84%), Positives = 317/347 (91%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
+ DKEM AAV+ GN TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCL
Sbjct: 35 IKDDKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCL 94
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPE
Sbjct: 95 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 154
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
T+YRV KHYS NQRMP+IYVKLYTYQI R LAYIH GVCHRD+KPQNLLV+P THQV
Sbjct: 155 TVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQV 214
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
KLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPL
Sbjct: 215 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPL 274
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL
Sbjct: 275 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDL 334
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386
SRLLQYSP+LR TA+EA HPFFDELR+PN RLPNGR PPLFNFK
Sbjct: 335 VSRLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFK 381
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 630 bits (1624), Expect = e-180, Method: Compositional matrix adjust.
Identities = 300/386 (77%), Positives = 331/386 (85%), Gaps = 10/386 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+ + P P P + ND+ R DKEM A V+ GN TGH
Sbjct: 1 MASVGIAPNPGARDSTGVDKLPEEM----NDMKIR------DDKEMEATVVDGNGTETGH 50
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
II TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRE
Sbjct: 51 IIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRE 110
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET++RV+KHY+ +NQRMPLIYV
Sbjct: 111 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYV 170
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFR L+YIH GVCHRD+KPQNLLV+P THQVKLCDFGSAKVLVKGE NISYI
Sbjct: 171 KLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 230
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPT
Sbjct: 231 CSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 290
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
REEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LR AL+ H
Sbjct: 291 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVH 350
Query: 361 PFFDELREPNARLPNGRPFPPLFNFK 386
PFFDELR+PNARLPNGR PPLFNFK
Sbjct: 351 PFFDELRDPNARLPNGRFLPPLFNFK 376
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1609), Expect = e-178, Method: Compositional matrix adjust.
Identities = 286/347 (82%), Positives = 318/347 (91%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
+ DKE+ AA++ GN TGHII TTIGG++G+PKQTISYMAER+VG GSFG+VFQAKCL
Sbjct: 34 IRDDKEIEAAIVDGNGTETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCL 93
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQD+RYKNRELQ MRL+DHPNV+ LKHCFFSTT KDE++LNLV+EYVPE
Sbjct: 94 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPE 153
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
T++RV+KHY+ +NQRMPLI VKLYTYQIFR L+YIH GVCHRD+KPQNLLV+P THQV
Sbjct: 154 TVHRVIKHYNKLNQRMPLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQV 213
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
KLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPL
Sbjct: 214 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPL 273
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPGE+ VDQLVEIIKVLGTPTREEI+CMNPNY +F+FPQIKAHPWHK+FHKRMPPEA+DL
Sbjct: 274 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDL 333
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386
SRLLQYSP+LRCTALEA H FFDELR+PN RLPNGR PPLFNFK
Sbjct: 334 VSRLLQYSPNLRCTALEAVTHAFFDELRDPNTRLPNGRVLPPLFNFK 380
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1609), Expect = e-178, Method: Compositional matrix adjust.
Identities = 291/359 (81%), Positives = 321/359 (89%), Gaps = 2/359 (0%)
Query: 30 NDLLKRHRPDMD--SDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGT 87
+D+L DM D+EM A V+ GN TGHII TTIGG+NG+PKQTISYMAERVVG
Sbjct: 24 DDILPEEMSDMKIRDDREMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGH 83
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147
GSFG+VFQAKCLETGETVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDE
Sbjct: 84 GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE 143
Query: 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207
L+LNLV+EYVPET++RV+KHYS +NQRMP+IYVKLYTYQIFR L+YIH GVCHRD+KP
Sbjct: 144 LYLNLVLEYVPETVHRVIKHYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKP 203
Query: 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAG 267
QNLLV+P THQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WS G
Sbjct: 204 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVG 263
Query: 268 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 327
CVLAELLLGQPLFPGE VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+
Sbjct: 264 CVLAELLLGQPLFPGERGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 323
Query: 328 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386
FHKRMP EA+DL SRLLQYSP+LRC AL+ HPFFDELR+PNARLP GR PPLFNFK
Sbjct: 324 FHKRMPAEAVDLVSRLLQYSPNLRCQALDCLTHPFFDELRDPNARLPTGRFLPPLFNFK 382
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 618 bits (1593), Expect = e-176, Method: Compositional matrix adjust.
Identities = 286/345 (82%), Positives = 317/345 (91%), Gaps = 1/345 (0%)
Query: 43 DKEMSAA-VIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 101
DKEM AA ++ GN TGHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLET
Sbjct: 37 DKEMEAATIVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLET 96
Query: 102 GETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETM 161
GETVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET+
Sbjct: 97 GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 156
Query: 162 YRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221
RV++HY+ MNQRMP+IYVKLY+YQI R LAYIH GVCHRD+KPQNLLV+P THQ+K+
Sbjct: 157 SRVIRHYNKMNQRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKI 216
Query: 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281
CDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVL ELLLGQPLFP
Sbjct: 217 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFP 276
Query: 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341
GE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL S
Sbjct: 277 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 336
Query: 342 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386
RLLQYSP+LR TALEA HPF+D++R+PN RLPNGR PPLFNFK
Sbjct: 337 RLLQYSPNLRSTALEALVHPFYDDVRDPNTRLPNGRFLPPLFNFK 381
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 615 bits (1587), Expect = e-175, Method: Compositional matrix adjust.
Identities = 283/347 (81%), Positives = 313/347 (90%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
+ DKEM A V+ GN GH+I TTIGGKNG+PKQTISYMAER VG GSFG+VFQAKCL
Sbjct: 35 IKDDKEMEAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCL 94
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQD+RYKNRELQ MRL+DHPNV++LKHCFFSTT KDEL+LNLV+E+VPE
Sbjct: 95 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPE 154
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
T++RV++HYS MNQRMPLIYVKLY+YQI R LAYIH GV HRD+KPQNLLV+P THQ+
Sbjct: 155 TVHRVIRHYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQL 214
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
KLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYT++IDIWSAGCVL ELLLGQPL
Sbjct: 215 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPL 274
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPG + VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL
Sbjct: 275 FPGASGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDL 334
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386
SRLLQYSP+LR TALEA HPFFDELR+PN RLPNGR PPLFNFK
Sbjct: 335 VSRLLQYSPNLRSTALEALVHPFFDELRDPNTRLPNGRHLPPLFNFK 381
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 395 | ||||||
| 15221476 | 407 | Shaggy-related protein kinase iota [Arab | 0.962 | 0.933 | 0.910 | 0.0 | |
| 222423077 | 407 | AT1G06390 [Arabidopsis thaliana] | 0.962 | 0.933 | 0.907 | 0.0 | |
| 15224593 | 412 | Shaggy-related protein kinase zeta [Arab | 0.964 | 0.924 | 0.905 | 0.0 | |
| 297843440 | 410 | hypothetical protein ARALYDRAFT_470656 [ | 0.969 | 0.934 | 0.907 | 0.0 | |
| 297826527 | 412 | hypothetical protein ARALYDRAFT_902112 [ | 0.964 | 0.924 | 0.902 | 0.0 | |
| 21593135 | 412 | putative shaggy-like protein kinase dzet | 0.964 | 0.924 | 0.9 | 0.0 | |
| 1225913 | 412 | shaggy-like kinase dzeta [Arabidopsis th | 0.964 | 0.924 | 0.897 | 0.0 | |
| 449463108 | 425 | PREDICTED: shaggy-related protein kinase | 0.913 | 0.849 | 0.925 | 0.0 | |
| 357452871 | 423 | Shaggy-related protein kinase [Medicago | 0.886 | 0.827 | 0.951 | 0.0 | |
| 356517324 | 419 | PREDICTED: shaggy-related protein kinase | 0.984 | 0.928 | 0.871 | 0.0 |
| >gi|15221476|ref|NP_172127.1| Shaggy-related protein kinase iota [Arabidopsis thaliana] gi|42571361|ref|NP_973771.1| Shaggy-related protein kinase iota [Arabidopsis thaliana] gi|11133004|sp|Q39012.1|KSG9_ARATH RecName: Full=Shaggy-related protein kinase iota; AltName: Full=ASK-iota gi|8927676|gb|AAF82167.1|AC068143_9 Contains a very strong similarity to a shaggy-like kinase iota from Arabidopsis thaliana gb|X99696 and contains an eukaryotic protein kinase PF|00069 domain. EST gb|N37432 comes from this gene [Arabidopsis thaliana] gi|1480078|emb|CAA68027.1| shaggy-like protein kinase iota [Arabidopsis thaliana] gi|2444277|gb|AAB71545.1| GSK3/shaggy-like protein kinase [Arabidopsis thaliana] gi|14334750|gb|AAK59553.1| putative shaggy kinase [Arabidopsis thaliana] gi|15293239|gb|AAK93730.1| putative shaggy kinase [Arabidopsis thaliana] gi|332189859|gb|AEE27980.1| Shaggy-related protein kinase iota [Arabidopsis thaliana] gi|332189860|gb|AEE27981.1| Shaggy-related protein kinase iota [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/389 (91%), Positives = 367/389 (94%), Gaps = 9/389 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLGPQP A APP Q D D LKR RP++DSDKEMSAAVI+GNDAVTGH
Sbjct: 1 MASLPLGPQPH------ALAPPLQL--HDGDALKR-RPELDSDKEMSAAVIEGNDAVTGH 51
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 52 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 111
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 112 LQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 171
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE NISYI
Sbjct: 172 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYI 231
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPT
Sbjct: 232 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPT 291
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH
Sbjct: 292 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 351
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQEV 389
PFF+ELREPNARLPNGRP PPLFNFKQE+
Sbjct: 352 PFFNELREPNARLPNGRPLPPLFNFKQEL 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|222423077|dbj|BAH19519.1| AT1G06390 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/389 (90%), Positives = 367/389 (94%), Gaps = 9/389 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLGPQP A APP Q D D LKR RP++DSDKEMSAAVI+GNDAVTGH
Sbjct: 1 MASLPLGPQPH------ALAPPLQL--HDGDALKR-RPELDSDKEMSAAVIEGNDAVTGH 51
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 52 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 111
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 112 LQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 171
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE NISYI
Sbjct: 172 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYI 231
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPG+N+VDQLVEIIKVLGTPT
Sbjct: 232 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGKNSVDQLVEIIKVLGTPT 291
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH
Sbjct: 292 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 351
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQEV 389
PFF+ELREPNARLPNGRP PPLFNFKQE+
Sbjct: 352 PFFNELREPNARLPNGRPLPPLFNFKQEL 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15224593|ref|NP_180655.1| Shaggy-related protein kinase zeta [Arabidopsis thaliana] gi|147744570|sp|Q39010.2|KSG6_ARATH RecName: Full=Shaggy-related protein kinase zeta; AltName: Full=ASK-zeta gi|3201623|gb|AAC20732.1| putative shaggy-like protein kinase dzeta [Arabidopsis thaliana] gi|17381128|gb|AAL36376.1| putative shaggy protein kinase dzeta [Arabidopsis thaliana] gi|20453108|gb|AAM19796.1| At2g30980/F7F1.19 [Arabidopsis thaliana] gi|20465727|gb|AAM20332.1| putative shaggy protein kinase dzeta [Arabidopsis thaliana] gi|330253376|gb|AEC08470.1| Shaggy-related protein kinase zeta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 723 bits (1867), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/390 (90%), Positives = 369/390 (94%), Gaps = 9/390 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLGP PQPP + AP Q PH D LKR RPD+D+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLGP-PQPP----SLAP--QPPHLHGGDSLKR-RPDIDNDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDFGSAKVLVKGEANISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
ICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTP
Sbjct: 233 ICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTP 292
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA
Sbjct: 293 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 352
Query: 360 HPFFDELREPNARLPNGRPFPPLFNFKQEV 389
HPFF+ELREPNARLPNGRP PPLFNFKQE+
Sbjct: 353 HPFFNELREPNARLPNGRPLPPLFNFKQEL 382
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843440|ref|XP_002889601.1| hypothetical protein ARALYDRAFT_470656 [Arabidopsis lyrata subsp. lyrata] gi|297335443|gb|EFH65860.1| hypothetical protein ARALYDRAFT_470656 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 722 bits (1863), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/389 (90%), Positives = 365/389 (93%), Gaps = 6/389 (1%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLG QP PP Q D D LKR RP+MDSDKEMSAAVI+GNDAVTGH
Sbjct: 1 MASLPLGHQPH-----ALAPPPPQPQLHDGDALKR-RPEMDSDKEMSAAVIEGNDAVTGH 54
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 55 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 114
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 115 LQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 174
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI
Sbjct: 175 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 234
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPT
Sbjct: 235 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPT 294
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH
Sbjct: 295 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 354
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQEV 389
PFF+ELREPNARLPNGRP PPLFNFKQE+
Sbjct: 355 PFFNELREPNARLPNGRPLPPLFNFKQEL 383
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297826527|ref|XP_002881146.1| hypothetical protein ARALYDRAFT_902112 [Arabidopsis lyrata subsp. lyrata] gi|297326985|gb|EFH57405.1| hypothetical protein ARALYDRAFT_902112 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/390 (90%), Positives = 367/390 (94%), Gaps = 9/390 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLG PQPP + AP Q PH D LKR RPDMD+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLG-HPQPP----SLAP--QPPHLHGGDALKR-RPDMDTDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDFGSAKVLVKGEANISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
ICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTP
Sbjct: 233 ICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTP 292
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA
Sbjct: 293 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 352
Query: 360 HPFFDELREPNARLPNGRPFPPLFNFKQEV 389
HPFF+ELRE NARLPNGRP PPLFNFKQE+
Sbjct: 353 HPFFNELREANARLPNGRPLPPLFNFKQEL 382
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|21593135|gb|AAM65084.1| putative shaggy-like protein kinase dzeta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1860), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/390 (90%), Positives = 369/390 (94%), Gaps = 9/390 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLGP PQPP + AP Q PH D LKR RPD+D+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLGP-PQPP----SLAP--QPPHLHGGDSLKR-RPDIDNDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDFGSAKVLVKGEANISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
ICSRYYR+PELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VD+LVEIIKVLGTP
Sbjct: 233 ICSRYYRSPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDRLVEIIKVLGTP 292
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA
Sbjct: 293 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 352
Query: 360 HPFFDELREPNARLPNGRPFPPLFNFKQEV 389
HPFF+ELREPNARLPNGRP PPLFNFKQE+
Sbjct: 353 HPFFNELREPNARLPNGRPLPPLFNFKQEL 382
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1225913|emb|CAA64408.1| shaggy-like kinase dzeta [Arabidopsis thaliana] gi|1669653|emb|CAA70483.1| serine/threonine kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1851), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/390 (89%), Positives = 367/390 (94%), Gaps = 9/390 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLGP PQPP + AP Q PH D LKR RPD+D+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLGP-PQPP----SLAP--QPPHLHGGDSLKR-RPDIDNDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRD+KPQNLLVDP THQ KLCDFGSAKVLVKGE NISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDIKPQNLLVDPHTHQCKLCDFGSAKVLVKGEPNISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
ICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTP
Sbjct: 233 ICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTP 292
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA
Sbjct: 293 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 352
Query: 360 HPFFDELREPNARLPNGRPFPPLFNFKQEV 389
HPFF+ELREPNARLPNGRP PPLFNFKQE+
Sbjct: 353 HPFFNELREPNARLPNGRPLPPLFNFKQEL 382
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463108|ref|XP_004149276.1| PREDICTED: shaggy-related protein kinase zeta-like [Cucumis sativus] gi|449505439|ref|XP_004162470.1| PREDICTED: shaggy-related protein kinase zeta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 708 bits (1828), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/364 (92%), Positives = 349/364 (95%), Gaps = 3/364 (0%)
Query: 29 DNDLLK--RHRPD-MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVV 85
DND L HR MD+DKEMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVV
Sbjct: 31 DNDRLNLNSHRASAMDTDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVV 90
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145
G+GSFGIVFQAKCLETGETVAIKKVLQD+RYKNRELQLMRLMDHPNV+SLKHCFFSTTSK
Sbjct: 91 GSGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQLMRLMDHPNVVSLKHCFFSTTSK 150
Query: 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV 205
DELFLNLVMEYVP+ MY VLKHY+SMNQRMPLIYVKLYTYQIFRGLAYIH+VPGVCHRDV
Sbjct: 151 DELFLNLVMEYVPQNMYHVLKHYNSMNQRMPLIYVKLYTYQIFRGLAYIHSVPGVCHRDV 210
Query: 206 KPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWS 265
KPQNLLVD LTHQVK+CDFGSAKVL+KGEANISYICSRYYRAPELIFGATEYTTSIDIWS
Sbjct: 211 KPQNLLVDTLTHQVKICDFGSAKVLIKGEANISYICSRYYRAPELIFGATEYTTSIDIWS 270
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325
AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPW+
Sbjct: 271 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWY 330
Query: 326 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 385
KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE N RLPN RP PPLFNF
Sbjct: 331 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREANVRLPNNRPLPPLFNF 390
Query: 386 KQEV 389
KQE+
Sbjct: 391 KQEL 394
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357452871|ref|XP_003596712.1| Shaggy-related protein kinase [Medicago truncatula] gi|355485760|gb|AES66963.1| Shaggy-related protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1824), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/350 (95%), Positives = 345/350 (98%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
MD+DKEMSA+V+ NDAVTGHIISTTIGGKNGEPK+TISYMAERVVGTGSFGIVFQAKCL
Sbjct: 46 MDTDKEMSASVVDSNDAVTGHIISTTIGGKNGEPKRTISYMAERVVGTGSFGIVFQAKCL 105
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGE VAIKKVLQD+RYKNRELQLMR+MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPE
Sbjct: 106 ETGEAVAIKKVLQDKRYKNRELQLMRVMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPE 165
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
TMYRVLKHY+++NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV
Sbjct: 166 TMYRVLKHYNNINQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 225
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 226 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 285
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPGEN VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL
Sbjct: 286 FPGENQVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 345
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEV 389
ASRLLQYSPSLRC+ALEACAHPFFDELREPNARLPNGRP PPLFNFKQE+
Sbjct: 346 ASRLLQYSPSLRCSALEACAHPFFDELREPNARLPNGRPLPPLFNFKQEL 395
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517324|ref|XP_003527338.1| PREDICTED: shaggy-related protein kinase zeta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1816), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/389 (87%), Positives = 352/389 (90%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLG P P + R DM++DK+MSA VI+GNDAVTGH
Sbjct: 1 MASLPLGHHHHHQPAAATIHPSQPPQCQPQPEVPRRSSDMETDKDMSATVIEGNDAVTGH 60
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFG+VFQAKCLETGE VAIKKVLQDRRYKNRE
Sbjct: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGVVFQAKCLETGEAVAIKKVLQDRRYKNRE 120
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE+MYRV+KHY++MNQRMPLIYV
Sbjct: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPESMYRVIKHYTTMNQRMPLIYV 180
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHT VCHRDVKPQNLLV PLTHQVKLCDFGSAKVLVKGE+NISYI
Sbjct: 181 KLYTYQIFRGLAYIHTALRVCHRDVKPQNLLVHPLTHQVKLCDFGSAKVLVKGESNISYI 240
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN VDQLVEIIKVLGTPT
Sbjct: 241 CSRYYRAPELIFGATEYTPSIDIWSAGCVLAELLLGQPLFPGENQVDQLVEIIKVLGTPT 300
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH
Sbjct: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQEV 389
PFFDELREPNARLPNG P PPLFNFKQE+
Sbjct: 361 PFFDELREPNARLPNGHPLPPLFNFKQEL 389
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 395 | ||||||
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.911 | 0.884 | 0.941 | 4.4e-187 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.906 | 0.868 | 0.941 | 1.2e-186 | |
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 0.886 | 0.921 | 0.931 | 1.6e-180 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.906 | 0.875 | 0.819 | 1.1e-165 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.901 | 0.879 | 0.824 | 2.7e-164 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.878 | 0.846 | 0.850 | 3.4e-164 | |
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.878 | 0.735 | 0.778 | 2.4e-156 | |
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.898 | 0.843 | 0.727 | 9e-148 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.886 | 0.799 | 0.709 | 2.6e-141 | |
| UNIPROTKB|Q91757 | 420 | gsk3b "Glycogen synthase kinas | 0.835 | 0.785 | 0.671 | 8.9e-125 |
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1814 (643.6 bits), Expect = 4.4e-187, P = 4.4e-187
Identities = 340/361 (94%), Positives = 352/361 (97%)
Query: 29 DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTG 88
D D LKR RP++DSDKEMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTG
Sbjct: 21 DGDALKR-RPELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTG 79
Query: 89 SFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148
SFGIVFQAKCLETGE+VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS+DEL
Sbjct: 80 SFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDEL 139
Query: 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208
FLNLVMEYVPET+YRVL+HY+S NQRMP+ YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ
Sbjct: 140 FLNLVMEYVPETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 199
Query: 209 NLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGC 268
NLLVDPLTHQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYT SIDIWSAGC
Sbjct: 200 NLLVDPLTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGC 259
Query: 269 VLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF 328
VLAELLLGQPLFPGEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF
Sbjct: 260 VLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF 319
Query: 329 HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQE 388
HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF+ELREPNARLPNGRP PPLFNFKQE
Sbjct: 320 HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQE 379
Query: 389 V 389
+
Sbjct: 380 L 380
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1810 (642.2 bits), Expect = 1.2e-186, P = 1.2e-186
Identities = 338/359 (94%), Positives = 352/359 (98%)
Query: 31 DLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSF 90
D LKR RPD+D+DKEMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSF
Sbjct: 25 DSLKR-RPDIDNDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSF 83
Query: 91 GIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150
GIVFQAKCLETGE+VAIKKVLQDRRYKNRELQLMRLMDHPNV+SLKHCFFSTT++DELFL
Sbjct: 84 GIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFL 143
Query: 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210
NLVMEYVPET+YRVLKHY+S NQRMP+ YVKLYTYQIFRGLAYIHT PGVCHRDVKPQNL
Sbjct: 144 NLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNL 203
Query: 211 LVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVL 270
LVDPLTHQ KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT+SIDIWSAGCVL
Sbjct: 204 LVDPLTHQCKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVL 263
Query: 271 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 330
AELLLGQPLFPGEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK
Sbjct: 264 AELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 323
Query: 331 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEV 389
RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF+ELREPNARLPNGRP PPLFNFKQE+
Sbjct: 324 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQEL 382
|
|
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1752 (621.8 bits), Expect = 1.6e-180, P = 1.6e-180
Identities = 326/350 (93%), Positives = 338/350 (96%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
M DKEM AAV+ G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQDRRYKNRELQLMR+MDHPNV+ LKHCFFSTTSKDELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
++YRVLKHYSS NQRMPL+YVKLY YQIFRGLAYIH V GVCHRD+KPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
K+CDFGSAK LVKGEANISYICSR+YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDF 300
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEV 389
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEV
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEV 350
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1612 (572.5 bits), Expect = 1.1e-165, P = 1.1e-165
Identities = 295/360 (81%), Positives = 325/360 (90%)
Query: 29 DNDLLKRHRPDM--DSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVG 86
D D L DM DKEM A ++ GN TGHII TTIGG+NG+PKQTISYMAERVVG
Sbjct: 21 DADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVG 80
Query: 87 TGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146
GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MRL+DHPNV+SLKHCFFSTT KD
Sbjct: 81 HGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD 140
Query: 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206
EL+LNLV+EYVPET++RV+KHY+ +NQRMPL+YVKLYTYQIFR L+YIH GVCHRD+K
Sbjct: 141 ELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIK 200
Query: 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSA 266
PQNLLV+P THQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WSA
Sbjct: 201 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSA 260
Query: 267 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 326
GCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK
Sbjct: 261 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 320
Query: 327 VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386
+FHKRMPPEA+DL SRLLQYSP+LRC AL++ HPFFDELR+PNARLPNGR PPLFNFK
Sbjct: 321 IFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFK 380
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1599 (567.9 bits), Expect = 2.7e-164, P = 2.7e-164
Identities = 295/358 (82%), Positives = 322/358 (89%)
Query: 31 DLLKRHRPDMD--SDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTG 88
D L DM DKEM A V+ GN TGHII TTIGG+NG+PKQTISYMAERVVG G
Sbjct: 19 DKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHG 78
Query: 89 SFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148
SFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL
Sbjct: 79 SFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL 138
Query: 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208
+LNLV+EYVPET++RV+KHY+ +NQRMPLIYVKLYTYQIFR L+YIH GVCHRD+KPQ
Sbjct: 139 YLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQ 198
Query: 209 NLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGC 268
NLLV+P THQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WSAGC
Sbjct: 199 NLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGC 258
Query: 269 VLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF 328
VLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F
Sbjct: 259 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF 318
Query: 329 HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386
HKRMPPEA+DL SRLLQYSP+LR AL+ HPFFDELR+PNARLPNGR PPLFNFK
Sbjct: 319 HKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFK 376
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1598 (567.6 bits), Expect = 3.4e-164, P = 3.4e-164
Identities = 296/348 (85%), Positives = 319/348 (91%)
Query: 43 DKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 102
DKEM AAV+ GN TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCLETG
Sbjct: 38 DKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETG 97
Query: 103 ETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMY 162
ETVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET+Y
Sbjct: 98 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVY 157
Query: 163 RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222
RV KHYS NQRMP+IYVKLYTYQI R LAYIH GVCHRD+KPQNLLV+P THQVKLC
Sbjct: 158 RVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLC 217
Query: 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
DFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPG
Sbjct: 218 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPG 277
Query: 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 342
E+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL SR
Sbjct: 278 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSR 337
Query: 343 LLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QEV 389
LLQYSP+LR TA+EA HPFFDELR+PN RLPNGR PPLFNFK QE+
Sbjct: 338 LLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQEL 385
|
|
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1524 (541.5 bits), Expect = 2.4e-156, P = 2.4e-156
Identities = 271/348 (77%), Positives = 313/348 (89%)
Query: 43 DKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 102
DK+M V+ G+ TG +I+TT+GG++G+PKQTISYMA+RVVGTGSFG+VFQAKCLETG
Sbjct: 102 DKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETG 161
Query: 103 ETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMY 162
E VAIKKVLQD+RYKNRELQ+MRL DHPNV+ L+H FFSTT KDEL+LNLV+EYVPET+Y
Sbjct: 162 EQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVY 221
Query: 163 RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222
R KHY+ MNQ MP+I+V+LYTYQI R L Y+H V GVCHRD+KPQNLLV+P THQ+K+C
Sbjct: 222 RASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKIC 281
Query: 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
DFGSAK+LV GE NISYICSRYYRAPELIFGATEYT +ID+WS GCV+AELLLGQPLFPG
Sbjct: 282 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPG 341
Query: 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 342
E+ +DQLVEIIK+LGTPTREEIRCMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SR
Sbjct: 342 ESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 401
Query: 343 LLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QEV 389
LLQYSP+LRCTALEACAHPFFD+LR+PN LPNGR PPLFNF QE+
Sbjct: 402 LLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQEL 449
|
|
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1443 (513.0 bits), Expect = 9.0e-148, P = 9.0e-148
Identities = 259/356 (72%), Positives = 306/356 (85%)
Query: 35 RHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVF 94
R + + D +++ +I G A GH+I TT+ G+NG+ +QT+SY++E VVGTGSFG+VF
Sbjct: 39 RDKVETDDERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVF 98
Query: 95 QAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154
QAKC ETGE VAIKKVLQD+RYKNRELQ+M+++DHPN ++LKH FFS T +E++LNLV+
Sbjct: 99 QAKCRETGEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVL 158
Query: 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214
E+VPET+ RV + YS NQ MPLIYVKLYTYQI R LAYIH G+CHRD+KPQNLLV+P
Sbjct: 159 EFVPETVNRVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNP 218
Query: 215 LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274
THQ+K+CDFGSAKVLVKGE N+SYICSRYYRAPELIFGA+EYTT+IDIWS GCV+AELL
Sbjct: 219 HTHQLKICDFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELL 278
Query: 275 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP 334
LGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PP
Sbjct: 279 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP 338
Query: 335 EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QEV 389
EA+DL R QYSP+LRCTALEAC HP FDELR+PN RLPNGRP PPLFNFK QE+
Sbjct: 339 EAVDLLCRFFQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQEL 394
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1382 (491.5 bits), Expect = 2.6e-141, P = 2.6e-141
Identities = 249/351 (70%), Positives = 298/351 (84%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
+ DK+M +I+GN +G II+T G N + +TISY AE V+GTGSFG+VFQAKCL
Sbjct: 70 LGDDKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCL 129
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ET E VAIKKVLQD+RYKNRELQ+MR++DHPNV+ LKH FFSTT KDEL+LNLV+EYVPE
Sbjct: 130 ETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPE 189
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
T+YR + Y+ MNQ MPLIY++LYTYQI R + Y+H V GVCHRD+KPQNLLV+ +TH+V
Sbjct: 190 TIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEV 249
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
K+CDFGSAK+L+ GE NISYICSRYYRAPELIFGATEYT++ID+WS GCV+AEL LG PL
Sbjct: 250 KICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPL 309
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPGE +VDQLVEIIK+LGTP REEI+ MNP Y DF+FPQIKA PWHK+F +++ PEA+DL
Sbjct: 310 FPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDL 369
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QEV 389
ASRLLQYSP+LRCTALEACAHPFFD+LR+P A LPNGR PPLF+F QE+
Sbjct: 370 ASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQEL 420
|
|
| UNIPROTKB|Q91757 gsk3b "Glycogen synthase kinase-3 beta" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 1226 (436.6 bits), Expect = 8.9e-125, P = 8.9e-125
Identities = 225/335 (67%), Positives = 280/335 (83%)
Query: 59 GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
G ++T + G+ + +Q ++Y +V+G GSFG+V+QAK +TGE VAIKKVLQD+R+
Sbjct: 34 GSKVTTVVATPGQGPDRQQEVTYTDTKVIGNGSFGVVYQAKLCDTGELVAIKKVLQDKRF 93
Query: 117 KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 175
KNRELQ+MR +DH N++ L++ F+S+ KDE++LNLV++YVPET+YRV +HYS Q +
Sbjct: 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQAL 153
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
P+IYVKLY YQ+FR LAYIH+ G+CHRD+KPQNLL+DP T +KLCDFGSAK LV+GE
Sbjct: 154 PIIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPETAVLKLCDFGSAKQLVRGEP 212
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 355
LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+ R T L
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRARTPPEAIALCSRLLEYTPTSRLTPL 332
Query: 356 EACAHPFFDELREPNARLPNGRPFPPLFNFK-QEV 389
+ACAH FFDELR+PN +LPNGR FP LFNF QE+
Sbjct: 333 DACAHSFFDELRDPNLKLPNGREFPALFNFTTQEL 367
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43289 | KSG3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7989 | 0.9392 | 0.9070 | no | no |
| P43288 | KSG1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7772 | 0.9518 | 0.9283 | no | no |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.5825 | 0.8177 | 0.8346 | yes | no |
| Q39012 | KSG9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9100 | 0.9620 | 0.9336 | yes | no |
| A8X5H5 | GSK3_CAEBR | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6187 | 0.8531 | 0.9387 | N/A | no |
| Q39010 | KSG6_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9051 | 0.9645 | 0.9247 | no | no |
| Q39011 | KSG7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9314 | 0.8860 | 0.9210 | no | no |
| Q39019 | KSG10_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7301 | 0.8911 | 0.8361 | no | no |
| P38615 | RIM11_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.5271 | 0.7898 | 0.8432 | yes | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6187 | 0.8531 | 0.9309 | yes | no |
| Q9FVS6 | KSG4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7414 | 0.8911 | 0.8380 | no | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.8242 | 0.8784 | 0.8484 | N/A | no |
| Q9WV60 | GSK3B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6696 | 0.8329 | 0.7833 | yes | no |
| P51136 | GSK3_DICDI | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6483 | 0.7772 | 0.6573 | yes | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.8105 | 0.9037 | 0.8686 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.8155 | 0.8784 | 0.8442 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.8289 | 0.8708 | 0.8369 | N/A | no |
| O04160 | KSGT_BRANA | 2, ., 7, ., 1, 1, ., 1 | 0.7392 | 0.9316 | 0.7863 | N/A | no |
| P18266 | GSK3B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6696 | 0.8329 | 0.7833 | yes | no |
| Q8VZD5 | KSG5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8472 | 0.8784 | 0.8463 | no | no |
| P49841 | GSK3B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6696 | 0.8329 | 0.7833 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSK1 | GSK1 (GSK3/SHAGGY-LIKE PROTEIN KINASE 1); glycogen synthase kinase 3/ kinase; encodes a GSK3/shaggy-like protein kinase. Gene expression is induced by NaCl and ABA but not KCl, suggesting that this gene may be involved in response to osmotic stress. This protein can interact with the BZR1 protein involved in brassinosteroid-mediated signaling in a Y2H assay and promotes BZR1 phosphorylation in protoplasts. ; May mediate extracellular signals to regulate transcription in differentiating cells (By similarity) (407 aa) | |||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | AT3G60200 | unknown protein; unknown protein; FUNCTIONS IN- molecular_function unknown; INVOLVED IN- biolog [...] (305 aa) | • | 0.923 | |||||||
 | AT3G50910 | unknown protein; unknown protein; FUNCTIONS IN- molecular_function unknown; INVOLVED IN- biolog [...] (447 aa) | • | 0.923 | |||||||
 | AT3G11150 | unknown protein; unknown protein; FUNCTIONS IN- molecular_function unknown; INVOLVED IN- biolog [...] (371 aa) | • | 0.813 | |||||||
 | LBD13 | LBD13 (LOB DOMAIN-CONTAINING PROTEIN 13); LOB DOMAIN-CONTAINING PROTEIN 13 (LBD13); FUNCTIONS I [...] (268 aa) | • | 0.690 | |||||||
 | ERA1 | ERA1 (ENHANCED RESPONSE TO ABA 1); farnesyltranstransferase/ protein farnesyltransferase; encod [...] (482 aa) | • | 0.621 | |||||||
 | PSK1 | PSK1; growth factor; Phytosulfokine 3 precursor, coding for a unique plant peptide growth facto [...] (81 aa) | • | 0.534 | |||||||
 | AT5G22310 | unknown protein; unknown protein; FUNCTIONS IN- molecular_function unknown; INVOLVED IN- biolog [...] (481 aa) | • | 0.462 | |||||||
 | AT4G20020 | unknown protein; unknown protein; EXPRESSED IN- 21 plant structures; EXPRESSED DURING- 13 growt [...] (419 aa) | • | 0.438 | |||||||
 | AT3G20930 | RNA recognition motif (RRM)-containing protein; RNA recognition motif (RRM)-containing protein; [...] (374 aa) | • | 0.438 | |||||||
 | AT4G37670 | GCN5-related N-acetyltransferase (GNAT) family protein / amino acid kinase family protein; GCN5 [...] (613 aa) | • | 0.435 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 395 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-131 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-91 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-87 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-85 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-84 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-82 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-79 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-76 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-75 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-75 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-74 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-70 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-70 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-69 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-68 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-67 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-64 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-62 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-62 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-60 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-59 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-58 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-57 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-57 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-57 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-57 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-57 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-57 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-57 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-56 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-56 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-56 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-56 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-56 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-55 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-53 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-52 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-51 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-49 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-49 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-49 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-49 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-48 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-48 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-47 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-47 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-45 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-45 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-45 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-44 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-43 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-41 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-39 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-39 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-39 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-38 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-37 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-35 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-34 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-33 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-32 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-32 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-32 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-29 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-28 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-25 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-23 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-21 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-20 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-19 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-18 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-17 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-17 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-13 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 9e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.002 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.002 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.004 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 383 bits (984), Expect = e-131
Identities = 167/315 (53%), Positives = 231/315 (73%), Gaps = 5/315 (1%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH 137
SY ++G GSFG+V++A C++T E VAIKKVLQD +YKNREL +M+ ++H N+I LK
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126
Query: 138 CFFSTTSKDE---LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+++ K +FLN+VME++P+T+++ +KHY+ N +PL VKLY+YQ+ R LAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H+ +CHRD+KPQNLL+DP TH +KLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
T YTT ID+WS GC++AE++LG P+F G+++VDQLV II+VLGTPT ++++ MNPNY D
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 374
+FP +K KVF K P +AI+ S+ L+Y P R +EA A PFFD+LR+P +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365
Query: 375 NG-RPFPPLFNFKQE 388
P LFNF
Sbjct: 366 KYIDKLPDLFNFCDA 380
|
Length = 440 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 278 bits (714), Expect = 1e-91
Identities = 111/305 (36%), Positives = 176/305 (57%), Gaps = 20/305 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y + +G+G++G+V A TG VAIKK+ L D + RE++L+R + H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I L + +D + +V E + +++V+K Q + +++ + YQI RGL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRGLK 117
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAP 248
Y+H+ V HRD+KP N+LV+ +K+CDFG A+ + E Y+ +R+YRAP
Sbjct: 118 YLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM- 307
EL+ ++ YT +IDIWS GC+ AELL +PLFPG + +DQL I++VLGTP+ E+++ +
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235
Query: 308 NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
+ ++ P+ P K+F PEAIDL ++L + P R TA EA AHP+ +
Sbjct: 236 SEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294
Query: 366 LREPN 370
L +P
Sbjct: 295 LHDPE 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 264 bits (678), Expect = 7e-87
Identities = 109/293 (37%), Positives = 170/293 (58%), Gaps = 31/293 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHPNVISLK 136
+G G++G+V++A+ +TGE VA+KK+ D + RE+ L++ + HPN++ L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 195
++ +L+L V EY LK Y + +K YQ+ RGLAY H
Sbjct: 65 DVI---HTERKLYL--VFEY----CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 252
+ + HRD+KPQN+L++ +KL DFG A+ G +Y + + +YRAPE++
Sbjct: 116 SH-RILHRDLKPQNILINR-DGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILL 171
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMNPN 310
G+ Y+T++DIWS GC+ AE++ G+PLFPG++ +DQL +I ++LGTPT E P+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
Y FP+ KV R+ PE IDL S++LQY+P+ R +A EA HP+F
Sbjct: 232 YKP-TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 260 bits (667), Expect = 3e-85
Identities = 115/293 (39%), Positives = 164/293 (55%), Gaps = 25/293 (8%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLK 136
+G G+ GIVF+AK ETGETVA+KKV R RE++ ++ HP V+ L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F + LVMEY+P + VL+ + +P VK Y + +G+AY+H
Sbjct: 66 DVFPHGSG-----FVLVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFG 253
G+ HRD+KP NLL+ +K+ DFG A++ E Y + +R+YRAPEL++G
Sbjct: 118 N-GIMHRDLKPANLLISA-DGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPELLYG 174
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 310
A +Y +D+W+ GC+ AELL G PLFPGEN ++QL + + LGTP E + + P+
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PD 233
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
Y FP+ K P ++F PEA+DL LL Y PS R +A EA HP+F
Sbjct: 234 YNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 4e-84
Identities = 110/294 (37%), Positives = 166/294 (56%), Gaps = 20/294 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKN---RELQLMRLMDHPNV 132
Y +G G++G+V++A+ TGE VAIKK+ RE++L++ ++HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I L F L LV E++ +Y+++K + +P +K Y YQ+ +GLA
Sbjct: 61 IKLLDVFRHKGD-----LYLVFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLA 112
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
+ H+ G+ HRD+KP+NLL++ +KL DFG A+ Y+ +R+YRAPEL+
Sbjct: 113 FCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 310
G Y+T +DIWS GC+ AELL +PLFPG++ +DQL +I + LGTP E
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 311 -YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
F FP+ P K+F P+A+DL S++L Y P R TA +A AHP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 250 bits (641), Expect = 7e-82
Identities = 102/291 (35%), Positives = 148/291 (50%), Gaps = 43/291 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
Y +G GSFG V+ A+ +TG+ VAIK + +DR RE+++++ + HPN++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L F +DE L LVMEY ++ +LK R+ + Y QI L
Sbjct: 61 RLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALE 111
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
Y+H+ G+ HRD+KP+N+L+D VKL DFG A+ L GE +++ + Y APE++
Sbjct: 112 YLHSK-GIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
G Y ++DIWS G +L ELL G+P FPG++ QL+E+ K +G P
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPPFPP------- 218
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ PEA DL +LL P R TA EA HPFF
Sbjct: 219 ---------------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 244 bits (626), Expect = 2e-79
Identities = 100/289 (34%), Positives = 145/289 (50%), Gaps = 39/289 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
R +G+GSFG V++AK TG+ VA+K + + RE++++R + HPN++ L
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F KD L+L VMEY L Y S + K QI RGL Y+H
Sbjct: 64 IDAF---EDKDHLYL--VMEYCEGG---DLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFGA 254
+ G+ HRD+KP+N+L+D VK+ DFG AK L+K + +++ + +Y APE++ G
Sbjct: 116 SN-GIIHRDLKPENILLDE-NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y +D+WS G +L ELL G+P F GEN +DQL I ++LG P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ + EA DL + L PS R TA E HP+F
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 2e-76
Identities = 110/296 (37%), Positives = 169/296 (57%), Gaps = 32/296 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ-LMRLMDHPNVIS 134
+ +G G+FG V+ A+ ETGE VAIKK+ + ++ + RE++ L +L +HPN++
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
LK F DEL+ V EY+ +Y+++K + ++ YQI +GLA+I
Sbjct: 63 LKEVF---RENDELYF--VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHI 115
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H G HRD+KP+NLLV VK+ DFG A+ + Y+ +R+YRAPE++ +
Sbjct: 116 HKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE-------IRCM 307
T Y++ +DIW+ GC++AEL +PLFPG + +DQL +I VLGTPT+++ +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
FRFPQ H++ PEAIDL +L++ P R TA +A HP+F
Sbjct: 234 G-----FRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 234 bits (599), Expect = 5e-75
Identities = 93/293 (31%), Positives = 159/293 (54%), Gaps = 26/293 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G V++A+ +TGE VA+KK+ + + RE++L++ + HPN++ LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
TSK + + +V EY+ + +L + +K Y Q+ GL Y+H+
Sbjct: 67 ---VTSKGKGSIYMVFEYMDHDLTGLLDSPEV---KFTESQIKCYMKQLLEGLQYLHSN- 119
Query: 199 GVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFG 253
G+ HRD+K N+L++ + +KL DFG A+ K + Y + + +YR PEL+ G
Sbjct: 120 GILHRDIKGSNILIN---NDGVLKLADFGLARPYTK-RNSADYTNRVITLWYRPPELLLG 175
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 310
AT Y +D+WS GC+LAEL LG+P+F G ++QL +I ++ G+PT E + + P
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PW 234
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ + + + + F + P A+DL +LL P R +A +A H +F
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 234 bits (599), Expect = 8e-75
Identities = 104/297 (35%), Positives = 162/297 (54%), Gaps = 25/297 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDH 129
Y + +G G++ +V++A+ ETG VAIKK+ R + RE++L++ + H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
PN+I L F K +NLV E++ + +V+K + + +K Y R
Sbjct: 62 PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRYYRAP 248
GL Y+H + HRD+KP NLL+ +KL DFG A+ +++ + +R+YRAP
Sbjct: 114 GLEYLH-SNWILHRDLKPNNLLIAS-DGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAP 171
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
EL+FGA Y +D+WS GC+ AELLL P PG++ +DQL +I + LGTPT E +
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231
Query: 309 --PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P+Y +F+ P ++F +A+DL RLL +P+ R TA +A HP+F
Sbjct: 232 SLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 2e-74
Identities = 103/291 (35%), Positives = 163/291 (56%), Gaps = 21/291 (7%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 137
VVG G++G+V + + TGE VAIKK + ++ RE++++R + H N+++LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F K L+L V EYV T+ +L+ +P V+ Y +Q+ + +AY H+
Sbjct: 68 AF---RRKGRLYL--VFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYICSRYYRAPELIFGAT 255
+ HRD+KP+N+LV + +KLCDFG A+ L A+ Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTD 313
Y +D+W+ GC++AELL G+PLFPG++ +DQL I K LG P+ +E+ NP +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 314 FRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
FP+ + + ++ A+D L+ P R T E HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 4e-70
Identities = 109/306 (35%), Positives = 169/306 (55%), Gaps = 28/306 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHP 130
Y VG+G++G V A +TG VAIKK+ + R Y REL+L++ MDH
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F +S ++ + LV + + ++K Q++ +++ YQI R
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILR 129
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAP 248
GL YIH+ G+ HRD+KP N+ V+ ++K+ DFG A+ + ++ Y+ +R+YRAP
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNE-DCELKILDFGLAR---HTDDEMTGYVATRWYRAP 184
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E++ Y ++DIWS GC++AELL G+ LFPG + +DQL I+ ++GTP E ++ ++
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244
Query: 309 P----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
NY PQ+ + +VF P AIDL ++L P R TA EA AHP+
Sbjct: 245 SESARNYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302
Query: 365 ELREPN 370
E +P
Sbjct: 303 EYHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 8e-70
Identities = 106/309 (34%), Positives = 171/309 (55%), Gaps = 31/309 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD--RRYKNRELQ-LMRLMDH 129
Y + +G G++GIV++A T E VA+KK+ D R + RE+ L L DH
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
PN++ L + + KD + LV EY+ ++ V++ + ++ + YQ+ +
Sbjct: 67 PNIVKLLNVIKAENDKD---IYLVFEYMETDLHAVIRANILED-----VHKRYIMYQLLK 118
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------YICSR 243
L YIH+ V HRD+KP N+L++ VKL DFG A+ L + E N Y+ +R
Sbjct: 119 ALKYIHS-GNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303
+YRAPE++ G+T YT +D+WS GC+L E+LLG+PLFPG + ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236
Query: 304 IRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
I + + P P ++ + +A+DL +LL ++P+ R TA EA H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295
Query: 361 PFFDELREP 369
P+ + P
Sbjct: 296 PYVAQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 1e-69
Identities = 110/326 (33%), Positives = 175/326 (53%), Gaps = 32/326 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
Y +G G++G+V A TG VAIKK+ R RE++++R H N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--REIKILRRFKHEN 64
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I + + + + +V E + +Y+++K Q + +++ + YQI RGL
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGL 119
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRA 247
YIH+ V HRD+KP NLL++ +K+CDFG A++ + Y+ +R+YRA
Sbjct: 120 KYIHSA-NVLHRDLKPSNLLLNT-NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE++ + YT +IDIWS GC+LAE+L +PLFPG++ + QL I+ VLGTP++E++ C+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237
Query: 308 -NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF-- 362
+ ++ P PW+K+F P+A+DL ++L ++P R T EA AHP+
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296
Query: 363 --FDELREPNARLPNGRPFPPLFNFK 386
D EP A PFP F
Sbjct: 297 QYHDPSDEPVAE----EPFPFDFELF 318
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 2e-68
Identities = 114/322 (35%), Positives = 183/322 (56%), Gaps = 19/322 (5%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y+ + +G G++GIV AK ET E VAIKK+ D + RE++L+R +DH NV
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I++K + + +V E + ++++++ +Q + + + + YQ+ RGL
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLK 122
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELI 251
YIH+ V HRD+KP NLL++ +K+CDFG A+ KG+ Y+ +R+YRAPEL+
Sbjct: 123 YIHSA-NVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-NPN 310
+EYTT+ID+WS GC+ AELL +PLFPG++ V QL I ++LG+P+ E++ + N
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 311 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
+ P + ++F P AIDL ++L + PS R T EA AHP+ L +
Sbjct: 241 ARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299
Query: 369 PNARLPNGRPFPPLFNFKQEVC 390
P+ PF F+F+++
Sbjct: 300 PSDEPVCQTPFS--FDFEEDAL 319
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 4e-67
Identities = 111/329 (33%), Positives = 177/329 (53%), Gaps = 32/329 (9%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRLMDHPN 131
Y +G+G++G+V A +G+ VAIKK V + REL+++R H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 132 VISLKHCFFSTTSKDELFLN--LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
+I+++ F + +VM+ + ++ ++ +S +Q + +++ + YQ+ R
Sbjct: 66 IIAIRDIL---RPPGADFKDVYVVMDLMESDLHHII--HS--DQPLTEEHIRYFLYQLLR 118
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-----ISYICSRY 244
GL YIH+ V HRD+KP NLLV+ +++ DFG A+ L Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
YRAPEL+ EYTT+ID+WS GC+ AE+L + LFPG+N V QL I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 305 RCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
+ Y P+ + PW K+F K PEA+DL S++LQ+ P R T +A H
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQEV 389
PF + +P+ + PP F+F E
Sbjct: 295 PFLAQYHDPD----DEPTCPPPFDFDFEA 319
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 1e-64
Identities = 103/291 (35%), Positives = 163/291 (56%), Gaps = 26/291 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G+V++A+ TGE VA+KK+ + + RE+ L++ ++HPN++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
S E L LV E++ LK Y SS + +K Y YQ+ +G+AY H+
Sbjct: 67 VHS-----ENKLYLVFEFLDLD----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 255
V HRD+KPQNLL+D +KL DFG A+ V + + +YRAPE++ G+
Sbjct: 118 -HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 312
+Y+T +DIWS GC+ AE++ +PLFPG++ +DQL I + LGTP + + + P+Y
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYK 234
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
FP+ KV + + +DL S++L Y P+ R +A A HP+F
Sbjct: 235 P-TFPKWARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 3e-62
Identities = 100/289 (34%), Positives = 151/289 (52%), Gaps = 25/289 (8%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMR-LMDHPNVISLKH 137
G G+F V +A+ +TG+ AIK + + +K+ RE+Q +R L HPN++ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKK--HFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL--IYVKLYTYQIFRGLAYIH 195
F + L LV E + +Y ++K ++ PL VK Y YQ+ + L ++H
Sbjct: 66 VLFDRKTGR---LALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
G+ HRD+KP+N+L+ +KL DFGS + + YI +R+YRAPE +
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-NYTDF 314
Y +DIW+ GCV E+L PLFPG N +DQ+ +I VLGTP E ++ + ++
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
FP K K+ E +DL +LL Y P R TA +A HP+F
Sbjct: 235 NFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 7e-62
Identities = 110/291 (37%), Positives = 172/291 (59%), Gaps = 23/291 (7%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKH 137
+VG GS+G+V + K ETG+ VAIKK L+ ++ RE+++++ + H N+++L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F K L+L V E+V T+ L+ Y + +++ V+ Y +QI RG+ + H+
Sbjct: 68 VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFGAT 255
+ HRD+KP+N+LV + VKLCDFG A+ L GE Y+ +R+YRAPEL+ G T
Sbjct: 119 -HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTD 313
+Y ++DIW+ GC++ E+L G+PLFPG++ +DQL IIK LG P +EI NP +
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236
Query: 314 FRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
R P++K P K F K + +DLA + L+ P R ++ + H FF
Sbjct: 237 MRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 9e-60
Identities = 121/326 (37%), Positives = 182/326 (55%), Gaps = 27/326 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y + V+G GS+G+V A TGE VAIKK+ + D RE++L+RL+ HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ +KH + ++ + +V E + +++V+K N + + + + YQ+ R L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANI---SYICSRYYRAP 248
YIHT V HRD+KP+N+L + ++K+CDFG A+V I Y+ +R+YRAP
Sbjct: 118 YIHTA-NVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 249 ELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-R 305
EL G+ ++YT +IDIWS GC+ AE+L G+PLFPG+N V QL I +LGTP+ E I R
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPF 362
N + K P F ++ P P A+ L RLL + P R TA EA A P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 363 FDELREPNARLPNGRPFPPL-FNFKQ 387
F L + R P+ +P L F F++
Sbjct: 293 FKGLAKVE-REPSAQPITKLEFEFER 317
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 2e-59
Identities = 114/306 (37%), Positives = 170/306 (55%), Gaps = 29/306 (9%)
Query: 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRLM 127
T Y+ + VG G+FG+V A+ TG+ VAIKK VL R Y REL+L++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY--RELKLLKHL 66
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
H N+ISL F S + V E + ++R+L Q +++ + YQI
Sbjct: 67 RHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQI 117
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 247
RGL Y+H+ GV HRD+KP N+L++ +K+CDFG A++ + Y+ +RYYRA
Sbjct: 118 LRGLKYVHSA-GVVHRDLKPSNILINE-NCDLKICDFGLARI--QDPQMTGYVSTRYYRA 173
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE++ +Y +DIWSAGC+ AE+L G+PLFPG++ V+Q I +LGTP + I +
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233
Query: 308 NPNYTDFRF----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
T RF P+ + P+ + F K P AIDL ++L + P R +A EA AHP+
Sbjct: 234 CSENT-LRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
Query: 364 DELREP 369
+P
Sbjct: 292 APYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 8e-58
Identities = 100/294 (34%), Positives = 165/294 (56%), Gaps = 34/294 (11%)
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHCFFS 141
G++G+V++A+ +TGE VA+KK+ ++ + RE+ ++ + HPN++++K
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 142 TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 201
+ D++++ VMEYV + +++ M Q VK Q+ G+A++H +
Sbjct: 76 SNL-DKIYM--VMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD-NWIL 128
Query: 202 HRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGATE 256
HRD+K NLL L + +K+CDFG A+ G Y + + +YRAPEL+ GA E
Sbjct: 129 HRDLKTSNLL---LNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
Y+T+ID+WS GC+ AELL +PLFPG++ +DQL +I K+LGTPT + P +++
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPG 239
Query: 317 PQIKAHPWH------KVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ K + K F + DL +RLL Y P+ R +A +A HP+F
Sbjct: 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 1e-57
Identities = 106/290 (36%), Positives = 164/290 (56%), Gaps = 24/290 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHCF 139
+G G++ V++ + TGE VA+K++ D RE+ LM+ + H N++ L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR---MPLIYVKLYTYQIFRGLAYIHT 196
T +K L LV EY M + LK Y + + VK +TYQ+ +G+A+ H
Sbjct: 67 IHTENK----LMLVFEY----MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 255
V HRD+KPQNLL++ ++KL DFG A+ + + + + +YRAP+++ G+
Sbjct: 119 -NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTD 313
Y+TSIDIWS GC++AE++ G+PLFPG N DQL++I +++GTPT ++ P Y
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
FP+ ++F P IDL RLLQ +P LR +A +A HP+F
Sbjct: 237 -TFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 1e-57
Identities = 97/293 (33%), Positives = 159/293 (54%), Gaps = 19/293 (6%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G V++A+ TG+ VA+KK + + RE+ L++++ I
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 139 FFSTTSKD-ELFLNLVMEYVPETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
K+ + L LV EY+ + + + + + +P +K + YQ+ +G+A+ H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 255
GV HRD+KPQNLLVD +K+ D G + + ++ I + +YRAPE++ G+T
Sbjct: 129 H-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y+T +DIWS GC+ AE+ QPLFPG++ + QL+ I K+LGTPT + P + R
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLR 243
Query: 316 ----FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
FPQ K + + PE +DL ++L+Y P+ R +A A HP+FD
Sbjct: 244 DWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 3e-57
Identities = 107/303 (35%), Positives = 167/303 (55%), Gaps = 29/303 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G++G+V++A+ T ET+A+KK+ ++ + RE+ L++ M H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSM-----NQRMPLIYVKLYTYQI 187
+ L+ S E L LV EY+ + KH S N R+ +K Y YQI
Sbjct: 64 VRLQDVVHS-----EKRLYLVFEYLDLDLK---KHMDSSPDFAKNPRL----IKTYLYQI 111
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYR 246
RG+AY H+ V HRD+KPQNLL+D T+ +KL DFG A+ + + + +YR
Sbjct: 112 LRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
APE++ G+ Y+T +DIWS GC+ AE++ +PLFPG++ +D+L +I ++LGTP E
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230
Query: 307 MN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
+ P+Y FP+ V + P +DL S++L+ PS R TA A H +F
Sbjct: 231 VTSLPDYKS-AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
Query: 365 ELR 367
+L
Sbjct: 289 DLG 291
|
Length = 294 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 4e-57
Identities = 102/299 (34%), Positives = 158/299 (52%), Gaps = 26/299 (8%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRLMDHPNV 132
+Y +G GS+ V++ + TG+ VA+K++ L+ RE L++ + H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
++L + + L LV EY + LK Y + + V+L+ +Q+ RGL
Sbjct: 66 VTLHDIIHTKKT-----LTLVFEY----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAP 248
AY H V HRD+KPQNLL+ ++KL DFG A+ K + +Y + + +YR P
Sbjct: 117 AYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARA--KSVPSKTYSNEVVTLWYRPP 172
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIR-- 305
+++ G+TEY+TS+D+W GC+ E+ G+PLFPG + DQL +I +VLGTPT E
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
NP + + FP P + P +LA + LQY P R +A EA HP+F
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 4e-57
Identities = 109/297 (36%), Positives = 160/297 (53%), Gaps = 32/297 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++GIV++A+ +GE VA+KKV D RE+ L+ + HPN++ LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
D +FL VMEY + + +L +M VK Q+ RGL Y+H
Sbjct: 75 VVGK-HLDSIFL--VMEYCEQDLASLL---DNMPTPFSESQVKCLMLQLLRGLQYLHE-N 127
Query: 199 GVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGAT 255
+ HRD+K NLL LT + +K+ DFG A+ ++ + + +YRAPEL+ G T
Sbjct: 128 FIIHRDLKVSNLL---LTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT 184
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI----RCMNPNY 311
YTT+ID+W+ GC+LAELL +PL PG++ ++QL II++LGTP E I + P
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDL-PLV 242
Query: 312 TDFRFPQIKAHPWHKVFHKRMP--PEA-IDLASRLLQYSPSLRCTALEACAHPFFDE 365
F P+ P++ + HK P EA + L + LL Y P R TA EA +F E
Sbjct: 243 GKFTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 6e-57
Identities = 110/306 (35%), Positives = 169/306 (55%), Gaps = 29/306 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRLMDHP 130
Y + + VG+G++G V A TGE VAIKK + R Y REL L++ M H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY--RELTLLKHMQHE 74
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F S S DE LVM Y+ + +++ H S ++ V+ YQ+
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLC 128
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAP 248
GL YIH+ G+ HRD+KP NL V+ ++K+ DFG A+ +A ++ Y+ +R+YRAP
Sbjct: 129 GLKYIHSA-GIIHRDLKPGNLAVNE-DCELKILDFGLAR---HADAEMTGYVVTRWYRAP 183
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E ++ +
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243
Query: 309 ----PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
+Y P+ + +F + P+A+DL ++L+ R TA EA HP+FD
Sbjct: 244 DKAAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301
Query: 365 ELREPN 370
R+ +
Sbjct: 302 SFRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 7e-57
Identities = 96/303 (31%), Positives = 153/303 (50%), Gaps = 46/303 (15%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMD---HPN 131
+G G++G V++A+ L TG VA+KKV R RE+ L++ ++ HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++ L + EL L LV E+V + + L +P +K Q+ RG+
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRGV 120
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
++H+ + HRD+KPQN+LV QVK+ DFG A++ A S + + +YRAPE++
Sbjct: 121 DFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
++ Y T +D+WS GC+ AEL +PLF G + DQL +I V+G P+ EE
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE-------- 229
Query: 312 TDFRFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAH 360
+P+ + P F + E +DL ++L ++P R +A EA H
Sbjct: 230 ----WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284
Query: 361 PFF 363
P+F
Sbjct: 285 PYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 1e-56
Identities = 107/306 (34%), Positives = 167/306 (54%), Gaps = 31/306 (10%)
Query: 85 VGTGSFGIVFQAKCLET--GETVAIKKV--------LQDRRYKNRELQLMR-LMDHPNVI 133
+G G++GIV A+ ET ETVAIKK+ L R REL+L+R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL--RELKLLRHFRGHKNIT 65
Query: 134 SLKHCFFSTTSK-DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L +EL+L E + ++++++ Q + + + + YQI GL
Sbjct: 66 CLYDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLK 119
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK----VLVKGEANIS-YICSRYYRA 247
YIH+ V HRD+KP NLLV+ ++K+CDFG A+ + ++ Y+ +R+YRA
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RC 306
PE++ YT +ID+WS GC+LAELL +P+F G++ VDQL +I++VLGTP E + R
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237
Query: 307 MNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
+P ++ P I P+ +F P A+DL +LL + P+ R + EA HP+
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 365 ELREPN 370
+P+
Sbjct: 297 IWHDPD 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-56
Identities = 107/300 (35%), Positives = 168/300 (56%), Gaps = 28/300 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHPNVISLK 136
VG+G++G V A TG VAIKK+ R Y REL+L++ M H NVI L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMKHENVIGLL 80
Query: 137 HCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F S D LVM ++ + +++KH R ++ YQ+ +GL YIH
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIH 135
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGA 254
G+ HRD+KP NL V+ ++K+ DFG A+ + ++ ++ Y+ +R+YRAPE+I
Sbjct: 136 AA-GIIHRDLKPGNLAVNE-DCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEVILNW 190
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----N 310
YT ++DIWS GC++AE+L G+PLF G + +DQL+EI+KV GTP++E ++ + N
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370
Y + P+ + + + P A+++ ++L R TA EA AHP+F+E +P
Sbjct: 251 YVK-KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 2e-56
Identities = 98/291 (33%), Positives = 158/291 (54%), Gaps = 25/291 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHC 138
+G GS+G+VF+ + ETG+ VAIKK ++ ++ RE+++++ + HPN+++L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
F + + L+LV EY T+ L+ + +P +K +Q + + + H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHK-H 119
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGATEY 257
HRDVKP+N+L+ Q+KLCDFG A++L + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTDFR 315
+D+W+ GCV AELL GQPL+PG++ VDQL I K LG P ++I N + F+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN-QF--FK 235
Query: 316 FPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPFF 363
I + + P A+ LQ P+ R + E HP+F
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 3e-56
Identities = 106/295 (35%), Positives = 163/295 (55%), Gaps = 34/295 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
S + L LV EY + + K++ S N + VK + +Q+ +GLA+ H+
Sbjct: 68 LHS-----DKKLTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-H 118
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISY---ICSRYYRAPELIF 252
V HRD+KPQNLL++ ++KL DFG A+ + V+ Y + + +YR P+++F
Sbjct: 119 NVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVR-----CYSAEVVTLWYRPPDVLF 172
Query: 253 GATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--P 309
GA Y+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT E ++ P
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232
Query: 310 NYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+Y + +P + V ++ DL LL +P R +A EA HP+F
Sbjct: 233 DYKPYPMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 3e-56
Identities = 102/293 (34%), Positives = 165/293 (56%), Gaps = 30/293 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN++ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ L LV E+ +++ LK + +S +PL +K Y +Q+ +GLA+ H+
Sbjct: 68 IHTENK-----LYLVFEF----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 255
V HRD+KPQNLL++ +KL DFG A+ V + + +YRAPE++ G
Sbjct: 119 -HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT--- 312
Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP + P T
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTSLP 232
Query: 313 DFR--FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
D++ FP+ + KV + + DL S++L Y P+ R +A A AHPFF
Sbjct: 233 DYKPSFPKWARQDFSKVV-PPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 2e-55
Identities = 108/317 (34%), Positives = 157/317 (49%), Gaps = 46/317 (14%)
Query: 85 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
+G G++G V++AK G+ AIKK D+ RE+ L+R + H NV+SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM-PLIYVKLYTYQIFRGLAYI 194
F K + L+ +Y +++++K + + P VK +QI G+ Y+
Sbjct: 68 VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 195 HTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSA-------KVLVKGEANISYICSRY 244
H+ V HRD+KP N+LV P VK+ D G A K L + + I +
Sbjct: 125 HS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKV 295
YRAPEL+ GA YT +IDIW+ GC+ AELL +P+F G A DQL I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 296 LGTPTREE---IRCMNPNY----TDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQY 346
LGTPT ++ I+ M P Y DF+ ++ K K + DL +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299
Query: 347 SPSLRCTALEACAHPFF 363
P+ R TA EA HP+F
Sbjct: 300 DPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 3e-55
Identities = 92/290 (31%), Positives = 134/290 (46%), Gaps = 44/290 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRLMDHPNVISLK 136
++G GSFG V+ A +TGE +A+K V L + RE++++ + HPN++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ S +++ LN+ +EYV L ++P ++ YT QI GLAY+H+
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSG---GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL---VKGEANISYICSRYYRAPELIFG 253
G+ HRD+K N+LVD VKL DFG AK L GE S + Y+ APE+I G
Sbjct: 120 -NGIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
EY + DIWS GC + E+ G+P + + I G P
Sbjct: 178 -EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-------------- 222
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P+I H + EA D + L+ P R TA E HPF
Sbjct: 223 ---PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 183 bits (465), Expect = 2e-54
Identities = 92/326 (28%), Positives = 166/326 (50%), Gaps = 38/326 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QDRRYKN--RELQLMRLMDHPNVIS 134
YM R +G GS G+VF A + + VA+KK++ + K+ RE++++R +DH N++
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 135 LKHCFFSTTSKDELFLN---------LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + S + +V EY+ + VL+ + + +L+ Y
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI----C 241
Q+ RGL YIH+ V HRD+KP N+ ++ +K+ DFG A+++ ++ Y+
Sbjct: 122 QLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL---VEIIKVLGT 298
+++YR+P L+ YT +ID+W+AGC+ AE+L G+PLF G + ++Q+ +E + V+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPW--HKVFHKRMP---PEAIDLASRLLQYSPSLRCT 353
R E+ + P++ ++ + +P PEA+D ++L ++P R T
Sbjct: 241 EDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
Query: 354 ALEACAHPFFDELREPNARLPNGRPF 379
A EA HP+ P + PF
Sbjct: 294 AEEALMHPYMSCYSCPFDEPVSLHPF 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 5e-53
Identities = 71/247 (28%), Positives = 121/247 (48%), Gaps = 40/247 (16%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHCF 139
+G G FG V+ A+ +TG+ VAIK + ++ RE+++++ ++HPN++ L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+DE L LVMEY ++ +LK ++ + QI GL Y+H+
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN- 111
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATEY 257
G+ HRD+KP+N+L+D +VKL DFG +K+L ++ + I + Y APE++ G Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD-FRF 316
+ DIWS G +L EL +L ++I+ + + +
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208
Query: 317 PQIKAHP 323
+I H
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-52
Identities = 95/292 (32%), Positives = 160/292 (54%), Gaps = 27/292 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNVIS 134
+G G++G+V++ + +TG+ VA+KK+ R ++ RE+ L++ + HPN++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L+ E L L+ E++ + + L Q M VK Y YQI +G+ +
Sbjct: 64 LQDVLM-----QESRLYLIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFC 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFG 253
H+ V HRD+KPQNLL+D +KL DFG A+ + + + +YRAPE++ G
Sbjct: 118 HS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNY 311
+ Y+T +DIWS G + AE+ +PLF G++ +DQL I ++LGTPT + + P+Y
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ FP+ K + K + + +DL ++L Y P+ R +A +A HP+F
Sbjct: 236 KN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 3e-51
Identities = 93/331 (28%), Positives = 138/331 (41%), Gaps = 46/331 (13%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHP 130
SY R +G GSFG V+ A+ + VA+K + + RE+Q++ ++HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
I + FF +DE L LVMEYV L + QI
Sbjct: 58 PNIVKLYDFF----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-------SYICSR 243
L Y+H+ G+ HRD+KP+N+L+D VKL DFG AK+L + + + +
Sbjct: 114 LEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 244 YYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGT 298
Y APE++ G + ++S DIWS G L ELL G P F GE A Q ++II L T
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358
P A P + + A DL +LL P R ++
Sbjct: 233 P-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
Query: 359 AHPFFDELREPNARLPNGRPFPPLFNFKQEV 389
+H L+ + L + + +
Sbjct: 274 SHDLLAHLKLKESDLSDLLKPDDSAPLRLSL 304
|
Length = 384 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 1e-49
Identities = 103/315 (32%), Positives = 150/315 (47%), Gaps = 51/315 (16%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV---------LQDRRYKN---------RELQLMRL 126
+G G++G V +A TG+ VAIKKV +DR+ REL++M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+ H N++ L + D F+NLVM+ M LK R+ VK Q
Sbjct: 77 IKHENIMGLVDVY---VEGD--FINLVMDI----MASDLKKVVDRKIRLTESQVKCILLQ 127
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-----VLVKGEANISYIC 241
I GL +H HRD+ P N+ ++ K+ DFG A+ + +
Sbjct: 128 ILNGLNVLHKW-YFMHRDLSPANIFINS-KGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 242 SR----------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
R +YRAPEL+ GA +Y ++D+WS GC+ AELL G+PLFPGEN +DQL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 292 IIKVLGTPTRE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 348
I ++LGTP + + + + P YT+F + K K +AIDL LL+ +P
Sbjct: 246 IFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLKLNP 301
Query: 349 SLRCTALEACAHPFF 363
R +A EA H +F
Sbjct: 302 LERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 2e-49
Identities = 93/309 (30%), Positives = 150/309 (48%), Gaps = 45/309 (14%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNVISL 135
G G+FG V++A+ ++TG VA+KK+L N RE+++++ + HPNV+ L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 136 KHCFFS---TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ + + +V Y+ + +L S+ I K Y Q+ G+
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-ENPSVKLTESQI--KCYMLQLLEGIN 129
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL---------VKGEANISY---I 240
Y+H + HRD+K N+L+D +K+ DFG A+ G Y +
Sbjct: 130 YLHE-NHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+R+YR PEL+ G YTT++DIW GCV AE+ +P+ G++ +DQL I K+ GTPT
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPT 247
Query: 301 REEIRCMNPNYTDF-RFPQIKAHPWH-----KVFHKRMPPEAIDLASRLLQYSPSLRCTA 354
E P + + + + + F ++ PE +DL S+LL P R TA
Sbjct: 248 EETW----PGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTA 302
Query: 355 LEACAHPFF 363
+A HP+F
Sbjct: 303 SDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-49
Identities = 107/292 (36%), Positives = 163/292 (55%), Gaps = 24/292 (8%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 137
VVG G++G+V + + ET E VAIKK + REL+++R + N++ LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F + +L+L V EYV + M +L+ M +P V+ Y YQ+ + + + H
Sbjct: 68 AF---RRRGKLYL--VFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK- 118
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EANIS-YICSRYYRAPELIFGAT 255
+ HRD+KP+NLL+ +KLCDFG A+ L +G AN + Y+ +R+YR+PEL+ GA
Sbjct: 119 NDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--NPNYTD 313
Y ++D+WS GC+L EL GQPLFPGE+ +DQL I KVLG E+++ NP +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 314 FRFPQIKAHP--WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
RFP + HP + + + +DL LL+ +P+ R + HP F
Sbjct: 237 LRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 7e-49
Identities = 109/330 (33%), Positives = 171/330 (51%), Gaps = 51/330 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 130
Y + +G+G+ GIV A TG+ VAIKK+ R ++N REL LM+L++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRV----LKHYSSMNQRMPLIYVKLYTY 185
N+I L + F S +E + LVME + + +V L H +RM + Y
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH-----ERMSYL-----LY 125
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
Q+ G+ ++H+ G+ HRD+KP N++V T +K+ DFG A+ Y+ +RY
Sbjct: 126 QMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
YRAPE+I G Y ++DIWS GC++ E++ G LFPG + +DQ +II+ LGTP+ E +
Sbjct: 183 YRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241
Query: 305 RCMNP---NYTDFRFPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPS 349
+ P NY + R P+ + + ++F +K +A DL S++L P
Sbjct: 242 SRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE 300
Query: 350 LRCTALEACAHPF----FDELREPNARLPN 375
R + +A HP+ +D E A P
Sbjct: 301 KRISVDDALQHPYINVWYDP-SEVEAPPPA 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-48
Identities = 103/311 (33%), Positives = 165/311 (53%), Gaps = 21/311 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y VG+G++G V A + VA+KK+ L R REL+L++ M H NV
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 133 ISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I L F TS + + LV + + ++K Q++ +V+ YQ+ RGL
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLRGL 131
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
YIH+ G+ HRD+KP N+ V+ ++++ DFG A+ + Y+ +R+YRAPE++
Sbjct: 132 KYIHSA-GIIHRDLKPSNVAVNE-DCELRILDFGLARQ--ADDEMTGYVATRWYRAPEIM 187
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
Y ++DIWS GC++AELL G+ LFPG + +DQL I++V+GTP+ E ++ ++ +
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 312 TDFRF---PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
P + K+F + P AIDL ++L R +A EA AHP+F + +
Sbjct: 248 ARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306
Query: 369 PNARLPNGRPF 379
P P P+
Sbjct: 307 PEDE-PEAEPY 316
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-48
Identities = 103/307 (33%), Positives = 157/307 (51%), Gaps = 37/307 (12%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKK---VLQD-----RRYKNRELQLMRLMDHPNVI 133
+R +G G+FG+V+ G+ VA+KK V Q+ R + REL+++ H NV+
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF--RELKMLCFFKHDNVL 62
Query: 134 S--------LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
S F +E+++ V E M L Q + +VK++ Y
Sbjct: 63 SALDILQPPHIDPF------EEIYV------VTELMQSDLHKIIVSPQPLSSDHVKVFLY 110
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI--SYICSR 243
QI RGL Y+H+ G+ HRD+KP NLLV+ +K+CDFG A+V E+ + ++
Sbjct: 111 QILRGLKYLHSA-GILHRDIKPGNLLVNS-NCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303
YYRAPE++ G+ YT+++DIWS GC+ AELL + LF ++ + QL I +LGTP+ E
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228
Query: 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAH 360
+R P V + EA+ L R+L + P R +A +A AH
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288
Query: 361 PFFDELR 367
P+ DE R
Sbjct: 289 PYLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-47
Identities = 106/316 (33%), Positives = 167/316 (52%), Gaps = 27/316 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHPNVISLK 136
VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H NVI L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 82
Query: 137 HCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F S +E + LV + + ++K Q++ +V+ YQI RGL YIH
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 137
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ + HRD+KP NL V+ ++K+ DFG A+ + Y+ +R+YRAPE++
Sbjct: 138 SA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 193
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 311
Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ ++ NY
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371
Q+ + VF P A+DL ++L R TA +A AH +F + +P+
Sbjct: 254 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 311
Query: 372 RLPNGRPFPPLFNFKQ 387
P P+ F +
Sbjct: 312 E-PVADPYDQSFESRD 326
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 1e-47
Identities = 97/308 (31%), Positives = 166/308 (53%), Gaps = 23/308 (7%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+Y+ +G G++ V++ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
++L + S L LV EY+ + + + L + + + VKL+ +Q+ RGL
Sbjct: 67 VTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLN 118
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISYICSRYYRAPE 249
Y H V HRD+KPQNLL++ ++KL DFG A+ + K +N + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSN--EVVTLWYRPPD 174
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 307
++ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT E +
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367
N + + +P+ +A H R+ + +L S+LLQ+ R +A EA HP+F L
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293
Query: 368 EPNARLPN 375
E +LP+
Sbjct: 294 ERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 7e-46
Identities = 98/298 (32%), Positives = 164/298 (55%), Gaps = 21/298 (7%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
++L + S L LV EY+ + + + + ++ M + VK++ YQI RGLA
Sbjct: 67 VTLHDIVHTDKS-----LTLVFEYLDKDLKQYMDDCGNI---MSMHNVKIFLYQILRGLA 118
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
Y H V HRD+KPQNLL++ ++KL DFG A+ V + + + + +YR P+++
Sbjct: 119 YCHRRK-VLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 310
G++EY+T ID+W GC+ E+ G+PLFPG D+L I ++LGTPT E ++ N
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236
Query: 311 -YTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ ++ FP+ K P + H R+ E I+L ++ LQY R +A EA H +F L
Sbjct: 237 EFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-45
Identities = 85/287 (29%), Positives = 131/287 (45%), Gaps = 46/287 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+G G FG V++A+ TG+ VAIK + L+ + K E+Q+++ HPN++
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ KDEL+ +VME+ ++ +LK NQ + + ++ +GL Y+H+
Sbjct: 66 YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 198 PGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
G+ HRD+K N+L LT +VKL DFG + L +A + + + Y+ APE+I G
Sbjct: 118 -GIIHRDIKAANIL---LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K 172
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y DIWS G EL G+P + + L +I G P R
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG-------------LR 218
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
P W F D + LQ +P R TA + HPF
Sbjct: 219 NP----EKWSDEFK--------DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 99/297 (33%), Positives = 162/297 (54%), Gaps = 25/297 (8%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
++L H T E L LV EY+ + + L + ++ M + VK++ +Q+ RGL+
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLS 117
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISYICSRYYRAPE 249
Y H + HRD+KPQNLL++ ++KL DFG A+ V K +N + + +YR P+
Sbjct: 118 YCHKRK-ILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSN--EVVTLWYRPPD 173
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CM 307
++ G+TEY+T ID+W GC+L E+ G+P+FPG ++L I ++LGTPT E
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233
Query: 308 NPNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
N + + FPQ +A P + H R+ + IDL S LL Y R +A A H +F
Sbjct: 234 NEEFRSYLFPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 9e-45
Identities = 102/299 (34%), Positives = 159/299 (53%), Gaps = 26/299 (8%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNV 132
SY+ +G GS+ V++ G+ VA+K + RE L++ + H N+
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY---VKLYTYQIFR 189
+ L + + L V EY M+ L Y M Q ++ V+L+ +Q+ R
Sbjct: 66 VLLHDIIHTKET-----LTFVFEY----MHTDLAQY--MIQHPGGLHPYNVRLFMFQLLR 114
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 248
GLAYIH + HRD+KPQNLL+ L ++KL DFG A+ + + S + + +YR P
Sbjct: 115 GLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCM 307
+++ GAT+Y++++DIW AGC+ E+L GQP FPG + +QL +I VLG PT + +
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232
Query: 308 N--PNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ PNY F K V+ + PP+A DLAS++L P R +A +A HP+F
Sbjct: 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 2e-44
Identities = 88/292 (30%), Positives = 138/292 (47%), Gaps = 55/292 (18%)
Query: 85 VGTGSFGIVFQAKCLETGETVAI----KKVLQDRR---YKNRELQLMRLMDHPNVISLKH 137
+G GSFG V + +TG+ A+ KK + R+ + E ++ ++HP ++ L +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 138 CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F + E L LV+EY P E ++ L ++ + Y +I L Y+H
Sbjct: 61 AF-----QTEEKLYLVLEYAPGGE-LFSHLSKEGRFSEER----ARFYAAEIVLALEYLH 110
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGA 254
++ G+ +RD+KP+N+L+D H +KL DFG AK L + + C + Y APE++ G
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y ++D WS G +L E+L G+P F E+ ++ E I
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFF 363
RFP + + PEA DL S LLQ P+ R + A AHPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 4e-43
Identities = 91/303 (30%), Positives = 150/303 (49%), Gaps = 39/303 (12%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 137
+G G++G V++A+ +TGE VA+KKV D + RE++++R ++H N+++LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 138 CFFSTTS-----KDELFLNLVMEYVPETMYRVLK----HYSSMNQRMPLIYVKLYTYQIF 188
KD+ LV EY+ + +L+ H+S + +K + Q+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-------IKSFMKQLL 126
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYICSRYYR 246
GL Y H HRD+K N+L++ Q+KL DFG A++ E+ + + + +YR
Sbjct: 127 EGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
PEL+ G Y +ID+WS GC+L EL +P+F + QL I ++ G+P
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA---- 240
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKR-------MPPEAIDLASRLLQYSPSLRCTALEACA 359
+ P+ + P K + +R +P A+DL +L PS RCTA EA
Sbjct: 241 VWPDVI--KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298
Query: 360 HPF 362
P+
Sbjct: 299 SPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 90/300 (30%), Positives = 143/300 (47%), Gaps = 30/300 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH- 137
+G G+FG VF+A+ +T + VA+KKVL + + RE+++++L+ H NV++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 138 CFFSTT--SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
C T ++ + LV E+ + +L S+ N + L +K + GL YIH
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLL---SNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV--KGEANISY---ICSRYYRAPEL 250
+ HRD+K N+L+ +KL DFG A+ K Y + + +YR PEL
Sbjct: 137 R-NKILHRDMKAANILITK-DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E + P
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE----VWPG 250
Query: 311 ------YTDFRFPQ-IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ PQ K ++ P A+DL +LL P+ R A A H FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 6e-41
Identities = 77/293 (26%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y + +G GSFG V+ + G+ +K++ ++R E+++++ ++HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I F +++ L +VMEY + + +K + P + + Q+ L
Sbjct: 62 IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPEL 250
Y+H+ + HRD+KPQN+ + VKL DFG +KVL + + + + YY +PEL
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
Y DIWS GCVL EL + F GEN + +L K+L + + +
Sbjct: 175 CQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KGQYPPIPSQ 226
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
Y E +L S LLQ P R + + PF
Sbjct: 227 Y---------------------SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 90/320 (28%), Positives = 136/320 (42%), Gaps = 77/320 (24%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRE-LQLMRLMDH 129
+ +++G GSF V AK ET + AI K+L R+ Y E L RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P +I L + F +DE L V+EY P + + ++ Y S++++ + Y +I
Sbjct: 62 PGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEIL 112
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICSRY 244
L Y+H+ G+ HRD+KP+N+L+D H +K+ DFG+AKVL
Sbjct: 113 LALEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 245 -----------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
Y +PEL+ S D+W+ GC++ ++L G+P F G N
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 347
+I+K ++ FP PP+A DL +LL
Sbjct: 230 TFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLD 260
Query: 348 PSLRCTALEAC----AHPFF 363
P R E AHPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 90/290 (31%), Positives = 140/290 (48%), Gaps = 48/290 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---------NRELQLMRLMDHPNVI 133
++G+GSFG V++ L+ G+ A+K+V + +E+ L+ + HPN++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ T ++E L + +E VP ++ ++LK Y S + P+I +LYT QI GL
Sbjct: 66 Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE--PVI--RLYTRQILLGLE 116
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
Y+H HRD+K N+LVD VKL DFG AK +V+ S+ S Y+ APE+I
Sbjct: 117 YLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
Y + DIWS GC + E+ G+P + + ++ + + K+ + I
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
P H + EA D + LQ PSLR TA E HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-39
Identities = 100/303 (33%), Positives = 158/303 (52%), Gaps = 28/303 (9%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRLMDHPNV 132
SY +G GS+ V++ K G+ VA+K + LQ+ RE L++ + H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ L + + L LV EYV + + + KH ++ VKL+ +Q+ RGL
Sbjct: 66 VLLHDIIHTKET-----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPEL 250
+YIH + HRD+KPQNLL+ T ++KL DFG A+ V + + + +YR P++
Sbjct: 117 SYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMN- 308
+ G+TEY+T +D+W GC+ E++ G FPG + DQL I VLGTP + ++
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234
Query: 309 -PNYTDFRFPQIKA----HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P++ RF W+K+ + A DLAS+LLQ P R +A A +H +F
Sbjct: 235 LPHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQAALSHEYF 291
Query: 364 DEL 366
+L
Sbjct: 292 SDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 9e-39
Identities = 101/314 (32%), Positives = 164/314 (52%), Gaps = 35/314 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 130
Y + +G+G+ GIV A G VA+KK+ R ++N REL L++ ++H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+ISL + F S +E + LVME + + +V+ H ++RM + YQ+
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLC 134
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 135 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+I G Y ++DIWS GC++ EL+ G +F G + +DQ ++I+ LGTP+ E + + P
Sbjct: 193 VILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 310 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 355
NY + R PQ + ++F + P +A DL S++L P R +
Sbjct: 252 TVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310
Query: 356 EACAHPFFDELREP 369
EA HP+ +P
Sbjct: 311 EALRHPYITVWYDP 324
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-38
Identities = 87/292 (29%), Positives = 142/292 (48%), Gaps = 24/292 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLM---DHPN 131
+G G++G V++A+ +G VA+K V R + RE+ L++ + DHPN
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++ L ++ + E + LV E+V + + L +P +K Q RGL
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGL 121
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
++H + HRD+KP+N+LV QVKL DFG A++ A + + +YRAPE++
Sbjct: 122 DFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
+T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++ +
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTL 237
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
F P V + L +L ++P R +A A HPFF
Sbjct: 238 PRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 94/296 (31%), Positives = 142/296 (47%), Gaps = 59/296 (19%)
Query: 88 GSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRLMDHPNVISLKHCFF 140
G++G VF AK TG+ AIK + D KN+ E ++ P V+ L ++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60
Query: 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
S K L+L VMEY+P + +L++ S+++ + ++Y +I L Y+H+ G
Sbjct: 61 SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISY--------ICSRYYRAPEL 250
+ HRD+KP N+L+D H +KL DFG +KV LV+ + N++ + + Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
I G ++ ++D WS GC+L E L+G P F GE EEI N
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP----------------EEI-FQNIL 214
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFF 363
+P+ + EAIDL S+LL P R A E HPFF
Sbjct: 215 NGKIEWPEDV----------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-36
Identities = 101/314 (32%), Positives = 166/314 (52%), Gaps = 35/314 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 130
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+ISL + F S +E + LVME + + +V++ ++RM + YQ+
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYLL-----YQMLC 130
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 131 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 310 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 355
NY + R P+ + K+F + P +A DL S++L P+ R +
Sbjct: 248 TVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 356 EACAHPFFDELREP 369
EA HP+ + +P
Sbjct: 307 EALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 101/326 (30%), Positives = 168/326 (51%), Gaps = 41/326 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 130
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+I L + F S +E + +VME + + +V++ ++RM + YQ+
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYLL-----YQMLC 137
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 310 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 355
Y + R P+ + + K+F + P +A DL S++L S R +
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 356 EACAHPFFD------ELREPNARLPN 375
EA HP+ + E P ++P+
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPD 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 83/292 (28%), Positives = 138/292 (47%), Gaps = 50/292 (17%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRLMDHPNVISLKHC 138
+G G+FG V+ A L+TGE +A+K++ +QD K E++++ L+ HPN++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ ++++ + MEY T+ +L+H +++ + +++YT Q+ GLAY+H+
Sbjct: 65 YGVEVHREKV--YIFMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLHS- 117
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-----GEANISYICSRYYRAPELIF 252
G+ HRD+KP N+ +D +KL DFG A L GE S + Y APE+I
Sbjct: 118 HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 253 GAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
G + + DIWS GCV+ E+ G+ + + Q++ + P
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP---------- 226
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
P ++ PE D R L+ P R TA E HPF
Sbjct: 227 -----IPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 6e-36
Identities = 83/292 (28%), Positives = 130/292 (44%), Gaps = 54/292 (18%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHC 138
V+G GS G+V++ + TG+ A+KK+ D + R EL+ +R + P V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F+ +++V+EY+ ++ +LK + + + + QI +GL Y+HT
Sbjct: 68 FYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHTK 118
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAPELIF 252
+ HRD+KP NLL++ +VK+ DFG +KVL N C+ + Y +PE I
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPN 310
G + Y+ + DIWS G L E LG+ P P +L++ I C P
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPP 220
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
+ PE D S LQ P R +A E HPF
Sbjct: 221 P----SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 54/291 (18%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM---------DHPNVIS 134
++G G+FG+V++ LETG+ VAIK++ K +E L +M HPN++
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQI---SLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ L +++EY ++ +++K + + + V +Y YQ+ +GLAY
Sbjct: 64 YIGSI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAY 114
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIF 252
+H GV HRD+K N+L VKL DFG A L + S + + Y+ APE+I
Sbjct: 115 LHE-QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
+ +T+ DIWS GC + ELL G P + N + L I++ + +
Sbjct: 173 M-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-------------DDHP- 217
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P + + PE D + Q P+LR TA + HP+
Sbjct: 218 --PLP------------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 97/294 (32%), Positives = 157/294 (53%), Gaps = 27/294 (9%)
Query: 85 VGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------RELQLMRLMD---HPNVIS 134
+G G++G VF+A+ L+ G VA+K+V + RE+ ++R ++ HPNV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 135 L-KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L C S T + E L LV E+V + + L +P +K +Q+ RGL +
Sbjct: 69 LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
+H+ V HRD+KPQN+LV + Q+KL DFG A++ A S + + +YRAPE++
Sbjct: 126 LHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ P D
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR--D 236
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLL----QYSPSLRCTALEACAHPFF 363
P+ H ++ + +L LL ++P+ R +A A +HP+F
Sbjct: 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 74/291 (25%), Positives = 124/291 (42%), Gaps = 47/291 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKH 137
+G G+ G+V + TG+ +A+K + + ++ REL ++ + P ++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F++ +++ MEY+ K + R+P + + +GL Y+H
Sbjct: 67 AFYNNGD-----ISICMEYMDGGSLD--KILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 257
+ HRDVKP N+LV+ Q+KLCDFG + LV A +++ + Y APE I G +Y
Sbjct: 120 HKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIRCMNPNYT 312
+ DIWS G L EL G+ +P EN + L I+ P
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP--- 221
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P++ + + P+ D + L P R + E HPF
Sbjct: 222 ----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 2e-32
Identities = 104/316 (32%), Positives = 158/316 (50%), Gaps = 44/316 (13%)
Query: 85 VGTGSFGIVFQAKCLE--TGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFF 140
VG G++G V++AK + A+K++ RE+ L+R + HPNVISL+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQR---MPLIYVKLYTYQIFRGLAYIH 195
S + + L+ +Y ++ ++K + S N++ +P VK YQI G+ Y+H
Sbjct: 69 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 196 TVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVL---VKGEANIS-YICSRYYRAP 248
V HRD+KP N+LV P +VK+ D G A++ +K A++ + + +YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 299
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244
Query: 300 TR---EEIRCMNPNYT---DFR------FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 347
E+I+ M + T DFR IK HKV + +A L +LL
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLLTMD 301
Query: 348 PSLRCTALEACAHPFF 363
P R T+ +A P+F
Sbjct: 302 PIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 102/314 (32%), Positives = 160/314 (50%), Gaps = 40/314 (12%)
Query: 85 VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFF 140
VG G++G V++AK + + A+K++ RE+ L+R + HPNVI+L+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQR---MPLIYVKLYTYQIFRGLAYIH 195
S + + + L+ +Y ++ ++K + S N++ +P VK YQI G+ Y+H
Sbjct: 69 SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 196 TVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVL---VKGEANIS-YICSRYYRAP 248
V HRD+KP N+LV P +VK+ D G A++ +K A++ + + +YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 299
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244
Query: 300 TR---EEIRCMNPNY----TDFRFPQIKAHPWHKVFHK-RMPPEA--IDLASRLLQYSPS 349
E+IR M P Y DFR K K ++ P++ L +LL P+
Sbjct: 245 ADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303
Query: 350 LRCTALEACAHPFF 363
R T+ +A P+F
Sbjct: 304 KRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 83/296 (28%), Positives = 137/296 (46%), Gaps = 60/296 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRLMDHPNVISL 135
+ +GTGSFG V + +G+ A+K K+++ ++ + E ++++ + HP +++L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F +D+ L LVMEYVP E L + + R P + Y Q+ L Y
Sbjct: 67 YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H++ + +RD+KP+NLL+D + +K+ DFG AK + +C + Y APE+I
Sbjct: 117 LHSL-DIVYRDLKPENLLLDSDGY-IKITDFGFAKRVKG---RTYTLCGTPEYLAPEIIL 171
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
Y ++D W+ G ++ E+L G P F +N Q+ E K+L
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYE--KILE--------------G 213
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 363
RFP P+A DL LLQ + R L+ HP+F
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 89/291 (30%), Positives = 133/291 (45%), Gaps = 58/291 (19%)
Query: 88 GSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLM---DHPNVISLKHCF 139
G+FG V+ AK TG+ AIK ++ + N + + +M + P V L +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63
Query: 140 FSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+S SKD L+L VMEY+ ++ + L +P + K Y ++ G+ +H
Sbjct: 64 YSFQSKDYLYL--VMEYLNGGDCASLIKTLGG-------LPEDWAKQYIAEVVLGVEDLH 114
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
G+ HRD+KP+NLL+D H +KL DFG ++ G N ++ + Y APE I G
Sbjct: 115 Q-RGIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
+ D WS GCV+ E L G P F E D + + I R +N
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNI---------LSRRIN------- 211
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 363
W + + PEA+DL +RLL P+ R A E +HPFF
Sbjct: 212 --------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 56/292 (19%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVL---QDRRYKNRELQLMRLMDHPNVISLKHCFF 140
+G G+ G V++A TG+ VAIKK+ Q++ E+ +M+ HPN++ +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 141 STTSKDELFLNLVMEYVPETMYR------VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
DEL+ +VMEY M + +++ MN+ + YV ++ +GL Y+
Sbjct: 86 ---VGDELW--VVMEY----MDGGSLTDIITQNFVRMNEPQ-IAYVCR---EVLQGLEYL 132
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEAN-ISYICSRYYRAPELI 251
H+ V HRD+K N+L L+ VKL DFG A L K ++ S + + Y+ APE+I
Sbjct: 133 HSQ-NVIHRDIKSDNIL---LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
+Y +DIWS G + E+ G+P + E + L I G P +
Sbjct: 189 KR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKN-------- 238
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
W F D ++ L P R +A E HPF
Sbjct: 239 ---------PEKWSPEF--------KDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 75/288 (26%), Positives = 121/288 (42%), Gaps = 49/288 (17%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCFFS 141
+G GS+G V++A ETG+ VAIK V + + +E+ +++ D P ++ +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 142 TTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
T L +VMEY V + M N+ + + YQ +GL Y+H+
Sbjct: 70 NTD-----LWIVMEYCGAGSVSDIM-------KITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFGAT 255
HRD+K N+L++ Q KL DFG + L A + I + ++ APE+I
Sbjct: 118 N-KKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y DIWS G E+ G+P + + + + I P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KP------ 215
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P + P ++ PE D + L P R +A++ HPF
Sbjct: 216 -PPTLSDP------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 70/240 (29%), Positives = 112/240 (46%), Gaps = 22/240 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLM---RLMDHPNVISL 135
++G G++G V++ K + TG VA+K + D + RE+ L+ R PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ L ++MEY R L + ++ Y+ + ++ L YIH
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-ISYICSRYYRAPELIFGA 254
V GV HRD+K N+LV T VKLCDFG A +L + + +++ + Y+ APE+I
Sbjct: 119 KV-GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y T DIWS G + E+ G P + +A ++ I K P R E + +F
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--SKPPRLEDNGYSKLLREF 234
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 50/293 (17%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHPNVISLKH 137
+G G FG V K T A+K V + + + E +++ +HP ++ L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 138 CFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F KD+ ++ ++MEY ++ +L+ ++ + Y + Y+H
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYT----ARFYIACVVLAFEYLHN 111
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
G+ +RD+KP+NLL+D VKL DFG AK L G+ ++ + Y APE+I
Sbjct: 112 R-GIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG- 168
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
Y S+D WS G +L ELL G+P F GE+ D + +I N F
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKLE---F 215
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 364
P + A DL +LL+ +P R L+ H +F+
Sbjct: 216 PNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 63/236 (26%), Positives = 110/236 (46%), Gaps = 44/236 (18%)
Query: 82 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+ +G G+FG V++ VA+K + +D + RE ++MR +DHPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRG 190
+ L T ++ L +VMEY+P L Y + + + L + + QI RG
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---- 246
+ Y+ + HRD+ +N LV VK+ DFG ++ L + YY+
Sbjct: 116 MEYLESKN-FIHRDLAARNCLVGE-NLVVKISDFGLSRDLYDDD---------YYKVKGG 164
Query: 247 -------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
APE + ++T+ D+WS G +L E+ LG+ +PG + +++E +K
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 82/297 (27%), Positives = 138/297 (46%), Gaps = 51/297 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNV 132
+ +GTG+F +QA+ ++TG +A+K+V R + +E++LM ++HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I + T +D F NL +E++ ++ +L Y + + + + YT Q+ RGL
Sbjct: 66 IRM----LGATCEDSHF-NLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGL 116
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-----GEANISYICSRYYR 246
+Y+H + HRDVK NLL+D ++++ DFG+A L GE + + +
Sbjct: 117 SYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
APE++ G +Y S D+WS GCV+ E+ +P + E + L I K I
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IAS 225
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P I H + P D+ R L+ P R + E HP F
Sbjct: 226 ATTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISLKH 137
+G GSFG V + + G+ + K++ ++++ E+ ++R + HPN++
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH- 195
+++ L +VMEY + ++++ + + ++ Q+ L H
Sbjct: 67 RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 196 -TVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPE 249
+ PG V HRD+KP N+ +D + VKL DFG AK+L G + +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ + Y DIWS GC++ EL P F N QL IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 89/308 (28%), Positives = 143/308 (46%), Gaps = 67/308 (21%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYK-----NRELQLMR 125
++ ++G+GSFG V+ +GE +A+K+V +DR+ RE+ L++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYT 184
+ H N++ S D LN+ +EYVP ++ +L +Y + + + V+ +
Sbjct: 62 ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI------- 237
QI +GL Y+H G+ HRD+K N+LVD +K+ DFG +K K EAN
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISDFGISK---KLEANSLSTKTNG 167
Query: 238 ---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
S S ++ APE++ T YT DIWS GC++ E+L G+ FP QL I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFK 223
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354
+ + P+I ++ + EAID + + + R TA
Sbjct: 224 IGENAS----------------PEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258
Query: 355 LEACAHPF 362
E HPF
Sbjct: 259 AELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 80/309 (25%), Positives = 130/309 (42%), Gaps = 79/309 (25%)
Query: 82 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+ +G G+FG V++ K + VA+K + +D + RE ++MR +DHPNV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
+ L T ++ L+ +VMEY+ L Y ++ L + + QI RG+
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + + HRD+ +N LV VK+ DFG ++ L + YYR
Sbjct: 116 EYLESKNFI-HRDLAARNCLVGE-NLVVKISDFGLSRDLYDDD---------YYRKRGGK 164
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP 299
APE + ++T+ D+WS G +L E+ LG+ +PG + ++++E +K
Sbjct: 165 LPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLK----- 217
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
+R PQ PPE DL + P R T
Sbjct: 218 ------------NGYRLPQP----------PNCPPELYDLMLQCWAEDPEDRPT------ 249
Query: 360 HPFFDELRE 368
F EL E
Sbjct: 250 ---FSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 94/313 (30%), Positives = 143/313 (45%), Gaps = 54/313 (17%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 137
VG G +G VF AK +TGE VA+K++ L + R+ E ++ ++ L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F +D+ +L L MEYVP +R +L + +++ + + Y ++F + +H
Sbjct: 69 AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ G HRD+KP+N L+D H +KL DFG +K +V AN S + S Y APE++ G
Sbjct: 120 L-GYIHRDLKPENFLIDASGH-IKLTDFGLSKGIVT-YAN-SVVGSPDYMAPEVLRG-KG 174
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
Y ++D WS GC+L E L G P F G + + T R P Y D RF
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------PVYDDPRF 227
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-----DELREPNA 371
+ EA DL ++L+ + + HPFF +ELRE
Sbjct: 228 --------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKP 273
Query: 372 RLPNGRPFPPLFN 384
PF P
Sbjct: 274 ------PFVPELE 280
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 93/344 (27%), Positives = 139/344 (40%), Gaps = 86/344 (25%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----LM---DHPNVISLK 136
V+G G+FG V+ + +TG+ A+K + + K ++ +R ++ D P ++ L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 137 HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ F +DE L LVMEY+P + +L P + Y ++ L +H
Sbjct: 67 YYSF----QDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH 118
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY----------- 244
+ G HRD+KP N+L+D H +KL DFG K + K + Y+ +
Sbjct: 119 KL-GFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 245 -------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
Y APE++ G T Y D WS G +L E+L G P F +
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234
Query: 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 345
L E T +I +N RFP + PEAIDL RLL
Sbjct: 235 ---LQE--------TYNKI--INWK-ESLRFPP----------DPPVSPEAIDLICRLLC 270
Query: 346 YSPSLRCTALEACAHPFF-----DELREPNARLPNGRPFPPLFN 384
+ E +HPFF + LRE PF P +
Sbjct: 271 DPEDRLGSFEEIKSHPFFKGIDWENLRETKP------PFVPELS 308
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR---ELQLMRLMDHPN 131
+ E+ +G G F +V++A CL G VA+KKV + D + + E+ L++ +DHPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
VI F + LN+V+E + R++KH+ + +P + Y Q+
Sbjct: 64 VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 249
L ++H+ + HRD+KP N+ + T VKL D G + K A S + + YY +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
I Y DIWS GC+L E+ Q F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 53/295 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVI 133
+++G G+FG V+ ++TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
C +D+ L++ MEY+P ++ LK Y ++ + + + YT QI G+
Sbjct: 68 QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICSRYYRAP 248
Y+H+ + HRD+K N+L D VKL DFG++K L G S + Y+ +P
Sbjct: 119 YLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E+I G Y D+WS GC + E+L +P + + + I K+ PT
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 225
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
PQ+ +H + P+A + R + R +A E H F
Sbjct: 226 --------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 79/303 (26%), Positives = 139/303 (45%), Gaps = 53/303 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------------ELQLM 124
++ ++G G++G V+ A + TGE +A+K+V R E++ +
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLY 183
+ +DH N++ E +L++ +EYVP ++ L+ Y +++ V+ +
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV---LVKGEANISYI 240
T Q+ GLAY+H+ G+ HRD+K NLLVD K+ DFG +K + + N+S
Sbjct: 114 TEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 241 CSRYYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
S ++ APE+I ++ Y+ +DIWS GCV+ E+ G+ + E A+ + ++
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL------- 224
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
+ A P + P A+D + +P R TA E
Sbjct: 225 ----------------GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
Query: 360 HPF 362
HPF
Sbjct: 269 HPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 46/293 (15%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHC 138
V+G G+ +V+ A CL E VAIK++ ++ + +E+Q M +HPNV+ +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F DEL+ LVM Y+ ++ ++K Y +I L ++ +GL Y+H+
Sbjct: 67 SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120
Query: 197 VPGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKVLVKG-----EANISYICSRYYRAPEL 250
G HRD+K N+L+ VK+ DFG + L G + +++ + + APE+
Sbjct: 121 -NGQIHRDIKAGNILLG--EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ Y DIWS G EL G + + L+ ++ N
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ-------------ND- 223
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P ++ +K + K + S LQ PS R TA E H FF
Sbjct: 224 -----PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-26
Identities = 89/313 (28%), Positives = 139/313 (44%), Gaps = 57/313 (18%)
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ 122
+P++ + + E +G GSFG V+ A+ + T E VAIKK+ + N +E++
Sbjct: 10 KDDPEKLFTDLRE--IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL 182
++ + HPN I K C+ + LVMEY + +L+ + + PL V++
Sbjct: 68 FLQQLRHPNTIEYKGCYLREHTA-----WLVMEYCLGSASDILEVH-----KKPLQEVEI 117
Query: 183 --YTYQIFRGLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
+ +GLAY+H+ HRD+K N LL +P VKL DFGSA + AN S+
Sbjct: 118 AAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEP--GTVKLADFGSAS--LVSPAN-SF 171
Query: 240 ICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297
+ + Y+ APE+I E Y +D+WS G EL +P NA+ L I +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--- 228
Query: 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
N + P + ++ W F +D LQ P R ++ E
Sbjct: 229 ----------NDS------PTLSSNDWSDYFRN-----FVDSC---LQKIPQDRPSSEEL 264
Query: 358 CAHPFFDELREPN 370
H F R P
Sbjct: 265 LKHRFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR-----ELQLMRLMDHPNVISLKHCF 139
G GS+G V++ K L + A+K+V L K R E++++ ++HPN+IS K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 140 FSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
L +VMEY P + + + + +P + Q+ RGL +H
Sbjct: 69 LDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 199 GVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 257
+ HRD+K N LLV VK+ D G +KVL K A + I + +Y APE ++ Y
Sbjct: 123 KILHRDLKSANILLVAN--DLVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ DIWS GC+L E+ P F + D ++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 87/302 (28%), Positives = 130/302 (43%), Gaps = 62/302 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRY-----KNRELQLMRLMDHPNV 132
+V+G GSFG V A+ T E A+K +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
L H F T KD LF VMEYV + M+ + + + R + Y +I G
Sbjct: 59 TQL-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLG 108
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L ++H G+ +RD+K N+L+D H +K+ DFG K + G S C + Y APE
Sbjct: 109 LQFLHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
++ Y ++D W+ G +L E+L GQ F G++ D+L + I
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSIL--------------- 209
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 364
+ R+P + + EA + L +P R L HPFF
Sbjct: 210 -EDEVRYP------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
Query: 365 EL 366
E+
Sbjct: 257 EI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ +G G+FG V++ GE VA+K + + + E +M+ + HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 192
L T + L+ +V EY+P L + +++ L + QI +G+
Sbjct: 65 RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + V HRD+ +N LV VK+ DFG ++ + + + YYR
Sbjct: 117 YLESKNFV-HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGGK 165
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + ++T+ D+WS G +L E+ LG+ +PG
Sbjct: 166 LPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 73/290 (25%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRLMDHPNVISL 135
RV+G G+FG V + +T + A+K K ++ +N E ++++ ++HP +++L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ F +DE + LV++ + + L+++ S + VK + +I L Y+H
Sbjct: 66 WYSF-----QDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ G+ HRD+KP N+L+D H V + DF A + S + Y APE++
Sbjct: 118 S-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y+ ++D WS G E L G+ + G + R++IR
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAK-------- 213
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEACAHPFF 363
Q A + EAID ++LL+ P R + HP+F
Sbjct: 214 --QETADVLYPATW---STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 89/300 (29%), Positives = 140/300 (46%), Gaps = 53/300 (17%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRLMDHPNVISLKHC 138
+G GS GIV A TG VA+KK+ D R + R E+ +MR HPN++ +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ S DEL++ VME++ + ++ H RM + + + L+++H
Sbjct: 82 YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA- 133
Query: 198 PGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGA 254
GV HRD+K ++L LT +VKL DFG A+V + S + + Y+ APE+I
Sbjct: 134 QGVIHRDIKSDSIL---LTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SR 189
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y T +DIWS G ++ E++ G+P + E + + + IR P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP----- 232
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 374
P++K HKV P R+L P+ R TA E HPF + P++ +P
Sbjct: 233 --PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 88/294 (29%), Positives = 135/294 (45%), Gaps = 58/294 (19%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 140
+G+G++G V++A+ + TGE VAIK + D +E+ +++ HPN++ F
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV---AYFG 67
Query: 141 STTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
S +D+L+ +VMEY + +Y+V + S Q + YV + +GLAY+H
Sbjct: 68 SYLRRDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV---CRETLKGLAYLHE 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEAN-ISYICSRYYRAPELIFG 253
G HRD+K N+L LT VKL DFG + L A S+I + Y+ APE+
Sbjct: 120 T-GKIHRDIKGANIL---LTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-- 173
Query: 254 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
A E Y DIW+ G EL QP P + + ++ L ++
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP--PMFD-----LHPMRALFLISKS------- 219
Query: 310 NYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
+F P++K W VFH D + L P R TA + HPF
Sbjct: 220 ---NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-24
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y RVVG G+FGIV + + V IK++ +R E Q+++L+ HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I F + L +VMEY P T+ ++ N + + + QI L
Sbjct: 62 IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
++HT + HRD+K QN+L+D VK+ DFG +K+L + + + Y +PEL
Sbjct: 115 HHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
G Y DIW+ GCVL EL + F N
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 50/230 (21%)
Query: 83 RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVIS 134
+ +G G+FG V++ K VA+K + +D + R E ++M+ + HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY---------SSMNQRMPLIYVKLYTY 185
L T ++ L+ LV+EY+ L Y S + L + +
Sbjct: 61 LLGV---CTEEEPLY--LVLEYME---GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
QI +G+ Y+ + V HRD+ +N LV VK+ DFG ++ + + YY
Sbjct: 113 QIAKGMEYLASKKFV-HRDLAARNCLVGE-DLVVKISDFGLSRDVYDDD---------YY 161
Query: 246 R------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
R APE + +T+ D+WS G +L E+ LG +PG
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 6e-23
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 22/220 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQ--DRRYKN---RELQLMRLMDHPNVISLKHC 138
+G GSFG+VF+ A+K++ L +RR + E +++ +D +I
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F D+ LN+VMEY ++++LK + +P V + QI GLA++H+
Sbjct: 68 FL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPELIFGA 254
+ HRD+K NL +D VK+ D G AK+L + + + + YY +PEL
Sbjct: 120 KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELC-ED 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y D+W+ G VL E G+ F N +++II+
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 6e-23
Identities = 74/296 (25%), Positives = 112/296 (37%), Gaps = 57/296 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
+ +G GSFG V++A T + VAIK + + +E+Q + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F + L ++MEY L +++ Y+ ++ GL Y
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGKLDET----YIAFILREVLLGLEY 113
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-------YYR 246
+H G HRD+K N+L+ VKL DFG V G+ S + R ++
Sbjct: 114 LHE-EGKIHRDIKAANILLSE-EGDVKLADFG-----VSGQLT-STMSKRNTFVGTPFWM 165
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
APE+I + Y DIWS G EL G+P + + L I K
Sbjct: 166 APEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------------ 212
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
NP P ++ + + K F D S L P R +A E H F
Sbjct: 213 NNP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 7e-23
Identities = 93/313 (29%), Positives = 142/313 (45%), Gaps = 57/313 (18%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
+V+G GSFG V A+ T E AIK + +D ++ +++ L +HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP---F 57
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L H F + +K+ LF VMEY+ + M+ H S + R + Y +I GL
Sbjct: 58 LTHLFCTFQTKEHLFF--VMEYLNGGDLMF----HIQS-SGRFDEARARFYAAEIICGLQ 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H G+ +RD+K N+L+D H +K+ DFG K + GE S C + Y APE++
Sbjct: 111 FLHK-KGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G +Y S+D WS G +L E+L+GQ F GE+ D+L + I +
Sbjct: 169 KG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSI-------LNDR------- 212
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACAHPFFDELREPN 370
P F + + EA D S+L + P+ R + HPFF R +
Sbjct: 213 -----------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGID 255
Query: 371 ARLPNGRPFPPLF 383
R PP F
Sbjct: 256 WERLEKREIPPPF 268
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 9e-23
Identities = 87/295 (29%), Positives = 125/295 (42%), Gaps = 52/295 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRLMDHPNV 132
Y+ RV+G G+FG + E V K+V L RR E+ ++ L+ HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I+ + F + L + MEY T+Y + Q V Y +QI +
Sbjct: 62 IAYYNHFMDDNT---LLIE--MEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYIC--SRYYRA 247
+YIH G+ HRD+K N+ LT +KL DFG +K+L E +++ + YY +
Sbjct: 115 SYIHKA-GILHRDIKTLNIF---LTKAGLIKLGDFGISKIL-GSEYSMAETVVGTPYYMS 169
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PEL G +Y DIW+ GCVL ELL + F N ++ +V+I +
Sbjct: 170 PELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--------------V 214
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
NYT E I L LLQ P R TA E P
Sbjct: 215 QGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-22
Identities = 73/220 (33%), Positives = 110/220 (50%), Gaps = 24/220 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ C+ E LVMEY + +L+ + Q + + V T+ +GLAY+H
Sbjct: 81 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 196 TVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
+ + HRDVK N LL +P VKL DFGSA ++ AN ++ + Y+ APE+I
Sbjct: 133 S-HNMIHRDVKAGNILLSEP--GLVKLGDFGSASIM--APAN-XFVGTPYWMAPEVILAM 186
Query: 255 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
E Y +D+WS G EL +P NA+ L I
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 77/296 (26%), Positives = 125/296 (42%), Gaps = 37/296 (12%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145
G G++G+V + + + TG +A+K++ R N + Q LMD + C ++ T
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRI---RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 146 DELFLN----LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 201
LF + ME + ++ + K +P + I + L Y+H+ V
Sbjct: 67 GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVI 126
Query: 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE---YT 258
HRDVKP N+L++ QVKLCDFG + LV A + Y APE I Y
Sbjct: 127 HRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYD 185
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 318
D+WS G + EL G+ FP ++ ++ +V+ P+ PQ
Sbjct: 186 VKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPS----------------PQ 227
Query: 319 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 374
+ A ++ PE D ++ L+ + R E HPFF+ N +
Sbjct: 228 LPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVA 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 5e-22
Identities = 72/218 (33%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISLKH 137
+G GSFG V+ A T E VA+KK+ + N +E++ ++ + HPN I K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
C+ + LVMEY + +L+ + Q + + + T+ +GLAY+H+
Sbjct: 89 CYLKEHTA-----WLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHS- 139
Query: 198 PGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ HRD+K N LL +P QVKL DFGSA AN S++ + Y+ APE+I E
Sbjct: 140 HNMIHRDIKAGNILLTEP--GQVKLADFGSASKS--SPAN-SFVGTPYWMAPEVILAMDE 194
Query: 257 --YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
Y +D+WS G EL +P NA+ L I
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 5e-22
Identities = 75/220 (34%), Positives = 112/220 (50%), Gaps = 24/220 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
R +G GSFG V+ A+ + T E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
K C+ E LVMEY + +L+ + Q + + + T+ +GLAY+H
Sbjct: 91 KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142
Query: 196 TVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
+ + HRD+K N LL +P QVKL DFGSA + AN S++ + Y+ APE+I
Sbjct: 143 S-HNMIHRDIKAGNILLTEP--GQVKLADFGSASIA--SPAN-SFVGTPYWMAPEVILAM 196
Query: 255 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
E Y +D+WS G EL +P NA+ L I
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 6e-22
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 31/213 (14%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYK--NRELQLMRLMDHPNVI 133
V+G G++G V+ G+ +A+K+V D + Y+ E+ L++ + H N++
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ T D+ +++ ME+VP ++ +L + + P YT QI G+A
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGPL----PEPVFCKYTKQILDGVA 116
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI-------CSRYY 245
Y+H V HRD+K N+++ P +KL DFG A+ L + ++ + Y+
Sbjct: 117 YLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
APE+I + Y DIWS GC + E+ G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 9e-22
Identities = 91/316 (28%), Positives = 146/316 (46%), Gaps = 57/316 (18%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
+V+G GSFG V A+ GE A+K + +D + +++ L ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L +C F T K+ LF VME++ + M+ + R L Y +I GL
Sbjct: 61 L-YCTFQT--KEHLFF--VMEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQ 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H+ G+ +RD+K N+++D H +K+ DFG K V G+ S C + Y APE++
Sbjct: 111 FLHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G +YT S+D WS G +L E+L+GQ F G++ D+L E I+V TP
Sbjct: 169 QG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP------------ 213
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 370
+P+ W + E+ D+ +L + P+ R + HPFF + N
Sbjct: 214 ---HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---N 255
Query: 371 ARLPNGRPFPPLFNFK 386
R P F K
Sbjct: 256 WTALEKRELDPPFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 91/319 (28%), Positives = 144/319 (45%), Gaps = 59/319 (18%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
+++G GSFG VF A+ T + AIK + +D + +++ L +HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 57
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L H + + +K+ LF VMEY+ + M+ H S + + L Y +I GL
Sbjct: 58 LTHLYCTFQTKENLFF--VMEYLNGGDLMF----HIQSCH-KFDLPRATFYAAEIICGLQ 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H+ G+ +RD+K N+L+D H +K+ DFG K + G+A C + Y APE++
Sbjct: 111 FLHS-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G +Y TS+D WS G +L E+L+GQ F G + + + IR NP Y
Sbjct: 169 LG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCY 215
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 370
+ + EA D+ +L P R + HPFF E+
Sbjct: 216 PRW-----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW-- 256
Query: 371 ARLPNGRPFPPLFNFKQEV 389
+ L PP FK +V
Sbjct: 257 SALEEREIEPP---FKPKV 272
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 24/209 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 137
VGTG+FG V + + A+K + L+ ++ + E ++++ + HP +I L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
T D+ FL ++MEYVP ++ L++ + L Y +I L Y+H+
Sbjct: 68 ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----FYASEIVCALEYLHS 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGAT 255
+ +RD+KP+N+L+D H +KL DFG AK L +C + Y APE+I +
Sbjct: 120 K-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVI-QSK 173
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+ ++D W+ G ++ E+L+G P F +N
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 35/299 (11%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHC 138
+G G+ G+V + +G +A K + + R REL+++ + P ++
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F+S +++ ME++ ++ +VLK R+P + + + RGL Y+
Sbjct: 68 FYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREK 118
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 257
+ HRDVKP N+LV+ ++KLCDFG + L+ AN S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-----TREEIRCMNPNYT 312
T DIWS G L E+ +G+ P +A E+ + G P +E R ++ +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSGHPP 231
Query: 313 DFRFPQ--------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
D P I P K+ E D + L+ +P R E HPF
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 48/299 (16%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
+G G++G V++ TG T+A+K++ L + ++ EL ++ P ++ F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
F + + + MEY+ L + +P ++ TY + +GL ++
Sbjct: 69 FIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI-----FGA 254
+ HRDVKP N+LV+ QVKLCDFG + LV A + C Y APE I
Sbjct: 124 IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQN 181
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEIRCMNPNY 311
YT D+WS G + E+ LG+ +P E N QL I+ G P + Y
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGY 234
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370
+ +A D ++ L P+ R T + HP+ + + +
Sbjct: 235 S---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 25/212 (11%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNR-ELQLMR-LMDHPNVISLKHCF 139
V+G G++G V++A+ +TG+ VAIK +++D + + E ++R +HPN+ + F
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 140 F---STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ D+L+ LVME ++ ++K +R+ ++ + RGLAY+H
Sbjct: 73 IKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 196 TVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIF 252
V HRD+K QN+L LT +VKL DFG SA++ ++I + Y+ APE+I
Sbjct: 131 E-NKVIHRDIKGQNIL---LTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI- 185
Query: 253 GATE------YTTSIDIWSAGCVLAELLLGQP 278
A + Y D+WS G EL G+P
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 7e-21
Identities = 82/311 (26%), Positives = 137/311 (44%), Gaps = 65/311 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRLMDHPNVISL 135
+++ G++G V+ + ET + A+KK+ Q+ +N+ E ++ ++P V+S+
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
C F T L +VMEYV +LK+ ++ P+ ++Y + L Y+
Sbjct: 67 -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGAL----PVDMARMYFAETVLALEYL 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY--------------- 239
H G+ HRD+KP NLL+ + H +KL DFG +K+ + Y
Sbjct: 118 HNY-GIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 240 IC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298
+C + Y APE+I Y +D W+ G +L E L+G F G+ + ++I
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---- 230
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TAL 355
++I P + +P +A DL SRLL+ +P R A
Sbjct: 231 ---DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAF 268
Query: 356 EACAHPFFDEL 366
E H FF L
Sbjct: 269 EVKQHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 8e-21
Identities = 70/247 (28%), Positives = 112/247 (45%), Gaps = 51/247 (20%)
Query: 83 RVVGTGSFGIVFQAKCLE-----TGETVAIKK-----VLQDRRYKNRELQLMRLMDHPNV 132
+ +G G FG V + TGE VA+K Q R RE++++R +DH N+
Sbjct: 10 KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
+ K L L+MEY+P L+ Y ++ ++ L + L++ QI +G+
Sbjct: 69 VKYKGV---CEKPGGRSLRLIMEYLP---SGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----------VKGEANISYIC 241
Y+ + HRD+ +N+LV+ VK+ DFG AKVL GE+ I
Sbjct: 123 DYLGSQ-RYIHRDLAARNILVES-EDLVKISDFGLAKVLPEDKDYYYVKEPGESPI---- 176
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELL---------LGQPL-----FPGENAVD 287
+Y APE + + + S D+WS G L EL + L G+ V
Sbjct: 177 -FWY-APECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233
Query: 288 QLVEIIK 294
+L+E++K
Sbjct: 234 RLLELLK 240
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 9e-21
Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 82 ERVV-GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK---NRELQLMRLMDHPNVISLK 136
ERVV G G++GIV+ A+ L T +AIK++ +D RY + E+ L + H N++
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F + ME VP L + + I YT QI GL Y+
Sbjct: 72 GSDSENG-----FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYL 124
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELI-F 252
H + HRD+K N+LV+ + VK+ DFG++K L ++ + Y APE+I
Sbjct: 125 HDNQ-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLF 280
G Y DIWS GC + E+ G+P F
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 83/302 (27%), Positives = 130/302 (43%), Gaps = 47/302 (15%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 139
+G G+ G V + K + TG +A K V R+ RELQ+M P ++S F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVS----F 68
Query: 140 FSTTSKDELFLN-----LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ FLN + ME++ ++ R+ K + P+ + + GL Y
Sbjct: 69 YGA------FLNENNICMCMEFMDCGSLDRIYKKGGPI----PVEILGKIAVAVVEGLTY 118
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
++ V + HRD+KP N+LV+ Q+KLCDFG + L+ A+ +++ + Y +PE I G
Sbjct: 119 LYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQG 176
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
+YT D+WS G + EL LG+ P D + + +L
Sbjct: 177 G-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-------------- 221
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-HPFFDELREPNA 371
QI P ++ P + D L P+ R T + CA PF LR N
Sbjct: 222 ---LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
Query: 372 RL 373
L
Sbjct: 279 DL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 90/322 (27%), Positives = 144/322 (44%), Gaps = 62/322 (19%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRR---YKNRELQ-LMRLMDHP 130
RV+GTG++G VF + + + G+ A+K ++Q + + E Q L + P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+++L H F T +K L+L+++YV + H + V++Y +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYVNGG--ELFTHLYQ-REHFTESEVRVYIAEIVLA 117
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYICSRYYRAP 248
L ++H + G+ +RD+K +N+L+D H V L DFG +K + E S+ + Y AP
Sbjct: 118 LDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 249 ELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
E+I G + + ++D WS G + ELL G F + + EI + R +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------RIL 225
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFF- 363
K+ P F K M EA D +LL+ P R A E HPFF
Sbjct: 226 ------------KSKP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
Query: 364 ----DELREPNARLPNGRPFPP 381
D+L R+P PF P
Sbjct: 271 GIDWDDLAA--KRIP--APFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHP 130
++ E+ +G G F V++A CL G VA+KKV L D + + +E+ L++ ++HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI F ++ LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 63 NVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 248
L ++H+ V HRD+KP N+ + T VKL D G + K A S + + YY +P
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 66/236 (27%), Positives = 115/236 (48%), Gaps = 27/236 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRLMDHPNVI 133
+++G G+FG V+ +TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
C + L++ ME++P ++ LK Y ++ + + + YT QI G++
Sbjct: 68 QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICSRYYRAP 248
Y+H+ + HRD+K N+L D VKL DFG++K L + G S + Y+ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
E+I G Y DIWS GC + E+L +P + + + I K+ PT +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 65/293 (22%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 133
+V+G GSFG V AK G+ A+ KVLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L H F T K L V++YV E + + + S R + Y +I L
Sbjct: 60 GL-HYSFQTADK----LYFVLDYVNGGELFFHLQRERSFPEPR-----ARFYAAEIASAL 109
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y+H++ + +RD+KP+N+L+D H V L DFG K ++ S C + Y APE+
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ Y ++D W G VL E+L G P F + ++ + +L P R + PN
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPN 218
Query: 311 YT-----------------------DFRFPQIKAHP------WHKVFHKRMPP 334
+ DF +IK H W + +K++ P
Sbjct: 219 ISVSARHLLEGLLQKDRTKRLGAKDDFL--EIKNHVFFSSINWDDLVNKKITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 83/312 (26%), Positives = 132/312 (42%), Gaps = 52/312 (16%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVISLK 136
+G G FG V + TG+ A KK L +R K R E +++ + ++SL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIH 195
+ F +KD+L L + + + Y H ++ + P Y QI GL ++H
Sbjct: 60 YAF---ETKDDLCLVMTLMNGGDLKY----HIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ +RD+KP+N+L+D + V++ D G A L G+ + Y APE++ G
Sbjct: 113 QR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE- 169
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y S+D ++ GC L E++ G+ F Q E ++ +EE++
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR-------- 209
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 370
+ + PEA DL LLQ P R +A E HP F +L
Sbjct: 210 ---TLEMA--VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR- 263
Query: 371 ARLPNGRPFPPL 382
RL G PP
Sbjct: 264 -RLEAGMLEPPF 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 50/283 (17%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFF 140
G G+ G V + + TG A+K + D ++ REL++ + P ++ F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 141 STTSKDELFLNLVMEYVP----ETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+S + + MEY +++Y +V K + ++ L + + +GL+Y+H
Sbjct: 70 DESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAPELI 251
+ + HRD+KP N+L+ QVKLCDFG V GE S + + +Y APE I
Sbjct: 123 S-RKIIHRDIKPSNILLT-RKGQVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPT------- 300
G Y+ + D+WS G L E+ + FP E +L+ I + P
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234
Query: 301 ----REEIR-----CMNPNYTDFRFP-QIKAHPWHKVFHKRMP 333
EE + C+ + T P + HPW K K+
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-19
Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISLK 136
+ +G GSFG ++ AK E IK++ ++++ +E+ L+ M HPN+++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F S LF+ VMEY + M R+ + + ++ + QI GL +I
Sbjct: 65 --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHI 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIF 252
H + HRD+K QN+ + KL DFG A+ L ++Y C + YY +PE I
Sbjct: 118 HDRK-ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-IC 174
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
Y DIWS GCVL EL + F G N + QLV
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 69/242 (28%), Positives = 119/242 (49%), Gaps = 27/242 (11%)
Query: 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRLM 127
I++ +++G G+FG V+ ++TG +A K+V D E+QL++ +
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
H ++ C + E L + MEY+P ++ LK Y ++ + + + YT Q
Sbjct: 62 QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICS 242
I G++Y+H+ + HRD+K N+L D VKL DFG++K L + G S +
Sbjct: 115 ILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302
Y+ +PE+I G Y D+WS GC + E+L +P + A + I K+ PT
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPTNP 228
Query: 303 EI 304
++
Sbjct: 229 QL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 89/354 (25%), Positives = 134/354 (37%), Gaps = 99/354 (27%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRLMDHPNVISL 135
+V+G G+FG V + +TG A+KK+ + + K + E ++ D+P V+ L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ F +DE +L L+MEY+P M +L + + Y+ + + I
Sbjct: 67 YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA----ETILAIDSI 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL--------------VKGEANISYI 240
H + G HRD+KP NLL+D H +KL DFG L + +I
Sbjct: 118 HKL-GYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 241 CSRY-------------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLL 275
Y APE +F T Y D WS G ++ E+L+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 276 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPE 335
G P F +N + +I +N T +FP + PE
Sbjct: 235 GYPPFCSDNPQETYRKI--------------INWKET-LQFPD----------EVPLSPE 269
Query: 336 AIDLASRLLQYSPSLRC---TALEACAHPFF-----DELREPNARLPNGRPFPP 381
A DL RL R E +HPFF + +RE A P P
Sbjct: 270 AKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPA------PIIP 316
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHP 130
++ E+ +G G F V++A CL + VA+KKV + D + + +E+ L++ ++HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI F LN+V+E + +++K++ + +P V Y Q+
Sbjct: 63 NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 248
+ ++H+ V HRD+KP N+ + T VKL D G + K A S + + YY +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 91/304 (29%), Positives = 132/304 (43%), Gaps = 64/304 (21%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQD-----RRYKNRELQLMRLMDHPNV 132
+V+G GSFG V A+ T E AIK +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA--KHPFL 58
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+L HC F T KD LF VMEYV + M+++ + R + Y ++
Sbjct: 59 TAL-HCCFQT--KDRLFF--VMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLA 108
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L ++H GV +RD+K N+L+D H KL DFG K + + C + Y APE
Sbjct: 109 LMFLHR-HGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
I EY S+D W+ G ++ E++ GQP F +N D L E I
Sbjct: 167 -ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL--------------- 209
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC-----AHPF 362
+ D +P W + EA+ + + +P+ R C A + HPF
Sbjct: 210 -HDDVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256
Query: 363 FDEL 366
F E+
Sbjct: 257 FKEI 260
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 86/293 (29%), Positives = 131/293 (44%), Gaps = 51/293 (17%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLKH 137
+G GSFG V Q + +T A+K + + E+ ++ ++ P ++ LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
FS S ++L+L L E L H+ R L + YT ++ L +H
Sbjct: 60 --FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLHKF 112
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATE 256
V +RD+KP+N+L+D H + LCDFG K+ +K + + C + Y APEL+ G
Sbjct: 113 -NVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
YT ++D W+ G +L E+L G P F EN V+++ K+L P RF
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEP--------------LRF 212
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDEL 366
P +A DL LL P+ R A E HPFF +L
Sbjct: 213 PD------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 65/236 (27%), Positives = 117/236 (49%), Gaps = 27/236 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRLMDHPNVI 133
+++G G+FG V+ +TG +A+K+V D + E+QL++ + H ++
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
C K L++ +EY+P ++ LK Y ++ + + + YT QI +G++
Sbjct: 68 QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK----VLVKGEANISYICSRYYRAP 248
Y+H+ + HRD+K N+L D VKL DFG++K + + G S + Y+ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
E+I G Y D+WS C + E+L +P + A + I K+ PT+ +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQPTKPML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 91/315 (28%), Positives = 148/315 (46%), Gaps = 47/315 (14%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 125
G+P++ + + +G GS GIV A TG+ VA+KK + R+ + REL +MR
Sbjct: 18 GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFNEVVIMR 74
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
H NV+ + + S DEL++ VME++ + ++ MN+ +
Sbjct: 75 DYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVCL 125
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRY 244
+ R L+Y+H GV HRD+K ++L+ ++KL DFG A+V + S + + Y
Sbjct: 126 SVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
+ APE+I Y T +DIWS G ++ E++ G+P + E P + +
Sbjct: 184 WMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---------------PPLQAM 227
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
R + N P++K HKV + +DL +L PS R TA E HPF
Sbjct: 228 RRIRDNLP----PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFLK 276
Query: 365 ELREPNARLPNGRPF 379
P+ +P R +
Sbjct: 277 LAGPPSCIVPLMRQY 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 95/330 (28%), Positives = 140/330 (42%), Gaps = 70/330 (21%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQD-----RRYKNRELQLMRLMDHPNV 132
RV+G GSFG V A+ E+G A+K +LQD + R L L R +HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 58
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
L CF + D LF VME+V + M+ + K ++R + Y +I
Sbjct: 59 TQLYCCFQTP---DRLF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSA 108
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L ++H G+ +RD+K N+L+D H KL DFG K + S C + Y APE
Sbjct: 109 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
I Y S+D W+ G +L E+L G F EN D L E I +E+
Sbjct: 167 -ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV----- 213
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEA----CAHPFF 363
V+ + +A+D+ + +P++R L HPFF
Sbjct: 214 -----------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256
Query: 364 DELREPNARLPNGR----PFPPLFNFKQEV 389
EL + N R PF P +++V
Sbjct: 257 KEL---DWEKLNRRQIEPPFRPRIKSREDV 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 7e-19
Identities = 90/312 (28%), Positives = 144/312 (46%), Gaps = 51/312 (16%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 125
G+P+ + + +G GS GIV A +G+ VA+KK + R+ + REL +MR
Sbjct: 16 GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFNEVVIMR 72
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
H NV+ + + S DEL++ VME++ + ++ MN+ +
Sbjct: 73 DYQHENVVEM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 123
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICS 242
+ + L+ +H GV HRD+K ++L LTH +VKL DFG A+V + S + +
Sbjct: 124 AVLKALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302
Y+ APELI Y +DIWS G ++ E++ G+P + E P +
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 223
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
++ + N P++K HKV P RLL P+ R TA E HPF
Sbjct: 224 AMKMIRDNLP----PKLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 272
Query: 363 FDELREPNARLP 374
+ P+ +P
Sbjct: 273 LAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 70/249 (28%), Positives = 124/249 (49%), Gaps = 20/249 (8%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 126
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
HPN+++ + DEL++ VMEY+ + + M++ + +
Sbjct: 73 NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 123
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 245
+ L ++H+ V HRD+K N+L+ + VKL DFG A++ + + + + Y+
Sbjct: 124 CLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPE 239
Query: 306 CMNPNYTDF 314
++ + DF
Sbjct: 240 KLSAIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 84/312 (26%), Positives = 134/312 (42%), Gaps = 50/312 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + + +KD L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H + +RD+KP+N+L+D H +++ D G A + +GE + + Y APE++
Sbjct: 119 HR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
YT S D W GC++ E++ G+ F E +K REE+
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVE--------- 214
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--C---TALEACAHPFFDELREP 369
++K + + ++ A + +LL P R C A E AHPFF
Sbjct: 215 --RRVKEDQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF- 269
Query: 370 NARLPNGRPFPP 381
RL G PP
Sbjct: 270 -KRLEAGMLEPP 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH------- 137
+G+G+ G V++ + +TG +A+K++ RR N+E LMD +V+ H
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMD-LDVVLKSHDCPYIVK 78
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
C+ + ++F+ ME + + ++LK + +P + T I + L Y+
Sbjct: 79 CYGYFITDSDVFI--CMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFGAT- 255
GV HRDVKP N+L+D + VKLCDFG + LV +A S C+ Y APE I
Sbjct: 134 HGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPDP 191
Query: 256 --EYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+Y D+WS G L EL GQ FP +N
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQ--FPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 81/296 (27%), Positives = 135/296 (45%), Gaps = 45/296 (15%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISLKHCF 139
+G GS GIV A+ +G VA+K ++ R+ + REL +MR H NV+ + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM---Y 84
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
S +EL++ +ME++ + + +N+ + + + L Y+H+ G
Sbjct: 85 KSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHS-QG 137
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATEYT 258
V HRD+K ++L+ L +VKL DFG A++ S + + Y+ APE+I T Y
Sbjct: 138 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPYG 195
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 318
T +DIWS G ++ E++ G+P + ++ V + + R+ P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------PP 234
Query: 319 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 374
K HK+ P D R+L P R TA E HPF + P +P
Sbjct: 235 PKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 30/233 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-MDHPNVISLKHC----- 138
+G G+FG V + +G +A+K++ R E + RL MD V+ C
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 139 FFSTTSKD-------ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
F+ ++ EL M+ + Y+ + Y + +P + + L
Sbjct: 68 FYGALFREGDCWICMEL-----MDISLDKFYKYV--YEVLKSVIPEEILGKIAVATVKAL 120
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
Y+ + HRDVKP N+L+D +KLCDFG + LV A R Y APE I
Sbjct: 121 NYLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179
Query: 252 --FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTR 301
Y D+WS G L E+ G+ +P N+V DQL +++K G P
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 94/363 (25%), Positives = 151/363 (41%), Gaps = 108/363 (29%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-------MDHPNVISL 135
+V+G G+FG V + +TG+ A+K +L+ +K +L ++ D P V+SL
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F +D +L L+ME++P + M ++K Y + ++ + + Y + +
Sbjct: 67 YYSF-----QDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDV----TRFYMAECVLAIEA 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG------------SAKVLVKGEANISYIC 241
+H + G HRD+KP N+L+D H +KL DFG + L++G++N + I
Sbjct: 117 VHKL-GFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 242 SRY------------------------------------YRAPELIFGATEYTTSIDIWS 265
+R Y APE IF Y D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWS 233
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325
G ++ E L+G P F EN+ + +II RE + FP H
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKIINW-----RETL----------YFPD-DIH--- 274
Query: 326 KVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFF-----DELREPNARLPNGRP 378
+ EA DL RL+ + + R A E +HPFF D +R+ A P
Sbjct: 275 ------LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA------P 322
Query: 379 FPP 381
F P
Sbjct: 323 FIP 325
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-18
Identities = 72/249 (28%), Positives = 125/249 (50%), Gaps = 20/249 (8%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 126
G+PK+ Y +G G+ G VF A + TG+ VAIK++ LQ + K E+ +M+
Sbjct: 15 GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+ +PN+++ F DELF+ VMEY+ + + M++ + +
Sbjct: 73 LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQ----IAAVCRE 123
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 245
+ L ++H V HRD+K N+L+ + VKL DFG A++ + + + + Y+
Sbjct: 124 CLQALEFLHA-NQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPE 239
Query: 306 CMNPNYTDF 314
++P + DF
Sbjct: 240 KLSPIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 22/221 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 139
+G G+ G+V + + +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+S +++ ME++ ++ +VLK +R+P + + + RGLAY+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 258
+ HRDVKP N+LV+ ++KLCDFG + L+ AN S++ +R Y +PE + G T Y+
Sbjct: 124 QIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
DIWS G L EL +G+ P +A E+ + G P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 26/210 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 133
+V+G GSFG V AK G+ A+K VLQ + NR+ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L H F TT K L V+++V E + + + S P + Y +I L
Sbjct: 60 GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASAL 109
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPEL 250
Y+H++ + +RD+KP+N+L+D H V L DFG K + + + ++ + Y APE+
Sbjct: 110 GYLHSI-NIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
I Y ++D W G VL E+L G P F
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 25/221 (11%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 136
V+G GSFG V A+ T E AIK + +D ++ +++ ++ L D P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAY 193
H F T + L VMEYV + MY H + + + P Y +I GL +
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMY----HIQQVGKFKEP--QAVFYAAEISVGLFF 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELIF 252
+H G+ +RD+K N+++D H +K+ DFG K +V G ++ + Y APE+I
Sbjct: 117 LHR-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII- 173
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 136
V+G GSFG V A+ T E AIK + +D ++ +++ ++ L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
H F T D L+ VMEYV + MY + + + + Y +I GL ++
Sbjct: 67 HSCFQTM--DRLYF--VMEYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFL 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 253
H+ G+ +RD+K N+++D H +K+ DFG K + G C + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 5e-17
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
Y RVVG GSFG + + + + A+K++ + +E L+ M HPN++
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT--------Y 185
+ K F + + L +VMEY + Q++ L KL+
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDG---------GDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVK-GEANISYICS 242
Q+ G+ +IH V HRD+K +N+ LT +VKL DFGSA++L G +Y+ +
Sbjct: 108 QMCLGVQHIHE-KRVLHRDIKSKNIF---LTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAEL 273
YY PE I+ Y DIWS GC+L EL
Sbjct: 164 PYYVPPE-IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 63/299 (21%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRLMDHPNV 132
+++G G+FG V + TG+ A+K + ++ ++R LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+LK+ F + D L VMEY E + + + R + Y +I
Sbjct: 58 TALKYSF---QTHDRLCF--VMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L Y+H+ V +RD+K +NL++D H +K+ DFG K + A + C + Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 213
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 363
F + + PEA L + LL+ P R A E H FF
Sbjct: 214 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 79/317 (24%), Positives = 133/317 (41%), Gaps = 60/317 (18%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLK 136
+VG G FG V + TG+ A+K + + + E ++ + + P + L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ F +D+ L LVMEY P + + + ++ ++ M + Y ++ + +
Sbjct: 68 YAF-----QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY--ICSRYYRAPELI- 251
H + G HRD+KP+N+L+D H +KL DFGSA L + S + + Y APE++
Sbjct: 119 HQM-GYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 252 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
G Y D WS G + E++ G+ F + I+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------------- 222
Query: 308 NPNYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
N+ F +FP+ ++ + +DL LL R C HPFF ++
Sbjct: 223 --NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269
Query: 367 REPNAR--LPNGRPFPP 381
N R LP PF P
Sbjct: 270 DWNNIRNSLP---PFVP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 84/306 (27%), Positives = 137/306 (44%), Gaps = 60/306 (19%)
Query: 83 RVVGTGSFGIVF--------------QAKCLETGETVAIKKVLQDRRYKNRELQLMRLMD 128
+V+GTG++G VF K L+ V K ++ R + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
P +++L H F T +K L+L+++YV M+ L + ++ V+ Y+ +I
Sbjct: 64 SPFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE----VRFYSGEI 114
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV--KGEANISYICSRYY 245
L ++H + G+ +RD+K +N+L+D H V L DFG +K + + E S+ + Y
Sbjct: 115 ILALEHLHKL-GIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEY 172
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE+I G + ++D WS G ++ ELL G F E + E+ +R ++
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRILK 225
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----H 360
C P F + PEA DL +LL+ P R A A H
Sbjct: 226 CDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267
Query: 361 PFFDEL 366
PFF L
Sbjct: 268 PFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 67/210 (31%), Positives = 108/210 (51%), Gaps = 38/210 (18%)
Query: 85 VGTGSFGIVFQAKCL------ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVIS 134
+G G+FG V C TGE VA+KK+ R RE+++++ + H N++
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAY 193
K +S ++ L LVMEY+P Y L+ Y ++ R+ + LY QI +G+ Y
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLP---YGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL--------VK--GEANISYICSR 243
+ + V HRD+ +N+LV+ VK+ DFG KVL V+ GE+ I
Sbjct: 124 LGSKRYV-HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI------ 175
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAEL 273
++ APE + ++++ + D+WS G VL EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 75/294 (25%), Positives = 130/294 (44%), Gaps = 43/294 (14%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHC 138
++G G+ G V++A L T +A+K + D ++ EL+++ D P +I
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
FF E +++ E++ V + ++P + + +GL Y+ ++
Sbjct: 68 FFV-----ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK 115
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 258
+ HRDVKP N+LV+ QVKLCDFG + LV A +Y+ + Y APE I G +Y
Sbjct: 116 -ILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPNYTDFRFP 317
D+WS G EL LG+ +P +I K G+ ++ +C+ D P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYP---------QIQKNQGSLMPLQLLQCI----VDEDPP 218
Query: 318 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371
+ + + F + ++ ++ P R HPF + + NA
Sbjct: 219 VLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 139
+G G+ G+VF+ +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+S +++ ME++ ++ +VLK R+P + + + +GL Y+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 123
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 258
+ HRDVKP N+LV+ ++KLCDFG + L+ AN S++ +R Y +PE + G T Y+
Sbjct: 124 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENA 285
DIWS G L E+ +G+ P +A
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 2e-16
Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 47/288 (16%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 140
+G+G++G V++A+ + TGE AIK + +D +E+ +M+ H N+++ F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
S +D+L++ ME+ + + H + + YV T Q GL Y+H+ G
Sbjct: 74 SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127
Query: 201 CHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATE--- 256
HRD+K N+L+ H VKL DFG SA++ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184
Query: 257 -YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y DIW+ G EL QP + + L + K ++F+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-----------------SNFQ 227
Query: 316 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
P++K W FH L +P R TA + HPF
Sbjct: 228 PPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 41/214 (19%)
Query: 83 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
RV+G G FG V + TGE VA+K + ++ +N E+ +++ + H N++
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
K C + + L L+MEYVP R + KH ++ Q + L+ QI G+
Sbjct: 70 KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE-- 249
AY+H+ + HRD+ +N+L+D VK+ DFG AK + +G YYR E
Sbjct: 121 AYLHSQHYI-HRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--------EYYRVREDG 170
Query: 250 ---LIFGATE------YTTSIDIWSAGCVLAELL 274
+ + A E ++ + D+WS G L ELL
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 82/300 (27%), Positives = 131/300 (43%), Gaps = 61/300 (20%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQ---------DRRYKNRELQLMRLMDHP 130
+V+G G +G VFQ + + +TG+ A+K VL+ D + E ++ + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
++ L F T K L L++EY+ ++ L+ + Y +I
Sbjct: 61 FIVDL-IYAFQTGGK----LYLILEYLSGGELFMHLEREGIFMEDT----ACFYLSEISL 111
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAP 248
L ++H G+ +RD+KP+N+L+D H VKL DFG K + C Y AP
Sbjct: 112 ALEHLHQQ-GIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E I + + ++D WS G ++ ++L G P F EN + +I+K +
Sbjct: 170 E-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNL 219
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 363
P Y + PEA DL +LL+ +PS R A E +HPFF
Sbjct: 220 PPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 82/308 (26%), Positives = 142/308 (46%), Gaps = 46/308 (14%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 126
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+PN+++ + DEL++ VMEY+ + + M++ + +
Sbjct: 73 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 123
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 245
+ L ++H+ V HRD+K N+L+ + VKL DFG A++ + + + + Y+
Sbjct: 124 CLQALDFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQ--- 236
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
NP +R+ D +R L+ R +A E HPF +
Sbjct: 237 --NP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL-K 273
Query: 366 LREPNARL 373
L +P + L
Sbjct: 274 LAKPLSSL 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 47/285 (16%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIK-------KVLQDRRYKNRELQLMRLMDHPNV 132
+V+G GSFG VF + + + G+ A+K KV +DR E ++ ++HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFI 60
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+ L H F T K L L+++++ + R+ K + VK Y ++
Sbjct: 61 VKL-HYAFQTEGK----LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALA 110
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPE 249
L ++H++ G+ +RD+KP+N+L+D H +KL DFG +K + E C Y APE
Sbjct: 111 LDHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTP------TRE 302
++ +T S D WS G ++ E+L G F G++ + + I+K LG P +
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227
Query: 303 EIRCM---NPNYTDFRFPQ----IKAHP------WHKVFHKRMPP 334
+R + NP P IK HP W+K++ + + P
Sbjct: 228 LLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
+V+G G+FG V + + + A+K + + K E +M + ++ L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
H F +D+ +L +VMEY+P + ++ +Y +P + + YT ++ L I
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAI 158
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAPE 249
H++ G HRDVKP N+L+D H +KL DFG+ +K +AN C Y +PE
Sbjct: 159 HSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPE 213
Query: 250 LIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286
++ G Y D WS G L E+L+G F ++ V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 86/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG V + TG+ A K+ L+ +R K R E Q++ ++ V++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + + +KD L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H +RD+KP+N+L+D H +++ D G A + +GE+ + + Y APE++
Sbjct: 119 HR-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
YT S D W GC++ E++ GQ F G E +K REE+ D
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK------EKVK------REEV--------DR 215
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFDELREP 369
R + + +V+ + EA + LL P R C A E HPFF +
Sbjct: 216 RVLETE-----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN-- 268
Query: 370 NARLPNGRPFPPL 382
RL G PP
Sbjct: 269 FKRLEAGMLDPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 58/230 (25%), Positives = 115/230 (50%), Gaps = 32/230 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL--------MDHPNVIS 134
RV+G GS+ V + +T A+K + ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF T S+ L V+E+V + M+ + + +++P + + Y+ +I L
Sbjct: 61 LHSCF-QTESR----LFFVIEFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELI 251
++H G+ +RD+K N+L+D H +KL D+G K + G+ ++ + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 293
G +Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 9e-16
Identities = 68/249 (27%), Positives = 124/249 (49%), Gaps = 20/249 (8%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 126
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ LQ + K E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+PN+++ + DEL++ VMEY+ + + M++ + +
Sbjct: 74 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 124
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 245
+ L ++H+ V HRD+K N+L+ + VKL DFG A++ + + + + Y+
Sbjct: 125 CLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 183 MAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPE 240
Query: 306 CMNPNYTDF 314
++ + DF
Sbjct: 241 KLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 79/306 (25%), Positives = 140/306 (45%), Gaps = 59/306 (19%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIK-----------KVLQDRRYKNRELQLMRLMD 128
+V+GTG++G VF + + ++G+ A+K K + R + + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--Q 63
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P +++L H F T +K L+L+++Y+ + H S +R V++Y+ +I
Sbjct: 64 SPFLVTL-HYAFQTDTK----LHLILDYINGG--ELFTHLSQ-RERFKEQEVQIYSGEIV 115
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRY-YR 246
L ++H + G+ +RD+K +N+L+D H V L DFG +K + E +Y C Y
Sbjct: 116 LALEHLHKL-GIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 247 APELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
AP+++ G + ++D WS G ++ ELL G F + + EI + +
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--------- 224
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAH 360
+K+ P + + M A D+ RLL P R A E H
Sbjct: 225 -------------LKSEP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
Query: 361 PFFDEL 366
PFF ++
Sbjct: 269 PFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 22/204 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYK-----NRELQLMRLMDHPNVISLK 136
+GTGSFG V AK TGE AI K L+ R + K +E ++ + HP ++++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAI-KCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F +DE + ++E+V + H R P K Y ++ Y+H+
Sbjct: 85 CSF-----QDENRVYFLLEFV--VGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS 136
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ +RD+KP+NLL+D H VK+ DFG AK + + + + Y APE+I +
Sbjct: 137 K-DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKG 191
Query: 257 YTTSIDIWSAGCVLAELLLGQPLF 280
+ ++D W+ G +L E + G P F
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 24/222 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
+V+G GSFG V A+ + A+K + + K +E + L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L H F T K L V++Y+ E Y + + + R + Y +I L
Sbjct: 61 L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
Y+H++ + +RD+KP+N+L+D H V L DFG K ++ S C + Y APE++
Sbjct: 111 YLHSL-NIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
Y ++D W G VL E+L G P F N + I+
Sbjct: 169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 81/286 (28%), Positives = 127/286 (44%), Gaps = 51/286 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 133
+V+G GSFG V AK G A+K VLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L H F T K L V++YV E + + + + R + Y ++ +
Sbjct: 60 GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAI 109
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y+H++ + +RD+KP+N+L+D H V L DFG K V+ E S C + Y APE
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII----------------K 294
+ Y ++D W G VL E+L G P F + V Q+ + I
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQLPGGKTVAACD 225
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAH------PWHKVFHKRMPP 334
+L ++ R DF +IK H W ++HKR+ P
Sbjct: 226 LLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 75/301 (24%), Positives = 124/301 (41%), Gaps = 68/301 (22%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKHC 138
G G+FG V++A+ ETG A K + L+D E+ ++ HPN++ L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70
Query: 139 FFSTTSKDELFLNLVMEYVP--------ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+F +++L++ ++E+ + R L ++ Q+
Sbjct: 71 YFY---ENKLWI--LIEFCDGGALDSIMLELERGLTEP----------QIRYVCRQMLEA 115
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPE 249
L ++H+ V HRD+K N+L+ L VKL DFG SAK + ++I + Y+ APE
Sbjct: 116 LNFLHS-HKVIHRDLKAGNILL-TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173
Query: 250 LI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
++ F Y DIWS G L EL +P P + ++ + ++K+L +
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEP----- 225
Query: 306 CMNPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
P + W F+ D L P R TA E HPF
Sbjct: 226 -----------PTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVS 266
Query: 365 E 365
+
Sbjct: 267 D 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y+ + +G GSFG K E G+ IK++ ++R +E+ ++ M HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY----VKLYTYQIF 188
+ + F + L +VM+Y Y +N + +++ + + QI
Sbjct: 62 VQYQESFEENGN-----LYIVMDYCEGG-----DLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKG-EANISYICSRYY 245
L ++H + HRD+K QN+ LT +KL DFG A+VL E + I + YY
Sbjct: 112 LALKHVHDRK-ILHRDIKSQNIF---LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+PE I Y DIW+ GCVL E+ + F N + +++II+
Sbjct: 168 LSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 61/298 (20%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL----------MDHPNVI 133
V+G G FG V A+ +TGE AIK + + E++ + HP ++
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+L CF ++D + VMEY + M + S + Y + GL
Sbjct: 66 NLFACF---QTEDHVCF--VMEYAAGGDLMMHIHTDVFSEPR------AVFYAACVVLGL 114
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y+H + +RD+K NLL+D VK+ DFG K + S C + + APE+
Sbjct: 115 QYLHE-NKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ T YT ++D W G ++ E+L+G+ FPG++ + I+ +E+R
Sbjct: 173 LTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------DEVR----- 219
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 363
+P + EAI + RLL+ +P R + E A PFF
Sbjct: 220 -----------YPRF------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 140
VG+G++G V++A+ L TGE A+K + D +E+ +++ H N+++ F
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
S S+++L+ + MEY + + H + + + YV T Q GLAY+H+ G
Sbjct: 74 SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHS-KGK 127
Query: 201 CHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATE--- 256
HRD+K N+L+ VKL DFG +AK+ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTD-NGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184
Query: 257 -YTTSIDIWSAGCVLAELLLGQP 278
Y DIW+ G EL QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 65/229 (28%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHPN 131
Y +V+G G+FG V + T + A+K + + D + E +M + P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
V+ L + F +D+ +L +VMEY+P + ++ +Y +P + + YT ++
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLA 154
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 247
L IH++ G HRDVKP N+L+D H +KL DFG+ + K E + + + + Y +
Sbjct: 155 LDAIHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 211
Query: 248 PELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
PE++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE----------LQLMRLMDHPNVIS 134
+G G+FG V+Q + +T A+K + + +E L L + P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
LK FS + +L+L V +Y+ E + + K R K Y ++ L
Sbjct: 61 LK---FSFQTDSDLYL--VTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALE 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H + +RD+KP+N+L+D H + LCDFG +K + + C + Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
YT +D WS G ++ E+ G F E+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 61/230 (26%), Positives = 114/230 (49%), Gaps = 32/230 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL--------MDHPNVIS 134
RV+G GS+ V + +T A+K V ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF ++ LF V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 61 LHSCF---QTESRLFF--VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
Y+H G+ +RD+K N+L+D H +KL D+G K ++ S C + Y APE++
Sbjct: 111 YLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 293
G +Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 169 RGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 66/228 (28%), Positives = 112/228 (49%), Gaps = 25/228 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHPN 131
Y +V+G G+FG V + + + A+K + + D + E +M + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
V+ L C F +D+ +L +VMEY+P + ++ +Y +P + K YT ++
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLA 154
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANI-SYICSRYYRAP 248
L IH++ G+ HRDVKP N+L+D H +KL DFG+ K+ G + + + Y +P
Sbjct: 155 LDAIHSM-GLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPDYISP 212
Query: 249 ELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
E++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 84/313 (26%), Positives = 134/313 (42%), Gaps = 50/313 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + + +KD L L L + + + + Y Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H + +RD+KP+N+L+D H +++ D G A + +G+ + + Y APE++
Sbjct: 119 HQ-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
YT S D W+ GC+L E++ GQ F Q + IK REE+ +
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL------- 216
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369
+K + + ++ P+A L LL P R A E HP F ++
Sbjct: 217 ----VKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN-- 268
Query: 370 NARLPNGRPFPPL 382
RL G PP
Sbjct: 269 FKRLEAGMLEPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 9e-15
Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 46/288 (15%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRLMDHPNV 132
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ + + F + D+L L + + Y + +H M + Y +I GL
Sbjct: 60 VCMSYAF---HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
++H V +RD+KP N+L+D H V++ D G A K + + S + + Y APE++
Sbjct: 112 HMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPG-----ENAVDQLVEIIKV------------ 295
Y +S D +S GC+L +LL G F ++ +D++ + V
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
Query: 296 -----LGTPTREEIRCMNPNYTDFR-FPQIKAHPWHKVFHKRMPPEAI 337
L + C+ + + P ++ W VF ++ PP I
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLI 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 83/299 (27%), Positives = 128/299 (42%), Gaps = 62/299 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRLMDHPNV 132
+++G G+FG V K TG E + K + +NR LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+LK+ F + D L VMEY E + + + R + Y +I
Sbjct: 58 TALKYSF---QTHDRLCF--VMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L Y+H+ V +RD+K +NL++D H +K+ DFG K +K A + C + Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 363
F + + PEA L S LL+ P R A E H FF
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPN 131
+Y RVVG GS+G V + G+ IKK+ ++R+ +E QL+ + HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+++ + S +D L L +VM + +Y LK + +P V + QI
Sbjct: 61 IVAYRE---SWEGEDGL-LYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 249
L Y+H + HRD+K QN+ + T+ +K+ D G A+VL + + + I + YY +PE
Sbjct: 115 LQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 250 LIFGATEYTTSIDIWSAGCVLAEL 273
L F Y D+W+ GC + E+
Sbjct: 173 L-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 136
V+G GSFG V A+ T E AIK + +D ++ +++ ++ L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
H F T + L VMEYV + MY++ R + Y +I GL ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELIFG 253
H+ G+ +RD+K N+++D H +K+ DFG K + G ++ + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
Y S+D W+ G +L E+L GQ F GE+ D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 66/236 (27%), Positives = 118/236 (50%), Gaps = 32/236 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDH--------PNVIS 134
RV+G GS+ V + + + A+K V ++ + + ++ ++ H P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF TTS+ L LV+EYV + M+ + + +++P + + Y +I L
Sbjct: 61 LHSCF-QTTSR----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELI 251
++H G+ +RD+K N+L+D H +KL D+G K L G+ ++ + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLF------PGENAVDQLVEIIKVLGTPTR 301
G EY S+D W+ G ++ E++ G+ F P N D L ++I L P R
Sbjct: 169 RGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 68/253 (26%), Positives = 118/253 (46%), Gaps = 29/253 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHCF 139
+G G+FG V++AK ETG +A KV++ + + E++++ +HP ++ L F
Sbjct: 20 LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+ L +++E+ P + P I ++ Q+ L Y+H++
Sbjct: 79 YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQMLEALQYLHSMK- 130
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGAT--- 255
+ HRD+K N+L+ L +KL DFG SAK + + S+I + Y+ APE++ T
Sbjct: 131 IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 256 -EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIRCMNPN 310
Y DIWS G L E+ +P N + L++I K L P++ +
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK-----WSME 244
Query: 311 YTDFRFPQIKAHP 323
+ DF + HP
Sbjct: 245 FRDFLKTALDKHP 257
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 40/292 (13%)
Query: 9 QPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMD---SDKEMSAAV---IQGNDAVTGHII 62
+P PPP ++ R RPD+ ++ S AV + + +
Sbjct: 2 KPIQPPPGVPLPSTARH---TTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSS 58
Query: 63 STTIGGKNGEPKQTISYMAERV--VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RR 115
S++ G +++S + ERV +G+G+ G V++ TG A+K + + RR
Sbjct: 59 SSSASGSAPSAAKSLSEL-ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR 117
Query: 116 YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 175
RE++++R ++HPNV+ H F + ++ L E M + +
Sbjct: 118 QICREIEILRDVNHPNVVKC-HDMFDHNGEIQVLL--------EFMDGGSLEGTHIADEQ 168
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-E 234
L V QI G+AY+H V HRD+KP NLL++ VK+ DFG +++L + +
Sbjct: 169 FLADV---ARQILSGIAYLHRRHIV-HRDIKPSNLLINS-AKNVKIADFGVSRILAQTMD 223
Query: 235 ANISYICSRYYRAPELI-----FGATEYTTSIDIWSAGCVLAELLLGQPLFP 281
S + + Y +PE I GA + DIWS G + E LG+ FP
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 57/255 (22%), Positives = 115/255 (45%), Gaps = 38/255 (14%)
Query: 85 VGTGSFGIVFQAKCLETGET-VAIKKVL-------QDRRYKNR-------ELQLMR-LMD 128
+G+G+FG V++ + G+ +A+K++ +D+R +++ E+ +++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSM---NQRMPLIYVKLYTY 185
HPN++ F D L++ VM+ + +H++S+ QR +
Sbjct: 68 HPNIVRYYKTF---LENDRLYI--VMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
Q+ L Y+H + HRD+ P N+++ +V + DFG AK S + + Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI- 304
PE++ Y D+W+ GC+L ++ QP F N + +I++ + P E +
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
Query: 305 ---------RCMNPN 310
C+ P+
Sbjct: 239 SEDVTDVITSCLTPD 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 6e-14
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVISLK 136
+G G FG V + TG+ A KK L +R K + E +++ ++ P +++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIH 195
+ F S T L LVM + + H ++ +R + + V Y+ QI G+ ++H
Sbjct: 60 YAFESKTH-----LCLVMSLMNGGDLKY--HIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
++ + +RD+KP+N+L+D +L D G A L G+ + Y APE I
Sbjct: 113 SM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKEE 169
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLF 280
Y+ +D ++ GC + E++ G+ F
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 43/216 (19%)
Query: 85 VGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLK 136
+G G+FG V + L VA+K + Q+ RE +M +DHP ++ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
K E + LVME P L Y + +P+ +K +Q+ G+AY+ +
Sbjct: 62 ----IGVCKGEPLM-LVMELAPLG---PLLKYLKKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 197 VPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR--------- 246
V HRD+ +N LLV+ HQ K+ DFG ++ L G S YYR
Sbjct: 114 KHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWPL 162
Query: 247 ---APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 278
APE I +++ D+WS G L E G
Sbjct: 163 KWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 83 RVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYKNR-------ELQLMRLMDHPNVIS 134
R +GTGSFG V A E VAIK+ + + K + E +++ ++HP ++
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L F KDE +L LV+E+V + + N+R P Y QI Y+
Sbjct: 96 LYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 253
++ + +RD+KP+NLL+D +K+ DFG AKV+ + +C + Y APE++
Sbjct: 148 QSL-NIVYRDLKPENLLLDK-DGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLF 280
+ + D W+ G + E+L+G P F
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 89/344 (25%), Positives = 148/344 (43%), Gaps = 58/344 (16%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLM---RLMDHPNVISLKH 137
++G G+FG V +A + E A+K V +Y E+Q M R D + L
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 138 C--FFSTTSKDELFLNLVM-EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+F + + +VM +Y P + ++KH + R ++ +Q L Y
Sbjct: 196 IQRYFQNETGH---MCIVMPKYGPCLLDWIMKH-GPFSHR----HLAQIIFQTGVALDYF 247
Query: 195 HTVPGVCHRDVKPQNLL-------VDPLTHQ--------VKLCDFGSAKVLVKGEANISY 239
HT + H D+KP+N+L VDP+T++ V++CD G + + +
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTAI 305
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT- 298
+ +R+YR+PE++ G + S D+WS GC++ EL G+ L+ + ++ L + K LG
Sbjct: 306 VSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364
Query: 299 PTREEIRCMNPN----YTDFRFPQIKAHPWH--KVFHKRMPPEAI------DLASRLLQY 346
P+ RC Y + P H ++ R E I DL LL Y
Sbjct: 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424
Query: 347 SPSLRCTALEACAHP----FFDELRE-PNARLPNGRPF---PPL 382
R A + HP ++ E R+ PN P+ R P+
Sbjct: 425 DRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRPTPI 466
|
Length = 467 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 73/303 (24%), Positives = 127/303 (41%), Gaps = 46/303 (15%)
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147
GS G VF A + V +K + + E L++ ++HP+VI +K S
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSG----- 129
Query: 148 LFLNLVMEYVPETMYRVLKHYSS--------MNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
VL HYSS ++ +P+ + QI GL Y+H
Sbjct: 130 -----------AITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR- 177
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 259
+ HRDVK +N+ ++ + QV + D G+A+ V A + + APE + +Y +
Sbjct: 178 IIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNS 235
Query: 260 SIDIWSAGCVLAELLL----------GQPLFPGENAVDQLVEIIKVLGT-----PTREEI 304
DIWSAG VL E+L P ++ L++II L P
Sbjct: 236 KADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
R + + ++ + + + + F + +P + L ++L + ++R +A E +P F
Sbjct: 296 R-LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354
Query: 364 DEL 366
+L
Sbjct: 355 AQL 357
|
Length = 357 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 79/324 (24%), Positives = 130/324 (40%), Gaps = 79/324 (24%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRLMDHPNVISL 135
+++G G G VF + TG+ A+K K + R R E +++ +DHP + +L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F + T +L LVM+Y P ++R+L+ + + + Y ++ L Y+
Sbjct: 67 YASFQTET-----YLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYL 119
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDF-------------------GSAKVLVKGEA 235
H + G+ +RD+KP+N+L+ H + L DF GS + V
Sbjct: 120 HLL-GIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 236 NISYICS-----------RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+ ++ Y APE+I G + +++D W+ G +L E+L G F G N
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 344
+ I+K + FP + A DL +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269
Query: 345 QYSPSLRC----TALEACAHPFFD 364
PS R A E HPFF
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 26/224 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+V+G+G+FG V++ + GE VAIK + ++ K E +M +DHP+V+
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L S+ + L+ + +P + +L + + + Y+ + QI +G++Y
Sbjct: 73 RLLGICLSSQ------VQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 250
+ + HRD+ +N+LV H VK+ DFG AK+L E + + A E
Sbjct: 125 LEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 291
I YT D+WS G + EL+ G + G AV+ L+E
Sbjct: 183 IL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 68/326 (20%), Positives = 108/326 (33%), Gaps = 52/326 (15%)
Query: 83 RVVGTGSFG--IVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRLMDHPNVIS 134
++G IV AK T VA+KK+ D K E+ R + HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTYQIFRGLA 192
F EL++ V + L H+ + +P + + + L
Sbjct: 64 YVTSF---IVDSELYV--VSPLMAYGSCEDLLKTHF---PEGLPELAIAFILKDVLNALD 115
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELI 251
YIH+ G HR VK ++L+ +V L + ++K G+ L
Sbjct: 116 YIHSK-GFIHRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 252 FGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---- 299
+ + E Y DI+S G EL G F A L+E KV GT
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLL 231
Query: 300 ----------TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 349
+ + R N + + + LQ P
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPN-------NRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284
Query: 350 LRCTALEACAHPFFDELREPNARLPN 375
R +A + H FF + + N L +
Sbjct: 285 SRPSASQLLNHSFFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-----RLMDHPN---VIS 134
RV+G G FG V + TG+ A KK L+ +R K R+ + M R+++ N V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + + +KD L L L + + + + Y+ N Y ++ GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
+ +RD+KP+N+L+D H +++ D G A + +GE + + Y APE+I
Sbjct: 119 QR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLF 280
+YT S D W GC++ E++ GQ F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 66/248 (26%), Positives = 112/248 (45%), Gaps = 37/248 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR--ELQLMRLMDHPNV 132
Y + +G G FG VF K T E K + L++R E+ +MR + H N+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ F + ++ L ++ME+ + R ++ M ++ + T Q+ L
Sbjct: 75 VRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 192 AYIHTVPG------VCHRDVKPQNLL-------VDPLTHQV---------KLCDFGSAKV 229
AY H + V HRD+KPQN+ + +T Q K+ DFG +K
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 230 LVKGEANISYIC--SRYYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAV 286
+ G ++++ C + YY +PEL+ T+ Y D+W+ GC++ EL G+ F N
Sbjct: 192 I--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249
Query: 287 DQLVEIIK 294
QL+ +K
Sbjct: 250 SQLISELK 257
|
Length = 1021 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRLMDHPNV 132
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ + + F + D+L L + + Y + +H + M + Y +I GL
Sbjct: 60 VCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
++H V +RD+KP N+L+D H V++ D G A K + + S + + Y APE++
Sbjct: 112 HMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 288
T Y +S D +S GC+L +LL G F D+
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 67/296 (22%), Positives = 131/296 (44%), Gaps = 50/296 (16%)
Query: 79 YMAERVVGTGSFGIVF--QAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDH 129
Y+ ++ +G GSFG V+ + K E + + K + + N+E QL+ +DH
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P ++ F ++ + + F ++ EY + L+ + + V + Q+
Sbjct: 62 PAIVK----FHASFLERDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI--SYICSRYYR 246
G+ Y+H + HRD+K +N+ + + +K+ DFG +++L+ G ++ ++ + YY
Sbjct: 117 LGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLM-GSCDLATTFTGTPYYM 172
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
+PE + Y + DIWS GC+L E+ F G+N L +++++ PT
Sbjct: 173 SPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT------ 222
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
P+ + + + +L PSLR +A E +PF
Sbjct: 223 --PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 89/343 (25%), Positives = 139/343 (40%), Gaps = 97/343 (28%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
+ +G G+FG V A ++T A+K L+ + NR E ++ D+ V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L ++S KD L+ VM+Y+P M +L + + Y+ T I
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI----ES 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG---------SAKVLVKGE---------- 234
+H + G HRD+KP N+L+D L +KL DFG ++K KG
Sbjct: 117 VHKM-GFIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 235 ------ANI-----------------------SYICSRYYRAPELIFGATEYTTSIDIWS 265
+N S + + Y APE++ YT D WS
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWS 233
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325
G +L E+L+GQP F + TPT +++ +N T PQ+K
Sbjct: 234 VGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK----- 274
Query: 326 KVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDEL 366
+ PEA+DL ++L + R A + AHPFF E+
Sbjct: 275 ------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRLMDHPNVISLKHCF 139
VVG G++G V++ + ++TG+ AIK V +D + E+ +++ H I+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 140 FSTTS----KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F S D+L+ LVME+ L + N + ++ +I RGLA++H
Sbjct: 82 FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLAHLH 138
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK--GEANISYICSRYYRAPELIF- 252
V HRD+K QN+L+ +VKL DFG + L + G N ++I + Y+ APE+I
Sbjct: 139 -AHKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 195
Query: 253 ---GATEYTTSIDIWSAGCVLAELLLGQP 278
Y DIWS G E+ G P
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 76/296 (25%), Positives = 130/296 (43%), Gaps = 57/296 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 135
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
K+ F + D L VMEY E + + + +R + Y +I L Y
Sbjct: 61 KYAF---QTHDRLCF--VMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 110
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H+ V +RD+K +NL++D H +K+ DFG K + A + C + Y APE +
Sbjct: 111 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
+Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 213
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 363
F + + PEA L + LL+ P R A E H FF
Sbjct: 214 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 66/249 (26%), Positives = 112/249 (44%), Gaps = 39/249 (15%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHCF 139
+G G+FG V++A+ ETG +A KV+ + + E+ ++ DHPN++ L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 140 FSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ + L +++E+ V M + + + +++ Q L Y+
Sbjct: 72 YYENN-----LWILIEFCAGGAVDAVMLELERPLTEPQ-------IRVVCKQTLEALNYL 119
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFG 253
H + HRD+K N+L L +KL DFG SAK + S+I + Y+ APE++
Sbjct: 120 HE-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 254 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIR 305
T Y D+WS G L E+ +P N + L++I K L P+R
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR---- 233
Query: 306 CMNPNYTDF 314
+ + DF
Sbjct: 234 -WSSEFKDF 241
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 16/221 (7%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFST 142
+V+G G+FG V K T A+K + + K E R + NV+ C + T
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64
Query: 143 T----SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
T +DE +L LVM+Y +L S R+P + Y ++ + IH +
Sbjct: 65 TLHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISY-ICSRYYRAPELIF---- 252
V HRD+KP N+L+D H ++L DFGS K+ G S + + Y +PE++
Sbjct: 123 YV-HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
G +Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-----LM--DHPNVISL 135
+V+G G+FG V K TG+ A+K + + K E R L+ D + +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 136 KHCFFSTTSKDELFLNLVMEY-VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ F +DE L LVM+Y V + +L S R+P + Y ++ + +
Sbjct: 67 HYAF-----QDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKG--EANIS-----YICSRYYR 246
H + G HRD+KP N+L+D H ++L DFGS ++L G ++N++ YI +
Sbjct: 119 HQL-GYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
A E G Y D WS G + E+L G+ F E+ V+
Sbjct: 177 AME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 33/219 (15%)
Query: 83 RVVGTGSFGIVFQAK-CLETGE--TVAIKKVLQDRRYKNREL-----QLMRLMDHPNVIS 134
R +G G FG V+Q E VA+K RE +MR DHP+++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAY 193
L +++ ++ +VME P L+ Y +N+ + L + LY+YQ+ LAY
Sbjct: 72 L----IGVITENPVW--IVMELAP---LGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 194 IHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRA 247
+ + V HRD+ +N+LV P VKL DFG ++ L E Y S+ + A
Sbjct: 123 LESKRFV-HRDIAARNVLVSSP--DCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 248 PELIFGATEYTTSIDIWSAG-CVLAELLLG-QPLFPGEN 284
PE I +T++ D+W G C+ L+LG +P +N
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 6e-12
Identities = 59/221 (26%), Positives = 109/221 (49%), Gaps = 24/221 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 135
+++G G+FG V + +G+ A+K + ++ E+ ++++ HP + SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
K+ F +KD L VMEYV E + + + R + Y +I L Y
Sbjct: 61 KYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDY 110
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H+ + +RD+K +NL++D H +K+ DFG K + A + C + Y APE +
Sbjct: 111 LHS-GKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 83 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
R +G G FG V + + TGE VA+K + + + +E++++R + H N++
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
K T + L+ME++P LK Y N+ ++ L Y QI +G+
Sbjct: 70 KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-------YY 245
Y+ + V HRD+ +N+LV+ HQVK+ DFG K + E + Y + ++
Sbjct: 124 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFW 178
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELL 274
APE + + Y S D+WS G L ELL
Sbjct: 179 YAPECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 2e-11
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 45/225 (20%)
Query: 122 QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYV 180
QLM+ D+PN I L + TT K + L+M+Y+ + ++ +LK ++ V
Sbjct: 63 QLMK--DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLFDLLK----KEGKLSEAEV 111
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
K Q+ L +H + H D+K +N+L D ++ LCD+G K+ +
Sbjct: 112 KKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTP------ 163
Query: 241 CSRY-----YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI--- 292
S Y Y +PE I G Y S D W+ G + ELL G+ P + D+ +++
Sbjct: 164 -SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDEDEELDLESL 219
Query: 293 ----------IKVLGTPTREEIRCM---NPNYTDFRFPQIKAHPW 324
IK + + ++ M N NY + +I HP+
Sbjct: 220 LKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264
|
Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKNR-----ELQLM-RLMDHPN 131
+ +G G+FG V +A ++ VA+K + R EL++M L +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFR 189
+++L + T + + + EY Y L ++ + L L ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC---CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEANISYICS 242
G+A++ + + HRD+ +N+L+ VK+CDFG A+ +VKG A +
Sbjct: 153 GMAFLASKNCI-HRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ APE IF YT D+WS G +L E+ LG +PG
Sbjct: 208 -KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 55/247 (22%)
Query: 85 VGTGSFGIVFQAKCLETGE-----TVAIKKVLQDRRYKN-----RELQLMRLM-DHPNVI 133
+G G+FG V +A+ + TVA+K + D K+ E+++M+++ H N+I
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 134 SLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLIYV 180
+L T + L++ V+EY P Y + + +
Sbjct: 80 NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ YQ+ RG+ ++ + + HRD+ +N+LV H +K+ DFG A+ +I +I
Sbjct: 135 VSFAYQVARGMEFLASKKCI-HRDLAARNVLVTE-DHVMKIADFGLAR-------DIHHI 185
Query: 241 CSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 287
YYR APE +F YT D+WS G +L E+ LG +PG V+
Sbjct: 186 --DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 241
Query: 288 QLVEIIK 294
+L +++K
Sbjct: 242 ELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRLMDHPNVISLKHCF 139
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
T L ++MEY+ L ++ +K +I +GL Y+H+
Sbjct: 72 LKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHSEKK 122
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIFGATEYT 258
+ HRD+K N+L+ VKL DFG A L + +++ + ++ APE+I + Y
Sbjct: 123 I-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 179
Query: 259 TSIDIWSAGCVLAELLLGQP 278
+ DIWS G EL G+P
Sbjct: 180 SKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 26/220 (11%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDH 129
P++++ ER +G G FG V+ T + VA+K + +E Q+M+ + H
Sbjct: 4 PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMP-LIYVKLYTYQI 187
++ L ++ S++E +V EY+ + ++ LK R+P L+ + QI
Sbjct: 61 DKLVQL----YAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQI 112
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY--- 244
G+AY+ + HRD+ +N+LV K+ DFG A+++ E + +++
Sbjct: 113 AEGMAYLESR-NYIHRDLAARNILVGE-NLVCKIADFGLARLIEDDEYT-AREGAKFPIK 169
Query: 245 YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ APE +G +T D+WS G +L E++ G+ +PG
Sbjct: 170 WTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRLMDHPNVISLKHCF 139
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTY--QIFRGLAYIH 195
T L ++MEY L S+++ + PL ++ T +I +GL Y+H
Sbjct: 72 LKDTK-----LWIIMEY--------LGGGSALDLLEPGPLDETQIATILREILKGLDYLH 118
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGA 254
+ + HRD+K N+L+ +VKL DFG A L + + ++ + ++ APE+I
Sbjct: 119 SEKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQ 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQP 278
+ Y + DIWS G EL G+P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 32/200 (16%)
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147
G+ G F +T E V IK R E ++R ++HP++I LK F T +K
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--TYNK-- 156
Query: 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207
F L++ +Y Y + + + + + + R + Y+H + HRD+K
Sbjct: 157 -FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKA 210
Query: 208 QNLLVDPLTHQVKLC--DFGSAKVLVKGEANISYICSRYY--------RAPELIFGATEY 257
+N+ ++ H +C DFG+A V AN +YY APEL+ Y
Sbjct: 211 ENIFIN---HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPY 260
Query: 258 TTSIDIWSAGCVLAELLLGQ 277
++DIWSAG VL E+
Sbjct: 261 GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 1e-10
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRLMDHPNVISLKHCFF 140
+VG G++G V++ + ++TG+ AIK V D + +E+ +++ H I+ + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 141 STTS----KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ D+L+ LVME+ L + N + ++ +I RGL+++H
Sbjct: 73 IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQ 129
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK--GEANISYICSRYYRAPELIF-- 252
V HRD+K QN+L+ +VKL DFG + L + G N ++I + Y+ APE+I
Sbjct: 130 -HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 186
Query: 253 --GATEYTTSIDIWSAGCVLAELLLGQP 278
Y D+WS G E+ G P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-----LMDHPN--VISL 135
+V+G G+FG V K + A+K + + K E R L++ N + +L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ F +DE L LVM+Y +L S R+P + Y ++ + +H
Sbjct: 67 HYAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISY-ICSRYYRAPELIF- 252
+ V HRD+KP N+L+D + ++L DFGS K++ G S + + Y +PE++
Sbjct: 120 QLHYV-HRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 253 ---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
G +Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 60/238 (25%), Positives = 108/238 (45%), Gaps = 49/238 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQ-----DRRYKNRELQLMRLMDHPNV 132
+ +G G FG V +A TVA+K + + + R E L++ ++HP+V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL---------- 182
I L + S+D L L++EY Y L+ + ++++ Y+
Sbjct: 66 IKL----YGACSQDGPLL-LIVEY---AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 183 --------------YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228
+ +QI RG+ Y+ + V HRD+ +N+LV ++K+ DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLVAE-GRKMKISDFGLSR 175
Query: 229 VLVKGEANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ + ++ + R + A E +F YTT D+WS G +L E++ LG +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 30/206 (14%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRLMDHPNVISLKHCF 139
+G GSFG V++ T E VAIK + L++ + +E+ ++ D P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP----LIYVKLYTYQIFRGLAYIH 195
T L ++MEY L S+++ P Y+ +I +GL Y+H
Sbjct: 72 LKGTK-----LWIIMEY--------LGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIF 252
+ + HRD+K N+L L+ Q VKL DFG A L + +++ + ++ APE+I
Sbjct: 119 SERKI-HRDIKAANVL---LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI- 173
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQP 278
+ Y DIWS G EL G+P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 83/320 (25%), Positives = 128/320 (40%), Gaps = 64/320 (20%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVISLK 136
+G G FG V + TG+ A KK L +R K R E +++ + ++SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI---YVKLYTYQIFRGLAY 193
+ F + T L LVM + R H ++++ P YT QI GL +
Sbjct: 60 YAFQTKTD-----LCLVMTIMNGGDLRY--HIYNVDEENPGFPEPRACFYTAQIISGLEH 112
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIF 252
+H + +RD+KP+N+L+D + V++ D G A L G++ Y + + APEL+
Sbjct: 113 LHQ-RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLF--PGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
G EY S+D ++ G L E++ + F GE KV ++ I +
Sbjct: 171 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGE----------KVENKELKQRILNDSVT 219
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-------CTALEACAHPFF 363
Y D + P + LL P R C L HP F
Sbjct: 220 YPD-----------------KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLR--THPLF 260
Query: 364 DELREPNARLPNGRPFPPLF 383
+L N R PP F
Sbjct: 261 RDL---NWRQLEAGMLPPPF 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 70/278 (25%), Positives = 109/278 (39%), Gaps = 46/278 (16%)
Query: 100 ETGETVAIKKVLQD-----RRYK--NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152
TG VAIK + D + RE L + HPN+++L + L
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFA 56
Query: 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212
V EYVP R L+ + + +P Q+ LA H G+ HRD+KPQN++V
Sbjct: 57 VFEYVPG---RTLREVLAADGALPAGETGRLMLQVLDALACAHN-QGIVHRDLKPQNIMV 112
Query: 213 DP--LTHQVKLCDFGSAKVLVKGEANI--------SYICSRYYRAPELIFGATEYTTSID 262
+ K+ DFG +L + + Y APE + G T + D
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-TPNSD 171
Query: 263 IWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ-IKA 321
+++ G + E L GQ + G + + EI+ + ++P D P I
Sbjct: 172 LYAWGLIFLECLTGQRVVQGAS----VAEILY----------QQLSPV--DVSLPPWIAG 215
Query: 322 HPWHKVFHKRM---PPEAIDLASRLLQYSPSLRCTALE 356
HP +V K + P + A L + +L AL
Sbjct: 216 HPLGQVLRKALNKDPRQRAASAPALAERFRALELCALV 253
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 50/242 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----LMDHPNVISLKHC 138
+V+G G+FG V + +TG A+K + + + ++ +R ++ + + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F+S +D+L L L+ME++P M +L ++ + + Y + + IH +
Sbjct: 67 FYSF--QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEE----TQFYIAETVLAIDSIHQL 120
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG------------------------ 233
G HRD+KP NLL+D H VKL DFG L K
Sbjct: 121 -GFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 234 ------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281
+ S + + Y APE +F T Y D WS G ++ E+L+G P F
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 282 GE 283
E
Sbjct: 238 SE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLM 127
P + ++ +G G++G VF+ + G A+K +L + E++ L L
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
DHPNV+ ++ K+ L LV+E ++ ++K + +RM + ++
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFG-SAKVLVKGEANISYICSR 243
GL ++H V HRDVK N+L LT + VKL DFG SA++ + + +
Sbjct: 133 ALMGLQHLH-VNKTIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 188
Query: 244 YYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQP 278
++ APE+I + Y D+WS G EL G P
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 24/169 (14%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEA 235
Y++Q+ +G+ ++ + + HRD+ +N+L+ + VK+CDFG A+ + KG+A
Sbjct: 184 YSFQVAKGMEFLASRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
+ + APE IF YT D+WS G +L E+ LG +PG V+I +
Sbjct: 242 RLPL----KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDE 289
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 343
+E R P+YT Q WH +R P +L L
Sbjct: 290 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 68/244 (27%)
Query: 72 EPKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIK--------KVLQDRRYKN 118
P + ++ E +G G+FG V++ + + +VAIK KV Q+ R
Sbjct: 2 IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--- 56
Query: 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ----- 173
+E +LM + HPN++ C +K++ ++ EY+ + L + N
Sbjct: 57 QEAELMSDLQHPNIV----CLLGVCTKEQP-TCMLFEYLA---HGDLHEFLVRNSPHSDV 108
Query: 174 ---------RMPLIYVKLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222
+ L QI G+ Y+ + HRD+ +N LV VK+
Sbjct: 109 GAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGE-GLTVKIS 166
Query: 223 DFGSAKVLVKGEANISYICSRYYR------------APELI-FGATEYTTSIDIWSAGCV 269
DFG ++ + + YYR PE I +G ++TT DIWS G V
Sbjct: 167 DFGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVV 215
Query: 270 LAEL 273
L E+
Sbjct: 216 LWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 35/227 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR----ELQLMRLMDHPNVISLKH 137
ER +G+G FG V++ VAIK + D K + E+Q ++ + H ++ISL
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYR-VLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYI 194
F+ S E + E M + L + S Q +P+ + Q+ G+AY+
Sbjct: 68 --FAVCSVGEPVY-----IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 195 HTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVL-----VKGEANISYICSRYYRAP 248
HRD+ +N+LV + L K+ DFG A+++ + + I Y + AP
Sbjct: 121 EE-QNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY----KWTAP 173
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN---AVDQLVE 291
E ++T D+WS G +L E+ GQ +PG N DQ+
Sbjct: 174 EAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 52/243 (21%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-----LMDHPNVISLKH 137
+V+G G+FG V + +TG A+K + + + ++ +R L++ +K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVK- 65
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F+S K L+L +ME++P M +L ++++ + Y + + IH
Sbjct: 66 MFYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA----TQFYIAETVLAIDAIHQ 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFG------------------------------- 225
+ G HRD+KP NLL+D H VKL DFG
Sbjct: 120 L-GFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 226 ---SAKVLVKGEANISY--ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
A+ K ++Y + + Y APE +F T Y D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 281 PGE 283
E
Sbjct: 237 CSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 73/270 (27%), Positives = 110/270 (40%), Gaps = 69/270 (25%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKC--LETGET---VAIKKVLQD------RRYKNREL 121
+ TI R +G G+FG VF +C LE VA+ K L++ R+ RE
Sbjct: 3 QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59
Query: 122 QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-------SMNQ 173
+L+ H N++ T D +V EY+ + + L+ + S +
Sbjct: 60 ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 174 RM-PLIYVKLY--TYQIFRGLAYI---HTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGS 226
M L +L QI G+ Y+ H V HRD+ +N LV L VK+ DFG
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV----HRDLATRNCLVGYDLV--VKIGDFGM 168
Query: 227 AKVLVKGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL 274
++ + Y YYR PE I +TT D+WS G VL E+
Sbjct: 169 SRDV--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIF 218
Query: 275 L--GQPLFPGENAVDQLVEIIK---VLGTP 299
QP + N ++++E I +L P
Sbjct: 219 TYGKQPWYGLSN--EEVIECITQGRLLQRP 246
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 18/221 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISLKHCF 139
+G G++G V++ + G A+K +L + E++ L L +HPNV+ F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+ L LV+E ++ ++K QR+ + Y GL ++H
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147
Query: 199 GVCHRDVKPQNLLVDPLTHQ--VKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ HRDVK N+L LT + VKL DFG SA++ + + + ++ APE+I
Sbjct: 148 RIIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204
Query: 256 EYTTS----IDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
+Y S D+WS G EL G P + V L +I
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 15/168 (8%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242
Y++Q+ RG+ ++ + + HRD+ +N+L+ + VK+CDFG A+ + K + +
Sbjct: 179 YSFQVARGMEFLASRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 243 RY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGT 298
R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP-PEAIDLASRLLQ 345
++ R P +I W +R +++ LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 65/244 (26%), Positives = 101/244 (41%), Gaps = 44/244 (18%)
Query: 88 GSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS 144
GS G VF C + G+ I K + + RE+ +++ + H +I+L H +
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155
Query: 145 KDELFLNLVMEYVPETMYRVLKH----YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
+ + + +VM K Y + +PL ++ LAY+H G+
Sbjct: 156 RWKSTVCMVM--------PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGI 206
Query: 201 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAPELIFGAT 255
HRDVK +N+ +D + V L DFG+A L + C + +PEL+
Sbjct: 207 IHRDVKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALD 262
Query: 256 EYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y DIWSAG VL E+ + LF + K + R IRCM +
Sbjct: 263 PYCAKTDIWSAGLVLFEMSVKNVTLFGKQV---------KSSSSQLRSIIRCMQVH--PL 311
Query: 315 RFPQ 318
FPQ
Sbjct: 312 EFPQ 315
|
Length = 392 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRYKNRELQLMRLMDHPNVISLKH 137
+G G+FG V++ L+ VA+K +R +E ++++ DHPN++ L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
K +++ VME VP L R+ + + + G+ Y+ +
Sbjct: 58 -IGVCVQKQPIYI--VMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES- 111
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-------APE- 249
HRD+ +N LV + +K+ DFG + + E Y S + APE
Sbjct: 112 KNCIHRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
L +G YT+ D+WS G +L E LG +PG
Sbjct: 167 LNYG--RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 66/285 (23%), Positives = 113/285 (39%), Gaps = 64/285 (22%)
Query: 83 RVVGTGSFGIVFQAKCLE-----TGET-VAIKK-----VLQDRRYKNRELQLMRLMDHPN 131
+G+G+FG V++ + +G VA+K Q+++ +E LM +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-------TMYRVLKHYSSMNQRMPLIYVKLYT 184
++ L ++ME + RV + + L+ + L
Sbjct: 61 IVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL-- 113
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ----VKLCDFGSAKVLVKGEANISYI 240
+ +G Y+ + + HRD+ +N LV + VK+ DFG A+ + K
Sbjct: 114 -DVAKGCVYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK-------- 163
Query: 241 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 286
S YYR APE L+ G +TT D+WS G ++ E+L LGQ +P N
Sbjct: 164 -SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220
Query: 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 331
+ L + R P + Q+ + W + +R
Sbjct: 221 EVLQHV--------TAGGRLQKPENCPDKIYQLMTNCWAQDPSER 257
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 55/235 (23%)
Query: 82 ERVVGTGSFGIVFQ--AKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
R +G GSFG+V++ AK + GE VAIK V +++R E +M+ + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--------SSMNQRMPLIYVKLY 183
V+ L S + L +VME + + LK Y + P K
Sbjct: 71 VVRL----LGVVSTGQPTL-VVMELMAKGD---LKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 184 TY--QIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYI 240
+I G+AY+ HRD+ +N +V + LT VK+ DFG + +I
Sbjct: 123 QMAAEIADGMAYLAAKK-FVHRDLAARNCMVAEDLT--VKIGDFGMTR-------DIYE- 171
Query: 241 CSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ YYR APE + +TT D+WS G VL E+ L + + G
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQG 224
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 67/247 (27%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 55 DAVTGHIIST---TIGGKNGEPK-QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV 110
DA+ G + T T K Q Y RV+G+G+ G V AK + GE A+K V
Sbjct: 6 DAMIGRVCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVV 65
Query: 111 ------LQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE---LFLNLVMEYVPETM 161
D+ E+ + D +++ F ++ L + LV++Y
Sbjct: 66 DMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGD 125
Query: 162 YRV-LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220
R +K + N+ L Q+ + ++H+ + HRD+K N+L+ VK
Sbjct: 126 LRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVK 183
Query: 221 LCDFGSAKVL---VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277
L DFG +K+ V + ++ + YY APE I+ Y+ D++S G +L ELL +
Sbjct: 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLK 242
Query: 278 PLFPGEN 284
F GEN
Sbjct: 243 RPFDGEN 249
|
Length = 496 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 79 YMAERVVGTGSFGIVFQA-KCLETGETVAIKKV-LQDRR---YKNRELQLMRLMDHPNVI 133
Y+ +VG F A + + E V K V L D R Y EL + DH ++
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 134 SLKHCFFSTTSKDELFLNLVMEY-VPETMYRVLKHYSSMNQRMPL--IYVKLYTYQIFRG 190
KH F S D+L L +MEY + + +K + + +P V L YQI
Sbjct: 129 --KH-FDDFKSDDKLLL--IMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVLA 181
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL---VKGEANISYICSRYYRA 247
L +H+ + HRD+K N+ + P T +KL DFG +K V + S+ + YY A
Sbjct: 182 LDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
PEL + Y+ D+WS G +L ELL F G
Sbjct: 240 PEL-WERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 29/212 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------LMRLMDHPNVI 133
+V+G+G+FG V++ + GETV I K+L + ++ +M MDHP+++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L S T + LV + +P + V +H ++ ++ L + QI +G+
Sbjct: 73 RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC----VQIAKGM 122
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 248
Y+ + HRD+ +N+LV H VK+ DFG A++L E + + + A
Sbjct: 123 MYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLL--GQP 278
E I ++T D+WS G + EL+ G+P
Sbjct: 181 ECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NREL----QLMRLMDHPNVI 133
+V+G+G+FG V++ + GE V I +++ R N+E+ +M +D+P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 134 SLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
L C ST + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 73 RLLGICLTST-------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 248
Y+ V HRD+ +N+LV H VK+ DFG AK+L E + + A
Sbjct: 123 NYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELL 274
E I YT D+WS G + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 133
E V+G G FG V + + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
L+ T S+ + + ME L + N + +I + I G+
Sbjct: 69 HLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------YYR 246
Y+ + V HRD+ +N+LV+ K+ DFG ++ L ++ +Y S +
Sbjct: 121 YLSEMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELL 274
APE I ++T++ D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 52/228 (22%), Positives = 98/228 (42%), Gaps = 37/228 (16%)
Query: 85 VGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLK 136
+G GSFG+V + + +G VA+K + D+ +E +M +DH N+I L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 137 HCFFSTTSKDELFLNLVMEYVP-----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ +V E P + + + + + + Y QI G+
Sbjct: 63 GVVLTHPLM------MVTELAPLGSLLDRLRKDALGH------FLISTLCDYAVQIANGM 110
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + + HRD+ +N+L+ +VK+ DFG + L + E + Y+ + +
Sbjct: 111 RYLESKRFI-HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAW 166
Query: 247 -APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 292
APE + T ++ + D+W G L E+ G+ + G + L +I
Sbjct: 167 CAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 46/150 (30%), Positives = 71/150 (47%), Gaps = 20/150 (13%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242
Y++Q+ RG+ ++ + + HRD+ +N+L+ + VK+CDFG A+ + K + Y+
Sbjct: 178 YSFQVARGMEFLASRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYK---DPDYVRK 232
Query: 243 RYYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKV 295
R APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEE 284
Query: 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325
+E R P Y I WH
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEA 235
++ Q+ +G+ ++ HRDV +N+L+ K+CDFG A+ +VKG A
Sbjct: 217 FSSQVAQGMDFL-ASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGNA 274
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ + APE IF YT D+WS G +L E+ LG+ +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 26/152 (17%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAK-------VLVKG 233
++YQ+ +G++++ HRD+ +N+L LTH K+CDFG A+ +VKG
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNIL---LTHGRITKICDFGLARDIRNDSNYVVKG 274
Query: 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 292
A + + APE IF YT D+WS G +L E+ LG +PG + ++
Sbjct: 275 NARLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 324
IK E R ++P I W
Sbjct: 330 IK-------EGYRMLSPECAPSEMYDIMKSCW 354
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 44/217 (20%)
Query: 84 VVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVI 133
+G G FG VF AK E GET+ + K LQ + +N REL + R + H NV+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYT--YQI 187
L + E +++EY + R K + PL + QI
Sbjct: 72 RL----LGLCREAEPHY-MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR- 246
G+ ++ V HRD+ +N LV +VK+ S L K N S YY+
Sbjct: 127 ALGMDHLSNARFV-HRDLAARNCLVSS-QREVKV----SLLSLSKDVYN-----SEYYKL 175
Query: 247 ----------APELIFGATEYTTSIDIWSAGCVLAEL 273
APE + +++T D+WS G ++ E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 47/284 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGET---VAIKKV-----LQDRRYKNRELQLMRLMDHPNVIS 134
RV+G G FG V+ +++ A+K + L++ +E +M+ HPNV+S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP----LIYVKLYTYQIFRG 190
L E + +P + L+++ P LI L Q+ +G
Sbjct: 61 L----LGICLPSE---GSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL---QVAKG 110
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 250
+ Y+ + V HRD+ +N ++D + VK+ DFG A+ + E Y + +L
Sbjct: 111 MEYLASKKFV-HRDLAARNCMLDE-SFTVKVADFGLARDIYDKE----YYSVHNHTGAKL 164
Query: 251 --IFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301
+ A E +TT D+WS G +L EL+ G P +P ++ D V +++ G
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLL 222
Query: 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 345
+ C +P Y ++ WH R P +L SR+ Q
Sbjct: 223 QPEYCPDPLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQL------MRLMDHPNVISLKHCFF 140
G+FG V+ + + A+K V + D KN Q+ + L P ++ L ++
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL---YY 71
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
S S + ++L VMEY+ + L H Y ++ M + Y+ ++ L Y+H G
Sbjct: 72 SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR-HG 124
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ HRD+KP N+L+ H +KL DFG +KV + E N+ I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 54/281 (19%)
Query: 85 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRLM-DHPN 131
+G G FG V A+ L + TVA+K + D K+ E+++M+++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVL--------KHYSSMNQRMP---LIYV 180
+I+L + T L++ ++EY + R YS R+P + +
Sbjct: 83 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 181 KLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
L TYQ+ RG+ Y+ + + HRD+ +N+LV + +K+ DFG L + NI
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVTE-NNVMKIADFG----LARDVNNID 191
Query: 239 YICSRY-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 290
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF 249
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 331
+++K G + C N Y R WH + R
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 133
E+V+G G FG V + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
L+ T SK + +V EY+ + R KH + + +I + I
Sbjct: 69 HLEGVV--TKSKPVM---IVTEYMENGSLDAFLR--KH----DGQFTVIQLVGMLRGIAS 117
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----Y 244
G+ Y+ + G HRD+ +N+LV+ K+ DFG ++VL + + +Y
Sbjct: 118 GMKYLSDM-GYVHRDLAARNILVNS-NLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIR 174
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ APE I ++T++ D+WS G V+ E++
Sbjct: 175 WTAPEAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRY--KNREL----QLMRLMDHPNVI 133
+V+G+G+FG V++ + GE V I KVL++ N+E+ +M + P V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
L ++T + LV + +P Y L Y N+ R+ + + QI +G++
Sbjct: 73 RLLGICLTST------VQLVTQLMP---YGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPE 249
Y+ V V HRD+ +N+LV H VK+ DFG A++L E + + A E
Sbjct: 124 YLEEVRLV-HRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL 274
I +T D+WS G + EL+
Sbjct: 182 SIL-HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 133
E+V+G G FG V + + G+ VAIK + + R E +M DHPN+I
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L+ +K + ++ EY+ ++ + L+ + V + I G+
Sbjct: 69 RLE----GVVTKSRPVM-IITEYMENGSLDKFLRENDG--KFTVGQLVGM-LRGIASGMK 120
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQV-KLCDFGSAKVLVKGEANISY------ICSRYY 245
Y+ + HRD+ +N+LV+ ++ V K+ DFG ++ L ++ +Y I R+
Sbjct: 121 YLSEM-NYVHRDLAARNILVN--SNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW- 174
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELL 274
APE I ++T++ D+WS G V+ E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANIS-- 238
+TYQ+ RG+ ++ + V HRD+ +N+L L VK+CDFG A+ ++ +S
Sbjct: 242 FTYQVARGMEFLASKNCV-HRDLAARNVL---LAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 239 -YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 298 STFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 72/279 (25%), Positives = 113/279 (40%), Gaps = 49/279 (17%)
Query: 4 MPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIIS 63
+P P P P APP + L+R D+E + A+ +G S
Sbjct: 115 LPGDGAPDHDPAPCGPAPPGG---LTPEELER------LDREAARAISRG-----CKPPS 160
Query: 64 TTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL 123
G + + R + GS G VF++ + + V +K E +L
Sbjct: 161 EVAKVVAG-----LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYAS--SVHEARL 213
Query: 124 MRLMDHPNVISL--KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK 181
+R + HP V++L T LV+ +Y L + + + L V
Sbjct: 214 LRRLSHPAVLALLDVRVVGGLTC-------LVLPKYRSDLYTYL---GARLRPLGLAQVT 263
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 241
Q+ + YIH G+ HRD+K +N+LV+ + L DFG+A +G S+
Sbjct: 264 AVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWST 316
Query: 242 SRYY--------RAPELIFGATEYTTSIDIWSAGCVLAE 272
+Y APE++ G YT S+DIWSAG V+ E
Sbjct: 317 PFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRLMDHPNVISL 135
+ +G G+FG V + ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
++S KD L+ VM+Y+P + M +++ + Y ++ +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIES 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225
+H + G HRD+KP N+L+D H +KL DFG
Sbjct: 117 VHKM-GFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
R +G G FG V++ L T VA+K + E Q+M+ + HP +I L
Sbjct: 12 RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66
Query: 139 FFSTTSKDE--LFLNLVMEYVPETMYRVLKHYSSMNQRMP-LIYVKLYTYQIFRGLAYIH 195
++ + +E + +M+Y ++ L+ + ++P LI + Q+ G+AY+
Sbjct: 67 -YAVCTLEEPIYIVTELMKY--GSLLEYLQGGAGRALKLPQLIDM---AAQVASGMAYLE 120
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIF 252
+ HRD+ +N+LV + K+ DFG A+V+ + + +++ + APE
Sbjct: 121 AQNYI-HRDLAARNVLVGE-NNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAAL 177
Query: 253 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
++ D+WS G +L E++ G+ +PG
Sbjct: 178 -YNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 69/243 (28%), Positives = 98/243 (40%), Gaps = 62/243 (25%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 122
P+ I Y R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 3 PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 123 LMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYV-PETMYRVLKHYSSMNQ------- 173
LM DHPN++ L C + L+ EY+ + L+H S Q
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKP------MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114
Query: 174 ---------RMPLIYVKLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222
+PL + Q+ G+AY+ V HRD+ +N LV VK+
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGE-NMVVKIA 172
Query: 223 DFGSAKVLVKGEANISYICSRYYRA------------PELIFGATEYTTSIDIWSAGCVL 270
DFG ++ NI + YY+A PE IF YTT D+W+ G VL
Sbjct: 173 DFGLSR-------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVL 222
Query: 271 AEL 273
E+
Sbjct: 223 WEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 141
+G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL----LG 69
Query: 142 TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTVPG 199
+++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 70 VCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KN 124
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATE 256
HRD+ +N LV H VK+ DFG ++ L+ G+ ++ +++ + APE + +
Sbjct: 125 FIHRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL-AYNK 181
Query: 257 YTTSIDIWSAGCVLAEL-LLGQPLFPG 282
++ D+W+ G +L E+ G +PG
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 79/315 (25%), Positives = 131/315 (41%), Gaps = 70/315 (22%)
Query: 85 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRLMD-HPN 131
+G G FG V +A+ + TVA+K + + K+ E++LM+L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 132 VISLK---------HCFFSTTSKDEL--FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
+I+L + +K L FL P+ + + K L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-----QLSFK 134
Query: 181 KLYT--YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
L + YQ+ RG+ Y+ + + HRD+ +N+LV + +K+ DFG L +G +I
Sbjct: 135 DLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVTE-DNVMKIADFG----LARGVHDID 188
Query: 239 YICSRY-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 290
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELF 246
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR----------------MPP 334
+++ RE R P+ + WH V +R +
Sbjct: 247 KLL-------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299
Query: 335 EAIDLASRLLQYSPS 349
E +DL+ QYSPS
Sbjct: 300 EYLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 16/169 (9%)
Query: 171 MNQRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228
+N+ L Y+ L ++YQ+ G+ ++ + V HRD+ +N+L+ VK+CDFG A+
Sbjct: 230 INESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLICE-GKLVKICDFGLAR 287
Query: 229 VLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGEN 284
+++ IS + APE IF YTT D+WS G +L E+ LG +P
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 333
+Q IK R P + +I W + F R
Sbjct: 347 MNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 57/220 (25%), Positives = 84/220 (38%), Gaps = 69/220 (31%)
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY- 244
QI L +H+ G+ HRDVKPQN++ + K+ D G+A L G I+YI +
Sbjct: 263 QILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 245 ----YRAPELIFGATEYTTS----------------------IDIWSAGCVLAELLLGQP 278
Y APE +T+ T S DI+SAG L+ Q
Sbjct: 319 LDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----LIFLQM 372
Query: 279 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---- 334
FP + L++ R+ R D+ W K+ R P
Sbjct: 373 AFPNLRSDSNLIQF-------NRQLKRN------DYDLVA-----WRKLVEPRASPDLRR 414
Query: 335 --EAIDLASR--------LLQYSPSLRCTALEACAHPFFD 364
E +DL ++++ R +A A AHP+FD
Sbjct: 415 GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454
|
Length = 566 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 46/189 (24%), Positives = 77/189 (40%), Gaps = 40/189 (21%)
Query: 106 AIKKVLQDRRYKNRELQLMRLMDHPNVISL-------KHCFFSTTSKDELFLN-LVMEYV 157
A +D +E++++ + PN+ L + LN + ++V
Sbjct: 58 ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114
Query: 158 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217
ET L S L+Y+ QI G+ Y+ ++ V HRD+ +N LV +
Sbjct: 115 AET--SGLACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV-HRDLATRNCLVGKN-Y 167
Query: 218 QVKLCDFGSAKVLVKGEANISYICSRYY----RAP--------ELIFGATEYTTSIDIWS 265
+K+ DFG ++ L Y YY RAP E + ++TT D+W+
Sbjct: 168 TIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWA 217
Query: 266 AGCVLAELL 274
G L E+L
Sbjct: 218 FGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 65/246 (26%)
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
PN++ L H + S+D +FL V+++ L + S +P VK + ++
Sbjct: 45 PNMVCL-HKYI--VSEDSVFL--VLQHAEGGK---LWSHISKFLNIPEECVKRWAAEMVV 96
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK---GEANISYICSRYYR 246
L +H VC RD+ P N+L+D H ++L F + GEA Y
Sbjct: 97 ALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSRWSEVEDSCDGEA-----VENMYC 149
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
APE + G +E T + D WS G +L ELL G+ L + C
Sbjct: 150 APE-VGGISEETEACDWWSLGAILFELLTGKTL------------------------VEC 184
Query: 307 MNPN----YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---- 358
+P+ +T P+ + EA L +LLQ++P+ R A A
Sbjct: 185 -HPSGINTHTTLNIPEW------------VSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231
Query: 359 -AHPFF 363
+HPFF
Sbjct: 232 KSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 81/316 (25%), Positives = 132/316 (41%), Gaps = 71/316 (22%)
Query: 85 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRLM-DHPN 131
+G G FG V A+ + + TVA+K + D K+ E+++M+++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVL--------KHYSSMNQRMP---LIYV 180
+I+L + T L++ ++EY + R YS ++P L +
Sbjct: 80 IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 181 KLYT--YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
L + YQ+ RG+ Y+ + + HRD+ +N+LV + +K+ DFG L + NI
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVTE-DNVMKIADFG----LARDVHNID 188
Query: 239 YICSRY-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 290
Y + APE +F YT D+WS G +L E+ LG +PG V++L
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELF 246
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-----------------MP 333
+++K E R P I WH V +R
Sbjct: 247 KLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299
Query: 334 PEAIDLASRLLQYSPS 349
E +DL+ QYSP
Sbjct: 300 DEYLDLSVPFEQYSPG 315
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 56/291 (19%)
Query: 83 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVI 133
R++G G FG V +A+ + + VA+K + D + RE M+ DHPNVI
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ------RMPLIYVKLYTYQI 187
L + +K L + +V+ +P + L + M++ +PL + + I
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVI--LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR- 246
G+ Y+ + HRD+ +N +++ V + DFG +K + G+ YYR
Sbjct: 123 ASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFGLSKKIYSGD---------YYRQ 171
Query: 247 --APELIFG--ATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENAVDQLVEIIK 294
A +L A E YTT D+W+ G + E++ GQ + G EN+ EI
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYN 226
Query: 295 VL--GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 343
L G ++ C+ Y ++ W R P L +L
Sbjct: 227 YLIKGNRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 58/234 (24%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRL---MDHPNVISL 135
R++G G G V+ A VA+KK+ +D K R L+ ++ + HP ++ +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPL---------------IY 179
+S S + + M Y+ T+ +LK S+ Q+ L I+
Sbjct: 68 ----YSICSDGDP-VYYTMPYIEGYTLKSLLK---SVWQKESLSKELAEKTSVGAFLSIF 119
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVK 232
K I + Y+H+ GV HRD+KP N+L+ L +V + D+G+A L+
Sbjct: 120 HK-----ICATIEYVHS-KGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 233 GEANISYICSRY------------YRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ + IC Y APE + G + S DI++ G +L ++L
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDH 129
P++T+ + +G G FG V+ VAIK + Q E LM+ + H
Sbjct: 4 PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P ++ L ++ +++ +++ + EY+ ++ LK + ++ + + QI
Sbjct: 61 PRLVRL----YAVVTQEPIYI--ITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIA 112
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYR 246
G+A+I HRD++ N+LV K+ DFG A+++ E A +
Sbjct: 113 EGMAFIE-RKNYIHRDLRAANILVSETLC-CKIADFGLARLIEDNEYTAREGAKFPIKWT 170
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE I T +T D+WS G +L E++ G+ +PG
Sbjct: 171 APEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 61/268 (22%), Positives = 117/268 (43%), Gaps = 35/268 (13%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVISLKHCFF 140
+G+G FG+V+ LE + VAIK + + + + E Q+M + HP ++ L
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69
Query: 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+ + LV E++ + L+ + L+ + L + G+AY+ +
Sbjct: 70 ERSP-----ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL---DVCEGMAYLES-SN 120
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATE 256
V HRD+ +N LV VK+ DFG + ++ + S +++ + +PE +F ++
Sbjct: 121 VIHRDLAARNCLVGE-NQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSFSK 177
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
Y++ D+WS G ++ E + + P EN + E+++ + R P
Sbjct: 178 YSSKSDVWSFGVLMWE-VFSEGKTPYENRSNS--EVVETINA----GFRLYKPRLASQSV 230
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLL 344
++ H W + PE S LL
Sbjct: 231 YELMQHCW------KERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 61/225 (27%), Positives = 109/225 (48%), Gaps = 25/225 (11%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRLMDHPNVI 133
S + +G G FG V+ G T VA+K + E Q+M+ + H ++
Sbjct: 7 SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L ++ S++ +++ V EY+ + ++ LK ++P + V + Q+ G+A
Sbjct: 65 QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116
Query: 193 YIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPE 249
YI + + HRD++ N+LV D L K+ DFG A+++ E A + APE
Sbjct: 117 YIERMNYI-HRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 250 L-IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 292
++G +T D+WS G +L EL+ G+ +PG N + L ++
Sbjct: 174 AALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
++V+G G FG VF+ G VAIK + K R E +M H N+I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L+ T K + + ME + + L+ + L+ + I G+ Y
Sbjct: 70 RLEGVV--TKFKPAMIITEYME--NGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMKY 122
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 248
+ + V HRD+ +N+LV+ + K+ DFG ++VL + + +Y S + AP
Sbjct: 123 LSDMNYV-HRDLAARNILVNS-NLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAP 179
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELL 274
E I ++T++ D+WS G V+ E++
Sbjct: 180 EAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 62/235 (26%), Positives = 95/235 (40%), Gaps = 53/235 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGET-----VAIKKV----LQDRRYKNRELQLMRLMDHPNV 132
+R +G G+FG VF A+C T VA+K + L R+ RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLIY 179
+ F D L +V EY+ P+ M V + L
Sbjct: 70 VK-----FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
+ QI G+ Y+ + V HRD+ +N LV VK+ DFG ++ +
Sbjct: 125 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGA-NLLVKIGDFGMSRDVYS------- 175
Query: 240 ICSRYYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLF 280
+ YYR PE I ++TT D+WS G +L E+ QP F
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 51/197 (25%), Positives = 81/197 (41%), Gaps = 26/197 (13%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRLMDHPNVISLKHCFFS 141
+G G FG V G+ VA+K + D E +M + HPN++ L
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 142 TTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
L +V EY+ + L Y S + L + + G+ Y+
Sbjct: 72 GNP-----LYIVTEYMAKG---SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATE 256
V HRD+ +N+LV K+ DFG AK EA+ + + APE + +
Sbjct: 124 V-HRDLAARNVLVSE-DLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175
Query: 257 YTTSIDIWSAGCVLAEL 273
++T D+WS G +L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLM---DHPNVISLKHC 138
++G G+FG VF+ L+ VA+K +D + K + L R++ DHPN++ L
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
T + ++ +VME VP + L + + + G+AY+ +
Sbjct: 58 IGVCTQRQPIY--IVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLES-K 112
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG---EANISYICSRYYRAPELIFGAT 255
HRD+ +N LV + +K+ DFG ++ G + + I ++ L +G
Sbjct: 113 NCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG-- 169
Query: 256 EYTTSIDIWSAGCVLAELL-LGQPLFPG 282
Y++ D+WS G +L E LG +PG
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 83/331 (25%), Positives = 135/331 (40%), Gaps = 85/331 (25%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQ 122
++ I+ + E +G GSFG+V++ A+ + GE VA+K V + + R E
Sbjct: 4 SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLI 178
+M+ +V+ L SK + L +VME + ++ R L+ + N P
Sbjct: 62 VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 179 YVK---LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
++ +I G+AY++ V HRD+ +N +V VK+ DFG + + + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFV-HRDLAARNCMVAH-DFTVKIGDFGMTRDIYETD- 173
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFP 281
YYR APE + +TTS D+WS G VL E+ L QP
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQG 224
Query: 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341
N +Q+++ + M+ Y D P P DL
Sbjct: 225 LSN--EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255
Query: 342 RLLQYSPSLRCTALEACA------HPFFDEL 366
Q++P +R T LE HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 19/151 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRLMDHPNVISL 135
+ +G G+FG V A+ ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
++S KD L+ VM+Y+P M +L + + + Y ++ + +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMGIFPEDL----ARFYIAELTCAVESV 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225
H + G HRD+KP N+L+D H +KL DFG
Sbjct: 118 HKM-GFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR------ELQLMRLMDHPNVI 133
+++G+G FG V + + G+++ I K +QDR + + M +DH ++
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 134 SLKH-CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
L C ++ L LV + P + V +H S++ + L + QI +G
Sbjct: 73 RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKG 121
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY----ICSRYYR 246
+ Y+ + HR++ +N+L+ V++ DFG A +L + Y ++
Sbjct: 122 MYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELL 274
++FG YT D+WS G + E++
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 37/126 (29%), Positives = 49/126 (38%), Gaps = 38/126 (30%)
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
Y APE++ T YT D WS G +L E+L+GQP F + TP ++
Sbjct: 210 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAD--------------TPAETQL 254
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFH----KRMPPEAIDLASRLLQYSPSLRC---TALEA 357
+ +N W H ++ EA DL RL R A E
Sbjct: 255 KVIN---------------WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEI 298
Query: 358 CAHPFF 363
AHPFF
Sbjct: 299 KAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 50/223 (22%)
Query: 85 VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISL 135
+G G+FG VF A+C E + + K L++ R+ RE +L+ ++ H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLK------HYSSMNQRMPLIYVKL-----Y 183
F+ ++ L +V EY+ + R L+ + + + + L
Sbjct: 72 ---FYGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 243
QI G+ Y+ ++ V HRD+ +N LV VK+ DFG ++ + +
Sbjct: 128 ASQIASGMVYLASLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD--------- 176
Query: 244 YYRA------------PELIFGATEYTTSIDIWSAGCVLAELL 274
YYR PE I ++TT DIWS G VL E+
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 39/230 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ-------LMRLMDHPNV 132
+++G G FG V + + L + +K K ++ + E++ M+ DHPNV
Sbjct: 5 KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 133 ISLKHCFFSTTSKDELFLNLV----MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
+ L F +S ++ +V M++ + + + +++PL + + I
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
G+ Y+ HRD+ +N ++ V + DFG +K + G+ YYR
Sbjct: 124 LGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFGLSKKIYSGD---------YYRQG 172
Query: 249 ELI-----FGATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENA 285
+ + A E YT+ D+W+ G + E+ GQ +PG EN
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVI 133
+ V+G G+FG V +A+ + G AIK++ + D R EL+++ +L HPN+I
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP----------------ETMYRVLKHYSSMNQRMPL 177
+L + +L L +EY P + + + +S L
Sbjct: 72 NLL-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGE 234
++ + + RG+ Y+ + HRD+ +N+LV + K+ DFG ++ V VK
Sbjct: 127 LH---FAADVARGMDYLSQKQFI-HRDLAARNILVGE-NYVAKIADFGLSRGQEVYVK-- 179
Query: 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ + R+ L + YTT+ D+WS G +L E++
Sbjct: 180 KTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 64/286 (22%)
Query: 85 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRLM-DHPN 131
+G G FG V A+ + + VA+K + D K+ E+++M+++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLI 178
+I+L + T L++ ++EY P M +++
Sbjct: 86 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
+ YQ+ RG+ Y+ + + HRD+ +N+LV + +K+ DFG A+ +I
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTE-DNVMKIADFGLAR-------DIH 191
Query: 239 YICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 285
+I YY+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 192 HI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV-P 247
Query: 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 331
V++L +++K G + C N Y R WH V +R
Sbjct: 248 VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 45/195 (23%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 141
+GTG FG+V K VAIK + + ++ E ++M + H ++ L +
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 142 TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 201
T + +++ V EY+ +L + +R + + G+AY+ + +
Sbjct: 68 CTKQRPIYI--VTEYMSNGC--LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI- 122
Query: 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATEYT 258
HRD+ +N LVD VK+ DFG ++ ++ E S + S++ + PE + ++++
Sbjct: 123 HRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE-VLLYSKFS 179
Query: 259 TSIDIWSAGCVLAEL 273
+ D+W+ G ++ E+
Sbjct: 180 SKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 31/123 (25%)
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---VLGTPTR 301
Y APE++ T YT D WS G +L E+L+GQP F + ++ +++I L P +
Sbjct: 214 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ 272
Query: 302 EEIRCMNPNYTDF-----RFP----------QIKAHPWHKVFHKRMPPEAIDLASRLLQY 346
+ ++P +D R P +IKAHP+ K ID +S L Q
Sbjct: 273 AK---LSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFK---------TIDFSSDLRQQ 320
Query: 347 SPS 349
S
Sbjct: 321 SAP 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 60/262 (22%), Positives = 95/262 (36%), Gaps = 56/262 (21%)
Query: 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV----MEYVPETMYRVLKHYSSMNQR 174
E M+ DHPNV+ L T + +V M++ + + Q
Sbjct: 49 SEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY 108
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234
+P + + I G+ Y+ + HRD+ +N +++ V + DFG +K + G+
Sbjct: 109 LPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGLSKKIYNGD 166
Query: 235 ANISYICSRYYRAPELIFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPG-ENAV 286
Y R + P + + A E YTT D+WS G + E+ GQ +PG EN+
Sbjct: 167 ---YYRQGRIAKMP-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS- 221
Query: 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 346
EI L R + PP+ +D Y
Sbjct: 222 ----EIYDYLRQGNR----------------------------LKQPPDCLDGL-----Y 244
Query: 347 SPSLRCTALEACAHPFFDELRE 368
S C L P F+ LR
Sbjct: 245 SLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 46/222 (20%), Positives = 89/222 (40%), Gaps = 35/222 (15%)
Query: 70 NGEPKQTIS---YMAERVVGTGSFGIVFQAKCLE---------------TGETVAIKKVL 111
G P I+ + ++++G G FG V++ +C ET+ ++ ++
Sbjct: 2 EGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLV 61
Query: 112 QDRRY-KNRELQLMRL--MDHPNVISLKHC-FFSTTSKDELFLNLVMEYVPETMYRVLKH 167
+ Y ++ + +DH + C F F+ ++E + E + K
Sbjct: 62 YNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFI--LLEKLVENTKEIFKR 119
Query: 168 YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227
N+ LI K + L YIH G+ H D+KP+N++VD ++ + D+G A
Sbjct: 120 IKCKNK--KLI--KNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDG-NNRGYIIDYGIA 173
Query: 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCV 269
+ +I Y + + + T Y +D + CV
Sbjct: 174 SHFIIHGKHI-----EYSKEQKDLHRGTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 23/54 (42%), Positives = 34/54 (62%), Gaps = 2/54 (3%)
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233
+K Q+ GL +H + G+ HRD+KP+NLLV + QVK+ DFG+A + G
Sbjct: 311 IKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 64/311 (20%), Positives = 121/311 (38%), Gaps = 49/311 (15%)
Query: 101 TGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154
TGE V ++++ + + EL + +L +HPN++ + F + +EL++
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI---ADNELWVVTSF 80
Query: 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214
+ H+ + + Y+ + + L YIH + G HR VK ++L+
Sbjct: 81 MAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIHHM-GYVHRSVKASHILIS- 135
Query: 215 LTHQVKLCDFGSAKVLVK--GEANISYICSRY------YRAPELIFGATE-YTTSIDIWS 265
+ +V L S ++ + + +Y + +PE++ + Y DI+S
Sbjct: 136 VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIK-----VLGTPT--REEIR------------C 306
G EL G F A L+E + +L T T EE+
Sbjct: 196 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLG 255
Query: 307 MNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
+ + R + +HP+++ F P + LQ +P R +A H FF
Sbjct: 256 ESTTVSTPRPSNGESSSHPYNRTF----SPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311
Query: 365 EL-REPNARLP 374
++ R + LP
Sbjct: 312 QIKRRASEALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 141
+G G FG V+ T + VAIK + +E Q+M+ + H ++ L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68
Query: 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
S++ +++ V E++ + ++ LK ++P + V + QI G+AYI + +
Sbjct: 69 VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIERMNYI 124
Query: 201 CHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPEL-IFGATE 256
HRD++ N+LV D L K+ DFG A+++ E A + APE ++G
Sbjct: 125 -HRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--R 179
Query: 257 YTTSIDIWSAGCVLAELLL-GQPLFPG 282
+T D+WS G +L EL+ G+ +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVI 133
E V+G G+FG V +A + G AIK + + D R EL+++ +L HPN+I
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK------LYTYQI 187
+L ++ +L + +EY P S + + P + L + Q+
Sbjct: 67 NL-----LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 188 FR-------GLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISY 239
+ G+ Y+ + HRD+ +N+LV + L K+ DFG L +GE Y
Sbjct: 122 LQFASDVATGMQYLSEKQFI-HRDLAARNVLVGENLA--SKIADFG----LSRGEE--VY 172
Query: 240 ICSRYYRAPELIFGATE------YTTSIDIWSAGCVLAELL 274
+ R P + + A E YTT D+WS G +L E++
Sbjct: 173 VKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 55/229 (24%), Positives = 103/229 (44%), Gaps = 44/229 (19%)
Query: 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMR 125
T+ +M E +G FG V++ E + VAIK L+D+ R + + +MR
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62
Query: 126 L-MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPET---MYRVLKHYSS----------- 170
+ HPN++ C +K++ L+++ Y + + V++ S
Sbjct: 63 SRLQHPNIV----CLLGVVTKEQP-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKV 229
+ P +V + T QI G+ ++ + V H+D+ +N+LV D L VK+ D G +
Sbjct: 118 KSTLEPADFVHIVT-QIAAGMEFLSS-HHVVHKDLATRNVLVFDKLN--VKISDLGLFRE 173
Query: 230 LVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ + S + R+ +++G +++ DIWS G VL E+
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 55/254 (21%)
Query: 82 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNV 132
+R +G G+FG VF A+C E + + K L+D R+ +RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY-------SSMNQRMPLIYVKLY- 183
+ F+ + + + +V EY+ + + L+ + + N+ L ++
Sbjct: 70 VK----FYGVCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 184 -TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242
QI G+ Y+ + V HRD+ +N LV VK+ DFG ++ + +
Sbjct: 125 IAQQIAAGMVYLASQHFV-HRDLATRNCLVGE-NLLVKIGDFGMSRDVYSTD-------- 174
Query: 243 RYYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQ 288
YYR PE I ++TT D+WS G VL E+ QP + N ++
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE 230
Query: 289 LVEII---KVLGTP 299
++E I +VL P
Sbjct: 231 VIECITQGRVLQRP 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 85 VGTGSFGIVFQAKCLETGETVA--IKKVLQDRRYKNRELQLM------RLMDHPNVIS-L 135
+G G FG V + G + A + K L+ + +L + R ++HPNV+ L
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM------PLIYVKLYTYQIFR 189
C S LV+E+ P LK+Y N+ M + ++ ++
Sbjct: 62 GQCIESIP------YLLVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111
Query: 190 GLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---Y 245
GL ++H + H D+ +N L L+ VK+ D+G A + I+ C +
Sbjct: 112 GLLWLHQADFI-HSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 246 RAPEL--IFGA----TEYTTSIDIWSAGCVLAEL 273
APEL I G + T +IWS G + EL
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 44/188 (23%), Positives = 86/188 (45%), Gaps = 27/188 (14%)
Query: 105 VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
VA+K + D R E+++M + +PN+I L D+ L ++ EY+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL----LGVCVSDDP-LCMITEYMEN 101
Query: 160 ---TMY---RVLKHYSSMNQRMPLIYVKLYTY---QIFRGLAYIHTVPGVCHRDVKPQNL 210
+ R ++ + +P + + Y QI G+ Y+ ++ V HRD+ +N
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFV-HRDLATRNC 160
Query: 211 LVDPLTHQVKLCDFGSAKVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSA 266
LV + +K+ DFG ++ L G+ + + R+ ++ G ++TT+ D+W+
Sbjct: 161 LVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAF 217
Query: 267 GCVLAELL 274
G L E+
Sbjct: 218 GVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 84 VVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVISL 135
V+G G+FG V +A+ + G AIK++ + D R EL+++ +L HPN+I+L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK------LYTYQIFR 189
+ +L L +EY P S + + P + L + Q+
Sbjct: 62 L-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 190 -------GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISY 239
G+ Y+ + HRD+ +N+LV + K+ DFG ++ V VK +
Sbjct: 117 FAADVARGMDYLSQKQFI-HRDLAARNILVGE-NYVAKIADFGLSRGQEVYVK--KTMGR 172
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ R+ L + YTT+ D+WS G +L E++
Sbjct: 173 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 395 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.58 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.4 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.36 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.02 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.96 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.79 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.78 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.68 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.68 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.45 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.43 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.34 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.15 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.98 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.89 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.87 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.86 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.86 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.77 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.76 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.67 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.64 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.54 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.53 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.41 | |
| PLN02236 | 344 | choline kinase | 97.37 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.24 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.21 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.13 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.12 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.01 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.97 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.94 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.9 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.74 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.67 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.85 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.84 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.68 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.57 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 95.42 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.62 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.3 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 94.29 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.29 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.0 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-68 Score=472.45 Aligned_cols=328 Identities=73% Similarity=1.228 Sum_probs=310.1
Q ss_pred eeccCCCCCCCccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeec
Q 016115 63 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFST 142 (395)
Q Consensus 63 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 142 (395)
.....+..........|...+++|+|+||.||+|....+++.||||++..+.+...+|+++|+.+.|||||++..+|...
T Consensus 10 ~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~ 89 (364)
T KOG0658|consen 10 QTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSS 89 (364)
T ss_pred EEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEec
Confidence 34444555555666789999999999999999999999999999999999999999999999999999999999998777
Q ss_pred CCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEe
Q 016115 143 TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (395)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~ 222 (395)
.+.++.++.+||||++.+|.+.++++...+..++...++-+..||++||.|||+ .||+||||||.|+|+|++.|.+|||
T Consensus 90 ~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 90 TESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred CCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEEec
Confidence 766677888999999999999999998889999999999999999999999999 5999999999999999989999999
Q ss_pred ecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 223 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
|||.|+.+..+..+.++.+|..|+|||.+.|...|+.+.||||.||++.||+-|++.|.+.+..+++..|.+.+|.|..+
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPL 382 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~ 382 (395)
++..+++++.++.++++...+|.+.+....++++.+|+.++|.++|.+|.++.|++.||||..+++++..+++++.+|+|
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~l 328 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPL 328 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCc
Confidence 99999999999999999999999989999999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhhhh
Q 016115 383 FNFKQEVCI 391 (395)
Q Consensus 383 ~~~~~~~~~ 391 (395)
.+|++..++
T Consensus 329 f~f~~~e~~ 337 (364)
T KOG0658|consen 329 FNFKRAELG 337 (364)
T ss_pred cCchHHHhc
Confidence 999966443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-59 Score=403.18 Aligned_cols=281 Identities=35% Similarity=0.659 Sum_probs=246.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.|+...++|+|+||+||+|+++.||+.||||++..... ...+|+++|+.++|+|+|.++++| .....++
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrklh 77 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKLH 77 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----HhcceeE
Confidence 58888899999999999999999999999999975433 345899999999999999999999 6677799
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|+|||+.++++.|.++ ...++...+..++.|++.|+.|+|+ .+++||||||+|||++ .++.+||||||+|+.+.
T Consensus 78 LVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit-~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILIT-QNGVVKLCDFGFARTLS 152 (396)
T ss_pred EEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEe-cCCcEEeccchhhHhhc
Confidence 99999999988888775 4678899999999999999999999 5999999999999999 89999999999999987
Q ss_pred -cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc--C
Q 016115 232 -KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--N 308 (395)
Q Consensus 232 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 308 (395)
.+...+.++.|.+|+|||.+.|...|+..+||||+||++.||++|.+.|++.++.+++..|.+.+|....+....+ +
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 5666677889999999999999888999999999999999999999999999999999999999999888766543 4
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
+-+....+|+.....-.+.-...++.-+.||+++||..||++|++.+|+|.||+|..+.+
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 555666666655433223333457789999999999999999999999999999976544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-59 Score=420.63 Aligned_cols=258 Identities=31% Similarity=0.489 Sum_probs=215.1
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----------cchHHHHHHHHHcCCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (395)
..+.|.+.+.||+|+||.|-+|..+.||+.||||++.+.. ....+|+++|++|+|||||+++++|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---- 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---- 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence 3456889999999999999999999999999999996431 1235899999999999999999999
Q ss_pred CCCceeEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCcEE
Q 016115 144 SKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVK 220 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~~k 220 (395)
+...+.|+||||++|| |.+. .-.++.+.+..-+.+++|++.|+.|||+ +||+||||||+|||++.+ +-.+|
T Consensus 246 -~~~ds~YmVlE~v~GGeLfd~----vv~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 246 -EVPDSSYMVLEYVEGGELFDK----VVANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred -ecCCceEEEEEEecCccHHHH----HHhccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEE
Confidence 5555689999999975 3333 3346788888889999999999999999 699999999999999732 25799
Q ss_pred EeecccccccccCCcceeeeecccccCchhhcCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Q 016115 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLG 297 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~ 297 (395)
|+|||+|+.........+++||+.|.|||++.+.+ .+..++||||+||+||-+++|.+||....... ...+|.+.
T Consensus 320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G-- 397 (475)
T KOG0615|consen 320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG-- 397 (475)
T ss_pred ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC--
Confidence 99999999998888888999999999999996533 24558999999999999999999998765544 44555442
Q ss_pred CCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
...+....+.++|+++.+||++||..||++|||++|+|+||||+...
T Consensus 398 -----------------------~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 398 -----------------------RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred -----------------------cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 11112224567899999999999999999999999999999999654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-58 Score=428.55 Aligned_cols=266 Identities=31% Similarity=0.510 Sum_probs=230.3
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.+|...+.||+|||+.||.+++..+|+.||+|++.+. +....+|+++-+.|+|||||+++++| ++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 5799999999999999999999999999999999642 34456799999999999999999999 88888
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+|||.|+|.. +|.++++. .+.++|.+++.+++||+.||.|||+ .+|+|||||..|++++ ++..|||+|||+|.
T Consensus 93 VYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~-~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLN-ENMNVKIGDFGLAT 166 (592)
T ss_pred eEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeec-CcCcEEecccceee
Confidence 9999999995 55444443 5889999999999999999999999 5999999999999999 78899999999999
Q ss_pred ccccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 229 VLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 229 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
..... ....+.+|||.|.|||++... .++..+||||+||+||.||+|++||...+-.+.+..|...
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~------------ 233 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN------------ 233 (592)
T ss_pred eecCcccccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc------------
Confidence 88744 677889999999999999754 4899999999999999999999999999999988888762
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLF 383 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~ 383 (395)
+| .++..+|.++++||.++|+.||.+|||++++|.|+||+...-+.....+.-...+.+
T Consensus 234 -----~Y------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~~l~~~p~~ 292 (592)
T KOG0575|consen 234 -----EY------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSSCLTMVPRF 292 (592)
T ss_pred -----Cc------------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCccccccCCcC
Confidence 22 245578999999999999999999999999999999976655555444333333333
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-59 Score=422.59 Aligned_cols=284 Identities=37% Similarity=0.658 Sum_probs=253.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHHcC-CCceeeeceeeeecCCCCcee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 149 (395)
.++|.++++||.|.||.||+|+.+.+|+.||||.+++... ...||+..|++++ |||||++.+++.+.. ..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence 3579999999999999999999999999999998875532 2347999999999 999999999984322 17
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|+|||||+.+|+++++.+ +..+++..++.|+.||++||+|+|+ .|+.||||||||||+. .+..+||+|||+|+.
T Consensus 85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~-~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILIS-GNDVIKIADFGLARE 159 (538)
T ss_pred EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEec-ccceeEecccccccc
Confidence 9999999999999999875 6899999999999999999999999 5999999999999999 588899999999999
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC-
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 308 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 308 (395)
.......+.++.|.+|+|||++.....|+.+.|||++|||++|+++-++.|++.++.|++.+|..++|.|..+.|....
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 9888888999999999999999988899999999999999999999999999999999999999999999988876521
Q ss_pred -CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 309 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 309 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
.....+.+++....++...++. .+.++.+||.+||.+||.+||||+|+|+||||+.....
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 2334566777777777776666 89999999999999999999999999999999876553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-57 Score=401.70 Aligned_cols=258 Identities=29% Similarity=0.526 Sum_probs=216.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.+.+..+.||+|..|+||+++++.|++.+|+|++..+ ++...+|+++++..+||+||+++++|+.... .++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is 154 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS 154 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence 3567778999999999999999999999999999433 3445689999999999999999999965332 489
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
|+||||+|+.++.+... .++++|.....++.+|++||.|||...+||||||||+|||++ ..|.|||||||.++.+.
T Consensus 155 I~mEYMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN-skGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN-SKGEVKICDFGVSGILV 230 (364)
T ss_pred eehhhcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec-cCCCEEeccccccHHhh
Confidence 99999997655544332 378999999999999999999999535999999999999999 79999999999999887
Q ss_pred cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCChhhhhh
Q 016115 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-----NAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+. ...+++||..|||||.+.+. .|+.++||||||++++||++|+.||... +..+.+..|.. .++.
T Consensus 231 nS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP----- 300 (364)
T KOG0581|consen 231 NS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPP----- 300 (364)
T ss_pred hh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCC-----
Confidence 66 56789999999999999775 5999999999999999999999999875 44444444443 1111
Q ss_pred cCCCCCCCCCCCccCCCccccccc-cCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
.++. .+|+++++||..||++||.+|+|+.|+++|||+++....+..
T Consensus 301 --------------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd 347 (364)
T KOG0581|consen 301 --------------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVD 347 (364)
T ss_pred --------------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccccc
Confidence 1233 379999999999999999999999999999999988776554
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-55 Score=428.82 Aligned_cols=310 Identities=54% Similarity=1.007 Sum_probs=270.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecC---CCCceeEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTT---SKDELFLNL 152 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~~~~~l 152 (395)
..+|.+.+.||+|+||+||+|.+..+++.||||++..+.....+|+.+++.++|+||++++++++... .....++++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 45799999999999999999999999999999999777666778999999999999999998875432 123456889
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
||||+++++...+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++..++.+||+|||+|+....
T Consensus 145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 99999999888887766667889999999999999999999999 69999999999999985556899999999987766
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+..+.+.+.
T Consensus 224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 303 (440)
T PTZ00036 224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA 303 (440)
T ss_pred CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence 55555678899999999987766689999999999999999999999999999999999999999999988888888888
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCC-CCCCCCCCCch
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN-GRPFPPLFNFK 386 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~-~~~~~~~~~~~ 386 (395)
+..++......+...++...+.++.+||.+||++||.+|+|+.|+|+||||+.++++...++. ...++++.+|.
T Consensus 304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 378 (440)
T PTZ00036 304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFC 378 (440)
T ss_pred cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCC
Confidence 888887777777777788889999999999999999999999999999999999886655443 34677777776
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-56 Score=388.81 Aligned_cols=287 Identities=32% Similarity=0.556 Sum_probs=244.1
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..+.|++...|++|.||.||+|+++.|++.||+|+++.+.. ...+|+.+|.+++|||||.+..+.... +..
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d 150 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMD 150 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---ccc
Confidence 34579999999999999999999999999999999975542 125899999999999999999987543 333
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+|+|||||+.+|..++... ..+|...+++.++.|++.|++|||. ..|+|||||++|+|++ ..|.+||+|||+|+
T Consensus 151 ~iy~VMe~~EhDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~-~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLS-HKGILKIADFGLAR 225 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeec-cCCcEEecccchhh
Confidence 49999999999888887753 3689999999999999999999999 6999999999999999 78999999999999
Q ss_pred ccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 229 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.+..... .+..+.|.+|+|||.+.+...|+++.||||+|||+.||+++++.|.+....+++.+|.+.+|.|....|.-.
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 9876643 455678999999999999999999999999999999999999999999999999999999999998877532
Q ss_pred C--CCCCCCCCCCccCCCcccccccc-CChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 308 N--PNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 308 ~--~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
. +....+.++...-.+++..+... +++...+|+..+|.+||.+|.||+|.|.|+||.+...+
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 2 11112333333334445555444 78999999999999999999999999999999985443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=374.80 Aligned_cols=279 Identities=38% Similarity=0.700 Sum_probs=240.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.+|...+.||+|.||.||+|++..+|+.||||+++... ....+|+..|+.++|+||+.++++| .....+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 36888899999999999999999999999999996442 2235899999999999999999999 444448
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
.||+||++.+|...+++ ....++...++.++.+++.||+|||+ +.|+||||||.|+|++ .+|.+||+|||+|+.+
T Consensus 77 ~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis-~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLIS-SDGQLKIADFGLARFF 151 (318)
T ss_pred EEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEc-CCCcEEeecccchhcc
Confidence 89999999987777654 45778999999999999999999999 6999999999999999 7999999999999987
Q ss_pred ccCCcc-eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC-
Q 016115 231 VKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 308 (395)
Q Consensus 231 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 308 (395)
...... ...+.|.+|+|||.+.|...|+..+||||.|||+.||+-|.+.|++.++.+++..+.+.+|.|..+.|..+.
T Consensus 152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 655443 334789999999999999999999999999999999999999999999999999999999999999998765
Q ss_pred -CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 309 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 309 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
++|..+. .....+... +....+.++.||+.+||.+||.+|+|+.|+|+|+||+....
T Consensus 232 lpdY~~~~--~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 232 LPDYVKIQ--QFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred cccHHHHh--cCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 3444333 222223332 33556888999999999999999999999999999997444
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-55 Score=401.21 Aligned_cols=284 Identities=36% Similarity=0.611 Sum_probs=238.9
Q ss_pred CccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
+...+.|+..++||+|.||.||+|++..+|+.||+|++.-+. ....+|+.||++|+||||+++.+..... .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~ 189 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---L 189 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---C
Confidence 445567999999999999999999999999999999986443 2345899999999999999999988553 3
Q ss_pred ceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...+|+|+|||+.+|.-++.. ..-.|++.++..++.||+.||+|||+ +||+|||||.+||||| .+|.+||+|||+
T Consensus 190 ~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLid-n~G~LKiaDFGL 264 (560)
T KOG0600|consen 190 SGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILID-NNGVLKIADFGL 264 (560)
T ss_pred CceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEc-CCCCEEeccccc
Confidence 456999999999887776653 24589999999999999999999999 7999999999999999 899999999999
Q ss_pred ccccccCC--cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 227 AKVLVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 227 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
|+++.... ..+..+.|.+|+|||.++|...|+.++|+||.||||.||++|++.|++.++.+++..|.+..|.+....|
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 99775554 3567788999999999999999999999999999999999999999999999999999999999999888
Q ss_pred hhcC-CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 305 RCMN-PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 305 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
...+ +.+..+.-...-...+... -..++..+.+|+..||..||.+|.||.++|+|+||+.
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 7221 1111111111111111222 3467999999999999999999999999999999944
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=401.69 Aligned_cols=268 Identities=32% Similarity=0.566 Sum_probs=233.6
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHc-CCCceeeeceeeeecCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (395)
+...+|..++.||+|+|++|++|+++.+++.||||++.+. ..+..+|..+|.+| .||.|++|+..| +
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence 4455799999999999999999999999999999987543 34556899999999 799999999999 7
Q ss_pred CceeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
|+..+|+|+||++ |.|++.+.++ +.+.+..++.++.+|+.||+|||+ .|||||||||+|||+| +++.+||+||
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd-~dmhikITDF 218 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLD-KDGHIKITDF 218 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEc-CCCcEEEeec
Confidence 7777999999999 6778777775 789999999999999999999999 6999999999999999 8999999999
Q ss_pred ccccccccCCc--------------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHH
Q 016115 225 GSAKVLVKGEA--------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290 (395)
Q Consensus 225 g~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 290 (395)
|.|+.+..... ..+++||..|.+||+|.. ...++.+|||+||||+|+|+.|.+||.+.+..-.+.
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq 297 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ 297 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence 99987643221 146899999999999965 458999999999999999999999999999999999
Q ss_pred HHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
+|+.. + ..++..+++.+.|||+++|..||.+|+|+.||-+||||..+++.+
T Consensus 298 kI~~l-----------------~------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 298 KIQAL-----------------D------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred HHHHh-----------------c------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 99884 2 224567899999999999999999999999999999999999988
Q ss_pred CCCCCCCCCCCC
Q 016115 371 ARLPNGRPFPPL 382 (395)
Q Consensus 371 ~~~~~~~~~~~~ 382 (395)
..-.+++.+.++
T Consensus 349 lw~~~PP~l~py 360 (604)
T KOG0592|consen 349 LWQQTPPKLQPY 360 (604)
T ss_pred hhhcCCCcccCC
Confidence 554455544444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=391.56 Aligned_cols=258 Identities=31% Similarity=0.479 Sum_probs=222.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..++|++.++||+|+||+||.++.+.+++.||+|++++. .+....|..+|..++||.||+++..| ++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccC
Confidence 345799999999999999999999999999999988643 23445799999999999999999998 777
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..+|+|+||+.|| .|......++.+++..++.++.+|+.||.|||+ +|||||||||+|||+| ..|.++|+|||++
T Consensus 98 ~kLylVld~~~GG---eLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd-~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 98 EKLYLVLDYLNGG---ELFYHLQREGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLD-EQGHIKLTDFGLC 172 (357)
T ss_pred CeEEEEEeccCCc---cHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeec-CCCcEEEeccccc
Confidence 7799999999985 222233447899999999999999999999999 7999999999999999 7899999999999
Q ss_pred ccc-ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 228 KVL-VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 228 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+.. ..+....+++||+.|||||++.+.+ |+..+|+|||||++|+|++|.+||.+.+.......+.+.-.
T Consensus 173 k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~--------- 242 (357)
T KOG0598|consen 173 KEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL--------- 242 (357)
T ss_pred hhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC---------
Confidence 854 4445556689999999999998764 99999999999999999999999999998888888776310
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC----CHHHHhcCCCCcCCCCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELREPNA 371 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp----t~~ell~hp~~~~~~~~~~ 371 (395)
...+..++.++++||+++|.+||++|. .+.++-+||||+.+++...
T Consensus 243 -------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l 292 (357)
T KOG0598|consen 243 -------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL 292 (357)
T ss_pred -------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence 112234799999999999999999996 6889999999999998653
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-55 Score=387.99 Aligned_cols=295 Identities=39% Similarity=0.701 Sum_probs=250.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.|...+.||+|+||.|+.|.+..+|+.||||++... .+...+|+.+|+.++|+||+.+.+++.......-..+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 466678999999999999999999999999998632 23445899999999999999999998764445566799
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|+|+|+.+|...++. +..++..++..++.||+.||+|+|+ .||+||||||+|+|++ .+-.+||+|||+|+...
T Consensus 103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n-~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLN-ADCDLKICDFGLARYLD 176 (359)
T ss_pred EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeec-cCCCEEeccccceeecc
Confidence 9999998877777665 4559999999999999999999999 7999999999999999 68889999999999876
Q ss_pred c---CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 232 K---GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 232 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
. ....+.++.|.+|+|||++.....|+.+.||||+|||+.||++|++.|.+.+..+++..+...+|.+..+.+....
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 4 3344667889999999999888889999999999999999999999999999999999999999999888776544
Q ss_pred CC-CCCC--CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCC
Q 016115 309 PN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPF 379 (395)
Q Consensus 309 ~~-~~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~ 379 (395)
.. ...+ ..+.....++...++ ..++.+.+|+.+||..||.+|+|++|+|+||||..+.+++.-......+
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~ 329 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIF 329 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCC
Confidence 11 1111 234455556666565 7899999999999999999999999999999999999987765444443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-54 Score=372.13 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=224.3
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
...++|+..+.||.|+||+|.+++.+.+|..||+|++.+.. +...+|..+|+.+.||.++++.+.+ .+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence 44568999999999999999999999999999999986542 3345799999999999999999988 77
Q ss_pred ceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...+|+||||++|+ .+..+....+++++..++.++.||+.||+|||+ .+|++|||||+|||+| .+|-+||+|||+
T Consensus 116 ~~~lymvmeyv~GG---ElFS~Lrk~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD-~~G~iKitDFGF 190 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGG---ELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLD-QNGHIKITDFGF 190 (355)
T ss_pred CCeEEEEEeccCCc---cHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeec-cCCcEEEEeccc
Confidence 77899999999975 233333446899999999999999999999999 6999999999999999 799999999999
Q ss_pred ccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
|+..... ..+.+|||.|+|||++... .|+.++|+|||||++|||+.|.+||...+....+.+|...
T Consensus 191 AK~v~~r--T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~----------- 256 (355)
T KOG0616|consen 191 AKRVSGR--TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG----------- 256 (355)
T ss_pred eEEecCc--EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-----------
Confidence 9987544 5678999999999999765 4999999999999999999999999999999999998873
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPNA 371 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~~~ 371 (395)
...+++.++.++++||+++|++|-++|. ...++-.||||+.+.+.+.
T Consensus 257 ------------------~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i 308 (355)
T KOG0616|consen 257 ------------------KVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI 308 (355)
T ss_pred ------------------cccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence 1225667899999999999999999994 5679999999999988653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-54 Score=405.88 Aligned_cols=257 Identities=33% Similarity=0.524 Sum_probs=228.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
+-|++++.||.|+.|.|.+|++..||+.+|||++.+. ....++|+-+|+.++|||+++++++| ++..+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCce
Confidence 4599999999999999999999999999999999766 45567899999999999999999999 77778
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|+|.||++|| .+.++....+++++.+++++++||+.|+.|||.. +|+||||||+|+|+| ..+.|||+|||+|..
T Consensus 87 lylvlEyv~gG---ELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd-~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 87 LYLVLEYVPGG---ELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLD-VKNNIKIADFGMASL 161 (786)
T ss_pred EEEEEEecCCc---hhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhh-cccCEeeeccceeec
Confidence 99999999965 2333334478999999999999999999999995 999999999999999 556699999999998
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
...+.-..+.||++.|.|||++.|..+.+.++||||+|||||.||||++||++.+-...+.++.+.
T Consensus 162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G-------------- 227 (786)
T KOG0588|consen 162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG-------------- 227 (786)
T ss_pred ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC--------------
Confidence 888888888999999999999999998899999999999999999999999988888888877663
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
.| .++..+|.++++||++||.+||.+|+|.+|++.|||+.++......
T Consensus 228 ---~f------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 228 ---VF------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred ---cc------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 11 2456789999999999999999999999999999999987765443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-54 Score=384.43 Aligned_cols=254 Identities=30% Similarity=0.526 Sum_probs=217.2
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..++|.+.+.||+|+||+||+|+++.++..||||.+.+.. +....|+.+|+.++|||||.++++. +...
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence 3457999999999999999999999999999999986542 3345799999999999999999999 5666
Q ss_pred eEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--C---CcEEEe
Q 016115 149 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--T---HQVKLC 222 (395)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~---~~~kl~ 222 (395)
++|+|||||+|+ |...+. ..+.+++..++.++.||+.||++||+ ++||||||||.|||++.. + -.+||+
T Consensus 83 ~i~lVMEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred eEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEec
Confidence 799999999964 444443 35689999999999999999999999 799999999999999842 1 359999
Q ss_pred ecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 223 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
|||+|+....+....+.+|++.|||||++.. .+|+.|+|+||+|+|+|+|++|+.||...+..+.+..+.+...
T Consensus 158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~----- 231 (429)
T KOG0595|consen 158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE----- 231 (429)
T ss_pred ccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc-----
Confidence 9999999988888888999999999999965 4599999999999999999999999999988887775443211
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
....++..++....+|+...|+.++.+|.+..+-+.|+++..
T Consensus 232 ---------------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 232 ---------------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ---------------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 112244556788889999999999999999999999999865
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-53 Score=395.73 Aligned_cols=252 Identities=33% Similarity=0.513 Sum_probs=217.2
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc---------ccchHHHHHHHHHcC-CCceeeeceeeeecCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMD-HPNVISLKHCFFSTTS 144 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 144 (395)
..+.|.+++.||+|+||+|++|.+..+|+.||+|++.+. .....+|+.+++.++ ||||+++++++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~----- 89 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF----- 89 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE-----
Confidence 345799999999999999999999999999999977553 123347999999999 99999999999
Q ss_pred CCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCC-CcEEEe
Q 016115 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-HQVKLC 222 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~-~~~kl~ 222 (395)
.....+|+|||||.| .|++.+.. .+++.+..++.+++||+.|++|||+ +||+||||||+|||++ .+ +.+||+
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld-~~~~~~Kl~ 163 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLD-GNEGNLKLS 163 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEec-CCCCCEEEe
Confidence 445559999999997 55555443 6889999999999999999999999 6999999999999999 56 899999
Q ss_pred eccccccc-ccCCcceeeeecccccCchhhcCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 223 DFGSAKVL-VKGEANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 223 Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
|||++... .......+.+||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||...+....+..+.+.
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~----- 238 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG----- 238 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-----
Confidence 99999988 4566677889999999999998766 5578999999999999999999999998777777765541
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccC-ChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM-PPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.+. ++..+ |.++++||++||..||.+|+|+.+++.||||+..
T Consensus 239 ------------~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 239 ------------EFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred ------------Ccc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 122 33446 9999999999999999999999999999999973
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-53 Score=390.18 Aligned_cols=271 Identities=32% Similarity=0.507 Sum_probs=225.3
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..++|.+.+.||+|+||.||+|+-+.||+.||+|++++..- ....|..+|...+.++||+++..| ++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 45689999999999999999999999999999999976532 234588899999999999999999 788
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.++||||||++||-...|. .....+++.+++.++.+++.|++.||++ |+|||||||+|+||| ..|.+||+|||++
T Consensus 214 ~~LYLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD-~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLID-AKGHIKLSDFGLS 288 (550)
T ss_pred CeeEEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeec-CCCCEeecccccc
Confidence 8899999999976333332 2257899999999999999999999995 999999999999999 7889999999998
Q ss_pred ccccc------------------------CCc----c--------------------eeeeecccccCchhhcCCCCCCc
Q 016115 228 KVLVK------------------------GEA----N--------------------ISYICSRYYRAPELIFGATEYTT 259 (395)
Q Consensus 228 ~~~~~------------------------~~~----~--------------------~~~~gt~~y~aPE~~~~~~~~~~ 259 (395)
..+.. ... . .+.+|||.|||||++.+.+ |+.
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~ 367 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGK 367 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCc
Confidence 43311 000 0 1357999999999998866 999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHH
Q 016115 260 SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339 (395)
Q Consensus 260 ~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 339 (395)
.+|+||||||+||||.|.+||.+.+..+...+|+..... +.+|. ...+++++.||
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~----------~~~~s~eA~DL 422 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPE----------EVDLSDEAKDL 422 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCC----------cCcccHHHHHH
Confidence 999999999999999999999999999999999875211 11111 12468999999
Q ss_pred HHHhhccCCCCCCC---HHHHhcCCCCcCCCCCCCCCCCCCCCCCCC
Q 016115 340 ASRLLQYSPSLRCT---ALEACAHPFFDELREPNARLPNGRPFPPLF 383 (395)
Q Consensus 340 i~~~L~~dp~~Rpt---~~ell~hp~~~~~~~~~~~~~~~~~~~~~~ 383 (395)
|.+||+ ||++|.. ++||-.||||+.++++..+- ...+|.|.+
T Consensus 423 I~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~-~~apfvP~v 467 (550)
T KOG0605|consen 423 ITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLRE-MPAPFVPQV 467 (550)
T ss_pred HHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhc-CCCCCCCCC
Confidence 999999 9999996 89999999999999988763 335555554
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-52 Score=371.27 Aligned_cols=295 Identities=34% Similarity=0.673 Sum_probs=244.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHcCCCc-eeeeceeeeecCC-CCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPN-VISLKHCFFSTTS-KDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~-~~~~ 148 (395)
..|..+++||+|+||+||+|+.+.+|+.||+|++.-+.. ...+|+.+++.++|+| ||.+++++..... ....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 357778889999999999999999999999999864432 2368999999999999 9999999865442 2334
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+++|+||++-++...+.........++...++.+++||+.||+|||+ .||+||||||.||||+ +.|.+||+|||+|+
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~-~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLIS-SSGVLKLADFGLAR 168 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEEC-CCCcEeeeccchHH
Confidence 689999999998888887765443567778999999999999999999 5999999999999999 69999999999999
Q ss_pred ccc-cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 229 VLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 229 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
... .....+..++|.+|+|||++.+...|+...||||+|||++||++++..|.+..+.+++..|.+.+|.|....|...
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 776 3344667889999999999999988999999999999999999999999999999999999999999999888754
Q ss_pred C--CCCCCCCCCCcc-CCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCC
Q 016115 308 N--PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 375 (395)
Q Consensus 308 ~--~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~ 375 (395)
. +.+.. .++... ...+. ......+++..+++.+||+++|.+|.|++.+|.||||..+......+..
T Consensus 249 ~~~~~~k~-~f~~~~~~~~l~-~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~~~~ 317 (323)
T KOG0594|consen 249 SSLPDYKA-PFPKWPGPKDLS-SILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQLLL 317 (323)
T ss_pred cccccccc-cCcCCCCccchH-HhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhhhhc
Confidence 3 22221 222222 11111 1223445799999999999999999999999999999998776665443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-54 Score=366.41 Aligned_cols=247 Identities=30% Similarity=0.489 Sum_probs=210.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecc------cccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
..+|.+.++||+|+||.||++.+..+|..+|.|.+.- .+...-.|+.+|+.|+|||||++++.-+. ++...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence 3469999999999999999999999999999998852 23344579999999999999999884332 33444
Q ss_pred EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-CC--ceeccCCCCceeecCCCCcEEEeecc
Q 016115 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PG--VCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
++||||||+ |+|...++++....+.+++..+|+++.|+|.||.++|.. .. |+||||||.||+++ .+|.+||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccch
Confidence 889999999 688889999999999999999999999999999999982 13 99999999999999 79999999999
Q ss_pred cccccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 226 SAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 226 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
+++.+..... ..+.+|||+||+||++.+.+ |+.+|||||+||++|||+.-++||.+.+-.+...+|.+.--.+.
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~---- 248 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL---- 248 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC----
Confidence 9998866544 34689999999999998765 99999999999999999999999999977777777765311111
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~ 354 (395)
....+|.++..||..|+.+||+.||+.
T Consensus 249 -----------------------p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 249 -----------------------PDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred -----------------------cHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 114579999999999999999999985
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-55 Score=366.01 Aligned_cols=276 Identities=29% Similarity=0.410 Sum_probs=232.0
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecc------cccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..+.|.+.+.||+|.|+.||++.+..+|+.+|+|++.. +.+..++|+++.+.|+||||+++.+.+ ....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence 34579999999999999999999999999999998842 345567899999999999999999988 7777
Q ss_pred eEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCcEEEeecc
Q 016115 149 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFG 225 (395)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg 225 (395)
+.|+|+|++.|+ +...+-. ...+++..+-.+++||++||.|+|. +||||||+||+|+++.++ +--+||+|||
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred eeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccc
Confidence 899999999974 4443333 2567888899999999999999999 799999999999999633 3469999999
Q ss_pred cccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 226 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
+|.....+.....+.|||.|||||++... .|+..+|||+.||+||-||.|.+||.+.+....+++|+..--+.+.
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~---- 233 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS---- 233 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC----
Confidence 99998877777788999999999999765 4999999999999999999999999999999999988874222111
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCCCCc
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 385 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~ 385 (395)
..++.+++++++||++||..||.+|+|+.|+|+|||+.+-...+........+..+.+|
T Consensus 234 ---------------------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkf 292 (355)
T KOG0033|consen 234 ---------------------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKF 292 (355)
T ss_pred ---------------------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHh
Confidence 13367899999999999999999999999999999998866655555555555555556
Q ss_pred h
Q 016115 386 K 386 (395)
Q Consensus 386 ~ 386 (395)
+
T Consensus 293 N 293 (355)
T KOG0033|consen 293 N 293 (355)
T ss_pred h
Confidence 5
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=391.21 Aligned_cols=280 Identities=36% Similarity=0.615 Sum_probs=232.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchH---HHHHHHHHcC-C-----CceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMD-H-----PNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~~~ 148 (395)
+|.+.+.||+|+||.|.+|.+..|++.||||+++....+.. .|+.+|..|+ | -|+|+++++| ...+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence 58999999999999999999999999999999988766554 5888888887 3 4899999999 5566
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec-CCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD-PLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~-~~~~~~kl~Dfg~a 227 (395)
++|||+|+++-+|+++++.... ..++...++.++.||+.||.+||+ .||||+|||||||||. .....|||+|||.|
T Consensus 262 HlciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 6999999999999999987554 569999999999999999999999 5999999999999995 23457999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
+.....-. +++.+..|+|||++.|.. |+.+.||||||||++||++|.+.|.+.+..+++..|+.++|.|+...++..
T Consensus 339 c~~~q~vy--tYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFESQRVY--TYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccCCcce--eeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 87644433 788999999999999865 999999999999999999999999999999999999999999998877654
Q ss_pred CCCCCCCCC----CC---c---------------------------cCCCccccccccCChhHHHHHHHhhccCCCCCCC
Q 016115 308 NPNYTDFRF----PQ---I---------------------------KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 353 (395)
Q Consensus 308 ~~~~~~~~~----~~---~---------------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt 353 (395)
......+.- +. . ....+...........+.|||++||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 332221111 00 0 1111112222233456899999999999999999
Q ss_pred HHHHhcCCCCcCCCC
Q 016115 354 ALEACAHPFFDELRE 368 (395)
Q Consensus 354 ~~ell~hp~~~~~~~ 368 (395)
+.++|+||||+....
T Consensus 496 p~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 496 PAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHhcCcccccccc
Confidence 999999999985443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=388.57 Aligned_cols=257 Identities=30% Similarity=0.497 Sum_probs=224.2
Q ss_pred CccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcC-CCceeeeceeeeecCC
Q 016115 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMD-HPNVISLKHCFFSTTS 144 (395)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 144 (395)
....++|.+.++||+|+||+|+++..+.+++.||||.++++. +....|.+|+...+ ||.++.++.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f----- 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF----- 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence 345668999999999999999999999999999999987653 23346788877775 99999999999
Q ss_pred CCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
+...++|+||||+.|+. +.+ ......+++..++.++.+|+.||.|||+ +|||+||||.+|||+| ..|.+||+||
T Consensus 439 QT~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD-~eGh~kiADF 512 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLD-TEGHVKIADF 512 (694)
T ss_pred ccCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEc-ccCcEEeccc
Confidence 77778999999999984 222 2335789999999999999999999999 6999999999999999 6888999999
Q ss_pred ccccccc-cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 225 GSAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 225 g~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
|+++..- .+...++++||+.|||||++.+. .|+.++|+|||||+|||||.|..||.+.+.++.+..|+..
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-------- 583 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-------- 583 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------
Confidence 9998754 56667789999999999999765 5999999999999999999999999999999999988762
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCCCcCCCCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN 370 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~hp~~~~~~~~~ 370 (395)
...++..+|.++.++++++|.+||++|..+ .++..||||+.+++.+
T Consensus 584 ---------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 584 ---------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred ---------------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence 122556789999999999999999999975 7899999999999854
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=371.49 Aligned_cols=258 Identities=33% Similarity=0.538 Sum_probs=207.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.+|...+.||+|+||+||++.+..+|+.+|||.+... .....+|+.+|+.++|||||+.+|....... ..++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence 3588889999999999999999999999999998765 3345789999999999999999996422111 46899
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
.|||++| ++.+.+..+. ..+++..++.+++||++||.|||+ +||+|+||||+|||++..++.+||+|||+++...
T Consensus 94 ~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999996 5545544421 279999999999999999999999 7999999999999999437899999999998765
Q ss_pred c----CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCChhhhhh
Q 016115 232 K----GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 232 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
. ........||+.|||||++..+.....++|||||||++.||+||..||... ...+.+..+... .
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---~------- 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---D------- 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---C-------
Confidence 3 222345789999999999975333446999999999999999999999874 332322222221 0
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
....++..+|+++++||.+||.+||.+||||+++|+|||.+.-..
T Consensus 240 -----------------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 240 -----------------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred -----------------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 011356678999999999999999999999999999999976444
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=364.66 Aligned_cols=274 Identities=27% Similarity=0.438 Sum_probs=222.3
Q ss_pred CCCCCccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecC
Q 016115 69 KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (395)
Q Consensus 69 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (395)
+...+.....|++...||.|..++||+|++..+++.||||++.-+ .....+|+..++.++||||++.+.+|...
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~- 96 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD- 96 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-
Confidence 334555667899999999999999999999999999999999633 24556899999999999999999999444
Q ss_pred CCCceeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEe
Q 016115 144 SKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~ 222 (395)
..+|+||.||. |++++.++.+.. ..+.|..++.|+++++.||.|||. +|.||||||+.||||+ ++|.|||+
T Consensus 97 ----~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~-~dG~VkLa 168 (516)
T KOG0582|consen 97 ----SELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILID-SDGTVKLA 168 (516)
T ss_pred ----ceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEc-CCCcEEEc
Confidence 44999999999 577777776554 559999999999999999999999 6999999999999999 89999999
Q ss_pred ecccccccccCC-cc----eeeeecccccCchhh-cCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016115 223 DFGSAKVLVKGE-AN----ISYICSRYYRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296 (395)
Q Consensus 223 Dfg~a~~~~~~~-~~----~~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~ 296 (395)
|||.+..+.... .. ..++||++|||||++ .....|+.|+|||||||+.+||.+|..||........+..-++
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq-- 246 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ-- 246 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--
Confidence 999876553332 21 345899999999994 4444599999999999999999999999998877665544333
Q ss_pred CCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
+.++.-. ..-........++..++.+|..||.+||++|||++++|.|+||+.....+
T Consensus 247 n~pp~~~-----------------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 247 NDPPTLL-----------------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred CCCCCcc-----------------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 3333111 01111222345688999999999999999999999999999999876644
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=382.30 Aligned_cols=255 Identities=28% Similarity=0.474 Sum_probs=216.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
..|.....||+|+.|.||.|+...+++.||||.+... ++..-+|+.+|+.++|+|||.+++.|... ..+++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEE
Confidence 3588888999999999999999999999999998533 34455799999999999999999999654 33999
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
||||++|+.+..+.. ...++|.+++.|+++++.||+|||. +||+|||||.+|||++ .+|.+||+|||++..+..
T Consensus 348 VMEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~-~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLT-MDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EEeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEec-cCCcEEEeeeeeeecccc
Confidence 999999754444332 3569999999999999999999999 7999999999999999 788999999999988766
Q ss_pred CC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
.. ...+.+||++|||||++. ...|+++.||||||+++.||+-|.+||-..+....+..|.. .|.+..
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~l---------- 489 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKL---------- 489 (550)
T ss_pred ccCccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCc----------
Confidence 65 566789999999999995 45699999999999999999999999998777766665554 222221
Q ss_pred CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
..+..+|+.+++|+.+||+.|+.+|+++.|||+||||+.....
T Consensus 490 ---------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ 532 (550)
T KOG0578|consen 490 ---------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPE 532 (550)
T ss_pred ---------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCH
Confidence 1345789999999999999999999999999999999655443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=367.25 Aligned_cols=277 Identities=33% Similarity=0.640 Sum_probs=226.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
..+|.+.+.||+|+||+||+|++..++..||+|.+.... ....+|+.+++.++|+||+++++++ .+....
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 346999999999999999999999999999999886332 2345799999999999999999988 445568
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||++|++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 79 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 79 TLVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLIN-EKGELKLADFGLARAK 153 (288)
T ss_pred EEEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEC-CCCCEEECcCcceeec
Confidence 999999999877766532 3457899999999999999999999 6999999999999999 7889999999998764
Q ss_pred ccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... ......+++.|+|||++.+...++.++|||||||++|+|+||+.||.+.+..+.+..+.+..+.+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 3322 223456799999999987666689999999999999999999999999999999999999888888877654321
Q ss_pred --CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 --NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 --~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
.+..+.++.....++.. ....++.++.+||++||++||.+|||++|+|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLIN-HAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred chhhhccccCccCCCchHH-hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 22222222222222211 234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-51 Score=370.81 Aligned_cols=260 Identities=28% Similarity=0.448 Sum_probs=215.3
Q ss_pred CCCccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------------------cchHHHHHHHHHcCCCce
Q 016115 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------RYKNRELQLMRLMDHPNV 132 (395)
Q Consensus 71 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------------~~~~~e~~~l~~l~h~ni 132 (395)
...+...+|++.+.||+|.||+|-+|++..+++.||||++.+.. +...+|+.+|+++.|+||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 33455668999999999999999999999999999999985431 133579999999999999
Q ss_pred eeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCC-CCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCcee
Q 016115 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL 211 (395)
Q Consensus 133 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~-~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nil 211 (395)
|+++++. ++.....+|||+|||..+ .+.. ....+. +.+.+++.+++.++.||+|||. +||+||||||+|+|
T Consensus 171 V~LiEvL---DDP~s~~~YlVley~s~G---~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 171 VKLIEVL---DDPESDKLYLVLEYCSKG---EVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLL 242 (576)
T ss_pred eEEEEee---cCcccCceEEEEEeccCC---cccc-CCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheE
Confidence 9999987 345566799999999965 2222 222344 9999999999999999999999 69999999999999
Q ss_pred ecCCCCcEEEeecccccccccC------CcceeeeecccccCchhhcC---CCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 016115 212 VDPLTHQVKLCDFGSAKVLVKG------EANISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (395)
Q Consensus 212 l~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~ 282 (395)
++ ++|.+||+|||.+.....+ ......+|||.|+|||.+.+ ....+.+.||||+||+||.|+.|+.||-+
T Consensus 243 l~-~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 243 LS-SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred Ec-CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 99 7899999999999766322 12234789999999999876 33457899999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 016115 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (395)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 362 (395)
....+.+.+|+.. ...++.. ..+.+.++|||++||++||++|++..++..|||
T Consensus 322 ~~~~~l~~KIvn~-----------------pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 322 DFELELFDKIVND-----------------PLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred chHHHHHHHHhcC-----------------cccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 9999888888762 1222221 236889999999999999999999999999999
Q ss_pred CcCC
Q 016115 363 FDEL 366 (395)
Q Consensus 363 ~~~~ 366 (395)
...-
T Consensus 375 vt~~ 378 (576)
T KOG0585|consen 375 VTRD 378 (576)
T ss_pred eccC
Confidence 8654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-51 Score=378.89 Aligned_cols=250 Identities=30% Similarity=0.540 Sum_probs=217.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.+|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+ ...+|+++++.++|||||.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 368888999999999999999999999999999865433 245899999999999999999999 777779
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++|.|||.|+|...+.. ++.++|+.++.++.+++.||.|||+ .+|+|||+||.|||++ .++.+|+||||+|+..
T Consensus 77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLE-KGGTLKLCDFGLARAM 150 (808)
T ss_pred EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeec-CCCceeechhhhhhhc
Confidence 99999999987777765 6899999999999999999999999 5999999999999999 7999999999999987
Q ss_pred ccCCcc-eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..+... +...|||.|||||++.+ ..|+..+|+||||||+|||++|++||......+....|... +.
T Consensus 151 ~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~v--------- 217 (808)
T KOG0597|consen 151 STNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---PV--------- 217 (808)
T ss_pred ccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---CC---------
Confidence 665543 44569999999999975 45999999999999999999999999987666665555541 11
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
.++...|..+..|+..+|.+||.+|.|..+++.|||+++--
T Consensus 218 -----------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 218 -----------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred -----------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 12346799999999999999999999999999999998743
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=373.69 Aligned_cols=289 Identities=37% Similarity=0.654 Sum_probs=226.6
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||+|+||.||+|++..+|..||||.+... .....+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 489999999999999999999999999999988632 12345799999999999999999988655444445689
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||+++++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILAN-ADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEC-CCCcEEEccCccccccc
Confidence 9999999887776654 4568999999999999999999999 6999999999999999 78899999999997643
Q ss_pred cCCc----ceeeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 232 KGEA----NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 232 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
.... .....||+.|+|||++.+. ..++.++|||||||++|+|+||+.||.+.+....+..+....+.+....+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 1235689999999998542 4589999999999999999999999999888888887777777776654433
Q ss_pred cCCCCC-CC--CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCC
Q 016115 307 MNPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 373 (395)
Q Consensus 307 ~~~~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~ 373 (395)
...... .+ ........++.. ....+++.+.+||.+||+.||++|||++|+++||||+.+.......
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~ 303 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQ-KFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREP 303 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHH-hcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcccccc
Confidence 211100 00 000000001111 1124678899999999999999999999999999999887765443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-50 Score=358.46 Aligned_cols=276 Identities=27% Similarity=0.440 Sum_probs=234.1
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
....|++.+.||.|.-|+||+++...++..+|+|++.+.. .....|.+||+.++||.+++++..| +..
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETD 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ecc
Confidence 3456999999999999999999999999999999996542 2234588999999999999999999 777
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+.|+|||||+|+-+..+.+ .+.++.+++..++.++.+++-||+|||.+ |||+|||||+||||. ++|.|-|+||.++
T Consensus 150 ~~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvr-edGHIMLsDFDLS 226 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVR-EDGHIMLSDFDLS 226 (459)
T ss_pred ceeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEe-cCCcEEeeecccc
Confidence 78999999999875555554 34578999999999999999999999995 999999999999999 7899999999987
Q ss_pred ccccc---------------------------------C-C-----------------------cceeeeecccccCchh
Q 016115 228 KVLVK---------------------------------G-E-----------------------ANISYICSRYYRAPEL 250 (395)
Q Consensus 228 ~~~~~---------------------------------~-~-----------------------~~~~~~gt~~y~aPE~ 250 (395)
..... . . ...+++||..|.|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 33210 0 0 0124678999999999
Q ss_pred hcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccc
Q 016115 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 330 (395)
Q Consensus 251 ~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (395)
+.|.+ .+.++|+|+|||++||||.|..||.+.+..+++.+|+.. +..++.. .
T Consensus 307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~----------~ 358 (459)
T KOG0610|consen 307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE----------P 358 (459)
T ss_pred eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC----------C
Confidence 98876 899999999999999999999999999999999988762 2222221 2
Q ss_pred cCChhHHHHHHHhhccCCCCCCC----HHHHhcCCCCcCCCCCCCCCCCCCCCCCCCCch
Q 016115 331 RMPPEAIDLASRLLQYSPSLRCT----ALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386 (395)
Q Consensus 331 ~~s~~~~~li~~~L~~dp~~Rpt----~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (395)
.++..++|||+++|.+||.+|.. |.||-+||||+.+++..-+....+.+|......
T Consensus 359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~ 418 (459)
T KOG0610|consen 359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGG 418 (459)
T ss_pred cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccC
Confidence 46889999999999999999999 999999999999999988888888878777664
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=351.46 Aligned_cols=259 Identities=31% Similarity=0.487 Sum_probs=219.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------------ccchHHHHHHHHHc-CCCceeeeceeeeecCC
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------------RRYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 144 (395)
.|.-.+.||+|..++|.++.++.+|..+|+|++... .+...+|+.+|+++ .||+|+++.++|
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----- 92 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----- 92 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence 477778899999999999999999999999988421 12234689999987 599999999999
Q ss_pred CCceeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEee
Q 016115 145 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (395)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~D 223 (395)
+...++++|+|.|+ |.|.+.| .....++++..++|++|+++|+.|||. ++||||||||+|||++ ++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILld-dn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLD-DNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeec-cccceEEec
Confidence 77778999999999 5555444 446789999999999999999999999 7999999999999999 899999999
Q ss_pred cccccccccCCcceeeeecccccCchhhcC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016115 224 FGSAKVLVKGEANISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (395)
Q Consensus 224 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~ 298 (395)
||+|+.+..+......+|||+|.|||.+.. ...|+..+|+|++|||||.|+.|.+||......-++..|+...-.
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999843 334888999999999999999999999988777777777763211
Q ss_pred CChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
.. .+ -+..+|...+|||.+||++||++|.|++|+|.||||..+.....+
T Consensus 247 F~---------------sp----------eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 247 FR---------------SP----------EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred cC---------------Cc----------chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence 11 11 124579999999999999999999999999999999765544443
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=365.37 Aligned_cols=283 Identities=33% Similarity=0.562 Sum_probs=217.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++ .+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence 357999999999999999999999999999999986432 2345799999999999999999988 445569
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||+++++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLIS-DTGELKLADFGLARAK 153 (303)
T ss_pred EEEEECCCcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCCEEECCCCcceec
Confidence 999999999887776542 3568899999999999999999999 6999999999999999 7889999999998754
Q ss_pred ccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhhhhcC
Q 016115 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 231 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.. ..+.+..+....+.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 322 222345679999999998766668999999999999999999999998754 345556666655655544332211
Q ss_pred --CCCCCCCCCCccCCCccccc-cccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 309 --PNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 309 --~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
+.+....+.......+...+ ...+++++.+||.+||++||.+|||+.|+++||||+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 00000001000011111111 1135678999999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=335.75 Aligned_cols=253 Identities=29% Similarity=0.453 Sum_probs=221.4
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
...++|++++.||+|.||.||+|+.+.++-.||+|++.+. .....+|++|...|+||||+++++.| .+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd 93 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HD 93 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ec
Confidence 4556899999999999999999999999999999998644 24456899999999999999999999 67
Q ss_pred ceeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+|+++||.+ |.++..|.. .....+++...+.++.|++.||.|+|. ++++||||||+|+|++ ..+.+||+|||
T Consensus 94 ~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg-~~~~lkiAdfG 169 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLG-SAGELKIADFG 169 (281)
T ss_pred cceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccC-CCCCeeccCCC
Confidence 777999999998 566666653 235778999999999999999999999 7999999999999999 78999999999
Q ss_pred cccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 226 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
.+.... .....+.+||..|.+||...+.. ++..+|+|++|++.||++.|.+||...+..+.+..|.+.
T Consensus 170 wsV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~---------- 237 (281)
T KOG0580|consen 170 WSVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV---------- 237 (281)
T ss_pred ceeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc----------
Confidence 997654 55667889999999999997654 899999999999999999999999999888888888773
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
++ .++..++.++.|||.+||.++|.+|.+..|++.|||+.+.
T Consensus 238 -------~~------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 238 -------DL------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred -------cc------------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 11 1345789999999999999999999999999999998764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=359.25 Aligned_cols=279 Identities=34% Similarity=0.586 Sum_probs=219.3
Q ss_pred CceeeeeeecCCceEEEEEEECC-CCcEEEEEEecccc------cchHHHHHHHHHc---CCCceeeeceeeeecCCCCc
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~ 147 (395)
+|++.+.||+|+||+||+|++.. +|..||+|.+.... ....+|+.+++.+ +||||+++++++........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 69999999999999999999854 46889999885322 1234577777665 69999999998855444455
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..+++||||+++++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~-~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVT-SSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEc-CCCCEEEccccce
Confidence 5689999999998877775432 3458999999999999999999999 6999999999999999 6889999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
+............||..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 876555444556789999999999654 5899999999999999999999999999999999888887776655443221
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
. ......+......+. ..+...++..+.+||.+||+.||++|||+.++|+||||
T Consensus 237 ~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 V-ALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred h-cccchhccCCCCCCH-HHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1 011111111111111 12234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=358.69 Aligned_cols=275 Identities=37% Similarity=0.709 Sum_probs=221.0
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++ .....++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY 76 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence 6999999999999999999999999999999886431 2345799999999999999999988 5555699
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||+++++++.+.. ....+++..++.++.||+.||.|||+ .||+||||||+||+++ .++.+||+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLIS-HNDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEc-CCCcEEEeeccCccccc
Confidence 9999999987766543 23578999999999999999999999 6999999999999999 78899999999998764
Q ss_pred cCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC-
Q 016115 232 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 308 (395)
Q Consensus 232 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 308 (395)
.... .....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....+..+...+....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 3322 23456899999999997654 8999999999999999999999999988888877777777766655443221
Q ss_pred -CCCCCCCCCCcc-CCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 309 -PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 309 -~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
+.+....++... ...+...+...+|.++.+||++||++||++|||++++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 111111111111 1112223344578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=367.50 Aligned_cols=257 Identities=31% Similarity=0.513 Sum_probs=220.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcC-CCceeeeceeeeecCCCCc
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~ 147 (395)
...|.+.+.||+|.||.||+|+.+.+|+.+|+|.+.+.. ....+|+.+|+.+. |||||.+.+.| ++.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----EDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----EcC
Confidence 346999999999999999999999999999999996543 35678999999999 99999999999 556
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC---CCcEEEee
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL---THQVKLCD 223 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~---~~~~kl~D 223 (395)
..+++|||+|.| .|++.+... .+++..+..++.|++.|+.|||+ .||+||||||+|+|+... ++.+|++|
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEee
Confidence 679999999996 555555443 39999999999999999999999 699999999999999743 24799999
Q ss_pred cccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 224 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
||++.....+......+||+.|+|||++.. ..|+..+||||+|+++|.|++|..||.+.+......++....-
T Consensus 183 FGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~------ 255 (382)
T KOG0032|consen 183 FGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF------ 255 (382)
T ss_pred CCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC------
Confidence 999999887667778899999999999964 4599999999999999999999999999998888887766311
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
. +....+..++..+++||++||..||.+|+|+.++|+|||++.....
T Consensus 256 -----------~--------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 256 -----------D--------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred -----------C--------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence 1 1122345679999999999999999999999999999999876443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=367.22 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=199.7
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
...+|...+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++|+||+++++++ .....
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 146 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE 146 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence 3456889999999999999999999999999999985432 3345799999999999999999988 55556
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++||||+.++.+.. .....+..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 147 ~~lv~e~~~~~~L~~-------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~~~~kL~DfG~~~~ 217 (353)
T PLN00034 147 IQVLLEFMDGGSLEG-------THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLIN-SAKNVKIADFGVSRI 217 (353)
T ss_pred EEEEEecCCCCcccc-------cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEc-CCCCEEEccccccee
Confidence 899999999864321 2345677888999999999999999 6999999999999999 788999999999986
Q ss_pred cccCC-cceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 230 LVKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 230 ~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
..... ......||..|+|||++.. ....+.++|||||||++|+|++|+.||......+....+.......
T Consensus 218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----- 292 (353)
T PLN00034 218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----- 292 (353)
T ss_pred cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-----
Confidence 54332 2234578999999998743 2234568999999999999999999997443222222111110000
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
.......++.++.+||.+||..||++|||+.|+++||||.+-.
T Consensus 293 --------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 --------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred --------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0012235688999999999999999999999999999998753
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=365.39 Aligned_cols=289 Identities=32% Similarity=0.558 Sum_probs=228.1
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (395)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 357999999999999999999999999999999986431 233468999999999999999988744321 2334
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+|+||||+++++...+. ..+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEEC-CCCcEEEEeCCCcc
Confidence 589999999998777664 347888899999999999999999 6999999999999999 78899999999998
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
............||..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+....
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 76554444556789999999999764 48999999999999999999999999999999888888888877665444332
Q ss_pred C----------CCCCCCCCCc---cCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCC
Q 016115 309 P----------NYTDFRFPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 373 (395)
Q Consensus 309 ~----------~~~~~~~~~~---~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~ 373 (395)
+ .+..+.+... ...++........+..+++||.+||+.||.+|||+.|+|+||||....++....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 331 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence 1 1111111000 001111112223467899999999999999999999999999998766655443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=357.03 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=207.7
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++.+++ .+...+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 3788999999999999999999999999999885332 1234689999999999999999988 455569
Q ss_pred EEEEecccchHH-HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~l~-~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||++++.+ ..+.. .....+++..++.++.|++.||.|||+ +||+||||||+|||++ +++.+||+|||++..
T Consensus 76 ~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~-~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLD-DRGHIRISDLGLAVQ 151 (285)
T ss_pred EEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEEC-CCCCEEEeeCCCcEE
Confidence 999999996543 33332 123468999999999999999999999 6999999999999999 788999999999987
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
...........||..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.......
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 220 (285)
T cd05631 152 IPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED---------- 220 (285)
T ss_pred cCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------
Confidence 6544444456789999999999754 58999999999999999999999998765443333222211110
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~~ 369 (395)
...++..++.++.+||++||+.||.+|++ ++++++||||+.++..
T Consensus 221 ---------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 221 ---------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred ---------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 01133457899999999999999999997 8999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=353.66 Aligned_cols=279 Identities=30% Similarity=0.545 Sum_probs=220.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHc---CCCceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 148 (395)
+|++.+.||+|+||+||+|++..+|+.||+|.+.... ....+|+.+++.+ +|+||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4889999999999999999999999999999886421 1234577776655 799999999988655444556
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+++||||+.+++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~-~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVT-SGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC-CCCCEEECccCccc
Confidence 789999999998777765432 2458999999999999999999999 6999999999999999 78899999999998
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
............||..|+|||++.+. .++.++|||||||++|+|++|.+||......+.+..+....+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 76554444456789999999999664 48999999999999999999999999988888888888877766554433210
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
. .....+......+ .......++..+.+||.+||++||.+|||+.|++.||||
T Consensus 236 ~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 T-LPRGAFSPRGPRP-VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred c-ccccccCCCCCCc-hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0000011100011 112234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=360.30 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=209.0
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+.+++.++||||+++++++ .+...+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 76 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL 76 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence 689999999999999999999999999999998532 22345799999999999999999887 556679
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLD-KEGHIKLTDFGFAKK 150 (291)
T ss_pred EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEEC-CCCCEEEEecCcchh
Confidence 999999986 45554443 4578999999999999999999999 6999999999999999 788999999999986
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+....
T Consensus 151 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------------- 214 (291)
T cd05612 151 LRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK------------- 214 (291)
T ss_pred ccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 6432 2345689999999999654 48999999999999999999999999887766665554310
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~~ 369 (395)
..++..++..+++||++||+.||.+|++ ++++++||||+.+...
T Consensus 215 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 215 ----------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred ----------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 0123456889999999999999999995 9999999999987664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=367.33 Aligned_cols=285 Identities=32% Similarity=0.566 Sum_probs=222.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCC-CCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (395)
..+|++.+.||+|+||.||++.+..+|..||+|++... .....+|+.+++.++||||+++++++..... ....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 35799999999999999999999999999999998543 2233478999999999999999998854332 1223
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+|+||||+++++...+. ..+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEC-CCCCEEEecCCCcc
Confidence 578999999998776653 347888999999999999999999 6999999999999999 78899999999997
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.+.++.+.........
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 65544444556789999999999664 58999999999999999999999999988888888888877776654332211
Q ss_pred ----------CCCCCCCCCCc-cCC--CccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 309 ----------PNYTDFRFPQI-KAH--PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 309 ----------~~~~~~~~~~~-~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
+.+....+.+. ..+ +.........+.++.+||.+||..||++|||+.|+|+||||+....+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 11111111000 000 00011122357889999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=356.43 Aligned_cols=282 Identities=34% Similarity=0.645 Sum_probs=227.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
..+|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++ ......
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeE
Confidence 356999999999999999999999999999999886332 2345799999999999999999988 444568
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||+++++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 80 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLIN-ERGELKLADFGLARAK 154 (309)
T ss_pred EEEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCCEEECccccceec
Confidence 999999999877766542 3457889999999999999999999 6999999999999999 6889999999998764
Q ss_pred ccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... .....++..|+|||++.+...++.++|||||||++|+|+||+.||.+.+..+.+..+.+..+.+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 33222 23346789999999987666689999999999999999999999999998899999999888888776654321
Q ss_pred C--CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 310 N--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 310 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
. +..+.++......+.. ....++.++.+||.+||+.||.+|||+.|+++||||+.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred hhhhhhhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 1 1111122111111111 22357899999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=363.26 Aligned_cols=251 Identities=28% Similarity=0.430 Sum_probs=209.1
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..+|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence 457999999999999999999999999999999986432 2345799999999999999999988 4555
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~-~~~~~kl~Dfg~~ 165 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLD-NKGHVKVTDFGFA 165 (329)
T ss_pred EEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEC-CCCCEEEeeccCc
Confidence 69999999986 44444443 4678999999999999999999999 6999999999999999 7889999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
+..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~--------- 231 (329)
T PTZ00263 166 KKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--R--------- 231 (329)
T ss_pred eEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--C---------
Confidence 865433 2345789999999999765 4799999999999999999999999887766655544331 0
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~~ 369 (395)
..++..++..+.+||++||+.||.+|++ ++++++||||++..+.
T Consensus 232 ------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 232 ------------------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred ------------------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 0122346889999999999999999997 7999999999886543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=364.02 Aligned_cols=245 Identities=27% Similarity=0.440 Sum_probs=202.1
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 36999999999999999999999999986432 2234688999999999999999988 55566999999
Q ss_pred cccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc-C
Q 016115 156 YVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-G 233 (395)
Q Consensus 156 ~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~ 233 (395)
|++|+ +.+.+.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++ .++.+||+|||+++.... .
T Consensus 76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCC
Confidence 99965 4344332 4678999999999999999999999 6999999999999999 688999999999875322 2
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 211 (323)
T ss_pred CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 233456789999999999654 5899999999999999999999999887765554443321 0
Q ss_pred CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
..++..+++++.+||++||+.||++|| ++.++++||||+.+..
T Consensus 212 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 212 ------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred ------------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 012345789999999999999999999 8999999999988644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=363.84 Aligned_cols=285 Identities=33% Similarity=0.575 Sum_probs=225.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (395)
.++|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 357999999999999999999999999999999886431 233468999999999999999998754332 2234
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+++||||+++++...+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~-~~~~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEC-CCCCEEEeeCcccc
Confidence 578999999998776654 347888899999999999999999 6999999999999999 78899999999998
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
............||..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...++.+....+....
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 76555444556789999999999664 48999999999999999999999999998888888888888777665544332
Q ss_pred CC----------CCCCCCCCcc---CCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 309 PN----------YTDFRFPQIK---AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 309 ~~----------~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
+. +....++... ..+.........+.++.+||.+||+.||.+|||+.|+|+||||....++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 21 1111111100 0011111223456789999999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=368.75 Aligned_cols=284 Identities=33% Similarity=0.573 Sum_probs=224.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||+|+||.||++.+..+|+.||||.+... .....+|+.+++.++|+||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 377889999999999999999999999999988542 12345799999999999999999988543322223689
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||+.+++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVN-SNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEEC-CCCCEEeccccceeecc
Confidence 9999999887766543 4678999999999999999999999 6999999999999999 78899999999997654
Q ss_pred cCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 232 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 232 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.+|.+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 3322 22346788999999997766689999999999999999999999999999999999999888887765533211
Q ss_pred CCCCCCCCCcc---CCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 310 NYTDFRFPQIK---AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 310 ~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
........... ............++++.+||.+||+.||.+|||+.|+++||||+..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 10000000000 00000112344688999999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=336.48 Aligned_cols=278 Identities=28% Similarity=0.441 Sum_probs=213.3
Q ss_pred ccCceee-eeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHH-cCCCceeeeceeeeecCCCCceeEEEE
Q 016115 76 TISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 76 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
+++|.+. ++||-|-.|+|-.+.++.||+.+|+|++... ....+|+++-.. -.|+|||.++++|.... .+...+.+|
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiV 137 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-PKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIV 137 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-HHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEee
Confidence 3456664 5799999999999999999999999976544 345568887444 46999999999984433 345678899
Q ss_pred Eecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC--CCCcEEEeeccccccc
Q 016115 154 MEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAKVL 230 (395)
Q Consensus 154 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~--~~~~~kl~Dfg~a~~~ 230 (395)
||.++|+ |+..+.. .....++|.++..|++||+.|+.|||++ +|.||||||+|+|... .+-.+||+|||+|+..
T Consensus 138 mE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 138 MECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred eecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEeccccccccc
Confidence 9999976 3333332 2346799999999999999999999995 9999999999999962 3457999999999987
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.......+.+.|++|.|||++ +..+|+..+|+||+||++|-||+|.+||+.......-..+.+. ++
T Consensus 215 ~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~r--------I~----- 280 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRR--------IR----- 280 (400)
T ss_pred CCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhH--------hh-----
Confidence 666666777889999999998 5566999999999999999999999999876543211111111 00
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC-CCCCCCCCCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE-PNARLPNGRPFP 380 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~-~~~~~~~~~~~~ 380 (395)
...|.|+.. -++.+|++++|+|+++|..+|++|.|++++++|||+..... +...+.+++.++
T Consensus 281 ~gqy~FP~p--------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l~ 343 (400)
T KOG0604|consen 281 TGQYEFPEP--------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRMLK 343 (400)
T ss_pred ccCccCCCh--------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhcc
Confidence 122333332 12567999999999999999999999999999999987554 444444444443
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=371.49 Aligned_cols=286 Identities=22% Similarity=0.338 Sum_probs=214.1
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCC------ceeeeceeeeecCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHP------NVISLKHCFFSTTSK 145 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~ 145 (395)
...+|++.+.||+|+||+||+|.+..+++.||||++.... .....|+.+++.++|. +++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~---- 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN---- 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----
Confidence 3467999999999999999999999999999999986432 2334578888777654 47888777632
Q ss_pred CceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC--------
Q 016115 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-------- 217 (395)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~-------- 217 (395)
...++|+|||++++++++.+.. ...+++..++.++.||+.||.|||+..||+||||||+|||++..+.
T Consensus 203 ~~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 2346899999999888877654 3578999999999999999999997239999999999999983221
Q ss_pred -------cEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHH
Q 016115 218 -------QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290 (395)
Q Consensus 218 -------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 290 (395)
.+||+|||.+.... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+.
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred ccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 49999999876432 233456789999999999765 48999999999999999999999999999888888
Q ss_pred HHHHHhCCCChhhhhhcCCC-CCCC----C--CCCccCCCcc-----cccc-ccCChhHHHHHHHhhccCCCCCCCHHHH
Q 016115 291 EIIKVLGTPTREEIRCMNPN-YTDF----R--FPQIKAHPWH-----KVFH-KRMPPEAIDLASRLLQYSPSLRCTALEA 357 (395)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~-~~~~----~--~~~~~~~~~~-----~~~~-~~~s~~~~~li~~~L~~dp~~Rpt~~el 357 (395)
.+.+.++..+.......... ..++ . .+......+. .... ...++.+.|||.+||++||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 88888877654432211000 0000 0 0000000000 0000 0124678899999999999999999999
Q ss_pred hcCCCCcCCCCCCC
Q 016115 358 CAHPFFDELREPNA 371 (395)
Q Consensus 358 l~hp~~~~~~~~~~ 371 (395)
|+||||++....+.
T Consensus 436 L~Hp~~~~~~~~~~ 449 (467)
T PTZ00284 436 TTHPYVLKYYPECR 449 (467)
T ss_pred hcCccccccCCccc
Confidence 99999998666443
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=369.97 Aligned_cols=278 Identities=23% Similarity=0.341 Sum_probs=212.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
..+|.+.+.||+|+||.||+|.+..+++.||+|.... ....+|+++++.++||||+++++++ ......++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTF-----TYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeEEEEe
Confidence 3579999999999999999999999999999997543 3456899999999999999999988 44556899999
Q ss_pred cccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC--
Q 016115 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-- 233 (395)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-- 233 (395)
++.+++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.....
T Consensus 164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEc-CCCCEEEEeCCcccccccccc
Confidence 999887766654 3568899999999999999999999 6999999999999999 6889999999999754322
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCChhhhhh
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-------NAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||... .....+..+....+..+......
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 222345789999999999654 5899999999999999999999877543 23445666666666544321100
Q ss_pred cCCCCCC-------CCCCCccC-CCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 307 MNPNYTD-------FRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 307 ~~~~~~~-------~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
....... ........ ..|.. ...++.++.+||.+||++||.+|||+.|+|+||||+.+..+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTN--LYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHH--HhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 0000000 00000000 00110 12357789999999999999999999999999999886543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=358.24 Aligned_cols=257 Identities=27% Similarity=0.423 Sum_probs=229.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
-|.+.+.||+|.|++|-+|++..||+.||||++.+... ...+|++.|+.++|||||+++++. .....+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTKly 93 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTKLY 93 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccceEE
Confidence 48999999999999999999999999999999965432 234799999999999999999988 5556699
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+|+|+-+| +|++.+.+ ....+.+..+++++.||+.|+.|+|+. .+|||||||+||.+-..-|-+||.|||++..+
T Consensus 94 LiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 99999885 66665543 467899999999999999999999995 99999999999988767899999999999999
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
..+....+.+|+..|.|||++.|..+..+++||||||||||-|++|++||+..++.+.+..|+..
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC--------------- 234 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC--------------- 234 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc---------------
Confidence 99999999999999999999999887889999999999999999999999999999999988874
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
....+..+|.++++||..||..||.+|.+.+++..|+|++.++.+...
T Consensus 235 --------------KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 235 --------------KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred --------------cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence 122456789999999999999999999999999999999999886654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=351.01 Aligned_cols=249 Identities=26% Similarity=0.454 Sum_probs=220.0
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..+|++.+.||+|.||+|-+|+....|+.||||.+.++. ....+|++||..|+||||+.++++| ++..
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCc
Confidence 447999999999999999999999999999999987553 2345899999999999999999999 6666
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+.|||||..| .|++.+.. .+.+++.+++.+++||.+|+.|+|+ ++++|||||.+|||+| .++.+||+|||++
T Consensus 127 KIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD-~N~NiKIADFGLS 200 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLD-QNNNIKIADFGLS 200 (668)
T ss_pred eEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeec-CCCCeeeeccchh
Confidence 79999999995 55555544 6889999999999999999999999 5999999999999999 7899999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
..+.+.....+++|++.|.+||++.|..+-++.+|-|||||+||.|+.|..||++.+......+|.+..
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga----------- 269 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA----------- 269 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc-----------
Confidence 999988889999999999999999988877999999999999999999999999998888777776631
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
|. ...-+.++.-||+.||.+||++|.|++++..|=|++-
T Consensus 270 ------Yr-------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 270 ------YR-------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred ------cc-------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 11 1123667999999999999999999999999988753
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=350.17 Aligned_cols=283 Identities=32% Similarity=0.612 Sum_probs=226.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.++|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++ ......
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence 347999999999999999999999999999999885332 2345799999999999999999998 455569
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||+++++...+... ...+++..++.++.||+.||.|||+ .||+|+||||+||+++ .++.+||+|||++...
T Consensus 80 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLIN-ERGELKLADFGLARAK 154 (301)
T ss_pred EEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEEC-CCCcEEECcCcchhcc
Confidence 999999999877766542 3468899999999999999999999 6999999999999999 7889999999998764
Q ss_pred ccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... .....++..|+|||++.+...++.++|||||||++|+|+||+.||...+..+....+...++.+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 33222 22345688999999987666688999999999999999999999999888888888888777776655543211
Q ss_pred --CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 310 --NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 310 --~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
.+..+.++....... ......+++.+.+||.+||+.||.+|||++|+++||||+.+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 235 NEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred cccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 111112222111111 12234678999999999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=359.85 Aligned_cols=285 Identities=34% Similarity=0.609 Sum_probs=224.3
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (395)
++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 46999999999999999999999999999999986432 223479999999999999999988743221 22345
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|++++++++++...+. ...+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+||+|||+++.
T Consensus 95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVN-EDCELRILDFGLARQ 167 (343)
T ss_pred EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEEC-CCCCEEEcCCcccee
Confidence 78999999887766554 2568999999999999999999999 6999999999999999 788999999999986
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..........
T Consensus 168 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 5432 33457899999999997756689999999999999999999999999888888888888777766554433221
Q ss_pred CCCCCC---CCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 310 NYTDFR---FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 310 ~~~~~~---~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
...... .+......+. ......++.+.+||.+||..||.+|||+.|+|+||||.....+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~ 309 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPED 309 (343)
T ss_pred hhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcc
Confidence 110000 0111001111 112346778999999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=354.70 Aligned_cols=245 Identities=32% Similarity=0.487 Sum_probs=199.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcE-EEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce-e
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL-F 149 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~-vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~-~ 149 (395)
...+.+.||+|+||+||+|.+ .|.. ||||++... ...+.+|+.+|.+++|||||+++|++. +.. .
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~-----~~~~~ 114 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT-----SPPGS 114 (362)
T ss_pred HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCc
Confidence 345556699999999999998 5666 999998643 235678999999999999999999983 333 5
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceeccCCCCceeecCCCC-cEEEeecccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-VCHRDVKPQNLLVDPLTH-QVKLCDFGSA 227 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~-ivH~Dlkp~Nill~~~~~-~~kl~Dfg~a 227 (395)
++|||||++++.+..+.+.. ....++...+..++.+|+.||.|||+ ++ ||||||||+|||++ .++ .+||+|||++
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~-~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVD-LKGKTLKIADFGLS 191 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEc-CCCCEEEECCCccc
Confidence 89999999965444444322 46789999999999999999999999 69 99999999999999 675 9999999999
Q ss_pred cccccC-CcceeeeecccccCchhhcC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 228 KVLVKG-EANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 228 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
+..... ...+...||+.|||||++.+ ...|+.++|||||||++|||+||+.||......+....+... +.+
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~-~~R------ 264 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG-GLR------ 264 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-CCC------
Confidence 876554 33344689999999999975 346999999999999999999999999998885544444432 111
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..++..+++.+..|+.+||..||.+||+..+++.
T Consensus 265 --------------------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 265 --------------------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred --------------------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 1133447899999999999999999999998873
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=362.59 Aligned_cols=255 Identities=28% Similarity=0.413 Sum_probs=205.0
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|++.+.||+|+||+||+|.+..+++.||||++.+.. ....+|+.+++.++|+||+++++.+ .+...+
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~ 76 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL 76 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence 6899999999999999999999999999999986432 2345688999999999999999988 556679
Q ss_pred EEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|+||||++|+ |.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~-~~~~vkL~DFGla~~ 150 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLD-SKGHVKLSDFGLCTG 150 (363)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEEC-CCCCEEEeeccCccc
Confidence 9999999864 4444433 4678999999999999999999999 6999999999999999 688999999999875
Q ss_pred cccCC------------------------------------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHH
Q 016115 230 LVKGE------------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAEL 273 (395)
Q Consensus 230 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 273 (395)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 229 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence 43211 01235789999999999765 489999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCC---C
Q 016115 274 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS---L 350 (395)
Q Consensus 274 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~---~ 350 (395)
++|..||.+.+..+....+....... .++. ...+++++++||.+|+. +|. .
T Consensus 230 l~G~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~ 283 (363)
T cd05628 230 LIGYPPFCSETPQETYKKVMNWKETL---------------IFPP----------EVPISEKAKDLILRFCC-EWEHRIG 283 (363)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCcCcc---------------cCCC----------cCCCCHHHHHHHHHHcC-ChhhcCC
Confidence 99999999888777666655421100 0110 01368899999999775 444 4
Q ss_pred CCCHHHHhcCCCCcCCCCCC
Q 016115 351 RCTALEACAHPFFDELREPN 370 (395)
Q Consensus 351 Rpt~~ell~hp~~~~~~~~~ 370 (395)
||+++|+++||||+..+...
T Consensus 284 r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 284 APGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCCHHHHhCCCCCCCCCHHH
Confidence 58999999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=359.35 Aligned_cols=251 Identities=29% Similarity=0.449 Sum_probs=207.5
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCC-cEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
...+|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+.+++.++||||+++++++ .+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence 4457999999999999999999876655 689999885321 2334699999999999999999998 55
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~-~~~~ikL~DFG 176 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLD-KDGFIKMTDFG 176 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEEC-CCCCEEEecCC
Confidence 5669999999986 45444443 4678999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 226 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+....
T Consensus 177 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--------- 244 (340)
T PTZ00426 177 FAKVVDTR--TYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--------- 244 (340)
T ss_pred CCeecCCC--cceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence 99865332 3456789999999999764 48999999999999999999999999877665555544310
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
..++..+++.+.++|++||+.||.+|+ +++++++||||+.+.+
T Consensus 245 --------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 245 --------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 012345688999999999999999996 8999999999998764
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=352.59 Aligned_cols=278 Identities=32% Similarity=0.561 Sum_probs=209.3
Q ss_pred eeeeecCCceEEEEEEEC--CCCcEEEEEEecccc--cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecc
Q 016115 82 ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
.+.||+|+||+||+|+++ .+++.||+|.+.... ....+|+.+++.++||||+++++++.. .....++++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEecc
Confidence 357999999999999965 467899999886542 335679999999999999999998854 2334588999999
Q ss_pred cchHHHHHHhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec---CCCCcEEEeecccccc
Q 016115 158 PETMYRVLKHYSS-----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDFGSAKV 229 (395)
Q Consensus 158 ~~~l~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~---~~~~~~kl~Dfg~a~~ 229 (395)
++++...+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ ..++.+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 9988777653221 22358999999999999999999999 6999999999999994 2457899999999986
Q ss_pred cccCC----cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 016115 230 LVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL 296 (395)
Q Consensus 230 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~~~~~~ 296 (395)
..... ......||+.|+|||++.+...++.++||||+||++|+|++|+.||..... .+.+..+....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 54332 123457799999999997766689999999999999999999999975432 35567777777
Q ss_pred CCCChhhhhhcCCCCC------CC---CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 297 GTPTREEIRCMNPNYT------DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
+.+....+........ .+ .+.......+........+..+.+||++||++||.+|+|++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 7776665543221000 00 0000000000001112346679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=357.05 Aligned_cols=257 Identities=30% Similarity=0.468 Sum_probs=210.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~ 76 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL 76 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence 6999999999999999999999999999999986432 2334688999999999999999988 555669
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLID-ASGHIKLTDFGLSKG 150 (333)
T ss_pred EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEC-CCCCEEEEeCcCCcc
Confidence 999999986 45444433 4578999999999999999999999 6999999999999999 788999999999976
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+........
T Consensus 151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------- 218 (333)
T cd05600 151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------- 218 (333)
T ss_pred ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------
Confidence 543 23456789999999999765 589999999999999999999999998877766665543211000
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
.+.. ......++.++.+||.+||..+|.+|+++.++++||||+.....
T Consensus 219 ------~~~~------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 219 ------RPVY------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred ------CCCC------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence 0000 00012468999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=362.63 Aligned_cols=254 Identities=32% Similarity=0.512 Sum_probs=206.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL 76 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence 6999999999999999999999999999999986431 2234699999999999999999988 556679
Q ss_pred EEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|+||||+.|+ |.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLD-AKGHIKLSDFGLCTG 150 (364)
T ss_pred EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEEC-CCCCEEEeeccccee
Confidence 9999999864 4444433 4578999999999999999999999 6999999999999999 788999999999865
Q ss_pred cccCCc---------------------------------------ceeeeecccccCchhhcCCCCCCcccchHhHHHHH
Q 016115 230 LVKGEA---------------------------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVL 270 (395)
Q Consensus 230 ~~~~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 270 (395)
...... ....+||+.|+|||++.+. .++.++|||||||++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il 229 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIM 229 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHH
Confidence 422110 0124689999999998654 489999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCC
Q 016115 271 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 350 (395)
Q Consensus 271 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 350 (395)
|+|++|..||...+..+....+...... ..++. ...+++++.+||++||. +|.+
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~~li~~ll~-~p~~ 283 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWKET---------------LQFPD----------EVPLSPEAKDLIKRLCC-EAER 283 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCc---------------cCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence 9999999999988776665554431100 00000 12468999999999997 9999
Q ss_pred CCC---HHHHhcCCCCcCCCCC
Q 016115 351 RCT---ALEACAHPFFDELREP 369 (395)
Q Consensus 351 Rpt---~~ell~hp~~~~~~~~ 369 (395)
|++ +.++++||||+..+..
T Consensus 284 R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 284 RLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred cCCCCCHHHHhcCCCcCCCCHH
Confidence 998 9999999999987653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=360.37 Aligned_cols=257 Identities=33% Similarity=0.538 Sum_probs=211.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|.+.+.||+|+||+||+|++..+|+.||||++... .....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL 76 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence 699999999999999999999999999999998643 22345789999999999999999988 556679
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILID-ADGHIKLADFGLCKK 150 (350)
T ss_pred EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEEC-CCCCEEeecCCCCcc
Confidence 999999986 55555543 3678999999999999999999999 6999999999999999 788999999999976
Q ss_pred cccCC------------------------------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCC
Q 016115 230 LVKGE------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279 (395)
Q Consensus 230 ~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p 279 (395)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence 64433 22345689999999999765 589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-HHHHh
Q 016115 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEAC 358 (395)
Q Consensus 280 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~ell 358 (395)
|...+..+....+...... ..++. ...+++++.+||.+||. ||.+|++ +.+++
T Consensus 230 f~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 230 FYSDTLQETYNKIINWKES---------------LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred CCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 9988766655555431110 00010 11268999999999998 9999999 99999
Q ss_pred cCCCCcCCCCCCCC
Q 016115 359 AHPFFDELREPNAR 372 (395)
Q Consensus 359 ~hp~~~~~~~~~~~ 372 (395)
+||||+.+......
T Consensus 284 ~hp~~~~~~~~~~~ 297 (350)
T cd05573 284 SHPFFKGIDWENLR 297 (350)
T ss_pred cCCCcCCCCHHHHh
Confidence 99999987665443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=363.35 Aligned_cols=253 Identities=30% Similarity=0.492 Sum_probs=203.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|.+.+.||+|+||.||++.+..+|+.||||++.... ....+|+++++.++||||+++++++ .+..++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 76 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL 76 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence 6899999999999999999999999999999885432 2345689999999999999999988 556679
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|+||||++| +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~-~~~~~kl~DfGla~~ 150 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILID-RGGHIKLSDFGLSTG 150 (377)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEC-CCCCEEEeecccccc
Confidence 999999985 55454443 4678999999999999999999999 6999999999999999 788999999999863
Q ss_pred cccCCc------------------------------------------------ceeeeecccccCchhhcCCCCCCccc
Q 016115 230 LVKGEA------------------------------------------------NISYICSRYYRAPELIFGATEYTTSI 261 (395)
Q Consensus 230 ~~~~~~------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~ 261 (395)
...... ....+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 229 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQEC 229 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCce
Confidence 321000 0124689999999999654 589999
Q ss_pred chHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHH
Q 016115 262 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341 (395)
Q Consensus 262 DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 341 (395)
|||||||++|+|++|..||...+..+.+..+...... ..++. ...++.++.+||.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~dli~ 284 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET---------------LYFPD----------DIHLSVEAEDLIR 284 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc---------------cCCCC----------CCCCCHHHHHHHH
Confidence 9999999999999999999988776666555431000 00110 1246889999999
Q ss_pred HhhccCCCCC---CCHHHHhcCCCCcCCCC
Q 016115 342 RLLQYSPSLR---CTALEACAHPFFDELRE 368 (395)
Q Consensus 342 ~~L~~dp~~R---pt~~ell~hp~~~~~~~ 368 (395)
+||. +|.+| +++.+++.||||+..+.
T Consensus 285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 285 RLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred HHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9998 77765 59999999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=353.19 Aligned_cols=250 Identities=27% Similarity=0.437 Sum_probs=206.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.|+..+.||+|+||.||+|.+..+++.||+|++.-+. ....+|+.++..++++||.+.++.|+.... +++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HHH
Confidence 5778899999999999999999999999999996443 345579999999999999999999955444 899
Q ss_pred EEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||.|+ +.++++. ...+.+.++..++++++.||.|||. ++.+|||||+.|||+. ..|.+||+|||.+....
T Consensus 89 iMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s-~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLS-ESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEe-ccCcEEEEecceeeeee
Confidence 99999964 4444433 4445888888999999999999999 6999999999999999 67999999999998876
Q ss_pred cCCcc-eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
..... .+++||+.|||||++.+. .|+.++||||||++.+||++|.+|+........+..|-+
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---------------- 225 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---------------- 225 (467)
T ss_pred chhhccccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC----------------
Confidence 55443 678999999999999854 599999999999999999999999987654222221111
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
.....+...+|+.+++||..||++||+.||+|.++|.|+|++...
T Consensus 226 ------------~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 226 ------------SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred ------------CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 001112345799999999999999999999999999999998833
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=353.23 Aligned_cols=242 Identities=31% Similarity=0.533 Sum_probs=199.4
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecc
Q 016115 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 85 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++||||+++++++ .+...+++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 799999999999999999999999986431 2234688999999999999999888 4555689999999
Q ss_pred cch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC-Cc
Q 016115 158 PET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EA 235 (395)
Q Consensus 158 ~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~ 235 (395)
+|+ |.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..... ..
T Consensus 76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCc
Confidence 964 4444433 4678999999999999999999999 6999999999999999 7889999999998754322 22
Q ss_pred ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCC
Q 016115 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315 (395)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...
T Consensus 150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-------------------- 208 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-------------------- 208 (312)
T ss_pred cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--------------------
Confidence 3345789999999999764 5899999999999999999999999987766555544321
Q ss_pred CCCccCCCccccccccCChhHHHHHHHhhccCCCCCC---CHHHHhcCCCCcCCC
Q 016115 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELR 367 (395)
Q Consensus 316 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~ell~hp~~~~~~ 367 (395)
...++..+++++.+||.+||..||.+|+ ++.+++.||||+...
T Consensus 209 ---------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 209 ---------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 0012345789999999999999999997 589999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=360.33 Aligned_cols=255 Identities=29% Similarity=0.478 Sum_probs=202.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.|.+++.||+|+||+||+|++..+++.||||++.... ....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 5889999999999999999999999999999986431 2345789999999999999999998 455569
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~-~~~~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILID-LDGHIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEEC-CCCCEEEeeCcCCcc
Confidence 999999986 44444433 4568999999999999999999999 6999999999999999 688999999999753
Q ss_pred cccCC------------------------------------------------cceeeeecccccCchhhcCCCCCCccc
Q 016115 230 LVKGE------------------------------------------------ANISYICSRYYRAPELIFGATEYTTSI 261 (395)
Q Consensus 230 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~ 261 (395)
..... .....+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC 229 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence 21000 01234689999999999764 489999
Q ss_pred chHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHH
Q 016115 262 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341 (395)
Q Consensus 262 DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 341 (395)
|||||||++|+|+||..||...+..+....+...... ..++ ....+++++.+||.
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~dli~ 284 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIP----------PQVKLSPEAVDLIT 284 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCC----------CCCCCCHHHHHHHH
Confidence 9999999999999999999887766555544321100 0000 11246899999999
Q ss_pred Hhhc--cCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 342 RLLQ--YSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 342 ~~L~--~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
+||. .++..|++++++++||||+.+...
T Consensus 285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 285 KLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 9654 455559999999999999987653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=362.07 Aligned_cols=254 Identities=29% Similarity=0.467 Sum_probs=204.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++.+ .+...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 5899999999999999999999999999999986432 2345799999999999999999998 455569
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~-~~g~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILID-RDGHIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC-CCCCEEEeECCCCcc
Confidence 999999986 45444433 3568999999999999999999999 6999999999999999 788999999999753
Q ss_pred cccC------------------------------------------------CcceeeeecccccCchhhcCCCCCCccc
Q 016115 230 LVKG------------------------------------------------EANISYICSRYYRAPELIFGATEYTTSI 261 (395)
Q Consensus 230 ~~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 261 (395)
.... ......+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence 2100 001124689999999999764 489999
Q ss_pred chHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHH
Q 016115 262 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341 (395)
Q Consensus 262 DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 341 (395)
|||||||++|+|++|..||...+..+....+....... .++ ....+++++.+||.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p----------~~~~~s~~~~~li~ 284 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL---------------HIP----------PQAKLSPEASDLII 284 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---------------CCC----------CcccCCHHHHHHHH
Confidence 99999999999999999999887766555544311100 000 11346899999999
Q ss_pred HhhccCCCCCCC---HHHHhcCCCCcCCCCC
Q 016115 342 RLLQYSPSLRCT---ALEACAHPFFDELREP 369 (395)
Q Consensus 342 ~~L~~dp~~Rpt---~~ell~hp~~~~~~~~ 369 (395)
+|+ .||.+|++ +.++++||||+.+...
T Consensus 285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 976 59999997 9999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=355.03 Aligned_cols=245 Identities=27% Similarity=0.422 Sum_probs=200.3
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
+.||+|+||.||++++..+|+.||+|++.... ....+|+.+++.++||||+++++++ .....+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 36999999999999999999999999986432 2334688999999999999999888 55556999999
Q ss_pred cccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC-
Q 016115 156 YVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG- 233 (395)
Q Consensus 156 ~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 233 (395)
|++++ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.....
T Consensus 76 y~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 76 YVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEEC-CCCcEEEecCcCCccCCCcc
Confidence 99865 433333 24578999999999999999999999 6999999999999999 7889999999998754322
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D 211 (328)
T ss_pred cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence 222345689999999999654 4899999999999999999999999877665544433210 0
Q ss_pred CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
..++..++.++.+||++||++||.+|+ ++.++++||||.....
T Consensus 212 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 212 ------------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred ------------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 012345789999999999999999997 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=354.19 Aligned_cols=245 Identities=27% Similarity=0.428 Sum_probs=201.2
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
+.||+|+||.||++++..+|..||+|.+.... ....+|+.+++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 36999999999999999999999999986432 1234688999999999999999988 45556999999
Q ss_pred cccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC-
Q 016115 156 YVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG- 233 (395)
Q Consensus 156 ~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 233 (395)
|++|+ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEc-CCCCEEecccHHhccccCCC
Confidence 99975 333333 24578999999999999999999999 6999999999999999 7889999999998753222
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E 211 (323)
T ss_pred CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 222345689999999998654 5899999999999999999999999887766555544321 0
Q ss_pred CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
..++..+++++.+||.+||+.||.+|+ ++.++++||||.....
T Consensus 212 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 212 ------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred ------------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 012345789999999999999999998 8999999999988654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=304.02 Aligned_cols=277 Identities=36% Similarity=0.678 Sum_probs=232.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.|.-.++||+|.||+||+|++..+++.||+|.+.-+. ....+|+.+++.++|.|||++++.. ..+..+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 3566678999999999999999999999999986432 2345899999999999999999988 5555588
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|+|||...+...+. ..++.+..+.++.++.|++.||.|+|++ ++.||||||.|.|++ .+|.+|++|||+++.+.
T Consensus 78 lvfe~cdqdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin-~ngelkladfglarafg 152 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLIN-RNGELKLADFGLARAFG 152 (292)
T ss_pred EeHHHhhHHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEec-cCCcEEecccchhhhcC
Confidence 999999986554443 4568899999999999999999999995 999999999999999 89999999999998765
Q ss_pred cCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC-
Q 016115 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 308 (395)
Q Consensus 232 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 308 (395)
-.- ..+..+.|.+|++|.++.+.+-|++..|+||.|||+.|+.. |++.|++.+..+++..|.+.+|.+..+.|..+.
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 443 23445679999999999999999999999999999999987 999999999999999999999999999887654
Q ss_pred -CCCCCCCC-CCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 309 -PNYTDFRF-PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 309 -~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
+.|..+.+ +... .|. ++-.+++..-+||++++|.-+|..|+++++.++||||.+..
T Consensus 233 lpdyk~yp~ypatt--sws-qivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 233 LPDYKPYPIYPATT--SWS-QIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CCCCcccCCccccc--hHH-HHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 33333322 1111 121 23346677899999999999999999999999999998754
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=342.39 Aligned_cols=275 Identities=35% Similarity=0.573 Sum_probs=215.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|.+.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+.+++.++|+||+++++++ .+...++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 4888999999999999999999999999999885421 2345799999999999999999988 4555689
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|+||+++++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++....
T Consensus 76 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLIN-KNGELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEc-CCCcEEECccchhhccC
Confidence 99999999877765532 3568999999999999999999999 6999999999999999 68899999999987653
Q ss_pred cCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 232 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... .....++..|+|||++.+...++.++|||||||++|+|+||..|| .+.+..+.+..+.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 3222 223456889999999877666799999999999999999988774 55666667777777766665544432211
Q ss_pred CCCCCCCCCccC-CCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 NYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 ~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
......++.... ..| ......+++++.+||++||+.||.+|||+++++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSL-VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchh-hhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 100001111100 111 12234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=351.99 Aligned_cols=249 Identities=29% Similarity=0.474 Sum_probs=202.6
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHH---HHcCCCceeeeceeeeecCCCCce
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM---RLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
|++.+.||+|+||.||+|.+..+|+.||||.+.... ....+|++++ +.++||||+++++++ .+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 678899999999999999999999999999986432 1223454444 466799999999988 4555
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+|+||||++|+.+..... ...+++..++.++.||+.||.|||+ .||+||||||+||+++ .++.+||+|||+++
T Consensus 76 ~~~lv~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~-~~~~~kL~Dfg~~~ 149 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLD-TEGFVKIADFGLCK 149 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEEC-CCCcEEeCcccCCc
Confidence 6999999999764433322 3578999999999999999999999 6999999999999999 68899999999987
Q ss_pred cccc-CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 229 VLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 229 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.... ........|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------- 217 (324)
T cd05589 150 EGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------- 217 (324)
T ss_pred cCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 5322 2223346789999999999654 58999999999999999999999999887776665554310
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
..++..++..+.+||++||..||.+|| ++.++++||||+.+..
T Consensus 218 ------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 218 ------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 012345789999999999999999999 7999999999988653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=359.07 Aligned_cols=275 Identities=25% Similarity=0.336 Sum_probs=204.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+++++.++|+|||++++++ ......++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~-----~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVR-----VVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEE-----EECCEEEEEEE
Confidence 4479999999999999999999999999999996432 3346799999999999999999987 34445889999
Q ss_pred cccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCc
Q 016115 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235 (395)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 235 (395)
++.+++...+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.......
T Consensus 241 ~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVN-GPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred ccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEEC-CCCCEEEcccCCceecccccc
Confidence 9999887776542 3468999999999999999999999 6999999999999999 688899999999976543221
Q ss_pred ---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCChhhh-
Q 016115 236 ---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-------AVDQLVEIIKVLGTPTREEI- 304 (395)
Q Consensus 236 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~- 304 (395)
.....||..|+|||++.+. .++.++|||||||++|||++|..++.... ....+..+++..+.......
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2235689999999999765 48999999999999999999875543211 12334444443332111100
Q ss_pred -------hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 305 -------RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 305 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
............+......|... ..++.++.+||.+||++||.+|||+.|+|+||||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00000000000011111112111 245778999999999999999999999999999974
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=343.70 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=208.0
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.|++.+.||+|+||.||++.+..+++.||+|++.... ....+|+.+++.++|+||+++++++ .....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 3889999999999999999999999999999885431 2234699999999999999999988 455569
Q ss_pred EEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||+.|+ +...+.. .....+++..++.++.|++.||.|||+ .||+||||||+||+++ +++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLD-DYGHIRISDLGLAVE 151 (285)
T ss_pred EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEEC-CCCCEEEeeCCCcee
Confidence 9999999865 4333332 223568999999999999999999999 6999999999999999 688999999999987
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
...........|+..|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+...+....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 221 (285)
T cd05605 152 IPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--------- 221 (285)
T ss_pred cCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------
Confidence 6544444455789999999999654 489999999999999999999999987665444333332211000
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~ 369 (395)
..++..++..+.+||.+||..||.+|| +++++++||||......
T Consensus 222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 222 ----------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred ----------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 112345788999999999999999999 99999999999886553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=341.75 Aligned_cols=276 Identities=34% Similarity=0.650 Sum_probs=216.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||+|++|.||+|++..+|..||+|.+.... ....+|+.+++.++|+||+++++.+ .+...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence 4889999999999999999999999999999885331 2345799999999999999999998 4455689
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||+++++.+.+.... ....+++..++.++.||+.||.|||+ +||+|+||||+||+++ .++.+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLID-NKGVIKLADFGLARAFG 152 (285)
T ss_pred EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEc-CCCcEEECcccceeecC
Confidence 999999988777665432 24678999999999999999999999 6999999999999999 78899999999987543
Q ss_pred cCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.... .....++..|+|||++.+...++.++||||||+++|+|+||+.||......+....+....+.+....+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS- 231 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh-
Confidence 2221 22345688899999987665678999999999999999999999998887777777766666554443321110
Q ss_pred CCCCC--CCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 311 YTDFR--FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 311 ~~~~~--~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
..++. ++...... .......+++++.+||++||+.||.+|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGS-LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcch-hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00000 01110000 111234579999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=351.36 Aligned_cols=245 Identities=30% Similarity=0.508 Sum_probs=200.1
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||.||+|+++.+++.||||++.... .....|..+++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 36999999999999999999999999986432 2223567777765 699999999988 4555699999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc-
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 232 (395)
||++|+ |...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcC
Confidence 999975 3333332 4678999999999999999999999 6999999999999999 788999999999875422
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~---------------- 212 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE---------------- 212 (320)
T ss_pred CCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 2233345789999999999654 58999999999999999999999999888776665554310
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH------HHHhcCCCCcCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELRE 368 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~ell~hp~~~~~~~ 368 (395)
..++..++.++.+||++||+.||.+|+++ +++++||||+.+..
T Consensus 213 -------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 213 -------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred -------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 01223468899999999999999999998 99999999988764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=353.38 Aligned_cols=278 Identities=26% Similarity=0.409 Sum_probs=206.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
..+|.+.+.||+|+||.||+|++..++..||+|+.... ....|+.+++.++|+||+++++++ ......++|||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 137 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTL-----VSGAITCMVLP 137 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheE-----EeCCeeEEEEE
Confidence 34799999999999999999999999999999975433 335699999999999999999988 44455889999
Q ss_pred cccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCc
Q 016115 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235 (395)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 235 (395)
|+.+++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.......
T Consensus 138 ~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 138 HYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred ccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCCEEEecCccccccccCcc
Confidence 999988777654 24578999999999999999999999 6999999999999999 788899999999976544444
Q ss_pred ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHHhCCCChhhhh
Q 016115 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENA---------VDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~ 305 (395)
.....||..|+|||++.+. .++.++|||||||++|+|+++. .+|..... ...+..+...++..+.....
T Consensus 213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 4456789999999999664 4899999999999999999854 44443221 22333444443332221110
Q ss_pred hcCCCCCC-C-CCCCccCCCcc--c-cccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 306 CMNPNYTD-F-RFPQIKAHPWH--K-VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 306 ~~~~~~~~-~-~~~~~~~~~~~--~-~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
........ + .+......++. . .-...++.++.+||.+||+.||.+|||+.|+|+||||+.+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 00000000 0 00000000000 0 0112467889999999999999999999999999999864
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=354.59 Aligned_cols=246 Identities=28% Similarity=0.427 Sum_probs=200.3
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
+.||+|+||.||++++..+|+.||+|++.... ....+|+++++.++|+||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 36999999999999999999999999986432 2234688889999999999999888 55556999999
Q ss_pred cccchH-HHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc-C
Q 016115 156 YVPETM-YRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-G 233 (395)
Q Consensus 156 ~~~~~l-~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~ 233 (395)
|++|+. ...+. ....+++..++.++.||+.||.|||+.+||+||||||+|||++ .++.+||+|||+++.... .
T Consensus 76 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDG 150 (325)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCC
Confidence 999753 33332 2467899999999999999999999634999999999999999 788999999999875332 2
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
.......||+.|+|||++.+. .++.++|||||||++|+|+||..||...+.......+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~ 212 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 212 (325)
T ss_pred cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 223345689999999999654 5899999999999999999999999887765554443321 0
Q ss_pred CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
..++..+++++.+||++||++||.+|+ ++.++++||||+....
T Consensus 213 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 213 ------------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred ------------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 012345789999999999999999997 9999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=355.76 Aligned_cols=257 Identities=26% Similarity=0.443 Sum_probs=208.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
...+|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 4557999999999999999999999999999999985421 2244689999999999999999988 556
Q ss_pred eeEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+++||||++|+ |.+.+.. ..+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~-~~~~~kL~DfG~ 188 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLD-KSGHLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEc-CCCCEEEEeccc
Confidence 6799999999864 4444432 458899999999999999999999 6999999999999999 789999999999
Q ss_pred ccccccCCc--ceeeeecccccCchhhcCC---CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 227 AKVLVKGEA--NISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 227 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+........ .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+....+.++......
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--- 265 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS--- 265 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc---
Confidence 976543321 2345689999999998643 24789999999999999999999999988776666655431100
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCC--CCCHHHHhcCCCCcCCCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE 368 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~~ 368 (395)
..++. ...+|.++.+||++||+.+|.+ |+|++++++||||+....
T Consensus 266 ------------~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 266 ------------LTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred ------------CCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 01110 1246899999999999999988 999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=349.71 Aligned_cols=250 Identities=29% Similarity=0.459 Sum_probs=203.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCC-ceeeeceeeeecCCCCcee
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHP-NVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 149 (395)
+|++.+.||+|+||.||+|++..+++.||||++.... .....|.+++..++|+ +|+++++++ .+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 4889999999999999999999999999999986432 2234678888888765 577888877 44456
Q ss_pred EEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+|+||||++|+ |...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~-~~~~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLD-AEGHIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEc-CCCCEEEeecCcce
Confidence 89999999864 4444432 4568899999999999999999999 6999999999999999 68899999999986
Q ss_pred ccc-cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 229 VLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 229 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
... .........||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----------- 217 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----------- 217 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 532 22233456789999999999764 48999999999999999999999999887766665554310
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCCCcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELRE 368 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~hp~~~~~~~ 368 (395)
..++..++.++.+||++||.+||.+|+++ .++++||||+..++
T Consensus 218 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 218 ------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 11234578999999999999999999986 89999999998654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=353.25 Aligned_cols=258 Identities=27% Similarity=0.475 Sum_probs=209.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|.+.+.||+|+||+||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~ 76 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL 76 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence 6999999999999999999999999999999986432 2345788899999999999999888 455569
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||++| +|.+.+... ...+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~ 151 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLID-RTGHIKLADFGSAAR 151 (330)
T ss_pred EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEEC-CCCCEEeccCCCCeE
Confidence 999999986 555544432 3578999999999999999999999 6999999999999999 788999999999987
Q ss_pred cccCCcc--eeeeecccccCchhhcC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 230 LVKGEAN--ISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 230 ~~~~~~~--~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
....... ....||+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+..+......
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~---- 227 (330)
T cd05601 152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF---- 227 (330)
T ss_pred CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc----
Confidence 6443322 23468999999999863 345789999999999999999999999988776666555432000
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
..++. ...++.++.+||.+||. ||.+|||+.++++||||+.+.....
T Consensus 228 -----------~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~ 274 (330)
T cd05601 228 -----------LKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNI 274 (330)
T ss_pred -----------cCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHH
Confidence 00010 12468899999999998 9999999999999999998765443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=359.08 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=203.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.|++.+.||+|+||.||+|++..+|+.||||++... .....+|+++++.++|+||+++++.+ .+...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence 599999999999999999999999999999998542 12345799999999999999999988 555679
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++ .++.+||+|||+|..
T Consensus 77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~-~~~~ikL~DFG~a~~ 150 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILID-RDGHIKLTDFGLCTG 150 (376)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEEC-CCCCEEEEeCCCCcc
Confidence 999999986 45555443 4568999999999999999999999 6999999999999999 788999999999753
Q ss_pred cccC--------------------------------------------CcceeeeecccccCchhhcCCCCCCcccchHh
Q 016115 230 LVKG--------------------------------------------EANISYICSRYYRAPELIFGATEYTTSIDIWS 265 (395)
Q Consensus 230 ~~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 265 (395)
+... ......+||+.|+|||++.+. .++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeee
Confidence 2100 001134689999999999654 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhc
Q 016115 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 345 (395)
Q Consensus 266 lG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 345 (395)
|||++|+|++|..||...+..+....+...... ..++ ....+++++.+||.+|+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~~li~~l~- 283 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIP----------SQAKLSREASDLILRLC- 283 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCC----------CCCCCCHHHHHHHHHHh-
Confidence 999999999999999988766555444321000 0000 11346899999999976
Q ss_pred cCCCCCC---CHHHHhcCCCCcCCCC
Q 016115 346 YSPSLRC---TALEACAHPFFDELRE 368 (395)
Q Consensus 346 ~dp~~Rp---t~~ell~hp~~~~~~~ 368 (395)
.+|.+|+ ++.++++||||+.+..
T Consensus 284 ~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 284 CGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 5999999 9999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=336.09 Aligned_cols=282 Identities=27% Similarity=0.485 Sum_probs=225.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHHcCC--C----ceeeeceeeeecCCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDH--P----NVISLKHCFFSTTSKD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h--~----niv~~~~~~~~~~~~~ 146 (395)
..+|.+.+.+|+|.||.|-.+.+..++..||||+++.-.+ ...-|++++.++++ | -+|.+.++| ..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence 5689999999999999999999999999999999875433 33468999998842 2 366777777 77
Q ss_pred ceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC------------
Q 016115 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------------ 214 (395)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~------------ 214 (395)
.++.|||+|.++-++.+.+.... ..+++...++.++.|++++++|||+ .+++|.||||+|||+..
T Consensus 163 rghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence 77899999999989888887633 3678999999999999999999999 59999999999999831
Q ss_pred -------CCCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH
Q 016115 215 -------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287 (395)
Q Consensus 215 -------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 287 (395)
.+..|+|+|||.|+..... .+..+.|..|+|||++++-+ ++.++||||+||||+|++||...|+..++.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 2346999999999875443 36678899999999999866 9999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChhhhhhc-C-----CCCCCCCCCC---------ccCCCcccccc--ccCChhHHHHHHHhhccCCCC
Q 016115 288 QLVEIIKVLGTPTREEIRCM-N-----PNYTDFRFPQ---------IKAHPWHKVFH--KRMPPEAIDLASRLLQYSPSL 350 (395)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~---------~~~~~~~~~~~--~~~s~~~~~li~~~L~~dp~~ 350 (395)
.+..+.+.+|..+...+... . .+..+|.-.. ....++..... +..-.++.|||++||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 99999999998888777654 1 1111111000 00112221111 112346999999999999999
Q ss_pred CCCHHHHhcCCCCcCCCC
Q 016115 351 RCTALEACAHPFFDELRE 368 (395)
Q Consensus 351 Rpt~~ell~hp~~~~~~~ 368 (395)
|+|+.|+|.||||+.+..
T Consensus 397 RiTl~EAL~HpFF~~~~~ 414 (415)
T KOG0671|consen 397 RITLREALSHPFFARLTP 414 (415)
T ss_pred cccHHHHhcCHHhhcCCC
Confidence 999999999999987653
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=341.38 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=200.5
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecc
Q 016115 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 85 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
||+|+||+||++.+..+|+.||+|.+.... .....|+++++.++|+||+++.+++ .....+++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999999999999999986432 2234688999999999999999888 4555689999999
Q ss_pred cch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCc-
Q 016115 158 PET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA- 235 (395)
Q Consensus 158 ~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~- 235 (395)
+|+ |...+.........+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.++|+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCcc
Confidence 865 434443333445679999999999999999999999 6999999999999999 688999999999976544332
Q ss_pred ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCC
Q 016115 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315 (395)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.......
T Consensus 154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 216 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND---------------- 216 (280)
T ss_pred ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence 2235689999999999765 58999999999999999999999998654332222222110000
Q ss_pred CCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCC
Q 016115 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (395)
Q Consensus 316 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~ 369 (395)
...++..++..+.+|+.+||+.||++|+ +++++++||||+.+.+.
T Consensus 217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 0012345789999999999999999999 88999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=351.90 Aligned_cols=255 Identities=30% Similarity=0.470 Sum_probs=200.9
Q ss_pred CceeeeeeecCCceEEEEEEEC---CCCcEEEEEEecccc--------cchHHHHHHHHHcC-CCceeeeceeeeecCCC
Q 016115 78 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSK 145 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 145 (395)
+|++.+.||+|+||+||++++. .+|+.||+|++.+.. ....+|+.+++.++ |+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4889999999999999999864 478999999986421 22346888999995 99999999888 5
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
....+++||||++| ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~-~~~~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLD-SEGHVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEEC-CCCCEEEeeC
Confidence 55668999999996 44444433 4678999999999999999999999 6999999999999999 6889999999
Q ss_pred ccccccccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 225 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
|+++....... .....||..|+|||++.+...++.++|||||||++|+|+||..||...........+......
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---- 225 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK---- 225 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence 99976533322 234578999999999976555789999999999999999999999754322211111111000
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
....++..+++.+.+||.+||+.||++|| +++++++||||+....
T Consensus 226 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 226 ---------------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred ---------------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 00112345789999999999999999999 8889999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=344.33 Aligned_cols=278 Identities=32% Similarity=0.561 Sum_probs=207.0
Q ss_pred eeeeecCCceEEEEEEECC--CCcEEEEEEecccc--cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecc
Q 016115 82 ERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
...||+|+||.||+|++.. ++..||+|.+.... ....+|+.+++.++|+||+++++++.. .....+++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEeee
Confidence 3679999999999999654 66889999886542 235679999999999999999998854 2334588999999
Q ss_pred cchHHHHHHhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec---CCCCcEEEeecccccc
Q 016115 158 PETMYRVLKHYSS-----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDFGSAKV 229 (395)
Q Consensus 158 ~~~l~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~---~~~~~~kl~Dfg~a~~ 229 (395)
++++...+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||+. ..++.+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 9988877653221 22358899999999999999999999 6999999999999993 2467899999999986
Q ss_pred cccCCc----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 016115 230 LVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL 296 (395)
Q Consensus 230 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~~~~~~ 296 (395)
...... .....||..|+|||++.+...++.++|||||||++|+|+||..||..... ...+..+...+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 643322 23456799999999997766689999999999999999999999975432 34556666666
Q ss_pred CCCChhhhhhcCCC--CCCC----CCCCccCCC---ccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 297 GTPTREEIRCMNPN--YTDF----RFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 297 ~~~~~~~~~~~~~~--~~~~----~~~~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
+.+....+...... +... ......... .........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 66655544332110 0000 000000000 0011112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=354.09 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=206.4
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
...+|++.+.||+|+||.||++++..+++.||+|++.+. .....+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 445799999999999999999999999999999998542 22345789999999999999999988 555
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+|+||||++| +|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~-~~~~~kL~DFG~ 188 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLD-KHGHLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEC-CCCCEEEEeccc
Confidence 679999999986 55554432 458899999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCc--ceeeeecccccCchhhcCC---CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 227 AKVLVKGEA--NISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 227 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+........ .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+....+..+......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~--- 265 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS--- 265 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc---
Confidence 986543222 2345689999999998653 23788999999999999999999999988776666655542110
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCC--CCCHHHHhcCCCCcCCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELR 367 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~ 367 (395)
..++. ...++..++++|.+||..++.+ |+|+.|+++||||+...
T Consensus 266 ------------~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 266 ------------LNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred ------------cCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 01110 1246889999999999855543 88999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=347.24 Aligned_cols=287 Identities=35% Similarity=0.683 Sum_probs=225.0
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
++|.+.+.||+|+||.||+|.+..+|+.||||.+.... ....+|+.+++.++|+||+++++++...........+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 47999999999999999999999999999999885321 2234689999999999999999887554444445689
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|+||+++++...+.. ..+++..++.++.||+.||.|||+ .||+||||||+||+++ .++.+||+|||++....
T Consensus 85 lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 85 IVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN-TNCDLKICDFGLARIAD 157 (336)
T ss_pred EEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEC-CCCCEEECcccceeecc
Confidence 9999999987666543 578999999999999999999999 6999999999999999 78899999999987654
Q ss_pred cCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 232 KGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 232 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
..... ....|+..|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+...++.+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 33221 23467889999998866556899999999999999999999999988887777777777777665544322
Q ss_pred CCCCCC-C--CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 308 NPNYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 308 ~~~~~~-~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
...... + ..+.....++. .....++.++.+||.+||+.||.+|||+.++++||||+.+..+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 303 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWN-KLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303 (336)
T ss_pred hchhhhhHHhhcCcCCcccHH-HHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence 111000 0 00000011111 112346889999999999999999999999999999999877644
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=349.13 Aligned_cols=246 Identities=29% Similarity=0.484 Sum_probs=200.8
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||.||+|++..+|+.||||++.... .....|.++++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 36999999999999999999999999986532 1233577777765 799999999998 5555699999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||++|+ |...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++......
T Consensus 76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLD-AEGHCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEEC-CCCCEEEeecccceecccC
Confidence 999964 4333332 4578999999999999999999999 6999999999999999 7889999999998754322
Q ss_pred -CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 234 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~----------------- 211 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD----------------- 211 (321)
T ss_pred CccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 223345689999999998654 5899999999999999999999999988877766655431
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-------CHHHHhcCCCCcCCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-------TALEACAHPFFDELREP 369 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-------t~~ell~hp~~~~~~~~ 369 (395)
+ ..++..++.++.+||++||+.||.+|+ ++.++++||||..+...
T Consensus 212 ~------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 212 D------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred C------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 0 012234688999999999999999999 99999999999886543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=347.41 Aligned_cols=277 Identities=26% Similarity=0.436 Sum_probs=206.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.++|++.+.||+|+||.||++++..+|..||+|.+.... ....+|+++++.++|+||+++++++. +...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 357999999999999999999999999999999886432 23557999999999999999999883 44458
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||++| +|.+.+.. ...+++..++.++.|++.||.|||+..+|+||||||+|||++ .++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN-SRGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc-CCCcEEEccCccccc
Confidence 999999996 44444433 356899999999999999999999833699999999999999 788999999999876
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh---
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC--- 306 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 306 (395)
.... ......|+..|+|||++.+. .++.++|||||||++|+|+||+.||...+..+... +. +.+.......
T Consensus 154 ~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~~---~~~~~~~~~~~~~ 227 (331)
T cd06649 154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-IF---GRPVVDGEEGEPH 227 (331)
T ss_pred cccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-Hh---cccccccccCCcc
Confidence 5433 22345689999999999764 48999999999999999999999998766544322 21 1111000000
Q ss_pred -cCCC----CCCC------CCCC---------ccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 307 -MNPN----YTDF------RFPQ---------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 307 -~~~~----~~~~------~~~~---------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
..+. .... ..+. +............+++++++||.+||++||++|||+.++++||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000 0000 0000 000000000112468899999999999999999999999999999864
Q ss_pred CC
Q 016115 367 RE 368 (395)
Q Consensus 367 ~~ 368 (395)
..
T Consensus 308 ~~ 309 (331)
T cd06649 308 EV 309 (331)
T ss_pred cc
Confidence 43
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=351.35 Aligned_cols=254 Identities=29% Similarity=0.464 Sum_probs=220.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+.|..++++|+|+||.+++++++.++..|++|++... ++....|..+++++.|||||.+.+.|+ .+...+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence 4799999999999999999999999999999998532 345568999999999999999999993 333349
Q ss_pred EEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|||+||+|+ +.+.+.... ...+++..+..|+.||+.|+.|||+ ++|+|||||+.||+++ .++.|||+|||+|+.
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Niflt-k~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLT-KDKKVKLGDFGLAKI 155 (426)
T ss_pred EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhcc-ccCceeecchhhhhh
Confidence 9999999975 444444432 5789999999999999999999999 7999999999999999 677789999999999
Q ss_pred cccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 230 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 230 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... ...+.+||+.||+||.+.+. .|+.++|||||||++|||++-+.+|.+.+-.....++.+....+
T Consensus 156 l~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P--------- 225 (426)
T KOG0589|consen 156 LNPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP--------- 225 (426)
T ss_pred cCCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC---------
Confidence 87776 66778999999999999765 59999999999999999999999999999988888888754332
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
++..++.+++.||+.||..+|..||++.++|.+|.+....
T Consensus 226 -------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 226 -------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred -------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 2345789999999999999999999999999999987544
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=317.22 Aligned_cols=268 Identities=26% Similarity=0.393 Sum_probs=214.8
Q ss_pred cCCCCCCCccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccc-----hHHHHHHHH-HcCCCceeeeceee
Q 016115 66 IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQLMR-LMDHPNVISLKHCF 139 (395)
Q Consensus 66 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~e~~~l~-~l~h~niv~~~~~~ 139 (395)
+++....+....+...+..||.|..|.|++++.+.+|...|||.+.+.... ....+.++. ...+|.||+.+|+|
T Consensus 81 i~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 81 IGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred ecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 333333344445667778899999999999999999999999998654322 122344433 33489999999999
Q ss_pred eecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcE
Q 016115 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219 (395)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~ 219 (395)
+...+ ++|.||.+..-...+++.. .++++|..+-.+...++.||.||.+..||+|||+||+|||+| +.|.+
T Consensus 161 i~n~d-----V~IcMelMs~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD-e~Gni 231 (391)
T KOG0983|consen 161 ITNTD-----VFICMELMSTCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGNI 231 (391)
T ss_pred eeCch-----HHHHHHHHHHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc-cCCCE
Confidence 65544 8899999986555555443 467999999999999999999999856999999999999999 79999
Q ss_pred EEeecccccccccCCcceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHh
Q 016115 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 296 (395)
Q Consensus 220 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~~~~~~~~~~~ 296 (395)
||||||++..+.+...++...|.+.|||||.+.- ...|+.++||||||++++||.||..||.+ ..+.+.+..+.+..
T Consensus 232 KlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e 311 (391)
T KOG0983|consen 232 KLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE 311 (391)
T ss_pred EeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC
Confidence 9999999999999999999999999999999843 34589999999999999999999999987 45667777766621
Q ss_pred CCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
. +.. .....+|+.+++|+..||.+|+.+||...++|+|||++....
T Consensus 312 P-P~L-------------------------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 312 P-PLL-------------------------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred C-CCC-------------------------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 1 110 012347999999999999999999999999999999887654
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=339.17 Aligned_cols=286 Identities=34% Similarity=0.546 Sum_probs=224.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
..+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++.. .....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence 457999999999999999999999999999999886332 123469999999999999999998743 22235
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++||||+.+++.+.+... ...+++..++.++.||+.||.|||+ .|++||||||+||+++ .++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~-~~~~~kL~dfg~~~~ 157 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLT-DKGCLKIADFGLART 157 (309)
T ss_pred EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC-CCCCEEECccceeee
Confidence 7899999998877776643 2568999999999999999999999 6999999999999999 788999999999987
Q ss_pred cccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 230 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 230 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... ......++..|+|||++.+...++.++||||||+++|+|++|..||...+..+.+..+....+.+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 64432 22233457889999998766668999999999999999999999999999999998888887776655443221
Q ss_pred C--CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 309 P--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 309 ~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
. ....+.........+.. ....+++++.+||++||+.||++|||+.+++.||||++...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~ 300 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKH-KFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300 (309)
T ss_pred cccccccccccCCCCCchHH-hccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence 1 01111111111011111 1123688999999999999999999999999999998766653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=347.33 Aligned_cols=250 Identities=29% Similarity=0.435 Sum_probs=203.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHHc-CCCceeeeceeeeecCCCCcee
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 149 (395)
+|.+.+.||+|+||.||+|++..+++.||||++.+... ....|..++..+ .|++|+++++++ .+...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 48899999999999999999999999999999865321 123466666666 588899998888 45556
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+++||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~-~~~~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLD-SEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEEC-CCCcEEEccCCCce
Confidence 9999999986 44444432 4568999999999999999999999 6999999999999999 78899999999987
Q ss_pred cccc-CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 229 VLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 229 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.... ........||+.|+|||++.+. .++.++|||||||++|+|+||+.||...+..+....+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------- 217 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----------- 217 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 5432 2223345689999999999754 58999999999999999999999999887776666554410
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 368 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 368 (395)
..++..++.++.+||.+||++||.+|++ ..++++||||+.+++
T Consensus 218 ------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 218 ------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred ------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 0123457899999999999999999998 489999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=347.12 Aligned_cols=245 Identities=29% Similarity=0.491 Sum_probs=199.9
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||+||+|++..+++.||||++.+.. ....+|..+++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 36999999999999999999999999986432 2234577788777 699999999988 4555699999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc-
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 232 (395)
||+.|+ |...+.. ...+++..+..++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEEC-CCCcEEecccCCCeecCcC
Confidence 999865 4333332 4578999999999999999999999 6999999999999999 788999999999865322
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
........|+..|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~----------------- 211 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED----------------- 211 (318)
T ss_pred CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 2223345689999999999764 5899999999999999999999999887766555444321
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCCCcCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELRE 368 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~hp~~~~~~~ 368 (395)
...++..++..+.+||++||..||.+|||+ .+++.||||+...+
T Consensus 212 ------------~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 212 ------------EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred ------------CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 001234568999999999999999999999 99999999988754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=346.10 Aligned_cols=289 Identities=36% Similarity=0.666 Sum_probs=226.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.+|.+.+.||+|+||+||+|++..+|+.||||.+... .....+|+.+++.++|+||+++++++..........+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 3699999999999999999999999999999987542 1223468999999999999999998754433333458
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
|+|+||+++++.+.+.. ...+++..++.++.||+.||.|||+ +|++||||||+||+++ .++.+||+|||++...
T Consensus 85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLN-ANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEc-CCCCEEECcCcccccc
Confidence 99999999887766653 4679999999999999999999999 6999999999999999 6889999999999765
Q ss_pred ccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
... .......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+....+.+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 433 2223456788999999986545589999999999999999999999998888777777777777766554422111
Q ss_pred C-CCCCC--CCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 310 N-YTDFR--FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 310 ~-~~~~~--~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
. ...+. .+....... ......+++++.+||++||+.||.+|||+.++++||||+.+......
T Consensus 239 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 239 EKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred hhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 0 00000 000000001 11234578999999999999999999999999999999998887654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=348.47 Aligned_cols=246 Identities=25% Similarity=0.467 Sum_probs=195.7
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||.||+|++..+++.||+|++.... ....+|..+++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 36999999999999999999999999986432 2234678888887 699999999988 5556699999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc-c
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-K 232 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~ 232 (395)
||++|+ |...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++... .
T Consensus 76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEC-CCCCEEECcCccccccccC
Confidence 999864 433333 24679999999999999999999999 6999999999999999 68899999999987532 2
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCChhhh
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~ 304 (395)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .+...+.... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~------ 220 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--K------ 220 (329)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc--C------
Confidence 3333456789999999999764 589999999999999999999999963211 1111111110 0
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC------HHHHhcCCCCcCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELRE 368 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt------~~ell~hp~~~~~~~ 368 (395)
...++..++..+.+||++||+.||.+|+| +.++++||||+.+..
T Consensus 221 --------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 221 --------------------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 01133457899999999999999999997 789999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=330.33 Aligned_cols=270 Identities=28% Similarity=0.421 Sum_probs=227.7
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccc-------hHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
...+|...++||+|.||+|-+++.+.+|+.||||+++++.-. ...|-++|+..+||.+..+...| +..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 455788899999999999999999999999999998765322 23477899999999999998888 666
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..+|+||||..|+ + |..+......+++..++.+-.+|+.||.|||+ ++||.||||.+|.|+| .+|.+||+|||++
T Consensus 241 drlCFVMeyanGG--e-Lf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLD-kDGHIKitDFGLC 315 (516)
T KOG0690|consen 241 DRLCFVMEYANGG--E-LFFHLSRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLD-KDGHIKITDFGLC 315 (516)
T ss_pred ceEEEEEEEccCc--e-EeeehhhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheec-cCCceEeeecccc
Confidence 6799999999986 2 22233446889999999999999999999999 7999999999999999 7899999999999
Q ss_pred ccc-ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 228 KVL-VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 228 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+.- ..+....+++|||.|.|||++.. ..|+.++|+|.+||++|||++|++||...+....+..|.-.
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------- 383 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------- 383 (516)
T ss_pred hhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------
Confidence 753 44555678999999999999965 45999999999999999999999999998887777766542
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCCC-CCCCCCCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN-ARLPNGRPFP 380 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~~-~~~~~~~~~~ 380 (395)
+.+ ++..++++++.|+..+|.+||.+|. .+.|+.+|+||..+++.+ -+..-.+++.
T Consensus 384 ------d~k------------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfK 445 (516)
T KOG0690|consen 384 ------DLK------------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFK 445 (516)
T ss_pred ------hcc------------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCC
Confidence 222 5567899999999999999999998 478999999999999854 3445566666
Q ss_pred CCCC
Q 016115 381 PLFN 384 (395)
Q Consensus 381 ~~~~ 384 (395)
|.+.
T Consensus 446 PqVt 449 (516)
T KOG0690|consen 446 PQVT 449 (516)
T ss_pred CCcc
Confidence 6664
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=345.41 Aligned_cols=245 Identities=29% Similarity=0.491 Sum_probs=197.8
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHH-cCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||.||+|++..+|+.||+|.+.... .....|..++.. ++|+||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 36999999999999999999999999986432 223346666664 4899999999988 5556799999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc-
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 232 (395)
||+.|+ |...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEC-CCCCEEeCccCCCeecccC
Confidence 999864 4444332 4678999999999999999999999 6999999999999999 688999999999875322
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~-------------- 212 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--T-------------- 212 (316)
T ss_pred CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence 2223456789999999999764 5899999999999999999999999887766555443321 0
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH-HHHhcCCCCcCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELRE 368 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-~ell~hp~~~~~~~ 368 (395)
..++..++.++.+||.+||+.||++|+++ +++++||||+....
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 213 -------------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 01223468899999999999999999997 58999999988754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=347.45 Aligned_cols=245 Identities=29% Similarity=0.495 Sum_probs=199.5
Q ss_pred eeeecCCceEEEEEEEC---CCCcEEEEEEecccc--------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 83 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+.||+|+||.||++++. .+++.||+|.+.... ....+|+.+++.++||||+++++++ .....+|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence 57999999999999864 478899999986421 2234689999999999999999988 4455689
Q ss_pred EEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||++|+ |.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLD-AQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEC-CCCCEEEeeCcCCeec
Confidence 999999974 4444432 4568889999999999999999999 6999999999999999 7889999999998754
Q ss_pred ccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+....+..+... .
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~----------- 216 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--K----------- 216 (323)
T ss_pred ccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C-----------
Confidence 322 223345689999999998654 4889999999999999999999999988776655554431 0
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
..++..+++++.+||++||++||++|+ ++.++++||||+....
T Consensus 217 ----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 217 ----------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 012345688999999999999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=344.88 Aligned_cols=245 Identities=31% Similarity=0.507 Sum_probs=197.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHH-cCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||+||+|++..+++.||||.+.... .....|..++.. .+||||+++++++ .....+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 36999999999999999999999999986432 112245555554 4899999999988 4555699999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||++|+ |...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.....
T Consensus 76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCC
Confidence 999864 4333332 4578999999999999999999999 6999999999999999 7889999999999764332
Q ss_pred -CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 234 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------------- 211 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND----------------- 211 (316)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 223345789999999999764 4899999999999999999999999988776655544321
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH-HHHhcCCCCcCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELRE 368 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-~ell~hp~~~~~~~ 368 (395)
...++..++.++.+||.+||+.||.+|+++ .++++||||+....
T Consensus 212 ------------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 212 ------------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 011234568899999999999999999986 58899999988653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=348.37 Aligned_cols=245 Identities=29% Similarity=0.463 Sum_probs=197.5
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeccccc-------chHHHH-HHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||+||+|++..+|+.||||++..... ....|. .+++.++||||+++++.+ .+...+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 369999999999999999999999999864321 111233 356789999999999888 4455689999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||+.|+ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++......
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEEC-CCCcEEEeccCCCcccccC
Confidence 999974 434333 24678999999999999999999999 6999999999999999 7889999999998754222
Q ss_pred -CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 234 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P------------- 212 (323)
T ss_pred CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence 223345689999999999664 4899999999999999999999999987766655554431 0
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH----HHHhcCCCCcCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELRE 368 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~hp~~~~~~~ 368 (395)
..+...++..+.+||++||+.||.+||++ .++++||||..+..
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 213 -------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred -------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 01223468899999999999999999998 69999999987664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=335.85 Aligned_cols=285 Identities=33% Similarity=0.591 Sum_probs=219.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcC-CCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++ |+||+++++++...........
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 6899999999999999999999999999999875432 23457999999995 6999999998855443344458
Q ss_pred EEEEecccchHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSM-NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|+||||+++++.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+||+++..++.+||+|||++..
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 899999999887777654332 4568999999999999999999999 69999999999999994488999999999876
Q ss_pred cccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 230 LVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 230 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
...... .....+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+....+..+....+.+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 533221 2233568889999998765668999999999999999999999999888888777777766655443332111
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
.......++...... .......++..+.+||.+||.+||.+||++.|++.||||+
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWHEFPQWKPQD-LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchhhcCcccchh-HHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000000011110000 0112235789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=352.53 Aligned_cols=255 Identities=28% Similarity=0.437 Sum_probs=205.1
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.++..++|+||+++++.+ .+...+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 6899999999999999999999999999999986421 2334688899999999999999988 555679
Q ss_pred EEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|+||||++|+ |.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~-~~~~vkL~DfG~~~~ 150 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLD-AKGHVKLSDFGLCTG 150 (360)
T ss_pred EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEEC-CCCCEEEeeccCCcc
Confidence 9999999864 4444433 4678999999999999999999999 6999999999999999 788999999999865
Q ss_pred cccCC------------------------------------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHH
Q 016115 230 LVKGE------------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAEL 273 (395)
Q Consensus 230 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 273 (395)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel 229 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeec
Confidence 42211 01134689999999999764 489999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-
Q 016115 274 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC- 352 (395)
Q Consensus 274 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp- 352 (395)
++|..||...+.......+...... ..++. ...+++++++||.+|+ .||.+|+
T Consensus 230 ~tG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~-~~p~~R~~ 283 (360)
T cd05627 230 LIGYPPFCSETPQETYRKVMNWKET---------------LVFPP----------EVPISEKAKDLILRFC-TDSENRIG 283 (360)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCCc---------------eecCC----------CCCCCHHHHHHHHHhc-cChhhcCC
Confidence 9999999988777666555431000 00000 0136889999999977 4999998
Q ss_pred --CHHHHhcCCCCcCCCCCC
Q 016115 353 --TALEACAHPFFDELREPN 370 (395)
Q Consensus 353 --t~~ell~hp~~~~~~~~~ 370 (395)
++.++++||||+.+++..
T Consensus 284 ~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 284 SNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred CCCHHHHhcCCCCCCCCHHH
Confidence 489999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=326.31 Aligned_cols=286 Identities=36% Similarity=0.617 Sum_probs=228.2
Q ss_pred cCceeeeeeecCCceEEEEEEECCCC----cEEEEEEeccccc------chHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
..|++...||+|.||.||+|....++ +.+|||.++.+.. ..-+|+.+++.++|+|++.+..+|...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 46999999999999999999655443 3689999875532 234899999999999999999998542
Q ss_pred ceeEEEEEecccchHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCC----CcEEE
Q 016115 147 ELFLNLVMEYVPETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT----HQVKL 221 (395)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~----~~~kl 221 (395)
+..+++++||.+.+|+..++.... ....++...++.|+.||+.|+.|||+ +-|+||||||.|||+. .+ |.+||
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvm-gdgperG~VKI 177 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVM-GDGPERGRVKI 177 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEe-ccCCccCeeEe
Confidence 455999999999999998876543 34678999999999999999999999 6999999999999997 44 89999
Q ss_pred eecccccccccCCc----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC---------hHHH
Q 016115 222 CDFGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AVDQ 288 (395)
Q Consensus 222 ~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---------~~~~ 288 (395)
+|||+++.+.+.-. ....+.|.+|+|||.+.|...|+.+.|||++|||+.||+|-.+.|.+.. ..++
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 99999998755432 2235679999999999999999999999999999999999999996642 3478
Q ss_pred HHHHHHHhCCCChhhhhhcCCCCCCC-------CCCCccCCCcccccc--ccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 289 LVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKAHPWHKVFH--KRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+..|++++|.|....|..+.. +.++ .........+...+. ..-++...+|+.+||.+||.+|+|++++++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk-~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKK-MPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHcCCCccccchhhhh-CcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 899999999999988876542 1222 101111111222221 223566999999999999999999999999
Q ss_pred CCCCcCCCCC
Q 016115 360 HPFFDELREP 369 (395)
Q Consensus 360 hp~~~~~~~~ 369 (395)
|+||++-..+
T Consensus 337 h~yF~~d~lp 346 (438)
T KOG0666|consen 337 HPYFTEDPLP 346 (438)
T ss_pred ccccccCCCC
Confidence 9999876554
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=343.52 Aligned_cols=245 Identities=30% Similarity=0.517 Sum_probs=197.9
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHH-cCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||+||+|++..+++.||||.+.... .....|..+++. ++||||+++++++ .+...+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 36999999999999999999999999986532 122346667765 5899999999988 4445699999
Q ss_pred ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||++| +|...+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++......
T Consensus 76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLD-TDGHIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEEC-CCCCEEEccCCcceECCCC
Confidence 99986 44444432 3568899999999999999999999 6999999999999999 6889999999998753222
Q ss_pred -CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 234 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
.......||..|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~-------------- 212 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--N-------------- 212 (316)
T ss_pred CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence 223456789999999999654 4899999999999999999999999887766555443221 0
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHH-HHhcCCCCcCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELRE 368 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~-ell~hp~~~~~~~ 368 (395)
..++..++.++.+||.+||+.||.+|+++. ++++||||+.+..
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 213 -------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred -------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 002234688999999999999999999996 8999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=352.69 Aligned_cols=281 Identities=23% Similarity=0.343 Sum_probs=213.5
Q ss_pred ccCceeeeeeecCCceEEEEEEEC--CCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
..+|.+.+.||+|+||.||+|... .++..||+|.+... ....+|+++++.++|+||+++++++ .....+|+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence 346999999999999999999754 35678999987654 3446799999999999999999988 455568999
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||++.+++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.++|+|||+++.....
T Consensus 165 ~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEc-CCCCEEEccCccccccCcc
Confidence 99999988776632 4678999999999999999999999 6999999999999999 7889999999999765443
Q ss_pred Cc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChhhhhhc
Q 016115 234 EA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 234 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.. .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ....+..+.+.++..+.......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 22 2245689999999999654 48999999999999999999999997643 34556666665554332211100
Q ss_pred CCC----CCCCCCCCccCCCccccc-cccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 308 NPN----YTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 308 ~~~----~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
... +..+.............+ ...++.++.+||++||.+||++|||+.|+|.||||++....
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 000 000000000000000111 12457889999999999999999999999999999875543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=339.99 Aligned_cols=276 Identities=28% Similarity=0.410 Sum_probs=227.8
Q ss_pred CCccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCC
Q 016115 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (395)
Q Consensus 72 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (395)
.+.....|+.-++||+|+||.||-+..+.||+.||.|.+.+.+ .....|..+|.+++.+.||.+-.+|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf----- 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF----- 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----
Confidence 3445567888999999999999999999999999999874432 2234689999999999999998888
Q ss_pred CCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
+....+|+|+..|+|+-+... -+.-.+..+++..++.++.+|+.||++||. .+||.|||||+|||+| +.|.++|+|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfH-iyn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLD-d~GhvRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFH-IYNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLD-DHGHVRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEE-eeccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeec-cCCCeEeecc
Confidence 444559999999998722211 122334589999999999999999999999 7999999999999999 7899999999
Q ss_pred ccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 225 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
|+|..+..+......+||.+|||||++.+.. |+...|+|||||++|+|+.|+.||........-.++-+..-..
T Consensus 332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~----- 405 (591)
T KOG0986|consen 332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED----- 405 (591)
T ss_pred ceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-----
Confidence 9999999998888889999999999998765 9999999999999999999999998765444333333221111
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCCCCCCCCCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPNARLPNGRPF 379 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~~~~~~~~~~~ 379 (395)
...+++++|+++++|.+.+|.+||.+|. +++++-+||||+.+++ .++..+...
T Consensus 406 --------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw--~rleagml~ 463 (591)
T KOG0986|consen 406 --------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW--RRLEAGMLE 463 (591)
T ss_pred --------------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH--hHHhccCCC
Confidence 1235678899999999999999999998 4679999999999888 566777777
Q ss_pred CCCC
Q 016115 380 PPLF 383 (395)
Q Consensus 380 ~~~~ 383 (395)
||++
T Consensus 464 PPfi 467 (591)
T KOG0986|consen 464 PPFI 467 (591)
T ss_pred CCCC
Confidence 7765
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=343.22 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=204.6
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|++.+.||+|+||.||++++..+++.||+|++.+. .....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL 76 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence 699999999999999999999999999999998642 12245688899999999999999988 555679
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|+||||+.| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLD-KNGHIRLADFGSCLR 151 (331)
T ss_pred EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEEC-CCCCEEEEECCceee
Confidence 999999986 55444433 24578999999999999999999999 6999999999999999 788999999999876
Q ss_pred cccCCcc--eeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 230 LVKGEAN--ISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 230 ~~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
....... ....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+..+....+......
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~----- 226 (331)
T cd05597 152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH----- 226 (331)
T ss_pred cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc-----
Confidence 5433322 23468999999999863 234788999999999999999999999887766665554431000
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCC--CCCHHHHhcCCCCcCCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE 368 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~~ 368 (395)
+.++. ....++..+++||++||+.++++ |+++.++++||||..++.
T Consensus 227 ----------~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 227 ----------FQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred ----------ccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 00000 11236899999999998765544 889999999999988654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=350.13 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=205.8
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
....+|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++||||+++++++ .+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~ 114 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD 114 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence 3446899999999999999999999999999999998532 12345788999999999999999988 55
Q ss_pred ceeEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+++||||++|+ |.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~-~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLD-KSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEEC-CCCCEEEEeCC
Confidence 56799999999864 4444432 458899999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCc--ceeeeecccccCchhhcCCC---CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 226 SAKVLVKGEA--NISYICSRYYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 226 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
++........ .....||+.|+|||++.+.. .++.++|||||||++|+|++|..||...+.......+......
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-- 265 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-- 265 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc--
Confidence 9986643322 23457899999999986432 3789999999999999999999999988776666655432110
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCC--CCCHHHHhcCCCCcCCC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELR 367 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~ 367 (395)
..++ ....++..+++||.+||..++.+ |++++++++||||+...
T Consensus 266 -------------~~~~----------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 266 -------------LTFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred -------------ccCC----------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 0011 11247899999999999844433 78999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=331.76 Aligned_cols=276 Identities=34% Similarity=0.648 Sum_probs=215.1
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++ .....++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKLH 76 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEEE
Confidence 6899999999999999999999999999999885332 2245799999999999999999988 4455689
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||++++++..+.. ....+++..++.++.||+.||.|||+ .|++|+||||+||+++ .++.++|+|||++....
T Consensus 77 ~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 77 LVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILIT-KQGQIKLCDFGFARILT 151 (286)
T ss_pred EEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEc-CCCcEEECccccceecC
Confidence 9999999876665543 23568999999999999999999999 6999999999999999 78899999999998765
Q ss_pred cCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
... ......++..|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+....+.............
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 443 2233457888999999876566889999999999999999999999988877777766665554433221111100
Q ss_pred --CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 311 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 311 --~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
+.....+......-.......++..+.+||.+||+.||++|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 01111111111100111223568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=332.08 Aligned_cols=275 Identities=35% Similarity=0.633 Sum_probs=216.9
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
|++.+.||+|+||.||+|.+..++..||+|.+..... ...+|+.+++.+. |+||+++++++... ....+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 6788999999999999999999999999998865321 1235778888885 99999999988432 1245899
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
||||+++++++.+... ...+++..++.++.||+.||.|||+ +|++||||||+||+++ . +.+||+|||++.....
T Consensus 78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~-~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIK-D-DILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEc-C-CCeEEEeccccccccc
Confidence 9999999887776542 3568999999999999999999999 6999999999999999 4 8999999999987655
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC-C
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN-Y 311 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 311 (395)
........++..|+|||++.+...++.++|||||||++|+|++|..||...+..+....+....+.+........... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 444445567899999998766556789999999999999999999999998888888888777776665432221111 1
Q ss_pred CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
..+.++......+ ......++..+.+||.+||.+||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1122222111111 11223568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=346.77 Aligned_cols=245 Identities=28% Similarity=0.458 Sum_probs=200.8
Q ss_pred eeeecCCceEEEEEEE---CCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 83 RVVGTGSFGIVFQAKC---LETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
+.||+|+||.||++++ ..+|+.||+|++.... ....+|+++++.++||||+++++++ .+...+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 5799999999999886 3578999999986432 2234688999999999999999988 455568999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLD-EEGHIKLTDFGLSKESID 150 (318)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEEC-CCCcEEEeeccCCcccCC
Confidence 999985 44444432 4568999999999999999999999 6999999999999999 788999999999876544
Q ss_pred C-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 233 G-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 233 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.+..
T Consensus 151 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--------------- 214 (318)
T cd05582 151 HEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--------------- 214 (318)
T ss_pred CCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 3 223346789999999999654 47899999999999999999999999887766655544310
Q ss_pred CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCC
Q 016115 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 368 (395)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 368 (395)
..++..+++++.+||++||+.||.+||+ +.+++.||||+.+..
T Consensus 215 --------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 215 --------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred --------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 0122356889999999999999999999 788999999987643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=345.28 Aligned_cols=246 Identities=26% Similarity=0.480 Sum_probs=193.7
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.++..+ +||||+++++++ .....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986532 1234577777665 799999999988 4455699999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc-
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 232 (395)
||++++ |...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||+++....
T Consensus 76 E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEC-CCCCEEEeeCCccccccCC
Confidence 999965 333332 24679999999999999999999999 6999999999999999 788999999999875322
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCCCChhhh
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--------AVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~ 304 (395)
........||..|+|||++.+. .++.++|||||||++|+|++|..||.... ....+.+.... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~------ 220 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--K------ 220 (329)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--C------
Confidence 2233456789999999999764 58999999999999999999999995321 11111111110 0
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC------HHHHhcCCCCcCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELRE 368 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt------~~ell~hp~~~~~~~ 368 (395)
...++..++..+.+||++||+.||.+|++ +.++++||||+.+.+
T Consensus 221 --------------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 221 --------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 01133457889999999999999999998 579999999988654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=358.30 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=212.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC---CC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---KD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 146 (395)
..+|.+.+.||+|+||+||+|++..+|+.||||.+.... ....+|+.++..++|+||+++++.+..... ..
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 458999999999999999999999999999999985431 234568888999999999998877643321 12
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~-~~~~vkL~DFG 188 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLC-SNGLVKLGDFG 188 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEe-CCCCEEEEecc
Confidence 2357899999985 6666666555556779999999999999999999999 6999999999999999 68899999999
Q ss_pred cccccccC---CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 226 SAKVLVKG---EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 226 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~----- 262 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY----- 262 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-----
Confidence 99765432 122345789999999999764 489999999999999999999999998776665554433100
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
..++..+++++.+||.+||+.||.+||++.++++|||++.+..
T Consensus 263 -----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~ 305 (496)
T PTZ00283 263 -----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS 305 (496)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence 0123457899999999999999999999999999999886543
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=341.06 Aligned_cols=250 Identities=29% Similarity=0.445 Sum_probs=202.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcC-CCceeeeceeeeecCCCCcee
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 149 (395)
+|+..+.||+|+||.||+|.+..+|+.||+|++.... .....|..+++.+. |++|+++++++ .+...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 3778899999999999999999999999999986432 12335777887776 56777888877 44556
Q ss_pred EEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+|+||||++|+ |...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 76 ~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~-~~~~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLD-SEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEEC-CCCCEEEecccccc
Confidence 99999999864 443333 24678999999999999999999999 6999999999999999 78899999999987
Q ss_pred ccccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 229 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 229 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----------- 217 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----------- 217 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 543222 23345689999999999654 48999999999999999999999999887766665554310
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 368 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 368 (395)
..++..++.++.+|+.+||+.||.+|++ ..++++||||+.+..
T Consensus 218 ------------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 218 ------------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred ------------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 0123456889999999999999999997 579999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=345.51 Aligned_cols=245 Identities=29% Similarity=0.482 Sum_probs=196.8
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHH-HHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNREL-QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||.||+|++..+|+.||+|++.... .....|. .+++.++||||+++++.+ .....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 36999999999999999999999999986432 1112333 356789999999999888 4555689999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc-
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 232 (395)
||+.|+ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEEC-CCCCEEEeecCCcccCCCC
Confidence 999975 333333 34678999999999999999999999 6999999999999999 788999999999875322
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~---~------------- 212 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK---P------------- 212 (325)
T ss_pred CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence 2233456789999999999664 4899999999999999999999999987766655554431 0
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH----HHHhcCCCCcCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELRE 368 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~hp~~~~~~~ 368 (395)
..+...++..+.++|++||..||.+||++ .+++.||||+....
T Consensus 213 -------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 213 -------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred -------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 00123468899999999999999999977 59999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=342.59 Aligned_cols=282 Identities=33% Similarity=0.581 Sum_probs=221.2
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (395)
.+|.+.+.||+|+||.||+|.+..+|+.||||.+.... ....+|+.+++.++|+||+++++++..... .+...
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 47999999999999999999999999999999885421 223468999999999999999998753322 22345
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.|+||||+.+++.+.+.. .+++..+..++.|++.||.|||+ .||+||||||+||+++ .++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 96 VYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLART 167 (353)
T ss_pred EEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEC-CCCCEEEccCcccee
Confidence 789999999987776643 27888999999999999999999 6999999999999999 688999999999987
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
...........++..|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+...++.+..+.......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 6554444455678999999999764 489999999999999999999999999888888888888888776654433221
Q ss_pred CCC----------CCCCCCccCC-Cc---cccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 310 NYT----------DFRFPQIKAH-PW---HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 310 ~~~----------~~~~~~~~~~-~~---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
... ...+...... .+ ........+..+.+||.+||+.||.+|||+.|+|.||||+.--
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 111 1111110000 00 0000223567899999999999999999999999999997533
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=333.10 Aligned_cols=282 Identities=35% Similarity=0.642 Sum_probs=220.3
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
++|++.+.||+|++|.||+|.+..+|+.||+|.+.... ....+|+++++.++|+||+++++++ .+....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 36999999999999999999999999999999885431 2345799999999999999999998 455569
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||+++++.+.+.... ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++..++.+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 9999999988777665422 2346788899999999999999999 699999999999999855678999999999765
Q ss_pred ccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... .....++..|+|||.+.+...++.++||||||+++|+|+||..||...+..+...++....+.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT- 232 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc-
Confidence 33221 2234568899999998765568899999999999999999999999888888887777777766554443111
Q ss_pred CCCCCC--CCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 310 NYTDFR--FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 310 ~~~~~~--~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
...++. .+.... .........+++++.++|.+||+.||++||++.++++||||+.+++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 233 SLPDYKSAFPKWPP-KDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred cchhhhhhcccCCC-CCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 001110 000000 0011123457889999999999999999999999999999998764
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=333.29 Aligned_cols=275 Identities=35% Similarity=0.657 Sum_probs=216.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||.|++|.||+|++..+|+.||||.+..+. ....+|+++++.++|+||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 4889999999999999999999999999999886432 2345799999999999999999988 4455689
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||+.+++...+... ....+++..++.++.|++.||+|||+ .|++|+||+|+||+++ .++.+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCCEEEeeccchhhcc
Confidence 99999998776665432 23568999999999999999999999 6999999999999999 78899999999987654
Q ss_pred cCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.... .....++..|+|||++.+...++.++||||||+++|+|+||+.||...+..+...++.+..+.+....+.....
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS- 230 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH-
Confidence 3322 22345688899999987655578899999999999999999999999888888888887777665443321100
Q ss_pred CCCC--CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 311 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 311 ~~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
..++ .++....... ......++.++.++|.+||+.||.+|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 231 LPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000 0111111111 11223578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=334.02 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=203.4
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+.+.+.+ .+...++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence 778899999999999999999999999999885431 1234689999999999999999888 4455699
Q ss_pred EEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||+.|+ |.+.+.. .....+++..+..++.|++.||.|||+ .||+||||||+||+++ .++.++|+|||++...
T Consensus 77 lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 77 LVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLD-DHGHIRISDLGLAVHV 152 (285)
T ss_pred EEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEEC-CCCCEEEeeccceeec
Confidence 999999864 4444433 223468999999999999999999999 6999999999999999 6888999999998765
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
..........|+..|+|||++.+. .++.++||||||+++|+|++|..||..................
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------------ 219 (285)
T cd05630 153 PEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------------ 219 (285)
T ss_pred CCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------------
Confidence 444433445789999999999654 4899999999999999999999999865432111111110000
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~~ 369 (395)
....+...+++++.+||.+||+.||.+|+| ++|+++||||+.+...
T Consensus 220 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 220 -------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred -------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 001123456889999999999999999999 9999999999886553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=333.90 Aligned_cols=279 Identities=34% Similarity=0.608 Sum_probs=221.3
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
++|++.+.||+|+||.||+|.+..+++.+|+|.+..... ...+|+.+++.++||||+++++++... +....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence 469999999999999999999999999999998864321 234689999999999999999987542 12569
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
|+||||+++++.+.+... ...+++..++.++.||+.||.|||+ +|++|+||||+||+++ .++.++|+|||++...
T Consensus 82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~-~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLN-NRGILKICDFGLAREY 156 (293)
T ss_pred EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEEC-CCCcEEEeecCceeec
Confidence 999999998877766542 2368999999999999999999999 6999999999999999 7889999999998866
Q ss_pred ccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
... .......++..|+|||.+.+...++.++||||||+++|+|++|..||......+.+..+....+.+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 544 2233455788899999987655578999999999999999999999999988888888888777776655543210
Q ss_pred --CCCCCCCCCccCCCcccccccc-CChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 --NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 --~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
......+.......+...++.. +++.+.+||++||+.||++|||+.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0000111111111222233333 68899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=330.89 Aligned_cols=276 Identities=41% Similarity=0.737 Sum_probs=221.0
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|.+.+.||+|+||.||+|.+..+|..||+|++.... ....+|+.+++.++|+||+++++.+ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 4889999999999999999999999999999986432 2345789999999999999999988 4455689
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||+++++.+.+... ...+++..++.++.||+.||.|||+ .|++|+||||+||+++ .++.++|+|||++....
T Consensus 76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLIS-ADGVLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEc-CCCcEEEeeeeeccccc
Confidence 99999976776665542 2668999999999999999999999 6999999999999999 68899999999988765
Q ss_pred cCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 232 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 232 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... .....++..|+|||.+.+...++.++||||||+++|+|++|.++|...+....+..+....+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 4332 33456789999999987666678999999999999999999999998888888888888777776655443211
Q ss_pred --CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 310 --NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 310 --~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
.+....++......+. .....++..+.+||.+||..||.+|||++++++||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 231 LPDYNKITFPESKPIPLE-EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchhhcccCCCCCcchHH-HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 1111111111111111 12245678999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=331.64 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=197.2
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecc
Q 016115 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 85 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
||+|+||.||++++..+|+.||+|.+.... .....|+++++.++||||+++++++ .+...+++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 799999999999999999999999885321 1223589999999999999999988 5556699999999
Q ss_pred cch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcc
Q 016115 158 PET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (395)
Q Consensus 158 ~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (395)
.|+ +...+.. .....+++..+..++.||+.||.|||+ +||+||||||+||+++ .++.++|+|||++.........
T Consensus 76 ~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 76 NGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEc-CCCCEEEeeceeeeecCCCcee
Confidence 864 4444432 223458889999999999999999999 6999999999999999 6889999999999876554444
Q ss_pred eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCC
Q 016115 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316 (395)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
....|+..|+|||++.+.. ++.++|||||||++|+|++|..||...........+....-.. ..
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~-- 215 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-------------EV-- 215 (277)
T ss_pred eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-------------cc--
Confidence 4556899999999997654 8999999999999999999999997654322222221110000 00
Q ss_pred CCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH----HHHhcCCCCcCCCC
Q 016115 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELRE 368 (395)
Q Consensus 317 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~hp~~~~~~~ 368 (395)
......++.++.+||++||++||.+||++ ++++.||||+.++.
T Consensus 216 ---------~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 216 ---------KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred ---------ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 00113468899999999999999999999 67889999998765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=342.82 Aligned_cols=245 Identities=27% Similarity=0.444 Sum_probs=197.2
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeccccc-------chHHH-HHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRE-LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~e-~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||+||+|++..+++.||+|++..... ....| ..+++.++|+||+++++++ .....+++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 369999999999999999999999999864321 11122 3356788999999999988 4555689999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc-
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 232 (395)
||++|+ +...+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEC-CCCCEEEccCCCCcccccC
Confidence 999975 4343332 4668889999999999999999999 6999999999999999 688999999999875432
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+.+..+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P------------- 212 (325)
T ss_pred CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-------------
Confidence 2223456789999999999764 5899999999999999999999999988776665555431 0
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHH----HHhcCCCCcCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL----EACAHPFFDELRE 368 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~----ell~hp~~~~~~~ 368 (395)
..+...++..+.++|.+||+.||.+|+++. ++++|+||..+.+
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 213 -------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred -------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 012235789999999999999999999876 8999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=357.37 Aligned_cols=253 Identities=27% Similarity=0.348 Sum_probs=208.8
Q ss_pred CceeeeeeecCCceEEEEEEECCC-CcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ....+|+.+++.++|||||++++++ .....+|+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEEE
Confidence 499999999999999999998877 7889999764332 2345699999999999999999998 44556999
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
||||++| +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~-~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLM-PTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEEC-CCCcEEEEeCcCceecC
Confidence 9999985 6666665544445678999999999999999999999 6999999999999999 68899999999998764
Q ss_pred cCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 232 KGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 232 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+.+..+......
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------- 289 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---------- 289 (478)
T ss_pred CccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence 4322 2345689999999998654 5899999999999999999999999887776655554431000
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.++..++.++.+||.+||..||++||++.+++.|+|++.+
T Consensus 290 ------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 290 ------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred ------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0223568899999999999999999999999999998753
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=332.05 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=207.1
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
|+..+.||+|+||+||+|.+..+++.||+|.+.... ....+|+++++.++|+||+.+.+.+ ......+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 778899999999999999999999999999885431 2235689999999999999998888 4455699
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||+.++.+...... .....+++..+..++.|++.||.|||+ +||+||||||+||+++ +++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLD-DYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEC-CCCCEEEecCCcceecC
Confidence 99999997544332221 223569999999999999999999999 6999999999999999 67889999999987654
Q ss_pred cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
.........|+..|+|||++.+. .++.++|+||||+++|+|++|..||...........+........
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----------- 221 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----------- 221 (285)
T ss_pred CCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc-----------
Confidence 44444455789999999999664 489999999999999999999999987765544443333211110
Q ss_pred CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCCC
Q 016115 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (395)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~~ 369 (395)
..+...++..+.+|+.+||+.||.+||+ +.+++.|+||+.+...
T Consensus 222 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 222 --------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred --------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 0123456889999999999999999999 8999999999987553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=366.27 Aligned_cols=265 Identities=27% Similarity=0.402 Sum_probs=212.4
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
....+|.+.+.||+|+||+||+|++..++..||+|.+... ...+..|+.+++.++|||||+++++|.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCC
Confidence 3445799999999999999999999999999999988532 2234579999999999999999998854 233
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC------CCceeccCCCCceeecC------
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV------PGVCHRDVKPQNLLVDP------ 214 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~------~~ivH~Dlkp~Nill~~------ 214 (395)
..+||||||+++ +|...+.........+++..++.|+.||+.||.|||+. ++|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 458999999985 67677765555556799999999999999999999983 24999999999999962
Q ss_pred ----------CCCcEEEeecccccccccCCcceeeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 016115 215 ----------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (395)
Q Consensus 215 ----------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~ 283 (395)
..+.+||+|||++.............||+.|+|||++.+. ..++.++||||||||||+|+||..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 1235899999999876544444456789999999998643 34789999999999999999999999876
Q ss_pred ChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
+....+...+... +. . ....++.++.+||.+||..+|.+||++.|+|.|||+
T Consensus 247 ~~~~qli~~lk~~--p~-------------l-------------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i 298 (1021)
T PTZ00266 247 NNFSQLISELKRG--PD-------------L-------------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298 (1021)
T ss_pred CcHHHHHHHHhcC--CC-------------C-------------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence 6555444333210 00 0 012357899999999999999999999999999999
Q ss_pred cCCCCC
Q 016115 364 DELREP 369 (395)
Q Consensus 364 ~~~~~~ 369 (395)
+.+..+
T Consensus 299 k~i~~p 304 (1021)
T PTZ00266 299 KNVGPP 304 (1021)
T ss_pred hhcCCC
Confidence 877654
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=335.35 Aligned_cols=281 Identities=36% Similarity=0.633 Sum_probs=213.5
Q ss_pred CceeeeeeecCCceEEEEEEECC--CCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 48889999999999999999988 89999999987632 2345699999999999999999988432 225
Q ss_pred eEEEEEecccchHHHHHHhhcccC-CCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC----CCcEEEee
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMN-QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL----THQVKLCD 223 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~----~~~~kl~D 223 (395)
.+++||||+++++.+.+....... ..+++..++.++.||+.||.|||+ +||+||||||+||+++ . ++.+||+|
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~-~~~~~~~~~kl~D 155 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVM-GEGPERGVVKIGD 155 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEc-CCCCccceEEECC
Confidence 689999999998887776544433 378999999999999999999999 6999999999999999 6 78899999
Q ss_pred cccccccccCCc----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 016115 224 FGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLV 290 (395)
Q Consensus 224 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---------~~~~ 290 (395)
||++........ .....++..|+|||++.+...++.++||||||+++|+|++|..||...... ..+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999886543322 123456888999999877666899999999999999999999999865432 3445
Q ss_pred HHHHHhCCCChhhhhhcC--CCCCC----CCCCCccCCCcccccc--ccCChhHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 016115 291 EIIKVLGTPTREEIRCMN--PNYTD----FRFPQIKAHPWHKVFH--KRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (395)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 362 (395)
.+...++.+....+.... +.+.. ................ ...+..+.++|.+||..||++|||+.|+++|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 555555555444332111 00000 0000000000111111 256889999999999999999999999999999
Q ss_pred C
Q 016115 363 F 363 (395)
Q Consensus 363 ~ 363 (395)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=345.92 Aligned_cols=244 Identities=27% Similarity=0.487 Sum_probs=195.3
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHHc---CCCceeeeceeeeecCCCCceeEEEEE
Q 016115 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLM---DHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 85 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
||+|+||+||+|++..+|+.||||++..... ....|..++..+ +||||+++++.+ .....+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 7999999999999999999999999864321 112355555544 699999999988 5555699999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||+.|+ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++......
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLD-ATGHIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCC
Confidence 999864 444443 24678999999999999999999999 6999999999999999 6889999999998754322
Q ss_pred -CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 234 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
.......||..|+|||++.+...++.++|||||||++|+|++|..||...+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 212 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG----------------- 212 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 22334678999999999976556899999999999999999999999887766555444321
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC----CHHHHhcCCCCcCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELR 367 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp----t~~ell~hp~~~~~~ 367 (395)
...++ ...+++++.+||++||+.||.+|| ++.++++||||+...
T Consensus 213 ~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 213 KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 00111 123688999999999999999998 799999999998765
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=331.30 Aligned_cols=281 Identities=36% Similarity=0.648 Sum_probs=219.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc---------chHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
+|.+.+.||+|+||.||+|.+..+|+.||||.+..... ....|+++++.++|+||+++++++ .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 48888999999999999999999999999999864422 224688999999999999999998 4456
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
..++||||+.|++.+.+... ...+++..++.++.||++||.|||+ +||+|+||||+||+++ .++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~-~~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIA-SDGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEc-CCCCEEEccceeee
Confidence 68999999977766665431 1368999999999999999999999 6999999999999999 78899999999997
Q ss_pred ccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 229 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
....... .....++..|+|||.+.+...++.++|||||||++|+|++|.++|...+..+.+..+....+.+....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 7644322 223456788999999866566889999999999999999999999888877777777776665554433221
Q ss_pred CCCCCCCCC-CCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 308 NPNYTDFRF-PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 308 ~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
.. ...+.. ......+. .......+..+.+||.+||++||++|||+.|++.||||++...+.
T Consensus 231 ~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 231 TS-LPDYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cc-ccccccccccCCcch-hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 11 011110 00001111 112245688999999999999999999999999999999866654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=329.94 Aligned_cols=252 Identities=35% Similarity=0.589 Sum_probs=204.5
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccc------hHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
|++++.||+|+||+||++++..+++.||+|.+...... ..+|+.+++.++|+||+++++++. +....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence 78999999999999999999999999999999654321 124889999999999999999984 4556889
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc-
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL- 230 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~- 230 (395)
||||+.+ ++.+.+. ....+++..++.++.||+.||.+||+ .||+|+||||+||+++ .++.++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLD-ENGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEES-TTSEEEESSGTTTEEST
T ss_pred ccccccccccccccc----cccccccccccccccccccccccccc-cccccccccccccccc-ccccccccccccccccc
Confidence 9999998 7766666 24778999999999999999999999 6999999999999999 7899999999998753
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
..........++..|+|||++.....++.++||||||+++|+|++|..||......+....+.+...........
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 224 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ----- 224 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence 223334456779999999998634568999999999999999999999999875445444444332211111000
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
.....+..+.++|.+||+.||++|||+.++++||||
T Consensus 225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 001123789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=340.04 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=205.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|.+.+.||+|+||.||++++..+++.||+|++.+.. ....+|+.++..++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL 76 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence 6899999999999999999999999999999985421 2245688889999999999999988 555669
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||+.| +|.+.+.. ....+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~-~~~~~kL~DfG~a~~ 151 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMD-MNGHIRLADFGSCLK 151 (332)
T ss_pred EEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEC-CCCCEEEeecchhee
Confidence 999999985 55555543 23568999999999999999999999 6999999999999999 788999999999876
Q ss_pred cccCCc--ceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 230 LVKGEA--NISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 230 ~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
...... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------ 225 (332)
T cd05623 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------ 225 (332)
T ss_pred cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc------
Confidence 533322 123568999999999852 34578999999999999999999999998877666665543100
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCC--CCCHHHHhcCCCCcCCCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP 369 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~~~ 369 (395)
.+.++. ....+++++.+||++||+.++.+ |++++++++||||+.++..
T Consensus 226 ---------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 226 ---------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred ---------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 000110 11346899999999999765544 7899999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=339.50 Aligned_cols=287 Identities=35% Similarity=0.660 Sum_probs=226.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.+|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++.... .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 47999999999999999999999999999999886432 22346899999999999999998774433 344568
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||+.+++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVN-EDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEc-CCCcEEecccccceee
Confidence 99999998876555432 4568999999999999999999999 6999999999999999 7899999999998765
Q ss_pred ccCCc-----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 231 VKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 231 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
..... .....++..|+|||.+.+...++.++||||||+++|+|++|+.||...+....+..+....|.++...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 33221 1234678899999998665568999999999999999999999999988888888888888877766544
Q ss_pred hcCCCCCCC---CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 306 CMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 306 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
......... .++.....++. .+...++.++.++|++||+.||.+|||+++++.||||++...+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWS-KIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHH-HHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 322111000 01111111111 122456899999999999999999999999999999998777655
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=351.23 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=214.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.+.|.|+..||.|+||+||+|.++.++...|.|+|... .....-|++||..+.||+||++++.|+..+. ++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eE
Confidence 34689999999999999999999989888899988532 2334468999999999999999999965444 89
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
|..|||+||-.+.+.- .....+++.++..+++|+|.||.|||+ ++|||||||..|||++ -+|.++|+|||.+....
T Consensus 106 iliEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLT-LDGDIRLADFGVSAKNK 181 (1187)
T ss_pred EEEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEE-ecCcEeeecccccccch
Confidence 9999999986665543 335789999999999999999999999 7999999999999999 78999999999975432
Q ss_pred -cCCcceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 232 -KGEANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 232 -~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
......+++|||+|||||+... ...|+.++||||||++|.+|..+.+|....+....+.++.+.-.+
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePP-------- 253 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-------- 253 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCC--------
Confidence 2233457899999999999854 345899999999999999999999999888887777766652111
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
....++..+..+.||+++||.+||..||+++++|+||||+.+..
T Consensus 254 ------------------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 254 ------------------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred ------------------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 11234566889999999999999999999999999999987544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=340.93 Aligned_cols=279 Identities=26% Similarity=0.421 Sum_probs=204.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.++|++.+.||+|+||.||++.+..+|..+|+|.+.... ....+|+++++.++|+||+++++++. +...+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence 357999999999999999999999999999999876432 23457999999999999999999984 44569
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||+.| +|.+.+.. ...+++..++.++.|++.||.|||+..+|+|+||||+|||++ .++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc-CCCCEEEeeCCcchh
Confidence 999999986 55555543 456889999999999999999999733799999999999999 688899999999876
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCChhhhhhcC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPTREEIRCMN 308 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 308 (395)
.... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||......+....+... .+......... .
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 230 (333)
T cd06650 154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP-R 230 (333)
T ss_pred hhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc-c
Confidence 5332 22345689999999999654 4899999999999999999999999876543332211100 00000000000 0
Q ss_pred CCCCCCCC----CC-------------ccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 309 PNYTDFRF----PQ-------------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 309 ~~~~~~~~----~~-------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
........ +. .............++.++.+||.+||++||++|||+.|++.||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00000000 00 0000000001123678999999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=329.39 Aligned_cols=276 Identities=34% Similarity=0.656 Sum_probs=214.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
++|++.+.||+|++|.||+|.+..+++.||||.+.... ....+|+++++.++|+||+++++++ .+....+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence 57999999999999999999999899999999885432 2235699999999999999999988 4556699
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||+.+++.+.+... ...+++..++.++.|++.||.|||+ .||+|+||||+||+++ .++.+||+|||+++...
T Consensus 80 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 80 LVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLIS-ERGELKLADFGLARAKS 154 (291)
T ss_pred EEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEc-CCCCEEECccccccccC
Confidence 99999999877766542 2468899999999999999999999 6999999999999999 78899999999987543
Q ss_pred cCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 232 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
... ......++..|+|||++.+...++.++||||+|+++|+|++|..||.... ..+.+..+.+..+.+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 221 12223467889999998765568899999999999999999999998665 5566666667666666555433221
Q ss_pred --CCCCCCCCCccCCCccccccccCC--hhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 --NYTDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 --~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
.+....+......+... ....++ .++.++|.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLIN-HAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHH-hCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11111111111111111 112234 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=339.84 Aligned_cols=247 Identities=26% Similarity=0.456 Sum_probs=196.1
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||.||+|++..+++.||+|++.... ....+|..++..+ +|+||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 36999999999999999999999999997532 2234677888777 699999999988 4555699999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc-c
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-K 232 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~ 232 (395)
||++|+ |...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++... .
T Consensus 76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEe-CCCCEEEeccccceeccCC
Confidence 999864 4333332 4679999999999999999999999 6999999999999999 68899999999987532 2
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChhhhhh
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ..+...+.... .+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~------- 219 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KP------- 219 (327)
T ss_pred CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CC-------
Confidence 2333456789999999999654 58999999999999999999999996422 11222222110 00
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC------HHHHhcCCCCcCCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP 369 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt------~~ell~hp~~~~~~~~ 369 (395)
..++..++..+.++|++||++||.+|++ +.++++||||+.+.+.
T Consensus 220 -------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 220 -------------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred -------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 0123456889999999999999999998 5799999999987653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=339.99 Aligned_cols=242 Identities=26% Similarity=0.370 Sum_probs=202.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc---ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
.+..++.||+|.||.||.|.++.+ ..||+|.++.. ...+.+|+++|++|+|+|||++++++ ..+.-+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~-----~~~~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVC-----TKQEPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEE-----ecCCceEEEE
Confidence 356678899999999999998532 37999988653 34566899999999999999999999 3333599999
Q ss_pred eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||+. |+|++.|.. .....+.......++.|||+|++||++ +++|||||...||||+ +++.+||+|||+|+...++
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVD-EDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeec-cCceEEEcccccccccCCC
Confidence 9999 778888776 446788899999999999999999999 6999999999999999 7899999999999965444
Q ss_pred Ccceeeee--cccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 234 EANISYIC--SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 234 ~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
......-+ ...|.|||.+... .++.+||||||||+||||+| |+.||.+.+..+.+..+.+....+
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp----------- 424 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP----------- 424 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC-----------
Confidence 43332222 4459999999654 59999999999999999999 999999999999998887743222
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHh
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 358 (395)
.+..+|+++-++++.||..+|++|||++.+.
T Consensus 425 -----------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 -----------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -----------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 2356899999999999999999999998664
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=328.44 Aligned_cols=276 Identities=35% Similarity=0.666 Sum_probs=219.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+|++.+.||.|++|.||+|++..+|..||||.+.... ....+|+.+++.++|+||+++++.+ .+....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEEE
Confidence 4889999999999999999999999999999886432 2334689999999999999999998 44455899
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
||||+++++.+.+.... ....+++..+..++.||+.||.|||+ .|++||||||+||+++ +++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLIN-KRGELKLADFGLARAFGI 152 (284)
T ss_pred EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEC-CCCcEEEeecchhhhhcC
Confidence 99999998777765432 23568999999999999999999999 6999999999999999 788999999999876533
Q ss_pred CC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
.. ......++..|++||++.+...++.++||||||+++|+|++|..||.+.+..+....+.+....+....+.... ..
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 231 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL 231 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence 22 12234568889999998766567899999999999999999999999988888888888777666665554332 11
Q ss_pred CCCC--CCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 312 TDFR--FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 312 ~~~~--~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
..+. ++....... ..+...++..+.++|.+||+.||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1111 111111111 12223568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=340.62 Aligned_cols=245 Identities=29% Similarity=0.437 Sum_probs=195.8
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeccccc-------chHHHH-HHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||.||+|++..+|+.||+|++.+... ...+|. .+++.++|+||+++++.+ .+...+++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 369999999999999999999999999864321 112233 467889999999999888 4555689999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc-
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 232 (395)
||++|+ +...+. ....+++..++.++.||+.||.|||+ .||+||||||+||+++ .++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 76 DYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEEC-CCCCEEEccCCCCccCCCC
Confidence 999974 433333 24678899999999999999999999 6999999999999999 688999999999875322
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P------------- 212 (321)
T ss_pred CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence 2223345789999999998654 4899999999999999999999999987765554444321 0
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH----HHHhcCCCCcCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELRE 368 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~hp~~~~~~~ 368 (395)
..++...+..+.++|.+||+.||.+|+++ .++++|+||..+..
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 213 -------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 01223468899999999999999999976 49999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=337.86 Aligned_cols=287 Identities=30% Similarity=0.539 Sum_probs=216.2
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCC-------
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK------- 145 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~------- 145 (395)
.+|.+.+.||.|+||.||+|.+..+|..||+|.+.... ....+|+++++.++|+||+++++++......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 47999999999999999999999999999999885432 2345799999999999999999876432211
Q ss_pred --CceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEee
Q 016115 146 --DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (395)
Q Consensus 146 --~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~D 223 (395)
.....++||||+++++.+.+.. ..+++..++.++.||+.||.|||+ .||+||||||+||+++..++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeecccccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECC
Confidence 1235789999999876665542 468999999999999999999999 69999999999999986677899999
Q ss_pred cccccccccCCc----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016115 224 FGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 224 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
||++........ .....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+..+....+.+.....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876532211 1223568889999988665568899999999999999999999999888777766666544333
Q ss_pred ChhhhhhcCCCCCCCCC--CCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 300 TREEIRCMNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
................. ......+. ..+...++.++.+||.+||+.||.+|||+.+++.||||+.+..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~ 310 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPL-RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF 310 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCH-HHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence 22211111100000000 00000111 112235788999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=325.35 Aligned_cols=304 Identities=28% Similarity=0.428 Sum_probs=244.6
Q ss_pred CcccceeeeccCCCCCCCccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccch---HHHHHHHHHcC----
Q 016115 56 AVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLMD---- 128 (395)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~e~~~l~~l~---- 128 (395)
...|......+|.. ....+|.+.++||.|.|++||+|.+..+.+.||+|+.+....+. ..|+.+|+.++
T Consensus 61 Y~kGGYHpV~IGD~----F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp 136 (590)
T KOG1290|consen 61 YRKGGYHPVRIGDV----FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDP 136 (590)
T ss_pred hhcCCCceeecccc----ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCC
Confidence 34455555555543 44578999999999999999999999999999999998765544 36899998874
Q ss_pred ----CCceeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceecc
Q 016115 129 ----HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRD 204 (395)
Q Consensus 129 ----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~D 204 (395)
..+||++++.|-... .+..++|+|+|+++.+|+.+++... .+.++...++.|++||+.||.|||+..||+|.|
T Consensus 137 ~~~~~~~VV~LlD~FkhsG-pNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTD 213 (590)
T KOG1290|consen 137 NDPGKKCVVQLLDHFKHSG-PNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTD 213 (590)
T ss_pred CCCCCceeeeeeccceecC-CCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccC
Confidence 347999999986544 6778899999999999999988754 477999999999999999999999877999999
Q ss_pred CCCCceeec-----------------------------------------------------------------------
Q 016115 205 VKPQNLLVD----------------------------------------------------------------------- 213 (395)
Q Consensus 205 lkp~Nill~----------------------------------------------------------------------- 213 (395)
|||+|||+.
T Consensus 214 lKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~ 293 (590)
T KOG1290|consen 214 LKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEG 293 (590)
T ss_pred CCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccc
Confidence 999999980
Q ss_pred -------------------------------------------CC-----------------------------------
Q 016115 214 -------------------------------------------PL----------------------------------- 215 (395)
Q Consensus 214 -------------------------------------------~~----------------------------------- 215 (395)
..
T Consensus 294 ~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~ 373 (590)
T KOG1290|consen 294 IEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGT 373 (590)
T ss_pred ccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccc
Confidence 00
Q ss_pred ----------------CCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCC
Q 016115 216 ----------------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279 (395)
Q Consensus 216 ----------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p 279 (395)
+-++||+|||-|+.... ..+..+.|..|+|||++.+.+ |++.+||||++|+++||+||...
T Consensus 374 ~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyL 450 (590)
T KOG1290|consen 374 IASNPLVNPDIPLPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYL 450 (590)
T ss_pred cccccccCCCCCCCccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCcee
Confidence 01378888888876532 234557799999999999876 99999999999999999999999
Q ss_pred CCCC------ChHHHHHHHHHHhCCCChhhhhhc-------CCCCCCCCCCCccCCCcccccccc------CChhHHHHH
Q 016115 280 FPGE------NAVDQLVEIIKVLGTPTREEIRCM-------NPNYTDFRFPQIKAHPWHKVFHKR------MPPEAIDLA 340 (395)
Q Consensus 280 f~~~------~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~------~s~~~~~li 340 (395)
|... .+++.+..|+..+|..++...... +....-..+..++.+++..++.++ ...++.+|+
T Consensus 451 FePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL 530 (590)
T KOG1290|consen 451 FEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFL 530 (590)
T ss_pred ecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHH
Confidence 9754 467889999999999888766542 223333355666777776655443 346789999
Q ss_pred HHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 341 SRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 341 ~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
.-||+++|++|+||.++|+|||++.+..+
T Consensus 531 ~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 531 SPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHhcCccccccHHHHhcCccccCCCCC
Confidence 99999999999999999999999977664
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=343.60 Aligned_cols=252 Identities=31% Similarity=0.476 Sum_probs=212.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.|.-.+.||+|+||.||.|++..+.+.||||++.-.. ....+|+..|+.++|||+|.+.+||.- +...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchH
Confidence 3677788999999999999999999999999986332 233479999999999999999999943 3448
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++|||||-|+-.+++... .+++.+.++..|+.+.+.||.|||++ +.||||||..|||++ +.|.|||+|||.|...
T Consensus 102 WLVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLS-EPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEec-CCCeeeeccccchhhc
Confidence 899999999776766543 47899999999999999999999996 999999999999999 8999999999999775
Q ss_pred ccCCcceeeeecccccCchhhc--CCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 231 VKGEANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.. ..+++|||+|||||++. ..+.|+-++|||||||+..||...++|.-..+....+..|...-.
T Consensus 177 ~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes----------- 242 (948)
T KOG0577|consen 177 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----------- 242 (948)
T ss_pred Cc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-----------
Confidence 33 35789999999999984 456799999999999999999999999988888887777765211
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
|.+.. ...|..+..||..||++-|.+|||++++|.|+|...-+.+
T Consensus 243 --------PtLqs--------~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 243 --------PTLQS--------NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred --------CCCCC--------chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence 11111 2348899999999999999999999999999998764443
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=337.65 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=204.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
++|.+.+.||+|+||.||++++..+++.||+|.+.+.. ....+|..++..++|+||+++++++ .+...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 36999999999999999999999999999999986421 2234678889999999999999988 55667
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.|+||||+.| +|.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~-~~~~~kl~DfG~a~ 150 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLD-MNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEc-CCCCEEEEecccee
Confidence 9999999986 44444433 23578999999999999999999999 6999999999999999 78899999999997
Q ss_pred ccccCCcc--eeeeecccccCchhhcCC----CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 229 VLVKGEAN--ISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 229 ~~~~~~~~--~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
........ ....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+....+......
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~---- 226 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER---- 226 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc----
Confidence 65433222 234689999999998542 34788999999999999999999999987766655554431000
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCC--CCCHHHHhcCCCCcCCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE 368 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~~ 368 (395)
+.++. ....+++++.+||.+||+.++.+ |++++++++||||+.+.+
T Consensus 227 -----------~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 227 -----------FQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred -----------ccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 00000 11246899999999999976654 568999999999988654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=341.40 Aligned_cols=276 Identities=28% Similarity=0.387 Sum_probs=229.8
Q ss_pred CCCccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC
Q 016115 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (395)
Q Consensus 71 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (395)
........|.+.+.||+|.|++|.++++..+|..||||++.+.. ....+|+++|+.++|||||+++.+.
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~----- 124 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI----- 124 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence 34455667999999999999999999999999999999996542 2345899999999999999999998
Q ss_pred CCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
+....+|+||||+.++ .+.+|...+.++.+..++.++.|+.+|++|||+ ++|+|||||++|||++ .+..+||+||
T Consensus 125 ~t~~~lylV~eya~~g---e~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~-~~mnikIaDf 199 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGG---ELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLD-ENMNIKIADF 199 (596)
T ss_pred eecceeEEEEEeccCc---hhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhcccc-cccceeeecc
Confidence 4445599999999975 445555567888889999999999999999999 7999999999999999 7888999999
Q ss_pred ccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 225 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
|++..+..+....+++|++.|.|||++.+..+.++.+|+||+|+++|.|+.|.+||.+.+-.+.-...+..
T Consensus 200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--------- 270 (596)
T KOG0586|consen 200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--------- 270 (596)
T ss_pred ccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee---------
Confidence 99999988888889999999999999999888899999999999999999999999976543322221110
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFN 384 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~ 384 (395)
...++-.++-++.+||+++|..+|.+|++.+++..|.|.....+.....+.....++++.
T Consensus 271 --------------------k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p~~e~~~~~~~ 330 (596)
T KOG0586|consen 271 --------------------KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEARLLAPLIERSTPFIL 330 (596)
T ss_pred --------------------eecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhhhhhhcccccCccchh
Confidence 111234568899999999999999999999999999999887776443444444444444
Q ss_pred c
Q 016115 385 F 385 (395)
Q Consensus 385 ~ 385 (395)
.
T Consensus 331 ~ 331 (596)
T KOG0586|consen 331 A 331 (596)
T ss_pred h
Confidence 3
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=328.02 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=204.8
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHH-HHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||+|+||.||++.+..+|+.||+|.+..... ....|.. .++.++|+||+++++++. ....++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcEE
Confidence 68999999999999999999999999999998864321 1223444 467778999999999884 344589
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC-CceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++|||++|++.+.+.........+++..++.++.||+.||.|||+ + +++||||||+||+++ .++.+||+|||++...
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~-~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYL 154 (283)
T ss_pred EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEEC-CCCCEEEeeccccccc
Confidence 999999998888877655556789999999999999999999998 5 999999999999999 6889999999999876
Q ss_pred ccCCcceeeeecccccCchhhcCC---CCCCcccchHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhhhh
Q 016115 231 VKGEANISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
..........++..|+|||++.+. ..++.++|+||||+++|+|++|+.||.... ..+.+..+... ...
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~------ 226 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PSP------ 226 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CCC------
Confidence 544333445678899999988542 336889999999999999999999997532 22333222221 000
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
......+|.++.+||.+||..||.+||++.+++.||||+....
T Consensus 227 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 227 -------------------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred -------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 0011246889999999999999999999999999999987553
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=335.29 Aligned_cols=294 Identities=37% Similarity=0.668 Sum_probs=232.8
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|.+.+.||.|++|.||+|++..+|+.||||.+.... ....+|+.+++.++|+||+++.+++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4889999999999999999999899999999886432 3455799999999999999999988554433334689
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
++|||+++++.+.+.. ...+++..++.++.||+.||.|||+ .||+|+||||+|||++ .++.++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~-~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVN-SNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEcccCceEeec
Confidence 9999999876666543 3478999999999999999999999 6999999999999999 67999999999998765
Q ss_pred cCC----cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 232 KGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 232 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
... ......++..|+|||++.+...++.++||||||+++|+|++|..||...+..+.+..+....+.+....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 543 2334567889999999977646899999999999999999999999999998888888888887776655421
Q ss_pred CCC-CCCCC--CCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCC
Q 016115 308 NPN-YTDFR--FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 378 (395)
Q Consensus 308 ~~~-~~~~~--~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~ 378 (395)
... ...+. ........+.. ....++..+.+||.+||++||.+|||+.+++.||||+.+..+.........
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~ 307 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSK-LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPP 307 (330)
T ss_pred cccchhhHHhhcccCCcchhHH-hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCc
Confidence 111 11100 00000111111 223478999999999999999999999999999999998886655444333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=345.80 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=208.1
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecccc
Q 016115 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 159 (395)
+||+|.||+||-|+++.|...+|||.+... ..-..+|+.+-+.|+|.|||+++|++ ..++++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 699999999999999999999999998533 33456899999999999999999998 777788999999998
Q ss_pred hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCc-cee
Q 016115 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA-NIS 238 (395)
Q Consensus 160 ~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 238 (395)
+.++.|..-....-.-.+..+..+.+||++||+|||+ +.|||||||-+|||++.-.|.+||+|||.++.+..-.. ..+
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 7666665544423333888999999999999999999 69999999999999998889999999999988765544 346
Q ss_pred eeecccccCchhhcC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCC
Q 016115 239 YICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 317 (395)
Q Consensus 239 ~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
+.||..|||||++.. ...|+.++|||||||++.||.||++||......+... .++ |
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--FkV-G-------------------- 792 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--FKV-G-------------------- 792 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--hhh-c--------------------
Confidence 889999999999954 3459999999999999999999999998654433221 111 0
Q ss_pred CccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 318 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 318 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
....+..++..+|.+++.||.+|+.+||.+||++.++|.+||++.-
T Consensus 793 ---myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 793 ---MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ---ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 0111233567789999999999999999999999999999999876
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=365.24 Aligned_cols=268 Identities=28% Similarity=0.472 Sum_probs=224.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..++|.++++||+|+||.|.+++.+.+++.||+|++.+. ...+..|..+|.--+.+-|+.++-.| .++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~ 147 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE 147 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence 456799999999999999999999999999999998652 34567899999999999999999999 888
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
.++|+||||++| +++.++..+ .++++.+++.++..|..||.-||++ |+|||||||+|||+| ..|.+||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld-~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLD-KSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEec-ccCcEeeccchh
Confidence 999999999996 566666553 4799999999999999999999996 999999999999999 788999999999
Q ss_pred ccccc-cCCc-ceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 227 AKVLV-KGEA-NISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 227 a~~~~-~~~~-~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
+-.+. ++.. ....+|||.|.+||++.. .+.|++.+|+||+||++|||+.|..||+..+-.+++.+|++..
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk---- 297 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK---- 297 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence 87665 3333 234689999999999943 2568999999999999999999999999999999998888731
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC---HHHHhcCCCCcCCCCCCCCCCCCC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREPNARLPNGR 377 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~hp~~~~~~~~~~~~~~~~ 377 (395)
..+.||+. ..+|+++++||.++++ +|+.|.. ++++-.||||.++.+..-+=...+
T Consensus 298 -----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP 355 (1317)
T KOG0612|consen 298 -----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP 355 (1317)
T ss_pred -----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence 11223311 2479999999999887 7888998 999999999999999665533333
Q ss_pred CC
Q 016115 378 PF 379 (395)
Q Consensus 378 ~~ 379 (395)
-+
T Consensus 356 ~v 357 (1317)
T KOG0612|consen 356 VV 357 (1317)
T ss_pred CC
Confidence 33
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=325.89 Aligned_cols=274 Identities=35% Similarity=0.663 Sum_probs=215.3
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
|++.+.||.|++|.||+|.+..+|..||+|++..+. ....+|+++++.++|+|++++++++ .+....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 567889999999999999999999999999886432 2345799999999999999999988 44566999
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
+|||+++++.+.+.... ...+++..++.++.|++.||.|||+ ++++||||+|+||+++ .++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLID-REGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEc-CCCcEEEeecccccccCC
Confidence 99999887777665422 2468999999999999999999999 6999999999999999 688999999999875532
Q ss_pred CC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC--C
Q 016115 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--P 309 (395)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 309 (395)
.. ......++..|+|||++.+...++.++||||||+++|+|++|..||...+..+.+..+.+..+.+....+.... +
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 22 12233568889999988665557899999999999999999999999888888777777776666554432210 0
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
++.. .++...... .......++..+.++|.+||+.||.+|||+.|++.||||
T Consensus 232 ~~~~-~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKP-TFPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhh-hcccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0000 011100000 111234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=325.35 Aligned_cols=263 Identities=23% Similarity=0.334 Sum_probs=207.8
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHc-CCCceeeeceeeeecCCCCcee
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 149 (395)
...++|.+.+.||+|+||.||++.+..+++.+|+|.+.... ....+|+.+++.+ +|+|++++++.+..........
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence 34568999999999999999999999999999999886432 2345688888888 7999999999886544334456
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.++||||++| ++.+.+.........+++..++.++.|++.||.|||+ +|++|+||||+||+++ .++.+||+|||++.
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~-~~~~~kl~dfg~~~ 176 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLT-TEGGVKLVDFGVSA 176 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEc-CCCCEEEeecccch
Confidence 8999999986 5555554444445678999999999999999999999 6999999999999999 68889999999987
Q ss_pred ccccCCc-ceeeeecccccCchhhcCCC----CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 229 VLVKGEA-NISYICSRYYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 229 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
....... .....|+..|+|||++.... .++.++|||||||++|+|++|+.||...+....+..+.+... .
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~--~--- 251 (291)
T cd06639 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP--P--- 251 (291)
T ss_pred hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC--C---
Confidence 6543322 22346788899999985432 267899999999999999999999987765544443322100 0
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
....+..++..+.+||.+||+.||++||++.++++||||+
T Consensus 252 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 ---------------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ---------------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0001234577899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=323.58 Aligned_cols=247 Identities=29% Similarity=0.494 Sum_probs=201.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
+|.+.+.||+|++|.||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++++ .+..
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~ 77 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDDE 77 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccCC
Confidence 5899999999999999999999999999999875321 2345689999999999999999998 4455
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++|+||++| ++.+.+.. ...+++..++.++.|++.||.|||+ .||+|+||+|+||+++ .++.++|+|||++
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~-~~~~~~l~dfg~~ 151 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGAS 151 (263)
T ss_pred eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEeecccc
Confidence 79999999986 44444443 3568899999999999999999999 6999999999999999 7889999999998
Q ss_pred cccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 228 KVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 228 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
+........ ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------- 223 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP------- 223 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC-------
Confidence 765332211 2345678899999997654 8999999999999999999999998765554443332210
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
....++..++..+.++|++||..||.+|||+.++++||||
T Consensus 224 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 224 --------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0111334578899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=325.89 Aligned_cols=276 Identities=36% Similarity=0.664 Sum_probs=213.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++++ .+....+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY 76 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence 5899999999999999999998899999999875432 2345789999999999999999998 5556699
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||+.++++..+.. ....+++..++.++.||+.||.|||+ .|++|+||+|+||+++ +++.++|+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 77 LVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVS-QSGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEC-CCCcEEEEeeeeeeecc
Confidence 9999999876665443 23458999999999999999999999 6999999999999999 78899999999987654
Q ss_pred cCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC-
Q 016115 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP- 309 (395)
Q Consensus 232 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 309 (395)
.... .....++..|+|||++.+...++.++||||||+++|+|++|..||......+....+....+............
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 3322 23356788999999987655678899999999999999999999988877777666666555433221111100
Q ss_pred -CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 -NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
.......+..............++..+.+|+.+||..||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000111111111111111234678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=324.00 Aligned_cols=277 Identities=35% Similarity=0.619 Sum_probs=210.0
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
..+|.+.+.||+|+||.||+|.+..+|..||+|.+.... ....+|+.+++.++|+||+++.+++ .+....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCeE
Confidence 357999999999999999999999999999999985432 1345799999999999999999988 444568
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||+.+++++.+... ...+++..++.++.||+.||.|||+ .||+|+||||+||+++ .++.+||+|||+++..
T Consensus 79 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLIS-YLGELKLADFGLARAK 153 (291)
T ss_pred EEEEecccCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEc-CCCcEEEecccccccc
Confidence 999999998877665432 3457888899999999999999999 6999999999999999 7889999999998754
Q ss_pred ccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhhhhcC
Q 016115 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 231 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.... ......++..|+|||.+.+...++.++||||||+++|+|++|..||...+ ..+.+.++....+.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 3221 22334568899999998765557889999999999999999999997654 335555565656655444322111
Q ss_pred --CCCCCCCCCCccCCCccccccc--cCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 309 --PNYTDFRFPQIKAHPWHKVFHK--RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 309 --~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
+.+....+........ ..... ..+..+.+|+.+||..||.+|||+.|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQL-RVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcch-hhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 1111111110000000 00111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=317.79 Aligned_cols=261 Identities=26% Similarity=0.433 Sum_probs=203.5
Q ss_pred cee-eeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEE
Q 016115 79 YMA-ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 79 y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
|.+ .+.||+|+|+.|--+.+..+|..||||++.+. +...-+|++++...+ |+||+.++++| +++..+|+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYL 153 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYL 153 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEE
Confidence 544 35799999999999999999999999999654 334457999988885 99999999999 77777999
Q ss_pred EEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC--cEEEeecccccc
Q 016115 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKV 229 (395)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~--~~kl~Dfg~a~~ 229 (395)
|||-+.|+ ++..+.. .+.+++.++.++...|+.||.|||. +||.||||||+|||....+. -+|||||.++..
T Consensus 154 VfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred EEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 99999964 4444443 5789999999999999999999999 89999999999999873332 499999998754
Q ss_pred cccCCc--------ceeeeecccccCchhhc----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH----------
Q 016115 230 LVKGEA--------NISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD---------- 287 (395)
Q Consensus 230 ~~~~~~--------~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---------- 287 (395)
+..... ..+.+|+..|||||+.. ....|+.++|.||||||+|.||+|.+||.+....+
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 432222 23457888899999862 24568999999999999999999999998754322
Q ss_pred -HHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 288 -QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 288 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
....+... + ..+. |.||+. . +..+|.+++|||+.+|..|+.+|.++.++++|||++..
T Consensus 309 ~CQ~~LFes--------I---QEGk--YeFPdk---d-----WahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 309 VCQNKLFES--------I---QEGK--YEFPDK---D-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHHHH--------H---hccC--CcCChh---h-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 11111111 1 1111 222221 1 14579999999999999999999999999999999987
Q ss_pred CCCC
Q 016115 367 REPN 370 (395)
Q Consensus 367 ~~~~ 370 (395)
...+
T Consensus 368 ~~ek 371 (463)
T KOG0607|consen 368 APEK 371 (463)
T ss_pred chhc
Confidence 7754
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=331.77 Aligned_cols=286 Identities=36% Similarity=0.632 Sum_probs=222.7
Q ss_pred CceeeeeeecCCceEEEEEEECCC--CcEEEEEEecccc------cchHHHHHHHHHc-CCCceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (395)
+|.+.+.||+|+||.||++.+..+ +..||+|.+.... ....+|+.+++.+ +|+||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 488999999999999999999888 8999999886421 2335688899988 5999999988754322 2334
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+++++||++++|.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+||+++ .++.+||+|||++.
T Consensus 80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~-~~~~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVN-ADCELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEc-CCCCEEeCcCCCce
Confidence 5789999999887766643 4678999999999999999999999 6999999999999999 68899999999997
Q ss_pred ccccCCc-----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 229 VLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 229 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
....... .....|+..|+|||++.+...++.++||||||+++|+|++|..||...+....+..+...++.+....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6543221 12346789999999886655689999999999999999999999999988888999998888777654
Q ss_pred hhhcCCCCCC-C--CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 304 IRCMNPNYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 304 ~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
+......... + .........+. .....++..+.+||.+||+.||.+|||+.+++.||||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~ 303 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD 303 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccc
Confidence 4332211000 0 00000001111 122345889999999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=330.17 Aligned_cols=266 Identities=29% Similarity=0.494 Sum_probs=213.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|.+.+.||+|++|+||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++.+ .+....
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence 6899999999999999999999999999999886432 2245688999999999999999988 555668
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||+.| +|.+.+.. .....+++..++.++.||+.||.|||+ .|++|+||||+||+++ .++.++|+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~ 152 (316)
T cd05574 77 CLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLH-ESGHIMLSDFDLSKQ 152 (316)
T ss_pred EEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEc-CCCCEEEeecchhhc
Confidence 999999986 55554432 223678999999999999999999999 6999999999999999 688999999999865
Q ss_pred cccCCc------------------------------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCC
Q 016115 230 LVKGEA------------------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279 (395)
Q Consensus 230 ~~~~~~------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p 279 (395)
...... .....|+..|+|||++.+. .++.++||||||+++|+|++|..|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence 432211 1123678889999999654 489999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC----HH
Q 016115 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT----AL 355 (395)
Q Consensus 280 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt----~~ 355 (395)
|...+....+..+... ...++. ...++..+.++|.+||..||++||| ++
T Consensus 232 f~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 232 FKGSNRDETFSNILKK-----------------EVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCCCchHHHHHHHhcC-----------------CccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 9887766655544321 000000 1126889999999999999999999 99
Q ss_pred HHhcCCCCcCCCCCCCCCCCCCCCC
Q 016115 356 EACAHPFFDELREPNARLPNGRPFP 380 (395)
Q Consensus 356 ell~hp~~~~~~~~~~~~~~~~~~~ 380 (395)
++++||||+..+.+..++...+..+
T Consensus 285 ~ll~~~~~~~~~~~~~~~~~~~~~~ 309 (316)
T cd05574 285 EIKQHPFFRGVNWALIRHTTPPIIP 309 (316)
T ss_pred HHHcCchhhcCChhhcccCCCCCCC
Confidence 9999999999988877774444443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=327.02 Aligned_cols=282 Identities=31% Similarity=0.568 Sum_probs=218.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC---CC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---KD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 146 (395)
.++|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+++++.++|+||+++++.+..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999999999999999885321 234579999999999999999987754332 23
Q ss_pred ceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...+++||||+.+++...+.. ....+++..++.++.||++||.|||+ +||+|+||||+||+++ +++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILID-NQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC-CCCCEEECcCcc
Confidence 446789999999877666543 24579999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCc------------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 016115 227 AKVLVKGEA------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294 (395)
Q Consensus 227 a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~ 294 (395)
++....... .....+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 976543221 12235688899999987665689999999999999999999999999888888888877
Q ss_pred HhCCCChhhhhhcC--CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 295 VLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 295 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
..+.+....+.... +................. ....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 76665544433211 111110000000011111 123456889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=326.34 Aligned_cols=283 Identities=30% Similarity=0.503 Sum_probs=214.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC---CC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---KD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 146 (395)
.++|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346999999999999999999999999999999885332 122468999999999999999998754332 22
Q ss_pred ceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
....++||||+++++...+.. ....+++..++.++.||+.||.|||+ .|++|+||||+||+++ .++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~-~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILIT-KDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEC-CCCcEEECcCCC
Confidence 345789999999987766643 23468999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCcc-----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 227 AKVLVKGEAN-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 227 a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+......... ....++..|+|||.+.+...++.++||||||+++|+|++|..||...+.......+....+..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9765433221 23456788999999876555789999999999999999999999988877777777766665444
Q ss_pred hhhhhcC--CCCCCCCCCCccCCCcccc-ccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 302 EEIRCMN--PNYTDFRFPQIKAHPWHKV-FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 302 ~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
..+.... ..+....++.......... .....+..+.+||.+||..||.+|||++++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 3322110 0000011111000000011 111246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=326.30 Aligned_cols=260 Identities=26% Similarity=0.403 Sum_probs=205.1
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+|++.+.||+|+||.||++.+..+|..||+|.+.... ....+|+.+++.++|+||+++++.+ ......++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEEE
Confidence 5889999999999999999999999999999886431 2345789999999999999999988 44556999
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
||||++|+.+..+.........+++..+..++.||+.||.|||+..||+|+||||+||+++ .++.+||+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC-CCCCEEEeecCCcccccC
Confidence 9999997544443332222347899999999999999999999624999999999999999 688999999999876533
Q ss_pred CCcceeeeecccccCchhhcCCC-----CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 233 GEANISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.. .....++..|+|||++.+.. .++.++|||||||++|+|++|..||...........+........
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 227 (286)
T cd06622 156 SL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------- 227 (286)
T ss_pred Cc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-------
Confidence 22 22345788899999985432 257899999999999999999999976554443333322111110
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
..++..++.++.+||.+||+.||.+||++.++++||||...+..
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 228 ------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred ------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 01223478999999999999999999999999999999887765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=323.43 Aligned_cols=276 Identities=36% Similarity=0.677 Sum_probs=218.7
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||+|+||.||+|.+..+++.||+|.+... .....+|+++++.++|+||+++++++. .....+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEEE
Confidence 699999999999999999999999999999987532 133457999999999999999999984 344589
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||++++++..+.. ....+++..++.++.||+.||.|||+ .|++|+||+|+||+++ +++.+||+|||++....
T Consensus 77 iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 77 LVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVS-ESGVLKLCDFGFARALR 151 (288)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEC-CCCCEEEEeeecccccC
Confidence 9999999987765543 23568999999999999999999999 6999999999999999 68999999999988765
Q ss_pred cCC--cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC-
Q 016115 232 KGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 308 (395)
Q Consensus 232 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 308 (395)
... ......++..|+|||++.+...++.++||||||+++|+|++|..||...+..+.+..+....+...........
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 543 23345678899999999776468999999999999999999999999888777777776666655543332221
Q ss_pred -CCCCCCCCCCcc-CCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 309 -PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 309 -~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
..+....++... ...+...++..++.++.+||++||..||++|||+++++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 111111111111 1111222344568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=339.28 Aligned_cols=268 Identities=26% Similarity=0.406 Sum_probs=215.4
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEeccc-c
Q 016115 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-E 159 (395)
Q Consensus 81 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~ 159 (395)
..+.||+|+.|.||+|+. .++.||||+++. ..+.++.-|++|+|+||+.+.|+| .....+|||||||. |
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeeccccc
Confidence 456799999999999986 688999998743 334688899999999999999999 77777999999999 6
Q ss_pred hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcceee
Q 016115 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239 (395)
Q Consensus 160 ~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 239 (395)
-|.+.|+. ...++......|..+|+.|+.|||.+ .|||||||.-||||+ .+..|||+|||.++...+......+
T Consensus 198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILIS-YDDVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEee-ccceEEeccccchHhhhhhhhhhhh
Confidence 67777765 57788888999999999999999995 899999999999999 7889999999999988777777889
Q ss_pred eecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCc
Q 016115 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQI 319 (395)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.||..|||||++.+. ..+.|+|||||||+|||||||..||.+.+....+. .+|
T Consensus 272 aGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GVG---------------------- 324 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GVG---------------------- 324 (904)
T ss_pred hhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEE----ecc----------------------
Confidence 999999999999765 48999999999999999999999998765432211 111
Q ss_pred cCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCCCCchhhhhhccc
Q 016115 320 KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVCIHFV 394 (395)
Q Consensus 320 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (395)
...+..-.+..+++.++-||++||+-.|..||++.++|.|=-+..- .......+.=|...-.|.++++.||+
T Consensus 325 -sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p--ell~~tee~yf~sq~swrEevk~h~~ 396 (904)
T KOG4721|consen 325 -SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP--ELLSTTEETYFKSQASWREEVKLHFE 396 (904)
T ss_pred -CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH--HHhcccHHHHHHHHHHHHHHHHHhhh
Confidence 1122233456789999999999999999999999999998543221 11111222224444456677777775
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=302.95 Aligned_cols=259 Identities=26% Similarity=0.363 Sum_probs=206.0
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecc----cccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
...+|++.+.||+|||+.||++++..++..||+|++.- +.+...+|++..++++|||+++++++............
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 44589999999999999999999999999999999853 33455689999999999999999988765554456678
Q ss_pred EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC--ceeccCCCCceeecCCCCcEEEeecccc
Q 016115 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
||+++|.. |++++.+......+..+++.++..|+.+|++||++||+ .. +.||||||.|||++ +.+.++|.|||.+
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls-~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLS-DSGLPVLMDLGSA 176 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEec-CCCceEEEeccCc
Confidence 99999987 77999998888888899999999999999999999999 57 99999999999999 6899999999998
Q ss_pred cccccCCc----------ceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016115 228 KVLVKGEA----------NISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295 (395)
Q Consensus 228 ~~~~~~~~----------~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~ 295 (395)
+...-.-. .....+|..|+|||.+.- ....++++|||||||+||+|+.|..||...- .
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~- 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------Q- 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------h-
Confidence 76432211 123457889999998843 2236889999999999999999999996321 1
Q ss_pred hCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.|... .+.-....+.+++ ...+|+.+.+||+.||++||.+||++.+++.+
T Consensus 247 ~GgSl-----aLAv~n~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 247 QGGSL-----ALAVQNAQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cCCeE-----EEeeeccccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 01000 0000001111221 13479999999999999999999999999864
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=323.47 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=206.9
Q ss_pred CccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHc-CCCceeeeceeeeecCCCCce
Q 016115 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (395)
+....+|++.+.||+|+||.||+|.+..+++.+|+|++.... ....+|+.+++.+ +|+||+++++++.........
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 345668999999999999999999999999999999875422 3345688899988 699999999988655444556
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..++||||++| +|.+.+.........+++..++.++.|++.||.|||+ .+|+||||||+||+++ .++.+||+|||++
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~-~~~~~kl~dfg~~ 171 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLT-TEGGVKLVDFGVS 171 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEEC-CCCCEEEccCCce
Confidence 78999999986 4555555444445678999999999999999999999 6999999999999999 6788999999998
Q ss_pred cccccCC-cceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 228 KVLVKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 228 ~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
....... ......|+..|+|||++.. ...++.++|||||||++|+|++|..||........+..+... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~--- 246 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PP--- 246 (286)
T ss_pred eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CC---
Confidence 7654332 2223468899999998843 234788999999999999999999999876543333221110 00
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
+ ....+..++..+.+||.+||+.||++|||+.|+++|+||
T Consensus 247 --------------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 --------------P-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------------C-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0 000122357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=322.69 Aligned_cols=274 Identities=39% Similarity=0.734 Sum_probs=219.4
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
|.+.+.||+|++|.||+|.+..+|+.+++|.+..... ...+|+.+++.++|+||+++++++ .+....++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 5677899999999999999988999999998864422 345688999999999999999988 44456899
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|+||+++++...+... ...+++..++.++.||+.||.|||+ .||+|+||||+||+++ .++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLIN-TEGVLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEEC-CCCcEEEeeeeeeEecCC
Confidence 9999999877766542 3578999999999999999999999 6999999999999999 688999999999877654
Q ss_pred CC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
.. ......++..|+|||.+.+...++.++||||||+++|+|+||+.||...+..+.+..+....+.+....+.......
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 43 22334578889999998766468999999999999999999999999998888888888777776655444332211
Q ss_pred --CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 312 --TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 312 --~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
....++....... ......++.++.+||.+||++||.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1111111111111 12234578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=323.98 Aligned_cols=248 Identities=30% Similarity=0.502 Sum_probs=206.6
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|.+.+.||+|+||.||++.+..+++.||+|.+... .....+|+++++.++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSNL 76 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCeE
Confidence 689999999999999999999999999999988542 12345689999999999999999988 445568
Q ss_pred EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||++ +++.+.+.. ...+++..+..++.||+.||.|||+ +||+|+||+|+||+++ .++.+||+|||++..
T Consensus 77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~-~~~~~kl~dfg~~~~ 150 (290)
T cd05580 77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLD-SDGYIKITDFGFAKR 150 (290)
T ss_pred EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEC-CCCCEEEeeCCCccc
Confidence 99999996 555555543 3678999999999999999999999 6999999999999999 688999999999987
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+... .
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~----------- 214 (290)
T cd05580 151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K----------- 214 (290)
T ss_pred cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C-----------
Confidence 6444 3345678999999998654 4789999999999999999999999877754444443321 0
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
..++..++..+.++|.+||..||.+|+ +++++++||||+.+.+
T Consensus 215 ----------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 215 ----------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred ----------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 012334688999999999999999999 9999999999988774
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=329.45 Aligned_cols=278 Identities=36% Similarity=0.560 Sum_probs=217.2
Q ss_pred cCce-eeeeeecCCceEEEEEEECCCCcEEEEEEeccccc------------------chHHHHHHHHHcCCCceeeece
Q 016115 77 ISYM-AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------YKNRELQLMRLMDHPNVISLKH 137 (395)
Q Consensus 77 ~~y~-~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------------~~~~e~~~l~~l~h~niv~~~~ 137 (395)
.+|. +.+.||.|+||.||+|.+..+|+.||||.+..... ...+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3565 45779999999999999999999999998854321 2347899999999999999999
Q ss_pred eeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC
Q 016115 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217 (395)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~ 217 (395)
++ ......++||||+.|++.+.+.. ...+++..+..++.||+.||.|||+ .||+|+||+|+||+++ .++
T Consensus 88 ~~-----~~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~-~~~ 156 (335)
T PTZ00024 88 VY-----VEGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFIN-SKG 156 (335)
T ss_pred EE-----ecCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEEC-CCC
Confidence 88 44456899999999987777654 4568999999999999999999999 6999999999999999 788
Q ss_pred cEEEeecccccccccC---------------CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 016115 218 QVKLCDFGSAKVLVKG---------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (395)
Q Consensus 218 ~~kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 282 (395)
.++|+|||++...... .......++..|+|||.+.+...++.++||||||+++|+|++|..||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998765411 1112234678899999987665679999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCChhhhhhcC--CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 283 ENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.+..+.+..+....+.+....+.... +.+..+... . ...........+.++.++|.+||+.||.+|||++|+|.|
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR--K-PKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcC--C-cccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 98888888888777766554332211 001110000 0 000011223468899999999999999999999999999
Q ss_pred CCCcCCCC
Q 016115 361 PFFDELRE 368 (395)
Q Consensus 361 p~~~~~~~ 368 (395)
|||+....
T Consensus 314 ~~~~~~~~ 321 (335)
T PTZ00024 314 EYFKSDPL 321 (335)
T ss_pred cccCCCCC
Confidence 99986544
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.88 Aligned_cols=254 Identities=26% Similarity=0.454 Sum_probs=200.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+|++.+.||+|+||.||+|.+..++..||+|.+..+. ....+|+++++.++||||+++++.+. .....++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEEE
Confidence 5788899999999999999999999999999886432 23446899999999999999999984 4455889
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
||||++++.+... ..+++..+..++.|++.||.|||+ .||+|+||||+||+++ .++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEEC-CCCCEEEeeCCcceeccc
Confidence 9999998755432 346888899999999999999999 6999999999999999 688999999999976543
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhhhhhcCC
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ---LVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 309 (395)
. ......|+..|+|||++.+. .++.++||||||+++|+|++|..||......+. .............
T Consensus 148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 217 (279)
T cd06619 148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-------- 217 (279)
T ss_pred c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--------
Confidence 3 23345789999999998764 489999999999999999999999975322111 0011111000000
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
+ ......+++++.+||.+||+.||.+||++.++++||||+..+...
T Consensus 218 -------~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~ 263 (279)
T cd06619 218 -------P--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN 263 (279)
T ss_pred -------C--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCcc
Confidence 0 001134678999999999999999999999999999998875533
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=323.09 Aligned_cols=277 Identities=32% Similarity=0.612 Sum_probs=216.6
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
|.+.+.||+|+||.||+|.+..+|+.+|+|.+.... ....+|+++++.++|+|++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 678899999999999999999999999999987542 23456899999999999999999884321 256899
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
||||+++++.+.+... ...+++..++.++.||+.||.|||+ .|++|+||||+||+++ +++.+||+|||++.....
T Consensus 78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILIN-NDGVLKLADFGLARPYTK 152 (287)
T ss_pred EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEc-CCCCEEEccccceeeccC
Confidence 9999998776665432 2578999999999999999999999 6999999999999999 789999999999987654
Q ss_pred CCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 233 GEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 233 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
... .....++..|+|||.+.+...++.++||||||+++|+|++|+.||...+....+..+.+..+.+....+......
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 431 233456788999998866556899999999999999999999999998888888888777666655444321110
Q ss_pred --CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 311 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 311 --~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
.................+...++..+.++|++||+.||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000000000011112222348999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=323.76 Aligned_cols=259 Identities=26% Similarity=0.408 Sum_probs=205.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+.|++.+.||.|+||.||+|.+..++..|++|.+.... ....+|+.+++.++|+||+++++.+. .....++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence 46999999999999999999999999999999986432 23446889999999999999999884 3446899
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
||||++|+.+..+.. .....+++..++.++.|++.||.|||+ .|++||||||+||+++ .++.++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 87 MIEFCPGGAVDAIML--ELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEecCCCCcHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEc-CCCCEEEccCccceeccc
Confidence 999999865443322 223568999999999999999999999 6999999999999999 688999999999865433
Q ss_pred CC-cceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 233 GE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.. ......++..|+|||++.+ ...++.++|||||||++|+|++|..||...+......++... ..+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~------- 233 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP------- 233 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCc-------
Confidence 22 2234567889999999842 234678999999999999999999999876654444333221 000
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
....+..++.++.+||.+||..||++||++.++++||||+.++...
T Consensus 234 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 234 -----------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred -----------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 0001234678999999999999999999999999999998876643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=331.06 Aligned_cols=278 Identities=21% Similarity=0.331 Sum_probs=198.4
Q ss_pred eeeeeecC--CceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 81 AERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 81 ~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+.++||+| +|++||++.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++ ......++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-----~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----EECCEEEE
Confidence 45679999 78999999999999999999986432 2345689999999999999999988 44455899
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
||||+++ ++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.++++|||.+....
T Consensus 77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMI 152 (327)
T ss_pred EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEe-cCCcEEEcccchhhccc
Confidence 9999996 4444443321 2458999999999999999999999 6999999999999999 68899999998754332
Q ss_pred cCCc--------ceeeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC---
Q 016115 232 KGEA--------NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--- 299 (395)
Q Consensus 232 ~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~--- 299 (395)
.... .....++..|+|||++.+. ..++.++|||||||++|+|++|..||................-..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 232 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence 1111 1122456779999998653 348899999999999999999999998765544333322210000
Q ss_pred ----ChhhhhhcCC-------CCCCCCC----CCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 300 ----TREEIRCMNP-------NYTDFRF----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 300 ----~~~~~~~~~~-------~~~~~~~----~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
..+.. .+.+ .+.+... ...............+++.+.+||.+||+.||++|||++++++||||+
T Consensus 233 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 233 TTTIPAEEL-TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred ccchhhhhc-ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 00000 0000 0000000 000000000112335688999999999999999999999999999998
Q ss_pred CCCC
Q 016115 365 ELRE 368 (395)
Q Consensus 365 ~~~~ 368 (395)
.+..
T Consensus 312 ~~~~ 315 (327)
T cd08227 312 QIKR 315 (327)
T ss_pred hcch
Confidence 7653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=323.76 Aligned_cols=254 Identities=27% Similarity=0.439 Sum_probs=206.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.+|.+.+.||.|++|.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++.+ .....+++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence 46999999999999999999999999999999885432 2334688999999999999999988 44456899
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|+||+.|+.+..+.. ...+++..+..++.+++.||.|||+ .|++|+||||+||+++ .++.+||+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 94 VMEYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEccCccchhccc
Confidence 999999754444332 2468999999999999999999999 6999999999999999 688999999999876543
Q ss_pred CCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 233 GEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 233 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+... ..+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~----------- 234 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE----------- 234 (296)
T ss_pred ccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc-----------
Confidence 322 2234678899999998654 4889999999999999999999999887765554433221 0000
Q ss_pred CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
...+..+++.+.+||++||..||.+|||+.+++.||||+....
T Consensus 235 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 235 --------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred --------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 0012356889999999999999999999999999999987664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=332.10 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=191.7
Q ss_pred cccCceeeeeeecCCceEEEEEEEC-----CCCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (395)
..++|++.+.||+|+||.||+|.+. .++..||||++.... ....+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-- 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC--
Confidence 3457999999999999999999752 345789999986432 2345789999999 89999999998742
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhcc----------------------------------------------------
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS---------------------------------------------------- 170 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------------------------------------------- 170 (395)
....+++||||++| +|.+.+.....
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 83 --PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred --CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 23347899999995 55555543211
Q ss_pred ------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcc---eeeee
Q 016115 171 ------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYIC 241 (395)
Q Consensus 171 ------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~g 241 (395)
....+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++........ ....+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCCCC
Confidence 12357888899999999999999999 7999999999999999 6889999999999765332211 12234
Q ss_pred cccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCcc
Q 016115 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK 320 (395)
Q Consensus 242 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
+..|+|||++.+. .++.++|||||||++|+|++ |..||......+.+...... +..
T Consensus 239 ~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~--------------------- 295 (338)
T cd05102 239 PLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR--------------------- 295 (338)
T ss_pred CccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC---------------------
Confidence 6789999998654 48999999999999999997 99999876543333332221 000
Q ss_pred CCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 321 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 321 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 296 -----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 296 -----MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0012346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=329.29 Aligned_cols=283 Identities=36% Similarity=0.628 Sum_probs=219.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (395)
.+|.+.+.||+|+||.||+|.+..+|+.||||.+.... ....+|+.+++.++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 46999999999999999999999999999999886421 224579999999999999999998854322 12234
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++|+||+.+++.... ...+++..++.++.|++.||.|||+ .||+||||||+||+++ .++.+||+|||+++.
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~-~~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVN-EDCELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEeeCCCCcC
Confidence 6899999987544332 2468899999999999999999999 6999999999999999 688999999999876
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+..........
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 432 223456788999999987655688999999999999999999999999888888888887777666554433221
Q ss_pred CCCCCC---CCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 310 NYTDFR---FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 310 ~~~~~~---~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
...... .+......+.. ....++..+.+||.+||+.||.+||++.+++.||||+.++..+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred cchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 110000 00000011111 1234688899999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=330.96 Aligned_cols=289 Identities=34% Similarity=0.664 Sum_probs=223.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHc-CCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (395)
.++|.+.+.||+|+||.||+|.+..+|+.+|+|.+... .....+|+.+++.+ +|+||+++++++.. .+..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCc
Confidence 45799999999999999999999989999999987532 12334689999999 99999999998733 2334
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
..++||||+++++...+.. ..+++..++.++.||+.||.|||+ .||+|+||||+||+++ .++.+||+|||++.
T Consensus 83 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~-~~~~~kl~d~g~~~ 155 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLN-SDCRVKLADFGLAR 155 (337)
T ss_pred eEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEc-CCCcEEEeeccchh
Confidence 5889999999877665543 367888889999999999999999 6999999999999999 78899999999987
Q ss_pred ccccCC------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 229 VLVKGE------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 229 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
...... ......|+..|+|||++.+...++.++||||||+++|+|+||+.||......+....+....+.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 654332 12235678899999988665668899999999999999999999999888888877777776665544
Q ss_pred hhhhcCCCCCCCCC---CCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCC
Q 016115 303 EIRCMNPNYTDFRF---PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 375 (395)
Q Consensus 303 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~ 375 (395)
.+..+........+ .......... ....++.++.+||.+||+.||.+|||+.++++||||+.+..+......
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~ 310 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVL 310 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCC
Confidence 43322211111000 0000111111 223378999999999999999999999999999999998765544333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=318.72 Aligned_cols=262 Identities=28% Similarity=0.408 Sum_probs=207.6
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHc-CCCceeeeceeeeecCC-CCce
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTS-KDEL 148 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~~ 148 (395)
...++|++.+.||+|++|.||+|.+..+++.+++|++.... ....+|+.+++.+ +|+||+++++++..... ....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45678999999999999999999999899999999886442 3456789999988 69999999999865443 3455
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++||||+++ ++.+.+.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++ .++.++|+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~-~~~~~~l~d~~~~ 160 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLT-KNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEc-cCCeEEECCCccc
Confidence 68999999996 4445544433345788999999999999999999999 6999999999999999 6889999999998
Q ss_pred cccccCCc-ceeeeecccccCchhhcCC----CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 228 KVLVKGEA-NISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 228 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
........ .....|+..|+|||++... ..++.++||||||+++|+|++|..||..........++.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----- 235 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP----- 235 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC-----
Confidence 76543222 2345678899999987532 3467899999999999999999999986655444443332100
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
+.. .....++..+.+||.+||..||++|||+.++++|||+
T Consensus 236 --------------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 --------------PTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred --------------CCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000 0112357899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=331.16 Aligned_cols=286 Identities=37% Similarity=0.644 Sum_probs=222.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (395)
.++|.+.+.||+|++|.||+|++..++..||+|.+.... ....+|+.+++.++|+||+++.+++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 447999999999999999999999999999999875421 223468999999999999999987743322 2233
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
..++|+||+++++.+.+.. ..+++..++.++.||+.||.|||+ .||+||||||+||+++ .++.++|+|||++.
T Consensus 94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~-~~~~~kL~dfg~~~ 166 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVN-EDCELKILDFGLAR 166 (343)
T ss_pred cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEC-CCCCEEEccccccc
Confidence 5899999998887776653 578999999999999999999999 6999999999999999 68899999999997
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... .....++..|+|||.+.+...++.++||||||+++|+|++|+.||...+..+.+..+....+.+....+....
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 65433 2344678899999998665567899999999999999999999999888888888887776665544433221
Q ss_pred CCCC-CCC--CCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 309 PNYT-DFR--FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 309 ~~~~-~~~--~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
.... .+. .+......+ ......++..+.+||.+||+.||.+|||+.+++.||||++...+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~ 309 (343)
T cd07851 245 SESARNYIQSLPQMPKKDF-KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED 309 (343)
T ss_pred chhHHHHHHhccccCCCCH-HHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence 1100 000 000000001 1112346899999999999999999999999999999998777654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=330.24 Aligned_cols=288 Identities=34% Similarity=0.568 Sum_probs=222.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (395)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 357999999999999999999999999999999886432 233468999999999999999998743321 2234
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
..+++++++++++.+.+.. ..+++..++.++.||+.||.|||+ .||+||||||+||+++ .++.+||+|||++.
T Consensus 96 ~~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~-~~~~~kl~dfg~~~ 168 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVN-EDCELKILDFGLAR 168 (345)
T ss_pred cEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEc-CCCCEEEecccccc
Confidence 5789999998776655542 468999999999999999999999 6999999999999999 68899999999987
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.... ......++..|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+....+.+.........
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 6432 22345678899999998765568899999999999999999999999888877777777777766655443322
Q ss_pred CCCCCCCC---CCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCC
Q 016115 309 PNYTDFRF---PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 373 (395)
Q Consensus 309 ~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~ 373 (395)
.......+ +......+. ......++++.+||.+||+.||.+|+++.+++.||||++...+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~ 313 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 313 (345)
T ss_pred cHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccc
Confidence 11100000 000000000 01124588999999999999999999999999999999877766443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=319.78 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=201.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHc-CCCceeeeceeeeecCCC-CceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK-DELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~~~~~ 150 (395)
.+.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....|+.+++.+ +|+||+++++.+...... ....+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 446889999999999999999999999999999986432 2345788888888 699999999988654322 23468
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++|||+++ ++.+.+.. .....+++..++.++.|++.||.|||+ +||+|+||||+||+++ .++.++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~-~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEEC-CCCCEEEccCCCcee
Confidence 899999986 55544443 123568899999999999999999999 6999999999999999 788999999999876
Q ss_pred cccCC-cceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 230 LVKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 230 ~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
..... ......|+..|+|||++.+ ...++.++|||||||++|+|++|..||............... .
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~----- 232 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P----- 232 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence 53322 2234568899999999853 234788999999999999999999999765543333222110 0
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
........++.++.+||.+||..||.+|||+.+++.||||
T Consensus 233 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 -------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0000123467899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=320.24 Aligned_cols=275 Identities=39% Similarity=0.692 Sum_probs=219.4
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
|.+.+.||+|++|+||+|.+..+++.||||.+..... ...+|+..++.++ |+||+++++++ .+....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence 6788999999999999999988999999998865422 2345888899999 99999999988 44556899
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
||||++|++.+.+.... ...+++..+..++.|++.+|.|||+ +|++|+||+|+||+++ .++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEc-CCCCEEEeecccceeccC
Confidence 99999888777765422 3478999999999999999999999 6999999999999999 789999999999987655
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC-
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY- 311 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 311 (395)
........++..|+|||++.+...++.++|+||||+++++|++|..||......+.+..+...++.+....+.......
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 5444556788899999998666668999999999999999999999999998888888888877777655443221111
Q ss_pred -CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 312 -TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 312 -~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
....++....... .......+..+.+||++||+.||.+|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 1111111111111 11122337889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=323.44 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=203.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.+|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++.+. .....++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEEE
Confidence 47999999999999999999999999999999886432 23456889999999999999999884 3446899
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
||||+.| ++.+.+. ...+++.++..++.|++.||.|||+ .||+||||||+||+++ .++.++|+|||++....
T Consensus 95 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~-~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQIT 167 (296)
T ss_pred eecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEc-CCCCEEECccccchhcc
Confidence 9999986 4444443 2457889999999999999999999 6999999999999999 78899999999987654
Q ss_pred cCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.... .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+... +.+.
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---------- 235 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE---------- 235 (296)
T ss_pred ccccccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC----------
Confidence 3322 2334678899999998654 4789999999999999999999999877654433322210 0000
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
...+..++..+.+||.+||..||++|||+.++++||||...+.
T Consensus 236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 236 ---------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred ---------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 0012346888999999999999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=321.51 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=203.6
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.|++.+.||+|+||.||+|.+..++..+++|.+.... ....+|+++++.++|+||+++++.+. .....++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEE
Confidence 3788899999999999999999999999999885432 23456889999999999999999884 44568999
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
|||++++.+..+.. .....+++..++.++.|++.||.|||+ .|++||||||+||+++ .++.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 81 IEFCAGGAVDAVML--ELERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred EEecCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEc-cCCCEEEcccccccccccc
Confidence 99999765544322 123578999999999999999999999 6999999999999999 7889999999998764332
Q ss_pred C-cceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 234 E-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 234 ~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
. ......++..|+|||++.. ...++.++|||||||++|+|++|..||...+..+....+.......
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 227 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT--------- 227 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC---------
Confidence 2 1233567889999999842 2346789999999999999999999998877665555543321100
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
...+..++.++.+||.+||+.||.+||+++++++||||+..
T Consensus 228 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 -----------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00123468899999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=322.17 Aligned_cols=258 Identities=26% Similarity=0.371 Sum_probs=205.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.++|.+.+.||.|+||.||++.+..++..||+|.+.... ....+|+++++.++|+||+++++.+ ......+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeEE
Confidence 346999999999999999999998899999999885432 2345689999999999999999988 4445689
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||++++.+..+.. .....+++..++.++.|++.||.|||+ +||+|+||||+||+++ .++.++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 79 ILIEFCDGGALDSIML--ELERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLT-LDGDVKLADFGVSAKNK 154 (280)
T ss_pred EEeeccCCCcHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEC-CCCCEEEccCccchhhc
Confidence 9999999754433322 123568999999999999999999999 6999999999999999 78899999999987653
Q ss_pred cCC-cceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 232 KGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 232 ~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
... ......++..|+|||++.. ...++.++||||||+++|+|++|..||...+....+..+... ..+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------ 226 (280)
T cd06611 155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPP------ 226 (280)
T ss_pred ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCC------
Confidence 322 2234568899999999852 233678999999999999999999999877655544433221 000
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
. ...+..++.++.++|.+||+.||.+||++.++++||||+...+
T Consensus 227 -----------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (280)
T cd06611 227 -----------T-------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270 (280)
T ss_pred -----------C-------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence 0 0012346889999999999999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=346.67 Aligned_cols=280 Identities=20% Similarity=0.320 Sum_probs=198.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCc-EEEEE------------------Eeccc---ccchHHHHHHHHHcCCCcee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGE-TVAIK------------------KVLQD---RRYKNRELQLMRLMDHPNVI 133 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~vaiK------------------~~~~~---~~~~~~e~~~l~~l~h~niv 133 (395)
..+|++.+.||+|+||+||+|..+.... .+++| .+... .....+|+.+++.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4579999999999999999987643322 22222 11111 12345799999999999999
Q ss_pred eeceeeeecCCCCceeEEEEEecccchHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceee
Q 016115 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212 (395)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill 212 (395)
++++++ ......|+|++++.+++.+.+.... ..........++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 227 ~l~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl 300 (501)
T PHA03210 227 KIEEIL-----RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL 300 (501)
T ss_pred cEeEEE-----EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence 999998 4445589999999988777664321 112334567788999999999999999 699999999999999
Q ss_pred cCCCCcEEEeecccccccccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCC-CCC--CChHH
Q 016115 213 DPLTHQVKLCDFGSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPG--ENAVD 287 (395)
Q Consensus 213 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~--~~~~~ 287 (395)
+ .++.+||+|||+++....... .....||..|+|||++.+. .++.++|||||||++|+|++|..+ |.. .....
T Consensus 301 ~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 N-CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred C-CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9 688999999999987654332 2345789999999999765 489999999999999999998754 432 23444
Q ss_pred HHHHHHHHhCCCChhh-------hhhcCCCCCCCCCCCccCCCccccc-cccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 288 QLVEIIKVLGTPTREE-------IRCMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 288 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.+.+++..++...... +.... ...+.... ......+ ...++.++.++|.+||++||.+|||+.|+|.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~----~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYID----SAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhh----hhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 5555555443222110 00000 00000000 0000011 1246788999999999999999999999999
Q ss_pred CCCCcCCCC
Q 016115 360 HPFFDELRE 368 (395)
Q Consensus 360 hp~~~~~~~ 368 (395)
||||.....
T Consensus 454 hp~f~~~~~ 462 (501)
T PHA03210 454 LPLFSAEEE 462 (501)
T ss_pred ChhhhcCCc
Confidence 999987544
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=317.38 Aligned_cols=255 Identities=28% Similarity=0.419 Sum_probs=203.7
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+|++.+.||.|+||+||+|.+..++..+|+|.+.... ....+|+.+++.++|+||+++++.+ ......++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEEE
Confidence 6899999999999999999998899999999885432 3345789999999999999999888 44456899
Q ss_pred EEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
|||+++|+ +.+.+.. ......+++..++.++.|++.||.|||+ .|++|+||+|+||+++ +++.++|+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 77 VMPYLSGGSLLDIMKS-SYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLG-EDGSVKIADFGVSASLA 153 (267)
T ss_pred EEeccCCCcHHHHHHH-hcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEc-CCCCEEEcccchHHHhc
Confidence 99999875 4444432 2223568999999999999999999999 6999999999999999 68889999999987665
Q ss_pred cCCcc-----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 232 KGEAN-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 232 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
..... ....|+..|+|||++.....++.++|+||||+++|+|++|..||...+....+...... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~----- 225 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPP----- 225 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCC-----
Confidence 44322 23467889999999876546899999999999999999999999877655444443321 000
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
.+... .....++..+.+||.+||..||++||++.+++.||||
T Consensus 226 --------~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 --------SLETG-------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------CcCCc-------cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00000 0023568899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=320.16 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=204.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+|.+.+.||.|++|.||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++.+++. +...+++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEEE
Confidence 5888999999999999999999999999999886432 23457899999999999999999883 4456899
Q ss_pred EEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
|+||++++ +.+.+.. ..+++..++.++.|++.||.|||+ +|++|+||+|+||+++ +++.++|+|||+++...
T Consensus 77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLS-EEGDVKLADFGVSGQLT 149 (274)
T ss_pred EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEC-CCCCEEEcccccceeec
Confidence 99999874 4444332 378999999999999999999999 6999999999999999 68899999999998765
Q ss_pred cC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.. .......++..|+|||.+.+.. ++.++||||||+++|+|+||..||...+.......+....
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------- 214 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-------------- 214 (274)
T ss_pred ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--------------
Confidence 44 2233456788999999997654 8999999999999999999999998766443333222210
Q ss_pred CCCCCCCCccCCCcccccccc-CChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
....... ++.++.++|.+||..||++|||++++++||||++....
T Consensus 215 --------------~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 215 --------------PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred --------------CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 0001122 68899999999999999999999999999999875543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=324.16 Aligned_cols=277 Identities=25% Similarity=0.388 Sum_probs=202.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+|++.+.||+|+||.||++.+..+|..+|+|.+.... ....+|+++++.++||||+++++++ .+...+++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEEE
Confidence 5899999999999999999999999999999886432 2345799999999999999999998 44556999
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
||||++| +|.+.+.. ...+++..++.++.||+.||.|||+..+++|+||||+||+++ .++.+||+|||++....
T Consensus 77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe-cCCcEEEccCCCccccc
Confidence 9999986 44444433 367899999999999999999999723899999999999999 68889999999987653
Q ss_pred cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
... .....|+..|+|||++.+. .++.++||||||+++|+|++|..||...+.... ..+...................
T Consensus 152 ~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 152 DSM-ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ccc-cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccC
Confidence 322 2345788999999998654 488999999999999999999999976653322 2222110000000000000000
Q ss_pred CCCCCCC----------ccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 312 TDFRFPQ----------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 312 ~~~~~~~----------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
.....+. .............++.++.+||.+||..||++|||+.++++||||....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 0000000 0000000000123688999999999999999999999999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=333.64 Aligned_cols=246 Identities=31% Similarity=0.460 Sum_probs=202.1
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHH-cCCCceeeeceeeeecCCCCceeEEEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
....|.+...+|.|+|+.|-++.+..+++.+++|++.+......+|+.++.. -+|+||+++.+.+ .+....|+|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence 4567889899999999999999999999999999998876666778866554 4699999999999 777889999
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||++.|+. .+.+.. ....+. .++..|+++|+.|+.|||+ +|+|||||||+|||++.+.+.++|+|||.++.....
T Consensus 395 ~e~l~g~e--ll~ri~-~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 395 MELLDGGE--LLRRIR-SKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ehhccccH--HHHHHH-hcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999752 222221 123333 7788899999999999999 799999999999999436888999999999876544
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
..+.+-|..|.|||++.. ..|++++||||||++||+||+|+.||...... .++...++.+.
T Consensus 470 --~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~------------- 530 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK------------- 530 (612)
T ss_pred --hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc-------------
Confidence 334456888999999974 55999999999999999999999999876655 23333222222
Q ss_pred CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
+...+|..+++||.+||++||.+|+++.+++.||||
T Consensus 531 --------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 --------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 224689999999999999999999999999999999
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=324.33 Aligned_cols=263 Identities=24% Similarity=0.342 Sum_probs=203.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|...+.||+|+||.||++.+..+|+.||+|.+.... ....+|+.++.++. |+||+++++++.. ....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence 5667788999999999999999999999999886432 23346888888886 9999999998843 34478
Q ss_pred EEEecccchHHHHHHhh-cccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++|||+.+++....... ......+++..+..++.|++.||+|||+..|++||||||+||+++ .++.+||+|||+++..
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQL 158 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc-cCCcEEEeecchhHHh
Confidence 99999987665544322 223467999999999999999999999724999999999999999 6889999999999776
Q ss_pred ccCCcceeeeecccccCchhhcCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 231 VKGEANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..........|+..|+|||++.+. ..++.++|||||||++|+|++|+.||..... ....+.+.......
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~------- 229 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPP------- 229 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCC-------
Confidence 554444455678899999999665 3589999999999999999999999976541 22222221111000
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
. ........++.++.+||.+||+.||.+|||+++++.||||+.....
T Consensus 230 ---------~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 230 ---------I-----LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER 276 (288)
T ss_pred ---------c-----CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence 0 0001113468899999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=312.33 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=201.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||+|++|.||++.+..+++.||+|.+.... ....+|+++++.++|+|++++++.+. .....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 4899999999999999999999999999999985432 23456889999999999999988762 2334588
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++|||+++ ++.+.+... ....+++..++.++.+++.||.+||+ +|++|+||||+||+++ .++.++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~-~~~~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLT-RTNIIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEe-cCCcEEEecccceEEe
Confidence 99999986 555555432 23568999999999999999999999 6999999999999999 7889999999999766
Q ss_pred ccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------ 219 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------ 219 (257)
T ss_pred cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------
Confidence 43322 2334678899999998664 488999999999999999999999987765554443332100
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
...+..+++.+.+||.+||+.||.+|||+.+++.||||
T Consensus 220 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 ----------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ----------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=332.44 Aligned_cols=253 Identities=30% Similarity=0.562 Sum_probs=211.5
Q ss_pred cee--eeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 79 YMA--ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 79 y~~--~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
|++ .++||+|.||+||-|+++.+|+.||||++.+. ......|+.||..+.||.||.+.-.| +....+
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~erv 638 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERV 638 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceE
Confidence 444 46899999999999999999999999998543 34456799999999999999997666 444459
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCC--CcEEEeeccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAK 228 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~--~~~kl~Dfg~a~ 228 (395)
++|||-+.|++++.+.. ...+++++.....++.||+.||.|||- ++|+|+||||+|||+...+ -++||||||+|+
T Consensus 639 FVVMEKl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 639 FVVMEKLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EEEehhhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeecccccee
Confidence 99999999998888764 445889999999999999999999999 7999999999999997332 379999999999
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.+.+.....+.+||+.|.|||+++..+ |...-|+||.|||+|.-|.|..||....+... +|.+.
T Consensus 716 iIgEksFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNA------------- 779 (888)
T KOG4236|consen 716 IIGEKSFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNA------------- 779 (888)
T ss_pred ecchhhhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchhH--Hhhcc-------------
Confidence 998888888899999999999998755 99999999999999999999999976543322 22111
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
.|.++ ..+| ..+++.+.|||..+|++.-.+|.|.+..|.|||+++..
T Consensus 780 ----aFMyP---p~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 780 ----AFMYP---PNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred ----ccccC---CCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 11111 1222 56799999999999999999999999999999998754
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=321.53 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=207.6
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
-|.++.+||+|+||.||+|.++.+|..+|||.+..+. ...-+|+.++.++..+++|++++.|+-..+ ++||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence 4888899999999999999999999999999986553 445579999999999999999999965444 999999
Q ss_pred cccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCc
Q 016115 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235 (395)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 235 (395)
||+.+..+.+.+. .++.+++.++..+++..+.||+|||.+ .-+|||||..|||++ .+|..||+|||.|..+.+.-.
T Consensus 109 YCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 109 YCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLN-TDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEc-ccchhhhhhccccchhhhhHH
Confidence 9995433443332 258899999999999999999999996 789999999999999 688999999999988755433
Q ss_pred -ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCC
Q 016115 236 -NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314 (395)
Q Consensus 236 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
..+.+||+.|||||++...+ |+.++||||||++..||..|++||.+-.....+..+-. .++ -
T Consensus 185 KRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT---~PP-------------P 247 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT---KPP-------------P 247 (502)
T ss_pred hhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC---CCC-------------C
Confidence 34578999999999997654 99999999999999999999999987544322211110 000 0
Q ss_pred CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
.|. -+...|.++.|||++||.+.|++|.|+.++++|||++....
T Consensus 248 TF~----------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 248 TFK----------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred CCC----------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 010 12345889999999999999999999999999999987543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=320.11 Aligned_cols=282 Identities=30% Similarity=0.517 Sum_probs=218.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-----
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS----- 144 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 144 (395)
.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+++++.++||||+++++.+....+
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 457999999999999999999999999999999986432 223468999999999999999988744331
Q ss_pred CCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
.+...+++|+||+++++...+... ...+++..++.++.||+.||.|||+ .||+|+||||+||+++ +++.+||+||
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~-~~~~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLN-NKGQIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC-CCCcEEeCcc
Confidence 123368999999999876665432 3568999999999999999999999 6999999999999999 7889999999
Q ss_pred ccccccccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 225 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
|++........ .....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+..+.+..+.+..+.+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99976644332 2223567789999998665557899999999999999999999999888888888888777766554
Q ss_pred hhhhcCC--CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 303 EIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 303 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
.+..... .+............+. .....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 4322110 0000000000001111 1123468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=326.28 Aligned_cols=286 Identities=35% Similarity=0.649 Sum_probs=219.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCC-Cce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 148 (395)
.++|.+.+.||+|+||.||+|.+..+|..||||.+.... ....+|+.+++.++|+||+++++++...... ...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 346999999999999999999999999999999885421 2234699999999999999999988443221 123
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+++||||+++++...+. ...+++..++.++.||+.||.|||+ .||+||||||+||+++ .++.++|+|||++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~-~~~~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVN-EDCELKILDFGLAR 166 (343)
T ss_pred eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEeeccccc
Confidence 468999999777655543 2568999999999999999999999 6999999999999999 68899999999997
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+.+..+...........
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 167 QTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 65332 2334678899999998764558899999999999999999999999888777777777655554433322211
Q ss_pred CCCC-CC--CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 309 PNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 309 ~~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
.... .+ ..+...... .......++..+.++|.+||+.||.+|||+.+++.||||+..++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~ 309 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKD-FRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED 309 (343)
T ss_pred chhHHHHHHhccccCcch-HHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence 1000 00 000000000 11223467889999999999999999999999999999998877543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=316.81 Aligned_cols=274 Identities=38% Similarity=0.698 Sum_probs=220.3
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
|++.+.||+|++|.||+|++..+++.||+|.+.... .....|+.+++.++|+||+++++++ .+....++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence 567788999999999999999999999999987542 2234688999999999999999988 44456999
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
||||+++++.+.+.... ..+++..++.++.|++.||.|||+ .||+||||+|+||+++ +++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILIN-RDGVLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEc-CCCCEEEecCCcccccCC
Confidence 99999998777766522 468999999999999999999999 6999999999999999 688999999999876544
Q ss_pred CC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
.. ......++..|+|||.+.+...++.++||||||+++|+|++|..||...+..+.+..+.+..+.+....+.......
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 32 22234557789999998766568999999999999999999999999998888888888888877776654432211
Q ss_pred -CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 312 -TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 312 -~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
....++..........+ ..++..+.++|++||..||++||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 11122222222221222 2348899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=323.21 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=204.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.+|.+.+.||+|+||.||++.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++.+ ......++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEEE
Confidence 57999999999999999999999999999999886432 2345688999999999999999988 44556899
Q ss_pred EEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
||||++|+ +.+.+. ...+++..+..++.|++.||.|||+ .|++||||||+|||++ .++.++|+|||++....
T Consensus 94 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 94 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQIT 166 (297)
T ss_pred eecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEECcCccceEcc
Confidence 99999864 444332 2467889999999999999999999 6999999999999999 78899999999987654
Q ss_pred cCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.. .+.+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~----------- 233 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP----------- 233 (297)
T ss_pred CCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC-----------
Confidence 3322 223467889999999865 4488999999999999999999999976554322211111 0000
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
....+..++..+.+||.+||..||++||++.++++||||+..+....
T Consensus 234 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 234 --------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred --------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 00112356888999999999999999999999999999998776544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=315.36 Aligned_cols=247 Identities=28% Similarity=0.454 Sum_probs=197.1
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
+|.+.+.||+|+||.||+|.+ .+|+.+|+|.+.... ....+|+++++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 478889999999999999986 578999999875321 2245689999999999999999988 445
Q ss_pred eeEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...++++||++|+ +.+.+.. ...+++..++.++.|++.||.|||+ .||+|+||+|+||+++ .++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLM-PNGIIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEEC-CCCeEEeccchh
Confidence 6799999999874 4444432 3568899999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccC-------CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016115 227 AKVLVKG-------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 227 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
+...... .......++..|+|||++.+. .++.++||||||+++|+|++|..||...+.......+....+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 226 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL- 226 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence 8764221 111234578899999998654 4889999999999999999999999876544433322221000
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
....+..++.++.++|++||..||.+||++.++++||||
T Consensus 227 -------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 -------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 011234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=315.02 Aligned_cols=278 Identities=35% Similarity=0.617 Sum_probs=214.2
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHc---CCCceeeeceeeeecCCCCcee
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 149 (395)
|++.+.||+|+||.||+|++..++..||+|.+.... ....+|+.+++.+ +|+||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999998889999999986321 1233577776655 5999999999986654444456
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++++|||+++++.+.+.... ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++ .++.+||+|||++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~-~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVT-SDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEc-cCCCEEEeccCccee
Confidence 89999999988777665432 2368999999999999999999999 6999999999999999 678999999999987
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
...........++..|+|||++.+. .++.++||||||+++|+|++|..||......+.+..+....+.+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 6555444445678889999999764 489999999999999999999999999888888888777655443322211100
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
.....++....... ......+++.+.++|.+||+.||.+||++.+++.||||
T Consensus 236 -~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 -LPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred -cchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00000111111111 11123457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=322.94 Aligned_cols=284 Identities=37% Similarity=0.707 Sum_probs=221.3
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..++|.+.+.||.|+||.||+|.+..+|+.||+|.+... .....+|+++++.++||||+++.+++... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~ 83 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LE 83 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CC
Confidence 455799999999999999999999999999999987532 23345799999999999999999987432 23
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
..++++||+++++.+.+.. ..+++..+..++.||+.||.|||+ .||+|+||+|+||+++ .++.++|+|||++.
T Consensus 84 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~-~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILIN-ENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehhccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeEC-CCCCEEeCcccccc
Confidence 4789999998876665542 467888899999999999999999 6999999999999999 78899999999987
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.... ......++..|+|||.+.+...++.++||||||+++|+|++|..||...........+.+.++.++.+......
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5432 22344678889999998665568999999999999999999999999888877777777777776655443211
Q ss_pred CC-CCCC--CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 309 PN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 309 ~~-~~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
.. ..++ ..+.....+.. .....++..+.++|.+||+.||++|||+++++.||||...+.+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~ 300 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFS-EKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300 (328)
T ss_pred chhhHHHHhhccccCCCcHH-HHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence 10 0000 00000000111 1123568899999999999999999999999999999887776443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=310.92 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=202.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|.+.+.||+|++|.||+|.+..+|+.|++|.+... .....+|+++++.++|+||+++++.+ .+....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 478889999999999999999999999999987532 23344688999999999999999988 4455689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||++| ++.+.+... ....+++..++.++.|++.||.|||+ +|++|+||||+||+++ .++.++|+|||++...
T Consensus 76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~-~~~~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEe-CCCCEEEcccccceec
Confidence 99999986 555555432 23578899999999999999999999 6999999999999999 6889999999998765
Q ss_pred ccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... .....|+..|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+.....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 218 (256)
T cd08529 152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------ 218 (256)
T ss_pred cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 44322 2234678899999998664 488999999999999999999999988775554444332100
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
..+...++..+.++|.+||+.+|++||++.++++|||+
T Consensus 219 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 ----------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ----------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 01223468899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=317.60 Aligned_cols=257 Identities=27% Similarity=0.405 Sum_probs=200.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHc-CCCceeeeceeeeecCC-CCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTS-KDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~~ 150 (395)
.+.|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....|+.+++.+ +|+||+++++++..... .....+
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 357999999999999999999999999999999885432 2345678888887 69999999998854322 234578
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++|||+++ ++.+.+... ....+++..++.++.||+.||.|||+ .||+|+||||+||+++ .++.++|+|||++..
T Consensus 95 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~-~~~~~~l~dfg~~~~ 170 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEeeCcchhh
Confidence 999999986 555555432 23457888899999999999999999 6999999999999999 788899999999876
Q ss_pred cccC-CcceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 230 LVKG-EANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 230 ~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
.... .......|+..|+|||++.. ...++.++|||||||++|+|++|..||...........+... ..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~---- 243 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP---- 243 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC----
Confidence 5322 12234568899999999852 234788999999999999999999999765543333222110 00
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
.......++.++.+||++||..||.+|||+.|++.||||
T Consensus 244 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 --------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000123468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=315.44 Aligned_cols=249 Identities=29% Similarity=0.480 Sum_probs=196.7
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc---------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
+|.+.+.||+|+||.||+|.+..+|..||+|.+... .....+|+.+++.++|+||+++++++.. ....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence 588999999999999999999999999999987532 1234568999999999999999988743 2234
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++++||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ .||+|+||||+||+++ .++.+||+|||++
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~-~~~~~~l~dfg~~ 153 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGAS 153 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEC-CCCCEEEccCCCc
Confidence 57899999986 55555443 3458899999999999999999999 6999999999999999 6888999999998
Q ss_pred cccccCC----cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 228 KVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 228 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
....... ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+........... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~---- 225 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---P---- 225 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---C----
Confidence 7543211 11224578889999998654 5899999999999999999999999876544433322210 0
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
....++..+++.+.+|| +||..||++||+++|+++||||+
T Consensus 226 --------------------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 226 --------------------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --------------------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00112334678899999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=315.97 Aligned_cols=246 Identities=31% Similarity=0.531 Sum_probs=198.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------------cchHHHHHHHHHcCCCceeeeceeeeecCC
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (395)
+|.+.+.||+|++|.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 3778899999999999999998899999999885321 2244688999999999999999988
Q ss_pred CCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEee
Q 016115 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~D 223 (395)
......++||||+++ ++.+.+.. ...+++..++.++.|++.||.|||+ .|++||||+|+||+++ +++.++|+|
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~-~~~~~~l~d 149 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVD-NKGGIKISD 149 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEc-CCCCEEecc
Confidence 444568899999986 44444433 3568899999999999999999999 6999999999999999 788999999
Q ss_pred cccccccccCCc-------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016115 224 FGSAKVLVKGEA-------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296 (395)
Q Consensus 224 fg~a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~ 296 (395)
||+++....... .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 228 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence 999876642211 1123578889999998654 47899999999999999999999998765544333322200
Q ss_pred CCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
....+..++..+.++|++||+.||.+||++.++++||||
T Consensus 229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 ----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 001223568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=312.41 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=205.8
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||.|+||.||++.+..+|..||+|.+.... .....|+++++.++|+||+++++.+.. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 4888999999999999999999999999999885321 233468899999999999999987743 2344588
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH-----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH-----~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
++|||+++ ++.+.+.........+++..++.++.||+.||.||| + .+++|+||||+||+++ .++.+||+|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~-~~~~~kl~d~g 155 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLD-ANNNVKLGDFG 155 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEe-cCCCEEEeccc
Confidence 99999985 666666655455678999999999999999999999 8 6999999999999999 68899999999
Q ss_pred cccccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 226 SAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 226 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
++........ .....++..|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~------ 226 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--K------ 226 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC--C------
Confidence 9987655443 3345689999999998654 4889999999999999999999999887644433332221 0
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
...++..++..+.+++.+||+.||.+||++.++++|||+
T Consensus 227 --------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 --------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred --------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 011234568899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=344.01 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=197.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcC-CCceeeece-eeeecCCCC-ceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMD-HPNVISLKH-CFFSTTSKD-ELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~-~~~~~~~~~-~~~~ 150 (395)
+++|.+.|.+|||+.||+|.+...|..||+|++... .+...+|+++|++|. |+|||.+++ ......... ...+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 588999999999999999999888899999987543 234568999999997 999999999 443332233 3568
Q ss_pred EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC--ceeccCCCCceeecCCCCcEEEeecccc
Q 016115 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.|.||||. |+|.+.+..+.. .+|++.++++|+.++++|+.+||.. . |||||||-|||||+ .++..||||||.|
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls-~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLS-ADGNYKLCDFGSA 193 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEc-CCCCEEeCccccc
Confidence 89999999 699999987665 4499999999999999999999984 5 99999999999999 7889999999998
Q ss_pred cccccCCcc----------eeeeecccccCchhhc--CCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016115 228 KVLVKGEAN----------ISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295 (395)
Q Consensus 228 ~~~~~~~~~----------~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~ 295 (395)
......... ....-|+.|+|||.+. .+...++|+|||+|||+||-|+....||.......++.
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln----- 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN----- 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe-----
Confidence 654322211 1123489999999872 23458999999999999999999999998753322111
Q ss_pred hCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..|.+|.. ..++..+.+||+.||+.||.+||++.|++.
T Consensus 269 ----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 269 ----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred ----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 11222221 357899999999999999999999999885
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=315.68 Aligned_cols=252 Identities=29% Similarity=0.514 Sum_probs=199.7
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
+|+..+.||+|++|.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 3788899999999999999999999999999886422 2345789999999999999999998 555
Q ss_pred eeEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...++||||+.|+ +.+.+.. ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++..+..++|+|||.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 5689999999974 4444433 3578899999999999999999999 69999999999999985455799999999
Q ss_pred ccccccCCc-----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 227 AKVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 227 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+........ .....++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+.......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-- 227 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC--
Confidence 876643311 1234578899999998654 58999999999999999999999997554333222222210000
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
.....+..+++++.++|.+||..||.+||++.++++||||+
T Consensus 228 ----------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 ----------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ----------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00112345688999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=311.19 Aligned_cols=249 Identities=31% Similarity=0.459 Sum_probs=204.7
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||+|+||.||++.+..+++.+|+|.+... .....+|+++++.++|+||+++++.+ ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 488999999999999999999999999999988543 22345789999999999999999987 4455689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||++| ++.+.+... ....+++..++.++.+++.||.|||+ +|++|+||||+||+++.+++.+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999986 555555432 13458999999999999999999999 699999999999999855667899999999877
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
..........++..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~------------- 218 (256)
T cd08220 153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF------------- 218 (256)
T ss_pred CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence 655444456788899999998654 478999999999999999999999987766554444332100
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
..++..++.++.++|.+||..||.+|||+.|+++||||
T Consensus 219 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 ---------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ---------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 01223468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=314.04 Aligned_cols=245 Identities=30% Similarity=0.501 Sum_probs=198.8
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecc
Q 016115 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 85 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
||.|++|.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++.+ .+...+++++||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 699999999999999899999999986432 2345688999999999999999988 4445689999999
Q ss_pred cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcc
Q 016115 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (395)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (395)
+| +|.+.+.. ...+++..+..++.||+.||.|||+ +|++|+||+|+||+++ .++.++|+|||++.........
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEc-CCCCEEEeeCCcccccCccccc
Confidence 85 55444433 3458999999999999999999999 7999999999999999 6889999999999877555433
Q ss_pred eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhhhhhcCCCCCCC
Q 016115 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314 (395)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.... ..+....+.....
T Consensus 150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 211 (262)
T cd05572 150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG----------------- 211 (262)
T ss_pred ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-----------------
Confidence 445678899999998654 48999999999999999999999998765 3333333221000
Q ss_pred CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCC
Q 016115 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 368 (395)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 368 (395)
...++...+.++.++|.+||..||.+|++ +.|+++||||+++++
T Consensus 212 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 212 ----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 01122345789999999999999999999 999999999998755
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=312.10 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=201.5
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
++|.+.+.||+|+||.||+|.+..++..|++|.+.... ....+|+++++.++|+||+++++.+ .+...+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY-----FKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCcEEEEE
Confidence 46899999999999999999998889999999986543 4456799999999999999999988 4445689999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||++++ +.+.+.. ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++ .++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEC-CCCcEEEcccccchhcccC
Confidence 999974 4443322 23578999999999999999999999 6999999999999999 6889999999998876544
Q ss_pred C-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 234 E-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 234 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+... .
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~----~------------ 215 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK----P------------ 215 (256)
T ss_pred ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC----C------------
Confidence 3 22334578899999998654 5899999999999999999999999876544332221110 0
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
... ......++.++.++|.+||+.||.+|||+.+++.||||
T Consensus 216 ---~~~-------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 216 ---PPT-------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ---CCC-------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 000 00123467899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=329.03 Aligned_cols=249 Identities=20% Similarity=0.276 Sum_probs=194.7
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.......+...||+|.||+||+|+|.. .||||++..+ .+.+++|+.++++-+|.||+-+.|++. ..
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~-----~p 460 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM-----NP 460 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc-----CC
Confidence 334456788899999999999999843 5999998654 345678999999999999999999883 33
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
. +.||..+|+|+.+-...+ .....|.....+.|++||++|+.|||. ++|||||||..||++. ++++|||+|||++
T Consensus 461 ~-~AIiTqwCeGsSLY~hlH--v~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~-~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 461 P-LAIITQWCEGSSLYTHLH--VQETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLH-EDLKVKIGDFGLA 535 (678)
T ss_pred c-eeeeehhccCchhhhhcc--chhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEc-cCCcEEEecccce
Confidence 3 379999999953333332 234778899999999999999999999 8999999999999999 6799999999998
Q ss_pred cccccC---CcceeeeecccccCchhhcCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 228 KVLVKG---EANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 228 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
..-..- .......|...|||||+++.. ..|++.+||||||+++|||+||..||...+.++.+.++-+....+...
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS 615 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence 654222 122234567789999999642 348999999999999999999999999655555444433322222111
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
......+.++++|+..||.+++++||.+.+||.
T Consensus 616 ------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 616 ------------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ------------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 123456789999999999999999999999886
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=311.67 Aligned_cols=248 Identities=34% Similarity=0.542 Sum_probs=201.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
+|+..+.||+|+||.||+|.+..++..|++|.+.... ....+|+.+++.++|+||+++++.+ .+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 4777889999999999999998899999999875422 2345789999999999999999987 4445
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++++||++| ++.+.+.. ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++ .++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~-~~~~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVD-TNGVVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEccCccc
Confidence 68999999986 44444433 3568899999999999999999999 6999999999999999 6889999999998
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.............++..|+|||.+.....++.++|+||||+++|+|++|..||......+....+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------- 219 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE---------- 219 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc----------
Confidence 7765444344566888999999986543478999999999999999999999987664443333222100
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
...++..+++.+.+||++||+.||.+||++.+++.|||+
T Consensus 220 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 -----------------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -----------------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 001234568899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=319.85 Aligned_cols=256 Identities=28% Similarity=0.404 Sum_probs=204.7
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.|.....||+|+||.||++.+..++..||||.+.... ....+|+.+++.++|+||+++++.+ ......++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEEE
Confidence 3555677999999999999999999999999875422 2345788999999999999999988 444568999
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
|||++++.+..+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.++|+|||++......
T Consensus 98 ~e~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 98 MEFLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred EeCCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEc-CCCCEEEccCcchhhcccc
Confidence 99999764444332 2468899999999999999999999 6999999999999999 6889999999998754332
Q ss_pred Cc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 234 EA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 234 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
.. .....|+..|+|||.+.+. .++.++||||||+++|+|++|..||...+....+..+........
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 238 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV------------ 238 (292)
T ss_pred cccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc------------
Confidence 22 2345678999999998654 489999999999999999999999987766554443332111000
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
.....++..+.++|.+||..||.+|||+.++++||||+....+..
T Consensus 239 --------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 239 --------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred --------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 011246889999999999999999999999999999998777664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=317.41 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=190.3
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHH---HcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMR---LMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.||+|+||.||++.+..+|+.+|+|.+..... ...+|..+++ ..+|+||+.+++.+ ......++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence 38999999999999999999999998854321 1223333333 34799999998888 444458999
Q ss_pred EecccchHH-HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~~l~-~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||+.|+.+ +.+. ....+++..++.++.|++.||.|||+ +||+|+||||+|||++ .++.++|+|||++.....
T Consensus 76 ~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 76 LDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLD-EHGHVRISDLGLACDFSK 149 (279)
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEEC-CCCCEEEccCCcceeccc
Confidence 999997533 3332 24679999999999999999999999 6999999999999999 788999999999875533
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
.. .....|+..|+|||.+.+...++.++|||||||++|+|++|..||......... .+......
T Consensus 150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~-------------- 213 (279)
T cd05633 150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT-------------- 213 (279)
T ss_pred cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhc--------------
Confidence 32 223468999999999865455899999999999999999999999754322111 11110000
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~ 369 (395)
....++..++.++.++|++||..||.+|+ |+.++++||||+.++..
T Consensus 214 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 214 -----------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred -----------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 00113345789999999999999999999 69999999999986643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=304.66 Aligned_cols=283 Identities=31% Similarity=0.530 Sum_probs=226.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecC---CCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTT---SKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~~ 148 (395)
.|.-..+||+|.||.||+|+.+.+|+.||+|++.-+. ....+|+.+|..+.|+|++.+++++-... ..+..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4777789999999999999999999999998764321 12347999999999999999998874433 23455
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+|+|+.+|+.+|..+|... ..+++..++.+++.++++||.|+|+ ..|+|||+|++|+|++ .++.+||+|||+++
T Consensus 98 t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt-~dgilklADFGlar 172 (376)
T KOG0669|consen 98 TFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLIT-KDGILKLADFGLAR 172 (376)
T ss_pred eeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEc-CCceEEeecccccc
Confidence 69999999998877776542 4678999999999999999999999 5999999999999999 78999999999997
Q ss_pred ccccCCc-----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 229 VLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 229 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
.+..... .+..+.|.+|++||.+.|...|+++.|||..|||+.+|.|+.+.|++.++..++..|....|....+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 6643322 33456799999999999999999999999999999999999999999999999999999999988887
Q ss_pred hhhcCCC--CCCCCCCCccCCCcccc---c-cccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 304 IRCMNPN--YTDFRFPQIKAHPWHKV---F-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 304 ~~~~~~~--~~~~~~~~~~~~~~~~~---~-~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
|..+..- +......-+........ . +-.-.+++.||+.++|..||.+|++++++|+|.||.+
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 7654310 00000000000000000 0 0011468999999999999999999999999999975
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=324.93 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=194.5
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcC-CCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 149 (395)
..|++.+.||+||.+.||++... +...||+|++.... ..+..|+.+|.+|+ |.+||.++++- -.+.+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence 35999999999999999999953 34567777664322 23457999999996 99999999977 44667
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|+||||-+.+|-..|.... ..++...++.+..||+.|+.++|.+ ||||.||||.|+|+- .|.+||+|||+|..
T Consensus 435 lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlV--kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 435 LYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLV--KGRLKLIDFGIANA 508 (677)
T ss_pred EEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEE--eeeEEeeeechhcc
Confidence 99999998888777776642 3334357889999999999999995 999999999999997 68899999999998
Q ss_pred cccCCcc---eeeeecccccCchhhcCCC----------CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016115 230 LVKGEAN---ISYICSRYYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296 (395)
Q Consensus 230 ~~~~~~~---~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~ 296 (395)
+...... .+.+||..||+||.+.... +.++++||||||||||+|+.|+.||..... ...++.. +
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~a-I 585 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHA-I 585 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHh-h
Confidence 8666543 3578999999999984321 256899999999999999999999975431 1122111 1
Q ss_pred CCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
..+. .+..|+++. -..++.++++.||.+||++|||+.+||+|||++-+
T Consensus 586 ~~P~-----------~~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 586 TDPN-----------HEIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred cCCC-----------ccccccCCC-----------CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 1111 122333321 12349999999999999999999999999999863
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=312.15 Aligned_cols=249 Identities=30% Similarity=0.483 Sum_probs=197.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
+|.+.+.||+|+||.||++.+..+|..||||.+.... ....+|+.+++.++|+||+++++++.. ....
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER 79 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence 6899999999999999999999999999999874221 234568999999999999999997732 2234
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.++++|||++| ++.+.+.. ...+++..+..++.|++.||.|||+ +|++|+||||+||+++ .++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~Dfg~~ 153 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRD-SVGNVKLGDFGAS 153 (265)
T ss_pred eEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEec-CCCCEEECcCccc
Confidence 58899999986 45444433 3457889999999999999999999 6999999999999999 7889999999998
Q ss_pred cccccCC----cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 228 KVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 228 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
....... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||..........++.. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~--- 226 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT--- 226 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC---
Confidence 7543211 12234578899999998664 489999999999999999999999987654443332221 100
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
....+..++..+.++|++|+. +|.+||+++++++|||+.
T Consensus 227 ---------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 ---------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ---------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 011234568889999999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=315.55 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=196.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.+|++.+.||+|+||.||+|++..+|+.||+|++... .....+|+.+++.++|+||+++++.+ .....+++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-----~~~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY-----LSREKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE-----EeCCEEEE
Confidence 4699999999999999999999999999999988643 22345789999999999999999988 34455899
Q ss_pred EEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
||||++++ +.+.+.. ...+++..+..++.|++.||.|||+ .||+||||||+||+++ .++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLT-DNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEC-CCCCEEECcCccceeec
Confidence 99999964 4444432 3568999999999999999999999 6999999999999999 68889999999997654
Q ss_pred cCC-cceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 232 KGE-ANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 232 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
... ......|+..|+|||.+.. ...++.++|||||||++|+|++|..||......+....+...
T Consensus 158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------------- 224 (267)
T cd06646 158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------------- 224 (267)
T ss_pred ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------
Confidence 322 2234567889999998742 334678999999999999999999999654432221111110
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 362 (395)
.+..+.. .....++..+.+||++||..||++|||++++++|+|
T Consensus 225 ----~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 ----NFQPPKL-------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ----CCCCCCC-------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0000000 011246889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=334.28 Aligned_cols=248 Identities=27% Similarity=0.425 Sum_probs=201.4
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEec-----c---cccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----Q---DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 80 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-----~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+...+||+|+|-+||+|.|..+|..||--.++ + ....+..|+.+|+.|+|+|||+++..|.+... ..+.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence 33457999999999999999999999854332 1 12456679999999999999999999966443 5588
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-CCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|+|++.. +|....+ ..+.+....++.|++||+.||.|||++ .-|+|||||.+||+|+...|.|||+|+|+|+.
T Consensus 120 ~iTEL~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 120 FITELFTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeecccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 99999985 4444444 457788889999999999999999984 45999999999999998889999999999998
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhhhhcC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
........ .+|||.|||||.+. ..|+..+||||||+.++||+|+..||..-. ..+.+.++... ..+..
T Consensus 196 ~r~s~aks-vIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG--iKP~s------ 264 (632)
T KOG0584|consen 196 LRKSHAKS-VIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG--IKPAA------ 264 (632)
T ss_pred hhccccce-eccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC--CCHHH------
Confidence 76655544 79999999999994 469999999999999999999999998644 44445555442 22211
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
+..--.+++++||.+||.. ..+|+|+.|||.||||..
T Consensus 265 -------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 265 -------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred -------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1112267899999999999 999999999999999986
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=315.91 Aligned_cols=240 Identities=17% Similarity=0.193 Sum_probs=192.2
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
..||+|++|.||+|.+ +|+.||||.+.... ..+.+|+.+++.++||||+++++++.... .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5699999999999997 79999999986432 23348999999999999999999885421 22345889999
Q ss_pred cccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC
Q 016115 156 YVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (395)
Q Consensus 156 ~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (395)
|+.|+ |.+.+.. ...+++.....++.+++.||.|||+..+++||||||+|||++ +++.+||+|||+++.....
T Consensus 103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~- 176 (283)
T PHA02988 103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSP- 176 (283)
T ss_pred eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC-CCCcEEEcccchHhhhccc-
Confidence 99975 4444432 457888999999999999999999733899999999999999 7899999999998865332
Q ss_pred cceeeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 235 ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
.....|+..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 241 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL-------------- 241 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 2345678999999998642 458999999999999999999999999887766655544321100
Q ss_pred CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.++..+++.+.+||.+||+.||++|||+.++++
T Consensus 242 -------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 -------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 012246889999999999999999999999974
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=315.36 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=197.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++.+ .....+++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEEE
Confidence 46999999999999999999999999999999886432 2245688999999999999999988 44456899
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
||||+++ +|.+.+.. .+.+++..++.++.|++.||.|||+ .|++|+||||+||+++ .++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 84 CMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLT-DNGHVKLADFGVSAQIT 157 (267)
T ss_pred EEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCCEEECcceeeeEcc
Confidence 9999996 44444432 4578999999999999999999999 6999999999999999 78899999999987654
Q ss_pred cCCc-ceeeeecccccCchhhc--CCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 232 KGEA-NISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 232 ~~~~-~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.... .....|+..|+|||++. ....++.++|||||||++|+|++|..||............... .
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~---------- 225 (267)
T cd06645 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--N---------- 225 (267)
T ss_pred CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--C----------
Confidence 3222 23456899999999874 2334788999999999999999999999765443322221110 0
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 362 (395)
+..+.. .....++..+.++|.+||..||++|||++++++|||
T Consensus 226 -----~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 226 -----FQPPKL-------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----CCCCcc-------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000000 001235788999999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=315.38 Aligned_cols=249 Identities=28% Similarity=0.403 Sum_probs=198.2
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecc
Q 016115 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 85 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
||+|+||+||+|.+..+|+.||+|.+... .....+|+++++.++||||+++++.+ ......|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 69999999999999999999999988532 12234689999999999999999888 4455689999999
Q ss_pred cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcc
Q 016115 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (395)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (395)
+| ++.+.+.... ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++ .++.++|+|||++.........
T Consensus 76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCcc
Confidence 96 4444444321 2468999999999999999999999 6999999999999999 6889999999998776544444
Q ss_pred eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCC
Q 016115 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316 (395)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...........+......
T Consensus 152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 212 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------ 212 (277)
T ss_pred ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------
Confidence 4456788899999987654 899999999999999999999999765542222221111000
Q ss_pred CCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 317 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
....++..+++.+.++|.+||+.||.+|| ++.++++||||+.++.
T Consensus 213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 00112345689999999999999999999 8999999999988775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=312.66 Aligned_cols=246 Identities=27% Similarity=0.447 Sum_probs=202.1
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+++++.++||||+++++++ .+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 4889999999999999999999999999999886432 2345789999999999999999988 556679
Q ss_pred EEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++|+||+.|+ +...+.. ...+++..+..++.||++||.|||+ .|++|+||+|+||+++ +++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~-~~~~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLD-EQGHVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEc-CCCCEEEeecccccc
Confidence 9999999875 3333332 3578999999999999999999999 6999999999999999 788999999999887
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChhhhhhc
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
...........|+..|+|||.+.+. .++.++|+||||+++|+|++|..||...+. .+.+.+....
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 216 (258)
T cd05578 150 VTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------ 216 (258)
T ss_pred cCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------
Confidence 6554444455678899999998654 489999999999999999999999987664 2222221110
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH--HHHhcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA--LEACAHPFF 363 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~--~ell~hp~~ 363 (395)
.....+..++..+.++|.+||..||.+||++ .|+++||||
T Consensus 217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0011334568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=294.70 Aligned_cols=287 Identities=32% Similarity=0.594 Sum_probs=233.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
..++|++.+.+|+|.|+.||.|.+..+++.++||+++.- .+...+|+.+|..|+ ||||++++++..+ .......+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCchh
Confidence 345799999999999999999999999999999998754 345678999999997 9999999998844 33444679
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|+||++..-...+- ..++...++.++.+++.||.|||+ .||+|||+||.|+++|.....++|+|+|+|.+...
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999975333332 457778899999999999999999 69999999999999998888999999999999988
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhhhh-----h
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIR-----C 306 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 306 (395)
+......+.+..|--||.+..-..|+..-|+|||||++..|+..+.|| .+.++.+++.+|.+++|....-..- .
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 888888889999999999988778999999999999999999977665 6889999999999999875543221 1
Q ss_pred cCCCCCCCCCCCccCCCcccccc----ccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFH----KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
+++.+.+. ..+....+|....+ .-+++++.||+.++|.+|-.+|+|+.|++.||||..+.+...+
T Consensus 266 Ldp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~ 334 (338)
T KOG0668|consen 266 LDPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS 334 (338)
T ss_pred CChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence 23333321 11222233333222 2357999999999999999999999999999999887765543
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=310.30 Aligned_cols=251 Identities=27% Similarity=0.465 Sum_probs=194.0
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.......||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++ ......++|
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv 83 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIF 83 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEE
Confidence 3444467999999999999999999999999876432 3455799999999999999999988 445568999
Q ss_pred Eecccc-hHHHHHHhhcccCCCC--CHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRM--PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~--~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||+++ +|.+.+... ...+ ++..+..++.||+.||.|||+ +||+||||||+||+++..++.++|+|||++...
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 84 MEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999986 554444431 1234 788888999999999999999 799999999999999855779999999998765
Q ss_pred ccCCc-ceeeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 231 VKGEA-NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 231 ~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... .....++..|+|||.+.+. ..++.++||||||+++|+|++|..||.................
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 228 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK----------- 228 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc-----------
Confidence 33222 2234578899999998543 2378899999999999999999999975432211110000000
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
....++..+++++.+|+.+||+.+|.+|||+.+++.||||
T Consensus 229 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 ---------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ---------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0011234568899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=317.38 Aligned_cols=255 Identities=29% Similarity=0.478 Sum_probs=203.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+|.+.+.||+|+||.||++.+..+++.||+|.+.... ....+|+++++.++|+||+++++.+ .....+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence 5899999999999999999999999999999886432 2234688999999999999999888 455568
Q ss_pred EEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||++|+ +.+.+.. ...+++..++.++.|++.||.|||+ .|++||||||+||+++ .++.+||+|||+++.
T Consensus 77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~-~~~~~~l~dfg~~~~ 150 (305)
T cd05609 77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKI 150 (305)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEEC-CCCCEEEeeCCCccc
Confidence 9999999974 4444433 3568999999999999999999999 6999999999999999 788999999999864
Q ss_pred cccCC----------------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016115 230 LVKGE----------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293 (395)
Q Consensus 230 ~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~ 293 (395)
..... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+....+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 21100 01123567889999998654 48999999999999999999999998776665555443
Q ss_pred HHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC---HHHHhcCCCCcCCCCCC
Q 016115 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREPN 370 (395)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~hp~~~~~~~~~ 370 (395)
..... .+. ....++.++.+||.+||+.||++||+ +.++++||||...+...
T Consensus 230 ~~~~~-----------------~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 230 SDDIE-----------------WPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred hcccC-----------------CCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 31000 000 01246889999999999999999998 79999999998766544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=314.55 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=193.0
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeccccc-------chHHHH---HHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL---QLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.||+|+||.||+|.+..+|+.||+|.+..... ....|. .+++...|+||+++++.+ .....+++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 38999999999999999999999998864321 112233 334456799999999888 445568999
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
|||+.|+.+.... .....+++..++.++.|++.||.|||+ .+|+||||||+||+++ .++.++|+|||++......
T Consensus 76 ~e~~~g~~L~~~l---~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~ 150 (278)
T cd05606 76 LDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKK 150 (278)
T ss_pred EecCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEEC-CCCCEEEccCcCccccCcc
Confidence 9999975433222 224679999999999999999999999 6999999999999999 6889999999998765333
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
. .....|+..|+|||++.+...++.++||||+|+++|+|++|..||.................
T Consensus 151 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 213 (278)
T cd05606 151 K-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------- 213 (278)
T ss_pred C-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc----------------
Confidence 2 23456899999999997655689999999999999999999999986532211110000000
Q ss_pred CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCCCC
Q 016115 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPNA 371 (395)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~~~ 371 (395)
....++..++.++.++|.+||..||.+|+ ++.++++||||+.......
T Consensus 214 ----------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 214 ----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred ----------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 00112334689999999999999999999 9999999999998765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=309.52 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=201.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
++|.+.+.||.|+||.||+|.+..+++.+++|.+.... ....+|+++++.++|+||+++++.+ .+...+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence 47999999999999999999999999999999986432 3456789999999999999999988 44556999
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
+|||++++.+..+.. .....+++..++.++.|++.||.|||+ .||+|+||||+||+++ .++.+||+|||++.....
T Consensus 78 ~~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 78 VMEYCGGGSLQDIYQ--VTRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EEeCCCCCcHHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEEC-CCCCEEECccccchhhhh
Confidence 999999754443332 122578999999999999999999999 6999999999999999 788999999999876543
Q ss_pred CC-cceeeeecccccCchhhcCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 233 GE-ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.. ......++..|+|||.+.+. ..++.++||||||+++|+|+||..||...+.......+......+.
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 224 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP--------- 224 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc---------
Confidence 32 22345678889999998543 1478899999999999999999999987765554443322100000
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 362 (395)
. ......++.++.+||++||..||.+|||+.+++.|+|
T Consensus 225 --------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 --------K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred --------c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0 0012345788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=312.41 Aligned_cols=262 Identities=26% Similarity=0.443 Sum_probs=202.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+|...+.||.|++|.||++.+..+++.+|+|.+.... ....+|+++++.++|+||+++++++.. .....+++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEEE
Confidence 6889999999999999999999999999999886432 234579999999999999999998743 23445889
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
||||++| +|.+.+.........+++..+..++.||+.||.|||+ .|++|+||+|+||+++ .++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEe-cCCeEEEeecccccccc
Confidence 9999986 5555555444455678999999999999999999999 6999999999999999 68889999999987553
Q ss_pred cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhhhhh
Q 016115 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 306 (395)
.... ....++..|+|||.+.+. .++.++||||||+++|+|++|..||..... .+....+.. ....
T Consensus 157 ~~~~-~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~----- 226 (287)
T cd06621 157 NSLA-GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPNP----- 226 (287)
T ss_pred cccc-ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCch-----
Confidence 3222 234568889999998654 589999999999999999999999986521 111111111 0000
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
.+... .......++.+.+||.+||..||.+|||+.|++.||||+....
T Consensus 227 -----------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 227 -----------ELKDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred -----------hhccC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 00000 0000124678999999999999999999999999999976544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=316.72 Aligned_cols=257 Identities=28% Similarity=0.430 Sum_probs=204.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.|.....||+|+||.||+|.+..++..||+|.+... .....+|+.+++.++||||+++++++ ......++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~iv 96 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELWVL 96 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEEEE
Confidence 355566799999999999999989999999988532 22345688899999999999999988 444558999
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
|||++++.+..+.. ...+++..++.++.|++.||.|||+ .|++|+||||+||+++ .++.+||+|||++......
T Consensus 97 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 97 MEFLQGGALTDIVS----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred EecCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEc-cCCcEEEeechhHhhcccc
Confidence 99999754443332 2568899999999999999999999 6999999999999999 7889999999998755433
Q ss_pred Cc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 234 EA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 234 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
.. .....|+..|+|||++.+. .++.++||||||+++|+|++|..||...+..+.+..+... ...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~----------- 235 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP----------- 235 (297)
T ss_pred cccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC-----------
Confidence 22 2345688999999999654 4899999999999999999999999877655544433210 000
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
. ......++..+.++|++||+.||.+||++.++++||||.+...+.+.
T Consensus 236 -----~-------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~~ 283 (297)
T cd06659 236 -----K-------LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECL 283 (297)
T ss_pred -----C-------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcccc
Confidence 0 00113467889999999999999999999999999999987665553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=307.25 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=202.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||+|+||.||++.+..+|+.||+|.+... .....+|+.+++.++|+||+++.+++ ......+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 488999999999999999999999999999988532 12345789999999999999999988 5556799
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+|+||+.+ ++.+.+.. .....+++..++.++.|++.||.|||+ +|++|+||+|+||+++ .++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLT-KDGTIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEc-CCCCEEEeeccceeec
Confidence 99999986 55554443 122457889999999999999999999 6999999999999999 6888999999999765
Q ss_pred ccCCcc-eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
...... ....|+..|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+... ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------- 219 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYP--------- 219 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--CCC---------
Confidence 443221 234578889999998654 4889999999999999999999999877766655544331 100
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
..+..++.++.++|.+||+.+|.+||++.++++||||
T Consensus 220 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 -----------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0223568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=326.54 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=192.7
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCC-----cEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (395)
..++|.+.+.||+|+||.||+|++..+| ..||+|.+.... ....+|+.+++.+ +|+||+++++++
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~---- 111 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC---- 111 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe----
Confidence 3457999999999999999999865443 579999986432 2345799999999 899999999988
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhc-----------------------------------------------------
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYS----------------------------------------------------- 169 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~----------------------------------------------------- 169 (395)
.....+++||||+.+ +|.+.+....
T Consensus 112 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 112 -THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred -cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 444568999999985 5555543211
Q ss_pred -------------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcc
Q 016115 170 -------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (395)
Q Consensus 170 -------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (395)
.....+++..++.++.||+.||.|||+ +||+||||||+|||++ +++.+||+|||+++........
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEe-CCCeEEEeeceeeeeccCCcce
Confidence 012357888999999999999999999 7999999999999999 7889999999999765433221
Q ss_pred e---eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 237 I---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 237 ~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
. ...++..|||||++.+. .++.++|||||||++|+|++ |..||.................
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~--------------- 332 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY--------------- 332 (374)
T ss_pred eeccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc---------------
Confidence 1 12235679999998654 58999999999999999997 9999987654443333332100
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....+..+++++.++|.+||+.||.+|||+.++++
T Consensus 333 ------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 333 ------------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ------------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00012345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=310.40 Aligned_cols=252 Identities=30% Similarity=0.519 Sum_probs=197.8
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc--------------cchHHHHHHHHHcCCCceeeeceeeeecC
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (395)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 4888899999999999999998899999999874211 1234688999999999999999987
Q ss_pred CCCceeEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEe
Q 016115 144 SKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~ 222 (395)
......++||||+.|+ +.+.+.. ...+++..++.++.||+.||.|||+ +|++||||+|+||+++ .++.++|+
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~-~~~~~~l~ 150 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKIS 150 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEc-CCCeEEEe
Confidence 4445689999999864 4444433 3578999999999999999999999 6999999999999999 78899999
Q ss_pred ecccccccccCCc---ceeeeecccccCchhhcCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016115 223 DFGSAKVLVKGEA---NISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (395)
Q Consensus 223 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~ 298 (395)
|||+++....... .....++..|+|||.+.+.. .++.++|+||||+++|+|++|..||...+.......+....
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-- 228 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR-- 228 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--
Confidence 9999876432211 22345788899999986543 37899999999999999999999997655443333221100
Q ss_pred CChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
....+ .......++..+.++|.+||.+||.+|||+.++++||||
T Consensus 229 -------------~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 229 -------------SAPPI--------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred -------------cCCcC--------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00000 011223468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.22 Aligned_cols=251 Identities=26% Similarity=0.373 Sum_probs=201.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.|...+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++ .+....++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence 4778889999999999999999999999999876332 2345799999999999999999988 45556899
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
||||++++.+..+.. ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++ .++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 80 IMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEEccCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEe-CCCCEEEccccccccccC
Confidence 999999753332222 2568899999999999999999999 6999999999999999 688999999999876544
Q ss_pred CCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 233 GEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 233 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
... .....++..|+|||++.+. .++.++||||||+++|+|++|..||...........+...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------- 216 (277)
T cd06642 154 TQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---------------- 216 (277)
T ss_pred cchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC----------------
Confidence 322 2234578889999998654 4889999999999999999999999765443322211110
Q ss_pred CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
....+...++..+.++|.+||+.+|++||++.+++.||||+....
T Consensus 217 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 217 ------------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred ------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence 001122346788999999999999999999999999999987554
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.97 Aligned_cols=251 Identities=30% Similarity=0.452 Sum_probs=203.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
..|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+++++.++||||+++.+++. +...
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCCe
Confidence 35999999999999999999999899999999885321 23447899999999999999999984 3445
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.++||||+.|++.+.+... ...+++..+..++.||+.||.|||+ .||+|+||+|+||+++ +++.++|+|||++..
T Consensus 90 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~ 164 (307)
T cd06607 90 AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLT-EPGTVKLADFGSASL 164 (307)
T ss_pred EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEC-CCCCEEEeecCccee
Confidence 8899999999877766432 3468999999999999999999999 6999999999999999 788999999999876
Q ss_pred cccCCcceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 230 LVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.... ....++..|+|||++.+ ...++.++||||||+++|+|+||..||...+.......+... ..
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~-------- 231 (307)
T cd06607 165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS-------- 231 (307)
T ss_pred cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC--------
Confidence 4322 23467889999998742 345788999999999999999999999877655443332210 00
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
+. .....++..+.++|.+||..||.+||++.+++.||||....
T Consensus 232 ---------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 232 ---------PT--------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred ---------CC--------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 00 01123578899999999999999999999999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=315.00 Aligned_cols=253 Identities=20% Similarity=0.257 Sum_probs=191.6
Q ss_pred cCceeeeeeecCCceEEEEEEECC----------------CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISL 135 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~ 135 (395)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 479999999999999999998532 34579999886432 234579999999999999999
Q ss_pred ceeeeecCCCCceeEEEEEecccc-hHHHHHHhhcc---------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 016115 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS---------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199 (395)
Q Consensus 136 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ 199 (395)
++++. +....++||||+.+ ++.+.+..... ....+++..++.++.||+.||.|||+ .|
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~ 158 (304)
T cd05096 85 LGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LN 158 (304)
T ss_pred EEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CC
Confidence 99883 34458999999985 55555543211 11346788899999999999999999 69
Q ss_pred ceeccCCCCceeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-
Q 016115 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL- 275 (395)
Q Consensus 200 ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt- 275 (395)
|+||||||+|||++ .++.+||+|||+++........ ....++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 159 ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 159 FVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHc
Confidence 99999999999999 7889999999999765433221 122346789999998654 48999999999999999987
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH
Q 016115 276 -GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354 (395)
Q Consensus 276 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~ 354 (395)
+..||...+..+.+..+.......... .....+..++..+.+||.+||+.||.+|||+
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGEFFRDQGRQ---------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHHHhhhcccc---------------------ccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 567888776655554443321100000 0000123468899999999999999999999
Q ss_pred HHHh
Q 016115 355 LEAC 358 (395)
Q Consensus 355 ~ell 358 (395)
.++.
T Consensus 296 ~~i~ 299 (304)
T cd05096 296 SDIH 299 (304)
T ss_pred HHHH
Confidence 9994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=310.63 Aligned_cols=252 Identities=30% Similarity=0.509 Sum_probs=200.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+|++.+.||+|+||.||++.+..+++.+|+|.+.... ....+|+++++.++|+||+++++.+ .....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEEE
Confidence 5788889999999999999999999999999886442 2345688999999999999999988 44466999
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
++||+++ +|.+.+... ...+++..++.++.|++.||.|||+..|++|+||||+||+++ .++.++|+|||.+....
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 77 CMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC-CCCCEEEeecccchhhH
Confidence 9999995 555544432 267899999999999999999999923999999999999999 68899999999987664
Q ss_pred cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCChhhhhh
Q 016115 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-----AVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
...... ..++..|+|||.+.+. .++.++||||||+++|+|++|..||...+ ..+.+..+.. ...
T Consensus 153 ~~~~~~-~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~------ 221 (265)
T cd06605 153 NSLAKT-FVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPP------ 221 (265)
T ss_pred HHHhhc-ccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCC------
Confidence 332222 6678899999998665 58999999999999999999999997542 1111111111 000
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
+. .....++.++.++|.+||..||.+|||+.+++.||||+...
T Consensus 222 ----------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 222 ----------PR--------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred ----------CC--------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 00 00112688999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=312.81 Aligned_cols=267 Identities=29% Similarity=0.440 Sum_probs=221.3
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcC-CCceeeeceeeeecCCCCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 148 (395)
.+|....+||+|+||+|.+|..+.+.+.||||+++++. +-...|.++|.... -|.++.++.+| +...
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTmD 423 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTMD 423 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhhh
Confidence 36888999999999999999999999999999987653 22345778887764 67888898888 5556
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+|+||||+.|+-+. - ....-+.+.+..+..++.+|+-||-+||+ +||+.||||.+|||++ .+|.+||+|||+++
T Consensus 424 RLyFVMEyvnGGDLM--y-hiQQ~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd-~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLM--Y-HIQQVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLD-SEGHIKIADFGMCK 498 (683)
T ss_pred heeeEEEEecCchhh--h-HHHHhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEec-cCCceEeeeccccc
Confidence 699999999987322 2 22335778889999999999999999999 8999999999999999 78889999999997
Q ss_pred cc-ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 229 VL-VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 229 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.- ..+....+++||+.|+|||++.-. .|+..+|+||+||+||||+.|++||.+.+..+.+..|...
T Consensus 499 Eni~~~~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh------------ 565 (683)
T KOG0696|consen 499 ENIFDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH------------ 565 (683)
T ss_pred ccccCCcceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc------------
Confidence 54 334445678999999999998654 5999999999999999999999999999999999988873
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCCCcCCCCCCC-CCCCCCCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPNA-RLPNGRPFPP 381 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~hp~~~~~~~~~~-~~~~~~~~~~ 381 (395)
...++..+|.++.++++..|.+.|.+|... .++-.||||+.+++... +.+-.+++.|
T Consensus 566 -----------------nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkP 628 (683)
T KOG0696|consen 566 -----------------NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKP 628 (683)
T ss_pred -----------------cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCC
Confidence 223667889999999999999999999865 58999999999988542 3344444555
Q ss_pred CC
Q 016115 382 LF 383 (395)
Q Consensus 382 ~~ 383 (395)
-+
T Consensus 629 k~ 630 (683)
T KOG0696|consen 629 KI 630 (683)
T ss_pred cc
Confidence 44
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=304.42 Aligned_cols=248 Identities=33% Similarity=0.505 Sum_probs=203.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|+..+.||.|+||.||.+++..+++.+++|.+.... ....+|+++++.++|+||+++++++ .+...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence 4889999999999999999999999999999875321 2345799999999999999999998 4455689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++|||++| ++.+.+.... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++ .++.+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEe-CCCCEEECcCcceEEc
Confidence 99999985 5555554321 3568999999999999999999999 6999999999999999 7889999999998766
Q ss_pred ccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+... ...
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------- 219 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT--------- 219 (256)
T ss_pred ccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence 4433 22345678999999998654 4789999999999999999999999887766655554321 100
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
.....++.++.++|.+||..||.+||++.++++|+|+
T Consensus 220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0113468899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.51 Aligned_cols=246 Identities=33% Similarity=0.522 Sum_probs=193.4
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHH-HHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQL-MRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||.||+|.+..+|+.||+|.+..... ....|..+ ....+|+|++++++++ .....+++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 468999999999999999999999998864321 11223333 3455899999999988 4455699999
Q ss_pred ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||++|+ |.+.+.. ...+++..+..++.||+.||.|||+ .|++|+||+|+||+++ .++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEC-CCCcEEEeecccceeccc-
Confidence 999864 4444432 3568999999999999999999999 6999999999999999 688999999999876433
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.....
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 210 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI---------------- 210 (260)
T ss_pred --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc----------------
Confidence 22345788899999987654 89999999999999999999999988776555444332100
Q ss_pred CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC---HHHHhcCCCCcCCCC
Q 016115 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELRE 368 (395)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~hp~~~~~~~ 368 (395)
. +.......++..+.++|.+||..||++||+ ++|++.||||++.++
T Consensus 211 -~--------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 211 -N--------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred -C--------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 0 001122346899999999999999999995 579999999988765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=305.37 Aligned_cols=250 Identities=32% Similarity=0.506 Sum_probs=204.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+|++.+.||+|++|.||+|.+..+|+.|++|++.... ....+|+..+..++|+||+++++++ .....+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEEE
Confidence 5889999999999999999999999999999986542 3455788999999999999999988 44466999
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ . |++|+||+|+||+++ .++.++|+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~ 150 (264)
T cd06623 77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLIN-SKGEVKIADFGISKVL 150 (264)
T ss_pred EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEEC-CCCCEEEccCccceec
Confidence 9999995 55555443 3678999999999999999999998 6 999999999999999 6889999999999876
Q ss_pred ccCCcce-eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChhhhhh
Q 016115 231 VKGEANI-SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 231 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
....... ...++..|+|||.+.+. .++.++|+||||+++|+|+||..||.... ..+....+.. ...
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~------ 220 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP------ 220 (264)
T ss_pred ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC------
Confidence 5444332 45678899999998654 58999999999999999999999998764 2222222211 000
Q ss_pred cCCCCCCCCCCCccCCCcccccccc-CChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
...... ++..+.++|.+||..+|++||++.++++||||+.++
T Consensus 221 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 221 -------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred -------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 001223 688999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=308.57 Aligned_cols=246 Identities=18% Similarity=0.200 Sum_probs=192.6
Q ss_pred ccCceeeeeeecCCceEEEEEEEC---CCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..+|.+.+.||+|+||.||+|.+. ..+..||+|.+.... ..+.+|+.+++.++||||+++++++ ...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TRG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ecC
Confidence 346999999999999999999865 356789999886442 2345789999999999999999988 344
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
...++||||++++.+..+.. .....+++..++.++.||+.||+|||+ +|++||||||+||+++ .++.++++|||.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~--~~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~-~~~~~~l~dfg~~ 154 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLR--KHEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVN-SDLVCKISGFRRL 154 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEc-CCCcEEECCCccc
Confidence 55899999999764443332 113578999999999999999999999 6999999999999999 6889999999987
Q ss_pred cccccCCcce--eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 228 KVLVKGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 228 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
.......... ...++..|+|||.+.+. .++.++|||||||++|++++ |..||...+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------ 227 (266)
T cd05064 155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------ 227 (266)
T ss_pred ccccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------
Confidence 6543222111 12345689999998654 58999999999999999875 99999887766554444321000
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+..++..+.+++.+||+.+|.+||++.++++
T Consensus 228 ----------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 ----------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=310.47 Aligned_cols=253 Identities=28% Similarity=0.466 Sum_probs=200.7
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcC---CCceeeeceeeeecCCCCcee
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 149 (395)
.|.+.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+.+++.++ |+|++++++.+ .+...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence 477888999999999999999999999999988543 123456888898886 99999999988 44456
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.++||||+.|+.+..+.. ...+++..++.++.|++.||.|||+ .||+|+||+|+||+++ .++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~ 150 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVT-NTGNVKLCDFGVAAL 150 (277)
T ss_pred EEEEEecCCCCcHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEc-CCCCEEEccCCceee
Confidence 899999998753333322 2378899999999999999999999 6999999999999999 688999999999877
Q ss_pred cccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 230 LVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 230 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
...... .....|+..|+|||.+.+...++.++|+||||+++|+|++|..||...........+...
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------- 217 (277)
T cd06917 151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------- 217 (277)
T ss_pred cCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-------------
Confidence 644332 233468889999999876556789999999999999999999999876543222111000
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
..+.+ ....++.++.+++.+||+.||++||++.+++.|+||++...
T Consensus 218 ------~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 218 ------KPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred ------CCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 00000 01136789999999999999999999999999999987654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=302.23 Aligned_cols=270 Identities=24% Similarity=0.337 Sum_probs=213.8
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHH-HHHHcCCCceeeeceeeeecCCCCc
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQ-LMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
...++.+-...||.|+||+|++-.++.+|+..|||.+... ......|.+ +++.-+.||||+++|+.+...+
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--- 137 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--- 137 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc---
Confidence 3344555567899999999999999999999999998633 223334555 4566689999999999965444
Q ss_pred eeEEEEEecccchHHHHHHh-hcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
.+|.||+|+-++..+.+. +...+..++|..+-.|....+.||.||...-.|+|||+||+|||++ ..|.+||||||+
T Consensus 138 --cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld-r~G~vKLCDFGI 214 (361)
T KOG1006|consen 138 --CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD-RHGDVKLCDFGI 214 (361)
T ss_pred --eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe-cCCCEeeecccc
Confidence 899999999876555442 3445678999999999999999999999755899999999999999 789999999999
Q ss_pred ccccccCCcceeeeecccccCchhhcCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCChhhh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL-GTPTREEI 304 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 304 (395)
+..+.++-..+...|...|||||.+..... |+.+||+||||++|||+.||..||...+. .+.++..+. |.++.- .
T Consensus 215 cGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l-~ 291 (361)
T KOG1006|consen 215 CGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPIL-L 291 (361)
T ss_pred hHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCee-c
Confidence 998888777778889999999999966544 89999999999999999999999987654 444444332 222211 0
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
.. .. --.++..+..+|..||.+|-.+||...+++.+||++........
T Consensus 292 ~~--------------~~------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 292 FD--------------KE------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD 339 (361)
T ss_pred Cc--------------cc------ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence 00 00 01368899999999999999999999999999999877665444
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=303.16 Aligned_cols=250 Identities=30% Similarity=0.473 Sum_probs=205.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|.+.+.||+|+||.||++.+..++..||+|.+.... ....+|+++++.++|+|++++.+.+. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 4889999999999999999999899999999986432 23457899999999999999999883 345689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+|+||+++ ++.+.+.........+++..+..++.+++.||.|||+ .|++|+||+|+||+++ .++.++|+|||++...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLT-SNGLVKLGDFGISKVL 153 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEc-CCCcEEECCccceeec
Confidence 99999986 6666666544445789999999999999999999999 6999999999999999 6889999999999766
Q ss_pred ccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... ......|++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+.........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 219 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ------------- 219 (258)
T ss_pred ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence 4443 22335678899999998654 48899999999999999999999998776544444332210
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
. ..++..++..+.++|.+||..||++|||+.++|+||||
T Consensus 220 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 ------Y---------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ------C---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0 01223568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=310.46 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=202.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.|...+.||.|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++ .+....++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEEE
Confidence 4788899999999999999999999999999886432 2345688999999999999999998 45556999
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
||||++| ++.+.+. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++ .++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 80 IMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEc-CCCCEEEcccccceecc
Confidence 9999987 4444443 2468889999999999999999999 6999999999999999 78899999999997664
Q ss_pred cCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.... .....++..|+|||++.+. .++.++|+||||+++|+|+||..||...+.......+... .
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~------------ 217 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--N------------ 217 (277)
T ss_pred CCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--C------------
Confidence 4332 2234578889999998654 4899999999999999999999999876554333221110 0
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
...+...++..+.+||.+||+.||.+||++.+++.|+||......
T Consensus 218 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 218 --------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred --------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 011223467889999999999999999999999999999775543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=304.45 Aligned_cols=249 Identities=28% Similarity=0.436 Sum_probs=200.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|.+.+.||+|+||.||++.+..+|..+|+|.+... .....+|+.+++.++|+||+++++.+ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 488899999999999999999999999999998542 23445799999999999999999988 4555699
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+|+||+.+ ++.+.+... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++..+||+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999986 555544431 22457899999999999999999999 699999999999999954456899999998766
Q ss_pred ccCCcc-eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
...... ....|+..|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+....
T Consensus 153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 218 (257)
T cd08225 153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------- 218 (257)
T ss_pred cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence 443322 234578899999998654 48899999999999999999999998766554443322210
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
. ......++.++.++|.+||..+|++|||+.+++.||||
T Consensus 219 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ------F---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------C---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 00123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=307.38 Aligned_cols=247 Identities=27% Similarity=0.385 Sum_probs=190.1
Q ss_pred Cceeeeee--ecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEEEE
Q 016115 78 SYMAERVV--GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 78 ~y~~~~~l--g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
.|.+.+.+ |+|+||.||++.+..++..+|+|.+...... ..|..+...+ +|+||+++++.+ .....+++||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 88 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSV-----TTLKGHVLIM 88 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEE-----ecCCeeEEEE
Confidence 45565555 9999999999999999999999998654221 2234333333 699999999998 4444699999
Q ss_pred ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||++| +|.+.+.. ...+++..++.++.||+.||.|||+ .|++||||||+||+++..++.++|+|||++......
T Consensus 89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 99985 55555543 3488999999999999999999999 699999999999999943338999999998765332
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhhhhhcCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
....++..|+|||++.+. .++.++||||||+++|+|++|..||........ ...+......
T Consensus 164 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 225 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-------------- 225 (267)
T ss_pred ---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--------------
Confidence 234578899999999654 489999999999999999999999985543321 1111111000
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-HHHHhcCCCCcC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDE 365 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~ell~hp~~~~ 365 (395)
.......+++.+.+||.+||+.||.+|++ ++++|+||||+.
T Consensus 226 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 ------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 00122357899999999999999999996 599999999973
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=311.58 Aligned_cols=260 Identities=28% Similarity=0.423 Sum_probs=199.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.+|++.+.||+|+||+||++.+..+|..||+|++.... ....+|+++++.++|+||+++++.+ .....++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEEE
Confidence 46899999999999999999999999999999875432 2345789999999999999999998 4445689
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||++++.+..+.. ..+.+++..++.++.+++.||.|||+..|++|+||||+||+++ +++.++|+|||++....
T Consensus 80 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 80 MCMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN-SRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEEecCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC-CCCcEEEccCCcccchh
Confidence 9999999754433322 2356899999999999999999999624899999999999999 78899999999986543
Q ss_pred cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCChhhhhhc
Q 016115 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ----LVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 307 (395)
... .....|+..|+|||++.+. .++.++|||||||++|+|+||..||........ ...+..... ..+..
T Consensus 156 ~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~- 228 (284)
T cd06620 156 NSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ----QIVQE- 228 (284)
T ss_pred hhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH----HHhhc-
Confidence 222 2245688999999998654 589999999999999999999999986544211 000000000 00000
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
. .+ ......++.++.+||.+||+.||.+|||+.|+++|+||.+..
T Consensus 229 --~-----~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 229 --P-----PP--------RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred --c-----CC--------CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 00 000112578899999999999999999999999999996643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=322.36 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=192.9
Q ss_pred cccCceeeeeeecCCceEEEEEEE-----CCCCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (395)
...+|++.+.||+|+||.||+|.+ ..++..||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~---- 108 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC---- 108 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee----
Confidence 344799999999999999999974 3456789999886432 2345799999999 899999999988
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhcc----------------------------------------------------
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS---------------------------------------------------- 170 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------------------------------------------- 170 (395)
.+....++||||++| +|.+.+.....
T Consensus 109 -~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 109 -TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred -ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 444558999999995 55555543110
Q ss_pred -------------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 171 -------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 171 -------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLT-HGRITKICDFGLARDIR 265 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEE-CCCcEEEecCccceecc
Confidence 11357888999999999999999999 6999999999999999 68889999999997654
Q ss_pred cCCcce---eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 232 KGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 232 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
...... ...++..|+|||++.+. .++.++|||||||++|+|++ |..||..........+.......
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------- 335 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR--------- 335 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc---------
Confidence 332211 12235679999999664 58999999999999999998 89999876554444433321000
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+...+.++.+||.+||+.||++|||+.++++.
T Consensus 336 ------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 336 ------------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00122357899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=321.90 Aligned_cols=265 Identities=26% Similarity=0.347 Sum_probs=196.1
Q ss_pred CCCccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 71 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
+...++++|...+.||+|+||.||+|.. .+|..||||++.... +.+..|+.++.+++|||+|+++|+|.....
T Consensus 69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-- 145 (361)
T KOG1187|consen 69 ELRKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE-- 145 (361)
T ss_pred HHHHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc--
Confidence 3445677899889999999999999995 456899999886432 457889999999999999999999943321
Q ss_pred ceeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC--CceeccCCCCceeecCCCCcEEEee
Q 016115 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP--GVCHRDVKPQNLLVDPLTHQVKLCD 223 (395)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~ivH~Dlkp~Nill~~~~~~~kl~D 223 (395)
..+||+||++ |+|.+.|...... .++|..+.+|+.+++.||+|||... .|+|||||++|||+| +++..||+|
T Consensus 146 --~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsD 220 (361)
T KOG1187|consen 146 --HRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSD 220 (361)
T ss_pred --eEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccC
Confidence 4889999999 5665555542221 8899999999999999999999843 399999999999999 899999999
Q ss_pred ccccccccc-CCcceee-eecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC--hHHHHHHHH-HHhCC
Q 016115 224 FGSAKVLVK-GEANISY-ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEII-KVLGT 298 (395)
Q Consensus 224 fg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~~~-~~~~~ 298 (395)
||+|+.... ....... .||.+|+|||.+.. ...+.++|||||||+|+||+||+.+..... ....+..+. .....
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999976654 3333333 79999999999865 458999999999999999999998887542 111122222 11111
Q ss_pred CChhhhhhcCCCCCCCCCCCccCCCccccccc-cCChhHHHHHHHhhccCCCCCCCHHHHh
Q 016115 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEAC 358 (395)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dp~~Rpt~~ell 358 (395)
. ...+.+++.+.. . .+.. ..-..+..+..+|++.+|.+||++.|++
T Consensus 300 ~--~~~eiiD~~l~~--------~----~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 300 G--KLREIVDPRLKE--------G----EYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred c--chhheeCCCccC--------C----CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 1 111111111110 0 0000 1123477788999999999999999974
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=312.11 Aligned_cols=260 Identities=28% Similarity=0.412 Sum_probs=205.6
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
|.....||+|+||.||++.+..+|+.||||.+... .....+|+.+++.++|+||+++++.+ ......++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEE
Confidence 33346799999999999999999999999987532 22345688999999999999999988 4455689999
Q ss_pred ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC
Q 016115 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (395)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (395)
||++++.+..+.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++ .++.++|+|||++.......
T Consensus 97 e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 97 EFLEGGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred ecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCCEEEcccccceeccccc
Confidence 9999754443332 2468899999999999999999999 6999999999999999 68889999999987554322
Q ss_pred -cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 235 -ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 235 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||......+....+.......
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------- 235 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-------------- 235 (292)
T ss_pred ccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc--------------
Confidence 2233567889999998854 447899999999999999999999998776655444332211000
Q ss_pred CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCC
Q 016115 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 376 (395)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~ 376 (395)
+ .....++..+.++|.+||..||.+||++.+++.||||.+...+.+.+++.
T Consensus 236 --~----------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~~~~~~ 286 (292)
T cd06657 236 --L----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPLM 286 (292)
T ss_pred --c----------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCcccccHH
Confidence 0 01134688999999999999999999999999999999988766655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=308.28 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=201.1
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
-|.+.+.||+|+||.||+|.+..++..||||.+.... ....+|+.+++.++|+||+++++++ .+....++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEE
Confidence 3778899999999999999998899999999875322 2345788999999999999999988 45556899
Q ss_pred EEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
||||++++ +.+.+. ...+++..+..++.|++.|+.+||+ +|++|+||+|+||+++ .++.++|+|||++....
T Consensus 80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLT 152 (277)
T ss_pred EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEEC-CCCCEEEeecccceecc
Confidence 99999975 433332 2468899999999999999999999 7999999999999999 68899999999987654
Q ss_pred cCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.... .....++..|+|||.+.+. ..+.++|+|||||++|+|++|..||...........+... ..
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~------------ 218 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP------------ 218 (277)
T ss_pred cchhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC------------
Confidence 3321 2234678889999998654 4789999999999999999999999876544333322110 00
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
..+...++.++.++|.+||+.||.+||++.++++||||+....
T Consensus 219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 219 ---------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred ---------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 0122346889999999999999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=307.57 Aligned_cols=254 Identities=29% Similarity=0.462 Sum_probs=202.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.|...+.||+|++|.||++.+..+++.+++|.+.... ....+|+.+++.++|+||+++++.+ ......+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEEE
Confidence 3555578999999999999999999999999875322 2345688999999999999999988 344558999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
+||+.| ++.+.+.. ..+++..++.++.|++.||.|||+ .||+||||+|+||+++ .++.++|+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEc-CCCcEEEcccccchhhcc
Confidence 999986 44444332 568899999999999999999999 6999999999999999 788999999998875543
Q ss_pred CCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 233 GEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 233 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
... .....|+..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+... .+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--~~~----------- 233 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--LPP----------- 233 (285)
T ss_pred CCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc--CCC-----------
Confidence 322 2234678999999998654 4899999999999999999999999876655544433321 000
Q ss_pred CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
.. .....++..+.+||.+||..||++|||+.++++||||++.+++.
T Consensus 234 ------~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 279 (285)
T cd06648 234 ------KL-------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279 (285)
T ss_pred ------CC-------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence 00 01123678999999999999999999999999999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=318.23 Aligned_cols=280 Identities=32% Similarity=0.544 Sum_probs=228.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcC------CCceeeeceeeeecCCCCc
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD------HPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~~~~ 147 (395)
.+|.+....|+|-|++|.+|.+...|..||||+|..+. +.-.+|+++|++|+ --|+++++..| ...
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hk 506 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHK 506 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhc
Confidence 46888889999999999999999999999999997664 33457999999996 34789999988 566
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
+++|||+|-+.-+|-++|+.|.. +..+....++.++.|++.||..|.. .||+|.||||+||||+.....+||||||.|
T Consensus 507 nHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 507 NHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred ceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCccc
Confidence 67999999999999999998755 6778999999999999999999999 699999999999999987889999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.....+. .+.++.+..|.|||++.|-. |+...|+||.||+||||+||+..|++.++-+++...+.+-|+.+...++..
T Consensus 585 ~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 585 SFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred ccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 8765443 34667788999999998865 999999999999999999999999999999999999999999888877642
Q ss_pred C-------CC--CCCCCCCCccC----------CC---cccccc--ccC-------ChhHHHHHHHhhccCCCCCCCHHH
Q 016115 308 N-------PN--YTDFRFPQIKA----------HP---WHKVFH--KRM-------PPEAIDLASRLLQYSPSLRCTALE 356 (395)
Q Consensus 308 ~-------~~--~~~~~~~~~~~----------~~---~~~~~~--~~~-------s~~~~~li~~~L~~dp~~Rpt~~e 356 (395)
. .+ +.......... .| +...+- ..+ -.++.+|+.+||..||++|.|+.+
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 1 11 00000000000 00 000000 012 236889999999999999999999
Q ss_pred HhcCCCCcC
Q 016115 357 ACAHPFFDE 365 (395)
Q Consensus 357 ll~hp~~~~ 365 (395)
+|.||||+.
T Consensus 743 AL~HpFi~~ 751 (752)
T KOG0670|consen 743 ALKHPFITE 751 (752)
T ss_pred HhcCCcccC
Confidence 999999974
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=310.96 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=203.1
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.++|.+.+.||+|+||.||++.+..++..||+|.+.... ....+|+.+++.++||||+++++.+. .....+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEE
Confidence 357999999999999999999998899999999885332 23356888999999999999999883 444589
Q ss_pred EEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+|+||+.++ +.+.+.. ..+++..+..++.|++.||.|||+ +|++|+||||+||+++ .++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~-~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEc-CCCCEEEccCcceecc
Confidence 999999864 4443332 457888999999999999999999 6999999999999999 6889999999988655
Q ss_pred ccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+.. .+.+
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~---------- 233 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP---------- 233 (293)
T ss_pred cccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC----------
Confidence 43322 2234678889999998654 488999999999999999999999987654433222111 0000
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
.......++..+.++|++||..||++||++.+++.|+||+..+.-..
T Consensus 234 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~ 280 (293)
T cd06647 234 ---------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS 280 (293)
T ss_pred ---------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccc
Confidence 00012346788999999999999999999999999999988775433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=303.10 Aligned_cols=245 Identities=28% Similarity=0.459 Sum_probs=198.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+|.+.+.||+|+||.||++.+..++..||+|.+.... ....+|+.+++.++|+||+++++.+ .+...+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 4889999999999999999999999999999875321 2344688899999999999999988 55566999
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|||+++ ++.+.+.. .....+++..++.++.||+.||.|||+ +||+|+||||+||+++ +++.++|+|||++....
T Consensus 76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEC-CCCcEEEcccCcceeec
Confidence 9999986 55554443 123567899999999999999999999 6999999999999999 68899999999987654
Q ss_pred cCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.... .....|+..|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+... ..
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~----------- 217 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG--SY----------- 217 (255)
T ss_pred ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC--CC-----------
Confidence 3322 2345678899999998654 4899999999999999999999999877665544433321 00
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..++..+.+||.+||+.||.+|||+.++++-
T Consensus 218 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 ---------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00123467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=309.98 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=200.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHHc-CCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (395)
..++|.+.+.||+|+||.||+|.+..+++.||||.+..... ...+|+.++... .|+||+++++.+ .+..
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~ 87 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITDS 87 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecCC
Confidence 44579999999999999999999998899999999864321 123455555555 599999999988 4455
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
..+++|||+++.+...+... ...+++..+..++.||+.||.|||+..||+||||+|+||+++ +++.+||+|||++.
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~-~~~~~kL~dfg~~~ 163 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISG 163 (296)
T ss_pred eEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc-CCCCEEECccccch
Confidence 69999999988766655442 347899999999999999999999724999999999999999 78899999999997
Q ss_pred ccccCCcceeeeecccccCchhhcCC---CCCCcccchHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhh
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 304 (395)
............++..|+|||.+.+. ..++.++||||||+++|+|++|+.||..... .+.+..+... ..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~---- 236 (296)
T cd06618 164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EP---- 236 (296)
T ss_pred hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CC----
Confidence 76544444444578889999998643 2378899999999999999999999975432 2222222211 00
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
. .++ ....++.++.+||.+||..||.+||++.+++.||||+....
T Consensus 237 -------~--~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 237 -------P--SLP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred -------C--CCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 0 000 01136789999999999999999999999999999986544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.09 Aligned_cols=250 Identities=31% Similarity=0.530 Sum_probs=197.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|.+.+.||+|+||.||+|.+..++..||+|.+..... ...+|+.+++.++|+||+++++.+ .+...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 48899999999999999999988999999999864432 345789999999999999999987 4455689
Q ss_pred EEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+|+||+.++ +.+.+.. ...+++..++.++.+++.||.|||+ .||+|+||+|+||+++ +++.+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEccccccccc
Confidence 999999964 4443332 3457889999999999999999999 6999999999999999 6889999999998776
Q ss_pred ccCCcce-----eeeecccccCchhhcCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 231 VKGEANI-----SYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 231 ~~~~~~~-----~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
....... ...++..|+|||++.+.. .++.++||||||+++|+|++|..||...+........... +...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--- 225 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP--- 225 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence 4433221 235678899999986532 2788999999999999999999999765432222221111 1000
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
.++ ....++..+.+||.+||+.||.+|||+.+++.|||+
T Consensus 226 -----------~~~----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 -----------PIP----------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----------CCC----------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 012358899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=318.24 Aligned_cols=278 Identities=21% Similarity=0.318 Sum_probs=197.3
Q ss_pred eeeecC--CceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
..||+| +||+||++++..+|+.||+|++.... ....+|+.+++.++|+||+++++++ ......++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 346666 99999999999999999999986432 2345688888899999999999998 4455689999
Q ss_pred ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||+.+ ++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.++++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEe-CCCcEEEechHHHhhhhcc
Confidence 99996 5555555432 2458999999999999999999999 7999999999999999 6889999999865433221
Q ss_pred Ccce--------eeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh--
Q 016115 234 EANI--------SYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE-- 302 (395)
Q Consensus 234 ~~~~--------~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 302 (395)
.... ...++..|+|||++.+. ..++.++|||||||++|+|++|..||...................+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 1110 11235569999998653 347899999999999999999999998876555444333211100000
Q ss_pred -------hhhhcCCCCC----CCCC-----CCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 303 -------EIRCMNPNYT----DFRF-----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 303 -------~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.+........ +... .......+.......+++.+.+||++||+.||.+|||++++|+||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000000000 0000 00000111111223467889999999999999999999999999999887
Q ss_pred CCC
Q 016115 367 REP 369 (395)
Q Consensus 367 ~~~ 369 (395)
...
T Consensus 315 ~~~ 317 (328)
T cd08226 315 KEQ 317 (328)
T ss_pred HHh
Confidence 663
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=303.01 Aligned_cols=248 Identities=28% Similarity=0.482 Sum_probs=198.4
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc---------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
+|++.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+++++.++|+||+++++++.. ....
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEEK 79 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCCC
Confidence 699999999999999999999999999999987422 1234568999999999999999998743 2234
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++++||++| ++.+.+.. ...+++..++.++.||+.||.|||+ +|++|+||||+||+++ .++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~ 153 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEc-CCCCEEECccccc
Confidence 57899999986 44444432 3558899999999999999999999 6999999999999999 6888999999999
Q ss_pred cccccC----CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 228 KVLVKG----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 228 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
+..... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..........++.. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~--- 226 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT--- 226 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC---
Confidence 765321 112234678899999998664 488999999999999999999999987655544443321 110
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
...++..+++.+.++|.+||. ++..||++.+++.|||.
T Consensus 227 ---------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 ---------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 112345678999999999999 57999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=309.42 Aligned_cols=249 Identities=30% Similarity=0.455 Sum_probs=201.8
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
|...+.||+|+||+||+|++..+|..|++|.+.... ....+|+++++.++|+|++++++++ .+....+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY-----LKEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCEEE
Confidence 666788999999999999999999999999885321 2234688999999999999999998 4445589
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||+.|++.+.+... ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++ .++.+||+|||++....
T Consensus 98 lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~-~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 98 LVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLT-EPGQVKLADFGSASKSS 172 (313)
T ss_pred EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEEC-CCCCEEEeecCCCcccC
Confidence 99999999877766532 3568899999999999999999999 6999999999999999 68889999999986432
Q ss_pred cCCcceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 232 KGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
. .....|+..|+|||++.. ...++.++||||||+++|+|++|..||...+.......+... ..
T Consensus 173 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~---------- 237 (313)
T cd06633 173 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS---------- 237 (313)
T ss_pred C---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CC----------
Confidence 2 234567889999999842 345788999999999999999999999887665555443321 00
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
+. .....++..+.+||.+||+.+|.+||++.+++.||||+..+
T Consensus 238 -------~~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 238 -------PT--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred -------CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 00 01123577899999999999999999999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=304.05 Aligned_cols=249 Identities=28% Similarity=0.432 Sum_probs=196.2
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.+|.+.+.||+|+||.||+|++..+++.||||.+.... ....+|+++++.++||||+++++.+. +...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 36999999999999999999999999999999774321 23456999999999999999999884 3445
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.++++||+++ ++.+.+.........+++..+..++.||+.||.|||+ +|++|+||||+||+++ .++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~-~~~~~~l~d~g~~~ 154 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFIT-ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEc-CCCCEEECccccce
Confidence 8899999996 5555555444445668999999999999999999999 6999999999999999 68889999999987
Q ss_pred ccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhhhh
Q 016115 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 229 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 306 (395)
....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... ..+.......+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 227 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------ 227 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence 6543322 1234578889999998654 4889999999999999999999999754321 12222221111000
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.....++..+.++|.+||+.||++||++.++++
T Consensus 228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 012345788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=305.38 Aligned_cols=244 Identities=34% Similarity=0.567 Sum_probs=197.4
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecc
Q 016115 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 85 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
||.|+||.||++++..+|+.+++|.+.... ....+|+++++.++|+||+++++.+ ......|+++||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 689999999999999899999999886432 2345688899999999999999887 5556689999999
Q ss_pred cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC--
Q 016115 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-- 234 (395)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-- 234 (395)
.| ++.+.+.. ...+++..+..++.||+.||.|||+ .|++|+||+|+||+++ .++.++|+|||++.......
T Consensus 76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEc-CCCCEEEEecccchhcccCccc
Confidence 86 55555543 2478999999999999999999999 6999999999999999 68899999999987653331
Q ss_pred -------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 235 -------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 235 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
......++..|+|||.+.+.. ++.++||||||+++|+|++|..||......+....+... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~--------- 217 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--K--------- 217 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C---------
Confidence 122345688899999986654 889999999999999999999999887766555443320 0
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH---HHHhcCCCCcCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFFDELR 367 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~---~ell~hp~~~~~~ 367 (395)
..++. ...++..+.+||.+||+.+|.+|||+ .++++||||++++
T Consensus 218 ------~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 218 ------IEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred ------cCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 00000 01248899999999999999999999 9999999999765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=307.96 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=196.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCC-----cEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+.... ....+|+.+++.++|+||+++++++ .+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence 36889999999999999999976555 679999886432 2345789999999999999999988 44
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~ 213 (395)
....+++|||+++ ++.+.+..... ....+++..++.++.||+.||.|||+ +|++|+||||+||+++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG 158 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence 4558899999985 56555544211 11568889999999999999999999 6999999999999999
Q ss_pred CCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHH
Q 016115 214 PLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 289 (395)
Q Consensus 214 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 289 (395)
+++.++|+|||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+..
T Consensus 159 -~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 159 -EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred -CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 688999999999876533221 1233457889999998654 48999999999999999998 99999887766554
Q ss_pred HHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+..... ...+..++.++.+|+++||+.||.+||++.+++++
T Consensus 237 ~~i~~~~~----------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 237 EMIRSRQL----------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCc----------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 44332100 01234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=305.70 Aligned_cols=257 Identities=25% Similarity=0.324 Sum_probs=198.3
Q ss_pred cccCceeeeeeecCCceEEEEEEECC-----CCcEEEEEEeccccc-----chHHHHHHHHHcCCCceeeeceeeeecCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (395)
..++|.+.+.||+|+||.||+|.+.. .+..||+|.+..... ...+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 44679999999999999999997642 345899998754321 234688899999999999999987
Q ss_pred CCceeEEEEEecccc-hHHHHHHhhccc------CCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC
Q 016115 145 KDELFLNLVMEYVPE-TMYRVLKHYSSM------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~ 217 (395)
.+....++||||+.+ +|.+.+...... ....+...++.++.||+.||.|||+ +||+||||||+||+++ .++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~-~~~ 156 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVA-HDF 156 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEc-CCC
Confidence 344458999999984 666666543211 2345677888999999999999999 6999999999999999 788
Q ss_pred cEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 016115 218 QVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 293 (395)
Q Consensus 218 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~ 293 (395)
.++|+|||+++........ ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999998755332211 122346679999998654 48999999999999999999 789998776655444332
Q ss_pred HHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc------CCCCcCCC
Q 016115 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDELR 367 (395)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~------hp~~~~~~ 367 (395)
.. +. ......++..+.+++.+||+.||++|||+.++++ ||||+.+.
T Consensus 236 ~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 236 DG-GY---------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred cC-CC---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 21 00 0012345789999999999999999999999987 99998865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.88 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=196.0
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.+|.+.+.||+|+||.||+|.+..++..||+|.+..+.. ...+|+++++.++|+||+++++++ .....++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEEE
Confidence 358899999999999999999999999999999865432 345799999999999999999988 444558999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||+++ ++.+.+... ....+++..++.++.|++.||.|||+ +|++||||||+||+++ +++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEc-CCCcEEeCCCcccccccc
Confidence 999985 555544331 23468899999999999999999999 6999999999999999 788999999999976644
Q ss_pred CCcce--eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 233 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 233 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------------- 222 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY------------- 222 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence 32211 12235679999998654 48999999999999999998 999998876655444332210
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....+..++.++.++|.+||+.||++|||+.++++
T Consensus 223 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 ---------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=338.99 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=192.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
++|++.+.||+|+||.||+|.+..+|+.||||++..+. ....+|+++++.++||||+++++++ .+...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 47999999999999999999999999999999986431 2345789999999999999999988 44556
Q ss_pred EEEEEecccc-hHHHHHHhhcc-------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEE
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSS-------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl 221 (395)
.++||||++| +|.+.+..... ....++...+..++.||+.||.|||+ +||+||||||+|||++ .++.+||
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd-~dg~vKL 154 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLG-LFGEVVI 154 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEc-CCCCEEE
Confidence 8999999986 45555543211 12345667788999999999999999 6999999999999999 6889999
Q ss_pred eecccccccccCC-------------------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 016115 222 CDFGSAKVLVKGE-------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (395)
Q Consensus 222 ~Dfg~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 282 (395)
+|||+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|+||..||..
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999997652110 01124689999999998765 489999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.+....... .....+. .......+++.+.+++.+||..||++|++..+.+.
T Consensus 234 ~~~~ki~~~--~~i~~P~------------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 234 KKGRKISYR--DVILSPI------------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred cchhhhhhh--hhccChh------------------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 544322211 0000000 00011356889999999999999999988766554
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=297.04 Aligned_cols=248 Identities=30% Similarity=0.497 Sum_probs=201.1
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.|.+.+.||+|++|.||++.+..+++.+++|++.... ....+|+++++.++|+|++++++++ ......+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEE
Confidence 3788899999999999999998899999999986544 3456799999999999999999988 444558999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
+||++| ++.+.+... ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++ .++.++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 76 MEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEc-cCCeEEEeeccccccccc
Confidence 999995 444443331 2578999999999999999999999 6999999999999999 688999999999987655
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
........++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+........... ..+.
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~------------ 216 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG------------ 216 (253)
T ss_pred cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCC------------
Confidence 44334566788999999986544 889999999999999999999999876544443332220 0000
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 362 (395)
. .....++..+.++|.+||+.||++|||+.+++.|||
T Consensus 217 ------~-------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 ------L-------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------c-------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0 001124788999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=319.82 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=222.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.+..++..||-|+||.|=++........+|+|++++.. +....|.++|...+.+.||+++..| .+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence 35677788999999999999876666668999886432 2233588999999999999999999 88889
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+|++||-|-| .++..+.. .+.+....++.++..+++|++|||+ +|||.|||||+|.+++ .+|-+||.|||+|+
T Consensus 495 vYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd-~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLD-NRGYLKLVDFGFAK 568 (732)
T ss_pred hhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeec-cCCceEEeehhhHH
Confidence 9999999875 55555554 5788999999999999999999999 6999999999999999 78899999999999
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.+..+....+++||+.|.|||++.+.+ .+.++|.||||+++||||+|.+||.+.+....+..|++.+..
T Consensus 569 ki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~---------- 637 (732)
T KOG0614|consen 569 KIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK---------- 637 (732)
T ss_pred HhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------
Confidence 999999999999999999999998765 899999999999999999999999999999999999885321
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 370 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~~~ 370 (395)
-.++..++..+.+||+++...+|.+|.. +.++-.|-||..+++.-
T Consensus 638 -----------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg 687 (732)
T KOG0614|consen 638 -----------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG 687 (732)
T ss_pred -----------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence 1145678999999999999999999996 78999999999998854
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=349.78 Aligned_cols=256 Identities=27% Similarity=0.471 Sum_probs=206.3
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.+|.-...||.|.||.||-|.+..+|+..|+|.++-. .....+|..++..++|||+|+.+|+-.... .+
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----kv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----KV 1309 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----HH
Confidence 3577778899999999999999999999999987522 234468999999999999999999874433 27
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+|.||||.|+.+..+..+ ....++...+.+..|++.|+.|||++ |||||||||+||+++ .+|.+|++|||.|..+
T Consensus 1310 ~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLD-FNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeee-cCCcEEeecccceeEe
Confidence 899999997655444432 45567778888999999999999995 999999999999999 7889999999999877
Q ss_pred ccCCc-----ceeeeecccccCchhhcCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChh
Q 016115 231 VKGEA-----NISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 231 ~~~~~-----~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~ 302 (395)
..... .....||+.|||||++.+.. ....++|||||||++.||+||+.||...+. ...+..+.- |.
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~--gh---- 1458 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA--GH---- 1458 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc--cC----
Confidence 55531 23468999999999996643 356789999999999999999999986543 333333322 11
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
...++.++|.+..|||..||..||+.|.++.|+++|-|-+...+.+
T Consensus 1459 ----------------------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1459 ----------------------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred ----------------------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence 1224566899999999999999999999999999999987766544
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=315.40 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=191.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECC-----CCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 144 (395)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+|+.+++.+ +|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~--- 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK--- 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec---
Confidence 4579999999999999999997533 45789999886432 2234688999999 79999999997743
Q ss_pred CCceeEEEEEecccc-hHHHHHHhhcc-----------------------------------------------------
Q 016115 145 KDELFLNLVMEYVPE-TMYRVLKHYSS----------------------------------------------------- 170 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 170 (395)
....++++|||+++ ++.+.+.....
T Consensus 83 -~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 -PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred -CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 23358899999996 44444432111
Q ss_pred ----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcc---eeeeecc
Q 016115 171 ----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSR 243 (395)
Q Consensus 171 ----~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~ 243 (395)
....+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.++|+|||++......... ....++.
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 02368899999999999999999999 6999999999999999 6889999999999875433221 1233467
Q ss_pred cccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCC
Q 016115 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH 322 (395)
Q Consensus 244 ~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (395)
.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...... +..
T Consensus 240 ~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~----------------------- 294 (337)
T cd05054 240 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE-GTR----------------------- 294 (337)
T ss_pred cccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc-cCC-----------------------
Confidence 79999998765 48999999999999999998 99999875443333332221 000
Q ss_pred CccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 323 PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 323 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+...++++.+++.+||+.+|++||++.++++|
T Consensus 295 ---~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 295 ---MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00123457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=304.15 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=193.2
Q ss_pred cccCceeeeeeecCCceEEEEEEECC-----CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (395)
...+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 44579999999999999999998642 45679999885432 2234688999999999999999988
Q ss_pred CCceeEEEEEecccc-hHHHHHHhhccc------CCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC
Q 016115 145 KDELFLNLVMEYVPE-TMYRVLKHYSSM------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~ 217 (395)
......++||||+++ +|.+.+...... ...+++..+..++.|++.||.|||+ +|++|+||||+||+++ +++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~-~~~ 156 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVA-EDF 156 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEc-CCC
Confidence 455568999999986 555554432111 2345778889999999999999999 6999999999999999 788
Q ss_pred cEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 016115 218 QVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 293 (395)
Q Consensus 218 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~ 293 (395)
.++|+|||+++........ ....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+.
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998755332221 112346779999998654 48999999999999999999 789998776655444333
Q ss_pred HHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.. +. ...+..++..+.++|.+||+.||++|||+.|++++
T Consensus 236 ~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EG-GL---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC-Cc---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 21 00 00123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=311.26 Aligned_cols=280 Identities=21% Similarity=0.283 Sum_probs=194.9
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 80 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.+.+.+|.| |.||.+++..+|+.||||++.... ....+|+++++.++|+||+++++++ .+....+++
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~ 77 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVV 77 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEE
Confidence 334444444 555666666699999999986431 2345799999999999999999988 444558999
Q ss_pred Eecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||++++ +.+.+... ....+++..++.++.|++.||.|||+ .||+||||||+||+++ .++.+||+|||.+.....
T Consensus 78 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~ 153 (314)
T cd08216 78 SPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLS-GDGKVVLSGLRYSVSMIK 153 (314)
T ss_pred EeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEe-cCCceEEecCccceeecc
Confidence 9999964 44444432 23468899999999999999999999 6999999999999999 788999999998865432
Q ss_pred CCc--------ceeeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh-
Q 016115 233 GEA--------NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE- 302 (395)
Q Consensus 233 ~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 302 (395)
... .....++..|+|||++.+. ..++.++|||||||++|+|++|..||......................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence 211 1223457789999998653 347899999999999999999999998765544333222211000000
Q ss_pred -hhhhcCCCCCC----CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 303 -EIRCMNPNYTD----FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 303 -~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
........... ...+. ............++.++.+||.+||+.||++|||+.++|+||||+.+++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~ 306 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPN-NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNT 306 (314)
T ss_pred CchhhhcCCcCcccccccccc-hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccch
Confidence 00000000000 00000 0011111223345678999999999999999999999999999998875443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=298.50 Aligned_cols=249 Identities=29% Similarity=0.443 Sum_probs=203.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|++.+.||+|+||.||++.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++++ .+....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence 4889999999999999999999999999999886432 2234688899999999999999988 4445689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||+++ ++.+.+.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++ .++.+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLV-ANDLVKIGDLGISKVL 153 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEe-cCCcEEEeeccchhhh
Confidence 99999976 5555555544445678999999999999999999999 6999999999999999 6888999999999876
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+... .
T Consensus 154 ~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~------------ 217 (256)
T cd08530 154 KKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--K------------ 217 (256)
T ss_pred ccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C------------
Confidence 554 33345678899999998654 4888999999999999999999999887765443333221 0
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
++ .....++.++.++|.+||..+|.+|||+.++++||++
T Consensus 218 -----~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 218 -----YP---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -----CC---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 00 0123468899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=306.65 Aligned_cols=257 Identities=27% Similarity=0.471 Sum_probs=200.4
Q ss_pred CceeeeeeecCCceEEEEEEEC---CCCcEEEEEEecccc--------cchHHHHHHHHHc-CCCceeeeceeeeecCCC
Q 016115 78 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (395)
+|++.+.||.|+||.||+|++. .+|..||+|.+.... ....+|+.+++.+ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4888999999999999999874 478999999886421 2345688999999 599999999888 5
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
....+++||||+++ ++.+.+.. ...+++..+..++.|++.||.|||+ .|++||||||+|||++ .++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~-~~~~~kl~df 149 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLD-SNGHVVLTDF 149 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEC-CCCCEEEeeC
Confidence 55668999999996 44444433 4568899999999999999999999 6999999999999999 6889999999
Q ss_pred ccccccccCCc--ceeeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 225 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
|++........ .....|+..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+.......
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence 99876543322 2235678899999998643 246789999999999999999999997543322222222211000
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 370 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~~ 370 (395)
...++..++..+.+|+++||..||.+|+ ++.+++.||||+..++..
T Consensus 228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 0002234688999999999999999997 899999999999987533
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=297.99 Aligned_cols=250 Identities=34% Similarity=0.532 Sum_probs=201.1
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|.+.+.||+|++|.||+|.+..++..|++|.+.... ....+|+.+++.++|+||+++++.+.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4788899999999999999999899999999886543 24457899999999999999999884321 25689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+++||+++ ++.+.+.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++ .++.++|+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVD-SDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEc-CCCCEEEcccccEEec
Confidence 99999965 54444443 2388999999999999999999999 6999999999999999 6889999999999877
Q ss_pred ccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 231 VKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 231 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
..... .....++..|+|||.+.+. ..+.++||||||+++|+|++|..||...... .........
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~---------- 218 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGS---------- 218 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhccc----------
Confidence 65543 3445678899999998654 4899999999999999999999999876521 111111100
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
......++..++..+.+||.+||..||.+||++.+++.||||
T Consensus 219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000111334568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=307.77 Aligned_cols=251 Identities=31% Similarity=0.444 Sum_probs=203.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.|...+.||+|+||.||++++..+|..||+|.+.... ....+|+++++.++|+|++++++++ .+....
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-----LREHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCCeE
Confidence 3888899999999999999999999999999886331 1234688999999999999999988 344458
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||+.|++.+.+... ...+++..+..++.||+.||.|||+ +||+||||+|+||+++ .++.++|+|||++...
T Consensus 101 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~-~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 101 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLT-EPGQVKLADFGSASIA 175 (317)
T ss_pred EEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEEC-CCCCEEEecCCCcccc
Confidence 899999999877665432 3568899999999999999999999 6999999999999999 6889999999998654
Q ss_pred ccCCcceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 231 VKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
... ....|+..|+|||.+.. ...++.++|||||||++|+|++|..||...+.......+.......
T Consensus 176 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 243 (317)
T cd06635 176 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------- 243 (317)
T ss_pred CCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------
Confidence 322 23467889999999742 3457899999999999999999999998776655555444321100
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
.....++..+.+||.+||+.+|.+||++.++++|+|+.....
T Consensus 244 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 244 ------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 011235788999999999999999999999999999965333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=309.08 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=191.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcE--EEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecCCCCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (395)
.+|.+.+.||+|+||.||+|.+..+|.. +|+|.+.... ....+|++++..+ +|+||+++++++ ....
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence 4689999999999999999998877764 5777665321 2344689999999 899999999988 4455
Q ss_pred eEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~ 215 (395)
.+++||||+++ ++.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++ .
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~-~ 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG-E 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEec-C
Confidence 68999999985 56555543221 12368899999999999999999999 6999999999999999 6
Q ss_pred CCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016115 216 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (395)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~ 294 (395)
++.+||+|||++.............++..|+|||++.+. .++.++|||||||++|+|+| |..||...+..+....+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 889999999998643221111122335679999998554 48999999999999999998 9999987766554433211
Q ss_pred HhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
. .. ...+..++.++.+||.+||+.||++||++.+++.+
T Consensus 239 ~------------------~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 G------------------YR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred C------------------Cc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00 00112357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=307.64 Aligned_cols=252 Identities=30% Similarity=0.453 Sum_probs=203.1
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.|...+.||+|+||.||+|++..+++.+|+|.+.... ....+|+++++.++|+|++++.+++. .....
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCee
Confidence 4888889999999999999999999999999885321 12346889999999999999999884 34458
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||+.|++.+.+... ...+++..++.++.|++.||.|||+ +|++||||||+||+++ .++.++|+|||++...
T Consensus 91 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 91 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM 165 (308)
T ss_pred EEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEEC-CCCcEEECCcccceee
Confidence 899999998876665432 3568899999999999999999999 6999999999999999 6889999999998765
Q ss_pred ccCCcceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 231 VKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
... ....++..|+|||.+.+ ...++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------- 231 (308)
T cd06634 166 APA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----------- 231 (308)
T ss_pred cCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-----------
Confidence 332 23467889999999852 23478899999999999999999999987665544443332100
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
+. .....++..+.+||++||..+|.+||++.+++.|||+.....+
T Consensus 232 --------~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 232 --------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred --------CC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 00 0113467889999999999999999999999999999875443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=303.72 Aligned_cols=245 Identities=33% Similarity=0.598 Sum_probs=201.6
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcC-CCceeeeceeeeecCCCCcee
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 149 (395)
+|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|..+++.++ |+||+++++++ .+...
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~ 76 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN 76 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence 689999999999999999999999999999988642 123456888999998 99999999988 45556
Q ss_pred EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.++||||+. +++.+.+.. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++ .++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~-~~~~~~l~df~~~~ 150 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLD-KDMHIKITDFGTAK 150 (280)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEEC-CCCCEEecCCcccc
Confidence 899999995 566555544 3479999999999999999999999 6999999999999999 68899999999987
Q ss_pred ccccCCc---------------------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH
Q 016115 229 VLVKGEA---------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287 (395)
Q Consensus 229 ~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 287 (395)
....... .....++..|+|||++.+. .++.++||||||++++++++|..||...+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 6543221 1234567889999998654 48899999999999999999999999877554
Q ss_pred HHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH----HHHhcCCCC
Q 016115 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFF 363 (395)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~hp~~ 363 (395)
.+..+... ...++..+++.+.+||.+||+.||.+||++ .++++||||
T Consensus 230 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 230 TFQKILKL-----------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHhc-----------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 44443321 011234568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=301.03 Aligned_cols=249 Identities=25% Similarity=0.462 Sum_probs=197.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc---------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
+|.+.+.||+|+||.||++++..++..+++|.++.. .....+|+.+++.++||||+++++.+ .+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 488999999999999999999887777777765421 11234688899999999999999988 3444
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..++||||+++ ++...+.........+++..++.++.|++.||.|||+ .|++|+||||+||+++ ++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~--~~~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLK--NNLLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEee--cCCEeecccCce
Confidence 58899999986 5555555544556789999999999999999999999 6999999999999998 456999999998
Q ss_pred cccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 228 KVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 228 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
........ .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.. +..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~------- 222 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPT------- 222 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCC-------
Confidence 76543322 2334578889999998654 478899999999999999999999986655444333322 100
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
...+..++.++.++|.+||..||++||++.++++||||
T Consensus 223 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 -------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 01223568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=292.90 Aligned_cols=258 Identities=25% Similarity=0.424 Sum_probs=211.3
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHH-cCCCceeeeceeeeecCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRL-MDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~ 145 (395)
....+|.+.++||+|+|++|.+++.+.|.+.||+|+++++. .....|..+..+ .+||.+|.++.|| .
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----q 321 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----Q 321 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----c
Confidence 34457999999999999999999999999999999987542 223456666554 4799999999999 7
Q ss_pred CceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
.+..+++|.||++|+ +++.+ ...+..++++.++.+..+|+.||.|||+ +||+.||||.+|+|+| ..|.+||+|+|
T Consensus 322 tesrlffvieyv~gg--dlmfh-mqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlld-aeghikltdyg 396 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGG--DLMFH-MQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLD-AEGHIKLTDYG 396 (593)
T ss_pred ccceEEEEEEEecCc--ceeee-hhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEc-cCCceeecccc
Confidence 777799999999987 33332 3346789999999999999999999999 8999999999999999 68889999999
Q ss_pred ccccc-ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCC-------CChHHHHHHHHHHhC
Q 016115 226 SAKVL-VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-------ENAVDQLVEIIKVLG 297 (395)
Q Consensus 226 ~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~-------~~~~~~~~~~~~~~~ 297 (395)
+++.- ..+...++++||+.|.|||++++. .|+..+|+|+|||+++||+.|+.||.- .+.++.+.+++-..
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek- 474 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK- 474 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-
Confidence 99764 455667789999999999999875 599999999999999999999999952 23444444443210
Q ss_pred CCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC------HHHHhcCCCCcCCCCCC
Q 016115 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREPN 370 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt------~~ell~hp~~~~~~~~~ 370 (395)
.-.++..+|-.+..+++.-|++||.+|.. ..++-.|+||+.+++..
T Consensus 475 ---------------------------qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 475 ---------------------------QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred ---------------------------cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence 01134567888999999999999999974 57999999999887754
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=303.41 Aligned_cols=257 Identities=30% Similarity=0.457 Sum_probs=206.8
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
....|.+.+.||+|++|.||++.+..++..|++|.+.... ....+|+++++.++|+||+++++.+. .....+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL-----VGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEE-----ECCEEE
Confidence 4456888999999999999999998889999999986543 34457999999999999999999884 345689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+|+||++| +|.+.+.... ..+++..+..++.|++.||.|||+ .||+|+||+|+||+++ .++.++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLS-KDGSVKLADFGFAAQL 166 (286)
T ss_pred EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEc-CCCCEEECccchhhhh
Confidence 99999994 6655555421 378999999999999999999999 6999999999999999 7889999999998655
Q ss_pred ccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+... +.+.
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~--------- 235 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP--------- 235 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC---------
Confidence 43322 2234568889999998654 4899999999999999999999999877665544433321 0000
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
......++..+.+||++||+.+|.+|||+.+++.|+||++...
T Consensus 236 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 236 ----------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred ----------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 0011236789999999999999999999999999999998443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=298.89 Aligned_cols=243 Identities=21% Similarity=0.293 Sum_probs=192.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.+|.+.+.||+|+||.||++.+. ++..+|+|.+.... ....+|+.+++.++||||+++++++ ......++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEEE
Confidence 35889999999999999999875 45689999876432 3445799999999999999999988 444558999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||++| ++.+.+.. ....+++..++.++.|++.||.|||+ +||+|+||||+||+++ .++.+||+|||.++....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 78 TEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEc-CCCeEEECCCCCccccCC
Confidence 999985 45444432 12458899999999999999999999 6999999999999999 788999999999876533
Q ss_pred CCcce--eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 233 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 233 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... ...++..|+|||++.+. .++.++||||||+++|+|++ |+.||...+..+.+..+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~------------ 219 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR------------ 219 (256)
T ss_pred CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence 32221 12335679999998654 58999999999999999999 9999988776666555443100
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+...+..+.+|+.+||+.||++||++.++++
T Consensus 220 ----------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 220 ----------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0011235778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=306.54 Aligned_cols=248 Identities=22% Similarity=0.291 Sum_probs=192.3
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCc--EEEEEEeccc-----ccchHHHHHHHHHc-CCCceeeeceeeeecCCCCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQD-----RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (395)
++|.+.+.||+|+||.||+|.+..++. .+++|.++.. .....+|+.+++++ +||||+++++++ ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence 368999999999999999999877765 4688877632 12345688999888 799999999988 4445
Q ss_pred eEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~ 215 (395)
.++++|||+++ ++.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++ .
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~-~ 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVG-E 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEEC-C
Confidence 68999999985 66666543211 12358899999999999999999999 6999999999999999 6
Q ss_pred CCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016115 216 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (395)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~ 294 (395)
++.+||+|||++..............+..|+|||++.+. .++.++|||||||++|+|++ |..||......+....+..
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 889999999998643222111112234569999998654 48999999999999999997 9999988776665544332
Q ss_pred HhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
... ...+..++..+.+||.+||+.||.+|||++++++.
T Consensus 234 ~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 234 GYR----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 100 01223468899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=299.33 Aligned_cols=237 Identities=22% Similarity=0.316 Sum_probs=185.9
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEeccc
Q 016115 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP 158 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 158 (395)
.||+|+||.||+|.+..+|+.||+|.+... .....+|+++++.++|+||+++++++ .....+++||||+.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~ 76 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELVQ 76 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeecc
Confidence 589999999999999999999999987533 23355799999999999999999988 44455899999998
Q ss_pred ch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcce
Q 016115 159 ET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 237 (395)
Q Consensus 159 ~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~ 237 (395)
++ +.+.+.. ....+++..++.++.|++.||.|||+ +||+|+||||+||+++ .++.+||+|||++..........
T Consensus 77 ~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 77 GGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred CCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEc-CCCcEEECccccCcccccccccc
Confidence 64 4444332 23468899999999999999999999 6999999999999999 68889999999987643322111
Q ss_pred ---eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 238 ---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 238 ---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
...++..|+|||.+.+. .++.++||||||+++|+|++ |..||...........+.....
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---------------- 214 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---------------- 214 (252)
T ss_pred cCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----------------
Confidence 11124569999998654 48999999999999999998 9999977665443333322100
Q ss_pred CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..++..+.+|+.+||+.||++|||+.++++
T Consensus 215 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 ------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=303.88 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=195.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECC-----CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+++++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT----- 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----
Confidence 3468899999999999999998743 46789999986432 34457999999999999999999884
Q ss_pred CceeEEEEEecccc-hHHHHHHhhc----------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYS----------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~----------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~ 214 (395)
.....++||||++| +|.+.+.... .....+++..+..++.||+.||.|||+ +|++||||||+||+++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~- 156 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVG- 156 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEc-
Confidence 34558999999986 5555554321 123557889999999999999999999 6999999999999999
Q ss_pred CCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 016115 215 LTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 290 (395)
Q Consensus 215 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~ 290 (395)
.++.+||+|||++........ .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+..+...
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 789999999999875433221 1223456789999999764 48999999999999999998 999998777665554
Q ss_pred HHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.+... .. ...+..++..+.++|.+||+.||++||++.|+++
T Consensus 236 ~~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQG--RL--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHcC--Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 44321 00 0012346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=301.56 Aligned_cols=249 Identities=30% Similarity=0.472 Sum_probs=195.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.+|.+.+.||+|+||.||+|.+..+|..+|||.+... .....+|+.+++.++|+||+++++++. ....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 3688999999999999999999999999999987532 123446899999999999999999884 4445
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+++|||+.| ++.+.+.........+++..++.++.||+.||.|||+ +|++|+||||+||+++ .++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~-~~~~~~l~dfg~~~ 154 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFIT-ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEc-CCCCEEECcchhhh
Confidence 8899999986 5655565444445678999999999999999999999 6999999999999999 68899999999987
Q ss_pred ccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhhhh
Q 016115 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 229 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 306 (395)
....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 222 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ----------- 222 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-----------
Confidence 6543322 2234678899999998654 4889999999999999999999999754321 111111110
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+ ......++..+.++|.+||..||.+|||+.++++
T Consensus 223 -------~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 223 -------CDYP--------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -------CCCC--------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0000 0012346889999999999999999999997763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=295.89 Aligned_cols=246 Identities=33% Similarity=0.589 Sum_probs=201.7
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+|.+.+.||+|++|.||++.+..+++.|++|.+..... ...+|+++++.++|+|++++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence 48889999999999999999999999999999865432 345789999999999999999988 4445689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++|||+++ ++.+.+.. ...+++..++.++.|++.||.+||+ .||+||||+|+||+++ .++.++|+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTT-KDGVVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEC-CCCCEEEeccccceec
Confidence 99999987 44444433 3678999999999999999999999 6999999999999999 6889999999999876
Q ss_pred ccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+........... .
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~----------- 215 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--D----------- 215 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--C-----------
Confidence 54433 23346788999999986554 889999999999999999999999876654443332210 0
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
...++..++..+.++|.+||..+|++|||+.+++.||||
T Consensus 216 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 ---------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 011234568899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=309.15 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=190.5
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcE----EEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.+|++.+.||+|+||.||+|.+..+|+. ||+|.+.... ....+|+.+++.++|+||+++++++.. .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-----~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----C
Confidence 3699999999999999999998766664 8999885332 234568899999999999999998742 1
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..++++||+.+ ++.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~-~~~~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVK-TPQHVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEec-CCCcEEEccccc
Confidence 25689999885 55555543 23468888999999999999999999 6999999999999999 788899999999
Q ss_pred ccccccCCccee---eeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 227 AKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 227 a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
++.......... ..++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+....+.. .+... +.
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~-~~---- 228 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEK-GE---- 228 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhC-CC----
Confidence 987654333222 2235679999998654 58999999999999999998 99999876554432 22221 00
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+ .+..++.++.+++.+||..||.+||++.+++.+
T Consensus 229 ------------~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 229 ------------RLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------------CCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 112357789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=303.44 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=194.5
Q ss_pred ccCceeeeeeecCCceEEEEEEEC-----CCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
..+|.+.+.||+|+||.||++.+. .++..+|+|.+.... ....+|+++++.++|+||+++++++ ..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VE 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence 346999999999999999999852 345679999886432 2355799999999999999999988 44
Q ss_pred ceeEEEEEecccc-hHHHHHHhhc---------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCC
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYS---------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~ 216 (395)
...+++||||+++ ++.+.+.... .....+++..++.++.||+.||+|||+ +|++||||||+||+++ ++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~-~~ 156 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVG-EN 156 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEc-cC
Confidence 4568999999985 5555554322 122358999999999999999999999 6999999999999999 78
Q ss_pred CcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 016115 217 HQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 292 (395)
Q Consensus 217 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~ 292 (395)
+.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||......+....+
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 8999999999976533221 1123346789999998654 58999999999999999998 99999887766555444
Q ss_pred HHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
... .. ......++.++.+|+.+||+.||.+|||+.+++.
T Consensus 236 ~~~--~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 236 TQG--RV--------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HcC--Cc--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 331 00 0012346889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=303.12 Aligned_cols=248 Identities=21% Similarity=0.309 Sum_probs=193.2
Q ss_pred cCceeeeeeecCCceEEEEEEEC----CCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.+|++.+.||+|+||+||+|.+. .++..||+|.+.... ....+|+.+++.++|+||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence 46889999999999999999853 456789999886422 2345799999999999999999988 344
Q ss_pred eeEEEEEecccc-hHHHHHHhhc-------------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYS-------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~-------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~ 213 (395)
...++||||+++ ++.+.+.... .....+++..+..++.||+.||.|||+ +||+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIG 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEc
Confidence 458999999986 5555443211 112357888999999999999999999 6999999999999999
Q ss_pred CCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHH
Q 016115 214 PLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 289 (395)
Q Consensus 214 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 289 (395)
.++.+||+|||+++....... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||.+.+.....
T Consensus 159 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 -EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred -CCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 688899999999976533321 1223446679999998654 48999999999999999998 99999877655444
Q ss_pred HHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+... .. ...+..+++.+.+++.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 EMVRKR-QL---------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcC-Cc---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 433221 00 00223468899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=301.22 Aligned_cols=250 Identities=20% Similarity=0.276 Sum_probs=193.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECC-----CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+.+++.++|+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF----- 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence 4569999999999999999999877 77889999875332 23456889999999999999999884
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCcE
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQV 219 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~~ 219 (395)
+....++||||+.| +|.+.+..... ....+++..++.++.||+.||.|||+ +|++|+||||+||+++.. +..+
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence 33447899999975 56555544321 12358999999999999999999999 699999999999999832 2369
Q ss_pred EEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 016115 220 KLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV 295 (395)
Q Consensus 220 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~ 295 (395)
||+|||+++........ .....+..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999865322211 112234579999999654 48999999999999999997 99999877665544332221
Q ss_pred hCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.. ...+..++..+.+++.+||+.||++|||+.++++|
T Consensus 238 -~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 -GR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -Cc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 01223568899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=326.13 Aligned_cols=300 Identities=20% Similarity=0.243 Sum_probs=192.2
Q ss_pred cccCceeeeeeecCCceEEEEEEECCC----CcEEEEEEecccccchHHHHHHHH---HcCCCceeeeceeeeecC-CCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLET----GETVAIKKVLQDRRYKNRELQLMR---LMDHPNVISLKHCFFSTT-SKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vaiK~~~~~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~-~~~ 146 (395)
..++|.+.+.||+|+||.||+|++..+ +..||+|++..... .|..+.. ...+.+++.+...+.... ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence 556899999999999999999999888 89999998754322 2222222 223334444433332211 134
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcc----------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSS----------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~----------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~N 209 (395)
...+++||||+++ +|.+.+..... .........++.++.||+.||.|||+ +||+||||||+|
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~N 285 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQN 285 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHH
Confidence 5568899999986 45555432110 01112234567899999999999999 699999999999
Q ss_pred eeecCCCCcEEEeecccccccccCC--cceeeeecccccCchhhcCCC---------------------CCCcccchHhH
Q 016115 210 LLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGAT---------------------EYTTSIDIWSA 266 (395)
Q Consensus 210 ill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Diwsl 266 (395)
||++.+++.+||+|||+|+...... ......+++.|||||++.... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9998556789999999997654332 223567899999999764321 13456799999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhcc
Q 016115 267 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 346 (395)
Q Consensus 267 G~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 346 (395)
||++|+|+++..++. +....+.......+.. ...|....... ..+.... ...........+.+||.+||++
T Consensus 366 GviL~el~~~~~~~~--~~~~~~~~~l~~~~~~-~~~~~~~~~~~---~~~~~~~---~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 366 GLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYD-LVAWRKLVEPR---ASPDLRR---GFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCc-HHHHHHhhccc---cchhhhh---hhhhccccchHHHHHHHHHccC
Confidence 999999999775543 3333344333332221 11221110000 0000000 0001122345677999999999
Q ss_pred CCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCCCCchh
Q 016115 347 SPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQ 387 (395)
Q Consensus 347 dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (395)
||.+|||+.++|+||||+.....................++
T Consensus 437 dP~kR~ta~e~L~Hpff~~~~~~~~~~~~~~~~~~~~~~~~ 477 (566)
T PLN03225 437 KGRQRISAKAALAHPYFDREGLLGLSVMQNLRLQLFRATQQ 477 (566)
T ss_pred CcccCCCHHHHhCCcCcCCCCccccccccccccccchhhHH
Confidence 99999999999999999887665444444444444433333
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=297.81 Aligned_cols=244 Identities=19% Similarity=0.272 Sum_probs=192.3
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.+|.+.+.||+|+||+||++.+.. +..+|+|.+.... ....+|+.+++.++||||+++++++ .....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCcEEE
Confidence 368999999999999999998753 4569999886432 2345799999999999999999988 344458999
Q ss_pred Eecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||+.++ +.+.+... ...+++..++.++.||+.||.|||+ +|++|+||||+||+++ .++.+||+|||.++....
T Consensus 78 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 78 TEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEc-CCCCEEECCCccceecCC
Confidence 9999864 54444331 2368999999999999999999999 6999999999999999 688999999999876543
Q ss_pred CCcce--eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 233 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 233 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||...+..+....+......
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 220 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----------- 220 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------
Confidence 32211 12345679999999654 48999999999999999999 99999877765554444331100
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
......+..+.+++.+||+.||.+||++.+++.+
T Consensus 221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 -----------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=334.75 Aligned_cols=141 Identities=25% Similarity=0.399 Sum_probs=122.0
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.+|.+.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++ .....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence 47999999999999999999999999999999986432 3456788999999999999999887 44556
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+|+||||+.| +|...+.. ...+++..++.++.||+.||.|||. +||+||||||+|||++ .++.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 9999999975 55555443 3568889999999999999999999 6999999999999999 68899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=299.72 Aligned_cols=248 Identities=24% Similarity=0.309 Sum_probs=195.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCC-----CcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
.++|.+.+.||+|+||.||+|.+... +..||+|.+.... ....+|+.+++.++|+||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence 35799999999999999999997643 3789999986442 2345788999999999999999988 4
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcc------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCc
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSS------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~ 218 (395)
.....++||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ .||+|+||||+||+++ .++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~-~~~~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVA-EDLT 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEc-CCCC
Confidence 44568999999984 66655544322 12347888999999999999999999 6999999999999999 7899
Q ss_pred EEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016115 219 VKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (395)
Q Consensus 219 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~ 294 (395)
+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|+| |..||...+..+....+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 99999999876543321 1233457789999998654 48999999999999999998 9999987766555443331
Q ss_pred HhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+.. ...+..++..+.+||.+||+.+|++|||+.++++
T Consensus 237 --~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 --GGH--------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred --CCC--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 0122345889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=314.94 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=191.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECCC-----CcEEEEEEecccc-----cchHHHHHHHHHcC-CCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRLMD-HPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 143 (395)
...+|++.+.||+|+||.||+|.+... +..||||++.... ....+|+++++.+. ||||+++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~---- 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC---- 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE----
Confidence 355799999999999999999987433 3579999986432 23457999999996 99999999998
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhcc----------------------------------------------------
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS---------------------------------------------------- 170 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------------------------------------------- 170 (395)
.+...+|+|||||++ +|.+.+.....
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 111 -TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred -ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 455568999999985 55555433110
Q ss_pred ----------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCce
Q 016115 171 ----------------------------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (395)
Q Consensus 171 ----------------------------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Ni 210 (395)
....+++..+..++.||+.||.|||+ +||+||||||+||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Ni 268 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhE
Confidence 12357888899999999999999999 6999999999999
Q ss_pred eecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChH
Q 016115 211 LVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 286 (395)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~ 286 (395)
|++ .++.+||+|||+++........ ....++..|+|||++.+. .++.++|||||||++|+|++ |..||......
T Consensus 269 ll~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 269 LLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999 6888999999999765433221 223456789999998654 48999999999999999997 99999875444
Q ss_pred HHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+.+...... + .. ...+..++.++.++|.+||+.||++|||+.++.+
T Consensus 347 ~~~~~~~~~-~----------------~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNKIKS-G----------------YR----------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHhc-C----------------CC----------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333322221 0 00 0012346889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=297.80 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=194.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+|+.+++.++|+||+++++.+ .+....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence 457999999999999999999964 56789999876432 3445799999999999999999887 44455899
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|||+.+ ++.+.+... ....+++..++.++.|++.||.|||+ .|++|+||||+||+++ .++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVS-ESLMCKIADFGLARVIE 154 (261)
T ss_pred EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEec-CCCcEEECCCccceecC
Confidence 9999985 555555432 24567888999999999999999999 6999999999999999 78899999999998764
Q ss_pred cCCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 232 KGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 232 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... ....++..|+|||++.+. .++.++||||||+++|+|+| |..||......+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------- 222 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR----------- 222 (261)
T ss_pred CCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 43221 122346679999998654 48899999999999999998 9999988766655544432100
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.+ ....++.++.++|.+||..||++||+++++++
T Consensus 223 -------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 -------MP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -------CC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 11346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=335.79 Aligned_cols=257 Identities=30% Similarity=0.447 Sum_probs=194.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeec---------
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFST--------- 142 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------- 142 (395)
.+|+..+.||+||||.||+++++-+|..||||+|.-. .....+|+.++.+|+|||||+++..|...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4688889999999999999999999999999998643 22345799999999999999987655210
Q ss_pred ---------------------------------------------C----------------------------------
Q 016115 143 ---------------------------------------------T---------------------------------- 143 (395)
Q Consensus 143 ---------------------------------------------~---------------------------------- 143 (395)
.
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0
Q ss_pred ------------------CCCc--------eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 016115 144 ------------------SKDE--------LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197 (395)
Q Consensus 144 ------------------~~~~--------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~ 197 (395)
...+ ..+||-||||+.+++..+.+...... ....+|+++++|++||.|+|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~- 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD- 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh-
Confidence 0001 46899999999887777665322111 467799999999999999999
Q ss_pred CCceeccCCCCceeecCCCCcEEEeecccccccc-------------------cCCcceeeeecccccCchhhcCCC--C
Q 016115 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-------------------KGEANISYICSRYYRAPELIFGAT--E 256 (395)
Q Consensus 198 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~--~ 256 (395)
+|||||||||.||+++ +++.|||+|||+|+... +....+..+||..|+|||++.+.. .
T Consensus 716 ~giIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred CceeeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 6999999999999999 78889999999998721 011235678999999999997665 6
Q ss_pred CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhH
Q 016115 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEA 336 (395)
Q Consensus 257 ~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 336 (395)
|+.|+||||||||++||+. ||...-.......-++ . ..++.. ..+...--+.-
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR---~---------------g~iP~~------~~f~~~~~~~e 847 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR---K---------------GSIPEP------ADFFDPEHPEE 847 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc---c---------------CCCCCC------cccccccchHH
Confidence 9999999999999999985 5665433322222111 1 111110 11122223457
Q ss_pred HHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 337 IDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 337 ~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
..+|++||+.||++||||.|+|++.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 7899999999999999999999999987
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=299.23 Aligned_cols=251 Identities=21% Similarity=0.279 Sum_probs=193.3
Q ss_pred ceeeeeeecCCceEEEEEEECCC---CcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCce
Q 016115 79 YMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (395)
|.+.+.||+|+||.||+|.+..+ +..||+|.+..+. ....+|+.+++.++|+||+++++.+..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987653 4789999886432 234568899999999999999988754332 2334
Q ss_pred eEEEEEecccc-hHHHHHHhhc--ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
..+++|||+.+ ++...+.... .....+++..++.++.|++.||.|||+ +|++||||||+||+++ +++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLR-EDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEEC-CCCeEEECCcc
Confidence 57899999985 5554543322 223568999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 226 SAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 226 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+++........ ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+....+.+..+... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~-- 233 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG--NR-- 233 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CC--
Confidence 99865433221 11224567999999854 458999999999999999999 99999877665544433221 00
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..++..+.++|.+||+.||++|||+.+++.+
T Consensus 234 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00123468899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=302.98 Aligned_cols=247 Identities=21% Similarity=0.268 Sum_probs=193.5
Q ss_pred cCceeeeeeecCCceEEEEEEECCC-----CcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
..|++.+.||+|+||+||+|.+..+ +..||+|.+.... ....+|..+++.++|+||+++++.+ ..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence 3588899999999999999987543 5789999986442 2345688899999999999999988 44
Q ss_pred ceeEEEEEecccc-hHHHHHHhhc------------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~ 213 (395)
....++++||+.+ ++.+.+.... .....+++..+..++.|++.||.|||+ +||+||||||+||+++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVF 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEec
Confidence 4458899999985 4444443211 113457888899999999999999999 6999999999999999
Q ss_pred CCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHH
Q 016115 214 PLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 289 (395)
Q Consensus 214 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 289 (395)
+++.+||+|||+++........ ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+....+..
T Consensus 159 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 159 -DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred -CCCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 6888999999998765433221 123346789999998654 48999999999999999998 88999887766655
Q ss_pred HHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+...... ..+..++..+.+|+.+||+.||.+||++.+++.
T Consensus 237 ~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 237 EMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 554431000 122456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=300.37 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=191.1
Q ss_pred ceeeeeeecCCceEEEEEEECCCCc--EEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCC-CCcee
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (395)
|.+.+.||+|+||.||+|.+..++. .+|+|.+... .....+|+.+++.++|+||+++++.++.... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999877765 6899987533 2234568899999999999999987644322 12235
Q ss_pred EEEEEecccc-hHHHHHHhh--cccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
.+++|||+.+ ++.+.+... ......+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLN-ENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEc-CCCCEEECCCCc
Confidence 7899999985 544444321 1223458999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 227 AKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 227 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
++........ ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+.+. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~--- 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG--NR--- 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--CC---
Confidence 9876433221 122346679999998654 58999999999999999999 89999876665544433321 00
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
......++..+.++|.+||+.||++|||+.+++++
T Consensus 233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 -----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00123467889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=295.95 Aligned_cols=242 Identities=26% Similarity=0.385 Sum_probs=195.7
Q ss_pred eeeecCCceEEEEEEECCC---CcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||.||+|.+... +..||+|.+.... ....+|+++++.++|+||+++++++ .+...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC-----TEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeee-----cCCCceEEEE
Confidence 3689999999999999766 8899999986543 3445789999999999999999988 3455689999
Q ss_pred eccc-chHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 155 EYVP-ETMYRVLKHYSSM-----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 155 e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
||+. +++.+.+...... ...+++..++.++.|++.||.|||+ +|++|+||||+||+++ .++.+||+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~-~~~~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVG-EDLVVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEEC-CCCcEEEccccccc
Confidence 9996 5666655543221 3778999999999999999999999 6999999999999999 68899999999998
Q ss_pred ccccCC---cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 229 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 229 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
...... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~------ 224 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--Y------ 224 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C------
Confidence 765432 12334568889999998665 58999999999999999999 69999888665555444331 0
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
....+..++.++.+++.+||+.||.+|||+.+++++
T Consensus 225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 --------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred --------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 011234568999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=295.35 Aligned_cols=248 Identities=30% Similarity=0.475 Sum_probs=196.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+++++.++|+||+++++.+ .....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-----~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-----IENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence 4699999999999999999999989999999987521 23345789999999999999999988 34456
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.++||||+++ +|...+.........+++..++.++.+++.||.|||+ .||+|+||+|+||+++ .++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~-~~~~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFIT-ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEEC-CCCcEEEeccceee
Confidence 8999999985 6666665544445678999999999999999999999 6999999999999999 68899999999987
Q ss_pred ccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhhhh
Q 016115 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--DQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 229 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 305 (395)
....... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||...... +....+... .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~------- 224 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--D------- 224 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--C-------
Confidence 6543322 2345678899999998654 4899999999999999999999999654311 111111110 0
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
. .......++..+.++|.+||..+|++|||+.++++
T Consensus 225 ----------~--------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 225 ----------Y--------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ----------C--------CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 00011246789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=295.72 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=193.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
..+|++.+.||+|++|.||+|.+. ++..||+|.+.... ....+|+.+++.++|+||+++++++ ......++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeee
Confidence 446999999999999999999964 45789999986542 3355799999999999999999987 44445899
Q ss_pred EEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|||+. +++.+.+.... ...+++..+..++.|++.||.|||+ +||+|+||||+||+++ .++.+||+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 79 VTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVG-ENNICKVADFGLARVIK 154 (261)
T ss_pred eeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEc-CCCCEEECCcceEEEcc
Confidence 999996 56655554321 3568999999999999999999999 6999999999999999 68899999999998764
Q ss_pred cCCcceeeee---cccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 232 KGEANISYIC---SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 232 ~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
..... ...+ +..|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.+.......+......
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------- 223 (261)
T cd05068 155 EDIYE-AREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM--------- 223 (261)
T ss_pred CCccc-ccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 32211 1222 3579999998654 48999999999999999999 99999887766555544321000
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.....++..+.+++.+||+.||.+||++.++++
T Consensus 224 -------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 -------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 012345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=297.15 Aligned_cols=243 Identities=19% Similarity=0.289 Sum_probs=192.0
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+|++.+.||+|+||.||++.+. ++..+|+|.+.... ....+|+++++.++|+||+++++++ ......++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence 5888999999999999999875 56789999886432 2345799999999999999999887 4445689999
Q ss_pred ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||++| ++.+.+... ...+++..++.++.||+.||.|||+ +|++||||||+||+++ .++.+||+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEEC-CCCcEEECCcccceecccc
Confidence 99986 455544321 2468999999999999999999999 6999999999999999 7889999999998765433
Q ss_pred Ccce--eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 234 EANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 234 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.... ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||...+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------- 219 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------- 219 (256)
T ss_pred cccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-------------
Confidence 2211 11224579999998654 48999999999999999999 8999987766555444332100
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..++..+.+++.+||..+|++|||+.++++.
T Consensus 220 ---------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 ---------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=301.67 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=195.1
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCC-----cEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (395)
...+|.+.+.||+|+||.||++.+...+ ..+|+|.+.... ....+|+++++.+ +|+||+++++.+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC---- 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 4457999999999999999999976433 689999886432 2244688999999 799999999988
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhc------------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCce
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Ni 210 (395)
.....++++|||+.+ ++...+.... .....+++..++.++.||+.||.|||+ .||+||||||+||
T Consensus 86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Ni 163 (293)
T cd05053 86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNV 163 (293)
T ss_pred -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeE
Confidence 444558999999985 5555554321 234578999999999999999999999 6999999999999
Q ss_pred eecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChH
Q 016115 211 LVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 286 (395)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~ 286 (395)
+++ .++.+||+|||+++........ ....++..|+|||++.+. .++.++|||||||++|+|++ |..||......
T Consensus 164 l~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 164 LVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 999 7889999999999865443221 112235679999998654 58999999999999999998 99999877665
Q ss_pred HHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
+....+..... ...+..++..+.+|+.+||..||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKEGYR----------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 54443322100 00123457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=298.22 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=197.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
..+|.+.+.||.|+||.||+|.+.. +..+|+|.+.... ....+|+.+++.++|+||+++++++ .+....+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeE
Confidence 3469999999999999999999877 8899999986443 2445789999999999999999988 4445589
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +||+|+||||+||+++ .++.+||+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVG-EDLVCKVADFGLARLI 154 (261)
T ss_pred EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEc-CCceEEEccccchhhc
Confidence 99999986 665555432 24568999999999999999999999 6999999999999999 7889999999999765
Q ss_pred ccCCcc-eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 231 VKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 231 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
...... ....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+..+.+..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 223 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---------- 223 (261)
T ss_pred CCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----------
Confidence 433221 122346679999998654 58999999999999999998 89999887766665554431000
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 ------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=293.73 Aligned_cols=238 Identities=34% Similarity=0.581 Sum_probs=195.4
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecc
Q 016115 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 85 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
||+|+||.||++.+..+++.||+|.+.... .....|+.+++.++|+||+++++.+ ......++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 699999999999998899999999886432 2345788999999999999999888 5566799999999
Q ss_pred c-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC-c
Q 016115 158 P-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-A 235 (395)
Q Consensus 158 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~ 235 (395)
+ +++.+.+.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++ .++.++|+|||++....... .
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEc-CCCcEEEeecCcceecccCCCc
Confidence 5 565555543 3468999999999999999999999 7999999999999999 68899999999987764432 2
Q ss_pred ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCC
Q 016115 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315 (395)
Q Consensus 236 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
.....++..|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+.. ..
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~----------------- 209 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DP----------------- 209 (250)
T ss_pred ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CC-----------------
Confidence 3345678889999998654 478899999999999999999999987765433333322 00
Q ss_pred CCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH---HHHhcCCCC
Q 016115 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 363 (395)
Q Consensus 316 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~---~ell~hp~~ 363 (395)
..++..++..+.++|++||..||++||++ +++++||||
T Consensus 210 ----------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 210 ----------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ----------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 01234458899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=291.08 Aligned_cols=277 Identities=33% Similarity=0.576 Sum_probs=224.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCC-CCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~ 150 (395)
+|.-.+.+|.|+- .|..|.|.-+++.||+|+.... .+...+|+.+++.++|+||++++.+|..... .....+
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 6777888999998 7888888889999999987533 2334579999999999999999999854332 223358
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
|+||||+..++...+. ..++-..+..++.|++.|++|||+ .||+||||||+||++. .+..+||.|||+|+..
T Consensus 97 y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~-~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVN-SDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceec-chhheeeccchhhccc
Confidence 8999999998877665 345667889999999999999999 6999999999999999 7889999999999876
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
...-..+.++.|..|.|||++.+.. |...+||||+||++.||++|+..|.+.+..++..++.+.+|.+....+..+.+.
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred CcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 5555567788999999999998876 999999999999999999999999999999999999999999998877654432
Q ss_pred CCC----------CCCC-CccCCCccccc--cccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 311 YTD----------FRFP-QIKAHPWHKVF--HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 311 ~~~----------~~~~-~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
... +.+. .+....|.... ...-+..+++|+.+||..||++|.++.++|+||||+
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 111 1111 01111111111 112345789999999999999999999999999998
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=300.88 Aligned_cols=255 Identities=19% Similarity=0.235 Sum_probs=194.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCC----------------cEEEEEEecccc-----cchHHHHHHHHHcCCCceee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETG----------------ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVIS 134 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~ 134 (395)
..+|++++.||+|+||.||+|.+..++ ..||+|.+.... ....+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357999999999999999999876543 468999886442 23456899999999999999
Q ss_pred eceeeeecCCCCceeEEEEEecccc-hHHHHHHhhcc-------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCC
Q 016115 135 LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS-------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206 (395)
Q Consensus 135 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlk 206 (395)
+++++ ......+++|||+.+ ++.+.+..... ....+++..++.++.|++.||.|||+ .||+|+|||
T Consensus 84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlk 157 (296)
T cd05051 84 LLGVC-----TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLA 157 (296)
T ss_pred EEEEE-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccc
Confidence 99988 444568999999985 55555544321 12368999999999999999999999 699999999
Q ss_pred CCceeecCCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh--CCCCCC
Q 016115 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP 281 (395)
Q Consensus 207 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~ 281 (395)
|+||+++ .++.++|+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.
T Consensus 158 p~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 158 TRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999 678999999999876533321 1123456789999998654 48999999999999999998 778888
Q ss_pred CCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+..+.+............. .....+..++.++.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGRQ---------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChHHHHHHHHhcccccccc---------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 766655554443321110000 000012346789999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=295.69 Aligned_cols=245 Identities=23% Similarity=0.288 Sum_probs=192.5
Q ss_pred cCceeeeeeecCCceEEEEEEECCC---CcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.+|.+.+.||+|+||+||+|.+..+ ...||+|.+.... ....+|+.+++.++|+||+++++.+ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence 4689999999999999999998654 4579999876432 2334688999999999999999988 4445
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..++||||+++ ++.+.+.. ....+++..++.++.|++.||.|||+ +||+|+||||+||+++ +++.++|+|||++
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~-~~~~~~l~dfg~~ 153 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVN-SNLVCKVSDFGLS 153 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEc-CCCCEEECccchh
Confidence 58999999986 44444432 23478999999999999999999999 6999999999999999 7889999999999
Q ss_pred cccccCCcce---eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 228 KVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 228 ~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
.......... ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----- 227 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL----- 227 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 8764222211 12235679999998654 48999999999999999998 99999876655544443321000
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+..++..+.+|+.+||+.||++||++.+++++
T Consensus 228 -----------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 228 -----------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0123468899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.50 Aligned_cols=256 Identities=29% Similarity=0.466 Sum_probs=196.6
Q ss_pred CceeeeeeecCCceEEEEEEEC---CCCcEEEEEEeccc--------ccchHHHHHHHHHc-CCCceeeeceeeeecCCC
Q 016115 78 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD--------RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (395)
+|.+.+.||+|++|.||++++. .+++.||||.+... .....+|+.+++.+ +|+||+++++.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 3888999999999999999864 46789999988532 12344688999999 599999999888 4
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
....+++||||+.+ ++.+.+.. ...+++..++.++.|++.||.|||+ .|++||||||+||+++ .++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~-~~~~~~l~df 149 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLD-SEGHVVLTDF 149 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEEC-CCCCEEEEEC
Confidence 45568999999986 44444332 3568899999999999999999999 6999999999999999 6889999999
Q ss_pred ccccccccCCc--ceeeeecccccCchhhcCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 225 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
|++........ .....|+..|+|||.+.+.. ..+.++||||||+++|+|++|..||...+.......+.+.....
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 227 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-- 227 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence 99876543322 12345788999999985532 26789999999999999999999996543222212211110000
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC---HHHHhcCCCCcCCCCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP 369 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~hp~~~~~~~~ 369 (395)
....+..++..+.++|.+||+.||++||| +.++|+||||+...++
T Consensus 228 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 228 -----------------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred -----------------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 00122346889999999999999999998 5688999999988763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=299.92 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=193.4
Q ss_pred cCceeeeeeecCCceEEEEEEECC-----CCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.+|.+.+.||+|+||.||+|.+.. ++..+++|.+.... ....+|+++++.++|+||+++++++ .+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence 468899999999999999998543 45678999886442 3456799999999999999999988 444
Q ss_pred eeEEEEEecccc-hHHHHHHhhc------------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~ 214 (395)
...++||||+++ ++.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~- 157 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVG- 157 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEc-
Confidence 558999999985 5555554322 123458899999999999999999999 7999999999999999
Q ss_pred CCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 016115 215 LTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 290 (395)
Q Consensus 215 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~ 290 (395)
.++.++|+|||++........ .....++..|+|||++.+. .++.++||||||+++|+|+| |..||...+..+...
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 788999999999976543321 1223457789999998654 48999999999999999999 999998776655444
Q ss_pred HHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.+... .. ......++..+.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQG--RV--------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCC--CC--------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 32210 00 0012345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=294.70 Aligned_cols=244 Identities=26% Similarity=0.334 Sum_probs=191.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
..+|++.+.||+|+||.||+|.+..+ ..||+|.+.... ....+|+++++.++|+||+++++.+ .. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-----SE-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE-----CC-CCcEE
Confidence 34699999999999999999998655 469999886532 2346799999999999999998865 22 23689
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
||||+++ ++.+.+... ....+++..++.++.|++.||.|||+ +|++|+||||+||+++ +++.++|+|||.++...
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 78 VTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVG-ENLVCKVADFGLARLIE 153 (262)
T ss_pred EEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEc-CCCcEEeccCCceeecc
Confidence 9999986 555555432 23467889999999999999999999 7999999999999999 68889999999997654
Q ss_pred cCCcce--eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 232 KGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 232 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
...... ...++..|+|||++.+. .++.++||||||+++|+|+| |..||......+....+......
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------- 222 (262)
T ss_pred ccccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC----------
Confidence 333211 23346679999988654 48999999999999999999 88999877665554443221000
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.....++..+.+||.+||+.||++||++.++++
T Consensus 223 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 012346889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=289.89 Aligned_cols=285 Identities=33% Similarity=0.535 Sum_probs=224.6
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
+.+-.+-||-|+||.||.+.+..+|+.||+|++..- .+..-+|+.++..++|.|++..+++.....-..-..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 445567899999999999999999999999988532 23445799999999999999988876322211111256
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
++.|++.. .+.+.......++...+.-++.||++||+|||+ .||.||||||.|.|++ ++-.+||||||+++.-.
T Consensus 134 V~TELmQS----DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVN-SNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 134 VLTELMQS----DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVN-SNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHh----hhhheeccCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEec-cCceEEecccccccccc
Confidence 77777654 345555567889999999999999999999999 7999999999999999 78899999999998754
Q ss_pred cCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 232 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 232 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... .+..+.|.+|+|||+++|...|+.+.||||.|||+.||+..+..|...+..+++..|.+.+|.+..+.++....
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 4332 23345699999999999999999999999999999999999999999999999999999999999998876543
Q ss_pred CCCCCCCCCccC---CCcccccc--ccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 310 NYTDFRFPQIKA---HPWHKVFH--KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 310 ~~~~~~~~~~~~---~~~~~~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
+........... -+....+. ..-.-+..+++.++|.+||++|.+.++.+.|+++.+++-
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 333222211111 11111111 123457889999999999999999999999999988765
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=292.63 Aligned_cols=242 Identities=21% Similarity=0.304 Sum_probs=191.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc--chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
.+|.+.+.||+|+||.||++.. .|..||+|.+..+.. ...+|+.+++.++|+|++++++++.. .....+++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEEE
Confidence 4699999999999999999986 588899998865432 34579999999999999999987643 233478999
Q ss_pred ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||+++ ++.+.+... ....+++..++.++.||+.||.|||+ +|++||||||+||+++ +++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEc-CCCcEEecCCccceecccc
Confidence 99985 555555432 22458899999999999999999999 6999999999999999 7889999999998754332
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
. ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+.+..
T Consensus 156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------- 216 (256)
T cd05082 156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 216 (256)
T ss_pred C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 2 122345679999998654 48999999999999999998 999998766554444332210
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.......+++.+.++|.+||+.||++|||+.++++
T Consensus 217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 ------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00122456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=295.10 Aligned_cols=235 Identities=25% Similarity=0.329 Sum_probs=184.2
Q ss_pred eeecCCceEEEEEEE--CCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 84 VVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
.||+|+||.||+|.+ ..++..+|+|++.... ....+|+.+++.++|+||+++++++ .+. ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----EAE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCC-CcEEEEe
Confidence 589999999999964 4577899999886432 2345688999999999999999876 222 3679999
Q ss_pred cccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC
Q 016115 156 YVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (395)
Q Consensus 156 ~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (395)
|++++ +.+.+.. ...+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLV-TQHYAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEc-CCCeEEECCCccccccCCCC
Confidence 99964 5444432 3568999999999999999999999 6999999999999999 68889999999997654432
Q ss_pred cc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 235 AN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 235 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.. ....++..|+|||.+.. ..++.++||||||+++|+|++ |..||...+..+....+.+..
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~------------- 215 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE------------- 215 (257)
T ss_pred CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence 21 11223568999999854 458899999999999999998 999998876655544433210
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....+..+++++.+||.+||+.||.+||++.++..
T Consensus 216 ---------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 216 ---------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 00122357899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=298.83 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=189.5
Q ss_pred CceeeeeeecCCceEEEEEEECC-----CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... ....+|+.+++.++||||+++++.+ ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence 37788999999999999998753 23568898876432 2345789999999999999999988 444
Q ss_pred eeEEEEEecccc-hHHHHHHhhc--------------------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCC
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYS--------------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~--------------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlk 206 (395)
...++++||+.+ ++.+.+.... .....+++..++.++.|++.||.|||+ .||+|||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik 154 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA 154 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence 458899999995 5555443321 112457889999999999999999999 699999999
Q ss_pred CCceeecCCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCC
Q 016115 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 282 (395)
Q Consensus 207 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~ 282 (395)
|+|||++ +++.+||+|||+++....... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+
T Consensus 155 p~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999 788999999999876533222 1122346679999998654 48999999999999999999 9999987
Q ss_pred CChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.........+.... ....+..++.++.+||.+||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGY----------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCC----------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 76554433222100 00112356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=296.98 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=189.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCc----EEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
..+|++.+.||+|+||+||+|.+..+|. .||+|.+.... ....+|+.+++.+.|+||+++++.+..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 3468999999999999999999887776 48999875432 233468888999999999999987732
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...++++||+++ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++ +++.+||+|||
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~-~~~~~kL~dfG 154 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVK-SPNHVKITDFG 154 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEc-CCCcEEECCCC
Confidence 126689999984 55555443 23568999999999999999999999 7999999999999998 67889999999
Q ss_pred cccccccCCccee---eeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 226 SAKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 226 ~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+++.......... ..++..|+|||.+.+. .++.++|||||||++|||++ |..||...........+... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-- 230 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ERL-- 230 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcC--
Confidence 9987643332211 2235679999998654 48999999999999999998 99999876554433322210 000
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+..++.++.++|.+||..||++||++.+++.
T Consensus 231 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 -------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011345789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=299.60 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=193.0
Q ss_pred ccccCceeeeeeecCCceEEEEEEE-----CCCCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeec
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFST 142 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 142 (395)
...++|.+.+.||+|+||.||++.+ ..++..||+|.+.... ....+|+.+++.+ +|+||+++++++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 108 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC--- 108 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE---
Confidence 3445799999999999999999975 2345689999886432 2345799999999 799999999988
Q ss_pred CCCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEE
Q 016115 143 TSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (395)
Q Consensus 143 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl 221 (395)
......++||||+.+ +|.+.+... ....+++..+..++.||+.||.|||+ +||+|+||||+|||++ .++.++|
T Consensus 109 --~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~~l 182 (302)
T cd05055 109 --TIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLT-HGKIVKI 182 (302)
T ss_pred --ecCCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEc-CCCeEEE
Confidence 444458999999985 555554331 12348999999999999999999999 6999999999999999 7889999
Q ss_pred eecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016115 222 CDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 297 (395)
Q Consensus 222 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~ 297 (395)
+|||+++........ ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+.+...... +
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-~ 260 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-G 260 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-C
Confidence 999999765433221 112346789999998665 48999999999999999998 99999876655444333321 0
Q ss_pred CCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
. ....+...++.+.+|+.+||.+||++|||+.++++
T Consensus 261 ~--------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 261 Y--------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred C--------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 00012245789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=296.74 Aligned_cols=242 Identities=26% Similarity=0.373 Sum_probs=187.7
Q ss_pred eeeeeeecCCceEEEEEEEC----CCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 80 MAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 80 ~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.+.+.||.|.||.||+|.+. ..+..|+||.+... ...+.+|++.++.++||||+++++++.. ....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----cccc
Confidence 45688999999999999987 35678999999542 2345578999999999999999999952 2238
Q ss_pred EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++|+||+. |+|.+.+... ....+++..+..++.||+.||.|||+ ++++|+||+++||+++ .++.+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~-~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLD-SNGQVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEE-TTTEEEEESTTTGEE
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccc-cccccccccccccccc-ccccccccccccccc
Confidence 89999998 5677776653 23678999999999999999999999 6999999999999999 788999999999977
Q ss_pred cccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 230 LVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 230 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
....... ....+...|+|||.+.+.. ++.++||||||+++|||++ |..||...+..+....+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~--------- 222 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ--------- 222 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE---------
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---------
Confidence 6322211 2234567899999986654 8999999999999999999 789998887777666653310
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....+..++..+.++|.+||..||.+|||+.++++
T Consensus 223 -------------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 -------------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -------------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -------------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01123457889999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=297.93 Aligned_cols=256 Identities=27% Similarity=0.351 Sum_probs=187.5
Q ss_pred ceeeeeeecCCceEEEEEE----ECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 79 YMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
|.+.+.||+|+||+||++. ...++..||+|.+.... ....+|+++++.++|+||+++++++.. .....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 3888999999999998865 34578899999886432 234579999999999999999987743 23345
Q ss_pred EEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+++||||++++ +.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLD-NDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEc-CCCcEEEeeccccc
Confidence 88999999965 4444332 458999999999999999999999 6999999999999999 68899999999998
Q ss_pred ccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCChhh
Q 016115 229 VLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL-GTPTREE 303 (395)
Q Consensus 229 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~ 303 (395)
........ ....++..|+|||.+.+. .++.++||||||+++|+|+||..||...... +....... +......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVR 232 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhh
Confidence 66443221 112345679999998654 5899999999999999999999998654321 11111100 0000000
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
. ............+..++.++.+++.+||+.||++|||++++++
T Consensus 233 ~------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 233 L------------IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred h------------hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 0000000011123456889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=290.75 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=193.3
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.+|++.+.||.|+||.||+|.+ .|+.||+|.+..... ...+|+.+++.++|+||+++++++. +....++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeEEE
Confidence 4689999999999999999987 588999999876543 4457999999999999999999883 34558999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||+++ ++.+.+... ....+++..++.++.|++.||.|||+ +|++|+||||+||+++ .++.+||+|||.++....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEe-CCCCEEEccccccccccc
Confidence 999995 655555432 12368999999999999999999999 6999999999999999 788999999999987633
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
... ....+..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+...
T Consensus 155 ~~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------- 215 (256)
T cd05039 155 GQD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---------------- 215 (256)
T ss_pred ccc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC----------------
Confidence 222 22345679999998654 58899999999999999997 99999877655443333220
Q ss_pred CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+ ....+..+++.+.++|.+||..+|++|||+.+++.
T Consensus 216 --~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 --Y----------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --C----------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 00112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=299.38 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=193.1
Q ss_pred ccccCceeeeeeecCCceEEEEEEECC-------CCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeee
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFF 140 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~ 140 (395)
....+|.+.+.||+|+||.||+|.+.. .+..+|+|.+.... ....+|+.+++.+ +|+||+++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~- 87 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC- 87 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE-
Confidence 344579999999999999999998632 34579999876432 2234688899988 699999999988
Q ss_pred ecCCCCceeEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCC
Q 016115 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (395)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp 207 (395)
.+...++++|||+.+ +|.+.+..... ....+++..+..++.||+.||.|||+ +|++||||||
T Consensus 88 ----~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp 162 (314)
T cd05099 88 ----TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAA 162 (314)
T ss_pred ----ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccc
Confidence 444568999999985 55555544221 13458889999999999999999999 6999999999
Q ss_pred CceeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCC
Q 016115 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 283 (395)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~ 283 (395)
+|||++ .++.+||+|||+++........ ....++..|+|||++.+. .++.++||||||+++|+|++ |..||...
T Consensus 163 ~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 163 RNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred eeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 999999 6889999999999765432211 112234579999998654 58999999999999999999 89999877
Q ss_pred ChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+.+..+... .. ...+..++.++.+||.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 241 PVEELFKLLREG--HR--------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CHHHHHHHHHcC--CC--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 665555443321 00 0012346789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=297.67 Aligned_cols=254 Identities=18% Similarity=0.207 Sum_probs=184.2
Q ss_pred cCceeeeeeecCCceEEEEEEECCC---CcEEEEEEecccccchHH---------------HHHHHHHcCCCceeeecee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKNR---------------ELQLMRLMDHPNVISLKHC 138 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~---------------e~~~l~~l~h~niv~~~~~ 138 (395)
.+|.+.+.||+|+||+||+|.+..+ +..+|+|........... +...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4799999999999999999998777 667788864322221111 2223445689999999987
Q ss_pred eeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCc
Q 016115 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (395)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~ 218 (395)
..... ....+.+++++++..++.+.+... ...++..++.++.|++.||.|||+ +||+||||||+|||++ .++.
T Consensus 92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~-~~~~ 164 (294)
T PHA02882 92 GSFKR-CRMYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVD-GNNR 164 (294)
T ss_pred eeEec-CCceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCc
Confidence 64332 223356788998877766655442 335778889999999999999999 6999999999999999 6788
Q ss_pred EEEeecccccccccCC--------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHH
Q 016115 219 VKLCDFGSAKVLVKGE--------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290 (395)
Q Consensus 219 ~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 290 (395)
++|+|||+|+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999997653221 11234689999999998654 58999999999999999999999998764332222
Q ss_pred HHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+. +.+...... .......++.+.++++.|+..+|++||+..++++
T Consensus 244 ~~~~~------~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKC------DFIKRLHEG---------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHH------HHHHHhhhh---------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 21110 000000000 0011235788999999999999999999999864
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=292.43 Aligned_cols=243 Identities=24% Similarity=0.328 Sum_probs=191.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ....+|+.+++.++|+||+++++++ .. ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~~-~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-----SE-EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE-----CC-CCcEE
Confidence 346999999999999999999865 56779999886532 3345799999999999999998876 21 23689
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|||+++ ++.+.+.. .....+++..++.++.+++.||.|||+ .||+|+||||+||+++ +++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 78 VTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVG-DGLVCKIADFGLARLIE 153 (260)
T ss_pred EEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEe-CCceEEeCCceeeeecc
Confidence 9999986 55555443 123458999999999999999999999 6999999999999999 68899999999997654
Q ss_pred cCCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 232 KGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 232 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------- 221 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR----------- 221 (260)
T ss_pred CcccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 33221 122345679999998654 58999999999999999999 8999988776665554432100
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHh
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 358 (395)
...+...+..+.+|+.+||.+||++|||+.+++
T Consensus 222 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 222 -----------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred -----------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 001234578999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=300.16 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=191.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECC-------CCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeec
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFST 142 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 142 (395)
.++|.+.+.||+|+||.||++++.. ++..+|+|.+..+. ....+|+.+++.+ +|+||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--- 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 3579999999999999999998643 23569999886432 1234688899988 799999999988
Q ss_pred CCCCceeEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCc
Q 016115 143 TSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (395)
Q Consensus 143 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~N 209 (395)
......++||||+++ +|.+.+..... ....+++..++.++.|++.||+|||+ .|++||||||+|
T Consensus 94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 170 (307)
T cd05098 94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 170 (307)
T ss_pred --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence 444568999999985 66666554321 12358889999999999999999999 699999999999
Q ss_pred eeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCh
Q 016115 210 LLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 285 (395)
Q Consensus 210 ill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~ 285 (395)
|+++ .++.+||+|||+++........ ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.....
T Consensus 171 ill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 171 VLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred eEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999 6889999999998765432211 112234679999998664 48999999999999999998 8899987665
Q ss_pred HHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.+....+... . ....+..++.++.+||.+||..+|++|||+.++++
T Consensus 249 ~~~~~~~~~~--~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 249 EELFKLLKEG--H--------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHHHcC--C--------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 4433332210 0 00122346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=291.13 Aligned_cols=243 Identities=24% Similarity=0.317 Sum_probs=191.5
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.+|.+.+.||+|++|.||+|.+..+ ..+|+|.+.... ....+|+.+++.++|+|++++++++ .. ...+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~-~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-----SE-EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE-----cC-CCcEEE
Confidence 4699999999999999999997654 469999876433 2345799999999999999998876 22 236899
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||+.+ ++.+.+... ....+++..+..++.|++.||.|||+ .|++|+||||+||+++ +++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVG-DNLVCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEc-CCCeEEECCCccceEccC
Confidence 999986 666666442 23457889999999999999999999 6999999999999999 788999999999976543
Q ss_pred CCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 233 GEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 233 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... ....++..|+|||.+.+. .++.++||||||+++|+|+| |..||.+....+....+......
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------- 222 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM----------- 222 (260)
T ss_pred CcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 3221 122346679999988654 48999999999999999999 99999887766555444321000
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+..++..+.++|++||.+||.+||+++++++
T Consensus 223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -----------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -----------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 012345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=292.94 Aligned_cols=249 Identities=21% Similarity=0.372 Sum_probs=196.2
Q ss_pred CceeeeeeecCCceEEEEEEECC-CCcEEEEEEecccc--------------cchHHHHHHHH-HcCCCceeeeceeeee
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR--------------RYKNRELQLMR-LMDHPNVISLKHCFFS 141 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~--------------~~~~~e~~~l~-~l~h~niv~~~~~~~~ 141 (395)
+|.+.+.||+|+||.||+|.+.. +++.+|+|.+.... ....+|+.++. .++|+||+++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 37888999999999999999887 67899999874221 11234666665 47899999999988
Q ss_pred cCCCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEE
Q 016115 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (395)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~k 220 (395)
......+++|||++| ++.+.+.........+++..++.++.|++.||.|||+..|++|+||+|+||+++ .++.++
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~-~~~~~~ 154 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVT 154 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC-CCCcEE
Confidence 455569999999986 555555544444567999999999999999999999635899999999999999 788999
Q ss_pred EeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
|+|||++.............|+..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+......+
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 232 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP- 232 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-
Confidence 9999999876554444456688899999999764 48999999999999999999999998766554444333211000
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.....++..+.++|.+||+.||++||++.|+..+
T Consensus 233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 --------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred --------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0112467899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=298.87 Aligned_cols=254 Identities=20% Similarity=0.242 Sum_probs=191.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCC--------------CcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeece
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLET--------------GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKH 137 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~ 137 (395)
.+|++.+.||+|+||.||+|++..+ ...||+|.+.... ....+|+++++.++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 4799999999999999999987543 2358999886532 23457999999999999999999
Q ss_pred eeeecCCCCceeEEEEEecccc-hHHHHHHhhcc--------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCC
Q 016115 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS--------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (395)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~ 208 (395)
++ ......++||||+.+ ++.+.+..... ....+++..+..++.|++.||.|||+ .|++|+||||+
T Consensus 85 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~ 158 (295)
T cd05097 85 VC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATR 158 (295)
T ss_pred EE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChh
Confidence 88 444558999999986 55554432110 11246888899999999999999999 69999999999
Q ss_pred ceeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh--CCCCCCCC
Q 016115 209 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGE 283 (395)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~~ 283 (395)
||+++ .++.+||+|||++......... ....++..|+|||++.+. .++.++||||||+++|+|++ |..||...
T Consensus 159 Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 159 NCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999 6889999999998765333221 112346689999998654 48999999999999999998 67888877
Q ss_pred ChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+..+....+.......... . .......+++.+.+||.+||+.||.+|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~------------~---------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 SDEQVIENTGEFFRNQGRQ------------I---------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ChHHHHHHHHHhhhhcccc------------c---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 6665554443321100000 0 00012245789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=290.99 Aligned_cols=244 Identities=24% Similarity=0.329 Sum_probs=192.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+.... ....+|+.+++.++|+||+++++.+. . ...++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CCcEE
Confidence 35799999999999999999985 467889999886543 34457999999999999999988652 1 23789
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|||+.+ ++.+.+.. .....+++..+..++.|++.||.|||+ .|++|+||||+||+++ .++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 78 ITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVS-ETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEc-CCCCEEEccCcceeecC
Confidence 9999985 55555443 224568899999999999999999999 6999999999999999 78899999999997654
Q ss_pred cCCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 232 KGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 232 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... ....++..|+|||++.+. .++.++||||||+++|+|++ |+.||.+.+..+....+......
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---------- 222 (260)
T ss_pred CCCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC----------
Confidence 32221 123346779999998654 48899999999999999999 99999877665554443221000
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+..++.++.++|.+||+.||++|||++++++
T Consensus 223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 ------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 012346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=296.44 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=192.4
Q ss_pred cCceeeeeeecCCceEEEEEEEC-----CCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.+|.+.+.||+|+||.||++... .++..+|+|.+.... ....+|+++++.++|+||+++++++ .+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecC
Confidence 46888999999999999999742 356789999876432 3456789999999999999999987 444
Q ss_pred eeEEEEEecccc-hHHHHHHhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSS-----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~ 215 (395)
...+++|||+.+ ++.+.+..... ....+++..++.++.||+.||.|||+ +|++||||||+|||++ +
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~-~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVG-Q 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEc-C
Confidence 458999999985 55555543211 11357889999999999999999999 6999999999999999 6
Q ss_pred CCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 016115 216 THQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 291 (395)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~ 291 (395)
++.+||+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||......+....
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 88999999999875533221 1122346789999998654 48999999999999999998 9999987766555444
Q ss_pred HHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+..... ...+..+++.+.+||.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRE----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCcc----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 332100 0012346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=292.72 Aligned_cols=245 Identities=22% Similarity=0.285 Sum_probs=191.5
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCc---EEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.+|...+.||+|+||.||+|++..++. .+|+|.+.... .....|+++++.++|+||+++.+++ .+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccCC
Confidence 468889999999999999999876654 79999886432 2345688999999999999999988 4445
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
..++||||++++.+..+.. .....+++..+..++.|++.||.|||+ .|++|+||||+||+++ .++.+||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~-~~~~~kl~dfg~~~ 155 (268)
T cd05063 80 PAMIITEYMENGALDKYLR--DHDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVN-SNLECKVSDFGLSR 155 (268)
T ss_pred CcEEEEEcCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEc-CCCcEEECCCccce
Confidence 5899999999754333322 223568999999999999999999999 6999999999999999 68899999999987
Q ss_pred ccccCCccee----eeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 229 VLVKGEANIS----YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 229 ~~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
.......... ...+..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---- 230 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---- 230 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC----
Confidence 6543322111 1124569999998654 48999999999999999998 999998776655555443210000
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....++..+.+++.+||+.||++||++.++++
T Consensus 231 ------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 ------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11235788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=293.42 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=191.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCc---EEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..|++.+.||+|+||.||+|.+..+++ .||||.+... ...+..|+.+++.++||||+++++++ .+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 358899999999999999999877665 5999988643 12345689999999999999999988 4555
Q ss_pred eEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..++||||++++ +.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++ .++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~-~~~~~kl~dfg~~ 153 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVN-SNLVCKVSDFGLS 153 (269)
T ss_pred ceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEc-CCCcEEECCCccc
Confidence 689999999875 4333332 23568899999999999999999999 6999999999999999 6889999999998
Q ss_pred cccccCCcceee---e---ecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 228 KVLVKGEANISY---I---CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 228 ~~~~~~~~~~~~---~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
............ . .+..|+|||.+.+. .++.++||||||+++|+|++ |..||...+..+....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~----- 227 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD----- 227 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-----
Confidence 765433221111 1 13469999998654 48999999999999999987 99999877765544443221
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+..+ .+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 228 -------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 -------------YRLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------------CcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 11245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=293.48 Aligned_cols=244 Identities=25% Similarity=0.339 Sum_probs=191.4
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCc---EEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.+|++.+.||+|+||.||+|.+..++. .+|+|.+.... ....+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 468999999999999999999865543 79999885432 2345689999999999999999988 4445
Q ss_pred eEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..++||||++|+ +.+.+.. ....+++..+..++.|++.||.|||+ .|++||||||+|||++ .++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~-~~~~~~l~dfg~~ 153 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVN-SNLVCKVSDFGLS 153 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEEC-CCCeEEeCCCCcc
Confidence 589999999864 4444432 23468899999999999999999999 6999999999999999 6889999999999
Q ss_pred cccccCCcce----eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 228 KVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 228 ~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
.......... ...++..|+|||.+.+. .++.++|+||||+++|++++ |..||......+....+.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----- 227 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR----- 227 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-----
Confidence 8764432211 11224579999999654 48999999999999999887 9999987766554444332100
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.+ ....++..+.+++.+||+.+|.+||++.++++
T Consensus 228 -------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 -------------LP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------CC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 00 11245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=293.71 Aligned_cols=228 Identities=25% Similarity=0.316 Sum_probs=181.1
Q ss_pred CCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecccc-hHHHHHH
Q 016115 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLK 166 (395)
Q Consensus 88 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 166 (395)
|.+|+||++++..+|+.||+|.+..... ..+|...+....||||+++++++ .+....++||||++| +|.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHH
Confidence 8899999999999999999999876543 23455556666799999999988 444568999999996 5555554
Q ss_pred hhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcceeeeeccccc
Q 016115 167 HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 246 (395)
Q Consensus 167 ~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~ 246 (395)
. ...+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.++++|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEc-CCCCEEEecccchhccccc--cccCCcCcccc
Confidence 3 2458999999999999999999999 6999999999999999 6888999999987655332 22334577899
Q ss_pred CchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccc
Q 016115 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 326 (395)
Q Consensus 247 aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (395)
|||.+.+ ..++.++||||+|+++|+|++|..||....... . ... ..
T Consensus 150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~---------------~~~------------~~ 195 (237)
T cd05576 150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI------N---------------THT------------TL 195 (237)
T ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------c---------------ccc------------cc
Confidence 9998854 347899999999999999999998875321100 0 000 00
Q ss_pred cccccCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCCC
Q 016115 327 VFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFF 363 (395)
Q Consensus 327 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~hp~~ 363 (395)
.++..+++.+.+||.+||+.||.+|+++ +++++||||
T Consensus 196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 1234578899999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=316.53 Aligned_cols=265 Identities=27% Similarity=0.404 Sum_probs=217.2
Q ss_pred CCccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHc-CCCceeeeceeeeecCCCCc
Q 016115 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 72 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (395)
.+..++-|++...||.|.+|.||+++++.+|+.+|+|+...+. ...+.|.++++.+ .|||++.++++|.-...-..
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 4455667999999999999999999999999999999886543 3345577788876 59999999999977666666
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..++||||||+| +..++++..+ +.++.|..+..|++.++.||.+||. ..++|||||=.|||++ .++.|||+|||+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT-~e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLT-ENAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEe-ccCcEEEeeeee
Confidence 779999999996 5555666555 7899999999999999999999999 5999999999999999 788999999999
Q ss_pred ccccccCCc-ceeeeecccccCchhhcCCC----CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 227 AKVLVKGEA-NISYICSRYYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 227 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+........ ..+.+||++|||||++.... .|+..+|+||||++..||.-|.+|+.+....-.+..|.+ .|+.
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPP 246 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPP 246 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCc
Confidence 987755443 34678999999999995432 377799999999999999999999987766544443322 1111
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
...-+.+.+.++.+||..||.+|..+||+..++|.|||+++.
T Consensus 247 -----------------------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 247 -----------------------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred -----------------------cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 111234568899999999999999999999999999999843
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=316.87 Aligned_cols=206 Identities=27% Similarity=0.389 Sum_probs=171.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecC-CCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTT-SKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~ 151 (395)
.|...+.||+|+||.||+++++.+|+.||||.+... +....+|++++++++|+|||+++++-.... ..-...-.
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 466778899999999999999999999999988653 333457999999999999999988652221 00022356
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC---CCCcEEEeeccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP---LTHQVKLCDFGSAK 228 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~---~~~~~kl~Dfg~a~ 228 (395)
+|||||.|+.+............+++.+++.++..++.||.|||+ +||+||||||.||++-. ....-||+|||.|+
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 999999975444444445567889999999999999999999999 69999999999999842 22358999999999
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 284 (395)
...++....+.+||..|.+||.+...+.|+..+|.|||||++|+++||..||....
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99999999999999999999999755679999999999999999999999997543
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=297.59 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=193.9
Q ss_pred cccCceeeeeeecCCceEEEEEEEC-------CCCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeee
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFS 141 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (395)
...+|.+.+.||+|+||.||+|++. .++..||+|.+.... ....+|+.+++.+ +|+||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-- 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence 4457999999999999999999753 234579999876432 2345789999999 899999999988
Q ss_pred cCCCCceeEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCC
Q 016115 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (395)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~ 208 (395)
......++||||+.+ +|.+.+..... ....+++..+..++.||+.||.|||+ +|++||||||+
T Consensus 91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~ 166 (304)
T cd05101 91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAAR 166 (304)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccc
Confidence 444568999999985 56555554221 12457888899999999999999999 69999999999
Q ss_pred ceeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 016115 209 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (395)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~ 284 (395)
||+++ .++.+||+|||+++........ ....++..|+|||++.+. .++.++||||||+++|+|++ |..||....
T Consensus 167 Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 167 NVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred eEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999 7889999999999765432221 122346679999998664 48999999999999999998 889998776
Q ss_pred hHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+....+..... ...+..++..+.+||.+||..+|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 6554443322100 00123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=293.34 Aligned_cols=235 Identities=17% Similarity=0.195 Sum_probs=178.1
Q ss_pred eeecCCceEEEEEEECC------------CCcEEEEEEeccccc----chHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 84 VVGTGSFGIVFQAKCLE------------TGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~------------~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.||+|+||.||+|+... ....+++|.+..... .+.+|+.+++.++||||+++++++. ..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~~ 76 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----RD 76 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC
Confidence 58999999999998532 223588888754322 3346788999999999999999883 33
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCc-------EE
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-------VK 220 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~-------~k 220 (395)
...++||||++++.++.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++. ++
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~-~~~~~~~~~~~~~ 152 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLA-REGIDGECGPFIK 152 (262)
T ss_pred CCCEEEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEe-cCCccCCCCceeE
Confidence 447899999997655544332 23568999999999999999999999 7999999999999997 3443 89
Q ss_pred EeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCC
Q 016115 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
++|||++...... ....++..|+|||++.+...++.++|||||||++|+|+ +|..||......+... .... .
T Consensus 153 l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~---~ 225 (262)
T cd05077 153 LSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG---Q 225 (262)
T ss_pred eCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc---C
Confidence 9999998654322 23457888999999865566899999999999999998 5888887654332211 1110 0
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
. ......+.++.+||.+||+.||.+||++.+++++
T Consensus 226 --------------~------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 --------------C------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --------------c------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 0112235789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=296.99 Aligned_cols=248 Identities=25% Similarity=0.308 Sum_probs=193.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECC-----CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
..+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++++++ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence 4579999999999999999998743 67889999886432 3355789999999999999999988 4
Q ss_pred CceeEEEEEecccc-hHHHHHHhhc------------------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCC
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYS------------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~------------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlk 206 (395)
+....+++|||+++ ++.+.+.... .....+++..++.++.||+.||.|||+ +|++|||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~ 157 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLA 157 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeeccccc
Confidence 44458999999995 6655554321 112347888899999999999999999 699999999
Q ss_pred CCceeecCCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCC
Q 016115 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 282 (395)
Q Consensus 207 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~ 282 (395)
|+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+
T Consensus 158 p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999 788999999999875433221 1122345679999998654 48999999999999999998 8889987
Q ss_pred CChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.+..+....+... .. ...+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRDG--NV--------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhcC--CC--------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7665544433221 00 0012346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=291.30 Aligned_cols=236 Identities=23% Similarity=0.291 Sum_probs=183.5
Q ss_pred eeecCCceEEEEEEEC--CCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEec
Q 016115 84 VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 156 (395)
.||+|+||.||+|.+. .++..||+|++.... ....+|+.+++.++|+||+++++++ .. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-----~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----cC-CCeEEEEEe
Confidence 3899999999999765 445679999886442 2345789999999999999999976 22 247899999
Q ss_pred ccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCc
Q 016115 157 VPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235 (395)
Q Consensus 157 ~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 235 (395)
++++ +.+.+.. ....+++..++.++.||+.||.|||+ +|++||||||+||+++ .++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEc-CCCcEEeccCCccccccCCcc
Confidence 9864 4443332 24578999999999999999999999 6999999999999999 688999999999976543322
Q ss_pred ce----eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 236 NI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 236 ~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.. ...++..|+|||++.+. .++.++||||||+++|+|++ |..||......+....+... ..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~----------- 216 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG--KR----------- 216 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--CC-----------
Confidence 11 11224679999998654 48999999999999999996 99999887766544433221 00
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+...++++.++|.+||..||++||++.++.+
T Consensus 217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122456889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=307.49 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=193.4
Q ss_pred cccCceeeeeeecCCceEEEEEEEC-----CCCcEEEEEEecccc-----cchHHHHHHHHHcC-CCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMD-HPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 143 (395)
...+|.+.+.||+|+||.||+|++. .+++.||+|++.... ....+|+.++..+. |+||+++++++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~---- 110 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC---- 110 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE----
Confidence 3446888899999999999999864 345689999996442 13446999999997 99999999988
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhcc----------------------------------------------------
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS---------------------------------------------------- 170 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------------------------------------------- 170 (395)
.....+++||||+.+ +|.+.+.....
T Consensus 111 -~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 111 -TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred -ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 334458999999995 56555543210
Q ss_pred ------------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCC
Q 016115 171 ------------------------------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (395)
Q Consensus 171 ------------------------------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~ 208 (395)
....+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~ 268 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAAR 268 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcc
Confidence 11246777889999999999999999 79999999999
Q ss_pred ceeecCCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 016115 209 NLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (395)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~ 284 (395)
|||++ +++.+||+|||+++....... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||....
T Consensus 269 NiLl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 269 NVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eEEEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999 688999999999976532221 1223467889999999654 48999999999999999998 899998765
Q ss_pred hHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+........ +.. ...+..++.++.+|+.+||..||.+||++.++++.
T Consensus 347 ~~~~~~~~~~~-~~~--------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 347 MNEQFYNAIKR-GYR--------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred chHHHHHHHHc-CCC--------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55544333321 000 00123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=293.83 Aligned_cols=240 Identities=24% Similarity=0.340 Sum_probs=184.2
Q ss_pred eeecCCceEEEEEEECCCCc--EEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 84 VVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
.||+|+||.||+|.+..+|. .+++|.+.... ....+|++++..+ +||||+++++++ ......++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEEE
Confidence 58999999999999988776 46888776321 2344689999999 799999999988 44455899999
Q ss_pred cccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEe
Q 016115 156 YVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (395)
Q Consensus 156 ~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~ 222 (395)
|+.+ +|.+.+..... ....+++..++.++.|++.||+|||+ +|++||||||+||+++ +++.+||+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~-~~~~~kl~ 154 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG-ENYVAKIA 154 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEc-CCCeEEEC
Confidence 9985 66666544221 12357899999999999999999999 6999999999999999 78899999
Q ss_pred ecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 223 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
|||++..............+..|+|||++.+ ..++.++||||||+++|+|++ |..||...+..+....+...
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------ 227 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------ 227 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC------
Confidence 9999864322111112223567999999865 458999999999999999997 99999876655544433210
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+. ......++.++.+|+.+||..||.+|||+.+++.
T Consensus 228 ------------~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 ------------YR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------CC----------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00 0012245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=304.55 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=188.9
Q ss_pred ccCceeeeeeecCCceEEEEEEE-----CCCCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 144 (395)
.++|++.+.||+|+||.||+|.+ ..+++.||||.+.... ....+|+.++..+ +|+||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence 45799999999999999999985 3467899999986432 2344799999999 68999999987743
Q ss_pred CCceeEEEEEecccc-hHHHHHHhhcc-----------------------------------------------------
Q 016115 145 KDELFLNLVMEYVPE-TMYRVLKHYSS----------------------------------------------------- 170 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 170 (395)
....++++|||+++ +|.+.+.....
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 22347899999996 45444432110
Q ss_pred ----------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcc---e
Q 016115 171 ----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---I 237 (395)
Q Consensus 171 ----------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~ 237 (395)
....+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++......... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEc-CCCcEEEEecccccccccCcchhhcC
Confidence 01346788889999999999999999 6999999999999999 7889999999998765332211 1
Q ss_pred eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCC
Q 016115 238 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316 (395)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
...++..|+|||++.+. .++.++||||||+++|+|++ |..||........+...... +..
T Consensus 240 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~----------------- 300 (343)
T cd05103 240 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GTR----------------- 300 (343)
T ss_pred CCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc-cCC-----------------
Confidence 12345679999998654 48999999999999999997 99999765433322222210 000
Q ss_pred CCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 317 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..+++++.+++.+||+.||.+|||+.++++|
T Consensus 301 ---------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 301 ---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00112357789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=289.58 Aligned_cols=239 Identities=24% Similarity=0.347 Sum_probs=189.0
Q ss_pred eeeecCCceEEEEEEECC-CC--cEEEEEEeccccc-----chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLE-TG--ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~-~~--~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|++|.||+|.+.. .+ ..||||.+..... ...+|+.+++.++|+||+++++.+. + ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 368999999999999865 33 3689999875433 3457999999999999999999873 3 5589999
Q ss_pred ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||+++ ++.+.+..... ..+++..++.++.|++.||.|||+ +|++|+||||+||+++ .++.+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLA-SDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEe-cCCEEEecccccccccccc
Confidence 99974 66655554221 568999999999999999999999 6999999999999999 6789999999999876443
Q ss_pred Ccc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 234 EAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 234 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
... ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||...+..+....+... +.
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~---------- 218 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE-GE---------- 218 (257)
T ss_pred ccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CC----------
Confidence 221 123456789999998654 48999999999999999999 99999877776655544331 00
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....+..++..+.+++.+||+.+|++|||+.++++
T Consensus 219 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 219 ----------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ----------------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00012346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=290.48 Aligned_cols=236 Identities=26% Similarity=0.362 Sum_probs=185.4
Q ss_pred eeeecCCceEEEEEEECCCC---cEEEEEEeccccc-----chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||.||+|.+..++ ..+|+|.+..... ...+|+.+++.+.|+||+++++++. . ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----G-EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----C-CceEEEE
Confidence 36999999999999876555 7899998864432 3456889999999999999998762 2 2378999
Q ss_pred ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||+.+ ++.+.+.. ...+++..++.++.|++.||.|||. +|++|+||||+||+++ .++.+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLV-NRHQAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEc-CCCcEEeccccccceeecC
Confidence 99985 55555543 3468999999999999999999999 6999999999999999 7889999999999866443
Q ss_pred Ccce----eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 234 EANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 234 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.... ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||...+..+....+... ..
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~--~~--------- 216 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG--ER--------- 216 (257)
T ss_pred CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC--Cc---------
Confidence 3211 11224579999998654 48999999999999999998 99999877665544433221 00
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..++..+.++|.+||+.||++||++.++++
T Consensus 217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0122346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=296.49 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=190.3
Q ss_pred cCceeeeeeecCCceEEEEEEECC----------------CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISL 135 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~ 135 (395)
.+|++.+.||+|+||.||++.+.. ++..+|+|.+.... ....+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 469999999999999999986532 34578999886432 234579999999999999999
Q ss_pred ceeeeecCCCCceeEEEEEecccc-hHHHHHHhhccc-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCC
Q 016115 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSM-------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (395)
Q Consensus 136 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp 207 (395)
++++ ......++||||+.+ ++.+.+...... ...+++..++.++.||+.||.|||+ .|++|+||||
T Consensus 85 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp 158 (296)
T cd05095 85 LAVC-----ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT 158 (296)
T ss_pred EEEE-----ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence 9988 334458999999985 565555442211 2347788899999999999999999 6999999999
Q ss_pred CceeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh--CCCCCCC
Q 016115 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPG 282 (395)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~ 282 (395)
+|||++ .++.++|+|||+++........ ....++..|+|||+..+. .++.++|||||||++|+|++ |..||..
T Consensus 159 ~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 159 RNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred heEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999 6889999999998765433221 112335679999988654 48999999999999999998 7789987
Q ss_pred CChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.+..+............. ..... ..+..++..+.+|+.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~-----------~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFRDQG-----------RQVYL----------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHhhcc-----------ccccC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 665554433222110000 00000 012345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=301.84 Aligned_cols=267 Identities=23% Similarity=0.391 Sum_probs=209.0
Q ss_pred CCCCCccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccc-----------hHHHHHHHHHcCCCceeeece
Q 016115 69 KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----------KNRELQLMRLMDHPNVISLKH 137 (395)
Q Consensus 69 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----------~~~e~~~l~~l~h~niv~~~~ 137 (395)
..+.+...++|.+..+||+|||+.||+|.+....+.||+|+-..+..+ .-+|.+|-+.|.||.||++++
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 344556677899999999999999999999999999999987433221 226899999999999999999
Q ss_pred eeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-CCceeccCCCCceeecCC-
Q 016115 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPL- 215 (395)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~ivH~Dlkp~Nill~~~- 215 (395)
.|... ...+|.|+|||+|+-++ -|...++.+++.+++.|+.||+.||.||.+. ..|+|-||||.|||+-..
T Consensus 535 yfslD----tdsFCTVLEYceGNDLD---FYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 535 YFSLD----TDSFCTVLEYCEGNDLD---FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeec----cccceeeeeecCCCchh---HHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 88433 23488999999996333 3444568899999999999999999999974 369999999999999622
Q ss_pred -CCcEEEeecccccccccCCcc--------eeeeecccccCchhhcCC---CCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 016115 216 -THQVKLCDFGSAKVLVKGEAN--------ISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (395)
Q Consensus 216 -~~~~kl~Dfg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~ 283 (395)
.|.+||+|||+++...+.... +...||.+|.+||.+.-+ .+.+.++||||+|||+|.++.|+.||...
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 367999999999988665543 235689999999998543 35788999999999999999999999876
Q ss_pred ChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
.....+.+.-..+. ..+..||. ..-++.++++||++||++--++|..+.++..||+|
T Consensus 688 qsQQdILqeNTIlk-------------AtEVqFP~----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl 744 (775)
T KOG1151|consen 688 QSQQDILQENTILK-------------ATEVQFPP----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL 744 (775)
T ss_pred hhHHHHHhhhchhc-------------ceeccCCC----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence 54433222111100 11122221 12479999999999999999999999999999999
Q ss_pred cC
Q 016115 364 DE 365 (395)
Q Consensus 364 ~~ 365 (395)
.-
T Consensus 745 lP 746 (775)
T KOG1151|consen 745 LP 746 (775)
T ss_pred cc
Confidence 65
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=300.97 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=192.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCC-------CcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeec
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFST 142 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 142 (395)
..+|.+.+.||+|+||.||+|.+... +..||+|.+.... ....+|+++++.+ +|+||+++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 87 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 87 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE---
Confidence 34699999999999999999986432 2368999876432 2345789999999 799999999988
Q ss_pred CCCCceeEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCc
Q 016115 143 TSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (395)
Q Consensus 143 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~N 209 (395)
.....++++|||+++ +|.+.+..... ....+++..+..++.||+.||.|||+ +||+||||||+|
T Consensus 88 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N 164 (334)
T cd05100 88 --TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARN 164 (334)
T ss_pred --ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccce
Confidence 444558999999986 55555544221 22457888899999999999999999 699999999999
Q ss_pred eeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCh
Q 016115 210 LLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 285 (395)
Q Consensus 210 ill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~ 285 (395)
||++ .++.+||+|||+++........ ....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+.
T Consensus 165 ill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 165 VLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999 6889999999999765433221 112234679999999654 48999999999999999998 8899988766
Q ss_pred HHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.+....+..... ...+..++..+.+||.+||+.+|.+|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 555444332100 00123457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=289.52 Aligned_cols=246 Identities=25% Similarity=0.336 Sum_probs=194.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
..++|.+.+.||+|+||.||+|.+. ++..||||.+.... ....+|+.+++.++|+||+++++++ ......+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceE
Confidence 3457999999999999999999975 55789999886542 3456799999999999999999987 4445589
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||+.+ ++.+.+... ....+++..++.++.+|+.||.|||+ +|++|+||||+||+++ +++.+||+|||++...
T Consensus 78 ~v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~-~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVG-ENLVCKIADFGLARLI 153 (261)
T ss_pred EEEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEc-CCCCEEECccccceec
Confidence 99999986 555554431 23468999999999999999999999 6999999999999999 6889999999998765
Q ss_pred ccCCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 231 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
...... ....++..|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.+....+..+......
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------- 223 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM--------- 223 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 432111 122235679999998654 48999999999999999999 99999887766655554331110
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+...+.++.+++.+||+.||.+||+++++++
T Consensus 224 -------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 -------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 011234788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=294.29 Aligned_cols=243 Identities=20% Similarity=0.310 Sum_probs=186.0
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCc----EEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.+|++.+.||+|+||+||+|.+..+|. .+++|.+.... .....|+.+++.++|+||+++++++. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----G- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----C-
Confidence 468899999999999999999987776 46777764321 12334666778899999999999762 2
Q ss_pred eeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...++++||+. |++.+.+.. ....+++..++.++.||+.||.|||+ +|++||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~-~~~~~kl~Dfg~ 155 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLK-SDSIVQIADFGV 155 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEc-CCCcEEEcCCcc
Confidence 22678899998 465555543 23568999999999999999999999 7999999999999999 788999999999
Q ss_pred ccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 227 AKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 227 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
++....... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+....... ++... +...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~-~~~~-- 230 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEK-GERL-- 230 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHC-CCcC--
Confidence 986543322 1123456789999998654 48999999999999999998 99999876554332 22221 0000
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+..++.++.+++.+||..||.+|||+.|+++
T Consensus 231 ------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 ------------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 011234678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=288.83 Aligned_cols=245 Identities=19% Similarity=0.296 Sum_probs=192.4
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.+|++.+.||+|+||.||++.+. ++..+|+|.+.... ....+|+++++.++|+||+++++.+ ......++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEE
Confidence 36889999999999999999875 47789999886432 3456799999999999999999987 444568999
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
|||+.++.+..... .....+++..++.++.|++.||.|||+ .|++|+||||+||+++ .++.++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 78 FEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHH--hCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEc-CCCeEEECCCcceeecccC
Confidence 99999754333222 223467889999999999999999999 6999999999999999 7889999999998765333
Q ss_pred Ccc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 234 EAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 234 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
... ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||...........+.....
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------- 219 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR------------- 219 (256)
T ss_pred cccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC-------------
Confidence 221 122345679999998654 58999999999999999998 9999987766555444322100
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus 220 ---------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 220 ---------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00122357899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=293.92 Aligned_cols=236 Identities=19% Similarity=0.208 Sum_probs=178.6
Q ss_pred eeecCCceEEEEEEECCC------------------------CcEEEEEEecccc----cchHHHHHHHHHcCCCceeee
Q 016115 84 VVGTGSFGIVFQAKCLET------------------------GETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISL 135 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~------------------------~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~ 135 (395)
.||+|+||.||+|....+ ...|++|.+.... ..+.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999985322 2358888875432 234467889999999999999
Q ss_pred ceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC
Q 016115 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (395)
Q Consensus 136 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~ 215 (395)
++++. +....++||||++++.+..+.. .....+++..+..++.||+.||.|||+ +||+||||||+|||++..
T Consensus 82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCV-----RGSENIMVEEFVEHGPLDVCLR--KEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEE-----eCCceEEEEecCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEecc
Confidence 99883 4445889999999765544432 224578899999999999999999999 799999999999999732
Q ss_pred ------CCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHH-hCCCCCCCCChHHH
Q 016115 216 ------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 288 (395)
Q Consensus 216 ------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~ 288 (395)
...+|++|||++...... ....++..|+|||.+.+...++.++||||||+++|+|+ +|..||......+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 124899999987643222 22356788999999876566899999999999999995 69999987654432
Q ss_pred HHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 289 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.. ..... ...+...++.+.++|.+||+.+|++|||+.+++++
T Consensus 231 ~~-~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ER-FYEKK-----------------------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-HHHhc-----------------------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22 11100 00112245689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=294.37 Aligned_cols=235 Identities=18% Similarity=0.222 Sum_probs=178.9
Q ss_pred eeecCCceEEEEEEECCCCc-------EEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 84 VVGTGSFGIVFQAKCLETGE-------TVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~~-------~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.||+|+||.||+|.+..++. .+|+|.+.... ....+|..+++.++|+||+++++.+.. ....++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcEE
Confidence 58999999999999865544 38888775432 234568889999999999999998843 334789
Q ss_pred EEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC-------cEEEeec
Q 016115 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-------QVKLCDF 224 (395)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~-------~~kl~Df 224 (395)
||||++++ |...+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++.++. .++++||
T Consensus 77 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 77 VQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999975 4444332 12468899999999999999999999 69999999999999984332 2799999
Q ss_pred ccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 225 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
|++...... ....++..|+|||++.+...++.++||||||+++|+|++| ..||...+....... ...
T Consensus 153 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~-------- 220 (258)
T cd05078 153 GISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YED-------- 220 (258)
T ss_pred ccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHc--------
Confidence 998654322 2345788899999997655689999999999999999998 466665544332221 110
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...++...+.++.+||.+||+.||++|||++++++.
T Consensus 221 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 ---------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ---------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 001223346789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=307.95 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=203.6
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
|..++.||-|+||.|.+++...|...||+|.+.+.. .....|..||..-.++-||+|+..| .+...+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnLY 705 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNLY 705 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCceE
Confidence 888899999999999999988899999999885432 2234688999999999999999988 6666699
Q ss_pred EEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||+|++|+ +..+|.. -+-|+|..++.++.++..|+++.|.+ |+|||||||+||||| .+|.|||+|||++.-+
T Consensus 706 FVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILID-rdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILID-RDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEc-cCCceeeeeccccccc
Confidence 999999974 4444444 46789999999999999999999996 999999999999999 7899999999998543
Q ss_pred c---------cCCc----------------------------------ceeeeecccccCchhhcCCCCCCcccchHhHH
Q 016115 231 V---------KGEA----------------------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAG 267 (395)
Q Consensus 231 ~---------~~~~----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 267 (395)
. .+.- .-..+||+.|+|||++...+ |+..+|+||.|
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~g 858 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVG 858 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhh
Confidence 1 0000 01357899999999997655 89999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccC
Q 016115 268 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 347 (395)
Q Consensus 268 ~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 347 (395)
||||||+.|++||-.....+...+++++.. + +.-.+-.++|+++.+||.++++ +
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~kv~nw~~-------------~------------l~~~~~~~ls~e~~~li~kLc~-s 912 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYKVINWRN-------------F------------LHIPYQGNLSKEALDLIQKLCC-S 912 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceeeeeehhh-------------c------------cccccccccCHHHHHHHHHHhc-C
Confidence 999999999999987766554444333200 0 0111235689999999987654 6
Q ss_pred CCCCCC---HHHHhcCCCCcCCCCCCCC
Q 016115 348 PSLRCT---ALEACAHPFFDELREPNAR 372 (395)
Q Consensus 348 p~~Rpt---~~ell~hp~~~~~~~~~~~ 372 (395)
++.|.. ++|+-.||||+.++..+.+
T Consensus 913 ad~RLGkng~d~vKaHpfFkgIDfsslR 940 (1034)
T KOG0608|consen 913 ADSRLGKNGADQVKAHPFFKGIDFSSLR 940 (1034)
T ss_pred hhhhhcccchhhhhcCccccccchHhhh
Confidence 778874 6789999999998876543
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=287.18 Aligned_cols=242 Identities=27% Similarity=0.399 Sum_probs=192.7
Q ss_pred eeeeeeecCCceEEEEEEECCCC----cEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 80 MAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 80 ~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.+.+.||.|+||.||++.+..++ ..||+|.+.... .....|+.+++.++|+||+++++++ .+....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC-----TEEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE-----cCCCee
Confidence 46688999999999999998766 899999986443 2445789999999999999999988 444568
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++|||+++ ++.+.+.... ...+++..+..++.|++.||.+||+ .|++|+||||+||+++ .++.++|+|||++..
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~-~~~~~~l~dfg~~~~ 152 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRD 152 (258)
T ss_pred EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEc-cCCeEEEcccCCcee
Confidence 999999986 5555544321 1228999999999999999999999 6999999999999999 688999999999977
Q ss_pred cccCCccee--eeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 230 LVKGEANIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 230 ~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
......... ..++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+..+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------- 222 (258)
T ss_pred cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 654422211 235788999999854 458999999999999999998 8899987766655554433100
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..++.++.+++.+||..||++|||+.|+++
T Consensus 223 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 -------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0012336889999999999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=291.85 Aligned_cols=250 Identities=20% Similarity=0.269 Sum_probs=193.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECC----CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
..++|.+.+.||+|+||.||+|.+.. ++..|++|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 34579999999999999999999875 35789999886432 2245688999999999999999977432
Q ss_pred CceeEEEEEeccc-chHHHHHHhhccc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEE
Q 016115 146 DELFLNLVMEYVP-ETMYRVLKHYSSM----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (395)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~k 220 (395)
....+++++|++ +++.+.+...... ...+++..++.++.||+.||.|||+ .|++|+||||+||+++ +++.+|
T Consensus 81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~-~~~~~k 157 (280)
T cd05043 81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVID-EELQVK 157 (280)
T ss_pred -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEc-CCCcEE
Confidence 234789999998 4555555443221 1568999999999999999999999 6999999999999999 788999
Q ss_pred EeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 016115 221 LCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL 296 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~ 296 (395)
|+|||+++........ ....++..|+|||++.+. .++.++||||||+++|++++ |..||...+..+....+...
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~- 235 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG- 235 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-
Confidence 9999999765433221 122346679999998654 48999999999999999999 99999877665543332221
Q ss_pred CCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+... ....+++++.+++.+||..||++|||+.++++
T Consensus 236 -----------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 -----------------YRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -----------------CCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 11245789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=286.71 Aligned_cols=236 Identities=24% Similarity=0.371 Sum_probs=184.5
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEeccc
Q 016115 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP 158 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 158 (395)
.||+|+||.||+|.. .++..+|+|.+.... ....+|+++++.++|+||+++++++ ......++||||++
T Consensus 2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~ 75 (250)
T cd05085 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC-----TQRQPIYIVMELVP 75 (250)
T ss_pred ccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE-----ecCCccEEEEECCC
Confidence 689999999999985 468899999876432 2345789999999999999999988 34445899999998
Q ss_pred ch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcce
Q 016115 159 ET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 237 (395)
Q Consensus 159 ~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~ 237 (395)
++ +.+.+.. ....+++..++.++.+++.||.|||+ +|++|+||||+||+++ .++.+||+|||++..........
T Consensus 76 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 76 GGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEc-CCCeEEECCCccceecccccccc
Confidence 64 4443322 23457899999999999999999999 6999999999999999 78899999999987543332211
Q ss_pred --eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCC
Q 016115 238 --SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314 (395)
Q Consensus 238 --~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
...++..|+|||++.+. .++.++||||||+++|++++ |..||...........+....
T Consensus 151 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~------------------ 211 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY------------------ 211 (250)
T ss_pred CCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC------------------
Confidence 11235679999998654 58999999999999999998 999998776555444332210
Q ss_pred CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....+..++..+.+|+.+||..+|++||++.++++
T Consensus 212 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 212 ----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=290.25 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=193.3
Q ss_pred cCceeeeeeecCCceEEEEEEECC-----CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
.+|.+.+.||+|+||.||+|+++. +.+.|++|.+.... ....+|+++++.++|+||+++++.+ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 468999999999999999999754 34679999875432 2356799999999999999999987 45
Q ss_pred ceeEEEEEecccc-hHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEE
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSM-----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~k 220 (395)
....++||||+++ +|.+.+...... ...+++..+..++.||+.||.|||+ +||+||||||+||+++ .++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~-~~~~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVS-SQREVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEe-CCCcEE
Confidence 5568999999985 555555443211 1268999999999999999999999 6999999999999999 688899
Q ss_pred EeecccccccccCC--cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016115 221 LCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 297 (395)
Q Consensus 221 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~ 297 (395)
|+|||++....... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||...........+...
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~-- 234 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG-- 234 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence 99999986543221 12233557789999998654 47899999999999999999 88999766554444333210
Q ss_pred CCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
. ..+ .....++..+.++|.+||+.||.+|||+.+++.+
T Consensus 235 ~---------------~~~----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 K---------------LEL----------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred C---------------cCC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 000 0123568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=289.49 Aligned_cols=246 Identities=20% Similarity=0.225 Sum_probs=182.3
Q ss_pred eeeecCCceEEEEEEEC--CCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 83 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
+.||+|+||.||+|.+. .++..+|+|.+.... ....+|+.+++.++|+||+++++++ .+...+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence 35899999999999864 355689999886432 2345689999999999999999988 44445889999
Q ss_pred cccc-hHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 156 YVPE-TMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 156 ~~~~-~l~~~l~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
|+++ ++.+.+..... .....++..++.++.|++.||.|||+ +|++|+||||+||+++ .++.+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEc-CCCcEEECCccccccccCc
Confidence 9995 55555543222 22345677788899999999999999 6999999999999999 6889999999998754332
Q ss_pred Ccc---eeeeecccccCchhhcCC------CCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 234 EAN---ISYICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 234 ~~~---~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
... ....++..|+|||++.+. ..++.++||||||+++|+|++ |..||......+...........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----- 228 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL----- 228 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence 211 123457789999998532 135789999999999999996 99999876655543332221000
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.++ ........++.+.+++.+|+ .+|++|||+++++.
T Consensus 229 -----------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 -----------KLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -----------CCC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 00112245788999999998 68999999999973
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=290.01 Aligned_cols=245 Identities=21% Similarity=0.285 Sum_probs=182.8
Q ss_pred eeecCCceEEEEEEECC--CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEec
Q 016115 84 VVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 156 (395)
.||+|+||.||+|.... ....+|+|.+.... ....+|+.+++.++|+||+++++.+ .....+++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEEe
Confidence 58999999999996432 34578888775332 2335688899999999999999988 444558999999
Q ss_pred ccc-hHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC
Q 016115 157 VPE-TMYRVLKHYSSM-NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (395)
Q Consensus 157 ~~~-~l~~~l~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (395)
+++ +|.+.+...... ....++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEec-CCCcEEEeccccccccccch
Confidence 985 555555543221 2345677888999999999999999 6999999999999999 78899999999986543222
Q ss_pred cc---eeeeecccccCchhhcC------CCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 235 AN---ISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 235 ~~---~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
.. ....++..|+|||++.. ...++.++|||||||++|+|++ |..||......+.+..........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~----- 229 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK----- 229 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc-----
Confidence 11 12234667999999743 2346889999999999999999 889998777666555544321110
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
++ .......++..+.+++..|+ .||++|||++++++
T Consensus 230 -----------~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 230 -----------LP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -----------CC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 00 01123457888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=291.97 Aligned_cols=260 Identities=26% Similarity=0.357 Sum_probs=188.1
Q ss_pred cCceeeeeeecCCceEEEEEE----ECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.+|++.+.||+|+||.||++. +..++..||+|.+.... ....+|+++++.++|+||+++++++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence 468999999999999999997 34578899999986432 2345799999999999999999876432 234
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~-~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVE-SENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEEC-CCCeEEECCCccc
Confidence 58899999985 55555432 13458899999999999999999999 6999999999999999 6889999999999
Q ss_pred cccccCCcce----eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCh-
Q 016115 228 KVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG-TPTR- 301 (395)
Q Consensus 228 ~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~- 301 (395)
+......... ...++..|+|||++.+. .++.++||||||+++|+|++|..++...... ....+..... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchH
Confidence 8764432211 11224459999998654 4899999999999999999998776443211 1100000000 0000
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
......... ........++.++.+||.+||..||++|||+.+++.
T Consensus 234 ~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 234 HLIELLKNN-------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHhcC-------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000000000 000112356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=316.90 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=203.3
Q ss_pred CceeeeeeecCCceEEEEEEECC-----CCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
+.+..+.||+|+||+||+|+... +...||||.++.. +.++++|++++..++|||||+++|++ ...
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-----~~~ 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC-----REG 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----ccC
Confidence 45566789999999999998532 3457999988754 45678999999999999999999999 444
Q ss_pred eeEEEEEeccc-chHHHHHHhhccc------C----CCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCC
Q 016115 148 LFLNLVMEYVP-ETMYRVLKHYSSM------N----QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (395)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~------~----~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~ 216 (395)
.-+|+|+|||. |+|.+.|...... . ..++..+...|+.||+.|+.||-+ ..+|||||-..|.||+ ++
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVg-e~ 639 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVG-EN 639 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceec-cc
Confidence 45999999999 7888887654332 2 237889999999999999999999 5999999999999999 89
Q ss_pred CcEEEeecccccccccCCccee---eeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 016115 217 HQVKLCDFGSAKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 292 (395)
Q Consensus 217 ~~~kl~Dfg~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~ 292 (395)
..|||+|||+++.....+.... ..-...|||||.++-+ +++++|||||+||+|||+++ |..||.+..+.+.+..+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 9999999999987765544322 2235679999999765 59999999999999999998 99999999999888877
Q ss_pred HHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHh
Q 016115 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (395)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 358 (395)
....- -..++.+|.++.+|+..||+.+|.+||++.||-
T Consensus 719 ~~g~l----------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 719 RAGQL----------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HcCCc----------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 65200 113467899999999999999999999999873
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=285.82 Aligned_cols=237 Identities=24% Similarity=0.358 Sum_probs=185.6
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecc
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
+.||.|+||.||++.+.. ++.||+|.+.... ....+|+++++.++|+||+++++++ .+....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence 368999999999999877 9999999876432 2345789999999999999999988 4445589999999
Q ss_pred cch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcc
Q 016115 158 PET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (395)
Q Consensus 158 ~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (395)
.|+ +.+.+.. ....+++..+..++.+++.||.|||+ +|++||||||+||+++ .++.+||+|||++.........
T Consensus 75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEc-CCCcEEEeeccccccccCCcce
Confidence 864 4444432 23467888999999999999999999 6999999999999999 7889999999998765422211
Q ss_pred e---eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 237 I---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 237 ~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
. ...++..|+|||.+.+. .++.++||||||+++|+|+| |..||...........+.....
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~--------------- 213 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR--------------- 213 (251)
T ss_pred eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC---------------
Confidence 1 11225569999998654 58999999999999999999 8899987765444333322100
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..++.++.++|.+||+.+|.+|||+.|+++
T Consensus 214 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 214 -------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0012346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=285.94 Aligned_cols=244 Identities=24% Similarity=0.349 Sum_probs=191.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.++|.+.+.||+|+||.||++.+. .+..+|+|.+.... ....+|+.+++.++|+||+++++++. + ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeEE
Confidence 457999999999999999999854 55679999886532 33457999999999999999988873 2 34789
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|||+++ ++.+.+... ....+++..++.++.|++.||.|||+ .|++|+||||+||+++ .++.+||+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVS-ASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEc-CCCcEEECCCcceeecc
Confidence 9999985 666555432 23567888899999999999999999 6999999999999999 78899999999987654
Q ss_pred cCCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 232 KGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 232 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... ....++..|+|||++.+. .++.++|+||||+++|+++| |..||...+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------- 221 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR----------- 221 (260)
T ss_pred CCCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-----------
Confidence 33221 122345679999998654 58999999999999999999 9999987766554443322100
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
. .....++.++.+++.+||+.||++||++.++++
T Consensus 222 -------~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 -------M----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -------C----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0 012346889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=292.10 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=187.3
Q ss_pred CceeeeeeecCCceEEEEEEE----CCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.|.+.+.||+|+||.||++++ ..++..||+|.+.... ....+|+.+++.++|+||+++.+++... +..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 478999999999999999984 4578899999986332 2345799999999999999999887432 234
Q ss_pred eEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..++||||++|+ |.+.+.. ....+++..+..++.||+.||.|||+ +|++||||||+||+++ .++.++|+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~-~~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVE-SEHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEc-CCCCEEECCCccc
Confidence 578999999864 4444432 12458999999999999999999999 7999999999999999 6888999999999
Q ss_pred cccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh--
Q 016115 228 KVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-- 301 (395)
Q Consensus 228 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-- 301 (395)
+........ ....++..|+|||++.+. .++.++||||||+++|+|+|+..|+..... .. .+..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~ 230 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQM 230 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccc
Confidence 866443221 123456679999998654 489999999999999999998766533211 00 000000000
Q ss_pred --h-hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 302 --E-EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 302 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
. ........ ........++..+.+||.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 231 TVTRLVRVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cHHHHHHHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 00000000 0001123568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=289.63 Aligned_cols=243 Identities=25% Similarity=0.341 Sum_probs=190.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCc----EEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.+|++.+.||+|+||+||+|.+..+|. .+|+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 468999999999999999999877765 58999876442 234478999999999999999998743
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...++||||+.+ ++.+.+.. ....+++..+..++.||+.||+|||+ +|++|+||||+||+++ .++.+||+|||+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~-~~~~~kL~dfg~ 155 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVK-TPQHVKITDFGL 155 (279)
T ss_pred CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEc-CCCeEEECCCcc
Confidence 347899999985 55544432 23458999999999999999999999 7999999999999999 688999999999
Q ss_pred ccccccCCccee---eeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 227 AKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 227 a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
++.......... ..++..|+|||.+.. ..++.++|+||||+++|++++ |..||......+....+... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~--- 229 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG--ER--- 229 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC--CC---
Confidence 986643332221 112467999999854 458999999999999999999 99999887665544433321 00
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+...+..+.+++.+||..||.+||++.++++
T Consensus 230 -----------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 -----------------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0012235778999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=289.54 Aligned_cols=240 Identities=23% Similarity=0.313 Sum_probs=186.1
Q ss_pred eeecCCceEEEEEEECCCC------cEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 84 VVGTGSFGIVFQAKCLETG------ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.||+|+||.||+|++.... ..+|||.+.... ....+|+.+++.++|+||+++++++ .+....++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-----LLNEPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-----cCCCCeEE
Confidence 5899999999999976543 679999875432 2345789999999999999999988 34445899
Q ss_pred EEecccc-hHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC-----cEEEee
Q 016115 153 VMEYVPE-TMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-----QVKLCD 223 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~-----~~kl~D 223 (395)
||||+++ ++.+.+..... ....+++..+..++.||+.||.|||+ ++++|+||||+||+++ .++ .++|+|
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~-~~~~~~~~~~~l~d 154 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVS-EKGYDADRVVKIGD 154 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEe-cCCCCCCcceEECC
Confidence 9999985 66666544222 22457889999999999999999999 6999999999999998 455 799999
Q ss_pred cccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016115 224 FGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 224 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
||++......... ....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+... .
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--~- 230 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG--G- 230 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC--C-
Confidence 9998765333211 122346789999999654 48999999999999999998 99999877665544433210 0
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....+..++..+.+||.+||..+|.+||++.++++
T Consensus 231 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 -------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00122346889999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=285.97 Aligned_cols=240 Identities=23% Similarity=0.350 Sum_probs=189.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
.+|++.+.||+|+||.||++.. +++.||+|.+..+. ....+|+.+++.++|+||+++++++.. . ..+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----N-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----C-CcEEEE
Confidence 4699999999999999999864 78899999886432 234579999999999999999988732 2 268999
Q ss_pred ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||+.+ ++.+.+... ....+++..++.++.|++.||.|||+ .|++||||||+||+++ .++.+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVS-EDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEc-CCCcEEECCCccceecccc
Confidence 99985 665555432 23468899999999999999999999 6999999999999999 6889999999998754322
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
. .....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+.+..
T Consensus 154 ~--~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------- 214 (254)
T cd05083 154 V--DNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---------------- 214 (254)
T ss_pred C--CCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC----------------
Confidence 1 122335679999998654 58999999999999999998 999998776655433332210
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
. ......++..+.++|.+||+.+|++||++++++.
T Consensus 215 --~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 --R----------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --C----------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=286.62 Aligned_cols=243 Identities=28% Similarity=0.379 Sum_probs=190.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCC---CcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.+|.+.+.||+|+||.||+|.+... ...||||...... ....+|+.+++.++|+||+++++++. +.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~- 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-----EN- 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc-----CC-
Confidence 4688999999999999999987544 3468999876432 23457899999999999999998773 22
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..++||||+++ ++.+.+... ...+++..++.++.+++.||.|||+ .|++|+||||+||+++ .++.++|+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~-~~~~~~l~d~g~~ 154 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVS-SPDCVKLGDFGLS 154 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEe-cCCCeEEccCcee
Confidence 36799999985 555554431 3458999999999999999999999 6999999999999999 6889999999998
Q ss_pred cccccCCcce--eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 228 KVLVKGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 228 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
.......... ...++..|+|||.+... .++.++||||||+++|+|++ |..||...+..+....+... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~--~~----- 226 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG--ER----- 226 (270)
T ss_pred eecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--Cc-----
Confidence 7654432211 12234579999998554 58999999999999999996 99999887766555443321 00
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..++..+.++|.+||..+|.+|||+.+++.
T Consensus 227 ---------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 227 ---------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=285.83 Aligned_cols=233 Identities=19% Similarity=0.191 Sum_probs=178.7
Q ss_pred eeeecCCceEEEEEEECCCC----------cEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 83 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~----------~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
+.||+|+||.||+|.+..++ ..+++|.+.... ..+.+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence 36899999999999998776 357888765433 345578899999999999999998743 23
Q ss_pred EEEEEecccchHH-HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC-------cEEE
Q 016115 150 LNLVMEYVPETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-------QVKL 221 (395)
Q Consensus 150 ~~lv~e~~~~~l~-~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~-------~~kl 221 (395)
.++||||++++.+ +.+... ...+++..+..++.||+.||.|||+ +||+||||||+||+++ .++ .+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~-~~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVA-RYGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEe-cCccccCCceeEEe
Confidence 6899999996543 333321 2268899999999999999999999 6999999999999998 455 6999
Q ss_pred eecccccccccCCcceeeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016115 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
+|||++..... .....++..|+|||++.+. ..++.++||||||+++|+|++ |..||...+..+....... .
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~ 222 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q 222 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C
Confidence 99999876543 2234567789999998665 358999999999999999999 5788876543222111110 0
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+......+.++|.+||..||.+|||+.++++
T Consensus 223 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 --------------------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred --------------------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0001112368999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=284.76 Aligned_cols=245 Identities=20% Similarity=0.249 Sum_probs=182.0
Q ss_pred eeecCCceEEEEEEECCC--CcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEec
Q 016115 84 VVGTGSFGIVFQAKCLET--GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 156 (395)
.||+|+||+||++..... ...+++|.+.... ....+|+.+++.++||||+++++.+ .+....++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC-----VEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEe-----cCCCccEEEEec
Confidence 599999999999975432 2356677665332 3445688889999999999999988 444568999999
Q ss_pred ccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC-
Q 016115 157 VPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE- 234 (395)
Q Consensus 157 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 234 (395)
+++ +|.+.+..........++..++.++.||+.||.|||+ ++++||||||+|||++ .++.++|+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEc-CCccEEecccccccccCcchh
Confidence 995 5555555433334456777888999999999999999 6999999999999999 68899999999986432221
Q ss_pred --cceeeeecccccCchhhcCC------CCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 235 --ANISYICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 235 --~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
......++..|+|||++... ..++.++||||||+++|+|++ |..||...+..+.+..+.+......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~----- 229 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL----- 229 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc-----
Confidence 12234578889999987431 235789999999999999997 5788887776666665543211100
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+...+...+++.+.+++..|+ .+|++||++.++++
T Consensus 230 ------------------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 230 ------------------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ------------------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 011122346788999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=292.20 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=188.2
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCc----EEEEEEeccccc-----chHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.+|++.+.||+|+||.||+|.+..+|. .+|+|.+..... ...+|+.+++.++|+||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----P 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----C
Confidence 468889999999999999999887776 468887764422 34568899999999999999998732 1
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..++++||+++ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+|+||||+||+++ .++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~-~~~~~kL~Dfg~ 155 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVK-SPNHVKITDFGL 155 (303)
T ss_pred -CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeec-CCCceEEccccc
Confidence 25689999985 55555432 23468889999999999999999999 6999999999999998 678899999999
Q ss_pred ccccccCCcce---eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 227 AKVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 227 a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
++......... ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+....+.. .+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~---- 229 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGER---- 229 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCC----
Confidence 98654332211 22346689999998654 48999999999999999997 99999876544332 22221000
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.+ .+..++..+.+++.+||..||++||++.++++.
T Consensus 230 -------------~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 230 -------------LP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -------------CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 112357789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=284.61 Aligned_cols=239 Identities=23% Similarity=0.359 Sum_probs=179.7
Q ss_pred eeeecCCceEEEEEEECC---CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||.||+|.+.. .+..+|+|.+.... ....+|+.+++.++||||+++++++.. .+...+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 368999999999998653 34579999875321 234468889999999999999986632 233477999
Q ss_pred ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
||+.+ ++.+.+... ....++..+..++.||+.||.|||+ .|++||||||+|||++ .++.+||+|||+++.....
T Consensus 77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEc-CCCcEEECCccccccccCC
Confidence 99985 554444321 2345777788899999999999999 6999999999999999 6889999999998755332
Q ss_pred Cc-----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 234 EA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 234 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.. .....++..|+|||.+.+. .++.++||||||+++|+|++ |.+||...+..+....+... ..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~-------- 220 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR-------- 220 (262)
T ss_pred cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC--------
Confidence 11 1122346679999998654 58999999999999999999 56777766655443332220 00
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..++..+.+++.+||..||++||++.+++.
T Consensus 221 ------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 221 ------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0012245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=318.43 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=201.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCC-----cEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
...-...+.||+|+||.||.|...... ..||||.+.+. ...+.+|..+|+.++|||||+++|+++...
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~-- 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG-- 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC--
Confidence 345677889999999999999865432 24899988654 344568999999999999999999996533
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEE
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl 221 (395)
..+|++|||.| +|+..+++-.. ....++......++.+|+.|+.||++ +++|||||...|+|++ ....+||
T Consensus 769 ---~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~-~~r~VKI 843 (1025)
T KOG1095|consen 769 ---PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLD-ERRVVKI 843 (1025)
T ss_pred ---CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeec-ccCcEEE
Confidence 37899999995 66666655321 24678899999999999999999999 6999999999999999 6799999
Q ss_pred eecccccccccCCcceeee-e--cccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016115 222 CDFGSAKVLVKGEANISYI-C--SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 297 (395)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~-g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~ 297 (395)
+|||+|+.+.+........ + ...|||||.+.. ..++.++|||||||++||++| |..||.+.++.+.+..+.+.-
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg- 921 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG- 921 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-
Confidence 9999999665544432211 1 346999999976 459999999999999999999 999999999998888766531
Q ss_pred CCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
. -..+..++..+.+++.+||+.+|++||++..+++
T Consensus 922 -R--------------------------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 -R--------------------------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -c--------------------------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 1 1134678999999999999999999999999886
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.62 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=192.6
Q ss_pred CceeeeeeecCCceEEEEEEECCCCc---E-EEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGE---T-VAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~---~-vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
+-.+.++||+|+||.||+|+....+. . ||+|..+.+ ...+.+|+++++.++|||||+++|+. ..
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa-----~~ 232 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA-----VL 232 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----cC
Confidence 34455799999999999999765432 3 899987642 23345799999999999999999988 44
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
..-++||||+|.| +|.+.|... .+.++..+...++.+.+.||+|||+ ++++||||-..|+|++ .++.+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~-~~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYS-KKGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheec-CCCeEEeCccc
Confidence 4459999999997 555555542 2368999999999999999999999 6999999999999999 67778999999
Q ss_pred cccccccCCcceee-eecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 226 SAKVLVKGEANISY-ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 226 ~a~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
+++........... --...|+|||.+... .|+.++|||||||++||+++ |..||.+....+....+....
T Consensus 308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~------- 379 (474)
T KOG0194|consen 308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG------- 379 (474)
T ss_pred cccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC-------
Confidence 98764311111111 124569999999765 69999999999999999999 889999999888877774410
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+....+..-+.++..++.+|+..||++|||+.++.+
T Consensus 380 --------------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 380 --------------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --------------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 011123355888999999999999999999998864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=292.31 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=198.1
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
......++++||+|.||.|.+|.- ..+..||+|+++.+ +..+.+|+++|.+|+|||||.++++|.....
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP----- 609 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP----- 609 (807)
T ss_pred chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----
Confidence 344577889999999999999985 34689999998644 3566789999999999999999999954443
Q ss_pred EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+++|+||++ |+|.+.+....... +.-....+|+.||+.|++||.+. ++|||||.+.|+|++ .++++||+|||+++
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~-~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVD-GEFTIKIADFGMSR 685 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh-chhhccccccceeec-CcccEEecCccccc
Confidence 899999999 55555554432111 23334556999999999999995 999999999999999 79999999999999
Q ss_pred ccccCCccee---eeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 229 VLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 229 ~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
.+..+..... .+-...|||+|.+..+ ++++++|+|+||+++||+++ ...||....+++...+.-..+.......
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV 764 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce
Confidence 7766655432 3346789999999765 49999999999999999875 6789998888777766555443333221
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHH
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el 357 (395)
+ ...+.-++..+.+|+.+|+.+|-.+||+++++
T Consensus 765 ~---------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 765 V---------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred e---------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 1 11234578899999999999999999999998
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=283.36 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=188.7
Q ss_pred ceeeeeeecCCceEEEEEEEC---CCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc-e
Q 016115 79 YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE-L 148 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~-~ 148 (395)
|.+.+.||+|+||.||+|.+. .++..||||.+..+. ....+|+++++.++||||+++++.+......+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999864 357899999886532 224468999999999999999997754332222 2
Q ss_pred eEEEEEecccc-hHHHHHHhhc--ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
..+++++|+.+ ++...+.... .....+++..++.++.||+.||+|||+ +||+||||||+||+++ .++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~-~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLN-ENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEc-CCCCEEECccc
Confidence 35688899985 4443332211 122357889999999999999999999 7999999999999999 78899999999
Q ss_pred cccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 226 SAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 226 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+++....... .....++..|++||.+.+. .++.++||||||+++|+|++ |..||...+..+....+... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~~- 234 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG--NRL- 234 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--CcC-
Confidence 9886543321 1122345679999998654 47899999999999999999 89999877665444433321 000
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
......+..+.+++.+||+.+|++||++.+++.
T Consensus 235 -------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 235 -------------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred -------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=281.73 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=188.8
Q ss_pred cCceeeeeeecCCceEEEEEEEC----CCCcEEEEEEeccccc-----chHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..|.+.+.||+|+||.||+|.+. .+++.||+|.+..... ...+|+++++.++|+||+++++++.. .+.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 35788899999999999999864 3478999999865433 45678999999999999999987733 224
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...+++|||+++ ++.+.+... ...+++..+..++.|++.||.|||+ +|++|+||||+||+++ .++.++|+|||+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVE-SEDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEc-CCCCEEEccccc
Confidence 458899999985 555554431 2358999999999999999999999 6999999999999999 688999999999
Q ss_pred ccccccCCcce----eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHH-----------HHH
Q 016115 227 AKVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-----------LVE 291 (395)
Q Consensus 227 a~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-----------~~~ 291 (395)
+.......... ...++..|+|||.+.+. .++.++||||||+++|+|+||..||........ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 98765332211 12335569999998654 589999999999999999999999865432110 011
Q ss_pred HHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+..... ... . ...+..++.++.+|+.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~-----------~~~---~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 235 LLELLK-----------EGE---R----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHH-----------cCC---c----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111000 000 0 0011345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=293.73 Aligned_cols=273 Identities=23% Similarity=0.290 Sum_probs=182.6
Q ss_pred ccccCceeeeeeecCCceEEEEEEEC----------------CCCcEEEEEEeccccc------------------chHH
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCL----------------ETGETVAIKKVLQDRR------------------YKNR 119 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~ 119 (395)
...++|.+.++||+|+||+||+|.+. ..++.||||.+..... ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45668999999999999999999752 2456799999854321 1123
Q ss_pred HHHHHHHcCCCce-----eeeceeeeecC---CCCceeEEEEEecccc-hHHHHHHhhcc--------------------
Q 016115 120 ELQLMRLMDHPNV-----ISLKHCFFSTT---SKDELFLNLVMEYVPE-TMYRVLKHYSS-------------------- 170 (395)
Q Consensus 120 e~~~l~~l~h~ni-----v~~~~~~~~~~---~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------------------- 170 (395)
|+.++..++|.++ +++++++.... .......++||||+++ +|.+.+.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 5666677766654 56666653221 1123347899999996 55554432110
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCccee--eeecccccCc
Q 016115 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--YICSRYYRAP 248 (395)
Q Consensus 171 ~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~gt~~y~aP 248 (395)
....+++..++.++.|++.+|.|||+ .+|+||||||+|||++ .++.+||+|||++........... ..+|+.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 11234677888999999999999999 6999999999999999 678999999999976543332222 2347899999
Q ss_pred hhhcCCCC-------------------C--CcccchHhHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 249 ELIFGATE-------------------Y--TTSIDIWSAGCVLAELLLGQP-LFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 249 E~~~~~~~-------------------~--~~~~DiwslG~il~~lltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
|++..... + ..+.||||+||++|+|++|.. ||.......... +. .......|+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~---~~-~~~~~~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL---RQ-YDNDLNRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH---hh-ccchHHHHHh
Confidence 99853211 1 134799999999999999875 775432211110 00 0000011111
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCC---CCCCCHHHHhcCCCCc
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP---SLRCTALEACAHPFFD 364 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp---~~Rpt~~ell~hp~~~ 364 (395)
....- +........++.++||+.+||..+| .+|+|++|+|+||||.
T Consensus 456 ~~~~~------------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 456 YKGQK------------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred hcccC------------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 11000 0111234568999999999999876 6899999999999995
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=280.40 Aligned_cols=286 Identities=29% Similarity=0.484 Sum_probs=216.7
Q ss_pred cccCceeeeeeecCCceEEEEEEECC---CCcEEEEEEeccc--ccchHHHHHHHHHcC-CCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQD--RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 148 (395)
....|.++.+||+|.|++||++.+.. .++.||+|.+... ......|+++|..+. +.||+++.+++ ..+.
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCC
Confidence 34469999999999999999999877 7889999988533 344668999998885 99999999999 7777
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+.+|+||++..-...+. ..++...++.+++.++.||.++|. +|||||||||+|+|.+...+.-.|+|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHH
Confidence 799999999964333332 346688899999999999999999 7999999999999999888899999999986
Q ss_pred ccccCC---------------------------------------------cceeeeecccccCchhhcCCCCCCcccch
Q 016115 229 VLVKGE---------------------------------------------ANISYICSRYYRAPELIFGATEYTTSIDI 263 (395)
Q Consensus 229 ~~~~~~---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 263 (395)
...... ......||++|+|||++.....-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 210000 00124689999999999888778999999
Q ss_pred HhHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChhhhhhcC------------------CCCCCCCCCCc-cCC-
Q 016115 264 WSAGCVLAELLLGQPLFP-GENAVDQLVEIIKVLGTPTREEIRCMN------------------PNYTDFRFPQI-KAH- 322 (395)
Q Consensus 264 wslG~il~~lltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~-~~~- 322 (395)
||.|||++.++++..||- ..++.+.+.++...+|..........- ..+.......+ ...
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 999999999999998875 566667777777766654333221111 11111100000 001
Q ss_pred --CccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 323 --PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 323 --~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
-+.....+..+..+.+|+.+||..||.+|.|++++|.||||...++....
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~~~ 393 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTERG 393 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhhhh
Confidence 12233345567789999999999999999999999999999976665443
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=290.47 Aligned_cols=269 Identities=22% Similarity=0.303 Sum_probs=215.0
Q ss_pred ceeeeeeecCCceEEEEEEECCC-C--cEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~-~--~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
..+.++||+|.||+|++|.|... | ..||||.+..+. ..+.+|+.+|.+|+|+|+++++|+..+ .-+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~ 185 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPA 185 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chh
Confidence 45557899999999999998653 3 358999986543 346789999999999999999998843 125
Q ss_pred EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
-+|||+++ |+|++.|.+ .....+.......++.||+.|+.||.+ +++|||||-..|+|+- ....|||+|||+.+.
T Consensus 186 mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNllla-sprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLA-SPRTVKICDFGLMRA 261 (1039)
T ss_pred hHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheec-ccceeeeecccceec
Confidence 69999999 688887776 446778889999999999999999999 7999999999999998 578899999999999
Q ss_pred cccCCcceeeee----cccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 230 LVKGEANISYIC----SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 230 ~~~~~~~~~~~g----t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
+..+.......+ ...|+|||.+... .++.++|||++||++|||+| |..||.+....+.+..+-+. ...
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--erL---- 334 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--ERL---- 334 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc--ccC----
Confidence 877776654333 3459999999765 59999999999999999999 89999999988888776532 111
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFN 384 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~ 384 (395)
.-+..+++++.++++.||..+|.+|||+.+|.+.-++...-....+....-.-+.-+.
T Consensus 335 ----------------------pRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a~~~~d~~ep~aLh 392 (1039)
T KOG0199|consen 335 ----------------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVARETYDSIEPGALH 392 (1039)
T ss_pred ----------------------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCceeeeeccccCCCcee
Confidence 0234579999999999999999999999999776666665554444444444444444
Q ss_pred ch
Q 016115 385 FK 386 (395)
Q Consensus 385 ~~ 386 (395)
|+
T Consensus 393 ~~ 394 (1039)
T KOG0199|consen 393 LT 394 (1039)
T ss_pred ec
Confidence 43
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=286.08 Aligned_cols=241 Identities=23% Similarity=0.368 Sum_probs=201.7
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+....++||.|.||.||.|.|+.-...||||.++.+. ..+..|..+|+.+.|||+|+++++| ..+.-+|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-----T~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----THEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh-----ccCCCeEEEE
Confidence 4556678999999999999999999999999998764 4566799999999999999999999 5555699999
Q ss_pred eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
|||. |+|++.|+.... ..++......++.||..|++||.. +++|||||...|.|+. +++.+|++|||+++.+..+
T Consensus 343 EfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVg-EnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVG-ENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhcccc-ccceEEeeccchhhhhcCC
Confidence 9987 889998876443 456677788999999999999999 7999999999999999 8999999999999987555
Q ss_pred Ccceeeee---cccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 234 EANISYIC---SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 234 ~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.. +...| ..-|.|||.+.-. .++.++|||+|||+|||+.| |-.||.+.+-.+.+..+.+.
T Consensus 419 TY-TAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-------------- 482 (1157)
T KOG4278|consen 419 TY-TAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-------------- 482 (1157)
T ss_pred ce-ecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc--------------
Confidence 43 22333 4569999998544 48999999999999999998 89999998776665554442
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHH
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el 357 (395)
|+ -..+..+++.+.+|++.||++.|.+||+++|+
T Consensus 483 ----yR----------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 483 ----YR----------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred ----cc----------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 11 12346789999999999999999999999877
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=265.10 Aligned_cols=238 Identities=39% Similarity=0.669 Sum_probs=190.8
Q ss_pred CceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecccc-hHH
Q 016115 89 SFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMY 162 (395)
Q Consensus 89 ~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 162 (395)
+||.||+|.+..+|+.+|+|++... .....+|++.++.++|+||+++++++. .....++++||+++ ++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence 5899999999888999999998644 245567999999999999999999883 33558999999998 665
Q ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcceeeeec
Q 016115 163 RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242 (395)
Q Consensus 163 ~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt 242 (395)
+.+.. ...++...++.++.+++.++.+||+ .|++|+||+|+||+++ .++.++|+|||.+.............++
T Consensus 76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCC
Confidence 55543 2238899999999999999999999 6999999999999999 6789999999999877655444556778
Q ss_pred ccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCC
Q 016115 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH 322 (395)
Q Consensus 243 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (395)
..|++||.+.+. .++.++||||||+++++|++|..||......+........ .... .
T Consensus 150 ~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~---~~~~-------------~------ 206 (244)
T smart00220 150 PEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK---PKPP-------------F------ 206 (244)
T ss_pred cCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---cCCC-------------C------
Confidence 899999998644 4788999999999999999999999874333333322221 0000 0
Q ss_pred CccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 323 PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 323 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
......++.++.+++.+||..||++||++.++++||||
T Consensus 207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00001167899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=296.81 Aligned_cols=243 Identities=25% Similarity=0.351 Sum_probs=205.2
Q ss_pred ceeeeeeecCCceEEEEEEECCCC---cEEEEEEecc-----cccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQ-----DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
..|.++||.|.||.|++|+.+..| ..||||.++. .++.+..|+.||-++.||||+++.|+. ....-+
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~Pv 705 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKPV 705 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCcee
Confidence 568899999999999999987766 4699999963 456677899999999999999999988 555558
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
.||.|||+.+.++.+.+.. .+.++..++..+++.|+.|++||-++ |+|||||...|||++ .+...|++|||+++.+
T Consensus 706 MIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVN-snLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVN-SNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhc-Cchhhhhhhhheeec-cceEEEeccccceeec
Confidence 8999999955444443322 36699999999999999999999996 999999999999999 7999999999999988
Q ss_pred ccCCc-ceeeee---cccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 231 VKGEA-NISYIC---SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 231 ~~~~~-~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
.++.. ..+..| ...|.|||.+.-. +++.++||||+||+|||.++ |..||-+..+.+.+..|.+....|+.
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---- 856 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---- 856 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC----
Confidence 66652 222222 4679999999654 59999999999999999887 99999999999999999886555543
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
-.++..+-.|+..||++|-..||.+.||+.
T Consensus 857 ------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 857 ------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred ------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 246889999999999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=299.35 Aligned_cols=249 Identities=31% Similarity=0.442 Sum_probs=190.5
Q ss_pred ceeeeeeecCCceE-EEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEEEEe
Q 016115 79 YMAERVVGTGSFGI-VFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 79 y~~~~~lg~G~~g~-Vy~~~~~~~~~~vaiK~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
|.-.+++|.|+-|+ ||+|.. .|+.||||.+..+.. ...+|+..|+..+ |||||++++.- .+..+.||+.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence 44456789999886 699987 788999999876654 6678999998885 99999987654 77888999999
Q ss_pred cccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC----CCCcEEEeecccccccc
Q 016115 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~----~~~~~kl~Dfg~a~~~~ 231 (395)
.|..+|.+.+...............+.++.|++.||++||+ -+||||||||.||||+. ....++|+|||+++...
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999998887631111111114457788899999999999 59999999999999984 23579999999999886
Q ss_pred cCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 232 KGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 232 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
.+... ....||.+|+|||++.... -..++|||||||++|+.++| ..||...-.. -.+|+.. .
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~--~-------- 729 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTG--N-------- 729 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcC--c--------
Confidence 65443 3456899999999997654 57799999999999999995 8999765332 2223221 0
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
+....+ ......++.|||.+||.+||..||+|.++|.||||=
T Consensus 730 -------~~L~~L---------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 730 -------YTLVHL---------EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred -------cceeee---------ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 000010 011112899999999999999999999999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=251.07 Aligned_cols=211 Identities=24% Similarity=0.426 Sum_probs=176.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHH-HHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLM-RLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
....+..||+|++|.|-+.++..+|...|+|.+..... ...+|+.+. +...+|.+|.++|.++. +..++
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-----egdvw 121 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-----EGDVW 121 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-----cccEE
Confidence 44556679999999999999999999999999854322 222455543 33469999999998844 44499
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
|.||.+.-++.....+....+..++|..+-+|+..+..||.|||+.-.++|||+||+|||++ ..|++||||||++..+.
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN-YDGQVKICDFGISGYLV 200 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc-cCCcEEEcccccceeeh
Confidence 99999999888887787888999999999999999999999999855899999999999999 89999999999999887
Q ss_pred cCCcceeeeecccccCchhhcC---CCCCCcccchHhHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 016115 232 KGEANISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIK 294 (395)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~~~~~~~~~ 294 (395)
++-..+...|...|||||.+.. ...|+-++||||||+++.||.+++.||.. .+..+++.+++.
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 7776666788889999999843 23589999999999999999999999985 466677777665
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=284.51 Aligned_cols=240 Identities=30% Similarity=0.444 Sum_probs=192.4
Q ss_pred ceeeeeeecCCceEEEEEEECCC--Cc--EEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 79 YMAERVVGTGSFGIVFQAKCLET--GE--TVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~--~~--~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
....++||+|-||.||.|..... |+ .||||.-+.+ .+.+..|..+|+.++|||||+++|++. +. -
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-----e~-P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-----EQ-P 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-----cc-c
Confidence 34456899999999999986432 33 5888987653 345567999999999999999999983 22 2
Q ss_pred EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+||||+++ |.|...|.. ....++......++.||+.||.|||+ +..|||||...|||+. ....+||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVs-Sp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVS-SPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeec-Ccceeeecccchhh
Confidence 789999999 555444443 34678888899999999999999999 7999999999999999 78899999999999
Q ss_pred ccccCCcceeeee--cccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 229 VLVKGEANISYIC--SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 229 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
...+........| ..-|||||.+.- ..++.++|||.|||.+||++. |..||.+..+.+.+..+.+.-.
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-------- 610 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-------- 610 (974)
T ss_pred hccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC--------
Confidence 9877765544444 455999999854 459999999999999999987 9999998877665554443211
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHh
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 358 (395)
.-.+..+++.+..|+.+||.+||.+||++.++.
T Consensus 611 --------------------lP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 611 --------------------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred --------------------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 114567899999999999999999999987654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.57 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=182.6
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecc
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
.|...+.||+|+||.||+|++..+|..||||.+.........|+++++.++|||||++++++. +....++||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~-----~~~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCR-----SEKGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEE-----cCCCCEEEEeCC
Confidence 456677899999999999999899999999998766555567899999999999999999984 334588999999
Q ss_pred cch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 158 PET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH---TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 158 ~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
+++ +.+.+. .+++..+..++.||+.||+||| + ++|+||||||+||+++ .++..++. ||........
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEEC-CCCceEEE-eccccccccC
Confidence 864 444442 3788889999999999999999 5 5999999999999999 56667665 6665433211
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhhhhcCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYT 312 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (395)
....+|..|+|||++.+. .++.++|||||||++|||+||+.||..... ........+...... ......++..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~- 909 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC-HLDMWIDPSI- 909 (968)
T ss_pred ---CCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc-chhheeCccc-
Confidence 233678999999998654 589999999999999999999999954321 111111111100000 0000000000
Q ss_pred CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
... .........++.+++.+||+.||++|||+.|+++.
T Consensus 910 -------~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 910 -------RGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred -------cCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000 00011123467899999999999999999999865
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=270.78 Aligned_cols=199 Identities=28% Similarity=0.420 Sum_probs=173.0
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccch------------HHHHHHHHHcC---CCceeeecee
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------------NRELQLMRLMD---HPNVISLKHC 138 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------------~~e~~~l~~l~---h~niv~~~~~ 138 (395)
....+|...+.||+|+||.|++|.++.+...|+||.+.+++-.. -.|++||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34446999999999999999999999999999999987654221 25999999998 9999999999
Q ss_pred eeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCc
Q 016115 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (395)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~ 218 (395)
| +++.++||+||--+.+ . .|..+......++|.++..|++||+.|+++||+ .||||||||-+|+.++ .+|-
T Consensus 638 F-----Eddd~yyl~te~hg~g-I-DLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd-~~g~ 708 (772)
T KOG1152|consen 638 F-----EDDDYYYLETEVHGEG-I-DLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVD-SNGF 708 (772)
T ss_pred e-----ecCCeeEEEecCCCCC-c-chhhhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEe-cCCe
Confidence 9 8888899999987754 2 233445557899999999999999999999999 6999999999999999 7999
Q ss_pred EEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 016115 219 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (395)
Q Consensus 219 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 282 (395)
+||+|||.|.... ......+.||..|.|||++.|..+.+..-|||+||++||.++....||+.
T Consensus 709 ~klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 709 VKLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEEeeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999999987654 44556789999999999998888889999999999999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=257.31 Aligned_cols=266 Identities=24% Similarity=0.324 Sum_probs=187.5
Q ss_pred ccCCCCCCCccc-----cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHH--HHcCCCceeeec
Q 016115 65 TIGGKNGEPKQT-----ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLM--RLMDHPNVISLK 136 (395)
Q Consensus 65 ~~~~~~~~~~~~-----~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l--~~l~h~niv~~~ 136 (395)
++|+..+.|... .+..+.+.||+|.||.||+|++ .|+.||||+|... ++...+|.++. ..|+|+||+.++
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhh
Confidence 444545555322 3578889999999999999998 7999999999643 33334555555 578999999998
Q ss_pred eeeeecCCCCceeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCceeccCCCC
Q 016115 137 HCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-------PGVCHRDVKPQ 208 (395)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-------~~ivH~Dlkp~ 208 (395)
+.-.... .....++||.+|.+ |+|.+.|.. ..++.....+++..++.||++||.. ..|.|||||..
T Consensus 272 aaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 272 AADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 8764433 34557999999999 788888876 6678888999999999999999941 46999999999
Q ss_pred ceeecCCCCcEEEeecccccccccCCc-----ceeeeecccccCchhhcCCCCC-----CcccchHhHHHHHHHHHhC--
Q 016115 209 NLLVDPLTHQVKLCDFGSAKVLVKGEA-----NISYICSRYYRAPELIFGATEY-----TTSIDIWSAGCVLAELLLG-- 276 (395)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~lltg-- 276 (395)
||||. ++++..|+|+|+|........ ....+||..|||||++...... -..+||||||.++||++..
T Consensus 346 NILVK-kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 346 NILVK-KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred cEEEc-cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 99999 799999999999987655432 3457899999999999543211 1358999999999999742
Q ss_pred --------CCCCCCCChHH-HHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccC
Q 016115 277 --------QPLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 347 (395)
Q Consensus 277 --------~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 347 (395)
.+||.+.-..+ .++++.+++-.. ...|+.. ..| .....-..+..|++.||..+
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~------~~RP~ip---------nrW---~s~~~l~~m~klMkeCW~~N 486 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQ------KLRPNIP---------NRW---KSDPALRVMAKLMKECWYAN 486 (513)
T ss_pred cCCEehhhcCCcccCCCCCCCHHHHhcceeec------ccCCCCC---------ccc---ccCHHHHHHHHHHHHhhcCC
Confidence 36775432111 111111111100 0011100 011 11112245778999999999
Q ss_pred CCCCCCHHHH
Q 016115 348 PSLRCTALEA 357 (395)
Q Consensus 348 p~~Rpt~~el 357 (395)
|.-|.|+--+
T Consensus 487 p~aRltALri 496 (513)
T KOG2052|consen 487 PAARLTALRI 496 (513)
T ss_pred chhhhHHHHH
Confidence 9999998544
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=260.34 Aligned_cols=264 Identities=25% Similarity=0.299 Sum_probs=188.7
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHH--cCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRL--MDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
...+.++||+|.||.||+|.. +++.||||++... ......|.+|.+. ++|+||+++++.--... .+...++||+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEe
Confidence 456677899999999999986 6799999999744 4455677777775 57999999987653222 2245689999
Q ss_pred eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCceeccCCCCceeecCCCCcEEEeecc
Q 016115 155 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--------PGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 155 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--------~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
+|.+ |+|.+.|+. ..+++....+++..|++||+|||+- ..|+|||||..||||. ++++..|+|||
T Consensus 288 ~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDFG 361 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADFG 361 (534)
T ss_pred eeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeeccc
Confidence 9998 788888876 6789999999999999999999962 4699999999999999 79999999999
Q ss_pred cccccccCCc---ceeeeecccccCchhhcCCCCCC-----cccchHhHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHh
Q 016115 226 SAKVLVKGEA---NISYICSRYYRAPELIFGATEYT-----TSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKVL 296 (395)
Q Consensus 226 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~lltg~~pf~-~~~~~~~~~~~~~~~ 296 (395)
+|..+..+.. ....+||..|||||++.+..... .+.||||+|.+||||++....+. +.-..-++.--.++-
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 9988765433 23478999999999997765544 36999999999999998654442 111110100000111
Q ss_pred CCCChhhhhh------cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHH------HHhcCCC
Q 016115 297 GTPTREEIRC------MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL------EACAHPF 362 (395)
Q Consensus 297 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~------ell~hp~ 362 (395)
..|..+.+.. ..|.+.+... ...--..+.+.+..||..|++-|.|+. ..+.|.|
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~------------~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWR------------KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhh------------cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1222222211 1111111100 011245688999999999999999985 3445666
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=276.41 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=206.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.++|.....+|+|.||.||+++++.+++..|+|+++-+ ......|+-+++..+|+|||.+++.|.. ...++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-----~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-----RDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-----hcCcE
Confidence 45799999999999999999999999999999998643 3445678999999999999999999843 33489
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
|+||||+|+.++.+.+ ..+.+++.++..+++..+.+|+|||+ .|-+|||||-.|||++ +.+.+|++|||.+..+.
T Consensus 89 icMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanillt-d~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLT-DEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeec-ccCceeecccCchhhhh
Confidence 9999999875555433 36789999999999999999999999 6999999999999999 78999999999987664
Q ss_pred cCC-cceeeeecccccCchhhc--CCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 232 KGE-ANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 232 ~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..- ...+++||++|||||+-. ....|...+|||++|++..|+-.-++|-........+..+.+..-.++.
T Consensus 164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~------- 236 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT------- 236 (829)
T ss_pred hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc-------
Confidence 332 234689999999999862 2234899999999999999998888776655555554444432221111
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
..+ ..+.++.+-+|++.+|.++|++|||++.+|.|||...
T Consensus 237 -------lkD----------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 237 -------LKD----------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred -------ccC----------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 000 1245788999999999999999999999999999864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=271.22 Aligned_cols=245 Identities=24% Similarity=0.387 Sum_probs=190.8
Q ss_pred ceeeeeeecCCceEEEEEEECC-------CCcEEEEEEeccc-----ccchHHHHHHHHHcC-CCceeeeceeeeecCCC
Q 016115 79 YMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQD-----RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSK 145 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 145 (395)
..+.+.||+|.||.|++|.-.. ....||||..+.. ......|+++++.+. |+||+.+++++ .
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~-----t 372 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC-----T 372 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee-----c
Confidence 4566689999999999997431 1457999988643 334557999999885 99999999998 3
Q ss_pred CceeEEEEEeccc-chHHHHHHhhc---cc-------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceee
Q 016115 146 DELFLNLVMEYVP-ETMYRVLKHYS---SM-------N--QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212 (395)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~---~~-------~--~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill 212 (395)
....+++|+||+. |+|+..+++.. .. . ..++......++.||+.|++||++ +.++||||-..|||+
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVLI 451 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEEe
Confidence 3556899999999 78888887654 10 1 138899999999999999999999 699999999999999
Q ss_pred cCCCCcEEEeecccccccccCCccee--eee--cccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC-hH
Q 016115 213 DPLTHQVKLCDFGSAKVLVKGEANIS--YIC--SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN-AV 286 (395)
Q Consensus 213 ~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~-~~ 286 (395)
+ .+..+||+|||+|+.......... ..+ ...|||||.+.. ..|+.++||||+||+|||++| |..||.+.. ..
T Consensus 452 ~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 452 T-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred c-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 9 788999999999986544433321 112 234999999976 569999999999999999999 899998855 33
Q ss_pred HHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+.+..+.. |.. -..+..++.++.++++.||+.+|++||++.++.+
T Consensus 530 ~l~~~l~~--G~r--------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 530 ELLEFLKE--GNR--------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHhc--CCC--------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 44332222 111 1134567999999999999999999999998764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=262.98 Aligned_cols=241 Identities=26% Similarity=0.348 Sum_probs=191.8
Q ss_pred ceeeeeeecCCceEEEEEEECCCCc----EEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.+..++||+|+||+||+|.+...|+ +||||++... .....+|+-+|.+++|||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 4455789999999999999987776 5788877543 233457888999999999999999985432
Q ss_pred EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+-||++|++ |.|++.++. ....+..+....|+.||++|+.|||. +++|||||-..||||. .-..+||.|||+++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVk-sP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVK-SPNHVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeec-CCCeEEEEecchhh
Confidence 569999999 566666554 45778889999999999999999999 6999999999999999 67789999999998
Q ss_pred ccccCCcceeeee---cccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 229 VLVKGEANISYIC---SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 229 ~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
............+ .+-|||=|.+... .|+.++|||||||++||++| |..||.+....+.-..+.+. .
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g--e------ 917 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG--E------ 917 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc--c------
Confidence 8765544333222 4569999998654 59999999999999999999 99999987765543333221 0
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+-..+..++.++.-++.+||..|+..||+++++..
T Consensus 918 --------------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 918 --------------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred --------------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 11134567889999999999999999999998753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=235.68 Aligned_cols=255 Identities=21% Similarity=0.281 Sum_probs=183.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.+.|.|.+.||+|-||.+-+++++.+...+++|.+.... +.+.+|...--.| -|.||+..+++.+. ...+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq----t~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ----TSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhh----cCceEE
Confidence 356999999999999999999999999999999886543 3444555543333 48999998876654 333688
Q ss_pred EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceee-cCCCCcEEEeecccccc
Q 016115 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill-~~~~~~~kl~Dfg~a~~ 229 (395)
+++||++ |+|.+.+. ...+.|....+++.|+++|+.|||+ +++||||||.+|||+ +++...+||||||..+.
T Consensus 99 F~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred EeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccc
Confidence 9999999 55444433 2678888999999999999999999 799999999999998 33455899999999865
Q ss_pred cccCCcceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhh
Q 016115 230 LVKGEANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEI 304 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 304 (395)
...--. ..--+..|.+||+... .-...+.+|+|.||+++|.+|||++||+.....+ .+...+...+.....
T Consensus 173 ~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~-- 248 (378)
T KOG1345|consen 173 VGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA-- 248 (378)
T ss_pred cCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc--
Confidence 321111 1112556999998732 2235678999999999999999999998432222 233333332221110
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCC---CCHHHHhcCCCCc
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACAHPFFD 364 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---pt~~ell~hp~~~ 364 (395)
. ...-..+++.+..+.++-|..++++| .++...-..-|..
T Consensus 249 -----------~---------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 249 -----------L---------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred -----------C---------chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 0 01124578999999999999999999 5565555555543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=224.79 Aligned_cols=208 Identities=37% Similarity=0.618 Sum_probs=174.3
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEeccc-
Q 016115 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP- 158 (395)
Q Consensus 85 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~- 158 (395)
||+|++|.||++.+..+|+.+++|++..... ...+|++.++.++|++|+++++++ ......++++|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeee-----ecCCeEEEEEecCCC
Confidence 6899999999999988899999999976643 467899999999999999999988 34456889999999
Q ss_pred chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC-cce
Q 016115 159 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANI 237 (395)
Q Consensus 159 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~ 237 (395)
+++.+.+... ...++...++.++.+++.+|.+||+ .|++|+||+|.||+++..++.++|+|||.+....... ...
T Consensus 76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence 4555554431 1468899999999999999999999 6999999999999999327889999999997664432 123
Q ss_pred eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCC
Q 016115 238 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 317 (395)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...+...|++||.+.....++.++|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 345688899999986543578999999999999999
Q ss_pred CccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCC
Q 016115 318 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (395)
Q Consensus 318 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp 361 (395)
..+.+++.+|++.||.+||++.++++|+
T Consensus 188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1477999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=224.31 Aligned_cols=197 Identities=35% Similarity=0.619 Sum_probs=164.4
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
|.+.+.||+|++|.||++.+..+++.+|+|.+... .....+|++.++.++|+|++++++.+ ......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF-----EDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee-----ecCCceEEE
Confidence 56788999999999999999888999999998753 33455789999999999999999987 333458899
Q ss_pred Eecccc-hHHHHHHhhcccCCC-CCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~-~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|++++ ++.+.+... .. +++..++.++.+++.++.+||+ .+++|+||+|+||+++ .++.++|+|||.+....
T Consensus 76 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 76 MEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLG-MDGLVKLADFGLARFIH 149 (225)
T ss_pred EeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEeeCceeeEec
Confidence 999998 665555432 23 7889999999999999999999 6999999999999999 67899999999998775
Q ss_pred cCC--cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCC-CChH
Q 016115 232 KGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAV 286 (395)
Q Consensus 232 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~ 286 (395)
... ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 543 334556788899999984444577899999999999999999999977 4444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=275.77 Aligned_cols=207 Identities=18% Similarity=0.184 Sum_probs=145.4
Q ss_pred HcCC-CceeeeceeeeecC--CCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCcee
Q 016115 126 LMDH-PNVISLKHCFFSTT--SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 202 (395)
Q Consensus 126 ~l~h-~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH 202 (395)
.++| .||+++++.|-... ......+++++||++++|.+.+.. ....+++.+++.++.||+.||.|||+ +||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 3445 47777777651111 111234678899999988877753 23568999999999999999999999 79999
Q ss_pred ccCCCCceeecC------------------CCCcEEEeecccccccccCC-----------------cceeeeecccccC
Q 016115 203 RDVKPQNLLVDP------------------LTHQVKLCDFGSAKVLVKGE-----------------ANISYICSRYYRA 247 (395)
Q Consensus 203 ~Dlkp~Nill~~------------------~~~~~kl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~a 247 (395)
|||||+||||+. .++.+||+|||+++...... .....+||++|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999952 34456777777765421100 0112357889999
Q ss_pred chhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCcccc
Q 016115 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 327 (395)
Q Consensus 248 PE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (395)
||++.+. .++.++|||||||+||||++|..|+.... ..+..+.... .+. .
T Consensus 184 PE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~------------------------- 233 (793)
T PLN00181 184 PEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-Q------------------------- 233 (793)
T ss_pred hhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-h-------------------------
Confidence 9998765 48999999999999999999988875321 1111111110 000 0
Q ss_pred ccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 328 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 328 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
. ....+...+++.+||.+||.+||++.|+|+||||....
T Consensus 234 ~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~ 272 (793)
T PLN00181 234 I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR 272 (793)
T ss_pred h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence 0 01134567899999999999999999999999998754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=222.82 Aligned_cols=251 Identities=20% Similarity=0.222 Sum_probs=190.1
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCC-----cEEEEEEecccccc-----hHHHHHHHHHcCCCceeeeceeeeecC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDRRY-----KNRELQLMRLMDHPNVISLKHCFFSTT 143 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~-----~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (395)
....+++....+-+|.||.||+|.+.... +.|.+|.++..... ...|..++.-+.|||+..+.++....
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~- 359 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED- 359 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-
Confidence 34456777888999999999999876432 34556665543322 22466666677899999999887542
Q ss_pred CCCceeEEEEEeccc-chHHHHHHhhcc----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCc
Q 016115 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~ 218 (395)
...-++++.+.+ |+|...+..... ....++-.+...++.|++.|++|||+ .|+||.||...|.+++ +.-+
T Consensus 360 ---~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvId-d~Lq 434 (563)
T KOG1024|consen 360 ---YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVID-DQLQ 434 (563)
T ss_pred ---cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceeh-hhee
Confidence 223567778877 666666653221 22446667788899999999999999 5999999999999999 7899
Q ss_pred EEEeecccccccccCCcceee---eecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016115 219 VKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (395)
Q Consensus 219 ~kl~Dfg~a~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~ 294 (395)
+||+|=.+++.+-..+.+.-. .-...||+||.+... .|+.++|+|||||+||||+| |+.||..-+..+....+.+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 999999999877555443211 113459999999764 59999999999999999999 9999999888887666554
Q ss_pred HhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.. + -..+-++++++..++..||..+|++||+.+|+..
T Consensus 514 Gy------------------R----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 GY------------------R----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cc------------------e----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 21 1 1134578999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=211.72 Aligned_cols=166 Identities=21% Similarity=0.195 Sum_probs=124.6
Q ss_pred chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCccee
Q 016115 159 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238 (395)
Q Consensus 159 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~ 238 (395)
|+|.+.+... ...+++..++.++.||+.||.|||+ ++ ||+|||++ .++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~-~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLT-WDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEc-Cccceee--ccceEeecccc----
Confidence 4555665532 3569999999999999999999999 57 99999999 7888998 99987654332
Q ss_pred eeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhhhhcCCCCCCCCCC
Q 016115 239 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPNYTDFRFP 317 (395)
Q Consensus 239 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
..||+.|||||++.+. .++.++|||||||++|+|+||..||....... .+..+.........
T Consensus 64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------- 126 (176)
T smart00750 64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP---------------- 126 (176)
T ss_pred CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc----------------
Confidence 2678999999999765 48999999999999999999999997654332 22222221110000
Q ss_pred CccCCCccccccccCCh--hHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 318 QIKAHPWHKVFHKRMPP--EAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 318 ~~~~~~~~~~~~~~~s~--~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
........++. ++.++|.+||..||.+||++.++++|+|+.
T Consensus 127 ------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 127 ------RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ------cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00001112333 699999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=246.81 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=191.7
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEecc----ccc---c---hHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRR---Y---KNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 80 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~----~~~---~---~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.....+|.|++|.|+.+......+.++.|.+.. ... . ...|+.+-..+.|+|++..+..+.....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~----- 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG----- 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence 456789999999888888777777666665431 110 0 1234555567899999887776633222
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
..-+||||+++|...+.. ...++..++..++.|++.||.|||+ .||.|||||++|++++ .++.+||+|||.+..
T Consensus 396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~-~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVT-ENGILKIIDFGAASV 469 (601)
T ss_pred chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEe-cCCceEEeecCccee
Confidence 334499999976666654 2578888999999999999999999 5999999999999999 788999999999876
Q ss_pred cccCCc-----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChhh
Q 016115 230 LVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV-EIIKVLGTPTREE 303 (395)
Q Consensus 230 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~ 303 (395)
...... ....+|+..|+|||++.+........||||.|++++.|++|+.||......+... ....
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~--------- 540 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY--------- 540 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc---------
Confidence 644333 3457789999999999877655667999999999999999999997654333221 0000
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
.. +.....-...+...++...+.+|.+||++||.+|.|++++++.+||+.+....
T Consensus 541 --------~~----~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 541 --------SD----QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH 595 (601)
T ss_pred --------cc----ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence 00 00000001123355788999999999999999999999999999999987643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=195.97 Aligned_cols=202 Identities=24% Similarity=0.345 Sum_probs=164.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHcCC-CceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
..|.+++.||+|+||.+|.|....+|+.||||.-+... .....|..+.+.|++ ..|..+..+. .+..+-.+|
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvlV 89 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVLV 89 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccceee
Confidence 46999999999999999999999999999999876543 344579999999975 4565555544 555567799
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCcEEEeecccccccc
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKVLV 231 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~~ 231 (395)
|++++.+|.+++.-. ...++...+..++.|++.-++|+|. ++++||||||+|+|+.-. .+.+.|+|||+|+.+.
T Consensus 90 MdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999998877765432 3678999999999999999999999 799999999999998632 3579999999998875
Q ss_pred cCCc--------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHH
Q 016115 232 KGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 288 (395)
Q Consensus 232 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~ 288 (395)
+... .....||..|.+-....+. .-+.+.|+-|+|.+|.++.-|..||++......
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 5433 2346789999988777554 368899999999999999999999998654443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-26 Score=211.95 Aligned_cols=251 Identities=20% Similarity=0.203 Sum_probs=188.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCC-cEEEEEEecccc----cchHHHHHHHHHcCC----CceeeeceeeeecCCCCce
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR----RYKNRELQLMRLMDH----PNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~----~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 148 (395)
+|.+.+.||+|+||.||.+.+..++ ..+|+|...... .....|..++..+.. .++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999987775 678999775432 146679999998873 57777776652 2455
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCC----CcEEEeec
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT----HQVKLCDF 224 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~----~~~kl~Df 224 (395)
+.++||+.++.+|.++..... .+.++...+..++.|++.+|.+||+ .|++||||||+|+++.... ..+.|.||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 688999999999888765544 6889999999999999999999999 6999999999999998433 56999999
Q ss_pred cccc--ccccCC--------c-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016115 225 GSAK--VLVKGE--------A-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293 (395)
Q Consensus 225 g~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~ 293 (395)
|+++ ...... . ...+.||..|+++.+..+. ..+.+.|+||++.++.+|+.|..||..........+..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 9998 321111 1 1235599999999988664 58999999999999999999999997765433332222
Q ss_pred HHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
+........ . .....+.++.++...+-..+...+|....+...
T Consensus 251 ~~~~~~~~~---------------~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKLLTD---------------R---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhhccc---------------c---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 211000000 0 112235677777777777888889988766543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=201.02 Aligned_cols=197 Identities=22% Similarity=0.333 Sum_probs=166.6
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
.|+++++||+|+||.++.|++.-+++.||||.-... ......|.+..+.|. .++|..++-+- ....+-.+|+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhhh
Confidence 699999999999999999999999999999976433 344567889999886 67888776554 5666677999
Q ss_pred ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec----CCCCcEEEeeccccccc
Q 016115 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD----PLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~----~~~~~~kl~Dfg~a~~~ 230 (395)
|+++.+|.+++... ...|+.+.+..++.|++.-++|+|+ +.+|.|||||+|+||. .+.+.|.|+|||+|+.+
T Consensus 104 dLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 99999887776542 4789999999999999999999999 6999999999999996 23457999999999988
Q ss_pred ccCCcc--------eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Q 016115 231 VKGEAN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284 (395)
Q Consensus 231 ~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 284 (395)
.+.... .+..||..||+-...+|.. -+.+.|+-|||-+++++|-|.+||++..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 665432 3467999999999887754 7999999999999999999999998754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=212.81 Aligned_cols=157 Identities=18% Similarity=0.252 Sum_probs=119.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECC-CCcEEEEEEeccc---------ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
..+|.+.+.||+|+||+||+|.+.. ++..||||++... ...+.+|+++++.++|+|++..+..+
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------ 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------ 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------
Confidence 3469999999999999999999876 6778899986422 23356899999999999998533211
Q ss_pred CceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccC-CCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV-KPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dl-kp~Nill~~~~~~~kl~Df 224 (395)
...|+||||++|+.+.... . .. ...++.+++.||.|||+ +||+|||| ||+|||++ .++.+||+||
T Consensus 91 --~~~~LVmE~~~G~~L~~~~---~----~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~-~~~~ikLiDF 156 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLAR---P----HG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMG-PDGEAAVIDF 156 (365)
T ss_pred --CCcEEEEEccCCCCHHHhC---c----cc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEc-CCCCEEEEEC
Confidence 1268999999986443221 1 11 14577899999999999 69999999 99999998 6788999999
Q ss_pred ccccccccCCcc---------eeeeecccccCchhhc
Q 016115 225 GSAKVLVKGEAN---------ISYICSRYYRAPELIF 252 (395)
Q Consensus 225 g~a~~~~~~~~~---------~~~~gt~~y~aPE~~~ 252 (395)
|+|+........ ....++..|+|||.+.
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999866443211 2345677799999873
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-24 Score=200.29 Aligned_cols=262 Identities=34% Similarity=0.483 Sum_probs=195.8
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCC-ceeeeceeeeecCCCCceeE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHP-NVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 150 (395)
|.+.+.||.|+||.||++.+. ..+++|.+.... ....+|..+++.+.|+ +|+++.+.+ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 778899999999999999986 788999885432 2345788899999988 799999988 333337
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC-cEEEeecccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~-~~kl~Dfg~a~~ 229 (395)
+++++++.++.+..+.........+....+..++.|++.++.|+|+ .|++|||+||+||+++ ..+ .++++|||.+..
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~-~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLD-RDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeec-CCCCeEEEeccCccee
Confidence 8999999975444222211100378999999999999999999999 6999999999999999 455 799999999975
Q ss_pred cccCC-------cceeeeecccccCchhhcCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Q 016115 230 LVKGE-------ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLG 297 (395)
Q Consensus 230 ~~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~ 297 (395)
..... ......|+..|+|||.+.+. ..+....|+||+|++++++++|..||..... ............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 54443 23567889999999999763 4689999999999999999999999887764 333333333222
Q ss_pred CC-ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 298 TP-TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 298 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
.+ ... . ............+.+++.+++..+|..|.+..+...++|........
T Consensus 232 ~~~~~~--------------~------~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~ 285 (384)
T COG0515 232 TPSLAS--------------P------LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285 (384)
T ss_pred Cccccc--------------c------cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccccc
Confidence 11 000 0 00000011235799999999999999999999999987776655433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-27 Score=222.53 Aligned_cols=250 Identities=28% Similarity=0.402 Sum_probs=196.3
Q ss_pred eecCCceEEEEEEE---CCCCcEEEEEEeccc------ccchHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEEEE
Q 016115 85 VGTGSFGIVFQAKC---LETGETVAIKKVLQD------RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 85 lg~G~~g~Vy~~~~---~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+|.|+||.|++++- ...|..||+|...+. ......|..++...+ ||.+|++..++ +....+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHhh
Confidence 79999999987652 235677888877532 123345788888887 99999999988 5555589999
Q ss_pred ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC
Q 016115 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (395)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (395)
++..|+ .+.........+.+...+.+...++.+++++|+ .||+|||+|++||+++ .+|.+++.|||+++...+..
T Consensus 77 d~~rgg---~lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 77 DFLRGG---DLFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred hhcccc---hhhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeec-ccCccccCCchhhhHhHhhh
Confidence 999985 222233445677888888899999999999999 5999999999999999 78889999999998876655
Q ss_pred cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCC
Q 016115 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314 (395)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
.. +||..|||||++. .....+|.||||+++++|+||..||.. +....|.+..
T Consensus 152 ~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~------------------ 203 (612)
T KOG0603|consen 152 IA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE------------------ 203 (612)
T ss_pred hc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc------------------
Confidence 44 8999999999995 268899999999999999999999987 5555555421
Q ss_pred CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCCCcCCCCCC-CCCCCCCCCCCCC
Q 016115 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN-ARLPNGRPFPPLF 383 (395)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~hp~~~~~~~~~-~~~~~~~~~~~~~ 383 (395)
..++..++..+++++..++..+|.+|... .|+++|+||+.+.+.. .......++.+-+
T Consensus 204 -----------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~ 267 (612)
T KOG0603|consen 204 -----------LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGS 267 (612)
T ss_pred -----------cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcc
Confidence 11344568899999999999999999865 7999999999988863 2223334444443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=220.19 Aligned_cols=225 Identities=29% Similarity=0.506 Sum_probs=169.0
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
...+|..++.|--|+||.||.++++.+.+.+|+| +.++.. |++ ||..+.+ + .+.|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilR-----nilt~a~---------n--pfvv- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILR-----NILTFAG---------N--PFVV- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhh-----ccccccC---------C--ccee-
Confidence 3457999999999999999999999999999995 433321 111 2333321 1 1122
Q ss_pred ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC
Q 016115 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (395)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (395)
|+-...++. -+.++. +++.+++|||. .||+|||+||+|.+|+ .-|.+|++|||+++......
T Consensus 136 ----gDc~tllk~----~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLKN----IGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhccc----CCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceee-ecccccccchhhhhhhhhhc
Confidence 322223332 233443 33778999999 5999999999999999 68889999999986542211
Q ss_pred c----------------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016115 235 A----------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (395)
Q Consensus 235 ~----------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~ 298 (395)
. ....+||+.|+|||++...+ |+..+|+|++|+|+|+++.|+.||.+++.++.+.+++...
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-- 274 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-- 274 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh--
Confidence 1 11347899999999997655 9999999999999999999999999999999988887632
Q ss_pred CChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC---CHHHHhcCCCCcCCCCC
Q 016115 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREP 369 (395)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~ell~hp~~~~~~~~ 369 (395)
..|++- ...++++++++|.++|..+|..|. .+.++-+|+||+.+++.
T Consensus 275 ---------------i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 275 ---------------IEWPEE---------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ---------------cccccc---------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 222221 234689999999999999999997 46788899999999886
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=195.08 Aligned_cols=237 Identities=25% Similarity=0.307 Sum_probs=143.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchH-------HHHHHHHHcC----------CCceeeeceeee
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMD----------HPNVISLKHCFF 140 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~e~~~l~~l~----------h~niv~~~~~~~ 140 (395)
....++.||.|+++.||.+.+..||+.+|+|++........ +|.-....+. |-.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46678899999999999999999999999998853322211 1211111111 111111111111
Q ss_pred ec-------CCCCce-----eEEEEEecccchHHHHHHhhcccC---CCCCHHHHHHHHHHHHHHHHHHhcCCCceeccC
Q 016115 141 ST-------TSKDEL-----FLNLVMEYVPETMYRVLKHYSSMN---QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV 205 (395)
Q Consensus 141 ~~-------~~~~~~-----~~~lv~e~~~~~l~~~l~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dl 205 (395)
.. ...+.. ..+++|+-+.++|...+....... ..+.......+..|++..+++||. .|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence 00 001111 246788888888777755322222 223344445666899999999999 69999999
Q ss_pred CCCceeecCCCCcEEEeecccccccccCCcceeeeecccccCchhhcCC-------CCCCcccchHhHHHHHHHHHhCCC
Q 016115 206 KPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQP 278 (395)
Q Consensus 206 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~lltg~~ 278 (395)
+|+|++++ .+|.++|+||+......... .....+..|.+||..... ..++.+.|.|+||+++|.|.+|..
T Consensus 172 ~~~nfll~-~~G~v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLD-QDGGVFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE--TTS-EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEc-CCCCEEEcChHHHeecCcee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999 78999999999876543222 113346779999977332 237889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCC
Q 016115 279 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 351 (395)
Q Consensus 279 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 351 (395)
||........ .++ .+.. .. .+++.+++||.++|++||.+|
T Consensus 249 Pf~~~~~~~~-----------------------~~~--------~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEAD-----------------------PEW--------DFSR-CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGST-----------------------SGG--------GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccc-----------------------ccc--------cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence 9986532110 000 1111 22 578999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=187.47 Aligned_cols=210 Identities=22% Similarity=0.316 Sum_probs=147.6
Q ss_pred CCCceeeeceeeeecC----------------------CCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHH
Q 016115 128 DHPNVISLKHCFFSTT----------------------SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185 (395)
Q Consensus 128 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~ 185 (395)
+|||||++.++|.+.. -.....+|+||.-...+|.+.+.. ...+....+.++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence 5999999998884321 122346899999988877776654 4456667788889
Q ss_pred HHHHHHHHHhcCCCceeccCCCCceeecCCC---CcEEEeeccccccccc-------CCcceeeeecccccCchhhcCCC
Q 016115 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLCDFGSAKVLVK-------GEANISYICSRYYRAPELIFGAT 255 (395)
Q Consensus 186 ~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~---~~~kl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~ 255 (395)
|+++|+.|||++ ||.|||||.+|||+.-++ -.+.|+|||++-.-.. ........|...-||||+.....
T Consensus 349 QlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999999995 999999999999984222 3589999998743221 11122345677899999974321
Q ss_pred C-----CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccc
Q 016115 256 E-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 330 (395)
Q Consensus 256 ~-----~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (395)
. .-.++|.|+.|.+.||+++...||+...... +. ..+|.+-.. .-+++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~-----------------~r~Yqe~qL---------Palp~ 480 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LD-----------------TRTYQESQL---------PALPS 480 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-ec-----------------hhhhhhhhC---------CCCcc
Confidence 1 2347999999999999999999998732211 00 001111111 22567
Q ss_pred cCChhHHHHHHHhhccCCCCCCCHH---HHh------cCCCCcCCCCCC
Q 016115 331 RMPPEAIDLASRLLQYSPSLRCTAL---EAC------AHPFFDELREPN 370 (395)
Q Consensus 331 ~~s~~~~~li~~~L~~dp~~Rpt~~---ell------~hp~~~~~~~~~ 370 (395)
.+++.+++|+..+|+.||.+|+++. .+| .|.|++.+.+.+
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~~~ 529 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMMEKC 529 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhcccc
Confidence 8899999999999999999999864 444 366766655543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=179.58 Aligned_cols=135 Identities=16% Similarity=0.207 Sum_probs=102.9
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeccccc------------------------------chHHHHHHHHHcCCCc
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRLMDHPN 131 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~e~~~l~~l~h~n 131 (395)
...||+|+||.||+|.+. +|+.||||++..... ...+|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999986 899999999864321 1123888999998877
Q ss_pred eeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH-hcCCCceeccCCCCce
Q 016115 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI-HTVPGVCHRDVKPQNL 210 (395)
Q Consensus 132 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~L-H~~~~ivH~Dlkp~Ni 210 (395)
+....... ... .+|||||++|+.+.... .....+++..++.++.|++.+|.+| |+ .||+||||||+||
T Consensus 81 v~~p~~~~-----~~~--~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPIL-----LKS--HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEE-----ecC--CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence 64332221 111 36999999985332211 1135788999999999999999999 68 6999999999999
Q ss_pred eecCCCCcEEEeeccccccc
Q 016115 211 LVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~ 230 (395)
|++ ++.++|+|||+|...
T Consensus 150 li~--~~~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYH--DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEE--CCcEEEEEccccccC
Confidence 998 467999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-24 Score=211.01 Aligned_cols=241 Identities=29% Similarity=0.405 Sum_probs=170.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchH---HHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKN---RELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
+|...+.||++.|=+|.+|++. .|. |+||++.+.. +.+. +|++ ....++||.+.+.... ..+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 4777889999999999999863 454 9999885432 1111 2333 6677899999887665 44445
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.|+|-+|+..+|++.+.. ..-+...+.+-|+.|++.||..+|. .||+|||||.+|||++.-+. +.|+||..-+.
T Consensus 96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWNW-~~LtDFAsFKP 169 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWNW-LYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeech-hhhhcccccCC
Confidence 789999999887776653 3456777788899999999999999 69999999999999995444 89999986543
Q ss_pred cccCCc----ceeeee----cccccCchhhcCCC----------CCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 016115 230 LVKGEA----NISYIC----SRYYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 290 (395)
Q Consensus 230 ~~~~~~----~~~~~g----t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~ 290 (395)
..-..+ ..-+.- -.+|.|||.+.... ..+++.||||+||+++||++ |+++|.- .++.
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~ 245 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLL 245 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHH
Confidence 211111 111122 34699999985421 15678999999999999998 7999952 1222
Q ss_pred HHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.....- .... +..+..--+..++.||..|++.||.+|.++++.|+-
T Consensus 246 aYr~~~-~~~~-----------------------e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRSGN-ADDP-----------------------EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhccC-ccCH-----------------------HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111110 0000 011111124579999999999999999999999974
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=178.14 Aligned_cols=171 Identities=12% Similarity=0.120 Sum_probs=125.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cc---------hHHHHHHHHHcCCCceeeeceeeeec
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RY---------KNRELQLMRLMDHPNVISLKHCFFST 142 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~---------~~~e~~~l~~l~h~niv~~~~~~~~~ 142 (395)
..+|++.+.||.|+||.||++.. ++..+|||.+.... .. .++|+..+.+++|++|..+.+.+...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 35799999999999999999765 57789999985321 11 45788899999999999998876542
Q ss_pred CCC---CceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcE
Q 016115 143 TSK---DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219 (395)
Q Consensus 143 ~~~---~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~ 219 (395)
... .....+++|||++|..+..+. .+++ ....+++.+|..||+ .|++|||+||+||+++ .++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~-~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVS-KNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEe-CCC-E
Confidence 211 123478999999985333221 1223 235599999999999 6999999999999999 566 9
Q ss_pred EEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHH
Q 016115 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274 (395)
Q Consensus 220 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 274 (395)
+|+|||............. ... ...++.++|+||||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~d~-----------~vl-er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDR-----------IDL-ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHHH-----------HHH-HhHhcccccccceeEeehHHH
Confidence 9999998876532222111 222 234678999999999987664
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=169.23 Aligned_cols=182 Identities=16% Similarity=0.092 Sum_probs=133.6
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc--------chHHHHHHHHHcC-CCceeeeceeeeecCCCCceeE
Q 016115 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 80 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.+...|++|+||+||.+.. .+..++.+.+..... .+.+|+++|+.|. |+++++++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 4567899999999997764 677888777754432 3568999999996 47788887641 16
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccC-CCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV-KPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dl-kp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++|||+.|..+... .. .. ...++.|++.+|.++|+ .||+|||| ||+|||++ .++.++|+|||+|..
T Consensus 74 ~lvmeyI~G~~L~~~---~~------~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~-~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 74 HLDRSYLAGAAMYQR---PP------RG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQ-EDGSPAVIDFQLAVR 141 (218)
T ss_pred EEEEeeecCccHHhh---hh------hh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEc-CCCCEEEEECCCcee
Confidence 899999998643211 11 11 13467799999999999 69999999 79999999 678899999999985
Q ss_pred cccCCcce--------------eeeecccccCchhhcCCCCCC-cccchHhHHHHHHHHHhCCCCCCCCC
Q 016115 230 LVKGEANI--------------SYICSRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGEN 284 (395)
Q Consensus 230 ~~~~~~~~--------------~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~il~~lltg~~pf~~~~ 284 (395)
........ -...++.|+.|+...--...+ ...+.++.|+-+|.++|+..++.+++
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 54332110 012477788888753322233 56788899999999999998876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-23 Score=175.23 Aligned_cols=237 Identities=17% Similarity=0.237 Sum_probs=178.8
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecc------cccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
..+..+|.+...|..|+|++ .|..+++|++.. ..+.++.|.-.|+.+.||||+.+++.+.. ...+.+
T Consensus 192 lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppnlv~ 264 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVI 264 (448)
T ss_pred hhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCCceE
Confidence 45566799999999999998 566777787642 24567788889999999999999999843 344889
Q ss_pred EEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceec-cCCCCceeecCCCCcEEEe--eccccc
Q 016115 153 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR-DVKPQNLLVDPLTHQVKLC--DFGSAK 228 (395)
Q Consensus 153 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~-Dlkp~Nill~~~~~~~kl~--Dfg~a~ 228 (395)
+..|++ |+|+..+... .....+..++.+++..|+.|++|||+...++-| -|....+++| ++.+.+|. |--++.
T Consensus 265 isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfsf 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFSF 341 (448)
T ss_pred eeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceeee
Confidence 999999 6777776542 234566778889999999999999996555544 6889999999 67766654 322221
Q ss_pred ccccCCcceeeeecccccCchhhcCCCC--CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
. .......+.||+||.+..... .-.++|+|||++++|||.|...||......+.-.++.-
T Consensus 342 q------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial------------ 403 (448)
T KOG0195|consen 342 Q------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL------------ 403 (448)
T ss_pred e------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh------------
Confidence 1 122344788999999965432 24579999999999999999999998877665444332
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHh
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 358 (395)
..++..++..++..+..|++-|++.||.+||.++.++
T Consensus 404 ---------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 ---------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ---------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1123335677899999999999999999999987653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.9e-22 Score=170.03 Aligned_cols=136 Identities=17% Similarity=0.198 Sum_probs=104.7
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeccccc------------------------------chHHHHHHHHHcCCCc
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRLMDHPN 131 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~e~~~l~~l~h~n 131 (395)
.+.||+|++|.||+|.+. +|+.||||++..... ...+|.+.+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999986 899999999864311 1135788888999988
Q ss_pred eeeeceeeeecCCCCceeEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCce
Q 016115 132 VISLKHCFFSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (395)
Q Consensus 132 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Ni 210 (395)
+........ .. .++||||++|+ +...... ...++...+..++.|++.+|.+||+..||+||||||+||
T Consensus 81 i~~p~~~~~-----~~--~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NI 149 (190)
T cd05145 81 VPVPEPILL-----KK--NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNI 149 (190)
T ss_pred CCCceEEEe-----cC--CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhE
Confidence 754433321 11 37999999985 2222111 246778889999999999999999823999999999999
Q ss_pred eecCCCCcEEEeecccccccc
Q 016115 211 LVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~~ 231 (395)
|++ ++.++|+|||++....
T Consensus 150 ll~--~~~~~liDFG~a~~~~ 168 (190)
T cd05145 150 LYH--DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEE--CCCEEEEEcccceecC
Confidence 998 6789999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=194.79 Aligned_cols=192 Identities=23% Similarity=0.376 Sum_probs=148.2
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHcC---CCceeeeceeeeecCCCCcee
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 149 (395)
.....|.|.+.||+|+||+||+|.... |+.||||+-+... ..+.-=.+++.+|+ -+.|+.+..++...+.
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~----- 768 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA----- 768 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc-----
Confidence 344569999999999999999999766 9999999865432 21211233444444 3445555555533222
Q ss_pred EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec------CCCCcEEEe
Q 016115 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD------PLTHQVKLC 222 (395)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~------~~~~~~kl~ 222 (395)
.++|+||.+ |+|++++. ..+.+++..+..++.|++..++.||. .+||||||||+|+||. .+...++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEE
Confidence 569999999 77777665 47889999999999999999999999 5999999999999984 234569999
Q ss_pred eccccccc---ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCC
Q 016115 223 DFGSAKVL---VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277 (395)
Q Consensus 223 Dfg~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~ 277 (395)
|||.+-.+ .++.......+|-.+-.+|...|. .++..+|.|.|+.+++.||.|+
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHH
Confidence 99998543 344444556678899999998665 5999999999999999999997
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-21 Score=181.01 Aligned_cols=180 Identities=29% Similarity=0.427 Sum_probs=134.2
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.++||.|++|....++.+..........+......++.|+..|++| +|.+|+|+||.||++. .+..+||+|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~-~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFS-DDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccc-cchhhhhhhhhhe
Confidence 4688999999965555555444555667788889999999999999 4999999999999998 6778999999998
Q ss_pred cccccCC-------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016115 228 KVLVKGE-------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 228 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
....... ..+..+||..||+||++.+. .|+.++||||||++|+|+++ -...|... ..+..+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~------- 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDI------- 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhh-------
Confidence 7766655 45678899999999999765 59999999999999999998 22222110 011111
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
.+..++ +.+... -+.-.+|+.+||...|.+||++.+.-.|+|.+
T Consensus 473 ------------r~g~ip--------~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 473 ------------RDGIIP--------PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred ------------hcCCCC--------hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 111111 001111 23456899999999999999999888888853
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=164.52 Aligned_cols=140 Identities=16% Similarity=0.133 Sum_probs=105.5
Q ss_pred CceeeeeeecCCceEEEEEE-ECCCCcEEEEEEecccc----------------------------cchHHHHHHHHHcC
Q 016115 78 SYMAERVVGTGSFGIVFQAK-CLETGETVAIKKVLQDR----------------------------RYKNRELQLMRLMD 128 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~~~----------------------------~~~~~e~~~l~~l~ 128 (395)
.|.+.+.||+|+||.||+|. +..+|+.||||++.... ....+|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999999 67799999999886331 11246888888887
Q ss_pred CCceeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceeccCCC
Q 016115 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-VCHRDVKP 207 (395)
Q Consensus 129 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~-ivH~Dlkp 207 (395)
+. .+.+...+.. . ..++||||++|..+.... .....+....+..++.||+.+|.+||+ .| |+||||||
T Consensus 109 ~~-~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp 177 (237)
T smart00090 109 EA-GVPVPKPIAW---R---RNVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE 177 (237)
T ss_pred hc-CCCCCeeeEe---c---CceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence 53 3333333311 1 147999999985332221 123445666778999999999999999 69 99999999
Q ss_pred CceeecCCCCcEEEeeccccccc
Q 016115 208 QNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~--~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH--DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE--CCCEEEEEChhhhcc
Confidence 999998 678999999998653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.4e-20 Score=158.10 Aligned_cols=133 Identities=17% Similarity=0.230 Sum_probs=98.7
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHc-----CCCceeeeceeeeecCCCCcee-EE
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLM-----DHPNVISLKHCFFSTTSKDELF-LN 151 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~-~~ 151 (395)
.+.||+|+||.||. +..++.. +||++... .....+|+.+++.+ .||||+++++++.+.. .... +.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEEE
Confidence 46799999999995 6666665 69987643 34567899999999 5799999999885432 1233 34
Q ss_pred EEEeccc---chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHH-HHHhcCCCceeccCCCCceeecC---CCCcEEEeec
Q 016115 152 LVMEYVP---ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL-AYIHTVPGVCHRDVKPQNLLVDP---LTHQVKLCDF 224 (395)
Q Consensus 152 lv~e~~~---~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al-~~LH~~~~ivH~Dlkp~Nill~~---~~~~~kl~Df 224 (395)
+|+||++ |+|.+.+.. ..+++. ..++.+++.++ +|||+ .+|+||||||+|||++. .+..++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 7899955 466666643 335555 35577888777 99999 69999999999999973 2347999995
Q ss_pred ccc
Q 016115 225 GSA 227 (395)
Q Consensus 225 g~a 227 (395)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.9e-20 Score=183.19 Aligned_cols=255 Identities=24% Similarity=0.311 Sum_probs=190.2
Q ss_pred CceeeeeeecCCceEEEEEEECC-CCcEEEEEEecccc---cc---hHHHHHHHHHcC-CCceeeeceeeeecCCCCcee
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR---RY---KNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~---~~---~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 149 (395)
.|.+.+.||+|+|+.|-.+.... ....+|.|.+.... .. ...|..+-+.+. |.|++.+++.. .+...
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCcc
Confidence 58888889999999998887633 34456777664332 11 224667777777 99999999987 55556
Q ss_pred EEEEEecccchHHHHHHhh-cccCCCCCHHHHHHHHHHHHHHHHHHh-cCCCceeccCCCCceeecCCCC-cEEEeeccc
Q 016115 150 LNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH-TVPGVCHRDVKPQNLLVDPLTH-QVKLCDFGS 226 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~i~~al~~LH-~~~~ivH~Dlkp~Nill~~~~~-~~kl~Dfg~ 226 (395)
.+++++|..|+. ..... .......+...+..++.|+..++.|+| . .++.|+||||+|.+++ ..+ .++++|||+
T Consensus 96 ~~~~~~~s~g~~--~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~-~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 96 YLLSLSYSDGGS--LFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLD-ESGSALKIADFGL 171 (601)
T ss_pred cccccCcccccc--cccccccCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhc-cCCCcccCCCchh
Confidence 889999987752 22221 121225666778889999999999999 7 7999999999999999 566 899999999
Q ss_pred cccccc-CCc---ceeeee-cccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 227 AKVLVK-GEA---NISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 227 a~~~~~-~~~---~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
|..+.. ... ....+| ++.|+|||...+.....+..|+||+|+++..+++|..|+......+...
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~----------- 240 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY----------- 240 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-----------
Confidence 987766 222 234567 9999999999776667899999999999999999999997654332100
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
..+.... .......+..++....+++.++|..+|..|.+.+++-.+||+..
T Consensus 241 ------------~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 241 ------------SSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ------------eeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000000 11112234667899999999999999999999999999999988
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=149.55 Aligned_cols=134 Identities=19% Similarity=0.156 Sum_probs=100.7
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc--------------------------cchHHHHHHHHHcCCCc
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------------RYKNRELQLMRLMDHPN 131 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~e~~~l~~l~h~n 131 (395)
.|.+.+.||+|+||.||++.+. +|+.||||++.... ....+|..++..+.+.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3778899999999999999864 79999999865321 01345777888887774
Q ss_pred --eeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCc
Q 016115 132 --VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (395)
Q Consensus 132 --iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~N 209 (395)
+...++. ...++||||++|..+..+.. ......++.+++.++.++|+ .||+||||||+|
T Consensus 95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~N 155 (198)
T cd05144 95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFN 155 (198)
T ss_pred CCCCceeec---------CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCccc
Confidence 3333221 12479999999864433211 02356788899999999999 699999999999
Q ss_pred eeecCCCCcEEEeeccccccccc
Q 016115 210 LLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 210 ill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|+++ .++.++|+|||++.....
T Consensus 156 ill~-~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 156 ILVD-DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEEc-CCCcEEEEECCccccCCC
Confidence 9999 688999999999965433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.8e-18 Score=148.16 Aligned_cols=129 Identities=21% Similarity=0.326 Sum_probs=100.1
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
+.||+|++|.||+|.+ .|..+++|...... ....+|+.++..+.|++|.....++.. ....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCCC
Confidence 5699999999999987 77889999764221 123468889999999988766555532 2236
Q ss_pred EEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++|||++|. +.+.+.. . .. ....++.+++.+|.+||+ .|++|+|++|+|||++ ++.++|+|||.+..
T Consensus 75 ~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 7999999874 4443322 1 11 678899999999999999 6999999999999998 67799999999875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.5e-18 Score=160.14 Aligned_cols=204 Identities=27% Similarity=0.410 Sum_probs=146.3
Q ss_pred HHHcCCCceeeeceeeeecCCCCceeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCcee
Q 016115 124 MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 202 (395)
Q Consensus 124 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH 202 (395)
|+.+.|.|+.++++.++.. ...++|.+||. |++.+.+.. ....++......+++.|+.||.|||......|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence 3568899999999999554 44889999999 666666654 34567777788889999999999998433399
Q ss_pred ccCCCCceeecCCCCcEEEeecccccccccC---CcceeeeecccccCchhhcCCCC------CCcccchHhHHHHHHHH
Q 016115 203 RDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG---EANISYICSRYYRAPELIFGATE------YTTSIDIWSAGCVLAEL 273 (395)
Q Consensus 203 ~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~~l 273 (395)
+.|+..|-+++ ....+||+|||+....... .......-...|.|||.+.+... .+.+.||||+|++++|+
T Consensus 73 g~l~s~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 73 GALKSSNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeeccccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 99999999999 8999999999998765321 11111122456999999966321 35679999999999999
Q ss_pred HhCCCCCCCCChH----HHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCC
Q 016115 274 LLGQPLFPGENAV----DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 349 (395)
Q Consensus 274 ltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 349 (395)
++...||...... +....+.+ .+..... |.+ ... ....+++..++.+|+..+|.
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~~r--------------P~i------~~~-~e~~~~l~~l~~~cw~e~P~ 209 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKK-GGSNPFR--------------PSI------ELL-NELPPELLLLVARCWEEIPE 209 (484)
T ss_pred HhccCccccccccCChHHHHHHHHh-cCCCCcC--------------cch------hhh-hhcchHHHHHHHHhcccChh
Confidence 9999999763221 22222222 1111100 000 000 13456899999999999999
Q ss_pred CCCCHHHHh
Q 016115 350 LRCTALEAC 358 (395)
Q Consensus 350 ~Rpt~~ell 358 (395)
+||+++++-
T Consensus 210 ~rPs~~~i~ 218 (484)
T KOG1023|consen 210 KRPSIEQIR 218 (484)
T ss_pred hCccHHHHH
Confidence 999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=143.48 Aligned_cols=126 Identities=20% Similarity=0.275 Sum_probs=93.4
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.||+|+||.||+|.+ +|..+++|...... ....+|+++++.+.|+++.....++.. ....+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCE
Confidence 389999999999985 67889999854321 223468899999988775544333322 22257
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+||||++|..+..+... ... .++.+++.+|.+||+ .|++|+|++|+||+++ ++.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~---~~~-------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEE---GND-------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhh---cHH-------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999997533332211 110 678899999999999 6999999999999998 67899999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.5e-17 Score=161.71 Aligned_cols=132 Identities=19% Similarity=0.249 Sum_probs=98.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEec-cc-----------ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QD-----------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
.|...+.||+|+||+||++.+. +..+++|+.. +. .....+|+++++.++|++++........
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~---- 407 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD---- 407 (535)
T ss_pred ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe----
Confidence 4567889999999999999874 3344444321 11 1224579999999999998876554432
Q ss_pred CceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
....++||||++|..+..+.. ....++.+++.+|.+||+ .|++||||||+|||++ ++.++|+|||
T Consensus 408 -~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~--~~~~~liDFG 472 (535)
T PRK09605 408 -PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR--DDRLYLIDFG 472 (535)
T ss_pred -CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE--CCcEEEEeCc
Confidence 223679999999753332221 346788899999999999 6999999999999995 6789999999
Q ss_pred ccccc
Q 016115 226 SAKVL 230 (395)
Q Consensus 226 ~a~~~ 230 (395)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 98753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=151.67 Aligned_cols=249 Identities=25% Similarity=0.290 Sum_probs=188.3
Q ss_pred ccCceeeeeeec--CCceEEEEEEE--CCCCcEEEEEEec------ccccchHHHHHHHHHcC-CCceeeeceeeeecCC
Q 016115 76 TISYMAERVVGT--GSFGIVFQAKC--LETGETVAIKKVL------QDRRYKNRELQLMRLMD-HPNVISLKHCFFSTTS 144 (395)
Q Consensus 76 ~~~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~vaiK~~~------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 144 (395)
...+.+.+.+|+ |.+|.||.+.+ ..++..+|+|.-+ .......+|+..-+.++ |+|.++....+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~----- 187 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW----- 187 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----
Confidence 345777888999 99999999998 8899999999732 12223345666655554 99999977777
Q ss_pred CCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHH----HHHHHhcCCCceeccCCCCceeecCCC-CcE
Q 016115 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR----GLAYIHTVPGVCHRDVKPQNLLVDPLT-HQV 219 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~----al~~LH~~~~ivH~Dlkp~Nill~~~~-~~~ 219 (395)
.+....++-+|+|+.++..... .....++...++..+.+... ||.++|. .+|+|-|+||+||++. .+ ...
T Consensus 188 e~~~~lfiqtE~~~~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~-~~~~s~ 262 (524)
T KOG0601|consen 188 EGSGILFIQTELCGESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTT-SDWTSC 262 (524)
T ss_pred ccCCcceeeeccccchhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheecc-ccccee
Confidence 5666689999999976554432 23455788889999999999 9999999 7999999999999999 55 889
Q ss_pred EEeecccccccccCCccee-e-----eecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC--ChHHHHHH
Q 016115 220 KLCDFGSAKVLVKGEANIS-Y-----ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--NAVDQLVE 291 (395)
Q Consensus 220 kl~Dfg~a~~~~~~~~~~~-~-----~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~--~~~~~~~~ 291 (395)
+++|||+...+..+..... . .|...|++||.+.+ -++..+|||++|.++.+..+|..++... +....+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 9999999988876653322 2 46677999999854 4899999999999999999987666443 22111111
Q ss_pred HHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
+ + +...+-...+.++...+..|++.|+..|+++..+.+|+++...
T Consensus 341 ~------------------~------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 341 G------------------Y------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred c------------------c------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 0 0 1111223446677779999999999999999999999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=137.43 Aligned_cols=132 Identities=24% Similarity=0.192 Sum_probs=91.0
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEecccccch----------------------------HHHHHHHHHcCCCc--
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK----------------------------NRELQLMRLMDHPN-- 131 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~e~~~l~~l~h~n-- 131 (395)
.+.||+|+||+||+|.+. +|+.||||++....... ..|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999976 89999999876432110 12334444443322
Q ss_pred eeeeceeeeecCCCCceeEEEEEecccchHH--HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCc
Q 016115 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMY--RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (395)
Q Consensus 132 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~N 209 (395)
+.+.+++ ...++||||++|+.. ..+..... ...++.++.+++.++.++|...||+|+||||+|
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~~------~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVRL------LEDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhhh------cccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 2222221 125799999998211 11211110 155788999999999999983399999999999
Q ss_pred eeecCCCCcEEEeecccccccc
Q 016115 210 LLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 210 ill~~~~~~~kl~Dfg~a~~~~ 231 (395)
|+++ ++.++|+|||.+....
T Consensus 146 ili~--~~~~~liDfg~a~~~~ 165 (187)
T cd05119 146 ILVD--DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEEE--CCcEEEEECccccccc
Confidence 9998 7789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.3e-15 Score=135.63 Aligned_cols=134 Identities=18% Similarity=0.217 Sum_probs=96.3
Q ss_pred eeee-cCCceEEEEEEECCCCcEEEEEEeccc-----------------ccchHHHHHHHHHcCCCce--eeeceeeeec
Q 016115 83 RVVG-TGSFGIVFQAKCLETGETVAIKKVLQD-----------------RRYKNRELQLMRLMDHPNV--ISLKHCFFST 142 (395)
Q Consensus 83 ~~lg-~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------------~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~ 142 (395)
..|| .|+.|+||.+.. .+..++||.+... .....+|++++..++|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 888999999876 4788999977421 1123469999999998875 5555543221
Q ss_pred CCCCceeEEEEEecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEE
Q 016115 143 TSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (395)
Q Consensus 143 ~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~k 220 (395)
. ......++|||+++| ++.+.+.. ..+++.. +.+|+.+|.+||+ +||+|+||||+|||++ .++.++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~-~~~~v~ 182 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLD-PDGKFW 182 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEc-CCCCEE
Confidence 1 111123599999996 44444432 3455443 4589999999999 6999999999999999 567899
Q ss_pred Eeeccccccc
Q 016115 221 LCDFGSAKVL 230 (395)
Q Consensus 221 l~Dfg~a~~~ 230 (395)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.2e-16 Score=126.69 Aligned_cols=131 Identities=19% Similarity=0.233 Sum_probs=103.6
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEeccccc--chHHHHHHHHHcCC--CceeeeceeeeecCCCCceeEEEEEec
Q 016115 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEY 156 (395)
Q Consensus 81 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~ 156 (395)
+++.||+|.++.||++.+. +..+++|.+..... ...+|..+++.+++ .++++++..+ ......+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEe
Confidence 4578999999999999973 47899998866542 56789999999976 4788877665 333458899999
Q ss_pred ccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC--CCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 157 VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 157 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+.|.....+ +......++.+++.+|.+||.. .+++|+||+|+||+++ .++.++++|||.++.
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-CCcEEEEEecccccC
Confidence 998533221 4455667788999999999984 2699999999999999 578899999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.4e-16 Score=153.74 Aligned_cols=267 Identities=24% Similarity=0.303 Sum_probs=190.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.+.+.+.+-+-+|+++.++.+.-..+|...++|...... +....+-.++-...+|.++...-.+ ....
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence 446778888999999999998877778767766543221 1111222232233445555443332 2333
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
-.+++++|++| ++...+.. .......-++..+..+..++++||. ..+.|+|++|.|++.. .++..++.|||..
T Consensus 878 P~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~-~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIA-YDGHRPLTDFGTL 951 (1205)
T ss_pred CcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhc-ccCCcccCccccc
Confidence 47899999985 44444433 2345666677788889999999999 5799999999999998 7888999999843
Q ss_pred cccccC--------------------------------CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh
Q 016115 228 KVLVKG--------------------------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL 275 (395)
Q Consensus 228 ~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt 275 (395)
.....- .......||+.|.+||.+.+.. ....+|+|++|+++++.++
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhc
Confidence 221000 0011246789999999998765 7899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHH
Q 016115 276 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 355 (395)
Q Consensus 276 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 355 (395)
|.+||........+..+.+. +..++. -+...+..+++++.++|..++.+|..+.
T Consensus 1031 g~pp~na~tpq~~f~ni~~~-----------------~~~~p~---------g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFENILNR-----------------DIPWPE---------GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCCcchhhhhhccccC-----------------CCCCCC---------CccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999888777666552 111111 2235688999999999999999999988
Q ss_pred ---HHhcCCCCcCCCCCCCCCCCCCCCC
Q 016115 356 ---EACAHPFFDELREPNARLPNGRPFP 380 (395)
Q Consensus 356 ---ell~hp~~~~~~~~~~~~~~~~~~~ 380 (395)
++-.|+||+...+....+..-..+|
T Consensus 1085 ~~~e~k~~~~~~~~~~~~l~~q~~~~~p 1112 (1205)
T KOG0606|consen 1085 GAAEVKGHPFFQDVDWENLALQKAEFVP 1112 (1205)
T ss_pred cccccccCCccCCCCccccccccCccCC
Confidence 9999999999999887665444443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.3e-15 Score=132.21 Aligned_cols=212 Identities=17% Similarity=0.195 Sum_probs=149.8
Q ss_pred HHHHcCCCceeeeceeeeecCCCCceeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-CCc
Q 016115 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGV 200 (395)
Q Consensus 123 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~i 200 (395)
-+-.+-|.|||+++.++.+....+...+.++.||+. |++...|+.-......+......+|+-||++||.|||+. .-|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 345567999999999887666666777889999998 778888887777778888999999999999999999984 359
Q ss_pred eeccCCCCceeecCCCCcEEEeecccccccc-----cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh
Q 016115 201 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-----KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL 275 (395)
Q Consensus 201 vH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt 275 (395)
+|+++..+.|++. .++-+||+----..... .........+-++|.+||.=. ....+.++|||+||...++|..
T Consensus 200 ihgnlTc~tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccCCcchhheeec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHH
Confidence 9999999999999 68878876322111100 001112234577899999642 3346778999999999999988
Q ss_pred CCCCC-CCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH
Q 016115 276 GQPLF-PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354 (395)
Q Consensus 276 g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~ 354 (395)
|..-- ........-..+.+.. -..-..--+++|.+||+-.|..||++
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i--------------------------------~~len~lqr~~i~kcl~~eP~~rp~a 325 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVI--------------------------------IGLENGLQRGSITKCLEGEPNGRPDA 325 (458)
T ss_pred heeccCCCcceeehhhhhhhhe--------------------------------eeccCccccCcCcccccCCCCCCcch
Confidence 77432 2221111111111110 00012224578999999999999999
Q ss_pred HHHhcCCCCcCCCC
Q 016115 355 LEACAHPFFDELRE 368 (395)
Q Consensus 355 ~ell~hp~~~~~~~ 368 (395)
.+++.||.+-++.-
T Consensus 326 r~llfHpllfeVhs 339 (458)
T KOG1266|consen 326 RLLLFHPLLFEVHS 339 (458)
T ss_pred hhhhcCceeeecch
Confidence 99999999866543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.4e-13 Score=115.04 Aligned_cols=132 Identities=19% Similarity=0.206 Sum_probs=92.6
Q ss_pred eeeecCCceEEEEEEECC------CCcEEEEEEeccc--------------cc----------------chHHHHHHHHH
Q 016115 83 RVVGTGSFGIVFQAKCLE------TGETVAIKKVLQD--------------RR----------------YKNRELQLMRL 126 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~--------------~~----------------~~~~e~~~l~~ 126 (395)
..||.|--+.||.|.... .+..+|||+++.. .+ ..++|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 3579999987311 11 01268888887
Q ss_pred cCC--CceeeeceeeeecCCCCceeEEEEEecccch-HH-HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH-hcCCCce
Q 016115 127 MDH--PNVISLKHCFFSTTSKDELFLNLVMEYVPET-MY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI-HTVPGVC 201 (395)
Q Consensus 127 l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~L-H~~~~iv 201 (395)
+.. -++.+.+.+. . -+|||||++++ +. ..+.. ..++...+..+..+++.+|..| |+ .||+
T Consensus 83 l~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~-~glV 147 (197)
T cd05146 83 MQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE-CNLV 147 (197)
T ss_pred HHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh-CCee
Confidence 753 3344444321 1 46999999863 11 12222 2344556677888999999999 88 6999
Q ss_pred eccCCCCceeecCCCCcEEEeecccccccc
Q 016115 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 202 H~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
|+||++.|||++ ++.+.|+|||.+....
T Consensus 148 HGDLs~~NIL~~--~~~v~iIDF~qav~~~ 175 (197)
T cd05146 148 HADLSEYNMLWH--DGKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCCCHHHEEEE--CCcEEEEECCCceeCC
Confidence 999999999997 4679999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.2e-13 Score=135.16 Aligned_cols=142 Identities=19% Similarity=0.257 Sum_probs=87.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccc--------------------------------------hHH
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------------------------------------KNR 119 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------------------------------------~~~ 119 (395)
.|.. +.||+|++|.||+|+.+.+|+.||||+....... ..+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 6799999999999998878999999988533100 011
Q ss_pred HHHH------HHHc----CCCceeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccC---CCCCHHHHHHHHHH
Q 016115 120 ELQL------MRLM----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN---QRMPLIYVKLYTYQ 186 (395)
Q Consensus 120 e~~~------l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~---~~~~~~~~~~i~~~ 186 (395)
|+++ +..+ .+.+.+.+-.+|.+. ....+|||||+.|.-...+......+ ..+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 2222 2222 233334443433211 12256999999985443332211111 12444444444444
Q ss_pred HHHHHHHHhcCCCceeccCCCCceeecCCCC----cEEEeecccccccccC
Q 016115 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QVKLCDFGSAKVLVKG 233 (395)
Q Consensus 187 i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~----~~kl~Dfg~a~~~~~~ 233 (395)
++ . .|++|+|+||.||+++ .++ .++++|||++......
T Consensus 276 if-------~-~GffHaDpHPGNIlv~-~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 VF-------R-DGFFHADMHPGNIFVS-YDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HH-------h-CCeeeCCCChHHeEEe-cCCCCCCeEEEEecceEEECCHH
Confidence 44 4 4999999999999998 455 8999999999776443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=6e-13 Score=128.71 Aligned_cols=138 Identities=19% Similarity=0.221 Sum_probs=89.3
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeccccc-c-------------------------------------------hH
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-Y-------------------------------------------KN 118 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~-------------------------------------------~~ 118 (395)
+.||.|++|.||+|+. .+|+.||||+...... . +.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999995 5899999998743210 0 11
Q ss_pred HHHHHHHHc----CCCceeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHH-HHHH
Q 016115 119 RELQLMRLM----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR-GLAY 193 (395)
Q Consensus 119 ~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~-al~~ 193 (395)
+|...+..+ ++.+-+.+-.++.... ...++||||++|..+..+..... .... ...++..++. .+..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLNQ 272 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHHH
Confidence 233333332 2333344444442211 12579999999854433322111 1111 2345555555 4678
Q ss_pred HhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 194 LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
+|. .|++|+|++|.||+++ .++.++++|||++.....
T Consensus 273 l~~-~g~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 273 VLR-DGFFHADLHPGNIFVL-KDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHh-CCceeCCCCcccEEEC-CCCcEEEEeCCCeeECCH
Confidence 898 6999999999999998 688999999999977643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.3e-12 Score=122.80 Aligned_cols=165 Identities=24% Similarity=0.305 Sum_probs=120.4
Q ss_pred EEEECCCCcEEEEEEeccccc----chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcc
Q 016115 95 QAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSS 170 (395)
Q Consensus 95 ~~~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~ 170 (395)
.|..+.++.+|.|...+.... ...+-++-++.++||||+++++.+ +.+..+|||+|-+.. +...++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~P-l~~~lk~l-- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVTERVRP-LETVLKEL-- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEeecccc-HHHHHHHh--
Confidence 355577888888887764433 234667789999999999999988 556679999998874 22334332
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcc-eeeeecccccCch
Q 016115 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-ISYICSRYYRAPE 249 (395)
Q Consensus 171 ~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~gt~~y~aPE 249 (395)
....+..-+.||+.||.|||..++++|++|.-+.|+|+ ..|..||++|.++......... ....--..|..|+
T Consensus 102 -----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 -----GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred -----HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 24566677889999999998547999999999999999 7999999999988654333221 1111122366776
Q ss_pred hhcCCCCCCcccchHhHHHHHHHHHhC
Q 016115 250 LIFGATEYTTSIDIWSAGCVLAELLLG 276 (395)
Q Consensus 250 ~~~~~~~~~~~~DiwslG~il~~lltg 276 (395)
.+... .-..|.|-||+++++++.|
T Consensus 176 ~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCcc---ccchhhhhHHHHHHHHhCc
Confidence 54221 2356999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=9e-14 Score=132.93 Aligned_cols=248 Identities=20% Similarity=0.156 Sum_probs=173.0
Q ss_pred ccCceeeeeeecCCceEEEEEEEC-CCCcEEEEEEecccccch------HHHHHHHHHc-CCCceeeeceeeeecCCCCc
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYK------NRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~------~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (395)
..+|..+..||.|.|+.|+.+... .++..|++|...+..... ..|+.+...+ .|.+++.....|...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~----- 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL----- 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-----
Confidence 446888999999999999987754 577889999876543322 2455555544 488888877777332
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
...|+--|||.++..++-. .....+.+...+++..|++.++.++|+ +.++|+|+||+||++...++.-+++|||++
T Consensus 339 r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccccc
Confidence 2366889999875444333 223456777888999999999999999 699999999999999843488999999998
Q ss_pred cccccCCcceeeeeccccc-CchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 228 KVLVKGEANISYICSRYYR-APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
..+. -........-.++ ..|++.....+..+.|++|||..+.+.++|...-....... .+..
T Consensus 415 t~~~--~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~------------ 477 (524)
T KOG0601|consen 415 TRLA--FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRS------------ 477 (524)
T ss_pred cccc--eecccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeec------------
Confidence 6421 1112223333445 36666566668999999999999999999874332211100 0000
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
+ ..+ .......+++.+.+.++..|+..|+.+.++..|.=|...
T Consensus 478 ---~----~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 478 ---G----DTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred ---c----ccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 0 000 011234678899999999999999999999988877543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.1e-13 Score=111.62 Aligned_cols=125 Identities=15% Similarity=0.172 Sum_probs=90.6
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCcee-eeceeeeecCCCCceeEEEEEecc
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
.+.|+.|.++.||++.. .|..|++|...... ....+|+.+++.+.+.+++ +++.+. ... -++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence 35689999999999986 47899999875543 3456799999988765544 343322 111 36999999
Q ss_pred cchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCc-----eeccCCCCceeecCCCCcEEEeecccccc
Q 016115 158 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV-----CHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 158 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~i-----vH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|...... . .....++.+++.+|..||. .++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 74 ~G~~l~~~--------~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE--------D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc--------c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE--CCeEEEEecccccC
Confidence 98532211 0 1113456689999999999 474 9999999999998 45799999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.9e-11 Score=114.95 Aligned_cols=213 Identities=19% Similarity=0.252 Sum_probs=154.5
Q ss_pred ceEEEEEEECCCCcEEEEEEeccccc----chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecccc--hHHH
Q 016115 90 FGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE--TMYR 163 (395)
Q Consensus 90 ~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~ 163 (395)
-.+.|++....+|..|++|++..++. ....-++.++++.|.|+|++.++|.+.. -++..+++|++|.++ +|++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHH
Confidence 35679999999999999999954432 2235688999999999999999997444 455668899999985 6666
Q ss_pred HHHhh-----------cccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 164 VLKHY-----------SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 164 ~l~~~-----------~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
..... ...+...++..+|.++.|+..||.++|+ .|+.-+-|.|.+||++ .+.+++|...|+......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~-G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVT-GKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEee-CcceEEEecccceeeecC
Confidence 54322 1234568899999999999999999999 6999999999999999 566899998888765543
Q ss_pred CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCC-CCCCChHHH-HHHHHHHhCCCChhhhhhcCCC
Q 016115 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQ-LVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
+. . |.+. -..+-|.=.||.+++.|.||..- +........ +..
T Consensus 446 d~-----------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~------------------- 489 (655)
T KOG3741|consen 446 DP-----------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR------------------- 489 (655)
T ss_pred CC-----------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------------------
Confidence 32 0 1121 13456888999999999999632 111111111 111
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+...+|.++.++|.-+...++++ -++.+++.
T Consensus 490 -----------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 490 -----------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred -----------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 22346778888888888877775 56666654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-11 Score=101.58 Aligned_cols=140 Identities=19% Similarity=0.213 Sum_probs=96.1
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEe-ccc-----------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 81 AERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 81 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~-~~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
....|-+|+-+.|+++.+ .|+.+.||.= .+. +....+|++++.++.--.|.--.-++.+..
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence 456789999999999987 7889888843 111 223346888888776433332222232222
Q ss_pred eEEEEEecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcE--EEeec
Q 016115 149 FLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV--KLCDF 224 (395)
Q Consensus 149 ~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~--kl~Df 224 (395)
.-+|+|||++| ++.+.+..... ..........++..|-+.+.-||. .+|+|+||..+||++.++++.+ .++||
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence 14599999998 44444443222 222233336788899999999999 6999999999999998666655 89999
Q ss_pred cccccc
Q 016115 225 GSAKVL 230 (395)
Q Consensus 225 g~a~~~ 230 (395)
|++...
T Consensus 161 gls~~s 166 (229)
T KOG3087|consen 161 GLSSVS 166 (229)
T ss_pred cchhcc
Confidence 998643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.2e-13 Score=127.84 Aligned_cols=158 Identities=20% Similarity=0.298 Sum_probs=116.7
Q ss_pred HHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcc--------eee--eecccccCchhhcCCC
Q 016115 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--------ISY--ICSRYYRAPELIFGAT 255 (395)
Q Consensus 186 ~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~--------~~~--~gt~~y~aPE~~~~~~ 255 (395)
+++.|+.|+|...++||++|.|++|.++ .++..||+.|+++......... ... .-...|.|||.+.+ .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 3448999999988999999999999999 7999999999998655432111 011 12456999999976 4
Q ss_pred CCCcccchHhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCCh
Q 016115 256 EYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP 334 (395)
Q Consensus 256 ~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 334 (395)
..+.++|+||+|+++|.+. .|+..+...+............+. -...+...++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-------------------------~~~~~s~~~p~ 239 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-------------------------GAFGYSNNLPS 239 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-------------------------ccccccccCcH
Confidence 5899999999999999999 577666655433322221111000 01113357899
Q ss_pred hHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 335 EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 335 ~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
++++=+.++|..|...||++.+++..|||.+..-.+
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~a 275 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKA 275 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhhcccccCCchhhh
Confidence 999999999999999999999999999998755444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.9e-11 Score=98.52 Aligned_cols=124 Identities=18% Similarity=0.288 Sum_probs=84.5
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEe-ccc-----------ccchHHHHHHHHHcCCCce--eeeceeeeecCCCCcee
Q 016115 84 VVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----------RRYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELF 149 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~-~~~-----------~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~ 149 (395)
.+++|+-+.+|.+.+ -|..+++|.= .+. .....+|+.++..+.--.| ..++++. .+.
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-----~~~-- 73 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-----PDN-- 73 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCC--
Confidence 578999999999866 4555677742 111 1223468888887753333 2333322 222
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
..|+|||++|.++..... .. ...++..+-..+.-||. .||+|+||.++||++. ++.+.++|||++..
T Consensus 74 ~~I~me~I~G~~lkd~l~---~~-------~~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~--~~~i~~IDfGLg~~ 140 (204)
T COG3642 74 GLIVMEYIEGELLKDALE---EA-------RPDLLREVGRLVGKLHK-AGIVHGDLTTSNIILS--GGRIYFIDFGLGEF 140 (204)
T ss_pred CEEEEEEeCChhHHHHHH---hc-------chHHHHHHHHHHHHHHh-cCeecCCCccceEEEe--CCcEEEEECCcccc
Confidence 459999999975442221 11 13456677788889999 6999999999999998 44599999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-10 Score=99.55 Aligned_cols=122 Identities=25% Similarity=0.304 Sum_probs=76.2
Q ss_pred EEEEEEECCCCcEEEEEEecccc------------------------------cchHHHHHHHHHcCCC--ceeeeceee
Q 016115 92 IVFQAKCLETGETVAIKKVLQDR------------------------------RYKNRELQLMRLMDHP--NVISLKHCF 139 (395)
Q Consensus 92 ~Vy~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~e~~~l~~l~h~--niv~~~~~~ 139 (395)
.||.|.. .+|..+|||+..... ....+|.+.|..+..- ++.+.+.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4888885 568899999874210 1123689999998765 345554332
Q ss_pred eecCCCCceeEEEEEeccc--chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHH-HhcCCCceeccCCCCceeecCCC
Q 016115 140 FSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY-IHTVPGVCHRDVKPQNLLVDPLT 216 (395)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~-LH~~~~ivH~Dlkp~Nill~~~~ 216 (395)
. -+|||||++ |..+..+.... ++......++.+++..+.. +|+ .||+|+||.+.|||++ ++
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~-~~ 143 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVD-DG 143 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEE-TT
T ss_pred -----C----CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEee-cc
Confidence 1 359999999 64333343321 1123345667788885555 578 6999999999999998 34
Q ss_pred CcEEEeecccccccc
Q 016115 217 HQVKLCDFGSAKVLV 231 (395)
Q Consensus 217 ~~~kl~Dfg~a~~~~ 231 (395)
.+.|+|||.+....
T Consensus 144 -~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 144 -KVYIIDFGQAVDSS 157 (188)
T ss_dssp -CEEE--GTTEEETT
T ss_pred -eEEEEecCcceecC
Confidence 89999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.8e-09 Score=97.31 Aligned_cols=136 Identities=10% Similarity=0.077 Sum_probs=90.6
Q ss_pred CceEEEEEEECCCCcEEEEEEecccc---------------cchHHHHHHHHHcCCCceeee--ceeeeecCCCCceeEE
Q 016115 89 SFGIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRLMDHPNVISL--KHCFFSTTSKDELFLN 151 (395)
Q Consensus 89 ~~g~Vy~~~~~~~~~~vaiK~~~~~~---------------~~~~~e~~~l~~l~h~niv~~--~~~~~~~~~~~~~~~~ 151 (395)
....|+++.. .|+.|.||...... ....+|...+..+...+|... +.+...........-+
T Consensus 34 ~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 34 EGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred CCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 3344556554 57788888653211 124578888887754444332 3333221111123467
Q ss_pred EEEecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC------CCCcEEEee
Q 016115 152 LVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------LTHQVKLCD 223 (395)
Q Consensus 152 lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~------~~~~~kl~D 223 (395)
+|+|++++ ++.+.+.... ....+......++.+++..+.-||. .||+|+||++.|||++. ++..+.|+|
T Consensus 112 LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred EEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 99999998 4555544322 2445667778899999999999999 69999999999999973 246899999
Q ss_pred cccccc
Q 016115 224 FGSAKV 229 (395)
Q Consensus 224 fg~a~~ 229 (395)
|+.+..
T Consensus 189 l~r~~~ 194 (268)
T PRK15123 189 LHRAQI 194 (268)
T ss_pred CCcccc
Confidence 998853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.7e-10 Score=96.90 Aligned_cols=140 Identities=19% Similarity=0.197 Sum_probs=93.6
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCc--eeeeceeeeecCCCCceeEEEEEe
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
+.|+.|..+.||++... +|+.+++|..... .....+|.++++.+++.+ +.+++.+.... ......++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence 56899999999999863 3689999987643 235578999999987643 45555543211 11124679999
Q ss_pred cccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 016115 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-------------------------------------- 197 (395)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-------------------------------------- 197 (395)
|++|..+.... . ...+++.....++.+++.+|..||+.
T Consensus 81 ~i~G~~l~~~~---~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRL---L-RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCC---C-CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99985222111 0 02345555555666666666666631
Q ss_pred -----------------CCceeccCCCCceeecCC-CCcEEEeecccccc
Q 016115 198 -----------------PGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKV 229 (395)
Q Consensus 198 -----------------~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~ 229 (395)
..++|+|+++.||+++.+ ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 247999999999999942 45689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.1e-08 Score=94.33 Aligned_cols=255 Identities=16% Similarity=0.167 Sum_probs=153.0
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEecccccc-hHHHHHHHHH-cCCCceeeeceee----eecCCCCceeEEEEE
Q 016115 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-KNRELQLMRL-MDHPNVISLKHCF----FSTTSKDELFLNLVM 154 (395)
Q Consensus 81 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~e~~~l~~-l~h~niv~~~~~~----~~~~~~~~~~~~lv~ 154 (395)
..+.||+|+-+.+|-.-. -+ -.+.|++...... ..+.+..|.. -.||-+-.-+ .+ .... .....+.+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~-d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rv-aWPqa~L~G~-~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VR-DQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRV-AWPQATLHGG-RRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hh-chhheeecCCCchHHHHHHHHhccCCCCcchhhhh-cccHHHhhCC-CccceeEEec
Confidence 346799999999985432 12 2345776543221 1122223322 2344332200 11 1111 1222266788
Q ss_pred ecccch--HHHHHH--hhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 155 EYVPET--MYRVLK--HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 155 e~~~~~--l~~~l~--~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
..+.|- ....+. ..........+..+.++++.++.+.+.||. .|.+-+|++++|+|++ +++.+.|+|=..-...
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVs-d~~~V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVS-DDSKVVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeee-cCceEEEEcccceeec
Confidence 888862 222221 122233456788899999999999999999 4999999999999999 7899999986654444
Q ss_pred ccCCcceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhC-CCCCCCCChH----HHHH-HHHHHhCCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAV----DQLV-EIIKVLGTPT 300 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~----~~~~-~~~~~~~~~~ 300 (395)
.++......+|...|.+||.-.- +..-+...|.|.||+++++++.| +.||.+.... .-++ .|....-...
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya 247 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA 247 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence 55566666788999999997531 12346789999999999999986 9999764210 0000 1110000000
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhcc--CCCCCCCHH
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY--SPSLRCTAL 355 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dp~~Rpt~~ 355 (395)
+.-.....+...+++| .-++++++.|..+|+.. ++.-|||++
T Consensus 248 --------~~~~~g~~p~P~~~P~-----~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 248 --------SDQRRGLKPPPRSIPL-----SMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred --------hhccCCCCCCCCCCCh-----hhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 0000001122223333 44789999999999874 356899875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.4e-09 Score=91.68 Aligned_cols=131 Identities=20% Similarity=0.168 Sum_probs=90.2
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--------------------------ccchHHHHHHHHHcCCC--
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------------------------RRYKNRELQLMRLMDHP-- 130 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------------------------~~~~~~e~~~l~~l~h~-- 130 (395)
+.++..||.|--|.||.|.+ ..|.++|||.-... +...++|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 56778999999999999995 47999999965211 11123688888888654
Q ss_pred ceeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCce
Q 016115 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (395)
Q Consensus 131 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Ni 210 (395)
.+.+.++ .+.-.+||||++|-.+..+. +.......++..|+.-+..+-. .||||+|+++-||
T Consensus 172 ~VP~P~~---------~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNI 233 (304)
T COG0478 172 KVPKPIA---------WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNI 233 (304)
T ss_pred CCCCccc---------cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH-cCccccCCchheE
Confidence 4554433 22356999999984222111 1223334444555555554445 5999999999999
Q ss_pred eecCCCCcEEEeecccccc
Q 016115 211 LVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~ 229 (395)
+++ ++|.+.++||--+..
T Consensus 234 lV~-~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 234 LVT-EDGDIVVIDWPQAVP 251 (304)
T ss_pred EEe-cCCCEEEEeCccccc
Confidence 999 788899999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.6e-08 Score=84.26 Aligned_cols=107 Identities=18% Similarity=0.260 Sum_probs=74.4
Q ss_pred hHHHHHHHHHcCCCce--eeeceeeeecCCCCceeEEEEEecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHH
Q 016115 117 KNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192 (395)
Q Consensus 117 ~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~ 192 (395)
..+|...+..|....| .+.+.+........ ...++|+|+++| ++.+.+... ...+......++.+++..+.
T Consensus 58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHH
Confidence 3467777777654333 33333332222222 446799999997 344444432 22556667889999999999
Q ss_pred HHhcCCCceeccCCCCceeecCCCC---cEEEeeccccccc
Q 016115 193 YIHTVPGVCHRDVKPQNLLVDPLTH---QVKLCDFGSAKVL 230 (395)
Q Consensus 193 ~LH~~~~ivH~Dlkp~Nill~~~~~---~~kl~Dfg~a~~~ 230 (395)
-||. .||+|+|+++.|||++ .++ .+.++||+.++..
T Consensus 133 ~lH~-~gi~H~Dl~~~NILv~-~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHD-AGIYHGDLNPSNILVD-PDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH-CcCCCCCCCcccEEEe-CCCCceeEEEEcchhceeC
Confidence 9999 6999999999999999 444 7999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-09 Score=105.65 Aligned_cols=246 Identities=19% Similarity=0.133 Sum_probs=165.8
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCc-eeeeceeeeecCCCCceeEEEEEecc
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPN-VISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
|...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++.+ +.+.+..++++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRIC 316 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhhh
Confidence 555667899999999999876655554 6666554 33445889999999999 44444433 6677788999999
Q ss_pred cchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcce
Q 016115 158 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 237 (395)
Q Consensus 158 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~ 237 (395)
+++-... .........+..-+...+++.-+.++++||+. --+|+| ||+.. .+..+..||+....+.......
T Consensus 317 s~~rs~~-~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s--~~~~~~~~~~v~~~L~~~~~~~ 388 (829)
T KOG0576|consen 317 STGRSSA-LEMTVSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGS--EEEVKLLDFAVPPQLTRTMKPR 388 (829)
T ss_pred cCCcccc-ccCChhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----ccccc--ccccccccccCCcccCcccccc
Confidence 8640000 00011123344445566777778899999983 458988 88887 5779999999998876666566
Q ss_pred eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCC
Q 016115 238 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 317 (395)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
+..+++.++|||+..... +..+.|.|++|+--.+|.-|-+|-...-. .... .+.......
T Consensus 389 t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~----------------~~~~---~g~~p~s~~ 448 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPA----------------VLPM---IGNGPNSPM 448 (829)
T ss_pred cCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcc----------------ccCC---CCCCCCccc
Confidence 778999999999886554 89999999999887777777766544110 0000 000000000
Q ss_pred CccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 318 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 318 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
......|...+++ ++...|+...|..|+...+++-|.+|...
T Consensus 449 L~~~~aw~~~~~~-------~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 449 LTDKSAWSPVFHR-------DFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred cchhhhcCccccc-------CCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 0111222222211 57788999999999999999999999764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.2e-07 Score=79.71 Aligned_cols=139 Identities=11% Similarity=0.056 Sum_probs=95.5
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEecc----------cccchHHHHHHHHHcCCCc--eeeeceeeeecCCCCceeEEE
Q 016115 85 VGTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 85 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~----------~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~l 152 (395)
-|+||-+-|++... .|..+-+|.-.. ....+.+|+..+..+..-+ +.+.. ++........-.-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 36788888988765 455788886531 1234568999888886433 33333 222222233445679
Q ss_pred EEecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCc--EEEeeccccc
Q 016115 153 VMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAK 228 (395)
Q Consensus 153 v~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~--~kl~Dfg~a~ 228 (395)
|+|-++| +|.+.+... .-.+.+......++.+++.++.-||+ .|+.|+|+.+.||+++ .++. ++++||.-++
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~-~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVK-TEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeec-CCCCeeEEEEEhhccc
Confidence 9998885 555444331 12345677778899999999999999 6999999999999998 3445 9999999876
Q ss_pred cc
Q 016115 229 VL 230 (395)
Q Consensus 229 ~~ 230 (395)
..
T Consensus 179 ~~ 180 (216)
T PRK09902 179 RR 180 (216)
T ss_pred hh
Confidence 43
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.68 E-value=4e-07 Score=78.41 Aligned_cols=137 Identities=15% Similarity=0.190 Sum_probs=84.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchH-------------HHHHHHHHcCCCce---eeeceeee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------------RELQLMRLMDHPNV---ISLKHCFF 140 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------------~e~~~l~~l~h~ni---v~~~~~~~ 140 (395)
.+|.+.+++-......|.+..- +|..+++|......+..+ +++..+..++...+ ..++-+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 4688888888888888877764 788999998754322211 23333333332222 22111111
Q ss_pred ecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEE
Q 016115 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (395)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~k 220 (395)
-.........+++|||++|--+..+. .+++ .+...|.+++.-||+ .|++|+|..|.|++++ ++.++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~--~~~i~ 174 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVS--NNGIR 174 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEE--CCcEE
Confidence 11112223356899999994222111 1222 234567788999999 5999999999999998 44599
Q ss_pred Eeecccccc
Q 016115 221 LCDFGSAKV 229 (395)
Q Consensus 221 l~Dfg~a~~ 229 (395)
++||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.3e-07 Score=80.72 Aligned_cols=133 Identities=18% Similarity=0.163 Sum_probs=87.6
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEecccccc----------------------------hHHHHHHHHHcCC--Ccee
Q 016115 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY----------------------------KNRELQLMRLMDH--PNVI 133 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~e~~~l~~l~h--~niv 133 (395)
.|..|.-+.||+|.. .++..+|+|++...... ..+|..-|+.+.. -.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 688888899999984 56889999998532111 1245555555532 2233
Q ss_pred eeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec
Q 016115 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (395)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~ 213 (395)
+-+.+. . -.|||||++.. ....-.-....+...++..+..++++.+.-|-...|+||+||+.-|||+.
T Consensus 134 ~Pi~~~-----~----nVLvMEfIg~~---g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 134 EPIAFR-----N----NVLVMEFIGDD---GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred Cceeec-----C----CeEEEEeccCC---CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 333332 1 34999999853 01111111233334356777778888888776635999999999999998
Q ss_pred CCCCcEEEeecccccccc
Q 016115 214 PLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 214 ~~~~~~kl~Dfg~a~~~~ 231 (395)
++.+.|+|||-|....
T Consensus 202 --~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 --DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CCeEEEEECccccccC
Confidence 6789999999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.1e-07 Score=92.95 Aligned_cols=140 Identities=21% Similarity=0.205 Sum_probs=83.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccccc--------------------------------------------hH
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------------------------------------------KN 118 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------------------------------------------~~ 118 (395)
.-|+.++-|.||+|+.. +|+.||||+...+.+. ..
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 46899999999999964 5999999987432110 01
Q ss_pred HHHHHHHHc----CCCceeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH
Q 016115 119 RELQLMRLM----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194 (395)
Q Consensus 119 ~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~L 194 (395)
+|..-+..+ +...-+++-.+|.... ..-.++|||++|--.+.+..... ..++...+.....++.- ..+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f~--~q~ 281 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAFL--RQL 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHHH--HHH
Confidence 233333332 2333344445553222 22569999999843233322222 23333333222222211 111
Q ss_pred hcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 195 H~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
=. .|++|.|..|.||+++ .++.+.+.|||+...+...
T Consensus 282 ~~-dgffHaDpHpGNi~v~-~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 282 LR-DGFFHADPHPGNILVR-SDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred Hh-cCccccCCCccceEEe-cCCcEEEEcCcceecCCHH
Confidence 12 3999999999999999 6899999999998776443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.2e-06 Score=77.70 Aligned_cols=75 Identities=20% Similarity=0.200 Sum_probs=50.3
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcCCCc--eeeeceeeeecCCCCceeEEEEEecc
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
++.|+.|..+.||++.... ..+++|..... .....+|..+++.+.... +.+++... .........+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence 4679999999999999743 58999987655 344557888888876443 34454422 1223333478999999
Q ss_pred cch
Q 016115 158 PET 160 (395)
Q Consensus 158 ~~~ 160 (395)
+|.
T Consensus 78 ~g~ 80 (239)
T PF01636_consen 78 PGR 80 (239)
T ss_dssp SSE
T ss_pred ccc
Confidence 974
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.6e-06 Score=75.28 Aligned_cols=69 Identities=16% Similarity=0.087 Sum_probs=46.6
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHcCCCce--eeeceeeeecCCCCceeEEEEEeccc
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVMEYVP 158 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~ 158 (395)
..||+|..+.||+. .|..+++|...... ....+|.++++.+..-.+ .+.+++. .+.....+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 46899999999974 25568899875432 335679999988764333 3444443 33333678999999
Q ss_pred ch
Q 016115 159 ET 160 (395)
Q Consensus 159 ~~ 160 (395)
|.
T Consensus 78 G~ 79 (226)
T TIGR02172 78 GK 79 (226)
T ss_pred Cc
Confidence 84
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.8e-07 Score=92.34 Aligned_cols=206 Identities=22% Similarity=0.308 Sum_probs=135.3
Q ss_pred HHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc
Q 016115 118 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196 (395)
Q Consensus 118 ~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~ 196 (395)
+.|+..+..+.|+|++.++.+-....... -.+.+..++|.+ ++...+. .-..++...++.+..+++.||.|+|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 45677788889999998876553322211 112234456654 3333333 24678889999999999999999999
Q ss_pred CCCceeccCCCC---ceeecCCCCcEEEe--ecccccccccCCcceeeeecccccCchhhcCCC-CCCcccchHhHHHHH
Q 016115 197 VPGVCHRDVKPQ---NLLVDPLTHQVKLC--DFGSAKVLVKGEANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVL 270 (395)
Q Consensus 197 ~~~ivH~Dlkp~---Nill~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il 270 (395)
. ...|.-|..+ +.-.+ ..+.+.++ ||+.++................+.++|.+.... ......|+|++|...
T Consensus 305 ~-~l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 305 L-SLEHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred h-ccceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 4 5555555444 33344 34556666 999888776666655666677788998874322 123347999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCC
Q 016115 271 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 350 (395)
Q Consensus 271 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 350 (395)
..+..|..+-.... ..... +.........+++.+|+.-|.++
T Consensus 383 ~~~~~~~~i~~~~~---~~~~~-----------------------------------l~~~~~~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSA---VPVSL-----------------------------------LDVLSTSELLDALPKCLDEDSEE 424 (1351)
T ss_pred hhhhhcCccccccc---chhhh-----------------------------------hccccchhhhhhhhhhcchhhhh
Confidence 99988764321110 00000 00111126788999999999999
Q ss_pred CCCHHHHhcCCCCcCCCC
Q 016115 351 RCTALEACAHPFFDELRE 368 (395)
Q Consensus 351 Rpt~~ell~hp~~~~~~~ 368 (395)
|+++.+++.|+|.+.-..
T Consensus 425 Rl~~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 425 RLSALELLTHPFLRFPTD 442 (1351)
T ss_pred ccchhhhhhchhcccccc
Confidence 999999999999875333
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.8e-06 Score=82.97 Aligned_cols=141 Identities=19% Similarity=0.230 Sum_probs=83.4
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccccc-----------------------------------------hHHHH
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----------------------------------------KNREL 121 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----------------------------------------~~~e~ 121 (395)
+-||..+.|.||+|+.+ +|+.||||+-+...+. +.+|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46999999999999965 5999999975322111 11222
Q ss_pred H----HHHHcCCCc---eeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH
Q 016115 122 Q----LMRLMDHPN---VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194 (395)
Q Consensus 122 ~----~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~L 194 (395)
+ +.+.+.|-+ =|.+-.+|.... ..-.|+||||+|.-...+..... ..++...+..-+.++..-+- +
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qI-f 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQI-F 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHH-H
Confidence 2 223334555 223434442221 12569999999832222222111 34444444433333222221 2
Q ss_pred hcCCCceeccCCCCceeecC---CCCcEEEeecccccccccC
Q 016115 195 HTVPGVCHRDVKPQNLLVDP---LTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 195 H~~~~ivH~Dlkp~Nill~~---~~~~~kl~Dfg~a~~~~~~ 233 (395)
+ .|++|+|=.|.||++++ .+..+.+-|||+...+...
T Consensus 319 ~--~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 319 K--TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred h--cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2 48999999999999983 3678999999998776443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=7e-06 Score=67.77 Aligned_cols=128 Identities=21% Similarity=0.321 Sum_probs=83.4
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEec
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 156 (395)
-++.+.||+|.+|.||++.+ .|..+|+|+-..+ +.....|++++..+.-.++-.=+-.+ . . .++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g---~----~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G---E----DFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c---h----hhhhhhh
Confidence 34567899999999999998 6779999976544 34556899999988765554322212 1 1 2366999
Q ss_pred ccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCC-CC-ceeecCCCCcEEEeecccccc
Q 016115 157 VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK-PQ-NLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 157 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlk-p~-Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+.|--+..+.. . .+-.++ ..++++---|-. .||-|+.|. |. ||+++ ++.+.|+||..|++
T Consensus 94 i~G~~L~~~~~-----~-~~rk~l----~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~--~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEI-----G-GDRKHL----LRVLEKAYKLDR-LGIEHGELSRPWKNVLVN--DRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhh-----c-ccHHHH----HHHHHHHHHHHH-hccchhhhcCCceeEEec--CCcEEEEEccchhh
Confidence 99832222221 0 022223 345555444555 599998875 33 55555 55899999999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.2e-05 Score=70.34 Aligned_cols=69 Identities=17% Similarity=0.124 Sum_probs=43.3
Q ss_pred eecCCc-eEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEEEEecccch
Q 016115 85 VGTGSF-GIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLVMEYVPET 160 (395)
Q Consensus 85 lg~G~~-g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~ 160 (395)
|-.|.. +.||++.. .+..+.+|+.... .....+|+++++.+. +--+.+++++. .....-++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYG-----SDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEE-----ecCCccEEEEEeeCCc
Confidence 444444 78899874 3467888876543 133567999988875 32344555544 2223367899999984
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.7e-05 Score=81.95 Aligned_cols=77 Identities=18% Similarity=0.188 Sum_probs=51.1
Q ss_pred eeeeecCCceEEEEEEECCCC--cEEEEEEeccc-----ccchHHHHHHHHHcC-CCce--eeeceeeeecCCCCceeEE
Q 016115 82 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQD-----RRYKNRELQLMRLMD-HPNV--ISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~--~~vaiK~~~~~-----~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~ 151 (395)
.+.|+.|.++.+|+......+ ..+++|+.... .....+|.++++.+. |.++ .+++..+.+ .......|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d--~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTD--ASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecC--CCcCCCce
Confidence 467899999999998764332 46788876432 234668999999996 6664 555544421 11123467
Q ss_pred EEEecccch
Q 016115 152 LVMEYVPET 160 (395)
Q Consensus 152 lv~e~~~~~ 160 (395)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999974
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.1e-05 Score=72.32 Aligned_cols=138 Identities=16% Similarity=0.164 Sum_probs=94.0
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------------------------------cchHHHHHHHHHcCC
Q 016115 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------------------RYKNRELQLMRLMDH 129 (395)
Q Consensus 80 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~e~~~l~~l~h 129 (395)
.+..+|..|--+.||.|. ..+|..+|||+++... -+.++|.+-|++++.
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 345678889999999998 5689999999874221 011246666777765
Q ss_pred CceeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCc
Q 016115 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (395)
Q Consensus 130 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~N 209 (395)
..|.----+.. ..-.|||+++++. -+..-.-....++...++.+-.+++.-+.-|-...++||.||.=-|
T Consensus 226 aGIP~PePIlL-------k~hVLVM~FlGrd---gw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 226 AGIPCPEPILL-------KNHVLVMEFLGRD---GWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred cCCCCCCceee-------ecceEeeeeccCC---CCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 44332111110 0134999999852 1111122245667777888888888887777665799999999999
Q ss_pred eeecCCCCcEEEeeccccccc
Q 016115 210 LLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 210 ill~~~~~~~kl~Dfg~a~~~ 230 (395)
+|+. +|.+.|+|-+-+...
T Consensus 296 ~Lyh--dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 296 LLYH--DGKLYIIDVSQSVEH 314 (520)
T ss_pred heEE--CCEEEEEEccccccC
Confidence 9997 788999999887654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.7e-05 Score=63.35 Aligned_cols=126 Identities=25% Similarity=0.334 Sum_probs=86.2
Q ss_pred cCceeeeeeecCCc-eEEEEEEECCCCcEEEEEEecc-----------c--c------------cchHHHHHHHHHc---
Q 016115 77 ISYMAERVVGTGSF-GIVFQAKCLETGETVAIKKVLQ-----------D--R------------RYKNRELQLMRLM--- 127 (395)
Q Consensus 77 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~vaiK~~~~-----------~--~------------~~~~~e~~~l~~l--- 127 (395)
..++..+.||.|.- |.||+++. .|+.||+|.+.. . . ..+..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 35788899999999 99999986 788999999421 0 0 1123466654444
Q ss_pred CCCce--eeeceeeeecCC-------------CCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHH
Q 016115 128 DHPNV--ISLKHCFFSTTS-------------KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192 (395)
Q Consensus 128 ~h~ni--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~ 192 (395)
.+.++ |+.+|+..-... .......||.||+.... .+.... +.+|.+-+.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence 45566 888887744321 11223468888877541 222233 347888889
Q ss_pred HHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 193 ~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+|+ .||+-+|+++.|.. + -||+|||.+
T Consensus 179 ~~~k-~gI~~~Dv~~~ny~----~--G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK-LGIVPRDVKPRNYR----G--GKLVDFSSS 206 (207)
T ss_pred HHHH-CCeeeccCcccccc----C--CEEEecccC
Confidence 9999 59999999999986 2 389999975
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00026 Score=62.95 Aligned_cols=69 Identities=17% Similarity=0.309 Sum_probs=44.7
Q ss_pred eeeeecCCceEEEEEEECC-CCcEEEEEEecccc---cchHHHHHHHHHcCCCce-eeeceeeeecCCCCceeEEEEEec
Q 016115 82 ERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR---RYKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELFLNLVMEY 156 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 156 (395)
.+.|..|-...+|++.... .++.|++|+..... ....+|..+++.+...++ .+++..+ .+ .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence 3567888889999987532 35789999775432 223478888888864444 3333322 11 379999
Q ss_pred ccc
Q 016115 157 VPE 159 (395)
Q Consensus 157 ~~~ 159 (395)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 887
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.87 E-value=8.5e-05 Score=66.15 Aligned_cols=31 Identities=39% Similarity=0.511 Sum_probs=25.5
Q ss_pred CCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 198 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.+++|+|+.+.||+++ +++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~-~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQ-DGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEE-CCCEEEEEeCcccCc
Confidence 3589999999999998 555567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00014 Score=62.46 Aligned_cols=127 Identities=20% Similarity=0.304 Sum_probs=82.4
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccc--------------------cchHHHHHHHHHcC------CCceeeec
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------RYKNRELQLMRLMD------HPNVISLK 136 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------------~~~~~e~~~l~~l~------h~niv~~~ 136 (395)
..||+|+.-.||.-- .....+||+..... ....+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 469999999999643 45567889886554 33446776666655 78899999
Q ss_pred eeeeecCCCCceeEEEEEeccc---chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec
Q 016115 137 HCFFSTTSKDELFLNLVMEYVP---ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (395)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~---~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~ 213 (395)
|.. +.+.-..+|+|.+. |+....|..+.. ...++. .++. .+-+-..||-+ .+|+.+||+|.||++.
T Consensus 84 G~v-----eT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~---~L~~f~~~l~~-~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFV-----ETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQ---ALDEFKRYLLD-HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEE-----ecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHH---HHHHHHHHHHH-cCCeecCCCcccEEEE
Confidence 988 33334678888764 433333333332 345555 3333 34445567777 4999999999999996
Q ss_pred CCC--C-cEEEee
Q 016115 214 PLT--H-QVKLCD 223 (395)
Q Consensus 214 ~~~--~-~~kl~D 223 (395)
..+ . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 222 2 577776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00011 Score=66.47 Aligned_cols=132 Identities=18% Similarity=0.205 Sum_probs=73.9
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeccccc----chHHHHHHHHHcCCCcee-eeceeeeecCCCCceeEEEEEecccc
Q 016115 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLVMEYVPE 159 (395)
Q Consensus 85 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~~~ 159 (395)
+..|-.+.+|+... +|..+++|....... ...+|..+++.+....++ +++... . -++||||++|
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence 56677888998873 577889997654322 346788899988754332 232221 1 2489999987
Q ss_pred hHHH---------------HHHhhcc---cCCCCCHH-HHHHHHHHH---------HHHHHHHhc-------CCCceecc
Q 016115 160 TMYR---------------VLKHYSS---MNQRMPLI-YVKLYTYQI---------FRGLAYIHT-------VPGVCHRD 204 (395)
Q Consensus 160 ~l~~---------------~l~~~~~---~~~~~~~~-~~~~i~~~i---------~~al~~LH~-------~~~ivH~D 204 (395)
.... .+..... ....+... .+..+..++ ...+..+-. ...++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 4221 1111111 11122211 111211111 111222211 02589999
Q ss_pred CCCCceeecCCCCcEEEeecccccc
Q 016115 205 VKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 205 lkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+.|.||+++ +++ +.|+||..|..
T Consensus 153 l~~~Nil~~-~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVT-PQG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEe-CCC-CEEEeccccCc
Confidence 999999998 455 89999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=2.5e-05 Score=70.71 Aligned_cols=130 Identities=17% Similarity=0.170 Sum_probs=88.0
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----------c----------------cchHHHHHHHHHcCCC--
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------R----------------RYKNRELQLMRLMDHP-- 130 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----------~----------------~~~~~e~~~l~~l~h~-- 130 (395)
+.+++.||-|.-+.||.+.+ ..|.+.++|.-.-. + -...+|...|+.|.-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67888999999999999985 46899999954211 1 1112678888877532
Q ss_pred ceeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCce
Q 016115 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (395)
Q Consensus 131 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Ni 210 (395)
-+.+.++ .+.-++|||++.|--+..+.+. ..+..+...+..-+--|-. .|+||+|.+-=||
T Consensus 173 pVPkpiD---------~~RH~Vvmelv~g~Pl~~v~~v---------~d~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 173 PVPKPID---------HNRHCVVMELVDGYPLRQVRHV---------EDPPTLYDDLMGLIVRLAN-HGLIHGDFNEFNI 233 (465)
T ss_pred CCCCccc---------ccceeeHHHhhcccceeeeeec---------CChHHHHHHHHHHHHHHHH-cCceecccchhee
Confidence 2233332 2336799999987422222211 1233455566666677777 5999999999999
Q ss_pred eecCCCCcEEEeecccccc
Q 016115 211 LVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~ 229 (395)
+++ +++.++++||--...
T Consensus 234 mv~-dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 234 MVK-DDDKIVVIDFPQMVS 251 (465)
T ss_pred EEe-cCCCEEEeechHhhc
Confidence 999 688899999975433
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00045 Score=65.90 Aligned_cols=71 Identities=23% Similarity=0.320 Sum_probs=46.3
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEecc-----------cccchHHHHHHHHHcC---CCceeeeceeeeecCCCCc
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-----------~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~ 147 (395)
.+.||.|.+..||++.+...++.++||.-.. .......|.+.|+.+. ..++.+++.+- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~-- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----E-- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----C--
Confidence 3579999999999999753335899997431 1122345777777653 23566665542 2
Q ss_pred eeEEEEEecccc
Q 016115 148 LFLNLVMEYVPE 159 (395)
Q Consensus 148 ~~~~lv~e~~~~ 159 (395)
...++||||+++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 225699999875
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00016 Score=61.77 Aligned_cols=102 Identities=23% Similarity=0.177 Sum_probs=75.6
Q ss_pred HHHHHHHHHcCC-CceeeeceeeeecCCCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh
Q 016115 118 NRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195 (395)
Q Consensus 118 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH 195 (395)
..|.-+++.+.+ +++.+++|.+ . -++|.||.+. ++... ......-...++..+.+|+.++++.+.+|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence 357888888876 6999999988 2 3478899984 33211 000011134688889999999999999999
Q ss_pred cC--CCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 196 TV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 196 ~~--~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
.. ..+.-.|++++|+-++ +++.+|++|...+...
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVN-DDGRLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEe-CCCcEEEEechhcchh
Confidence 72 1366689999999999 7889999999987544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00065 Score=63.44 Aligned_cols=31 Identities=29% Similarity=0.267 Sum_probs=26.1
Q ss_pred CCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 198 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.|++|+|+.|.||+++ .+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~-~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFE-GDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEE-CCceEEEEecccccC
Confidence 4899999999999998 455558999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00067 Score=63.01 Aligned_cols=145 Identities=16% Similarity=0.064 Sum_probs=77.2
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcCCCc--eeeeceeeeec-CCCCceeEEEEEec
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPN--VISLKHCFFST-TSKDELFLNLVMEY 156 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e~ 156 (395)
.+.++.|....+|++.. ++..+++|+.... ......|.+++..|.... +.+++...... ........+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 45678888889998864 3446888987543 233446777777775333 23332211000 00123456899999
Q ss_pred ccchHH------------HHHHhhc--ccC------C--CCCH-HH--HH----------HHHHHHHHHHHHHhc-----
Q 016115 157 VPETMY------------RVLKHYS--SMN------Q--RMPL-IY--VK----------LYTYQIFRGLAYIHT----- 196 (395)
Q Consensus 157 ~~~~l~------------~~l~~~~--~~~------~--~~~~-~~--~~----------~i~~~i~~al~~LH~----- 196 (395)
++|... ..+.... ... . ..+. .. .. .....+...++++..
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 887210 1111000 000 0 0000 00 00 001122334444432
Q ss_pred -CCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 197 -VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 197 -~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
..+++|+|+.+.||+++ .++...|+||+.+..
T Consensus 185 ~~~~l~HgD~~~~Nvl~~-~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFD-GDSVKGVIDFYFACT 217 (307)
T ss_pred CCCccCCCCCCcCcEEEE-CCceEEEeecccccC
Confidence 15899999999999998 566568999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00086 Score=61.87 Aligned_cols=145 Identities=14% Similarity=0.019 Sum_probs=78.5
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEecc-cccchHHHHHHHHHcCCCc--eeeeceeeeec-CCCCceeEEEEEecc
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRLMDHPN--VISLKHCFFST-TSKDELFLNLVMEYV 157 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e~~ 157 (395)
.+.|..|....+|+... .+..+++|+... .......|+.++..+.+.+ +.+++...-.. ........++|++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 45678888889999864 345799998764 2334456888888875433 33333211000 001123467899999
Q ss_pred cchHH------------HHH---Hhhccc-CCC----CCHHHHHH------------HHHHHHHHHHHHhc------CCC
Q 016115 158 PETMY------------RVL---KHYSSM-NQR----MPLIYVKL------------YTYQIFRGLAYIHT------VPG 199 (395)
Q Consensus 158 ~~~l~------------~~l---~~~~~~-~~~----~~~~~~~~------------i~~~i~~al~~LH~------~~~ 199 (395)
+|... ..+ ...... ... ........ ....+..++.++.. ..+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 87321 111 111000 000 00000000 11112233344332 147
Q ss_pred ceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 200 ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~-~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFD-GDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEe-CCceEEEeehhhhcC
Confidence 99999999999999 566678999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0019 Score=59.63 Aligned_cols=75 Identities=4% Similarity=-0.047 Sum_probs=50.4
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcCC---CceeeeceeeeecCCCCceeEEEEEec
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDH---PNVISLKHCFFSTTSKDELFLNLVMEY 156 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~lv~e~ 156 (395)
.+.||+|..+.||+... .+..+.+|..+.. ......|...++.+.. -.+.++++++... ......+||||+
T Consensus 19 ~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEEEEec
Confidence 46799999999999864 2335777875442 3466789999998864 2456666554221 122346899999
Q ss_pred ccch
Q 016115 157 VPET 160 (395)
Q Consensus 157 ~~~~ 160 (395)
++|.
T Consensus 95 i~G~ 98 (297)
T PRK10593 95 LRGV 98 (297)
T ss_pred cCCE
Confidence 9873
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00014 Score=69.80 Aligned_cols=190 Identities=18% Similarity=0.208 Sum_probs=116.5
Q ss_pred HHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 016115 118 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197 (395)
Q Consensus 118 ~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~ 197 (395)
.....+++.+.|+|....+++-... .....+|||+++-++.+.+.... +-.. ++. .
T Consensus 30 lgr~~~lktl~~~~l~~yl~~~r~~----~~r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~- 85 (725)
T KOG1093|consen 30 LGRFQYLKSLQHDNLCQYLDFSRGK----HERVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------A- 85 (725)
T ss_pred hhhhHHHHhhcCccceeeEeeecCc----cceEEEEehhhccchHHHHHhcc-----cchh-------hhc-------c-
Confidence 3467788999999999887765221 12277999999988877765421 1000 111 1
Q ss_pred CCceeccCCCCceeecCCCCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCC
Q 016115 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277 (395)
Q Consensus 198 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~ 277 (395)
.|+.|- +.++++| -++. . | |- ..++++||||+|.++.++.-|.
T Consensus 86 ~~~~~~-------------~~~~~td-~~~t---~------------~--~~------~~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 86 HGVLHL-------------NIIYITD-HFLT---K------------Y--PS------PIGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred ccccee-------------hhhhccc-cccc---c------------C--CC------CCCcchhhhhHHHHHHHHHHhh
Confidence 133331 1233344 1110 0 0 11 1225999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHH
Q 016115 278 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357 (395)
Q Consensus 278 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el 357 (395)
..+......+.+..+.+....+..-..-.+. ..+.-.++....++.++|+-..|..||...++
T Consensus 129 ~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e-----------------~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 129 SLEAELTESEYLEILLKYYTDDQELLSTAME-----------------HLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHHHHHHHHHHHHHhccCchhHHHHHHH-----------------HHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 9888887777777776654433322111100 01222356678899999999999999999999
Q ss_pred hcCCCCcCCCCCCCCCCCCCCCCCCCCch
Q 016115 358 CAHPFFDELREPNARLPNGRPFPPLFNFK 386 (395)
Q Consensus 358 l~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (395)
..++-|.++-...- +...+.+..++.++
T Consensus 192 ~k~~i~~ev~~~~t-~e~~~~L~~e~~~~ 219 (725)
T KOG1093|consen 192 SKRCSFTEVYKDLT-VEMRAALRKEVANN 219 (725)
T ss_pred hcCccHHHHHhhhh-HHHHHhhccccccc
Confidence 99999987632211 13334444555544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0033 Score=59.32 Aligned_cols=139 Identities=17% Similarity=0.233 Sum_probs=77.1
Q ss_pred eeeeecCCceEEEEEEECC----CCcEEEEEEeccccc---chHHHHHHHHHcCCCcee-eeceeeeecCCCCceeEEEE
Q 016115 82 ERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv 153 (395)
.+.|..|-...+|++.... .++.|++|+...... ...+|..+++.+...++- ++++.+ .+. .|
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~-----~~g----~v 111 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF-----PNG----RV 111 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE-----CCc----eE
Confidence 4456668889999987432 346899998754322 235688888888654443 344443 221 46
Q ss_pred EecccchHHH---------------HHHhhcccC----C-CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 016115 154 MEYVPETMYR---------------VLKHYSSMN----Q-RMPLIYVKLYTYQI-----------------FRGLAYI-- 194 (395)
Q Consensus 154 ~e~~~~~l~~---------------~l~~~~~~~----~-~~~~~~~~~i~~~i-----------------~~al~~L-- 194 (395)
.+|++|..++ .+....... . ......+..+..++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 7777652111 111111111 0 11122233332211 1111111
Q ss_pred --hc---CCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 195 --HT---VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 195 --H~---~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.. ...++|+|+++.|||++..++.+.++||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 025899999999999984457899999998864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0058 Score=56.78 Aligned_cols=30 Identities=30% Similarity=0.595 Sum_probs=25.6
Q ss_pred CCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 198 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.+++|+|+.+.||+++ . +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~-~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK-D-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEe-C-CcEEEEECccccc
Confidence 4799999999999998 3 5689999997643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0058 Score=56.52 Aligned_cols=68 Identities=18% Similarity=0.260 Sum_probs=43.0
Q ss_pred eeeecCCceEEEEEEECC------CCcEEEEEEecccc---cchHHHHHHHHHcCCCcee-eeceeeeecCCCCceeEEE
Q 016115 83 RVVGTGSFGIVFQAKCLE------TGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~l 152 (395)
+.|..|-...+|++.... +++.+++|+..... ....+|..+++.+...++. +++..+ .+ .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~~----~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF-----PN----GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe-----CC----Cc
Confidence 456777777888887432 25789999876542 3346788888888644433 333332 11 25
Q ss_pred EEecccc
Q 016115 153 VMEYVPE 159 (395)
Q Consensus 153 v~e~~~~ 159 (395)
|+||++|
T Consensus 75 v~e~i~G 81 (302)
T cd05156 75 IEEFIPS 81 (302)
T ss_pred hhheeCC
Confidence 7888776
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0077 Score=55.57 Aligned_cols=31 Identities=29% Similarity=0.502 Sum_probs=26.7
Q ss_pred ceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 200 ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
++|+|+.+.||++++ ++.+-|.||+++..-.
T Consensus 200 lvHGD~~~gNlii~~-~~~~gVlDwe~~~lGD 230 (321)
T COG3173 200 LVHGDYRPGNLIIDP-GRPTGVLDWELATLGD 230 (321)
T ss_pred eeeCCcccCCEEEeC-CCeeEEEeccccccCC
Confidence 899999999999994 5559999999987643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0002 Score=76.58 Aligned_cols=215 Identities=16% Similarity=-0.003 Sum_probs=129.5
Q ss_pred HHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 016115 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198 (395)
Q Consensus 120 e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ 198 (395)
|...++...|+++.....-... ......+..++|+.+ .+...+.+-..........-+.....+...+..-+|+..
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3344555678888765443322 223335688899884 555555544333334444334333334366666666532
Q ss_pred C----ceeccCCCCceeecCCCCcEEEeecccccccccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHH
Q 016115 199 G----VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAEL 273 (395)
Q Consensus 199 ~----ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 273 (395)
+ .+|++||+-|.++. .+..+|++++|+.+...... .....++++.|+.+++... ..++.++|+|..|+.+|..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIV-tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIV-TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhcccee-cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence 3 58999999999998 68889999999998333222 2334567889999998744 4578889999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC
Q 016115 274 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 353 (395)
Q Consensus 274 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt 353 (395)
..|..+|.. ....+.+. . -.+...+.+ ....|.++..+...+|-..-..||.
T Consensus 1434 s~~n~~fi~-----flq~~Lkg--i---------idn~tf~sI------------e~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFIF-----FLQPALKG--I---------IDNHTFFSI------------EKLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred hcccHHHHH-----HHHHHHcC--c---------ccccccccc------------cccCCCcccHHHHHHHHHHhhhcch
Confidence 888766632 11211111 0 000111111 1122444555555555555677888
Q ss_pred HHHHhcCCCCcCCC
Q 016115 354 ALEACAHPFFDELR 367 (395)
Q Consensus 354 ~~ell~hp~~~~~~ 367 (395)
-...+.-+.|....
T Consensus 1486 q~isls~d~~a~~~ 1499 (2724)
T KOG1826|consen 1486 QYISLSRDHFAVGL 1499 (2724)
T ss_pred hhhhcccccccccc
Confidence 88888777665433
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0093 Score=55.95 Aligned_cols=30 Identities=20% Similarity=0.334 Sum_probs=26.4
Q ss_pred ceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 200 ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++|.||.+.|||++++++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975567899999998864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0094 Score=55.84 Aligned_cols=69 Identities=22% Similarity=0.180 Sum_probs=42.3
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeccc-----------ccchHHHHHHHHHcC--CC-ceeeeceeeeecCCCCcee
Q 016115 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----------RRYKNRELQLMRLMD--HP-NVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~~~~ 149 (395)
.||.|....||++.+...++.|+||.-..- ......|.+.|+... .| .+.+++.+- ...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-------~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-------TEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-------ccc
Confidence 479999999999997533368999964211 112234777776654 23 344554421 122
Q ss_pred EEEEEecccc
Q 016115 150 LNLVMEYVPE 159 (395)
Q Consensus 150 ~~lv~e~~~~ 159 (395)
..+|||+++.
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 4589999864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0071 Score=55.16 Aligned_cols=31 Identities=32% Similarity=0.500 Sum_probs=24.9
Q ss_pred CceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 199 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.++|+|+++.|||++.++...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999993233457999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.011 Score=54.96 Aligned_cols=31 Identities=19% Similarity=0.223 Sum_probs=27.3
Q ss_pred CCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 198 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.+++|+|+.++|||++ +++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYD-ETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEc-CCCCEEEEEhhhccc
Confidence 3799999999999998 577899999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.013 Score=55.74 Aligned_cols=71 Identities=18% Similarity=0.201 Sum_probs=44.8
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeccc----------ccchHHHHHHHHHcC--CC-ceeeeceeeeecCCCCce
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRLMD--HP-NVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----------~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~~~ 148 (395)
.+.||.|.-..||++.+...++.|+||.-..- ......|.+.|+.+. .| .+.+++.+- ..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D-------~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD-------SV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-------cH
Confidence 56789999999999997433568999964211 112234777777654 33 455554421 22
Q ss_pred eEEEEEecccc
Q 016115 149 FLNLVMEYVPE 159 (395)
Q Consensus 149 ~~~lv~e~~~~ 159 (395)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 24589999864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.029 Score=53.64 Aligned_cols=69 Identities=19% Similarity=0.246 Sum_probs=44.8
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEecc-----------cccchHHHHHHHHHcC---CCceeeeceeeeecCCCCc
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-----------~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~ 147 (395)
.+.||.|....||+..+ .+..++||.-.. .......|.+.|+.+. ..++.+++.+. ++.
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM 109 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence 56799999999999986 345799996541 1112234566666554 24666676654 322
Q ss_pred eeEEEEEecccc
Q 016115 148 LFLNLVMEYVPE 159 (395)
Q Consensus 148 ~~~~lv~e~~~~ 159 (395)
.+++||++++
T Consensus 110 --~vlvME~L~~ 119 (418)
T PLN02756 110 --ALIGMRYLEP 119 (418)
T ss_pred --CEEEEeecCC
Confidence 4588999976
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.15 Score=47.68 Aligned_cols=29 Identities=24% Similarity=0.280 Sum_probs=24.5
Q ss_pred CCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 198 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.+++|+|+.+.|||++ + .+.|+||+-+..
T Consensus 196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D--GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C--CcEEEeCCCCCC
Confidence 4799999999999996 3 478999998753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.14 Score=46.97 Aligned_cols=71 Identities=13% Similarity=0.060 Sum_probs=42.9
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHHcC---CCceeeeceeeeecCCCCceeEEEEEecc
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
.+.++.|....+|+.. .+++.+.||.-... ...+..|.+-|+.|. --.+.+++.+.... ..-++||||+
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-----~~~fLlle~l 94 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-----DDAFLLLEFL 94 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-----SCCEEEEE--
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-----CCceEEEEee
Confidence 4668999999999987 57889999987633 345678988888884 33355565554221 1247999998
Q ss_pred cc
Q 016115 158 PE 159 (395)
Q Consensus 158 ~~ 159 (395)
+.
T Consensus 95 ~~ 96 (288)
T PF03881_consen 95 EM 96 (288)
T ss_dssp --
T ss_pred cC
Confidence 74
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.3 Score=46.71 Aligned_cols=71 Identities=18% Similarity=0.194 Sum_probs=42.3
Q ss_pred eeeeeecCCceEEEEEEECCC-CcE-----EEEEEeccc---ccchHHHHHHHHHcCCCcee-eeceeeeecCCCCceeE
Q 016115 81 AERVVGTGSFGIVFQAKCLET-GET-----VAIKKVLQD---RRYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFL 150 (395)
Q Consensus 81 ~~~~lg~G~~g~Vy~~~~~~~-~~~-----vaiK~~~~~---~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~ 150 (395)
..+.|..|-...+|++..... +.. |.++..... .-...+|.++++.+...++- ++++.+ . -
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f-----~----~ 124 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF-----G----D 124 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEec-----C----C
Confidence 345666688899999875322 122 444443211 12235689999998755544 455544 2 2
Q ss_pred EEEEecccch
Q 016115 151 NLVMEYVPET 160 (395)
Q Consensus 151 ~lv~e~~~~~ 160 (395)
+++.||++|.
T Consensus 125 g~l~efIeGr 134 (383)
T PTZ00384 125 FTIQEWVEGN 134 (383)
T ss_pred EEEEEEeccc
Confidence 4888998873
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.049 Score=50.71 Aligned_cols=106 Identities=16% Similarity=0.166 Sum_probs=69.1
Q ss_pred CCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
.+..+.|++|++-++.+.. .+....+++..++.+.+..+.-+...-..-||||..+|||++ .|.|-|+||
T Consensus 296 de~~y~yl~~kdhgt~is~--------ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId--~GnvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISI--------IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID--EGNVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeee--------eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee--cCceEEEEe
Confidence 4456788999987764221 133455677788888888777777633689999999999998 778999999
Q ss_pred ccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhH
Q 016115 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSA 266 (395)
Q Consensus 225 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 266 (395)
-+++....+.... ....--|-.+.|. .+..-+||-+
T Consensus 366 klsRl~~~q~~is----y~rldhp~lF~G~--dd~QFeIYrl 401 (488)
T COG5072 366 KLSRLSYSQGIIS----YNRLDHPDLFNGV--DDYQFEIYRL 401 (488)
T ss_pred eeeecccCCceee----ccccCchhhhcCc--cceeeeHHHH
Confidence 9998543332211 1112234444432 3555667654
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.048 Score=52.60 Aligned_cols=31 Identities=19% Similarity=0.218 Sum_probs=24.6
Q ss_pred ceeccCCCCceeecCCCC----cEEEeeccccccc
Q 016115 200 VCHRDVKPQNLLVDPLTH----QVKLCDFGSAKVL 230 (395)
Q Consensus 200 ivH~Dlkp~Nill~~~~~----~~kl~Dfg~a~~~ 230 (395)
++||||..+|||.+.+++ -..|+||.++...
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~G 304 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHRG 304 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhhcC
Confidence 799999999999985343 4678899887543
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.094 Score=49.65 Aligned_cols=58 Identities=26% Similarity=0.322 Sum_probs=37.9
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~ 213 (395)
.++-+|..| ++...++. ...+++..++++.-..+|+--|--..+.+|.|+.|.||++-
T Consensus 321 vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 355566666 33333332 44555666677766677766554435899999999999985
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.92 Score=44.31 Aligned_cols=71 Identities=14% Similarity=0.161 Sum_probs=44.5
Q ss_pred eeeeeecCCceEEEEEEECC--------CCcEEEEEEeccccc---chHHHHHHHHHcCCCcee-eeceeeeecCCCCce
Q 016115 81 AERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDEL 148 (395)
Q Consensus 81 ~~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~ 148 (395)
-++.|..|-.-.+|++.... .++.|.+|+.-.... ....|..+++.+...+|- ++++.+ .+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f-----~g-- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF-----SG-- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe-----CC--
Confidence 45678888888999987542 156899998754322 234688888877654443 344433 21
Q ss_pred eEEEEEecccch
Q 016115 149 FLNLVMEYVPET 160 (395)
Q Consensus 149 ~~~lv~e~~~~~ 160 (395)
..|.||++|.
T Consensus 182 --g~I~efi~g~ 191 (442)
T PTZ00296 182 --GRIEEWLYGD 191 (442)
T ss_pred --CEEEEeeCCc
Confidence 2567887753
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.046 Score=50.04 Aligned_cols=85 Identities=20% Similarity=0.141 Sum_probs=60.5
Q ss_pred CCCceeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCC
Q 016115 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (395)
Q Consensus 128 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp 207 (395)
.+|-+|.+.... |||-+++.. -+..-.-++..++..+.+..-.|+..++.-|-.-.-+||-||.-
T Consensus 348 pcP~vV~lkkhv------------LVMsFiGd~---~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSE 412 (531)
T KOG2269|consen 348 PCPQVVKLKKHV------------LVMSFIGDQ---GLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSE 412 (531)
T ss_pred CCCceeeeecce------------EEEEeecCC---CCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhh
Confidence 467777775543 899998742 12222223456888888888888888887765435799999999
Q ss_pred CceeecCCCCcEEEeecccccc
Q 016115 208 QNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
-|+|.. .|.+-++|..-+..
T Consensus 413 yN~Lw~--~gKvw~IDVsQsve 432 (531)
T KOG2269|consen 413 YNLLWT--PGKVWVIDVSQSVE 432 (531)
T ss_pred hhheec--CCceEEEechhccC
Confidence 999998 45899999776643
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.2 Score=44.82 Aligned_cols=67 Identities=15% Similarity=0.122 Sum_probs=47.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHH---HHHHHcCCCceeeeceeeeecCCCCceeEEEEEeccc
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL---QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP 158 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 158 (395)
..+..|..+.|+.++ ..+|..+++|+....... ..|. ..|+..+-...|++++.- ...-.+++|.+.
T Consensus 8 ~~~~~g~~s~V~pv~-~~dG~~avLKl~~p~~~~-~~E~~g~~~L~~w~G~GaVrll~~d-------~~~~AlLLErl~ 77 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVR-RADGTPAVLKLAPPHAEA-EHEARGEAALRWWNGRGAVRLLAAD-------PERGALLLERLD 77 (253)
T ss_pred CCCCCCcceEEEEEE-cCCCCeEEEEecCCcccc-hhhhhHHhHhheeCCCCceeeeccc-------cccchhhhhhcc
Confidence 346778999999998 568999999987644332 2233 568888888889998743 112347888883
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.00 E-value=0.045 Score=46.42 Aligned_cols=30 Identities=27% Similarity=0.263 Sum_probs=25.3
Q ss_pred CceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 199 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
-.+|+|+.|+||+++ +++ ++|+||+.|...
T Consensus 78 ~p~H~D~~~~N~~~~-~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHS-ASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEE-CCC-EEEEeCCcccCC
Confidence 369999999999998 455 999999998653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 395 | ||||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-137 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-136 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-136 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-136 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-136 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-136 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-136 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-136 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-135 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-135 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-135 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-135 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-135 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-135 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-134 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-134 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-134 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-134 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-133 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-133 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-132 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-128 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-89 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-82 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-45 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-44 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-44 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-44 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-43 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-43 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-43 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-43 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-43 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-43 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-43 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-43 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-43 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-43 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-43 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-43 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-43 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-43 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-43 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-43 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-43 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-43 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-43 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-43 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-43 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-43 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-43 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-43 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-43 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-43 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-43 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-43 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-43 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-43 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-43 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-43 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-42 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-42 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-42 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-42 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-42 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-42 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-42 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-42 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-42 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-42 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-42 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-42 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-42 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-42 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-42 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-42 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-42 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-42 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-42 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-42 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-42 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-42 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-42 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-42 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-42 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-42 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-42 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-42 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-42 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-42 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-42 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-41 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-41 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-41 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-41 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-41 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-40 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-40 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-40 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-40 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-40 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-39 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-39 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-39 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-39 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-39 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-39 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-39 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-39 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-39 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-39 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-39 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-39 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-39 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-39 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-39 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-39 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-39 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-39 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-39 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-39 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-39 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-39 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-39 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-38 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-38 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-38 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-38 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-38 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-38 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-38 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-38 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-38 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-38 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-38 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-38 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-38 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-38 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-38 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-38 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-38 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-38 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-38 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-38 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-38 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-38 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-38 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-38 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-38 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-38 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-38 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-38 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-38 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-38 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-38 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-38 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-38 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-38 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-38 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-37 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-37 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-37 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-37 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-37 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-37 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-37 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-35 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-35 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-35 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-35 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-35 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-34 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-34 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-34 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-34 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-34 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-34 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-34 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-34 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-34 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-34 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-34 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-34 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-34 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-34 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-34 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-34 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-34 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-34 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-33 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-33 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-33 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-33 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-33 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-33 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-33 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-33 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-33 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-33 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-33 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-33 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-33 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-33 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-33 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-33 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-33 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-33 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-33 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-33 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 8e-33 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-33 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-32 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-32 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-32 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-32 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-32 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-32 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-32 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-32 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-32 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-31 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-31 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-31 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-31 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-31 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-31 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-31 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-31 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-31 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-31 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-30 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-30 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-29 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-29 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-28 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-28 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-28 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-28 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-28 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-28 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-28 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-28 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-27 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-26 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-26 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-26 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-25 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-25 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-25 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-25 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-25 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-25 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-25 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-25 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-23 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-22 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-21 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-21 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-21 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-21 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-21 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-21 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-21 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-21 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-21 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-21 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-21 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-21 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-21 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-21 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-21 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-21 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-20 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-19 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-19 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-19 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-18 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-18 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-18 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-18 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-18 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-17 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-16 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-16 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-16 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-16 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-15 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-14 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-14 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-14 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-14 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-14 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 9e-04 |
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 605 bits (1562), Expect = 0.0
Identities = 214/348 (61%), Positives = 272/348 (78%), Gaps = 4/348 (1%)
Query: 42 SDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 101
S+ ++ + D I GK GE ++ I+Y +V+G GSFG+VFQAK +E+
Sbjct: 6 SNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVES 64
Query: 102 GETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DELFLNLVMEYVPET 160
E VAIKKVLQD+R+KNRELQ+MR++ HPNV+ LK F+S K DE+FLNLV+EYVPET
Sbjct: 65 DE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET 123
Query: 161 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220
+YR +HY+ + Q MP++ +KLY YQ+ R LAYIH++ G+CHRD+KPQNLL+DP + +K
Sbjct: 124 VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLK 182
Query: 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
L DFGSAK+L+ GE N+SYICSRYYRAPELIFGAT YTT+IDIWS GCV+AEL+ GQPLF
Sbjct: 183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242
Query: 281 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 340
PGE+ +DQLVEIIKVLGTP+RE+I+ MNPNY + +FPQI+ HP+ KVF R PP+AIDL
Sbjct: 243 PGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLI 302
Query: 341 SRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQE 388
SRLL+Y+PS R TA+EA HPFFDELR AR+PNGR PPLFN+ +E
Sbjct: 303 SRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKE 350
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 600 bits (1550), Expect = 0.0
Identities = 223/333 (66%), Positives = 276/333 (82%), Gaps = 4/333 (1%)
Query: 59 GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
G ++T + G+ + Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQD+R+
Sbjct: 34 GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 93
Query: 117 KNRELQLMRLMDHPNVISLKHCFFSTTSK-DELFLNLVMEYVPETMYRVLKHYSSMNQRM 175
KNRELQ+MR +DH N++ L++ F+S+ K DE++LNLV++YVPET+YRV +HYS Q +
Sbjct: 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
P+IYVKLY YQ+FR LAYIH+ G+CHRD+KPQNLL+DP T +KLCDFGSAK LV+GE
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 355
LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+ R T L
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 356 EACAHPFFDELREPNARLPNGRPFPPLFNFKQE 388
EACAH FFDELR+PN +LPNGR P LFNF +
Sbjct: 333 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQ 365
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 581 bits (1499), Expect = 0.0
Identities = 152/342 (44%), Positives = 214/342 (62%), Gaps = 12/342 (3%)
Query: 59 GHIISTTIGGKNGEP--KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
G ++S E K+ + ER+ G G+FG V K TG +VAIKKV+QD R+
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 117 KNRELQLMRLM---DHPNVISLKHCFFSTTSK--DELFLNLVMEYVPETMYRVLKHYSSM 171
+NRELQ+M+ + HPN++ L+ F++ + +++LN+VMEYVP+T++R ++Y
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 172 NQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
P I +K++ +Q+ R + +H VCHRD+KP N+LV+ +KLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
E N++YICSRYYRAPELIFG YTT++DIWS GC+ AE++LG+P+F G+N+ QL
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYS 347
EI++VLG P+RE +R +NP++TD K PW VF + EA DL S LLQY
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302
Query: 348 PSLRCTALEACAHPFFDELREPNARLPNGRPFPP-LFNFKQE 388
P R EA HP+FDEL +P +LPN + P LF F
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPN 344
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 550 bits (1419), Expect = 0.0
Identities = 161/360 (44%), Positives = 228/360 (63%), Gaps = 43/360 (11%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHP 130
G + Y + +GTGSFGIV + +E+G+ A+KKVLQD RYKNREL +M+++DH
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 131 NVISLKHCFFSTTSK---------------------------------DELFLNLVMEYV 157
N+I L F++T + +LN++MEYV
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 158 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217
P+T+++VLK + + +P+ + +Y YQ+FR + +IH++ G+CHRD+KPQNLLV+ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDN 179
Query: 218 QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277
+KLCDFGSAK L+ E +++YICSR+YRAPEL+ GATEYT SID+WS GCV EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 278 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 337
PLF GE ++DQLV II+++GTPT+E++ MNP+YT+ RFP +KA W K+ + P AI
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 338 DLASRLLQYSPSLRCTALEACAHPFFDELREP-------NARLPNG--RPFPPLFNFKQE 388
DL ++L+Y P LR EA AHPFFD LR N+ P+G + P LFNF
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = e-101
Identities = 99/313 (31%), Positives = 157/313 (50%), Gaps = 22/313 (7%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G GS+G+VF+ + +TG+ VAIKK L+ RE+++++ + HPN+++L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
F L+LV EY T+ L + +P VK T+Q + + + H
Sbjct: 71 FRRKRR-----LHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 257
HRDVKP+N+L+ +KLCDFG A++L + + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 315
+D+W+ GCV AELL G PL+PG++ VDQL I K LG ++ N ++ +
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 316 FPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 374
P + P F + A+ L L P+ R T + HP+F+ +RE L
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE-DLA 298
Query: 375 NGRPFPPLFNFKQ 387
P + Q
Sbjct: 299 KEHDKPAENLYFQ 311
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = 3e-98
Identities = 97/295 (32%), Positives = 152/295 (51%), Gaps = 21/295 (7%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
VG GS+G+V + + +TG VAIKK L+ K RE++L++ + H N+++L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
LV E+V T+ L+ + V+ Y +QI G+ + H+
Sbjct: 93 CKKKKR-----WYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 257
+ HRD+KP+N+LV + VKLCDFG A+ L GE + +R+YRAPEL+ G +Y
Sbjct: 144 NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 315
++D+W+ GC++ E+ +G+PLFPG++ +DQL I+ LG E+ NP + R
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 316 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
P+IK P + + ++ IDLA + L P R E H FF
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 7e-97
Identities = 86/313 (27%), Positives = 155/313 (49%), Gaps = 30/313 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRLMDHPNV 132
YM + +G G G+VF A + + VAIKK+ L D RE++++R +DH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 133 ISLKHCFFSTTSKDELFLN---------LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLY 183
+ + + S+ + +V EY+ + VL+ + + +L+
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLF 125
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----Y 239
YQ+ RGL YIH+ V HRD+KP NL ++ +K+ DFG A+++ ++
Sbjct: 126 MYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
+ +++YR+P L+ YT +ID+W+AGC+ AE+L G+ LF G + ++Q+ I++ +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 300 TREEIRCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
E+ + + + P ++ + EA+D ++L +SP R TA EA
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAEEA 303
Query: 358 CAHPFFDELREPN 370
+HP+ P
Sbjct: 304 LSHPYMSIYSFPM 316
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 6e-96
Identities = 102/327 (31%), Positives = 168/327 (51%), Gaps = 35/327 (10%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMD 128
+Y+ +G G++ V++ K T VA+K++ R ++ RE+ L++ +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQI 187
H N+++L + S L LV EY + + LK Y + + VKL+ +Q+
Sbjct: 59 HANIVTLHDIIHTEKS-----LTLVFEY----LDKDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRY 244
RGLAY H V HRD+KPQNLL++ ++KL DFG A+ K +Y + + +
Sbjct: 110 LRGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARA--KSIPTKTYDNEVVTLW 165
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE-- 302
YR P+++ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT E
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225
Query: 303 -EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
I + + +P+ +A R+ + DL ++LLQ+ R +A +A HP
Sbjct: 226 PGILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283
Query: 362 FFDELREPNARLPNGRPFPPLFNFKQE 388
FF L E +LP+ L + +
Sbjct: 284 FFLSLGERIHKLPDTTSIFALKEIQLQ 310
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 1e-95
Identities = 93/303 (30%), Positives = 152/303 (50%), Gaps = 23/303 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMR-LMDHPNVISLK 136
Y R +G G + VF+A + E V +K + ++ K RE++++ L PN+I+L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 97
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
S+ LV E+V T ++ L Q + ++ Y Y+I + L Y H+
Sbjct: 98 DIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 148
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ G+ HRDVKP N+++D +++L D+G A+ G+ + SRY++ PEL+
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 257 YTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC-----MNPN 310
Y S+D+WS GC+LA ++ +P F G + DQLV I KVLGT + ++P
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267
Query: 311 YTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ D + W + H + PEA+D +LL+Y R TA EA HP+F +
Sbjct: 268 FND-ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326
Query: 367 REP 369
+
Sbjct: 327 VKD 329
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 287 bits (738), Expect = 3e-95
Identities = 100/333 (30%), Positives = 176/333 (52%), Gaps = 34/333 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
+ + ++G G++G+V A TGE VAIKK+ R RE+++++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I++ + + ++ + ++ E + ++RV+ Q + +++ + YQ R +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAV 125
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-----------YI 240
+H V HRD+KP NLL++ +K+CDFG A+++ + A+ S ++
Sbjct: 126 KVLHGS-NVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+R+YRAPE++ + +Y+ ++D+WS GC+LAEL L +P+FPG + QL+ I ++GTP
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 301 REEI--RCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
+ +P ++ P A P K+F + + P+ IDL R+L + P+ R TA E
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 357 ACAHPFFDELREPNARLPNGRPFPPL-FNFKQE 388
A HP+ +PN P G P PP F F
Sbjct: 303 ALEHPYLQTYHDPN-DEPEGEPIPPSFFEFDHY 334
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 2e-94
Identities = 96/332 (28%), Positives = 158/332 (47%), Gaps = 33/332 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------------RELQL 123
Y +R + +GS+G V G VAIK+V RE++L
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 124 MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL--IYVK 181
+ HPN++ L+ F L LV E + + +V+ QR+ + +++
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD-----QRIVISPQHIQ 137
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 241
+ Y I GL +H GV HRD+ P N+L+ + + +CDF A+ Y+
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVT 195
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301
R+YRAPEL+ +T +D+WSAGCV+AE+ + LF G +QL +I++V+GTP
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 302 EEIRCM-NP---NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
E++ +P +Y + A W V P A+DL +++L+++P R + +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 358 CAHPFFDELREPNARLPNGRPFPPLFNFKQEV 389
HP+F+ L +P L G F+F + V
Sbjct: 315 LRHPYFESLFDPL-DLTEGLSER--FHFDESV 343
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 4e-93
Identities = 103/312 (33%), Positives = 157/312 (50%), Gaps = 33/312 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVISL 135
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F ++ ++LV +++ + ++K + + ++K Y +GL Y+H
Sbjct: 78 LDAFGHKSN-----ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 252
+ HRD+KP NLL+D +KL DFG AK G N +Y + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLDE-NGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---RCMNP 309
GA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT EE C P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
+Y F P H +F + +DL L ++P R TA +A +F P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299
Query: 370 NARLPNGRPFPP 381
P P
Sbjct: 300 GPTPGCQLPRPN 311
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 8e-92
Identities = 99/306 (32%), Positives = 169/306 (55%), Gaps = 24/306 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
Y +G G++G+V A VAIKK+ R RE++++ H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I + + T + + +V + + +Y++LK Q + ++ + YQI RGL
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGL 141
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRA 247
YIH+ V HRD+KP NLL++ T +K+CDFG A+V + Y+ +R+YRA
Sbjct: 142 KYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P++E++ C+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 308 -NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
N ++ P PW+++F +A+DL ++L ++P R +A AHP+ +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 365 ELREPN 370
+ +P+
Sbjct: 319 QYYDPS 324
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 2e-91
Identities = 103/304 (33%), Positives = 162/304 (53%), Gaps = 25/304 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 130
Y++ VG+G++G V A +GE VAIKK+ R Y REL L++ M H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F +S + LVM ++ + +++ + ++ YQ+ +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
GL YIH+ GV HRD+KP NL V+ ++K+ DFG A+ Y+ +R+YRAPE
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNE-DCELKILDFGLARHA--DAEMTGYVVTRWYRAPE 193
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 308
+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E ++ + +
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 309 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ PQ + ++F R P+A DL ++L+ R TA +A HPFF+
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312
Query: 367 REPN 370
R+P
Sbjct: 313 RDPE 316
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-91
Identities = 95/313 (30%), Positives = 154/313 (49%), Gaps = 41/313 (13%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G V++A T ETVAIK++ + + RE+ L++ + H N+I LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
L+L+ EY LK Y N + + +K + YQ+ G+ + H+
Sbjct: 102 IHHNHR-----LHLIFEY----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151
Query: 199 GVCHRDVKPQNLLVDPLTH----QVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELI 251
HRD+KPQNLL+ +K+ DFG A+ G + I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMN 308
G+ Y+TS+DIWS C+ AE+L+ PLFPG++ +DQL +I +VLG P + +
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
P++ FP+ + +V + E +DL + +L+ P R +A A HP+F
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325
Query: 369 PNARLPNGRPFPP 381
F P
Sbjct: 326 ---------DFDP 329
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 3e-91
Identities = 103/318 (32%), Positives = 169/318 (53%), Gaps = 25/318 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 130
Y + VG+G++G V A TG VAIKK+ R Y REL+L++ M H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F + D+ LVM ++ + +++K ++++ ++ YQ+ +
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
GL YIH G+ HRD+KP NL V+ ++K+ DFG A+ Y+ +R+YRAPE
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPE 195
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 308
+I YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E ++ + +
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 309 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
++ P+++ + + P A++L ++L R TA EA AHP+F+ L
Sbjct: 256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
Query: 367 REPNARLPNGRPFPPLFN 384
+ P + + F+
Sbjct: 315 HDTEDE-PQVQKYDDSFD 331
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 275 bits (707), Expect = 4e-91
Identities = 101/294 (34%), Positives = 163/294 (55%), Gaps = 27/294 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
VG G++G+V++AK G VA+K++ D + RE+ L++ + HPN++SL
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
S L LV E++ + + +VL + +K+Y YQ+ RG+A+ H
Sbjct: 88 IHSERC-----LTLVFEFMEKDLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGAT 255
+ HRD+KPQNLL++ +KL DFG A+ G SY + + +YRAP+++ G+
Sbjct: 139 RILHRDLKPQNLLINS-DGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 312
+Y+TS+DIWS GC+ AE++ G+PLFPG DQL +I +LGTP +++ + P +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
F + PW + E IDL S +L + P+ R +A +A HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 5e-91
Identities = 94/294 (31%), Positives = 159/294 (54%), Gaps = 28/294 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N++ L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+ L LV E++ + + ++L + + K + Q+ G+AY H
Sbjct: 69 IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGAT 255
V HRD+KPQNLL++ ++K+ DFG A+ G Y I + +YRAP+++ G+
Sbjct: 120 RVLHRDLKPQNLLINR-EGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 312
+Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP + + + P Y
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYD 235
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
F + PW K + IDL S++L+ P+ R TA +A H +F E
Sbjct: 236 PN-FTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 2e-89
Identities = 95/320 (29%), Positives = 158/320 (49%), Gaps = 41/320 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVISL 135
+G G++ V++ TG VA+K+V + + RE+ LM+ + H N++ L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAY 193
+ L LV E++ + + + + + + + L VK + +Q+ +GLA+
Sbjct: 69 YDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPEL 250
H + HRD+KPQNLL++ Q+KL DFG A+ G ++ + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLINK-RGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ G+ Y+TSIDIWS GC+LAE++ G+PLFPG N +QL I ++GTP E + P+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN-ESLW---PS 235
Query: 311 YTDF-----RFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
T Q +V + +D LLQ +P +R +A +A HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 362 FFDELREPNARLPNGRPFPP 381
+F E A + R
Sbjct: 296 WFAEYYHH-ASMGGSRSHHH 314
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 4e-89
Identities = 96/329 (29%), Positives = 159/329 (48%), Gaps = 34/329 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 130
Y + +G+G+ GIV A VAIKK+ R Y REL LM+ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 131 NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+I L + F S +E + +VME + + +V++ + + YQ+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 138
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 139 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 197 VILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 310 NYTDF--RFPQIKAHPWHKVFHKRMP-----------PEAIDLASRLLQYSPSLRCTALE 356
+ P+ + + K+F + +A DL S++L S R + E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315
Query: 357 ACAHPFFDELREPNARLPNGRPFPPLFNF 385
A HP+ + +P+ P P
Sbjct: 316 ALQHPYINVWYDPS-EAEAPPPKIPDKQL 343
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 7e-89
Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 28/298 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
S L LV E+ + + + S N + VK + +Q+ +GL + H+
Sbjct: 70 LHSDKK-----LTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGAT 255
V HRD+KPQNLL++ ++KL +FG A+ G Y + + +YR P+++FGA
Sbjct: 121 NVLHRDLKPQNLLINR-NGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 256 EYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNY 311
Y+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT E + + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
+ V ++ DL LL+ +P R +A EA HP+F + P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 7e-89
Identities = 104/321 (32%), Positives = 168/321 (52%), Gaps = 25/321 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHP 130
Y VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F S +E + LV + + ++K Q++ +V+ YQI R
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILR 143
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
GL YIH+ + HRD+KP NL V+ ++K+ DFG A+ + Y+ +R+YRAPE
Sbjct: 144 GLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARHT--ADEMTGYVATRWYRAPE 199
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 308
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ + +
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 309 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ ++ Q+ + VF P A+DL ++L R TA +A AH +F +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 367 REPNARLPNGRPFPPLFNFKQ 387
+P+ P P+ +
Sbjct: 319 HDPDDE-PVADPYDQSLESRD 338
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 272 bits (696), Expect = 2e-87
Identities = 94/329 (28%), Positives = 163/329 (49%), Gaps = 34/329 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHP 130
Y + +G+G+ GIV A VAIKK+ + R Y REL LM+ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 131 NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+ISL + F + +E + LVME + + +V++ + + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 175
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 234 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 310 NYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALE 356
++ P+ + K+F +K +A DL S++L P+ R + +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 357 ACAHPFFDELREPNARLP-NGRPFPPLFN 384
A HP+ + +P + + +
Sbjct: 353 ALQHPYINVWYDPAEVEAPPPQIYDKQLD 381
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 7e-87
Identities = 93/359 (25%), Positives = 169/359 (47%), Gaps = 61/359 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---QD-----RRYKNRELQLMRLM-DH 129
Y + +G G++GIV+++ TGE VA+KK+ Q+ R + RE+ ++ + H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+++L + + +D + LV +Y+ ++ V++ + ++ + YQ+ +
Sbjct: 69 ENIVNLLNVLRADNDRD---VYLVFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----------- 238
+ Y+H+ G+ HRD+KP N+L++ VK+ DFG ++ V +
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 239 -----------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
Y+ +R+YRAPE++ G+T+YT ID+WS GC+L E+L G+P+FPG + ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 288 QLVEIIKVLGTPTREEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMP----------- 333
QL II V+ P+ E++ + +P +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 334 ----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQE 388
EA+DL +LLQ++P+ R +A +A HPF PN N +
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVK 357
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 2e-86
Identities = 101/380 (26%), Positives = 158/380 (41%), Gaps = 79/380 (20%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRLMDHP 130
Y ++GTGS+G V +A VAIKK+L+ R RE+ ++ ++H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+V+ + + L +V+E ++ + + +++K Y + G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVG 168
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------------ 238
+ Y+H+ G+ HRD+KP N LV+ VK+CDFG A+ + E S
Sbjct: 169 VKYVHSA-GILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 239 ----------------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL------- 275
++ +R+YRAPELI YT +ID+WS GC+ AELL
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 276 ----GQPLFPGENAV--------------------DQLVEIIKVLGTPTREEIRCM-NPN 310
PLFPG + DQL I +LGTP+ E+I + +
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 311 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
+ FP+ + + F +AI L R+L ++P+ R T E AHPFF E+R
Sbjct: 347 AKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405
Query: 369 PNARLPNGRPFPPLFNFKQE 388
FN
Sbjct: 406 AEVETNATEKVRLPFNDWMN 425
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 3e-86
Identities = 84/302 (27%), Positives = 141/302 (46%), Gaps = 35/302 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RE---LQLMRLMDHPNV 132
+G G++G V++A+ +G VA+K V RE L+ + +HPNV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRG 190
+ L ++ + E+ + LV E+ + + L+ Y + +P +K Q RG
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEH----VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRA 247
L ++H + HRD+KP+N+LV VKL DFG A++ ++ + + +YRA
Sbjct: 133 LDFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLARIY---SYQMALTPVVVTLWYRA 187
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE++ +T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW--- 243
Query: 308 NPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
P FP P V M L +L ++P R +A A H +
Sbjct: 244 -PRDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
Query: 365 EL 366
+
Sbjct: 302 KD 303
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 262 bits (673), Expect = 7e-86
Identities = 96/316 (30%), Positives = 155/316 (49%), Gaps = 37/316 (11%)
Query: 85 VGTGSFGIVFQAK-CLETGETVAIKKVLQDRRYKN-------RE---LQLMRLMDHPNVI 133
+G G++G VF+A+ G VA+K+V + RE L+ + +HPNV+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGL 191
L + + E L LV E+ + + L Y +P +K +Q+ RGL
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEH----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAP 248
++H+ V HRD+KPQN+LV + Q+KL DFG A++ ++ + + +YRAP
Sbjct: 134 DFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 188
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E++ ++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW---- 243
Query: 309 PNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
P F A P K + DL + L ++P+ R +A A +HP+F +
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 366 LREPNARLPNGRPFPP 381
L L + PP
Sbjct: 303 LERCKENLDS--HLPP 316
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 8e-86
Identities = 87/320 (27%), Positives = 142/320 (44%), Gaps = 36/320 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNVIS 134
+G G+FG VF+A+ +TG+ VA+KKV +N RE+++++L+ H NV++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 80
Query: 135 LK---HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRG 190
L S ++ + + LV ++ L S++ + L +K + G
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV--LVKGEANISY---ICSRYY 245
L YIH + HRD+K N+L+ +KL DFG A+ L K Y + + +Y
Sbjct: 137 LYYIHRN-KILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 302
R PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
+ Y + + P A+DL +LL P+ R + +A H
Sbjct: 255 NVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
Query: 362 FFDELREPNARLPNGRPFPP 381
FF +P G
Sbjct: 314 FFWS--DPMPSDLKGMLSTH 331
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 2e-84
Identities = 95/372 (25%), Positives = 158/372 (42%), Gaps = 71/372 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQD--RRYKNRELQLMRLMDHP 130
Y+ + ++G GS+G V+ A T + VAIKKV L D R RE+ ++ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+I L L +V+E + ++ K + ++K Y + G
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK----TPIFLTEEHIKTILYNLLLG 141
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------------ 238
+IH G+ HRD+KP N L++ VK+CDFG A+ + +
Sbjct: 142 ENFIHES-GIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 239 -----------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ---------- 277
++ +R+YRAPELI YT SIDIWS GC+ AELL
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 278 -PLFPG-----------------ENAVDQLVEIIKVLGTPTREEIRCM-NPNYTDF--RF 316
PLFPG ++ DQL I ++GTPT ++++ + P + F
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 376
P K + + + + I+L +L+++P+ R T +A HP+ ++R+ +
Sbjct: 320 PHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFST 378
Query: 377 RPFPPLFNFKQE 388
+ F+
Sbjct: 379 KKIILPFDDWMV 390
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 3e-78
Identities = 92/333 (27%), Positives = 152/333 (45%), Gaps = 40/333 (12%)
Query: 85 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCFF 140
VG G++G V++AK + + A+K++ + RE+ L+R + HPNVISL+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHY-----SSMNQRMPLIYVKLYTYQIFRGLAYIH 195
S + + L+ +Y ++ ++K + + ++P VK YQI G+ Y+H
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 196 TVPGVCHRDVKPQNLLVDPLTH---QVKLCDFGSAKVLVKGEANISYICSR----YYRAP 248
V HRD+KP N+LV +VK+ D G A++ ++ + +YRAP
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVEIIKVLGTP 299
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 300 TRE---------EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 350
+ E + ++ + + + + +A L +LL P
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324
Query: 351 RCTALEACAHPFFDELREP--NARLPNGRPFPP 381
R T+ +A P+F E P + P+P
Sbjct: 325 RITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPK 357
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 3e-63
Identities = 94/342 (27%), Positives = 155/342 (45%), Gaps = 60/342 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM------DH 129
Y +V+G GSFG V +A + + VA+K V ++R+ E++++ + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 130 PNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
NVI + F F N + E + +Y ++K Q L V+ + +
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHS 208
Query: 187 IFRGLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
I + L +H + H D+KP+N LL +K+ DFGS+ + +YI SR+Y
Sbjct: 209 ILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
RAPE+I GA Y ID+WS GC+LAELL G PL PGE+ DQL +I++LG P+++ +
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 306 -----------CMNPNYTDF---------------RFPQIKAHPWHKVFHKRMPPEA--- 336
P Y R +++ P + + +
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 337 -IDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 377
+D + L++ P++R T +A HP+ R + P G
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWL---RRRLPKPPTGE 423
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-62
Identities = 85/339 (25%), Positives = 145/339 (42%), Gaps = 42/339 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM-----DHP 130
Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 131 NVISLKHC-----FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + H F+ + + + +V E + E + ++K Y ++ +PLIYVK +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAKVLVKGEANISYI 240
Q+ GL Y+H G+ H D+KP+N+L++ + +K+ D G+A E + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIK 294
+R YR+PE++ GA + DIWS C++ EL+ G LF + D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 295 VLGTPTREEIR-------CMNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLAS 341
+LG +R N ++K P V ++ E D S
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315
Query: 342 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFP 380
+LQ P R A HP+ + R
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 5e-62
Identities = 93/336 (27%), Positives = 147/336 (43%), Gaps = 62/336 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM------DH 129
Y + ++G GSFG V +A E VAIK + + + N E++L+ LM
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 130 PNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
++ LK F F N LV E + +Y +L++ + + + L + + Q
Sbjct: 116 YYIVHLKRHFM--------FRNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQ 165
Query: 187 IFRGLAYIHTV-PGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
+ L ++ T + H D+KP+N LL +P +K+ DFGS+ G+ YI SR+
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRF 223
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
YR+PE++ G Y +ID+WS GC+L E+ G+PLF G N VDQ+ +I++VLG P +
Sbjct: 224 YRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282
Query: 305 R-----------CMNPNYTDFRFPQIKAH---PWHKVFH-----KRMPPEA--------- 336
+ + + K P + H + P
Sbjct: 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342
Query: 337 -------IDLASRLLQYSPSLRCTALEACAHPFFDE 365
DL R+L Y P R A H FF +
Sbjct: 343 VADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 1e-59
Identities = 79/337 (23%), Positives = 136/337 (40%), Gaps = 60/337 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRLM------D 128
Y +G G+FG V + + G VA+K V RY E+Q++ +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 129 HPNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + F +V E + + Y +K L +++ Y
Sbjct: 76 TFRCVQMLEWFE--------HHGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAY 125
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQN-LLVD-----------------PLTHQVKLCDFGSA 227
QI + + ++H+ + H D+KP+N L V + +K+ DFGSA
Sbjct: 126 QICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
E + + + +R+YRAPE+I ++ D+WS GC+L E LG +FP ++ +
Sbjct: 185 --TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
Query: 288 QLVEIIKVLGTPTREEIR-CMNPNY-TDFRFPQIKAHPWHKVFHKRMPP----------- 334
L + ++LG + I+ Y R + + + P
Sbjct: 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301
Query: 335 --EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
DL ++L+Y P+ R T EA HPFFD L++
Sbjct: 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 4e-59
Identities = 75/338 (22%), Positives = 137/338 (40%), Gaps = 66/338 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM-----DHP 130
++ R +G G+FG V + ++ + A+K V ++Y E +++ + ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 131 NVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
N++ F ++ + L+ E + ++Y ++ + + +KLY +I
Sbjct: 97 NIVKYHGKF--------MYYDHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEI 146
Query: 188 FRGLAYIHTVPGVCHRDVKPQN-LLVDPLTH-----------------------QVKLCD 223
+ L Y+ + + H D+KP+N LL DP +KL D
Sbjct: 147 LKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
FG A K + + S I +R YRAPE+I + S D+WS GCVLAEL G LF
Sbjct: 206 FGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH 262
Query: 284 NAVDQLVEIIKVLGTPTREEIR---------CMNPNYTDFRFPQIKAHPWHKVFHKRMPP 334
++ L + ++ + + +N + +P+ + K+ P
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322
Query: 335 EA--------IDLASRLLQYSPSLRCTALEACAHPFFD 364
D +LQ P+LR + E H F +
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-58
Identities = 77/346 (22%), Positives = 129/346 (37%), Gaps = 60/346 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRLM------D 128
Y +G G+FG V + G VA+K + +Y+ E+ +++ + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 129 HPNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + F F + E + + + LK + Q PL +V+ Y
Sbjct: 81 KFLCVLMSDWF--------NFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAY 130
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQN-LLVDPLTH-----------------QVKLCDFGSA 227
Q+ L ++H + H D+KP+N L V+ +++ DFGSA
Sbjct: 131 QLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
E + + + +R+YR PE+I + D+WS GC+L E G LF +
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 288 QLVEIIKVLGTPTREEIRCM---------NPNYTDFRFPQIKAHPWHKVFHKRMPPEA-- 336
LV + K+LG I + + K M ++
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306
Query: 337 ----IDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 378
DL R+L++ P+ R T EA HPFF L R
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-58
Identities = 77/394 (19%), Positives = 130/394 (32%), Gaps = 85/394 (21%)
Query: 5 PLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIIST 64
G P+ + A ++ H D+ L D S ++G
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRI--------- 57
Query: 65 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------ 118
Y + +G+G VFQ E + AIK V +
Sbjct: 58 --------------YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR 102
Query: 119 RELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP 176
E+ + + + +I L + ++ +VME + LK + +
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSID 153
Query: 177 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236
K Y + + IH G+ H D+KP N L+ +KL DFG A + +
Sbjct: 154 PWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTS 210
Query: 237 I---SYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG- 282
+ S + + Y PE I ++ + D+WS GC+L + G+ F
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 342
N + +L II +PN+ FP I + D+
Sbjct: 271 INQISKLHAII--------------DPNHE-IEFPDI------------PEKDLQDVLKC 303
Query: 343 LLQYSPSLRCTALEACAHPFFDELREPNARLPNG 376
L+ P R + E AHP+ P ++ G
Sbjct: 304 CLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-57
Identities = 68/320 (21%), Positives = 116/320 (36%), Gaps = 62/320 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN--RELQLMRLMDHPN- 131
Y + +G+G VFQ E + AIK V ++ + E+ + + +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 132 -VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+I L + ++ +VME + LK + + K Y +
Sbjct: 89 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 139
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 247
+ IH G+ H D+KP N L+ +KL DFG A + ++ S + + Y
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 248 PELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 296
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 253
Query: 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
+PN+ FP I + D+ L+ P R + E
Sbjct: 254 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 357 ACAHPFFDELREPNARLPNG 376
AHP+ P ++ G
Sbjct: 290 LLAHPYVQIQTHPVNQMAKG 309
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-57
Identities = 73/344 (21%), Positives = 120/344 (34%), Gaps = 52/344 (15%)
Query: 33 LKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGI 92
L S ++ + + + S E S+ +G GS+G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 93 VFQAKCLETGETVAIKKVL------QDRRYKNRELQ-LMRLMDHPNVISLKHCFFSTTSK 145
VF+ + E G A+K+ + +DR K E+ ++ HP + L+ + +
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----E 127
Query: 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV 205
+ L L E ++ + + + +P V Y LA++H+ G+ H DV
Sbjct: 128 EGGILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDV 183
Query: 206 KPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWS 265
KP N+ + P + KL DFG L A Y APEL+ Y T+ D++S
Sbjct: 184 KPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGSYGTAADVFS 240
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325
G + E+ L G QL +
Sbjct: 241 LGLTILEVACNMELPHGGEGWQQLRQGYL------------------------------P 270
Query: 326 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
F + E + +L+ P LR TA A P R+P
Sbjct: 271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL---RQP 311
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 8e-57
Identities = 68/324 (20%), Positives = 108/324 (33%), Gaps = 53/324 (16%)
Query: 70 NGEPKQTIS-----YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRE 120
+ Y+ + +G G F V + L G A+K++L QDR RE
Sbjct: 17 LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76
Query: 121 LQLMRLMDHPNVISLKHCFF-STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLI 178
+ RL +HPN++ L +K E + L++ + T++ ++ +
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG----- 233
+ I RGL IH G HRD+KP N+L+ Q L D GS
Sbjct: 135 QILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQACIHVEGSR 192
Query: 234 -----EANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286
+ + C+ YRAPEL D+WS GCVL ++ G+ +
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 346
V + V PQ R L + ++
Sbjct: 253 GDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMMTV 286
Query: 347 SPSLRCTALEACAHPFFDELREPN 370
P R + + P
Sbjct: 287 DPHQRPHIPLLLSQLEALQPPAPG 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-56
Identities = 68/320 (21%), Positives = 114/320 (35%), Gaps = 62/320 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPN- 131
Y + +G+G VFQ E + AIK V + E+ + + +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 132 -VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+I L + ++ +VME + LK + + K Y +
Sbjct: 70 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 247
+ IH G+ H D+KP N L+ +KL DFG A + ++ S + + Y
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 248 PELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 296
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 234
Query: 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
+PN+ FP I + D+ L+ P R + E
Sbjct: 235 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 270
Query: 357 ACAHPFFDELREPNARLPNG 376
AHP+ P ++ G
Sbjct: 271 LLAHPYVQIQTHPVNQMAKG 290
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 5e-56
Identities = 47/333 (14%), Positives = 91/333 (27%), Gaps = 57/333 (17%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHP 130
+ G +VF + +E E A+K + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 131 NVISLKHCFFSTTSKDELFLN---------------------LVMEYVP---ETMYRVLK 166
+ + D + + L+M E ++ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 167 HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226
++ + + T Q+ R A + + G+ H P NL + P ++ L D +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMP-DGRLMLGDVSA 240
Query: 227 AKVLVKGEANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
+ G + Y E + +T +++ W G + + F
Sbjct: 241 LWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 345
+ L P + +P L R L
Sbjct: 299 GIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFLN 338
Query: 346 YSPSLRCTALEACAHPFFDELR-EPNARLPNGR 377
+ R LEA P F +L+ E ++ L G+
Sbjct: 339 FDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 1e-55
Identities = 70/301 (23%), Positives = 124/301 (41%), Gaps = 51/301 (16%)
Query: 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-LMDHPNVIS 134
IS+ + V+G G+ G + + + VA+K++L + + +RE+QL+R +HPNVI
Sbjct: 24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
KD F + +E T+ V + + P+ ++ Q GLA+
Sbjct: 83 YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133
Query: 194 IHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVLVKGEANISY---IC-SRYY 245
+H++ + HRD+KP N+L+ + + DFG K L G + S + + +
Sbjct: 134 LHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 246 RAPELIFGATE--YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302
APE++ + T ++DI+SAGCV ++ G F +
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----------------QR 236
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
+ + P K A +L +++ P R +A HPF
Sbjct: 237 QANILLGAC-SLDCLH----PE-----KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 363 F 363
F
Sbjct: 287 F 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-55
Identities = 70/299 (23%), Positives = 116/299 (38%), Gaps = 45/299 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 68 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 192 AYIH----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYR 246
H V HRD+KP N+ +D VKL DFG A++L + + YY
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
+PE + Y DIWS GC+L EL P F + +L I+
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
+ +F +I R E ++ +R+L R + E +P E
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-54
Identities = 70/312 (22%), Positives = 113/312 (36%), Gaps = 59/312 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISL 135
+ V+G G+FG V +A+ AIKK+ + E+ L+ ++H V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 136 KHCF--------FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+ T K + L + MEY T+Y ++ S N Q
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWRLFRQ 124
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR--- 243
I L+YIH+ G+ HRD+KP N+ +D + VK+ DFG AK + + +
Sbjct: 125 ILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 244 ------------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
Y A E++ G Y ID++S G + E++ P G V
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RVN 236
Query: 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 351
I+K L + FP P F + L+ + P+ R
Sbjct: 237 ILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNKR 275
Query: 352 CTALEACAHPFF 363
A +
Sbjct: 276 PGARTLLNSGWL 287
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-54
Identities = 53/302 (17%), Positives = 113/302 (37%), Gaps = 23/302 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 133
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L TT++ L +ME+ P + + ++ +P + + G+
Sbjct: 71 KLFAIEEETTTR-HKVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
++ G+ HR++KP N++ KL DFG+A+ L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 249 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301
++ A +Y ++D+WS G G F + E++ + T
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
+ P + + + + +L+ + A
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 362 FF 363
Sbjct: 305 SD 306
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 4e-54
Identities = 80/323 (24%), Positives = 130/323 (40%), Gaps = 60/323 (18%)
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-LM 127
N E ++E+++G GS G V + G VA+K++L D E++L+
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKH--YSSMNQRMPLIYVKLYT 184
DHPNVI +C + FL + +E V +
Sbjct: 67 DHPNVIRY-YCSE----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVD------------PLTHQVKLCDFGSAKVLVK 232
QI G+A++H++ + HRD+KPQN+LV ++ + DFG K L
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 233 GEANISY----IC-SRYYRAPELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLF 280
G+++ + +RAPEL+ + T SIDI+S GCV +L G+ F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 281 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 340
+ + II+ F ++K + EA DL
Sbjct: 241 GDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLI 276
Query: 341 SRLLQYSPSLRCTALEACAHPFF 363
S+++ + P R TA++ HP F
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 9e-53
Identities = 63/309 (20%), Positives = 115/309 (37%), Gaps = 51/309 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHC 138
+ ++G+G FG VF+AK G+T IK+V + RE++ + +DH N++ C
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 139 F-----------FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+ +++ L + ME+ + T+ + ++ +++ + Q
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQ 130
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 246
I +G+ YIH+ + +RD+KP N+ + T QVK+ DFG L + Y
Sbjct: 131 ITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
+PE I +Y +D+++ G +LAELL ++
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD------------ 233
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DE 365
+ + L +LL P R E +
Sbjct: 234 -------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274
Query: 366 LREPNARLP 374
E N R
Sbjct: 275 SPEKNERHT 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-52
Identities = 86/322 (26%), Positives = 137/322 (42%), Gaps = 53/322 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDHPN 131
Y +RV+G GSFG V K TG+ A+K + D+ RE+QL++ +DHPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQI 187
++ L F +D+ + LV E E ++ +S + Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYY 245
G+ Y+H + HRD+KP+NLL++ + +++ DFG + + I + YY
Sbjct: 136 LSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE++ G Y D+WS G +L LL G P F G N D L ++ K
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK----------- 241
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
+ F W KV A DL ++L Y PS+R +A +A H +
Sbjct: 242 ------GKYTFE---LPQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
Query: 366 LREPNARLPNGRPFPPLFNFKQ 387
+ + + N +Q
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQ 309
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-52
Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 44/294 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
+ E+ +G G F V++A CL G VA+KKV + R +E+ L++ ++HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
VI F ++ LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 94 VIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 249
L ++H+ V HRD+KP N+ + T VKL D G + K A S + + YY +PE
Sbjct: 149 LEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMN 308
I Y DIWS GC+L E+ Q F G+ + L + I +C
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----------EQC-- 253
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
+P + + E L + + P R
Sbjct: 254 ------DYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-52
Identities = 79/341 (23%), Positives = 136/341 (39%), Gaps = 55/341 (16%)
Query: 62 ISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD 113
+ T G K +S Y + +G+G++G V + T AIK +
Sbjct: 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS 79
Query: 114 RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYS 169
E+ +++L+DHPN++ L F +D+ LVME E ++ ++
Sbjct: 80 NSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 170 SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSA 227
+ + Q+ G+ Y+H + HRD+KP+NLL++ +K+ DFG +
Sbjct: 135 EV-------DAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
V + + + YY APE++ +Y D+WS G +L LL G P F G+ D
Sbjct: 187 AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--D 242
Query: 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 347
Q EI+ ++ + W V A DL ++LQ+
Sbjct: 243 Q--EIL--------RKVEKGKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFD 279
Query: 348 PSLRCTALEACAHPFFDELREPNARLPNGRPFPPLF-NFKQ 387
R +A +A HP+ E+ N ++
Sbjct: 280 SQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRK 320
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-52
Identities = 81/322 (25%), Positives = 132/322 (40%), Gaps = 53/322 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRLMDHPNV 132
Y ++G GSFG V + K T + A+K + +D RE++L++ +DHPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIF 188
+ L +D +V E E ++K +S Q+F
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYR 246
G+ Y+H + HRD+KP+N+L++ +K+ DFG + + I + YY
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
APE++ G Y D+WSAG +L LL G P F G+N D L +
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ F W + +A DL ++L + PSLR TA + HP+ +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
Query: 367 REPNARLPNGRPFPPLF-NFKQ 387
+ + N +Q
Sbjct: 284 SSETPTISDLPSLESAMTNIRQ 305
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 7e-52
Identities = 71/318 (22%), Positives = 120/318 (37%), Gaps = 47/318 (14%)
Query: 60 HIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQ 112
H S G Q++ Y+ + +G GSFG K E G IK++ +
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65
Query: 113 DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSM 171
+R RE+ ++ M HPN++ + F ++ L +VM+Y +++ +
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESF-----EENGSLYIVMDYCEGGDLFKRINAQK-- 118
Query: 172 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231
+ + QI L ++H + HRD+K QN+ + V+L DFG A+VL
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLN 176
Query: 232 KGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
+ YY +PE+ Y DIW+ GCVL EL + F + + LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 350
I ++ +Y + L S+L + +P
Sbjct: 235 LKII------SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRD 267
Query: 351 RCTALEACAHPFFDELRE 368
R + F + E
Sbjct: 268 RPSVNSILEKGFIAKRIE 285
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-51
Identities = 74/306 (24%), Positives = 123/306 (40%), Gaps = 54/306 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRLMDHPNVISLKHC 138
V+G G++GIV+ + L +AIK++ +D RY E+ L + + H N++
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 139 FFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ + + F+ + ME VP + R + + I YT QI GL Y+
Sbjct: 84 -YLGSFSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQTI--GFYTKQILEGLKYL 138
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFG 253
H + HRD+K N+L++ + +K+ DFG++K L ++ + Y APE+I
Sbjct: 139 HD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 254 ATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
Y + DIWS GC + E+ G+P F +L E +
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM---------------- 235
Query: 313 DFRFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
F+ K HP +P EA + + P R A + F +
Sbjct: 236 -FKVGMFKVHP-------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
Query: 369 PNARLP 374
P
Sbjct: 288 KKKTQP 293
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-51
Identities = 85/308 (27%), Positives = 128/308 (41%), Gaps = 54/308 (17%)
Query: 71 GEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM 124
G K I+ Y E +G GS+G V A T A K ++D +E+++M
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYV 180
+ +DHPN+I L F +D + LVME E RV+ +
Sbjct: 61 KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANIS 238
+ +AY H + V HRD+KP+N L + +KL DFG A G+ +
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMR 166
Query: 239 YIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297
+ YY +P+++ G Y D WSAG ++ LL G P F + +++I +
Sbjct: 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG-- 222
Query: 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
F FP W V P+A L RLL SP R T+L+A
Sbjct: 223 ---------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 259
Query: 358 CAHPFFDE 365
H +F++
Sbjct: 260 LEHEWFEK 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 9e-51
Identities = 76/324 (23%), Positives = 133/324 (41%), Gaps = 60/324 (18%)
Query: 60 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ 112
H + G +N + TI ++ +R +G+G+FG V + +G IK +
Sbjct: 3 HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62
Query: 113 DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL----- 165
E+++++ +DHPN+I + F +D + +VME E + R++
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117
Query: 166 -KHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLC 222
K S YV Q+ LAY H+ V H+D+KP+N+L + +K+
Sbjct: 118 GKALSEG-------YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKII 169
Query: 223 DFGSAKVLVKGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281
DFG A++ E + + + Y APE+ + T DIWSAG V+ LL G F
Sbjct: 170 DFGLAELFKSDE-HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFT 226
Query: 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341
G + + + + + + P+A+DL
Sbjct: 227 GTSLEEVQQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLK 260
Query: 342 RLLQYSPSLRCTALEACAHPFFDE 365
++L P R +A + H +F +
Sbjct: 261 QMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-50
Identities = 76/332 (22%), Positives = 130/332 (39%), Gaps = 63/332 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----------------KVLQDRRYKNREL 121
Y R +G+G++G V K AIK + + E+
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 122 QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPL 177
L++ +DHPN+I L F +D+ + LV E+ E +++ +
Sbjct: 98 SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEA 235
QI G+ Y+H + HRD+KP+N+L++ +K+ DFG + K
Sbjct: 147 -DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+ + YY APE++ +Y D+WS G ++ LL G P F G+N DQ +II
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII-- 256
Query: 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 355
+++ + + W + EA +L +L Y + RCTA
Sbjct: 257 ------KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAE 297
Query: 356 EACAHPFFDELREPNARLPNGRPFPPLFNFKQ 387
EA + + + L N ++
Sbjct: 298 EALNSRWIKKYANNINKSDQKTLCGALSNMRK 329
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-50
Identities = 77/380 (20%), Positives = 141/380 (37%), Gaps = 45/380 (11%)
Query: 2 ASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHI 61
A G P P ++ + + +S+ +
Sbjct: 84 AENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQY 143
Query: 62 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYK 117
+ K+ Y +GTG+FG+V + TG A K V D+
Sbjct: 144 YPQPVEIKHDHVLDH--YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV 201
Query: 118 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRM 175
+E+Q M ++ HP +++L F +D+ + ++ E++ E +V ++ M++
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE 256
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGE 234
+ Y++ Q+ +GL ++H H D+KP+N++ ++++KL DFG L +
Sbjct: 257 AVEYMR----QVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ + + APE+ G D+WS G + LL G F GEN +
Sbjct: 312 SVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------- 363
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354
T ++ + N D F I + D +LL P+ R T
Sbjct: 364 -----TLRNVKSCDWNMDDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTI 405
Query: 355 LEACAHPFFDELREPNARLP 374
+A HP+ P
Sbjct: 406 HQALEHPWLTPGNAPGRDSQ 425
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-50
Identities = 67/313 (21%), Positives = 118/313 (37%), Gaps = 48/313 (15%)
Query: 59 GHIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRY 116
G +++ + + E ++ + + VG GSFG V + K +TG A+KKV L+ +
Sbjct: 39 GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--F 96
Query: 117 KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRM 175
+ EL + P ++ L ++ ++N+ ME + ++ +++K +
Sbjct: 97 RVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMG----CL 147
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
P Y Q GL Y+HT + H DVK N+L+ + LCDFG A L
Sbjct: 148 PEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 236 NISYICSR------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
S + + APE++ G +DIWS+ C++ +L G +
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265
Query: 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 349
++I P +I P L+ P
Sbjct: 266 LKIAS-EPPPI----------------REIPPS---------CAPLTAQAIQEGLRKEPV 299
Query: 350 LRCTALEACAHPF 362
R +A+E
Sbjct: 300 HRASAMELRRKVG 312
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-50
Identities = 64/318 (20%), Positives = 122/318 (38%), Gaps = 60/318 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 133
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 134 SLKHCFF-------STTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + S +++L + M+ E + + ++ +R
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-- 243
QI + ++H+ G+ HRD+KP N+ VK+ DFG + + E + +
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 244 -----------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
Y +PE I G Y+ +DI+S G +L ELL P F + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
++ + +FP + + P + +L SP R
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272
Query: 353 TALEACAHPFFDELREPN 370
A+ + F++L P
Sbjct: 273 EAINIIENAVFEDLDFPG 290
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-50
Identities = 55/307 (17%), Positives = 116/307 (37%), Gaps = 28/307 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 133
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L TT++ L +ME+ P + + ++ +P + + G+
Sbjct: 71 KLFAIEEETTTR-HKVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
++ G+ HR++KP N++ KL DFG+A+ L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 249 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301
++ A +Y ++D+WS G G F + E++ + T
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
+ P + + + + +L+ +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ----- 299
Query: 362 FFDELRE 368
FF E +
Sbjct: 300 FFAETSD 306
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-50
Identities = 83/348 (23%), Positives = 132/348 (37%), Gaps = 84/348 (24%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---------QDRRYKNRELQLMRLMDH 129
Y + +G GS+G+V A +T AIK + +D E++LM+ + H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKL----- 182
PN+ L + +DE ++ LVME + ++ + + VK
Sbjct: 88 PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 183 ------------------------------YTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212
QIF L Y+H G+CHRD+KP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201
Query: 213 D-PLTHQVKLCDFGSAKVLVKGEANISYIC-----SRYYRAPELIFGATE-YTTSIDIWS 265
+ ++KL DFG +K K Y + Y+ APE++ E Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325
AG +L LL+G FPG N D + +++ F ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301
Query: 326 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 373
+ P A DL S LL + R A+ A HP+ + + ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-50
Identities = 70/358 (19%), Positives = 137/358 (38%), Gaps = 53/358 (14%)
Query: 54 NDAVTGHIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIK---- 108
D ++ + + E + I+ Y R + G F + + + + A+K
Sbjct: 7 KDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEK 64
Query: 109 -KVLQDRRYKN----------------RELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151
+ + R + ELQ++ + + ++ + T+ DE+++
Sbjct: 65 SLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII---TNYDEVYI- 120
Query: 152 LVMEYVP-----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206
+ EY+ + + +P+ +K + +YIH +CHRDVK
Sbjct: 121 -IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATEY-TTSIDIW 264
P N+L+D +VKL DFG ++ +V + S + + PE + Y +DIW
Sbjct: 180 PSNILMDK-NGRVKLSDFGESEYMVDKKIKGS--RGTYEFMPPEFFSNESSYNGAKVDIW 236
Query: 265 SAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 324
S G L + F + ++ +L I+ + I P + F +
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVELFNNIR------TKNIEY--PLDRN-HFLYPLTNKK 287
Query: 325 HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-----DELREPNARLPNGR 377
+ + E ID L+ +P+ R T+ +A H + ++LRE + L R
Sbjct: 288 STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKR 345
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-49
Identities = 76/306 (24%), Positives = 133/306 (43%), Gaps = 56/306 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRL 126
Y+ + +G+G+ G V A +T + VAI+ + + E+++++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYT 184
++HP +I +K+ F D +V+E + E +V+ + +R+ KLY
Sbjct: 197 LNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYF 245
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC- 241
YQ+ + Y+H G+ HRD+KP+N+L+ +K+ DFG +K+L + + +C
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303
Query: 242 SRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
+ Y APE++ Y ++D WS G +L L G P F L + I G
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
+ F W +V +A+DL +LL P R T EA
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 399
Query: 360 HPFFDE 365
HP+ +
Sbjct: 400 HPWLQD 405
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-49
Identities = 77/326 (23%), Positives = 127/326 (38%), Gaps = 52/326 (15%)
Query: 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 124
+P+ Y+ R +G G F F+ +T E A K +L + E+ +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLY 183
R + H +V+ F D +F +V+E ++ + K + + + Y
Sbjct: 70 RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR----RKALTEPEARYY 120
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYIC- 241
QI G Y+H V HRD+K NL ++ +VK+ DFG + KV GE +C
Sbjct: 121 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGER-KKVLCG 177
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301
+ Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 178 TPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------ 230
Query: 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
++ P + P A L ++LQ P+ R T E
Sbjct: 231 -----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDE 267
Query: 362 FFDELREPNARLPNGRPFPPLFNFKQ 387
FF P PP F+
Sbjct: 268 FFTSGYIPARLPITCLTIPPRFSIAP 293
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-49
Identities = 76/330 (23%), Positives = 130/330 (39%), Gaps = 60/330 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRL 126
Y+ + +G+G+ G V A +T + VAIK + + E+++++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKL 182
++HP +I +K+ F D +V+E + E +V+ + L
Sbjct: 72 LNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK-------L 118
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYI 240
Y YQ+ + Y+H G+ HRD+KP+N+L+ +K+ DFG +K+L + + +
Sbjct: 119 YFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176
Query: 241 C-SRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297
C + Y APE++ Y ++D WS G +L L G P F L + I G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG 235
Query: 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
+ F W +V +A+DL +LL P R T EA
Sbjct: 236 ---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 272
Query: 358 CAHPFFDELREPNARLPNGRPFPPLFNFKQ 387
HP+ + Q
Sbjct: 273 LRHPWLQDEDMKRKFQDLLSEENESTALPQ 302
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-49
Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 52/302 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRLMDHPNVISL 135
R +G G FG V+ A+ ++ +A+K ++ + RE+++ + HPN++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F D + L++EY P T+YR L+ + Y ++ L+Y
Sbjct: 75 YGYF-----HDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 125
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 253
H+ V HRD+KP+NLL+ ++K+ DFG + +C + Y PE+I G
Sbjct: 126 HS-KRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTD--LCGTLDYLPPEMIEG 181
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
+ +D+WS G + E L+G+P F + I +V +
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 223
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 373
F FP + + A DL SRLL+++PS R E HP+ +
Sbjct: 224 FTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271
Query: 374 PN 375
N
Sbjct: 272 QN 273
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 8e-49
Identities = 60/290 (20%), Positives = 116/290 (40%), Gaps = 42/290 (14%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 137
+G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ ST + + LV E + T+ LK + + M + ++ + QI +GL ++HT
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147
Query: 197 -VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
P + HRD+K N+ + T VK+ D G A + A + I + + APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMY--EE 204
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
+Y S+D+++ G + E+ + + Q+ + T
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------TSGVKPASFDKVAI-- 256
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
PE ++ ++ + R + + H FF E
Sbjct: 257 ------------------PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 8e-49
Identities = 76/317 (23%), Positives = 124/317 (39%), Gaps = 44/317 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRLMDHPNVIS 134
Y +G+G+FG+V + TG K D+ E+ +M + HP +I+
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L F +D+ + L++E++ E R+ M++ V Y Q GL
Sbjct: 113 LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQACEGLK 163
Query: 193 YIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
++H + H D+KP+N++ VK+ DFG A L E + + APE I
Sbjct: 164 HMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
D+W+ G + LL G F GE+ ++ L + +
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------------- 265
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPN 370
D+ F + V PEA D LLQ P R T +A HP+ +
Sbjct: 266 -DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316
Query: 371 ARLPNGRPFPPLFNFKQ 387
+R+P+ R K+
Sbjct: 317 SRIPSSRYNKIRQKIKE 333
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 8e-49
Identities = 82/320 (25%), Positives = 135/320 (42%), Gaps = 54/320 (16%)
Query: 60 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQD 113
H + G +N + T + Y ++G GSFG V + K T + A+K ++
Sbjct: 3 HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62
Query: 114 RRYKN--RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--H 167
+ RE++L++ +DHPN++ L +D +V E E ++K
Sbjct: 63 KDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 168 YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG 225
+S Q+F G+ Y+H + HRD+KP+N+L++ +K+ DFG
Sbjct: 118 FSEH-------DAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
+ + I + YY APE++ G Y D+WSAG +L LL G P F G+N
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 345
D L + + F W + +A DL ++L
Sbjct: 228 YDILKRVET-----------------GKYAFD---LPQWRTI-----SDDAKDLIRKMLT 262
Query: 346 YSPSLRCTALEACAHPFFDE 365
+ PSLR TA + HP+ +
Sbjct: 263 FHPSLRITATQCLEHPWIQK 282
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-48
Identities = 82/388 (21%), Positives = 136/388 (35%), Gaps = 78/388 (20%)
Query: 10 PQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGK 69
P P P +A P P KE+ ++
Sbjct: 2 PAPADPGKAGVPGVAAP--------GAPAAAPPAKEIPEVLV------------------ 35
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQ 122
+P+ Y+ R +G G F F+ +T E A K +L + E+
Sbjct: 36 --DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEIS 93
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVK 181
+ R + H +V+ F D +F +V+E ++ + K + + +
Sbjct: 94 IHRSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR----RKALTEPEAR 144
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 241
Y QI G Y+H V HRD+K NL ++ +VK+ DFG A + +C
Sbjct: 145 YYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLC 202
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 203 GTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 256
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
++ P + P A L ++LQ P+ R T E
Sbjct: 257 ------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLND 292
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQE 388
FF P PP F+
Sbjct: 293 EFFTSGYIPARLPITCLTIPPRFSIAPS 320
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-48
Identities = 77/330 (23%), Positives = 117/330 (35%), Gaps = 64/330 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR-LMDHPNVI 133
RV+ G F V++A+ + +G A+K++L + R +E+ M+ L HPN++
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 134 SLKHCFF-----STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
S T + E L+ E + LK S + V YQ
Sbjct: 90 QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTC 146
Query: 189 RGLAYIHT-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-------------E 234
R + ++H P + HRD+K +NLL+ +KLCDFGSA + E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 235 ANISYICSRYYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
I+ + YR PE+I + DIW+ GC+L L Q F +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
R +N Y P H L +LQ +P R
Sbjct: 260 ------------RIVNGKY---SIPP----------HDTQYTVFHSLIRAMLQVNPEERL 294
Query: 353 TALEACAHPFFDELREPNARLPNGRPFPPL 382
+ E E+ P P L
Sbjct: 295 SIAEVVHQLQ--EIAAARNVNPK-SPITEL 321
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-48
Identities = 72/303 (23%), Positives = 129/303 (42%), Gaps = 50/303 (16%)
Query: 71 GEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQ 122
+ I + ++G GSF V++A+ + TG VAIK K + E++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVK 181
+ + HP+++ L + F + ++ LV+E M R LK+ + +
Sbjct: 64 IHCQLKHPSILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLKNR---VKPFSENEAR 115
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 241
+ +QI G+ Y+H+ G+ HRD+ NLL+ +K+ DFG A L +C
Sbjct: 116 HFMHQIITGMLYLHSH-GILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLC 173
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ Y +PE+ + + D+WS GC+ LL+G+P F + + L +++
Sbjct: 174 GTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA----- 227
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
D+ P + + EA DL +LL+ +P+ R + H
Sbjct: 228 ------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263
Query: 361 PFF 363
PF
Sbjct: 264 PFM 266
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-48
Identities = 49/323 (15%), Positives = 93/323 (28%), Gaps = 80/323 (24%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQ----LMRLMDHPN 131
+ +G+G FG VF+ G AIK+ L + L+ L H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
V+ + ++ + + EY ++ + + +K Q+ RG
Sbjct: 73 VVRYFSAWA-----EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDP------------------LTHQVKLCDFGSAKVLVK 232
L YIH+ + H D+KP N+ + K+ D G +
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
+ + A E++ + DI++ + +PL
Sbjct: 187 PQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---------- 233
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP-------EAIDLASRLLQ 345
WH++ R+P E +L ++
Sbjct: 234 ----------------------------GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIH 265
Query: 346 YSPSLRCTALEACAHPFFDELRE 368
P R +A+ H
Sbjct: 266 PDPERRPSAMALVKHSVLLSASR 288
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 9e-48
Identities = 71/310 (22%), Positives = 129/310 (41%), Gaps = 46/310 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVA---IKKVLQDRRYKNRELQLMRLMDHPNVISL 135
YM +G G FGIV + + +T +K D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F + L ++ E++ + R+ +N+R + Y +Q+ L +
Sbjct: 67 HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117
Query: 194 IHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
+H+ + H D++P+N++ + +K+ +FG A+ L G+ N + + Y APE +
Sbjct: 118 LHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPE-V 174
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
+T+ D+WS G ++ LL G F E +Q +II E I +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYTF 222
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP-- 369
+ F +I EA+D RLL R TA EA HP+ + E
Sbjct: 223 DEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269
Query: 370 NARLPNGRPF 379
+ +
Sbjct: 270 TKVIRTLKHR 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 9e-48
Identities = 75/320 (23%), Positives = 128/320 (40%), Gaps = 25/320 (7%)
Query: 67 GGKNGEPKQTI--SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----R 119
GG++ + + +GTG FG V + +TGE VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLN-LVMEYVP--ETMYRVLKH--YSSMNQR 174
E+Q+M+ ++HPNV+S + L L MEY + + + + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVK 232
+ I L Y+H + HRD+KP+N+++ P + K+ D G AK L +
Sbjct: 122 PIRTLLS----DISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
GE ++ + Y APEL+ +YT ++D WS G + E + G F Q
Sbjct: 177 GELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
++ + E I + +F + P H + + +L + R
Sbjct: 236 VR---EKSNEHIVVYDDLTGAVKFSSVLPTPNH--LSGILAGKLERWLQCMLMWHQRQRG 290
Query: 353 TALEACAHPFFDELREPNAR 372
T + F L +
Sbjct: 291 TDPQNPNVGCFQALDSILSL 310
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-47
Identities = 68/355 (19%), Positives = 113/355 (31%), Gaps = 83/355 (23%)
Query: 63 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----------KVL 111
+ + GE +T + V+G +A ETGE+ + +
Sbjct: 61 PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 112 QDRRYKNR---------------------ELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150
Q + R L++ +I ++ FL
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210
M+ +T VL +SS ++ + T Q+ R LA +H G+ H ++P ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDI 237
Query: 211 LVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI----------FGATEYTTS 260
++D V L F V+ A + SR + PEL T T S
Sbjct: 238 VLDQ-RGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 261 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK 320
D W+ G V+ + + A+ E I FR
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALG------------GSEWI---------FRSC--- 329
Query: 321 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP-NARLP 374
K +P L L+Y R L+A P +++LR +A LP
Sbjct: 330 ---------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-47
Identities = 70/327 (21%), Positives = 124/327 (37%), Gaps = 59/327 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 128
Y +G+G F +V + + TG A K + R RE+ +++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 184
HPNVI+L + +++ + L++E V E + + + +
Sbjct: 73 HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEE-------ATEFL 120
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 241
QI G+ Y+H++ + H D+KP+N+++ + ++K+ DFG A + G I
Sbjct: 121 KQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ + APE I D+WS G + LL G F G+ + L + V
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV----- 232
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
NY +F + A D RLL P R T ++ H
Sbjct: 233 ---------NY-EFEDE-----YFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQ 387
P+ ++ L + FK+
Sbjct: 273 PWIKP-KDTQQALSRKASAVNMEKFKK 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-47
Identities = 68/296 (22%), Positives = 123/296 (41%), Gaps = 52/296 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRLMDHPNVISL 135
R +G G FG V+ A+ + +A+K ++ ++ RE+++ + HPN++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ +F + + L++E+ P +Y+ L+ + R + ++ L Y
Sbjct: 80 -YNYFHDRKR----IYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYC 130
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 253
H V HRD+KP+NLL+ ++K+ DFG + C + Y PE+I G
Sbjct: 131 HE-RKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM--CGTLDYLPPEMIEG 186
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
+ +D+W AG + E L+G P F + + I+ V D
Sbjct: 187 -KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------D 228
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
+FP P+ + + DL S+LL+Y P R HP+
Sbjct: 229 LKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-47
Identities = 71/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRLMDHPNVIS 134
++ V+G+G+F VF K TG+ A+K E+ +++ + H N+++
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRG 190
L+ + + LVM+ V E R+L+ Y+ ++ + ++ Q+
Sbjct: 71 LEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYT---EKDASLVIQ----QVLSA 118
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC-SRYYRA 247
+ Y+H G+ HRD+KP+NLL ++ + DFG +K+ G +S C + Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVA 175
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE + Y+ ++D WS G + LL G P F E +I +
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367
+ F + W + A D LL+ P+ R T +A +HP+ D
Sbjct: 223 -----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269
Query: 368 EPNARL 373
+ +
Sbjct: 270 ALHRDI 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 6e-47
Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 53/298 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRLMDHPNV 132
Y + +G G+F +V + TG A K K L R ++ RE ++ R + HPN+
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIF 188
+ L ++E F LV + V E ++ YS + QI
Sbjct: 68 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+AY H+ G+ HR++KP+NLL+ VKL DFG A + EA + Y
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGY 173
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
+PE + Y+ +DIW+ G +L LL+G P F E+ +I
Sbjct: 174 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG---------- 222
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ +P + W V PEA L +L +P R TA +A P+
Sbjct: 223 -------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-47
Identities = 72/312 (23%), Positives = 119/312 (38%), Gaps = 58/312 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 128
Y +G+G F IV + + TG+ A K + R RE+ ++R +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 184
HPN+I+L F +++ + L++E V E + + + +
Sbjct: 67 HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDE-------ATQFL 114
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 241
QI G+ Y+H+ + H D+KP+N+++ + ++KL DFG A + G I
Sbjct: 115 KQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ + APE I D+WS G + LL G F GE + L I V
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----- 226
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
++ F + A D RLL P R T ++ H
Sbjct: 227 ------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266
Query: 361 PFFDELREPNAR 372
+ +R N R
Sbjct: 267 SWIKAIRRRNVR 278
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 8e-47
Identities = 80/379 (21%), Positives = 142/379 (37%), Gaps = 68/379 (17%)
Query: 8 PQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIG 67
P P +LL + D+ + + + + +
Sbjct: 30 PNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAA 89
Query: 68 GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK------------KVLQDRR 115
+ + Y + V+G G +V + TG A+K ++ + R
Sbjct: 90 KEFYQ-----KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 116 YKNRELQLMR-LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSS 170
RE ++R + HP++I+L + + F+ LV + + E + + S
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSE 199
Query: 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
R + ++++H + HRD+KP+N+L+D Q++L DFG + L
Sbjct: 200 KETR-------SIMRSLLEAVSFLHAN-NIVHRDLKPENILLDD-NMQIRLSDFGFSCHL 250
Query: 231 VKGEANISYIC-SRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGEN 284
GE + +C + Y APE++ + + Y +D+W+ G +L LL G P F
Sbjct: 251 EPGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309
Query: 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 344
+ L I++ ++F + W DL SRLL
Sbjct: 310 QILMLRMIMEG-----------------QYQFS---SPEWDDR-----SSTVKDLISRLL 344
Query: 345 QYSPSLRCTALEACAHPFF 363
Q P R TA +A HPFF
Sbjct: 345 QVDPEARLTAEQALQHPFF 363
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-46
Identities = 71/306 (23%), Positives = 113/306 (36%), Gaps = 58/306 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK---------KVLQDRRYKNRELQLMRLMDH 129
Y V+G G F +V + ETG+ A+K RE + ++ H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY----VKLY 183
P+++ L + + L +V E++ + + ++K + Y Y
Sbjct: 86 PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFV-----YSEAVASHY 135
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYI 240
QI L Y H + HRDVKP +L+ + + VKL FG A L +
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKEN-SAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 241 C-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
+ ++ APE + Y +D+W G +L LL G F G ++L E I
Sbjct: 194 VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII----- 245
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
++ W + A DL R+L P+ R T EA
Sbjct: 246 -----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALN 286
Query: 360 HPFFDE 365
HP+ E
Sbjct: 287 HPWLKE 292
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 83/381 (21%), Positives = 146/381 (38%), Gaps = 48/381 (12%)
Query: 3 SMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHII 62
++ + + N L P A I A H I
Sbjct: 18 NLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRI 77
Query: 63 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN 118
+ K G + ++G G FG V + + TG +A K + ++D+
Sbjct: 78 ---VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK 134
Query: 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMP 176
E+ +M +DH N+I L F + + + LVMEYV E R++ ++ +
Sbjct: 135 NEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 177 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEA 235
++++K QI G+ ++H + + H D+KP+N+L V+ Q+K+ DFG A+ E
Sbjct: 190 ILFMK----QICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243
Query: 236 NISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ + + APE + + D+WS G + LL G F G+N + L I+
Sbjct: 244 KLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354
+ D + + EA + S+LL S R +A
Sbjct: 303 C--------------RW-DLEDE-----EFQDI-----SEEAKEFISKLLIKEKSWRISA 337
Query: 355 LEACAHPFFDELREPNARLPN 375
EA HP+ + + +
Sbjct: 338 SEALKHPWLSDHKLHSRLSAQ 358
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-46
Identities = 73/327 (22%), Positives = 117/327 (35%), Gaps = 59/327 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 128
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 184
H NVI+L + ++ + L++E V E + + S +
Sbjct: 74 HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 241
QI G+ Y+HT + H D+KP+N+++ + +KL DFG A + G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ + APE I D+WS G + LL G F G+ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
+ F + A D +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQ 387
P+ + + L NF++
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFRK 299
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-46
Identities = 76/311 (24%), Positives = 123/311 (39%), Gaps = 64/311 (20%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-------------KVLQDRRYKNRELQ-LM 124
Y + ++G G +V + T + A+K +V + R +E+ L
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYV 180
++ HPN+I LK + + F LV + + E + + S R
Sbjct: 79 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------ 127
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ + +H + + HRD+KP+N+L+D +KL DFG + L GE + +
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEK-LREV 183
Query: 241 C-SRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
C + Y APE+I + Y +D+WS G ++ LL G P F + L I+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354
+++F + W DL SR L P R TA
Sbjct: 244 G-----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTA 278
Query: 355 LEACAHPFFDE 365
EA AHPFF +
Sbjct: 279 EEALAHPFFQQ 289
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 93/370 (25%), Positives = 132/370 (35%), Gaps = 63/370 (17%)
Query: 2 ASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHI 61
P P P P PPPQ P P P + V G I
Sbjct: 7 GQSPPVPFPAPAPPPQPPTPALPHPP-------AQPPPPPPQQFPQFHVKSGLQIKKNAI 59
Query: 62 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL 121
I + +V+G G G V Q T E A+K +LQD RE+
Sbjct: 60 IDDY-------------KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREV 105
Query: 122 QLM-RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLI 178
+L R P+++ + + L +VME + E R+ R
Sbjct: 106 ELHWRASQCPHIVRI-VDVYENLYAGRKCLLIVMECLDGGELFSRIQ-------DRGDQA 157
Query: 179 Y----VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLV 231
+ I + Y+H++ + HRDVKP+NLL P +KL DFG AK
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETT 215
Query: 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
+ + + YY APE + G +Y S D+WS G ++ LL G P F + +
Sbjct: 216 SHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 274
Query: 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 351
+ R Y +F P W +V E L LL+ P+ R
Sbjct: 275 MKT----------RIRMGQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQR 313
Query: 352 CTALEACAHP 361
T E HP
Sbjct: 314 MTITEFMNHP 323
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 86/347 (24%), Positives = 136/347 (39%), Gaps = 60/347 (17%)
Query: 60 HIISTTIGGKNGEPKQTIS---------YMAERVVGTGSFGIVFQAKCLETGETVAIK-- 108
H+ S T G + G + + Y + +G G+F +V + TG A K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 109 --KVLQDRRYKN--RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMY 162
K L R ++ RE ++ R + HPN++ L ++E F LV + V E
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFE 117
Query: 163 RVLK--HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQ 218
++ YS + QI +AY H+ G+ HR++KP+NLL+
Sbjct: 118 DIVAREFYSEADAS-------HCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAA 169
Query: 219 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
VKL DFG A + EA + + Y +PE + Y+ +DIW+ G +L LL+G P
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYP 228
Query: 279 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 338
F E+ +I + +P + W V PEA
Sbjct: 229 PFWDEDQHRLYAQIKAG-----------------AYDYP---SPEWDTV-----TPEAKS 263
Query: 339 LASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 385
L +L +P R TA +A P+ + + L F
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKF 310
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-46
Identities = 73/317 (23%), Positives = 124/317 (39%), Gaps = 49/317 (15%)
Query: 57 VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
V H I + + + Y + +G GS+ + + T A+K + + +R
Sbjct: 4 VGVHSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 117 KNRELQLM-RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSM 171
E++++ R HPN+I+LK + D ++ +V E + E + ++L+ +S
Sbjct: 62 PTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSER 116
Query: 172 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAK 228
+ I + + Y+H GV HRD+KP N+L +++CDFG AK
Sbjct: 117 EASA-------VLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 229 VLVKGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
L + C + + APE + Y + DIWS G +L +L G F
Sbjct: 169 QLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227
Query: 288 QLVEIIKVL-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 346
+ ++ G F W+ V A DL S++L
Sbjct: 228 PEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKMLHV 264
Query: 347 SPSLRCTALEACAHPFF 363
P R TA HP+
Sbjct: 265 DPHQRLTAALVLRHPWI 281
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 75/300 (25%), Positives = 119/300 (39%), Gaps = 52/300 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G+F +V + + G+ A + + RE ++ RL+ HPN+
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIF 188
+ L +E L+ + V E ++ +YS QI
Sbjct: 73 VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-------DASHCIQQIL 120
Query: 189 RGLAYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+ + H + GV HR++KP+NLL L VKL DFG A + + + Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
+PE + Y +D+W+ G +L LL+G P F E+ +I
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
+ FP + W V PEA DL +++L +PS R TA EA HP+
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-46
Identities = 74/327 (22%), Positives = 119/327 (36%), Gaps = 59/327 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 128
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 184
HPN+I+L + ++ + L++E V E + + S +
Sbjct: 74 HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 241
QI G+ Y+HT + H D+KP+N+++ + +KL DFG A + G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ + APE I D+WS G + LL G F G+ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----- 233
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
+ F + + A D +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQ 387
P+ + + L NFK+
Sbjct: 274 PWITP-VDTQQAMVRRESVVNLENFKK 299
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 75/316 (23%), Positives = 122/316 (38%), Gaps = 39/316 (12%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFF 140
++V+G G G V + TG+ A+K +L D +E+ + P+++ + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91
Query: 141 STTSKDELFLNLVMEYVP--ETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ L ++ME + E R + + +R I + ++H+
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE----AAEIMRDIGTAIQFLHSH 147
Query: 198 PGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGA 254
+ HRDVKP+NLL +KL DFG AK + + C + YY APE + G
Sbjct: 148 -NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGP 203
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
+Y S D+WS G ++ LL G P F + + R Y F
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----------RIRLGQY-GF 252
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPNARL 373
P W +V +A L LL+ P+ R T + HP+ + P L
Sbjct: 253 PNP-----EWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302
Query: 374 PNGRPFPPLFNFKQEV 389
R + EV
Sbjct: 303 HTARVLQEDKDHWDEV 318
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 50/303 (16%)
Query: 70 NGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR 125
+G + +S + E +G G+ IV++ K T + A+K + + K E+ ++
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVK 181
+ HPN+I LK F + ++LV+E V E R+++ +YS +R VK
Sbjct: 104 RLSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYYS---ERDAADAVK 155
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISY 239
QI +AY+H G+ HRD+KP+NLL P +K+ DFG +K++ +
Sbjct: 156 ----QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKT 209
Query: 240 IC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298
+C + Y APE I Y +D+WS G + LL G F E + I
Sbjct: 210 VCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL---- 264
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358
C ++ F + W +V A DL +L+ P R T +A
Sbjct: 265 ------NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQAL 304
Query: 359 AHP 361
HP
Sbjct: 305 QHP 307
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 75/297 (25%), Positives = 130/297 (43%), Gaps = 43/297 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMD-HPNVISL 135
+ ++ +G GSF I + ++ + A+ K++ R N +E+ ++L + HPN++ L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAV-KIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRGL 191
F D+L LVME + E R+ K H+S ++ +
Sbjct: 72 HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-------IMRKLVSAV 119
Query: 192 AYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISYIC-SRYYRAP 248
+++H V GV HRD+KP+NLL D + ++K+ DFG A++ + C + +Y AP
Sbjct: 120 SHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E + Y S D+WS G +L +L GQ F + ++++ ++I+
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG- 231
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
DF F W V EA DL LL P+ R + + +
Sbjct: 232 ----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-44
Identities = 80/323 (24%), Positives = 131/323 (40%), Gaps = 51/323 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN---RELQLMRLMDHP 130
Y+ ++G GS+G V + ET A+K K+ + + +E+QL+R + H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
NVI L ++ + + +VMEY M +L +R P+ Y Q+ G
Sbjct: 67 NVIQLVDVLYNEEKQK---MYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDG 121
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYIC-SRYYRA 247
L Y+H+ G+ H+D+KP NLL+ +K+ G A+ L A+ S ++
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 248 PELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
PE+ G ++ +DIWSAG L + G F G+N + +L E I
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIG------------ 226
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ P P DL +L+Y P+ R + + H +F +
Sbjct: 227 ----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270
Query: 367 REPNARLPNGRPFPPLFNFKQEV 389
P P PP + K
Sbjct: 271 HPPAEAPV---PIPPSPDTKDRW 290
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-43
Identities = 69/308 (22%), Positives = 121/308 (39%), Gaps = 50/308 (16%)
Query: 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDH-PNV 132
+ + +G G F +V Q TG+ A K + + RR ++ E+ ++ L P V
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFR 189
I+L + ++ + L++EY E L + +++ V QI
Sbjct: 92 INLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND----VIRLIKQILE 142
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAKVLVKGEANISYIC-SRYYR 246
G+ Y+H + H D+KPQN+L+ + +K+ DFG ++ + + I + Y
Sbjct: 143 GVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYL 200
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
APE I TT+ D+W+ G + LL F GE+ + + I +V
Sbjct: 201 APE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV----------- 248
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ + + V A D LL +P R TA +H + +
Sbjct: 249 ------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294
Query: 367 REPNARLP 374
N P
Sbjct: 295 DFENLFHP 302
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-42
Identities = 74/311 (23%), Positives = 122/311 (39%), Gaps = 47/311 (15%)
Query: 63 STTIGGKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRY 116
T G + Y + +G+G+FG+ + T E VA+K + +
Sbjct: 5 PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64
Query: 117 KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQR 174
RE+ R + HPN++ K + L ++MEY E R+ R
Sbjct: 65 --REIINHRSLRHPNIVRFKEVI---LTPTHLA--IIMEYASGGELYERICNA-----GR 112
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKVLVKG 233
+ + Q+ G++Y H++ +CHRD+K +N L+D ++K+CDFG +K V
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 234 EANISYICSRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
S + + Y APE++ EY D+WS G L +L+G F
Sbjct: 172 SQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-------- 222
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
T + I + + P R+ PE L SR+ P+ R
Sbjct: 223 EPRDYRKTIQRILSV-----KYSIPD----------DIRISPECCHLISRIFVADPATRI 267
Query: 353 TALEACAHPFF 363
+ E H +F
Sbjct: 268 SIPEIKTHSWF 278
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 72/311 (23%), Positives = 115/311 (36%), Gaps = 58/311 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM-RLMDHPNVISLK 136
E V+G G+ V L T + A+K + R RE++++ + H NV+ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRGLA 192
F ++E LV E + + + K H++ + + + L
Sbjct: 78 EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALD 125
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAKVLVKGEANISYICSR---- 243
++H G+ HRD+KP+N+L H VK+CDF +
Sbjct: 126 FLHN-KGIAHRDLKPENIL---CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 244 ----YYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
Y APE++ A+ Y D+WS G +L LL G P F G D + +
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 296 LGTPTR---EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
E I+ + FP W + A DL S+LL R
Sbjct: 242 CPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRL 288
Query: 353 TALEACAHPFF 363
+A + HP+
Sbjct: 289 SAAQVLQHPWV 299
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-42
Identities = 76/330 (23%), Positives = 132/330 (40%), Gaps = 34/330 (10%)
Query: 65 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNR 119
T K GE K + +G G+ G+VF+ +G +A K + R R
Sbjct: 22 TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLI 178
ELQ++ + P ++ F+S +++ ME++ ++ +VLK R+P
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLK----KAGRIPEQ 131
Query: 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
+ + + +GL Y+ + HRDVKP N+LV+ ++KLCDFG + L+ AN S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189
Query: 239 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298
++ +R Y +PE + G Y+ DIWS G L E+ +G+ P +A + + +
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVF---------------HKRMPPEAIDLASRL 343
E + + P +F E D ++
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308
Query: 344 LQYSPSLRCTALEACAHPFFDELREPNARL 373
L +P+ R + H F
Sbjct: 309 LIKNPAERADLKQLMVHAFIKRSDAEEVDF 338
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 56/342 (16%), Positives = 102/342 (29%), Gaps = 82/342 (23%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----------------- 125
V+G +A ETGE+ + R + ++ M+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 126 ---------------LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSS 170
+I ++ FL M+ +T VL +SS
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
++ + T Q+ R LA +H G+ H ++P ++++D V L F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRD 261
Query: 231 VKGEANISYICSRY----YRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPG 282
G + +S I + A ++ T T + D W+ G + +
Sbjct: 262 --GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH--KRMPPEAIDLA 340
+ A+ +F K +P L
Sbjct: 320 DAALGGS-----------------------------------EWIFRSCKNIPQPVRALL 344
Query: 341 SRLLQYSPSLRCTALEACAHPFFDELRE-PNARLPNGRPFPP 381
L+Y R L+A P +++LR +A LP +
Sbjct: 345 EGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGE 386
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 70/332 (21%), Positives = 123/332 (37%), Gaps = 73/332 (21%)
Query: 67 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--- 118
G +G+ Q Y + +G GS+G+V A A+K K+++ +
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 119 ----------------------RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156
+E+ +++ +DHPNV+ L ++D L++ V E
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFEL 119
Query: 157 VP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214
V M + + + Y + +G+ Y+H + HRD+KP NLLV
Sbjct: 120 VNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGE 172
Query: 215 LTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGAT-EYT-TSIDIWSAGCVLA 271
+K+ DFG + +A +S + + APE + ++ ++D+W+ G L
Sbjct: 173 -DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 272 ELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 331
+ GQ F E + L IK FP
Sbjct: 232 CFVFGQCPFMDER-IMCLHSKIK----------------SQALEFPD----------QPD 264
Query: 332 MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ + DL +R+L +P R E HP+
Sbjct: 265 IAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 70/289 (24%), Positives = 122/289 (42%), Gaps = 41/289 (14%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRLMDHPNVISLKH 137
+G G++G+V + + + +G+ +A+K++ Q+++ +L MR +D P ++
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F + + ME + ++ + K Q +P + I + L ++H+
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG---A 254
V HRDVKP N+L++ QVK+CDFG + LV A + Y APE I
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y+ DIWS G + EL + + + Q ++ + V
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
PQ+ A + E +D S+ L+ + R T E HPFF
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-41
Identities = 66/297 (22%), Positives = 122/297 (41%), Gaps = 52/297 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 133
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ + L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQY--LFLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYIC-SRYYRAP 248
Y+H + G+ HRD+KP+NLL+D +K+ DFG A V ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 249 ELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRC 306
EL+ E+ +D+WS G VL +L G+ P ++ + + +
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------ 223
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
PW K + + L ++L +PS R T + ++
Sbjct: 224 -----KKTYLN-----PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 80/330 (24%), Positives = 135/330 (40%), Gaps = 53/330 (16%)
Query: 65 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK-N 118
+I E +Y + +G G+F V A+ + TG VAIK ++ K
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMP 176
RE+++M++++HPN++ L ++ L+ L+MEY E + Y + RM
Sbjct: 63 REVRIMKILNHPNIVKLFEVI---ETEKTLY--LIMEYASGGE-----VFDYLVAHGRMK 112
Query: 177 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236
+ QI + Y H + HRD+K +NLL+D +K+ DFG + G
Sbjct: 113 EKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGK- 169
Query: 237 ISYIC-SRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ C + Y APEL G +Y +D+WS G +L L+ G F G+N + +L E +
Sbjct: 170 LDAFCGAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL 227
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354
+R P + M + +L R L +P R T
Sbjct: 228 ----------------RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTL 259
Query: 355 LEACAHPFFDELREPNARLPNGRPFPPLFN 384
+ + + E + P P + +
Sbjct: 260 EQIMKDRWINAGHEEDELKPFVEPELDISD 289
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-41
Identities = 83/307 (27%), Positives = 125/307 (40%), Gaps = 52/307 (16%)
Query: 67 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 119
G K+ + Y+ +G G+FG V + TG VA+K K+ R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPL 177
E+Q ++L HP++I L ++ + F +VMEYV E L Y + R+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVI---STPTDFF--MVMEYVSGGE-----LFDYICKHGRVEE 110
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 237
+ + QI + Y H V HRD+KP+N+L+D K+ DFG + ++ GE +
Sbjct: 111 MEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGE-FL 167
Query: 238 SYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296
C S Y APE+I G +DIWS G +L LL G F E+ V L + I+
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIR-- 224
Query: 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
F P + + L +LQ P R T +
Sbjct: 225 --------------GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKD 258
Query: 357 ACAHPFF 363
H +F
Sbjct: 259 IREHEWF 265
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 72/295 (24%), Positives = 107/295 (36%), Gaps = 68/295 (23%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKH 137
+ +V+G G G V Q T E A+ K+LQD RE++L R P+++ +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 138 CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY----VKLYTYQIFRGL 191
+ L +VME + E R+ R + I +
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQD-------RGDQAFTEREASEIMKSIGEAI 130
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAKVLVKGEANISYICSRYYR 246
Y+H++ + HRDVKP+NLL T + +KL DFG
Sbjct: 131 QYLHSI-NIAHRDVKPENLL---YTSKRPNAILKLTDFG--------------------F 166
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
A E +Y S D+WS G ++ LL G P F + + + R
Sbjct: 167 AKETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----------RI 214
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
Y +F P W +V E L LL+ P+ R T E HP
Sbjct: 215 RMGQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 258
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-40
Identities = 68/314 (21%), Positives = 128/314 (40%), Gaps = 52/314 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 133
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ + L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQY--LFLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYIC-SRYYRAP 248
Y+H + G+ HRD+KP+NLL+D +K+ DFG A V ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 249 ELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRC 306
EL+ E+ +D+WS G VL +L G+ P ++ + + +
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------ 223
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
PW K + + L ++L +PS R T + ++++
Sbjct: 224 -----KKTYLN-----PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
Query: 367 REPNARLPNGRPFP 380
+ A+ P
Sbjct: 269 LKKGAKRPRVTSGG 282
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 76/329 (23%), Positives = 128/329 (38%), Gaps = 55/329 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG VF + TG+ A K L +R K R E +++ + ++S
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L + F +K +L L VM + + Y + + N YT QI GL
Sbjct: 250 LAYAF---ETKTDLCL--VMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H + +RD+KP+N+L+D + V++ D G A L G+ + + APEL+
Sbjct: 304 HLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G EY S+D ++ G L E++ + F +E+
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE------------KVENKEL------- 401
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDEL 366
++ + + P + D LLQ P R + HP F ++
Sbjct: 402 ----KQRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455
Query: 367 REPN-ARLPNGRPFPPLFNFKQEVCIHFV 394
+ +L G PP + V +
Sbjct: 456 ---SWRQLEAGMLTPPFVPDSRTVYAKNI 481
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 77/308 (25%), Positives = 124/308 (40%), Gaps = 72/308 (23%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
+++G GSF V A+ L T AIK ++++ Y RE +M +DHP + L
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F +D+ L + Y E L Y + YT +I L Y
Sbjct: 96 YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS---------YICSRY 244
+H G+ HRD+KP+N+L++ H +++ DFG+AKVL Y+
Sbjct: 146 LHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
+PEL+ S D+W+ GC++ +L+ G P F N + + I
Sbjct: 200 --SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII---------- 245
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEAC 358
++ FP ++ P+A DL +LL + R
Sbjct: 246 ------KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 359 AHPFFDEL 366
AHPFF+ +
Sbjct: 288 AHPFFESV 295
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 69/318 (21%), Positives = 113/318 (35%), Gaps = 61/318 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRLMD 128
Y ++G+G FG V+ + VAIK ++ N E+ L++ +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 129 H--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
VI L F D L ++E L + + + + + +Q
Sbjct: 105 SGFSGVIRLLDWF---ERPDSFVL--ILERPEPVQD--LFDFITERGALQEELARSFFWQ 157
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+ + + H GV HRD+K +N+L+D ++KL DFGS +L + +R Y
Sbjct: 158 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVY 214
Query: 246 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
PE I Y S +WS G +L +++ G F + EII+
Sbjct: 215 SPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR---------- 257
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
F +R+ E L L PS R T E HP+
Sbjct: 258 -------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
Query: 365 ELREPNARLP-NGRPFPP 381
++ P + P
Sbjct: 299 DVLLPQETAEIHLHSLSP 316
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-40
Identities = 44/387 (11%), Positives = 110/387 (28%), Gaps = 73/387 (18%)
Query: 7 GPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTI 66
PQ A P +D+ L+ + + + + T
Sbjct: 2 SPQMSSLGTVDAPNFIVGNP-WDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEF 60
Query: 67 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIK----KVLQDRRYK 117
+ ++G G+F V++A + + +K +
Sbjct: 61 QLGSKL------VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 118 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRM 175
+ ++ ++ + ++ L V E + + + ++ + M
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVM 169
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ----------VKLCDFG 225
P V + ++ + +H + H D+KP N ++ + + L D G
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 226 SA---KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-P 281
+ K+ KG + + ++ E++ + ID + + +L G +
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVK 287
Query: 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341
E + + + R P + W++ FH
Sbjct: 288 NEGGECKPEGLFR--------------------RLPHL--DMWNEFFHV----------- 314
Query: 342 RLLQYSPSLRCTALEACAHPFFDELRE 368
+L +L+ ++
Sbjct: 315 -MLNIPDCHHLPSLDLLRQKLKKVFQQ 340
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-40
Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 49/293 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRLMDHPN 131
Y+ +G GSFG V A +T + VA+K + + + RE+ ++L+ HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I L T+ ++ +V+EY ++ Y +RM + + QI +
Sbjct: 71 IIKLYDVI---TTPTDIV--MVIEYAGGELF----DYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y H + HRD+KP+NLL+D VK+ DFG + ++ G + C S Y APE+
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEV 178
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
I G +D+WS G VL +L+G+ F E + L + +
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN---------------- 221
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ P + + P A L R++ P R T E P+F
Sbjct: 222 SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 81/374 (21%), Positives = 145/374 (38%), Gaps = 59/374 (15%)
Query: 7 GPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTI 66
Q ++ ++ + G+ + +
Sbjct: 77 CLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEV 136
Query: 67 GGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ 119
+ + T++ + +++G G+FG V K TG A+K +L+ +
Sbjct: 137 SLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHT 195
Query: 120 --ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRM 175
E ++++ HP + +LK+ F + D L VMEY E + + S +
Sbjct: 196 LTENRVLQNSRHPFLTALKYSF---QTHDRLCF--VMEYANGGELFFHL-----SRERVF 245
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
+ Y +I L Y+H+ V +RD+K +NL++D H +K+ DFG K +K A
Sbjct: 246 SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGA 304
Query: 236 NISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ C + Y APE++ +Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 305 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL 362
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--- 351
+ RFP + + PEA L S LL+ P R
Sbjct: 363 ----------------MEEIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGG 394
Query: 352 --CTALEACAHPFF 363
A E H FF
Sbjct: 395 GSEDAKEIMQHRFF 408
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 72/300 (24%), Positives = 121/300 (40%), Gaps = 39/300 (13%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRLMDHPNVISLKH 137
+G G++G V + +G+ +A+K++ ++++ +L +MR D P ++
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F + ME + + + K+ YS ++ +P + T + L ++
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ HRD+KP N+L+D + +KLCDFG + LV A R Y APE I +
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 257 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
Y D+WS G L EL G+ +P N+V + + V G P
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP-------------- 247
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 373
PQ+ + F P I+ + L S R E HPF E +
Sbjct: 248 ---PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-38
Identities = 73/302 (24%), Positives = 121/302 (40%), Gaps = 58/302 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRLMDHPN 131
R++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
++ + + F + D+L +++ + + Y + +H ++ Y +I
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
GL ++H V +RD+KP N+L+D H V++ D G A K + + + + + Y APE
Sbjct: 304 GLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
++ Y +S D +S GC+L +LL G F D + EI
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFD 364
PE L LLQ + R C A E PFF
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454
Query: 365 EL 366
L
Sbjct: 455 SL 456
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 88/323 (27%), Positives = 139/323 (43%), Gaps = 59/323 (18%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG V + TG+ A K L+ +R K R E Q++ ++ V+S
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L + + +KD L L V+ + + + + Y P Y +I GL
Sbjct: 249 LAYAY---ETKDALCL--VLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLE 300
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
+H + +RD+KP+N+L+D H +++ D G A + +G+ + + Y APE++
Sbjct: 301 DLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 358
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
YT S D W+ GC+L E++ GQ F REE+
Sbjct: 359 N-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKK------------KIKREEV-------- 397
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELR 367
+K P + + +R P+A L S+LL P+ R +A E HP F +L
Sbjct: 398 ---ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL- 451
Query: 368 EPN-ARLPNGRPFPPLFNFKQEV 389
N RL G PP FK +
Sbjct: 452 --NFKRLGAGMLEPP---FKPDP 469
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 75/320 (23%), Positives = 116/320 (36%), Gaps = 62/320 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRLMD 128
Y ++G G FG VF L VAIK +VL + E+ L+ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 129 ----HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 184
HP VI L +F T ++ L V+E L Y + + + +
Sbjct: 93 AGGGHPGVIRL-LDWFET--QEGFML--VLERPLPAQD--LFDYITEKGPLGEGPSRCFF 145
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SR 243
Q+ + + H+ GV HRD+K +N+L+D KL DFGS +L + +R
Sbjct: 146 GQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTR 202
Query: 244 YYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302
Y PE I +Y +WS G +L +++ G F + EI++
Sbjct: 203 VYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA------- 248
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
+ FP + P+ L R L PS R + E P+
Sbjct: 249 ----------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286
Query: 363 FDELREPNARLPNGRPFPPL 382
E P+ PL
Sbjct: 287 MQTPAEDVPLNPSKGGPAPL 306
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 67/302 (22%), Positives = 111/302 (36%), Gaps = 48/302 (15%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRLMDHPNVISLKH 137
+G+G+ G V++ + +TG +A+K++ ++ + +L +++ D P ++
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F + T + + ME M K M +P + T I + L Y+
Sbjct: 92 TFITNTD-----VFIAMEL----MGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI----F 252
GV HRDVKP N+L+D Q+KLCDFG + LV +A Y APE I
Sbjct: 143 KHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNY 311
+Y D+WS G L EL GQ + + L ++++ P
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------ 247
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371
P + H + L R + H F
Sbjct: 248 -----PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
Query: 372 RL 373
+
Sbjct: 296 DV 297
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 68/298 (22%), Positives = 128/298 (42%), Gaps = 54/298 (18%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
R +G GSFG V + +T + A+K K ++ R +ELQ+M+ ++HP +++L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F +DE + +V++ + + Y + + N VKL+ ++ L Y
Sbjct: 81 WYSF-----QDEEDMFMVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDY 130
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF- 252
+ + HRD+KP N+L+D H V + DF A +L + + ++ Y APE+
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 253 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCMNP 309
Y+ ++D WS G ELL G+ + ++ ++V +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------- 233
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFFDEL 366
T +P E + L +LL+ +P R + L P+ +++
Sbjct: 234 -TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-37
Identities = 63/359 (17%), Positives = 125/359 (34%), Gaps = 105/359 (29%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 134 SLKH----------------------------------------------------CFFS 141
+
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 142 TTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
S +++L + M+ E + + S+ R + + ++ QI + ++H+ G+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI-QIAEAVEFLHS-KGL 185
Query: 201 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-------------VKGEANISYICSRYYRA 247
HRD+KP N+ VK+ DFG + + + ++ Y +
Sbjct: 186 MHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE I G Y+ +DI+S G +L ELL E ++++ ++R
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQM-------ERVRII-----TDVR-- 287
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ +FP + + P+ + +L SP+ R A + + F+ L
Sbjct: 288 -----NLKFPLLFTQKY---------PQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 59/297 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
+++G G+FG V + TG A+K +L+ + E ++++ HP + +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
LK+ F + D L VMEY E + + + + + Y +I L
Sbjct: 70 LKYAF---QTHDRLCF--VMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPELI 251
Y+H+ V +RD+K +NL++D H +K+ DFG K + A + C Y APE++
Sbjct: 120 YLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------M 219
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 363
+ RFP + + PEA L + LL+ P R A E H FF
Sbjct: 220 EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 80/330 (24%), Positives = 123/330 (37%), Gaps = 79/330 (23%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 135
+V+G G+F V K +TG+ A+K + + K E+ ++ D + L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F +DE +L LVMEY + + S +R+P + Y +I +
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--------YICSRYY 245
+H + G HRD+KP N+L+D H ++L DFGS L S Y+
Sbjct: 178 VHRL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230
Query: 246 RAPELI------FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
+PE++ G Y D W+ G E+ GQ F ++ + I
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------ 282
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALE 356
++ P + +P EA D RLL P R A +
Sbjct: 283 -------VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324
Query: 357 ACAHPFF-----DELREPNARLPNGRPFPP 381
HPFF D LR+ PF P
Sbjct: 325 FRTHPFFFGLDWDGLRDSVP------PFTP 348
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 86/307 (28%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 68 GKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 119
+ + + I Y+ +G G+FG V K TG VA+K K+ R
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPL 177
E+Q ++L HP++I L ++ ++F +VMEYV E L Y N R+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVI---STPSDIF--MVMEYVSGGE-----LFDYICKNGRLDE 115
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 237
+ QI G+ Y H V HRD+KP+N+L+D K+ DFG + ++ GE +
Sbjct: 116 KESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGE-FL 172
Query: 238 SYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296
C S Y APE+I G +DIWS+G +L LL G F ++ V L + I
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC-- 229
Query: 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
F P + + P I L +LQ P R T +
Sbjct: 230 --------------DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATIKD 263
Query: 357 ACAHPFF 363
H +F
Sbjct: 264 IREHEWF 270
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 77/322 (23%), Positives = 125/322 (38%), Gaps = 65/322 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ--DRRYKNRELQLMRLMDHPNVISL 135
+V+G G+FG V K + A+K ++L+ + E ++ D + +L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F +D+ L LVM+Y + + S R+P + Y ++ +
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRY-YRAPELI 251
+H + HRD+KP N+L+D H ++L DFGS L++ S Y +PE++
Sbjct: 191 VHQL-HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 252 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
G Y D WS G + E+L G+ F E+ + + I M
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------M 294
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFF- 363
N F+FP + A DL RL+ S R + HPFF
Sbjct: 295 NHK-ERFQFPT---------QVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFS 343
Query: 364 ----DELREPNARLPNGRPFPP 381
D +R A P+ P
Sbjct: 344 GIDWDNIRNCEA------PYIP 359
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-37
Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 60/299 (20%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-------RELQLMRL 126
Y +G+G+FG V+ A E + V +K KVL+D ++ E+ ++
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
++H N+I + F ++ LVME + L + + R+ Q
Sbjct: 86 VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLD--LFAFIDRHPRLDEPLASYIFRQ 138
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+ + Y+ + HRD+K +N+++ +KL DFGSA L +G+ C + Y
Sbjct: 139 LVSAVGYLRLK-DIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGK-LFYTFCGTIEY 195
Query: 246 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
APE++ G Y +++WS G L L+ + F +L E ++
Sbjct: 196 CAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE---------- 238
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P + E + L S LLQ P R T + P+
Sbjct: 239 -------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 5e-36
Identities = 78/364 (21%), Positives = 136/364 (37%), Gaps = 84/364 (23%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLM-----DHP 130
Y R +G G F V+ + ++ + VA+K V Y E++L++ + + P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 131 N---VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
N V+ L F + + + +V E + + + + + Q +PL VK Q+
Sbjct: 99 NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLV----------------------------------- 212
+GL Y+HT + H D+KP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 213 -------------DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 259
+ +VK+ D G+A + + I +R YR+ E++ G+ Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272
Query: 260 SIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIKVLGTPTREEIR-------C 306
DIWS C+ EL G LF + D + II++LG R+ I
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLASRLLQYSPSLRCTALEACAH 360
++K +V ++ D +L+ P R TA E H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 361 PFFD 364
P+ +
Sbjct: 393 PWLN 396
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-36
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
E VVG G+FG+V +AK + VAIK++ + K EL+ + ++HPN++
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK----- 65
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--T 196
+ + L VMEY ++Y VL H + + + Q +G+AY+H
Sbjct: 66 LYGACLNPVCL--VMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ HRD+KP NLL+ +K+CDFG+A + S + APE+ G +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SN 179
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
Y+ D++S G +L E++ + F +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 56/294 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 133
+++G GSFG VF A+ +T + AIK L+ + L +HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ F +K+ LF VMEY+ + MY + + L Y +I GL
Sbjct: 82 HMFCTF---QTKENLFF--VMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGL 131
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPEL 250
++H+ G+ +RD+K N+L+D H +K+ DFG K + G+A + C Y APE+
Sbjct: 132 QFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ G +Y S+D WS G +L E+L+GQ F G++ ++L I+
Sbjct: 190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR---------------- 231
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFF 363
+ +P + + EA DL +L P R HP F
Sbjct: 232 MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-36
Identities = 72/300 (24%), Positives = 131/300 (43%), Gaps = 61/300 (20%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNR---ELQLMRLMDHPN 131
RV+G G +G VFQ + + TG+ A+K ++++ + E ++ + HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
++ L + F + +L+L ++EY+ E ++ + Y +I
Sbjct: 83 IVDLIYAF---QTGGKLYL--ILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISM 132
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAP 248
L ++H G+ +RD+KP+N++++ H VKL DFG K + C Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E++ + + ++D WS G ++ ++L G P F GEN + ++ I + ++
Sbjct: 191 EILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKI------LKCKL---- 238
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 363
P + EA DL +LL+ + + R A E AHPFF
Sbjct: 239 ------NLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-36
Identities = 73/297 (24%), Positives = 121/297 (40%), Gaps = 59/297 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQ--------LMRLMDHPNVI 133
+V+G GSFG V A+ A+K VLQ K +E + L++ + HP ++
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L F + D+L+ V++Y+ E Y + + + + Y +I L
Sbjct: 103 GLHFSF---QTADKLYF--VLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASAL 152
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPEL 250
Y+H++ + +RD+KP+N+L+D H + L DFG K ++ + S C Y APE+
Sbjct: 153 GYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ Y ++D W G VL E+L G P F N ++ + I
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------------- 252
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR----CTALEACAHPFF 363
+ + A L LLQ + R +E +H FF
Sbjct: 253 NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-36
Identities = 72/298 (24%), Positives = 129/298 (43%), Gaps = 59/298 (19%)
Query: 83 RVVGTGSFGIVFQAK---CLETGETVAIK-----KVLQDRRYKNR-ELQLMRLMDHPNVI 133
+V+G GSFG VF K + + A+K + R + + E ++ ++HP ++
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L + F ++ +L+L +++++ + R+ S VK Y ++ L
Sbjct: 90 KLHYAF---QTEGKLYL--ILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALAL 139
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
++H++ G+ +RD+KP+N+L+D H +KL DFG +K + E C + Y APE+
Sbjct: 140 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ +T S D WS G ++ E+L G F G++ + + +I
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------------- 239
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 363
PQ + PEA L L + +P+ R E H FF
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 77/298 (25%), Positives = 123/298 (41%), Gaps = 59/298 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
RV+G GSFG V A+ ETG+ A+K + +D ++ +++ L +HP +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF + D LF VME+V + M+ + K +R + Y +I L
Sbjct: 89 LFCCF---QTPDRLFF--VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALM 138
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPELI 251
++H G+ +RD+K N+L+D H KL DFG K + + C Y APE++
Sbjct: 139 FLHDK-GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
Y ++D W+ G +L E+L G F EN D L E I
Sbjct: 197 QE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------N 238
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 363
+ +P + +A + + +P++R HPFF
Sbjct: 239 DEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 77/307 (25%), Positives = 124/307 (40%), Gaps = 68/307 (22%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
+V+G G+FG V + T + A+K ++++ + E +M + P V+ L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F +D+ +L +VMEY+P + + ++ N +P + + YT ++ L
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGD-LVNLMS-----NYDVPEKWARFYTAEVVLALDA 183
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--------YICSRYY 245
IH++ G HRDVKP N+L+D H +KL DFG+ + K YI
Sbjct: 184 IHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236
Query: 246 RAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302
+PE++ G Y D WS G L E+L+G F ++ V T
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------TYS 283
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACA 359
+I MN FP + EA +L L +R E
Sbjct: 284 KI--MNHK-NSLTFP----------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKR 329
Query: 360 HPFFDEL 366
H FF
Sbjct: 330 HLFFKND 336
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 76/303 (25%), Positives = 121/303 (39%), Gaps = 46/303 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
Y + V+G+G+ +V A C E VAIK++ ++ + +E+Q M HPN++
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 134 SLKHCFFSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
S F KDEL+ LVM+ V + + ++ + + + ++
Sbjct: 77 SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSR---- 243
GL Y+H G HRDVK N+L+ V++ DFG SA + G+ + R
Sbjct: 132 EGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187
Query: 244 ---YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ APE++ Y DIWS G EL G + + L+ ++
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
N P ++ K K+ + S LQ P R TA E H
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288
Query: 361 PFF 363
FF
Sbjct: 289 KFF 291
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-35
Identities = 76/297 (25%), Positives = 121/297 (40%), Gaps = 58/297 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
V+G GSFG V ++ T E A+K + +D ++ +++ L P +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF + D L+ VMEYV + MY + + R + Y +I GL
Sbjct: 86 LHSCF---QTMDRLYF--VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 135
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPELI 251
++ + G+ +RD+K N+++D H +K+ DFG K + C Y APE+I
Sbjct: 136 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
Y S+D W+ G +L E+L GQ F GE+ D+L + I +
Sbjct: 194 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNV------- 238
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 363
+P K M EA+ + L+ P R + H FF
Sbjct: 239 ---AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 30/219 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHP 130
E+ +G G FG+V + + ++ VAIK ++ RE+ +M ++HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N++ + +VME+VP +Y L + I
Sbjct: 84 NIVK----LYGLMHNP---PRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIAL 133
Query: 190 GLAYIHTV-PGVCHRDVKPQNLLVD----PLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
G+ Y+ P + HRD++ N+ + K+ DFG ++ + + +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191
Query: 245 YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 282
+ APE I E YT D +S +L +L G+ F
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-35
Identities = 80/303 (26%), Positives = 125/303 (41%), Gaps = 68/303 (22%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
R +GTGSFG V + G A+K V++ + + N E ++ ++ HP +I +
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F +D + ++M+Y+ E + K +QR P K Y ++ L Y
Sbjct: 72 WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-----ISYICSRYYRAP 248
+H+ + +RD+KP+N+L+D H +K+ DFG AK V YI AP
Sbjct: 122 LHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKY-VPDVTYTLCGTPDYI------AP 172
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E++ Y SID WS G ++ E+L G F N + E I
Sbjct: 173 EVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL-------------- 216
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAHPFF 363
+ RFP + DL SRL+ S R L + HP+F
Sbjct: 217 --NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
Query: 364 DEL 366
E+
Sbjct: 263 KEV 265
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 60/299 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
+ +GTGSFG V K E+G A+K KV++ + + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F KD L +VMEYV E + + R + + Y QI Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEY 156
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H++ + +RD+KP+NLL+D + +++ DFG AK + + +C + APE+I
Sbjct: 157 LHSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAK---RVKGRTWTLCGTPEALAPEIIL 211
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
Y ++D W+ G ++ E+ G P F + Q+ E I
Sbjct: 212 S-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIV----------------SG 253
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAHPFFDEL 366
RFP + DL LLQ + R L + H +F
Sbjct: 254 KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 68/298 (22%), Positives = 126/298 (42%), Gaps = 50/298 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
RV+G GS+ V + +T A+K V ++ + ++ + +HP ++
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF ++ LF V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 75 LHSCF---QTESRLF--FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 124
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
Y+H G+ +RD+K N+L+D H +KL D+G K ++ S C + Y APE++
Sbjct: 125 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G +Y S+D W+ G ++ E++ G+ F + D + T + +
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 227
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 363
F I + + +A + L P R + HPFF
Sbjct: 228 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-34
Identities = 57/311 (18%), Positives = 108/311 (34%), Gaps = 42/311 (13%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
G V A+ TGE V ++++ + EL + +L +HPN++ + F
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+ +EL+ +V ++ + ++ + M + + + + L YIH +
Sbjct: 96 I---ADNELW--VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM- 147
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSA--------KVLVKGEANISYICSRYYRAPEL 250
G HR VK ++L+ + +V L S + V + + + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 251 IF-GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK--------------- 294
+ Y DI+S G EL G F A L+E +
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266
Query: 295 --VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
+ ++ + T +H+ P + LQ +P R
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326
Query: 353 TALEACAHPFF 363
+A H FF
Sbjct: 327 SASTLLNHSFF 337
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 9e-34
Identities = 80/377 (21%), Positives = 134/377 (35%), Gaps = 63/377 (16%)
Query: 8 PQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIG 67
Q + +F+ + + ++ G +
Sbjct: 267 LQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTI 326
Query: 68 GKNGEPKQTISYMAE-----RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ 122
K V+G GSFG V ++ T E A+K + +D ++ +++
Sbjct: 327 SKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE 386
Query: 123 --------LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMN 172
L P + L CF + D L+ VMEYV + MY + +
Sbjct: 387 CTMVEKRVLALPGKPPFLTQLHSCF---QTMDRLYF--VMEYVNGGDLMYHIQQV----- 436
Query: 173 QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232
R + Y +I GL ++ + G+ +RD+K N+++D H +K+ DFG K +
Sbjct: 437 GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIW 494
Query: 233 GEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
C + Y APE+I Y S+D W+ G +L E+L GQ F GE+ D+L +
Sbjct: 495 DGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQ 552
Query: 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 351
I + +P K M EA+ + L+ P R
Sbjct: 553 SI------MEHNV----------AYP------------KSMSKEAVAICKGLMTKHPGKR 584
Query: 352 -----CTALEACAHPFF 363
+ H FF
Sbjct: 585 LGCGPEGERDIKEHAFF 601
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 76/303 (25%), Positives = 131/303 (43%), Gaps = 59/303 (19%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHP 130
+V+GTG++G VF + + +TG+ A+K + + + + L + P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
+++L + F ++ +L L +++Y+ E + S +R V++Y +I
Sbjct: 120 FLVTLHYAF---QTETKLHL--ILDYINGGELFTHL-----SQRERFTEHEVQIYVGEIV 169
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-IC-SRYYR 246
L ++H + G+ +RD+K +N+L+D H V L DFG +K V E +Y C + Y
Sbjct: 170 LALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 247 APELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
AP+++ G + ++D WS G ++ ELL G F + + EI I
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL 279
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAH 360
++ +PQ M A DL RLL P R A E H
Sbjct: 280 -----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322
Query: 361 PFF 363
FF
Sbjct: 323 LFF 325
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 82/371 (22%), Positives = 141/371 (38%), Gaps = 73/371 (19%)
Query: 4 MPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIIS 63
M + + R D +++ + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDD--------- 51
Query: 64 TTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----- 118
P++ + R +G GSFG V+ A+ + E VAIKK+ + N
Sbjct: 52 ---------PEKL--FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 100
Query: 119 --RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP 176
+E++ ++ + HPN I + C+ + + LVMEY + +L+ + + +
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVH---KKPLQ 152
Query: 177 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGE 234
+ + T+ +GLAY+H+ + HRDVK N+L L+ VKL DFGSA ++
Sbjct: 153 EVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNIL---LSEPGLVKLGDFGSASIMAPAN 208
Query: 235 ANISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
S++ + Y+ APE+I E Y +D+WS G EL +P NA+ L I
Sbjct: 209 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 265
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
+ P +++ W + F + LQ P R
Sbjct: 266 AQ------------NES-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRP 298
Query: 353 TALEACAHPFF 363
T+ H F
Sbjct: 299 TSEVLLKHRFV 309
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 68/298 (22%), Positives = 126/298 (42%), Gaps = 50/298 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
RV+G GS+ V + +T A++ V ++ + ++ + +HP ++
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF ++ LF V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 118 LHSCF---QTESRLF--FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 167
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
Y+H G+ +RD+K N+L+D H +KL D+G K ++ S C + Y APE++
Sbjct: 168 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G +Y S+D W+ G ++ E++ G+ F + D + T + +
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 270
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFF 363
F I + + +A + L P R C HPFF
Sbjct: 271 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-33
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
+ +G GSFG V +A+ G VA+K +++ + RE+ +M+ + HPN++
Sbjct: 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ T L + V EY+ ++YR+L H S +++ Y + +G+ Y+
Sbjct: 100 MG---AVTQPPNLSI--VTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 195 HTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIF 252
H P + HR++K NLLVD + VK+CDFG +++ + S + + APE++
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
D++S G +L EL Q +
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHPNVI 133
E ++G G FG V++A + G+ VA+K D +E +L ++ HPN+I
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+L+ E L LVME+ + RVL +R+P + + QI RG+
Sbjct: 70 ALRGV-----CLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 193 YIH--TVPGVCHRDVKPQNLLVD-------PLTHQVKLCDFGSAKVLVKGEANISYICSR 243
Y+H + + HRD+K N+L+ +K+ DFG A+ + S +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAY 178
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
+ APE+I + ++ D+WS G +L ELL G+ F G
Sbjct: 179 AWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 74/306 (24%), Positives = 126/306 (41%), Gaps = 59/306 (19%)
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 125
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 15 VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+PN+++ + DEL+ +VMEY+ + + M++ +
Sbjct: 73 ENKNPNIVNYLDSYL---VGDELW--VVMEYLAGGSLTDVVTETCMDEG----QIAAVCR 123
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-- 243
+ + L ++H+ V HRD+K N+L+ + VKL DFG A I+ S+
Sbjct: 124 ECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFC-------AQITPEQSKRS 174
Query: 244 ------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297
Y+ APE++ Y +DIWS G + E++ G+P + EN + L I G
Sbjct: 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-G 232
Query: 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
TP + +F D +R L+ R +A E
Sbjct: 233 TPELQN-----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKEL 267
Query: 358 CAHPFF 363
H F
Sbjct: 268 LQHQFL 273
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 74/315 (23%), Positives = 125/315 (39%), Gaps = 58/315 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMR-LMDHPNVIS 134
+ +VG G++G V++ + ++TG+ AIK + + +E+ +++ H N+ +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 135 LKHCFF---STTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
F D+L+ LVME+ + + K + ++ +I
Sbjct: 86 YYGAFIKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREI 138
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLV--KGEANISYICSR 243
RGL+++H V HRD+K QN+L LT +VKL DFG + L G N ++I +
Sbjct: 139 LRGLSHLHQ-HKVIHRDIKGQNVL---LTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTP 193
Query: 244 YYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
Y+ APE+I Y D+WS G E+ G P + + L I +
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----- 248
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
NP P++K+ W K F L + S R +
Sbjct: 249 --------NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMK 286
Query: 360 HPFFDELREPNARLP 374
HPF +
Sbjct: 287 HPFIRDQPNERQVRI 301
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 48/302 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ +G GSFG VF+ T + VAIK + + +E+ ++ D P V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ +L+ ++MEY+ L +++ + +I +GL Y
Sbjct: 84 KYYGSYL---KDTKLW--IIMEYLGGGSALDLLEPGPLDET----QIATILREILKGLDY 134
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV--KGEANISYICSRYYRAPELI 251
+H+ HRD+K N+L+ +VKL DFG A L + + N +++ + ++ APE+I
Sbjct: 135 LHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN-TFVGTPFWMAPEVI 191
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
+ Y + DIWS G EL G+P + + L I K PT E
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEG-------- 241
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371
+ K + L PS R TA E H F + +
Sbjct: 242 -----------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282
Query: 372 RL 373
L
Sbjct: 283 YL 284
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-32
Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNVIS-LKH 137
+ +G G +G V+ K GE VA+K + RE + LM H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIH 195
T S +L+L + +Y ++Y LK + + L Y GL ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151
Query: 196 TV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS-----R 243
T P + HRD+K +N+LV + D G A + + + +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 244 YYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 274
Y PE++ + + D++S G +L E+
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 34/216 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNVIS-LKH 137
VG G +G V++ GE VA+K +D + RE L ++ H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIH 195
S S +L+L + Y ++Y L+ + + ++ I GLA++H
Sbjct: 71 DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122
Query: 196 TV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS-----R 243
P + HRD+K +N+LV Q + D G A + + + + +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 244 YYRAPELI-----FGATEYTTSIDIWSAGCVLAELL 274
Y APE++ + +DIW+ G VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 45/306 (14%)
Query: 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNV 132
++ V G FG V++A+ E VA+K QD++ E + + M H N+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80
Query: 133 IS-LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFR 189
+ + T+ +L+L + + + ++ LK S N+ + + R
Sbjct: 81 LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132
Query: 190 GLAYIHT---------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
GLAY+H P + HRD+K +N+L+ + DFG A EA S
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKF---EAGKSAG 188
Query: 241 CSRY------YRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
+ Y APE++ GA + ID+++ G VL EL G L
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 350
++ P+ E+++ + P ++ + W K M + +
Sbjct: 249 FEEEIGQHPSLEDMQ--EVVVHKKKRPVLRDY-WQKHAGMAM---LCETIEECWDHDAEA 302
Query: 351 RCTALE 356
R +A
Sbjct: 303 RLSAGC 308
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 47/300 (15%)
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 125
G+P+ + +G GS GIV A+ +G VA+K + Q R E+ +MR
Sbjct: 40 QGDPRLL--LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR 97
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYT 184
H NV+ + + +EL++ +ME++ + ++ R+ +
Sbjct: 98 DYQHFNVVEMYKSYLV---GEELWV--LMEFLQGGALTDIVSQ-----VRLNEEQIATVC 147
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSR 243
+ + LAY+H GV HRD+K ++L+ L +VKL DFG A++ S + +
Sbjct: 148 EAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTP 205
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303
Y+ APE+I + Y T +DIWS G ++ E++ G+P + ++ V + + P +
Sbjct: 206 YWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN 263
Query: 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+H V D R+L P R TA E HPF
Sbjct: 264 -----------------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 75/296 (25%), Positives = 119/296 (40%), Gaps = 55/296 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLK 136
+ +G GS+G V++A ETG+ VAIK+V + + +E+ +M+ D P+V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 137 HCFFSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+F +L+ +VMEY V + + N+ + + +GL
Sbjct: 91 GSYF---KNTDLW--IVMEYCGAGSVSDII-------RLRNKTLTEDEIATILQSTLKGL 138
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLV--KGEANISYICSRYYRA 247
Y+H + HRD+K N+L L KL DFG A L + N + I + ++ A
Sbjct: 139 EYLHFM-RKIHRDIKAGNIL---LNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTPFWMA 193
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE+I Y DIWS G E+ G+P + + + + I PT +
Sbjct: 194 PEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK---- 247
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
W F D + L SP R TA + HPF
Sbjct: 248 -------------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFV 282
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRLMDHPNVISLKH 137
V+G G FG + ETGE + +K++++ +R +E+++MR ++HPNV+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK--- 71
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F KD+ LN + EY+ T+ ++K SM+ + P + I G+AY+H+
Sbjct: 72 -FIGVLYKDKR-LNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------------- 243
+ + HRD+ N LV V + DFG A+++V + + S
Sbjct: 127 M-NIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 244 --YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
Y+ APE+I G Y +D++S G VL E++ P
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 36/211 (17%), Positives = 77/211 (36%), Gaps = 22/211 (10%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISL 135
+ G +++ + G + +K + R N E +R+ HPNV+ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
S L+ ++P ++Y VL + N + + + RG+A++
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 195 HTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
HT+ P + + +++++D ++ + + APE +
Sbjct: 128 HTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 254 --ATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
S D+WS +L EL+ + F
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-31
Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
+ +G+GSFG V++ K VA+K + E+ ++R H N++
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F ++ +L + V ++ ++Y L + + + + Q RG+ Y+
Sbjct: 85 ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELI 251
H + HRD+K N+ + + VK+ DFG A + + + S + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 252 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
Y+ D+++ G VL EL+ GQ + N DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 58/301 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVIS 134
+ +G G+FG V++AK ETG A K + ++ E++++ DHP ++
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 135 LKHCFFSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
L ++ +L+ +++E+ V M +++ + +++ Q+
Sbjct: 81 LLGAYY---HDGKLW--IMIEFCPGGAVDAIM-------LELDRGLTEPQIQVVCRQMLE 128
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICSRYYR 246
L ++H+ + HRD+K N+L +T ++L DFG SAK L + S+I + Y+
Sbjct: 129 ALNFLHSK-RIIHRDLKAGNVL---MTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 184
Query: 247 APELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302
APE++ T Y DIWS G L E+ +P N + L++I K PT
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLL 243
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
W F D L +P R +A + HPF
Sbjct: 244 T-----------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPF 278
Query: 363 F 363
Sbjct: 279 V 279
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 34/216 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNVIS-LKH 137
+ +G G FG V++ K GE VA+K ++ R RE + ++ H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ +L+L V +Y +++ L Y+ ++ + L GLA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156
Query: 196 TV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS-----R 243
P + HRD+K +N+LV + D G A I + +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 244 YYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 274
Y APE++ + E DI++ G V E+
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 68/241 (28%), Positives = 110/241 (45%), Gaps = 39/241 (16%)
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------ 113
H+I I + Y +G G V+ A+ VAIK +
Sbjct: 3 HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52
Query: 114 ---RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYS 169
+R++ RE+ + H N++S+ +D+ + LVMEY+ T L Y
Sbjct: 53 ETLKRFE-REVHNSSQLSHQNIVSM----IDVDEEDDCYY-LVMEYIEGPT----LSEYI 102
Query: 170 SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229
+ + + +T QI G+ + H + + HRD+KPQN+L+D +K+ DFG AK
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160
Query: 230 LVKGEANISY----ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
L E +++ + + Y +PE G + DI+S G VL E+L+G+P F GE A
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEATDECT-DIYSIGIVLYEMLVGEPPFNGETA 217
Query: 286 V 286
V
Sbjct: 218 V 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 30/225 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDH 129
Y ++G G V A+ L VA+K VL+ R++ RE Q ++H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFR-REAQNAAALNH 71
Query: 130 PNVISLKHCFFSTTSKDELFLN---LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTY 185
P ++++ + T + +VMEYV T L+ M
Sbjct: 72 PAIVAV----YDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIA 123
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY----IC 241
+ L + H G+ HRDVKP N+++ T+ VK+ DFG A+ + +++ I
Sbjct: 124 DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286
+ Y +PE G + S D++S GCVL E+L G+P F G++ V
Sbjct: 182 TAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 50/247 (20%), Positives = 96/247 (38%), Gaps = 45/247 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
++G G FG V+ + VAI+ + +R ++ RE+ R H NV+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 136 K-HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
C S L + + T+Y V++ + + + +I +G+ Y
Sbjct: 95 MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY--------Y 245
+H G+ H+D+K +N+ D +V + DFG + G + +
Sbjct: 146 LHA-KGILHKDLKSKNVFYD--NGKVVITDFGLFS--ISGVLQAGRREDKLRIQNGWLCH 200
Query: 246 RAPELIFGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297
APE+I + ++ D+++ G + EL + F + A II +G
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMG 256
Query: 298 TPTREEI 304
T + +
Sbjct: 257 TGMKPNL 263
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 68/307 (22%), Positives = 118/307 (38%), Gaps = 50/307 (16%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRL--MDHPNVISLKHC 138
++G G +G V++ VA+K +R+ E + R+ M+H N+
Sbjct: 18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIHT 196
T+ + LVMEY P ++ + L ++ L + + RGLAY+HT
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH------SVTRGLAYLHT 129
Query: 197 --------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---------ANISY 239
P + HRD+ +N+LV + DFG + L A IS
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 240 ICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVD-QLVE 291
+ + Y APE++ GA +D+++ G + E+ + LFPGE+ + Q+
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 292 IIKVLGTPTREEIR---CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 348
+V PT E+++ R P+ W + + +
Sbjct: 249 QTEVGNHPTFEDMQVLVSRE----KQR-PKFPEA-WKE--NSLAVRSLKETIEDCWDQDA 300
Query: 349 SLRCTAL 355
R TA
Sbjct: 301 EARLTAQ 307
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 61/252 (24%), Positives = 108/252 (42%), Gaps = 32/252 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD-------RRYKNRELQLMRLMDHP 130
Y + + G G ++ A G V +K L E Q + + HP
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139
Query: 131 NVISLKHCFFSTTSKDELFLN-LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
+++ + F T + + +VMEYV +++ R Q++P+ Y +I
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
L+Y+H++ G+ + D+KP+N+++ Q+KL D G+ + + ++AP
Sbjct: 193 PALSYLHSI-GLVYNDLKPENIMLTE--EQLKLIDLGAVSRI--NSFG-YLYGTPGFQAP 246
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-EEI--R 305
E++ T + DI++ G LA L L P G VD L E VL T + R
Sbjct: 247 EIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGR-YVDGLPEDDPVLKTYDSYGRLLRR 303
Query: 306 CMNPNYTDFRFP 317
++P+ RF
Sbjct: 304 AIDPDPRQ-RFT 314
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 55/220 (25%), Positives = 84/220 (38%), Gaps = 28/220 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYK---NRELQLMRLMDHP 130
Y R+VG G G V++A+ VA+K ++ D ++ RE + + P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
+V+ + D L + M + L + QI
Sbjct: 95 HVVPI----HDFGEIDGQ-LYVDMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGS 145
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYY 245
L H G HRDVKP+N+LV L DFG A + + + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
APE + T DI++ CVL E L G P + G+
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQL 240
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 40/233 (17%)
Query: 82 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
R +G G FG V TGE VA+K + D ++ +E+ ++R + H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I K C L LVMEYVP L+ Y + L + L+ QI G+A
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLP-RHSIGLAQLLLFAQQICEGMA 148
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+H + HRD+ +N+L+D VK+ DFG AK + +G YYR
Sbjct: 149 YLHAQHYI-HRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--------EYYRVREDGD 198
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 292
APE + + + D+WS G L ELL +L+ I
Sbjct: 199 SPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 50/231 (21%), Positives = 87/231 (37%), Gaps = 46/231 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
R++G G FG V +A+ + VA+K + D + RE M+ DHP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 133 ISLKH-CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKL--YTYQIF 188
L S +++ ++ ++ L L L + I
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 189 RGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
G+ Y+ + + HRD+ +N ++ V + DFG ++ + G+ YY
Sbjct: 148 CGMEYLSSRNFI----HRDLAARNCMLAE-DMTVCVADFGLSRKIYSGD---------YY 193
Query: 246 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
R A E L YT D+W+ G + E++ GQ + G
Sbjct: 194 RQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG 242
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-20
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 40/215 (18%)
Query: 82 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+ +G G+FG V + TGE VA+KK LQ ++ RE+++++ + H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
+ K S L L+MEY+P Y L+ Y +R+ I + YT QI +G+
Sbjct: 74 VKYKGV---CYSAGRRNLKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ T + HRD+ +N+LV+ ++VK+ DFG KVL + + +++
Sbjct: 128 EYLGTKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKE--------FFKVKEPG 177
Query: 247 -------APELIFGATEYTTSIDIWSAGCVLAELL 274
APE + ++++ + D+WS G VL EL
Sbjct: 178 ESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 47/230 (20%), Positives = 87/230 (37%), Gaps = 45/230 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
+++G G FG V + + VA+K + ++ E M+ HPNV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKL--YTYQIFR 189
I L +S+ +++ ++ ++ L + + L + I
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 190 GLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 246
G+ Y+ + + HRD+ +N ++ V + DFG +K + G+ YYR
Sbjct: 159 GMEYLSNRNFL----HRDLAARNCMLRD-DMTVCVADFGLSKKIYSGD---------YYR 204
Query: 247 ------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
A E L YT+ D+W+ G + E+ G +PG
Sbjct: 205 QGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPG 252
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 38/214 (17%)
Query: 82 ERVVGTGSFGIVFQAKCL----ETGETVAIKK----VLQDRRYKNRELQLMRLMDHPNVI 133
+ +G G+FG V + TGE VA+KK + R RE+++++ + H N++
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
K ++ L+MEY+P Y L+ Y ++ R+ I + YT QI +G+
Sbjct: 106 KYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ T + HRD+ +N+LV+ ++VK+ DFG KVL + + YY+
Sbjct: 160 YLGTKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKE--------YYKVKEPGE 209
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL 274
APE + ++++ + D+WS G VL EL
Sbjct: 210 SPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 82 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
R +G G FG V + TGE VA+K + + + +E++++R + H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN-QRMPLIYVKLYTYQIFRGL 191
+ K T L+ME++P LK Y N ++ L Y QI +G+
Sbjct: 86 VKYKGI--CTEDGGNGIK-LIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + V HRD+ +N+LV+ HQVK+ DFG K + + YY
Sbjct: 140 DYLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAIETDKE--------YYTVKDDR 189
Query: 247 -------APELIFGATEYTTSIDIWSAGCVLAELL 274
APE + + + + D+WS G L ELL
Sbjct: 190 DSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 6e-19
Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 52/238 (21%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
L + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 192 AYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-- 246
Y+ V HRD+ +N+LV VK+ DFG AK+L E Y
Sbjct: 131 NYLEDRRLV----HRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEK--------EYHAE 177
Query: 247 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 291
A E ++ YT D+WS G + EL+ G + G A + ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-19
Identities = 59/252 (23%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHP 130
+ +G G+FG V +A + TVA+K + L +R EL+++ L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPL 177
N+++L T ++ EY + + + L
Sbjct: 88 NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 178 IYVKLYT--YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
L + YQ+ +G+A++ + HRD+ +N+L+ K+CDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTH-GRITKICDFGLARDIKNDS- 199
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
Y APE IF YT D+WS G L EL LG +PG
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 283 ENAVDQLVEIIK 294
+ ++IK
Sbjct: 251 MPVDSKFYKMIK 262
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 82 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+G G+FG V + TG VA+K LQ RE+Q+++ + +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
+ + + + L LVMEY+P L+ + ++ R+ + LY+ QI +G+
Sbjct: 87 VKYRGVSYGPGRQS---LRLVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + V HRD+ +N+LV+ VK+ DFG AK+L + YY
Sbjct: 141 EYLGSRRCV-HRDLAARNILVES-EAHVKIADFGLAKLLPLDKD--------YYVVREPG 190
Query: 247 -------APELIFGATEYTTSIDIWSAGCVLAELL 274
APE + ++ D+WS G VL EL
Sbjct: 191 QSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 4e-18
Identities = 37/313 (11%), Positives = 68/313 (21%), Gaps = 76/313 (24%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNR---ELQLMRLMDHPN 131
Y G +QA VA+ V + +D P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
V + L +V E++ ++ V + +
Sbjct: 93 VARV----LDVVHTRAGGL-VVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAA 141
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 250
H GV P + V V L
Sbjct: 142 ADAAHRA-GVALSIDHPSRVRVSI-DGDVVLAYPA-------------------TMPDA- 179
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
DI G L LL+ + P L + E ++ +
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI-EPADIDRD 231
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370
+P + +A+R +Q +R + + +++
Sbjct: 232 ---------------------IPFQISAVAARSVQGDGGIRSASTLL------NLMQQAT 264
Query: 371 ARLPNGRPFPPLF 383
A P+
Sbjct: 265 AVADRTEVLGPID 277
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 5e-18
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 57/225 (25%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISL- 135
+ ++G G FG V++ L G VA+K+ + E + L HP+++SL
Sbjct: 44 KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLI 101
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-----ETMYRVLKHYSSM--NQRMPLIYVKLYTYQIF 188
C ++E+ L + +Y+ +Y SM QR+ +I
Sbjct: 102 GFC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL----------EIC 145
Query: 189 ----RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
RGL Y+HT + HRDVK N+L+D K+ DFG +K + + +++ +
Sbjct: 146 IGAARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISKKGTELDQ--THLSTVV 201
Query: 245 -----YRAPELIFGATEY------TTSIDIWSAGCVLAELLLGQP 278
Y P EY T D++S G VL E+L +
Sbjct: 202 KGTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 281
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
+++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 282 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APEL 250
HR++ +N LV H VK+ DFG ++++ Y + APE
Sbjct: 337 K-NFIHRNLAARNCLVGE-NHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 390
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ ++ D+W+ G +L E+ G +PG
Sbjct: 391 LAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPG 422
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 82.6 bits (203), Expect = 1e-17
Identities = 51/336 (15%), Positives = 91/336 (27%), Gaps = 86/336 (25%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRE--------------------LQL 123
+G G FG VFQ VAIK + ++ N L
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 124 MRLMDHPNVISLKHCFF---------------------------STTSKDELFLNLVMEY 156
I L D+LF+ L E+
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 157 VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216
+ ++ SS+ K +Q+ LA HRD+ N+L+ T
Sbjct: 146 GGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK-T 198
Query: 217 HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 276
KL + K L +YT S V ++ +
Sbjct: 199 SLKKLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 277 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-------NYTDFRFPQIKAHPW--HKV 327
+ LF G+ D +I +++ +P +Y + + +
Sbjct: 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303
Query: 328 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
K++ + + +L +S +A +
Sbjct: 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
++ S++ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APEL 250
+ HRD++ N+LV K+ DFG A+++ E Y + + APE
Sbjct: 299 M-NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 352
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+T D+WS G +L EL G+ +PG
Sbjct: 353 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 33/213 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 79
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTV 197
+++ L +V EY+ L Y R L L ++ + + Y+
Sbjct: 80 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APE-L 250
HRD+ +N+LV + K+ DFG K + APE L
Sbjct: 137 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 186
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+++T D+WS G +L E+ G+ +P
Sbjct: 187 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 43/225 (19%)
Query: 80 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKN------RELQLMRLMDHPN 131
+ ++ +G+G+FG V + VA+K + + E +M+ +D+P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++ + + LVME L Y N+ + + +Q+ G+
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ HRD+ +N+L+ H K+ DFG +K L E YY+
Sbjct: 131 KYLEES-NFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADEN--------YYKAQTHG 180
Query: 247 -------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + + ++++ D+WS G ++ E GQ + G
Sbjct: 181 KWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 33/213 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 251
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTV 197
+++ L +V EY+ L Y R L L ++ + + Y+
Sbjct: 252 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APE-L 250
HRD+ +N+LV + K+ DFG K + APE L
Sbjct: 309 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 358
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+++T D+WS G +L E+ G+ +P
Sbjct: 359 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 41/221 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLK 136
+G G+FG VF + VA+K + + E ++++ HPN++ L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL-YTYQIFRGLAYIH 195
++ + +VME V + + L G+ Y+
Sbjct: 178 ---IGVCTQKQPIY-IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR--------- 246
+ + HRD+ +N LV + +K+ DFG ++ G Y
Sbjct: 231 SKCCI-HRDLAARNCLVTE-KNVLKISDFGMSREEADGV---------YAASGGLRQVPV 279
Query: 247 ---APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE L +G Y++ D+WS G +L E LG +P
Sbjct: 280 KWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPN 318
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 53/239 (22%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKN---RELQLM 124
P + + ++RV+G G FG+V+ + ++ + AIK + + + RE LM
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL-- 182
R ++HPNV++L E ++++ Y+ + L + + + L
Sbjct: 77 RGLNHPNVLAL----IGIMLPPEGLPHVLLPYMC---HGDLLQF-IRSPQRNPTVKDLIS 128
Query: 183 YTYQIFRGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
+ Q+ RG+ Y+ V HRD+ +N ++D + VK+ DFG A+ ++ E
Sbjct: 129 FGLQVARGMEYLAEQKFV----HRDLAARNCMLDE-SFTVKVADFGLARDILDRE----- 178
Query: 240 ICSRYYR--------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY A E L +TT D+WS G +L ELL G P +
Sbjct: 179 ----YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRH 231
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 47/227 (20%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGL 191
SL S+ +V+ Y+ + L+++ N+ L + Q+ +G+
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNF-IRNETHNPTVKDLIGFGLQVAKGM 141
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + HRD+ +N ++D VK+ DFG A+ + E YY
Sbjct: 142 KYLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---------YYSVHNKT 190
Query: 247 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 191 GAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 235
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
++ S++ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APEL 250
+ HRD++ N+LV K+ DFG A+++ E Y + + APE
Sbjct: 382 M-NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 435
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+T D+WS G +L EL G+ +PG
Sbjct: 436 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 467
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-17
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 74
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
+++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 75 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APE- 249
HRD+ +N LV H VK+ DFG ++++ Y + APE
Sbjct: 130 K-NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 183
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
L + +++ D+W+ G +L E+ G +PG
Sbjct: 184 LAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 44/234 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
L + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ V HRD+ +N+LV VK+ DFG AK+L E Y
Sbjct: 131 NYLEDRRLV-HRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEK--------EYHAEGGK 180
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 291
A E I YT D+WS G + EL+ G + G A + ++E
Sbjct: 181 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 58/249 (23%), Positives = 103/249 (41%), Gaps = 53/249 (21%)
Query: 83 RVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHPN 131
+ +G G+FG V +A T TVA+K + + R EL+++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLI 178
V++L T L +++E+ E + + + L
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
++ Y++Q+ +G+ ++ + HRD+ +N+L+ + VK+CDFG A+ + K
Sbjct: 149 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP---- 202
Query: 239 YICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 285
Y APE IF YT D+WS G +L E+ LG +PG
Sbjct: 203 -----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 286 VDQLVEIIK 294
++ +K
Sbjct: 257 DEEFCRRLK 265
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 44/234 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRLMDHPNV 132
+V+G+G FG V + + GE V IK + R+ + + +DH ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
+ L L LV +Y+P L + ++ + + + QI +G+
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ G+ HR++ +N+L+ QV++ DFG A +L +
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDK--------QLLYSEAK 178
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 291
A E I YT D+WS G + EL+ G + G + L+E
Sbjct: 179 TPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 61/258 (23%), Positives = 99/258 (38%), Gaps = 63/258 (24%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHP 130
+V+G+G+FG V A VA+K + +R EL++M +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVP------------------ETMYRVLKHYSSMN 172
N+++L T ++ L+ EY E Y K
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 173 QRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
L + L + YQ+ +G+ ++ HRD+ +N+LV VK+CDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTH-GKVVKICDFGLARDI 222
Query: 231 VKGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLG 276
+ Y APE +F YT D+WS G +L E+ L
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272
Query: 277 QPLFPGENAVDQLVEIIK 294
P +PG ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 46/250 (18%), Positives = 81/250 (32%), Gaps = 49/250 (19%)
Query: 58 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK 117
G ++ G + ++ + +G+G FG+++ A E A V + +
Sbjct: 27 EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77
Query: 118 N---RELQLMRLMDHPNVISLK--------------HCFFSTTSKDELFLNLVMEYVPET 160
EL+ + + + I + T K + +VME
Sbjct: 78 GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER---- 133
Query: 161 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-HQV 219
+ L+ S N V ++ L YIH H D+K NLL+ QV
Sbjct: 134 LGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSI------------DIWSAG 267
L D+G + + Y + G E+ TS+ D+ G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247
Query: 268 CVLAELLLGQ 277
+ L G+
Sbjct: 248 YCMLRWLCGK 257
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 43/223 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR-LMDHPNVISL 135
Y R +G GSFG++F+ L + VAIK + E + + L + ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ ++ L LV++ + ++ +L ++ + V + Q+ + IH
Sbjct: 72 YYF-----GQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH 123
Query: 196 TVPGVCHRDVKPQNLLV----DPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YR 246
+ +RD+KP N L+ + + + DFG K Y YR
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---------FYRDPVTKQHIPYR 173
Query: 247 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 277
+ + G Y SI D+ + G V L G
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 56/246 (22%)
Query: 83 RVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLMRLMDHPNV 132
R +G GSFG+V++ + VAIK V +++R E +M+ + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--------SSMNQRMPLIYVKL-- 182
+ L S+ + L ++ME + LK Y ++ P K+
Sbjct: 91 VRLLGV----VSQGQPTL-VIMELMT---RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242
+I G+AY++ V HRD+ +N +V VK+ DFG + + + +
Sbjct: 143 MAGEIADGMAYLNANKFV-HRDLAARNCMVAE-DFTVKIGDFGMTRDIYETD-------- 192
Query: 243 RYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 288
YYR +PE L G +TT D+WS G VL E+ L + + G + +Q
Sbjct: 193 -YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQ 248
Query: 289 LVEIIK 294
++ +
Sbjct: 249 VLRFVM 254
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 41/219 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
++ +++ ++ ++ EY+ L + + L KL QI G+A+I
Sbjct: 74 -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---------- 246
HRD++ N+LV T K+ DFG A+++ E Y
Sbjct: 128 R-NYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNE---------YTAREGAKFPIKW 176
Query: 247 -APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + +G +T D+WS G +L E++ G+ +PG
Sbjct: 177 TAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 41/219 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
E+ +G G FG V+ A + VA+K + E +M+ + H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
+ +K+ ++ ++ E++ L + ++ KL ++ QI G+A+I
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---------- 246
HRD++ N+LV + K+ DFG A+V+ E Y
Sbjct: 303 R-NYIHRDLRAANILVSA-SLVCKIADFGLARVIEDNE---------YTAREGAKFPIKW 351
Query: 247 -APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + FG +T D+WS G +L E++ G+ +PG
Sbjct: 352 TAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 62/296 (20%), Positives = 111/296 (37%), Gaps = 49/296 (16%)
Query: 12 PPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNG 71
P P P + ++D + S + + + + + K
Sbjct: 271 PAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKL 330
Query: 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLM 124
K+ +A+ +G G+FG V Q + VAIK + Q + E Q+M
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 390
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLY 183
+D+P ++ L + L LVME L + + +P+ V
Sbjct: 391 HQLDNPYIVRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAEL 441
Query: 184 TYQIFRGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+Q+ G+ Y+ + V HR++ +N+L+ H K+ DFG +K L ++
Sbjct: 442 LHQVSMGMKYLEEKNFV----HRNLAARNVLLVN-RHYAKISDFGLSKALGADDS----- 491
Query: 241 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY APE + F ++++ D+WS G + E L GQ +
Sbjct: 492 ---YYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 58/252 (23%), Positives = 101/252 (40%), Gaps = 60/252 (23%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLM-RLMDHP 130
+ +G G+FG V +A G+ VA+K + ++ EL++M L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY------------SSMNQRMPLI 178
N+++L T + ++ EY Y L ++ +
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCC---YGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 179 YVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236
L ++ Q+ +G+A++ + HRDV +N+L+ H K+ DFG A+ ++
Sbjct: 163 TRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDS-- 218
Query: 237 ISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 282
Y APE IF YT D+WS G +L E+ LG P +PG
Sbjct: 219 -------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPG 269
Query: 283 ENAVDQLVEIIK 294
+ +++K
Sbjct: 270 ILVNSKFYKLVK 281
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-16
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 43/225 (19%)
Query: 80 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRLMDHPNV 132
+A+ +G G+FG V Q + VAIK + Q + E Q+M +D+P +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
+ L + L LVME L + + +P+ V +Q+ G+
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ HRD+ +N+L+ H K+ DFG +K L ++ YY
Sbjct: 124 KYLEEK-NFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDS--------YYTARSAG 173
Query: 247 -------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + F ++++ D+WS G + E L GQ +
Sbjct: 174 KWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 47/227 (20%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGL 191
SL S+ +V+ Y+ + L+++ N+ L + Q+ +G+
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNF-IRNETHNPTVKDLIGFGLQVAKGM 205
Query: 192 AY---IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-- 246
+ V HRD+ +N ++D VK+ DFG A+ + E + +
Sbjct: 206 KFLASKKFV----HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFD------SVHNKT 254
Query: 247 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 255 GAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 299
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 44/223 (19%), Positives = 82/223 (36%), Gaps = 43/223 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNRELQLMR-LMDHPNVISL 135
+ + +G G+FG + K L T E VAIK + + E + + L + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ + +V+E + ++ + ++ L V + Q+ + Y+H
Sbjct: 71 YYF-----GPCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 196 TVPGVCHRDVKPQNLLV----DPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YR 246
+ + +RDVKP+N L+ + + + DF AK YI YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172
Query: 247 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 277
+ + G Y SI D+ + G + L G
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 57/258 (22%), Positives = 101/258 (39%), Gaps = 64/258 (24%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
+ +G G FG V +A TVA+K + + R E +++ ++HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP-------------------ETMYRVLKHYSSMN 172
VI L + L L++EY +
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 173 QRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
L L + +QI +G+ Y+ + + HRD+ +N+LV ++K+ DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE-GRKMKISDFGLSRDV 200
Query: 231 VKGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG- 276
+ + Y A E +F YTT D+WS G +L E++ LG
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250
Query: 277 QPLFPGENAVDQLVEIIK 294
P +PG ++L ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 39/231 (16%), Positives = 77/231 (33%), Gaps = 52/231 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGET-------VAIKKVLQDRRYKN----RELQLMRLMDHP 130
+G G+F +F+ E G+ V +K + + R + +M + H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 131 NVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIF 188
+++ C DE L V E+V + L Y + +++ Q+
Sbjct: 73 HLVLNYGVC----VCGDENIL--VQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 189 RGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQ-------VKLCDFGSAKVLVKGEANIS 238
+ ++ + H +V +N+L+ + +KL D G + ++ +
Sbjct: 124 AAMHFLEENTLI----HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---- 175
Query: 239 YICSRYYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ PE I + D WS G L E+ G
Sbjct: 176 -----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
L +++ ++ ++ME L+ + + + + L + LY YQ+ LA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + V HRD+ +N+LV VKL DFG ++ + YY+
Sbjct: 506 YLESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 554
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + F +T++ D+W G + E+L G F G
Sbjct: 555 PIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG 595
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 57/259 (22%), Positives = 102/259 (39%), Gaps = 59/259 (22%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQL 123
++ I R +G G+FG VF A+C VA+K + L R+ RE +L
Sbjct: 13 KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 124 MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMN 172
+ + H +++ + + +V EY+ +L
Sbjct: 71 LTNLQHEHIVKFYGV----CGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 173 QRMPLIYVKLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
+ L ++ QI G+ Y+ + HRD+ +N LV VK+ DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA-NLLVKIGDFGMSRDV 183
Query: 231 VKGEANISYICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG 276
+ YYR PE +++ ++TT D+WS G +L E+ G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232
Query: 277 -QPLFPGENAVDQLVEIIK 294
QP + + +++E I
Sbjct: 233 KQP-WFQLS-NTEVIECIT 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 50/226 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
R++G G FG V++ VA+K +D N+ E +M+ +DHP+++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 192
L ++ + ++ME P Y L HY + ++ + LY+ QI + +A
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 193 YI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR--- 246
Y+ + V HRD+ +N+LV VKL DFG ++ + + YY+
Sbjct: 128 YLESINCV----HRDIAVRNILVAS-PECVKLGDFGLSRYIEDED---------YYKASV 173
Query: 247 --------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+PE + F +TT+ D+W + E+L G+ F
Sbjct: 174 TRLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFW 217
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 60/252 (23%), Positives = 104/252 (41%), Gaps = 57/252 (22%)
Query: 82 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RLMD 128
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMNQRMPL 177
H N+I+L ++D +++EY + S N L
Sbjct: 134 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 178 IYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
L YQ+ RG+ Y+ + HRD+ +N+LV + +K+ DFG A+ + +
Sbjct: 189 SSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHID- 245
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 283 ENAVDQLVEIIK 294
V++L +++K
Sbjct: 297 VP-VEELFKLLK 307
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
L +++ ++ ++ME L+ + + + + L + LY YQ+ LA
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + HRD+ +N+LV VKL DFG ++ + YY+
Sbjct: 131 YLESK-RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 179
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + F +T++ D+W G + E+L G F G
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQG 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 41/223 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
++VVG G FG V + + +VAIK + K R E +M DHPN+I
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 192
L +K + + +V EY+ L + + + +I + I G+
Sbjct: 110 RL----EGVVTKSKPVM-IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + G HRD+ +N+L++ K+ DFG +VL Y
Sbjct: 162 YLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLGRVLEDDP-------EAAYTTRGGKI 212
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+PE + + ++T++ D+WS G VL E++ G+ +
Sbjct: 213 PIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
E+++G+G G V + G+ VAIK + + R E +M DHPN+I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 192
L ++ L + +V EY+ L + + + + ++ + + G+
Sbjct: 114 RL----EGVVTRGRLAM-IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + G HRD+ +N+LVD K+ DFG ++VL E + Y
Sbjct: 166 YLSDL-GYVHRDLAARNVLVDS-NLVCKVSDFGLSRVL---EDDPDA----AYTTTGGKI 216
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + F ++++ D+WS G V+ E+L G+ +
Sbjct: 217 PIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 59/252 (23%), Positives = 107/252 (42%), Gaps = 57/252 (22%)
Query: 82 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RLMD 128
+ +G G FG V A+ + + TVA+K + +D E+++M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-----------TMYRVLKHYSSMNQRMPL 177
H N+I+L T L+ +++EY + + + +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 178 IYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
+ L TYQ+ RG+ Y+ + HRD+ +N+LV + +K+ DFG A+ + +
Sbjct: 201 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDINNID- 257
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 283 ENAVDQLVEIIK 294
V++L +++K
Sbjct: 309 IP-VEELFKLLK 319
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 9e-15
Identities = 45/218 (20%), Positives = 86/218 (39%), Gaps = 39/218 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G+G FG+V L + VAIK + + + E ++M + HP ++ L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL--- 68
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ + LV E++ + L+ + L+ + G+AY+
Sbjct: 69 -YGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGLFAAETLLG---MCLDVCEGMAYLEEA 123
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----------- 246
V HRD+ +N LV +K+ DFG + ++ + Y
Sbjct: 124 -CVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPVKWA 172
Query: 247 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+PE F Y++ D+WS G ++ E+ G+ +
Sbjct: 173 SPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 9e-15
Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G+G FG+V K VA+K + + ++ +E Q M + HP ++
Sbjct: 13 LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF--- 68
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ SK+ +V EY+ L +Y S + + + Y + G+A++ +
Sbjct: 69 -YGVCSKEYPIY-IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----------- 246
HRD+ +N LVD VK+ DFG + ++ + Y
Sbjct: 124 -QFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPVKWS 172
Query: 247 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + +Y++ D+W+ G ++ E+ LG+ +
Sbjct: 173 APEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 54/239 (22%), Positives = 86/239 (35%), Gaps = 57/239 (23%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
+G FG V++ E + VAIK + R E L + HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMNQRMPLIYV 180
V+ L +KD+ ++ Y V + L
Sbjct: 74 VVCLLGV----VTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 181 KL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
QI G+ Y+ + V H+D+ +N+LV VK+ D G + + +
Sbjct: 129 DFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYD-KLNVKISDLGLFREVYAAD---- 182
Query: 239 YICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 282
YY+ APE +++G +++ DIWS G VL E+ G QP + G
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCG 233
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 41/221 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR-LMDHPNVISL 135
Y R +G+GSFG ++ + GE VAIK ++ E ++ + + + ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ C + + +VME + ++ + +++ L V L Q+ + YIH
Sbjct: 71 RWC-----GAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 196 TVPGVCHRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 248
+ HRDVKP N L+ + V + DFG AK Y +R YR
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK---------KYRDARTHQHIPYREN 172
Query: 249 ELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 277
+ + G Y SI D+ S G VL LG
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 56/249 (22%), Positives = 98/249 (39%), Gaps = 56/249 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQLMRLMDHPNV 132
+ +G G+FG VF A+C VA+K + R+ RE +L+ ++ H ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP----------ETMYRVLKHYSSMNQRMPLIYVKL 182
+ ++ L +V EY+ L PL +L
Sbjct: 106 VRFFGV----CTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 183 --YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
Q+ G+ Y+ + HRD+ +N LV VK+ DFG ++ + +
Sbjct: 161 LAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD------ 212
Query: 241 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 285
YYR PE +++ ++TT D+WS G VL E+ G QP + +
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265
Query: 286 VDQLVEIIK 294
+ ++ I
Sbjct: 266 NTEAIDCIT 274
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 50/237 (21%), Positives = 86/237 (36%), Gaps = 59/237 (24%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-----SSMNQRMPLIYVKL--YT 184
++ + + +++E + LK + +Q L + L
Sbjct: 136 IVRCIGV----SLQSLPRF-ILLELMA---GGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 185 YQIFRGLAY---IHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISY 239
I G Y H + HRD+ +N L+ K+ DFG A+ + +
Sbjct: 188 RDIACGCQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----- 238
Query: 240 ICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YYR PE + G +T+ D WS G +L E+ LG +P
Sbjct: 239 ----YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 51/237 (21%), Positives = 87/237 (36%), Gaps = 59/237 (24%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-----SSMNQRMPLIYVKL--YT 184
++ + + ++ME + LK + +Q L + L
Sbjct: 95 IVRCIGV----SLQSLPRF-ILMELMA---GGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 185 YQIFRGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISY 239
I G Y+ H + HRD+ +N L+ K+ DFG A+ + +
Sbjct: 147 RDIACGCQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----- 197
Query: 240 ICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YYR PE + G +T+ D WS G +L E+ LG +P
Sbjct: 198 ----YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 55/240 (22%), Positives = 100/240 (41%), Gaps = 56/240 (23%)
Query: 82 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RLMD 128
+ +G G+FG V A+ + + TVA+K + +D E+++M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-----------TMYRVLKHYSSMNQRMPL 177
H N+I+L ++D +++EY + + + +
Sbjct: 100 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 178 IYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
+ L TYQ+ RG+ Y+ + HRD+ +N+LV + +K+ DFG A+ + +
Sbjct: 155 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDINNID- 211
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 82 ERVVGTGSFGIVFQAKC-LETGET--VAIKKVLQDRRYKN-------RELQLMRLMDHPN 131
+G GSFG+V + + +G+T VA+K + D + RE+ M +DH N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRG 190
+I L + + +V E P L +Q L + Y Q+ G
Sbjct: 83 LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---- 246
+ Y+ + HRD+ +NLL+ VK+ DFG + L + + +Y
Sbjct: 134 MGYLESK-RFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQND--------DHYVMQEH 183
Query: 247 --------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE L ++ + D W G L E+ GQ + G
Sbjct: 184 RKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 49/223 (21%), Positives = 90/223 (40%), Gaps = 40/223 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE----TVAIKKV-----LQDRRYKNRELQLMRLMDHPNV 132
++V+G G FG V++ + VAIK + + R E +M H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
I L SK + + ++ EY+ L + + ++ + I G+
Sbjct: 109 IRL----EGVISKYKPMM-IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + HRD+ +N+LV+ K+ DFG ++VL Y
Sbjct: 161 KYLANM-NYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEAT------YTTSGGKI 212
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + + +T++ D+WS G V+ E++ G+ +
Sbjct: 213 PIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 63/268 (23%), Positives = 105/268 (39%), Gaps = 68/268 (25%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 122
P+ I Y+ R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 45 PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYS 169
LM D+PN++ L + + L+ EY+ P T+ +
Sbjct: 103 LMAEFDNPNIVKLLGV----CAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 170 SMNQRMPLIYVKLYT--------YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221
S R+ + Q+ G+AY+ HRD+ +N LV VK+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGE-NMVVKI 215
Query: 222 CDFGSAKVLVKGEANISYICSRYYR------------APE-LIFGATEYTTSIDIWSAGC 268
DFG ++ + + YY+ PE + + YTT D+W+ G
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264
Query: 269 VLAELL-LG-QPLFPGENAVDQLVEIIK 294
VL E+ G QP + G ++++ ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 42/252 (16%), Positives = 80/252 (31%), Gaps = 50/252 (19%)
Query: 58 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG--------ETVAIKK 109
TG +++ G + + + + GI+++A T + ++K
Sbjct: 32 TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82
Query: 110 VLQDRRYKNRELQLMRLMDHPNVISLK-----------HCFFSTTSKDELFLNLVMEYVP 158
+D R N + R V K C +D+ LV+ +
Sbjct: 83 DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141
Query: 159 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-H 217
++ L + V ++ L ++H H +V +N+ VDP
Sbjct: 142 RSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQS 198
Query: 218 QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSI------------DIWS 265
QV L +G A +++Y G E+ S+ D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253
Query: 266 AGCVLAELLLGQ 277
G + + L G
Sbjct: 254 LGYCMLKWLYGF 265
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 6e-14
Identities = 69/296 (23%), Positives = 117/296 (39%), Gaps = 70/296 (23%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKK--------VLQ-DRRYKNRELQLMRLMDHPNVIS 134
+G G FG+V++ + TVA+KK + +++ E+++M H N++
Sbjct: 38 KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQ-EIKVMAKCQHENLVE 94
Query: 135 LK-HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL-------IYVKLYTYQ 186
L + D+L L V Y+P +L S ++ PL I
Sbjct: 95 LLGFS----SDGDDLCL--VYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQG----- 141
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR--- 243
G+ ++H HRD+K N+L+D K+ DFG A+ K + + SR
Sbjct: 142 AANGINFLHENH-HIHRDIKSANILLDE-AFTAKISDFGLARASEKFAQ--TVMTSRIVG 197
Query: 244 -Y-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ------LVEIIKV 295
Y APE + G E T DI+S G VL E++ G P AVD+ L++I +
Sbjct: 198 TTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP------AVDEHREPQLLLDIKEE 249
Query: 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 351
+ + ++ D ++ +AS+ L + R
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVE--------------AMYSVASQCLHEKKNKR 291
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR-LMDHPNVISL 135
+ R +G+GSFG ++ ++T E VAIK ++ E ++ R L + ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ + + LVM+ + ++ + ++++ L V + Q+ + ++H
Sbjct: 69 RWF-----GVEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 196 TVPGVCHRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAP 248
+ HRD+KP N L+ +QV + DFG AK Y + YR
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---------KYRDTSTHQHIPYREN 170
Query: 249 ELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 277
+ + G Y S+ D+ S G VL L G
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 7e-14
Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 46/220 (20%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLK 136
+ ++G G FG V++ + L G VA+K++ ++R E++++ + H N++ L+
Sbjct: 35 KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 137 HCFFSTTSKDELFLNLVMEYVP-----ETMYRVLKHYSSMN--QRMPLIYVKLYTYQIF- 188
T + L LV Y+ + + ++ +R +I
Sbjct: 94 GF--CMTPTERL---LVYPYMANGSVASCLRERPESQPPLDWPKRQ----------RIAL 138
Query: 189 ---RGLAYIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 243
RGLAY+H P + HRDVK N+L+D + + DFG AK++ + +++ +
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLM---DYKDTHVTTA 194
Query: 244 Y-----YRAPE-LIFGATEYTTSIDIWSAGCVLAELLLGQ 277
+ APE L G + + D++ G +L EL+ GQ
Sbjct: 195 VRGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQ 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 39/218 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL--- 84
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ +K ++ EY+ + L+ Q L+ + + Y+ +
Sbjct: 85 -YGVCTKQRPIF-IITEYMANGCLLNYLREMRHRFQTQQLLE---MCKDVCEAMEYLESK 139
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----------- 246
HRD+ +N LV+ VK+ DFG ++ ++ E Y
Sbjct: 140 -QFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDE---------YTSSVGSKFPVRWS 188
Query: 247 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
PE L++ ++++ DIW+ G ++ E+ LG+ +
Sbjct: 189 PPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 56/236 (23%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RLMDHPNVI 133
+ V+G G+FG V +A+ + G AIK++ D R EL+++ +L HPN+I
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMNQRMPLIYVKL 182
+L + L+ L +EY P + + + L +L
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 183 --YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ + RG+ Y+ HRD+ +N+LV + K+ DFG ++
Sbjct: 145 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGE-NYVAKIADFGLSRG----------- 191
Query: 241 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
Y A E L + YTT+ D+WS G +L E++ LG + G
Sbjct: 192 -QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 46/251 (18%), Positives = 77/251 (30%), Gaps = 50/251 (19%)
Query: 59 GHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQD 113
G II+ + +G G FG ++ A + + + +K D
Sbjct: 26 GEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD 76
Query: 114 RRYKNRELQLMRLMDHPNVISLK--------------HCFFSTTSKDELFLNLVMEYVPE 159
EL+ + P I + + ++M+
Sbjct: 77 NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS 136
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-HQ 218
+ K Y + +R V + +I L YIH H D+K NLL++ Q
Sbjct: 137 DLQ---KIYEANAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPDQ 192
Query: 219 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSI------------DIWSA 266
V L D+G A + +Y G E+ TSI D+
Sbjct: 193 VYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEIL 247
Query: 267 GCVLAELLLGQ 277
G + + L G
Sbjct: 248 GYCMIQWLTGH 258
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 47/196 (23%), Positives = 80/196 (40%), Gaps = 30/196 (15%)
Query: 116 YKNRELQLMRLMDHPNVI--SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 173
YK + + + D+ I LK S TS + +E + +
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE-DLY 186
Query: 174 RMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231
+ L L Y++Q+ +G+ ++ + + HRD+ +N+L+ + VK+CDFG A+ +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIY 244
Query: 232 KGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 278
K Y APE IF YT D+WS G +L E+ LG
Sbjct: 245 KDP---------DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGAS 294
Query: 279 LFPGENAVDQLVEIIK 294
+PG ++ +K
Sbjct: 295 PYPGVKIDEEFCRRLK 310
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 2e-07
Identities = 55/402 (13%), Positives = 106/402 (26%), Gaps = 116/402 (28%)
Query: 23 SQQPHFDNDLLKRHRPDMDSD------KEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQT 76
+ + D+L + ++M +++ + HII + +
Sbjct: 12 GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSIL--SKEEIDHII------MSKDAVSG 63
Query: 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLK 136
+ F L + + ++K +++ N + + + S+
Sbjct: 64 TLRL---------FW------TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMM 108
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ +D L+ N + + R L+ Y + Q L + + + I
Sbjct: 109 TRMYIEQ-RDRLY-NDNQVFAKYNVSR-LQPYLKLRQ-------ALLELRPAKNVL-IDG 157
Query: 197 VPG---------VCHRDVKPQNLLVDP---------------LTHQVKLCDF--GSAKVL 230
V G VC K Q + L KL +
Sbjct: 158 VLGSGKTWVALDVC-LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 231 VKGEANISYICSRYYRAPELIFGATEYTTSI----DIWSAGCVLAELLLGQPLFPGENAV 286
+NI + + Y + ++ +A NA
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--------------NAF 262
Query: 287 DQLVEII--KVLGTPTREEIRCMNPNYTDFRFPQIKAHP----WHKVFHKRMPPEAIDLA 340
+ + K+L T TR TDF H P E L
Sbjct: 263 N-----LSCKILLT-TR------FKQVTDFLSAATTTHISLDHHSMTLT---PDEVKSLL 307
Query: 341 SRLLQYSPS-LRCTALEACA-HPFF-----DELREPNARLPN 375
+ L P L E +P + +R+ A N
Sbjct: 308 LKYLDCRPQDLP---REVLTTNPRRLSIIAESIRDGLATWDN 346
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 395 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.15 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.76 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.6 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.47 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.32 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.3 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.21 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.82 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.72 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.72 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.58 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.48 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.47 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.29 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.27 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.17 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.56 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.37 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.13 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-65 Score=467.27 Aligned_cols=254 Identities=30% Similarity=0.533 Sum_probs=221.0
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
++|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+|+++++.++|||||+++++| ++...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 3699999999999999999999999999999999643 23456899999999999999999999 56667
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+|||||||+| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+
T Consensus 107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~-~~g~vKl~DFGla~ 180 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLN-EDMHIQITDFGTAK 180 (311)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEc-CCCCEEEEEcCCce
Confidence 9999999985 67666654 3679999999999999999999999 6999999999999999 78899999999998
Q ss_pred ccccCC---cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 229 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 229 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
...... ...+.+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+.++.+.
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---------- 249 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL---------- 249 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----------
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------
Confidence 764332 23467899999999999765 4899999999999999999999999999888888877762
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHH------HhcCCCCcCCCCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPNA 371 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e------ll~hp~~~~~~~~~~ 371 (395)
++ .++..+|+++++||++||++||++|+|++| +++||||+.+++...
T Consensus 250 -------~~------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 250 -------EY------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp -------CC------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred -------CC------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 11 133467999999999999999999999987 589999999988664
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-65 Score=458.95 Aligned_cols=249 Identities=29% Similarity=0.440 Sum_probs=204.3
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
++|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+|+++++.++|||||++++++ .+...
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence 47999999999999999999999999999999986432 2356899999999999999999999 55566
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|+|||||+|+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+.
T Consensus 88 ~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~-~~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLD-EHLNVKIADFGLSNI 161 (275)
T ss_dssp EEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEEC-TTCCEEECCSSCC--
T ss_pred EEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEEC-CCCCEEEeecCCCee
Confidence 999999999998888765 4679999999999999999999999 6999999999999999 788999999999988
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
........+.+||+.|||||++.+..+++.++|||||||++|+|+||+.||.+.+..+.+..+.+..
T Consensus 162 ~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------- 228 (275)
T 3hyh_A 162 MTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------- 228 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------------
T ss_pred cCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 7666666678999999999999876656789999999999999999999999988777776665520
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
..++..+|+++++||++||++||++|||++|+++||||+.
T Consensus 229 ----------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 ----------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ----------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 0123457999999999999999999999999999999973
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-63 Score=463.38 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=218.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
..|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+.+++.++|||||+++++| .+...+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence 4699999999999999999999999999999998532 34467899999999999999999999 44556999
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
|||||+| +|.+.+.+ ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+...
T Consensus 149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEC-CCCCEEEecCcCceecC
Confidence 9999996 55555543 579999999999999999999999 6999999999999999 78899999999998775
Q ss_pred cCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
... ...+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..+.......
T Consensus 222 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------- 289 (346)
T 4fih_A 222 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR----------- 289 (346)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-----------
T ss_pred CCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence 443 34567899999999999654 58999999999999999999999999988888777765521100
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
......+|+++++||.+||++||++|||++|+|+||||++...+.
T Consensus 290 ---------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p~ 334 (346)
T 4fih_A 290 ---------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPA 334 (346)
T ss_dssp ---------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred ---------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCCc
Confidence 012245799999999999999999999999999999999865543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-63 Score=474.27 Aligned_cols=256 Identities=29% Similarity=0.424 Sum_probs=218.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
...|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++|||||+++++| .+...+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEEE
Confidence 34699999999999999999999999999999998532 34456899999999999999999999 4445699
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
||||||+| +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+||||+ .++.+||+|||+|+..
T Consensus 225 iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~-~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQV 297 (423)
T ss_dssp EEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEc-CCCCEEEecCccceEC
Confidence 99999996 55555543 569999999999999999999999 6999999999999999 7889999999999876
Q ss_pred ccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
... ....+.+||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 298 ~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~---------- 366 (423)
T 4fie_A 298 SKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR---------- 366 (423)
T ss_dssp CSSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred CCCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----------
Confidence 544 334567899999999999654 59999999999999999999999999988888777765521100
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
......+|+++++||.+||++||++|||++|+|+||||++...+.
T Consensus 367 ----------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~ 411 (423)
T 4fie_A 367 ----------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPA 411 (423)
T ss_dssp ----------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred ----------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCCc
Confidence 011245799999999999999999999999999999999865543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-62 Score=468.73 Aligned_cols=290 Identities=34% Similarity=0.622 Sum_probs=236.4
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecC-CCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTT-SKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~ 149 (395)
++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+++|+.++|||||++++++.... ..+...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 46999999999999999999999999999999996432 23457999999999999999999875432 234456
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|||||||+|+|.+.+.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~-~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVN-ENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTCCEEECCCTTCBC
T ss_pred EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccC-CCCCEEEeecceeee
Confidence 899999999998777654 5789999999999999999999999 6999999999999999 789999999999987
Q ss_pred cccC-----CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 230 LVKG-----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 230 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
.... ....+.+||+.|||||++.+...|+.++||||+||++|+|++|++||.+.+..+++..+....+.+....+
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 6432 22345789999999999988777899999999999999999999999999999999999999999887655
Q ss_pred hhcCCCCCCC---CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCC
Q 016115 305 RCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 373 (395)
Q Consensus 305 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~ 373 (395)
.......... .++.....+|.. ....+++++.+||.+||.+||.+|||++|+|+||||+++.++....
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p 358 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWET-VYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEP 358 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSC
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHH-hCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcccc
Confidence 4322111000 111111222222 2345799999999999999999999999999999999988766543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-63 Score=462.73 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=211.3
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++++.++|||||++++++ .+..
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~ 96 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENG 96 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECC
Confidence 346899999999999999999999999999999998643 23456899999999999999999999 4556
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+|||||||+| +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+|
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~-~~g~vKl~DFGla 172 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLT-KDGTVQLGDFGIA 172 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEEC-TTCCEEECSTTEE
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEEC-CCCCEEEcccccc
Confidence 69999999985 676766542 24567999999999999999999999 6999999999999999 7889999999999
Q ss_pred cccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 228 KVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 228 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+....... ....+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+.++......
T Consensus 173 ~~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-------- 243 (350)
T 4b9d_A 173 RVLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-------- 243 (350)
T ss_dssp SCCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------
T ss_pred eeecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------
Confidence 87654322 3456799999999999764 5999999999999999999999999999988888877662110
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
..+..+|+++++||.+||++||++|||++|+|+||||++
T Consensus 244 --------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 244 --------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 022457999999999999999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=442.25 Aligned_cols=252 Identities=24% Similarity=0.370 Sum_probs=207.6
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
|++.+.||+|+||+||+|.+..++..||+|++.... ..+.+|+++++.++|||||+++++|.... .....+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 477889999999999999999999999999985432 33568999999999999999999885432 23456899
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC--ceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|||||+| +|.+.+.. ...+++..++.++.||+.||.|||+ +| |+||||||+|||++..++.+||+|||+|+.
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999995 66666654 3679999999999999999999999 58 999999999999984578999999999986
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.. .....+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.+....+...+.. +..
T Consensus 182 ~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~---------- 247 (290)
T 3fpq_A 182 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVK---------- 247 (290)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCC----------
T ss_pred CC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCC----------
Confidence 43 334456789999999999864 4999999999999999999999999876655544433321 000
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
...++..+++++.+||.+||++||++|||++|+|+||||++
T Consensus 248 ---------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 248 ---------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ---------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ---------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 01133457899999999999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-62 Score=446.87 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=210.2
Q ss_pred cCceeeeeeecCCceEEEEEEEC---CCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.+|++.+.||+|+||+||+|++. .+++.||||++.+. .....+|+++++.++|||||++++++ .+.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 47999999999999999999974 46789999998643 23456799999999999999999999 555
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+|||||||+| +|.+.+.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~-~~g~vKl~DFGl 172 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLD-EEGHIKLTDFGL 172 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEEC-TTSCEEEESSEE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEc-CCCCEEeccccc
Confidence 669999999995 66666654 3679999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 227 AKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 227 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
|+..... ....+.+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+.+..
T Consensus 173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------- 242 (304)
T 3ubd_A 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--------- 242 (304)
T ss_dssp EEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred ceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC---------
Confidence 9865443 334567899999999999765 48999999999999999999999999999888888776520
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~~ 369 (395)
..++..+|+++++||++||++||++||| ++|+++||||+.+++.
T Consensus 243 --------------------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 243 --------------------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred --------------------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 0123457999999999999999999998 5799999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-61 Score=447.98 Aligned_cols=256 Identities=26% Similarity=0.374 Sum_probs=213.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
...|.+.++||+|+||+||+|+++.+|+.||||++..+.. ..+|+.+++.++|||||++++++ .+...+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ivmE 130 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFME 130 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEE-----EETTEEEEEEC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEEEEe
Confidence 3468999999999999999999999999999999976543 35799999999999999999998 45556999999
Q ss_pred cccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC-cEEEeecccccccccC
Q 016115 156 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKVLVKG 233 (395)
Q Consensus 156 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~-~~kl~Dfg~a~~~~~~ 233 (395)
||+| +|.+.+.. .+.+++..++.++.||+.||.|||+ +||+||||||+||||+ .++ .+||+|||+|+.....
T Consensus 131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~-~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLS-SDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEEC-TTSCCEEECCCTTCEEC---
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEe-CCCCEEEEeeCCCCeEccCC
Confidence 9995 67666654 3679999999999999999999999 6999999999999999 455 6999999999876543
Q ss_pred Cc------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 234 EA------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 234 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.. ....+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+.++... .++
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~------- 274 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP------- 274 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG-------
T ss_pred CcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC-------
Confidence 22 1235799999999999765 5999999999999999999999999887766666655541 110
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHH-------------hcCCCCcCCCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-------------CAHPFFDELREPN 370 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el-------------l~hp~~~~~~~~~ 370 (395)
...++..+|+++.+||.+||++||.+|||+.|+ |+|||+++.+++.
T Consensus 275 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 275 -----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp -----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred -----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 012345689999999999999999999999997 6899999887754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=452.36 Aligned_cols=311 Identities=71% Similarity=1.236 Sum_probs=284.0
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCC-CCceeEEEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFLNLV 153 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv 153 (395)
...+|.+.+.||+|+||.||+|++..+|+.||||++..+.....+|+++++.++|+||+++++++..... .+..++++|
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 4457999999999999999999999999999999998777777789999999999999999998865432 445678899
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
|||+++++...+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++.+++.+||+|||+++.....
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 9999999888888777777889999999999999999999999 699999999999999955678999999999887666
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
.......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+.++.+.++.+..+.+..+++.+.+
T Consensus 211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~ 290 (420)
T 1j1b_A 211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290 (420)
T ss_dssp CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 66667789999999999977656999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCCCCch
Q 016115 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386 (395)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (395)
+.++.+...+|...+...+++++.+||.+||.+||.+|||+.|+++||||+.++++...+++....+.+++|.
T Consensus 291 ~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 363 (420)
T 1j1b_A 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFT 363 (420)
T ss_dssp CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCC
T ss_pred hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCC
Confidence 9999999999988888899999999999999999999999999999999999999988888888999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=443.06 Aligned_cols=310 Identities=66% Similarity=1.185 Sum_probs=283.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCC-CCceeEEEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFLNLVM 154 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~ 154 (395)
..+|.+.+.||+|+||+||+|++..+++ ||+|++..+.....+|+++++.++||||+++++++..... .+..++++||
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 4579999999999999999999877665 8999888777777789999999999999999999876554 5566788999
Q ss_pred ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC
Q 016115 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (395)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (395)
||++++++..+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++..++.+||+|||+++......
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 999999888888777777889999999999999999999999 6999999999999998668899999999998876666
Q ss_pred cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCC
Q 016115 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314 (395)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....+..+++.+.+.
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 276 (394)
T 4e7w_A 197 PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEH 276 (394)
T ss_dssp CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSS
T ss_pred CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh
Confidence 66778899999999999776679999999999999999999999999999999999999999999999999999999888
Q ss_pred CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCCCCchh
Q 016115 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQ 387 (395)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (395)
.++.....++...+...+++++.+||.+||++||.+|||+.|+++||||++++......+++..++++++|.+
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 349 (394)
T 4e7w_A 277 KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTK 349 (394)
T ss_dssp CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCH
T ss_pred ccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCH
Confidence 8888888888888888899999999999999999999999999999999999999999999999999999984
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-59 Score=443.50 Aligned_cols=315 Identities=51% Similarity=0.984 Sum_probs=273.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCC----------
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS---------- 144 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---------- 144 (395)
...+|.+.+.||+|+||+||+|++..+|+.||||++..+.....+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 3457999999999999999999999999999999998887777889999999999999999999866443
Q ss_pred -----------------------CCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCce
Q 016115 145 -----------------------KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 201 (395)
Q Consensus 145 -----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~iv 201 (395)
.+..++++||||++|++.+.+..+......+++..++.++.||+.||.|||+ +||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~ 163 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGIC 163 (383)
T ss_dssp -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEE
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCc
Confidence 3455689999999999998888877778899999999999999999999999 6999
Q ss_pred eccCCCCceeecCCCCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 016115 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281 (395)
Q Consensus 202 H~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~ 281 (395)
||||||+|||++..++.+||+|||+++............||+.|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 99999999999856889999999999987666666777899999999999776669999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCC
Q 016115 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (395)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp 361 (395)
+.+..+.+..+.+..+.+....+..+++.+.+..++......|...++..+++++.+||.+||.+||.+|||+.|+|+||
T Consensus 244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (383)
T 3eb0_A 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP 323 (383)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence 99999999999999999999999999999999999999899999999999999999999999999999999999999999
Q ss_pred CCcCCCC-------CCCCCCCC--CCCCCCCCch-hhhh
Q 016115 362 FFDELRE-------PNARLPNG--RPFPPLFNFK-QEVC 390 (395)
Q Consensus 362 ~~~~~~~-------~~~~~~~~--~~~~~~~~~~-~~~~ 390 (395)
||+.++. ....++++ ..++++.+|. .|+.
T Consensus 324 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 362 (383)
T 3eb0_A 324 FFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELS 362 (383)
T ss_dssp GGHHHHHC------------------CCCCSCCCHHHHH
T ss_pred HHHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHh
Confidence 9998765 34445555 7789999988 4544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-59 Score=438.96 Aligned_cols=280 Identities=29% Similarity=0.466 Sum_probs=214.4
Q ss_pred cccCceeeeeeecCCceEEEEEEEC---CCCcEEEEEEecccc--cchHHHHHHHHHc-CCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (395)
-.+.|++.+.||+|+||+||+|+++ .+++.||||.+.... ....+|+++++.+ +|||||+++++| .+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~~~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCF-----RKND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----EETT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEE-----EECC
Confidence 3457999999999999999999875 467899999886543 2345799999988 699999999999 5556
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
++|+|||||+| +|.+.+ +.+++.+++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+|||+|
T Consensus 94 ~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 69999999985 555544 358999999999999999999999 699999999999999855589999999999
Q ss_pred cccccCC-----------------------------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCC
Q 016115 228 KVLVKGE-----------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278 (395)
Q Consensus 228 ~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~ 278 (395)
+...... ...+.+||+.|||||++.+...|+.++||||+||++|+|+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 7653321 12345799999999999877679999999999999999999999
Q ss_pred CCC-CCChHHHHHHHHHHhCCCChhhhhhcCC-------CC--------------CCCCCCC----ccCCCccccccccC
Q 016115 279 LFP-GENAVDQLVEIIKVLGTPTREEIRCMNP-------NY--------------TDFRFPQ----IKAHPWHKVFHKRM 332 (395)
Q Consensus 279 pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~--------------~~~~~~~----~~~~~~~~~~~~~~ 332 (395)
||. +.+..+++..+....|.+.......... .. .+...+. .............+
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 985 5677788888888877543322211000 00 0000000 00011111223568
Q ss_pred ChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 333 PPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 333 s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
|++++|||++||++||.+|+|++|+|+||||++++
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-59 Score=429.54 Aligned_cols=261 Identities=22% Similarity=0.405 Sum_probs=191.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCC-------C
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS-------K 145 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-------~ 145 (395)
+|++.+.||+|+||+||+|+++.+|+.||||++.... ....+|+++++.++|||||+++++|..... .
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5999999999999999999999999999999986432 334579999999999999999999865442 2
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
...++|+|||||+| +|.+.+... ......++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~-~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFT-MDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEEC-CCCcEEEccC
Confidence 34568999999986 555555432 222334567788999999999999999 6999999999999999 7889999999
Q ss_pred ccccccccCCc-------------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 016115 225 GSAKVLVKGEA-------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291 (395)
Q Consensus 225 g~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~ 291 (395)
|+|+....... ..+.+||+.|||||++.+. .|+.++|||||||++|||++ ||... .+....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~ 236 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT 236 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence 99987654322 2345799999999999764 59999999999999999996 77643 222222
Q ss_pred HHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
+.......... .....++.+.+||++||++||.+|||+.|+|+||||++++.+..
T Consensus 237 ~~~~~~~~~p~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~~ 291 (299)
T 4g31_A 237 LTDVRNLKFPP-------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291 (299)
T ss_dssp HHHHHTTCCCH-------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-----
T ss_pred HHHHhcCCCCC-------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCCc
Confidence 22221111000 11234678899999999999999999999999999999877554
Q ss_pred C
Q 016115 372 R 372 (395)
Q Consensus 372 ~ 372 (395)
.
T Consensus 292 ~ 292 (299)
T 4g31_A 292 T 292 (299)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-57 Score=449.91 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=223.5
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
++|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+++|+.++|||||+++++| .+...+||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence 5799999999999999999999999999999998643 23456799999999999999999999 56667999
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC-CCcEEEeeccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVL 230 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~~ 230 (395)
|||||+| +|.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.+ .+.+||+|||+|+..
T Consensus 232 v~E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 232 IYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEeecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 9999986 5555443 234679999999999999999999999 699999999999999842 378999999999988
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.........+||+.|||||++.+. .|+.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 308 ~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~---------- 376 (573)
T 3uto_A 308 DPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---------- 376 (573)
T ss_dssp CTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC----------
T ss_pred cCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC----------
Confidence 777777778999999999999765 589999999999999999999999999998888877765311111
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
......+|+++++||++||++||.+|||+.|+|+||||+....+..
T Consensus 377 ---------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 377 ---------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp ---------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred ---------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence 1123467999999999999999999999999999999998776543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=452.42 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=212.0
Q ss_pred CccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHH---HHHHHHcCCCceeeeceeeeec
Q 016115 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRE---LQLMRLMDHPNVISLKHCFFST 142 (395)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e---~~~l~~l~h~niv~~~~~~~~~ 142 (395)
+...++|.+.+.||+|+||+||+|+++.+|+.||||++.+.. ....+| +.+++.++|||||+++++|
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f--- 261 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--- 261 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE---
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE---
Confidence 455678999999999999999999999999999999986432 112233 4555667899999999999
Q ss_pred CCCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEE
Q 016115 143 TSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (395)
Q Consensus 143 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl 221 (395)
.+...+|||||||+| +|...+.. .+.+++..++.++.||+.||.|||+ +|||||||||+||||+ .+|.+||
T Consensus 262 --~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld-~~G~vKL 333 (689)
T 3v5w_A 262 --HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLD-EHGHVRI 333 (689)
T ss_dssp --ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEEC-TTSCEEE
T ss_pred --EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEe-CCCCEEe
Confidence 566679999999995 66666654 3679999999999999999999999 6999999999999999 7889999
Q ss_pred eecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Q 016115 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLGT 298 (395)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~~~~~~~~ 298 (395)
+|||+|+...... ..+.+||+.|||||++.++..|+.++|||||||++|+|++|..||.+.+.. +....+...
T Consensus 334 ~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--- 409 (689)
T 3v5w_A 334 SDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--- 409 (689)
T ss_dssp CCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---
T ss_pred cccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---
Confidence 9999998765443 346789999999999975556999999999999999999999999764322 222222220
Q ss_pred CChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCCCC
Q 016115 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 370 (395)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~~~ 370 (395)
...++..+|+++++||.+||++||.+|++ ++|+++||||+.+++..
T Consensus 410 --------------------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 410 --------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp --------------------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred --------------------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 01134568999999999999999999998 79999999999988754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=409.80 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=208.3
Q ss_pred cccCceeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
...+|.+.+.||+|+||+||+|++. .+|..||||++... .+.+.+|+++++.++|||||++++++ .
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~ 85 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----V 85 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEE-----e
Confidence 3457999999999999999999875 36789999998643 23456899999999999999999999 4
Q ss_pred CceeEEEEEeccc-chHHHHHHhhc---------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC
Q 016115 146 DELFLNLVMEYVP-ETMYRVLKHYS---------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (395)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~ 215 (395)
+...++||||||+ |+|.+.+.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++ .
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~-~ 163 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVG-E 163 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-G
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEEC-C
Confidence 4455899999998 57777776432 234579999999999999999999999 6999999999999999 7
Q ss_pred CCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 016115 216 THQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 291 (395)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~ 291 (395)
++.+||+|||+|+........ ....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 242 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 889999999999876444322 234689999999999765 59999999999999999999 9999999888877776
Q ss_pred HHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
+... ... ..+..+|+++.+||.+||+.||++|||+.++ |+|++++.
T Consensus 243 i~~~--~~~--------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 243 ITQG--RVL--------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp HHHT--CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred HHcC--CCC--------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 6652 100 1234579999999999999999999999999 56776654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-56 Score=411.41 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=199.4
Q ss_pred cccCceeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
...+|.+.+.||+|+||+||+|++. .++..||||++... .+.+.+|+++++.++|||||++++++ .
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~ 113 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-----T 113 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 3457899999999999999999865 36889999999643 23456899999999999999999999 4
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSS-----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~ 213 (395)
+...+|||||||+| +|.+.+..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVG 192 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEEC
Confidence 44558999999995 66666654321 23569999999999999999999999 6999999999999999
Q ss_pred CCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHH
Q 016115 214 PLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 289 (395)
Q Consensus 214 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 289 (395)
.++.+||+|||+|+....... .....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+
T Consensus 193 -~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 193 -QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp -TTTEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred -CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 789999999999987644332 2345789999999999765 59999999999999999999 99999998888777
Q ss_pred HHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+.+. .. ...+..+++++.+||.+||+.||++|||+.|++++
T Consensus 271 ~~i~~g--~~--------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 271 DCITQG--RE--------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHT--CC--------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHcC--CC--------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 766552 10 01234579999999999999999999999999763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=405.03 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=194.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
...++.+.+.||+|+||+||+|++. ..||||+++.. .+.+.+|+.+++.++|||||++++++. + .
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~-~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-----K-D 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-S
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----C-C
Confidence 4457889999999999999999863 35999988532 234568999999999999999999762 2 2
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.++||||||+| +|.+.+.. ....+++..+..++.||+.||.|||+ +|||||||||+|||++ +++.+||+|||+|
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~-~~~~~Ki~DFGla 179 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLH-EGLTVKIGDFGLA 179 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEE-TTEEEEECCCSSC
T ss_pred eEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEEC-CCCcEEEeeccCc
Confidence 37899999995 66555543 24679999999999999999999999 6999999999999999 7899999999999
Q ss_pred cccccCC---cceeeeecccccCchhhcCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 228 KVLVKGE---ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 228 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
+...... .....+||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..+.......
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~--- 256 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS--- 256 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC---
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC---
Confidence 8764332 23346799999999999643 348999999999999999999999999877766665554421110
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHh
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 358 (395)
+. ....+..+++++.+||.+||+.||++|||+.|++
T Consensus 257 --------------p~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 257 --------------PD------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp --------------CC------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred --------------CC------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 00 0113346789999999999999999999999775
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=405.86 Aligned_cols=248 Identities=23% Similarity=0.275 Sum_probs=203.6
Q ss_pred cCceeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
.++++.+.||+|+||+||+|++. .+++.||||.+... .+.+.+|+.+++.++|||||++++++ .+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~-----~~ 100 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV-----TK 100 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE-----EE
Confidence 45788899999999999999863 46789999998643 23466899999999999999999998 44
Q ss_pred ceeEEEEEeccc-chHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec
Q 016115 147 ELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (395)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~ 213 (395)
...++||||||+ |+|.+.+..... ....+++..+..++.||+.||.|||+ ++||||||||+||||+
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEEC
Confidence 445899999999 477777754321 13568999999999999999999999 6999999999999999
Q ss_pred CCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHH
Q 016115 214 PLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 289 (395)
Q Consensus 214 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 289 (395)
+++.+||+|||+|+....... .....||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..+.+
T Consensus 180 -~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 180 -DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp -GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred -CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 789999999999987644322 2345789999999999765 59999999999999999999 89999998887776
Q ss_pred HHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+...... ..+..+++++.+|+.+||+.||.+|||+.|++++
T Consensus 258 ~~i~~~~~~----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 258 EMIRNRQVL----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 665431100 1234578999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=405.24 Aligned_cols=310 Identities=46% Similarity=0.871 Sum_probs=253.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccc---hHHHHHHHHHcCCCceeeeceeeeecCC--CCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRLMDHPNVISLKHCFFSTTS--KDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~~~~~ 150 (395)
.++|.+.+.||+|+||.||+|++..+|+.||||++..+... ..++++.++.++||||+++++++..... ....++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 45799999999999999999999999999999998655433 3346666788899999999999865443 345568
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh--cCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
++||||+++++...+..+......+++..++.++.||+.||.||| + +||+||||||+|||++..++.+||+|||+++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 899999999988888777677788999999999999999999999 8 6999999999999999448899999999998
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
............||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence 87766666667889999999999776668999999999999999999999999999999999999999999998888777
Q ss_pred CCCCCCCCCCccCCCccccccc---cCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCC-CCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFP-PLFN 384 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~-~~~~ 384 (395)
+......+......+|...+.. .+++++.+||.+||+.||.+|||+.|+|+||||+++.++....++...++ .+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~ 340 (360)
T 3e3p_A 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFR 340 (360)
T ss_dssp TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCCGGGGC
T ss_pred cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCCcHHHH
Confidence 7666555544444444443322 36789999999999999999999999999999999999888888888777 4445
Q ss_pred ch
Q 016115 385 FK 386 (395)
Q Consensus 385 ~~ 386 (395)
|.
T Consensus 341 ~~ 342 (360)
T 3e3p_A 341 FL 342 (360)
T ss_dssp CC
T ss_pred cC
Confidence 54
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-54 Score=403.91 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=203.5
Q ss_pred cccCceeeeeeecCCceEEEEEEECCC-----CcEEEEEEeccc-----ccchHHHHHHHHHcCC-CceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQD-----RRYKNRELQLMRLMDH-PNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~ 143 (395)
..++|++.+.||+|+||+||+|.+..+ ++.||||.+... .+.+.+|+.+++.++| ||||++++++...
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 346799999999999999999997654 368999998643 2345679999999976 8999999988432
Q ss_pred CCCceeEEEEEeccc-chHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCce
Q 016115 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Ni 210 (395)
...++||||||+ |+|.+.+..... ....+++..+..++.||+.||.|||+ ++||||||||+||
T Consensus 141 ---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NI 216 (353)
T 4ase_A 141 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI 216 (353)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccce
Confidence 234789999999 577777764322 13568999999999999999999999 6999999999999
Q ss_pred eecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChH
Q 016115 211 LVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 286 (395)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~ 286 (395)
|++ +++.+||+|||+|+........ ....||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..
T Consensus 217 Ll~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 217 LLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeC-CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999 7889999999999876544332 245789999999999765 59999999999999999998 99999987655
Q ss_pred HHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
+.+..++.. +.. ...+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 295 ~~~~~~i~~-g~~--------------------------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLKE-GTR--------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHH-TCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHc-CCC--------------------------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 544444432 110 01234578999999999999999999999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=389.24 Aligned_cols=282 Identities=34% Similarity=0.568 Sum_probs=227.3
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence 46999999999999999999999999999999986432 2345799999999999999999998 445568
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||++|++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLIN-RNGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEeecccceec
Confidence 99999999988777654 24679999999999999999999999 6999999999999999 7889999999999876
Q ss_pred ccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 231 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
... .......||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....+....
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 433 2234567899999999997766689999999999999999987766 67778888888898888887766554332
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
........+..............+++++.+||++||+.||.+|||++|+|+||||+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p 291 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence 111111111111111112233468999999999999999999999999999999997643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=391.58 Aligned_cols=258 Identities=27% Similarity=0.421 Sum_probs=220.5
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
...++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++ ...
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~ 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETE 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence 34567999999999999999999999999999999986432 2345799999999999999999998 455
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+|+||||++| ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~-~~~~~kl~DFG~ 160 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGF 160 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECSTTC
T ss_pred CEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEc-CCCCEEEeeccC
Confidence 569999999975 66666654 3579999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+............+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------- 230 (328)
T 3fe3_A 161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---------- 230 (328)
T ss_dssp CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 9877666666677899999999999876655689999999999999999999999988877776665520
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
+ .++..+++++.+||++||..||.+|||++|+++||||+...+...
T Consensus 231 -------~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~ 276 (328)
T 3fe3_A 231 -------Y------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276 (328)
T ss_dssp -------C------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTCC
T ss_pred -------C------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcccc
Confidence 0 122346899999999999999999999999999999998765443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=405.04 Aligned_cols=291 Identities=31% Similarity=0.611 Sum_probs=224.5
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcC-CCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 149 (395)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+. |+||+++++++.. .+...
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DNDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCCCE
Confidence 4799999999999999999999999999999988533 223347899999997 9999999998854 23345
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|+||||++|++...+.. ..+++..++.++.||+.||+|||+ .||+||||||+|||++ .++.+||+|||+|+.
T Consensus 86 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLN-AECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEc-CCCCEEecCCccccc
Confidence 899999999988877764 578999999999999999999999 6999999999999999 788999999999976
Q ss_pred cccC----------------------CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH
Q 016115 230 LVKG----------------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287 (395)
Q Consensus 230 ~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 287 (395)
.... ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 112345789999999999876679999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChhhhhhcCCCCCCCCCC------CccCCCccc------------cccccCChhHHHHHHHhhccCCC
Q 016115 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFP------QIKAHPWHK------------VFHKRMPPEAIDLASRLLQYSPS 349 (395)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~------------~~~~~~s~~~~~li~~~L~~dp~ 349 (395)
++..+...++.+....+......+....+. ......+.. .....+++++.+||++||++||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 999999999998877665432211000000 000000000 01126789999999999999999
Q ss_pred CCCCHHHHhcCCCCcCCCCCCCCCCCCC
Q 016115 350 LRCTALEACAHPFFDELREPNARLPNGR 377 (395)
Q Consensus 350 ~Rpt~~ell~hp~~~~~~~~~~~~~~~~ 377 (395)
+|||++|+|+||||+.+..+........
T Consensus 319 ~R~t~~e~l~Hp~~~~~~~~~~~~~~~~ 346 (388)
T 3oz6_A 319 KRISANDALKHPFVSIFHNPNEEPNCDH 346 (388)
T ss_dssp GSCCHHHHTTSTTTTTTCCGGGCCCCSS
T ss_pred cCCCHHHHhCCHHHHHhcCCccCCCCCC
Confidence 9999999999999999887665443333
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=413.72 Aligned_cols=285 Identities=32% Similarity=0.564 Sum_probs=225.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCC-CCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (395)
..+|++.+.||+|+||+||+|++..+|+.||||++... .....+|+.+++.++||||+++++++..... .+..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 45799999999999999999999999999999998643 2234579999999999999999999854332 2335
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+|+||||+++++...+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~-~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEe-CCCCEEEEEEEeee
Confidence 689999999998777663 348999999999999999999999 6999999999999999 78899999999998
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
...........+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+++..+.+.+|.+....+....
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 213 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 87666566678899999999999765 58999999999999999999999999999999999999999999887665432
Q ss_pred CCCCCCC--CCCccCCCccccccc-----------cCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 309 PNYTDFR--FPQIKAHPWHKVFHK-----------RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 309 ~~~~~~~--~~~~~~~~~~~~~~~-----------~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
.....+. .+......+...++. ..++++.+||.+||.+||.+|||++|+|+||||+...++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 1111100 000011111111111 126789999999999999999999999999999976654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=410.58 Aligned_cols=290 Identities=33% Similarity=0.564 Sum_probs=220.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.++|.+.+.||+|+||+||+|++..+|+.||||++... .....+|+.+++.++|+||+++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 35799999999999999999999999999999998643 233457999999999999999999986655455567
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|+||||+++++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 132 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVN-QDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTCCEEECCCTTCBC
T ss_pred EEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEEC-CCCCEeecccccchh
Confidence 999999999988877754 4679999999999999999999999 6999999999999999 788999999999987
Q ss_pred cccCC----------------------------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh------
Q 016115 230 LVKGE----------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL------ 275 (395)
Q Consensus 230 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt------ 275 (395)
..... .....+||+.|+|||++.....++.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 54221 22345789999999987666679999999999999999999
Q ss_pred -----CCCCCCCCC--------------------hHHHHHHHHHHhCCCChhhhhhcCCCCCC---CCCCCccCCCcccc
Q 016115 276 -----GQPLFPGEN--------------------AVDQLVEIIKVLGTPTREEIRCMNPNYTD---FRFPQIKAHPWHKV 327 (395)
Q Consensus 276 -----g~~pf~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 327 (395)
|.++|.+.+ ..+++..+.+.+|.+....+......... ..++......+..
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 364 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE- 364 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG-
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH-
Confidence 777787654 36778888999999988766543211000 0011111111111
Q ss_pred ccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 328 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 328 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
....+++++.+||++||.+||.+|||++|+|+||||+.++.....
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e 409 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVE 409 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGC
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccC
Confidence 224569999999999999999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=390.00 Aligned_cols=281 Identities=35% Similarity=0.657 Sum_probs=227.0
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.++|++.+.||+|+||+||+|++. +|+.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERC 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSSC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCCE
Confidence 357999999999999999999985 59999999986432 2345799999999999999999998 55556
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++||||++|++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 94 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 94 LTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLIN-SDGALKLADFGLARA 168 (311)
T ss_dssp EEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEEC-CCCCEEEccCcCcee
Confidence 999999999988777754 23568999999999999999999999 6999999999999999 688999999999987
Q ss_pred cccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 230 LVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 230 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 6433 223445789999999999776668999999999999999999999999999889999999988887765544322
Q ss_pred CC--CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 309 PN--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 309 ~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
.. +....+......++ ......+++++.+||++||++||.+|||++|+|+||||++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPW-SSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp TSHHHHSCCCCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred ccchhhhcccccccCCcH-HHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 10 00011111111222 1233567899999999999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=389.82 Aligned_cols=290 Identities=32% Similarity=0.555 Sum_probs=218.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.+|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence 46999999999999999999999999999999986432 3345799999999999999999998 5556699
Q ss_pred EEEecccchHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 152 LVMEYVPETMYRVLKHYSS--MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+||||++|+|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLIN-KRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCSSCEE
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEc-CCCCEEECcCcccee
Confidence 9999999998888765432 23468999999999999999999999 6999999999999999 788999999999987
Q ss_pred cccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 230 LVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 230 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+....
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 6433 223455789999999999765568999999999999999999999999999999999999988877655443321
Q ss_pred C--CCCCCCCCCccCCCc----cccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCC
Q 016115 309 P--NYTDFRFPQIKAHPW----HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 374 (395)
Q Consensus 309 ~--~~~~~~~~~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~ 374 (395)
. .+.. .+.......+ .......++.++.+||.+||+.||.+|||+.|+|+||||++...++...+
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~ 308 (317)
T 2pmi_A 238 KLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGG 308 (317)
T ss_dssp GCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC------
T ss_pred hhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhccc
Confidence 1 1100 0000000111 11223467899999999999999999999999999999999888765443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=385.35 Aligned_cols=285 Identities=30% Similarity=0.529 Sum_probs=229.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHHcC---CCceeeeceeeeecC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMD---HPNVISLKHCFFSTT 143 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~---h~niv~~~~~~~~~~ 143 (395)
..+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 457999999999999999999999999999999986322 23456777776664 999999999997766
Q ss_pred CCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEee
Q 016115 144 SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~D 223 (395)
......+++||||++|++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~-~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVT-SGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEEC-TTSCEEECS
T ss_pred CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEc-CCCCEEEee
Confidence 55566789999999998888776532 2448999999999999999999999 6999999999999999 788999999
Q ss_pred cccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 224 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
||+++............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99998776665556678899999999997654 89999999999999999999999999999999999999888877654
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
+..... .....++.....+ .......+++.+.+||.+||++||.+|||+.|+|+||||++..
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 243 WPRDVS-LPRGAFPPRGPRP-VQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp SCSSCS-SCGGGSCCCCCCC-HHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ccchhh-ccccccCCCCCCc-HHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 432111 0111111111111 1223456899999999999999999999999999999998744
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=382.66 Aligned_cols=277 Identities=34% Similarity=0.642 Sum_probs=221.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
++|++.+.||+|+||+||+|++ .+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeE
Confidence 4699999999999999999998 679999999985432 2345799999999999999999998 344558
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||+++++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 76 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLIN-REGELKIADFGLARAF 150 (288)
T ss_dssp EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECCTTHHHHH
T ss_pred EEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEc-CCCCEEEeECcccccc
Confidence 999999999887776542 3578999999999999999999999 6999999999999999 7889999999999865
Q ss_pred ccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 4332 233457899999999997666689999999999999999999999999999999999988888766554432110
Q ss_pred --CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 310 --NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 310 --~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.+. ..+......++ ..+...+++++.+||.+||+.||++|||+.|+++||||++.
T Consensus 231 ~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 231 LPKYD-PNFTVYEPLPW-ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp STTCC-TTCCCCCCCCG-GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccc-cccccccCccH-HHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000 01111111112 12335689999999999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=393.16 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=217.1
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
.+.|.+.+.||+|+||+||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++ .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----E 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----E
Confidence 457999999999999999999999999999999986432 2346899999999999999999998 5
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC---cEEE
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QVKL 221 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~---~~kl 221 (395)
+...+++||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+. .+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred eCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEEE
Confidence 55669999999975 66555533 4679999999999999999999999 69999999999999983332 7999
Q ss_pred eecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 161 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~- 238 (361)
T 2yab_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD- 238 (361)
T ss_dssp CCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-
T ss_pred EecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-
Confidence 999999887666555667899999999999654 589999999999999999999999999888877777655321111
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
..+...+++.+++||++||.+||.+|||+.|+++||||+...
T Consensus 239 ------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 239 ------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp ------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred ------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 123356799999999999999999999999999999998654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=388.61 Aligned_cols=283 Identities=32% Similarity=0.595 Sum_probs=227.3
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HHNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ecCC
Confidence 4457999999999999999999999999999999986432 2345799999999999999999998 4455
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC----CCCcEEEeec
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDF 224 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~----~~~~~kl~Df 224 (395)
.+++||||++|+|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+||
T Consensus 107 ~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 6999999999988887765 3568999999999999999999999 69999999999999951 4556999999
Q ss_pred ccccccccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 225 GSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 225 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
|+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|..||...+..+.+..+....+.+....
T Consensus 182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 999876433 2234457899999999997766689999999999999999999999999999999999999888777654
Q ss_pred hhhcC--CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 304 IRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 304 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
+.... +.+. ..++......+...+...+++++.+||.+||++||.+|||+.|+|+||||+..+.
T Consensus 262 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 262 WPGVTALPDWK-QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp STTGGGSTTCC-TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhh-hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 43221 1110 1222333334444455668999999999999999999999999999999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=390.12 Aligned_cols=299 Identities=32% Similarity=0.606 Sum_probs=234.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
++|.+.+.||+|+||+||+|++..+|+.||||++..... ...+|+.+++.++||||+++++++ .+...++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEEE
Confidence 469999999999999999999999999999999864321 233699999999999999999998 4445589
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||++|++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLIN-ERGELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEEC-TTCCEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEEC-CCCCEEEccCccccccc
Confidence 99999999888877653 3568999999999999999999999 6999999999999999 68899999999997654
Q ss_pred cCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+......
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 332 2334578999999999977667899999999999999999999999999999999999999888776554322110
Q ss_pred --CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCCCCch
Q 016115 311 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386 (395)
Q Consensus 311 --~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (395)
+..+.++......+ ......+++++.+||.+||+.||.+|||++|+|+||||+.+.+.....+.......+..++
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 308 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEAL-LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQ 308 (324)
T ss_dssp HHHHHTCCCCCCCCCH-HHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTCC
T ss_pred hhhcccccccccchhh-hhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHHH
Confidence 00111111111111 1223467899999999999999999999999999999999988776666655554444433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-52 Score=400.86 Aligned_cols=290 Identities=32% Similarity=0.540 Sum_probs=229.0
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++..........
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 347999999999999999999999999999999986432 33457999999999999999999986544333356
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|+||||++|+|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 105 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~-~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLN-QDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEEC-CCCCEEEccCCCccc
Confidence 899999999988877754 4679999999999999999999999 6999999999999999 788999999999987
Q ss_pred cccCCc-----------------------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-----------
Q 016115 230 LVKGEA-----------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL----------- 275 (395)
Q Consensus 230 ~~~~~~-----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt----------- 275 (395)
...... ....+||+.|+|||++.....++.++|||||||++|+|++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 644321 2456789999999997666679999999999999999998
Q ss_pred CCCCCCCCC-----------------hHHHHHHHHHHhCCCChhhhhhcCCCCCC-C--CCCCccCCCccccccccCChh
Q 016115 276 GQPLFPGEN-----------------AVDQLVEIIKVLGTPTREEIRCMNPNYTD-F--RFPQIKAHPWHKVFHKRMPPE 335 (395)
Q Consensus 276 g~~pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~s~~ 335 (395)
|.++|.+.+ ..+++..+...+|.+....+......... + .++......+.. ....++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~ 337 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQ-KYPSISDD 337 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHH-HCCCCCHH
Confidence 455555543 46788899999999988766543211000 0 001111111111 22457999
Q ss_pred HHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 336 AIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 336 ~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
+.+||++||.+||.+|||++|+|+||||+.+++....
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e 374 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLE 374 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccC
Confidence 9999999999999999999999999999999886654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=385.77 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=214.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.++|++.+.||+|+||+||+|++..+|+.||||++.+. .....+|+.+++.++||||+++++++ .+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 45799999999999999999999999999999998643 22345799999999999999999998 5555
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+|+||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~g~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLD-KDGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEEC-CCCCEEEeeccch
Confidence 69999999986 55555543 3678999999999999999999999 6999999999999999 7889999999999
Q ss_pred cccc-cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 228 KVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 228 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 220 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------- 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred hhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 8643 33344567899999999999654 5899999999999999999999999988877766665541
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~ 369 (395)
. ..++..+++++.+||.+||+.||.+|| +++|+++||||+.+++.
T Consensus 221 ------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 221 ------E------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ------C------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 0 012345799999999999999999999 99999999999987653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=398.45 Aligned_cols=261 Identities=27% Similarity=0.381 Sum_probs=198.5
Q ss_pred ccCceee-eeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHH-HHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 76 TISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 76 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.++|.+. +.||+|+||+||+|.+..+|+.||||++... ....+|+.++ +..+||||+++++++.... .+...+|+|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv 137 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV 137 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEE
Confidence 4467776 7899999999999999999999999998644 3355688876 5568999999999884322 235678999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCcEEEeeccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKVL 230 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~ 230 (395)
|||+.| +|.+.+... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.. ++.+||+|||+++..
T Consensus 138 ~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 138 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 999985 666666542 23469999999999999999999999 699999999999999832 678999999999876
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChhhhhh
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~ 306 (395)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+... ....+.. +
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~--~--------- 282 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--G--------- 282 (400)
T ss_dssp C-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH--T---------
T ss_pred CCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc--C---------
Confidence 65555566788999999999865 458999999999999999999999998654322 1122211 0
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
.+.++. .....++.++.+||++||+.||.+|||+.|+++||||....
T Consensus 283 ------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 283 ------QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp ------CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ------cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 011110 01235799999999999999999999999999999997643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=393.02 Aligned_cols=254 Identities=28% Similarity=0.475 Sum_probs=211.0
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc-CCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (395)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|..+++.+ +||||+++++++ .+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence 3457999999999999999999999999999999986432 2344688899887 699999999998 55
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+|+||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~-~~g~ikL~DFG 169 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLD-HEGHCKLADFG 169 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEEC-CCCCEEEcccc
Confidence 5569999999986 56555544 3679999999999999999999999 6999999999999999 78899999999
Q ss_pred ccccccc-CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 226 SAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 226 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 170 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------- 240 (353)
T 3txo_A 170 MCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-------- 240 (353)
T ss_dssp TCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred ceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Confidence 9986432 3334467899999999999764 48999999999999999999999999998888887776520
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH------HHHhcCCCCcCCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELREP 369 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~ell~hp~~~~~~~~ 369 (395)
..++..+++++.+||++||++||.+||++ +++++||||+.+++.
T Consensus 241 ---------------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 241 ---------------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 11234578999999999999999999999 899999999988653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=377.94 Aligned_cols=285 Identities=33% Similarity=0.609 Sum_probs=222.4
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-----RRKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-----ecCCeE
Confidence 47999999999999999999999999999999885432 2334799999999999999999998 444558
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILIT-KHSVIKLCDFGFARLL 152 (311)
T ss_dssp EEEEECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEc-CCCCEEEeeCCCchhc
Confidence 99999999876655543 24678999999999999999999999 6999999999999999 7889999999999876
Q ss_pred ccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC-
Q 016115 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 308 (395)
Q Consensus 231 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 308 (395)
.... ......||+.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+.+..+...........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 5332 23456789999999999876678999999999999999999999999999999998888887776654332211
Q ss_pred -CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 309 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 309 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
..+.....+..............++..+.+||++||+.||.+|||++|+++||||+++++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 296 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence 111111222211111112223468999999999999999999999999999999999877543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=385.92 Aligned_cols=293 Identities=33% Similarity=0.624 Sum_probs=238.2
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.+|++.+.||+|+||.||+|++..++..||||++.... ....+|+.+++.++||||+++++++..........++
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 47999999999999999999999999999999986432 3345799999999999999999998655444455689
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||++|++.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++....
T Consensus 107 iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 107 IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred EEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEEC-CCCCEEEEeCcceEecC
Confidence 9999999998887764 569999999999999999999999 6999999999999999 78899999999998764
Q ss_pred cCCc----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 232 KGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 232 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+...
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 4322 234578999999999877666899999999999999999999999999999999999999999887766532
Q ss_pred CCCCC---CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCC
Q 016115 308 NPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 377 (395)
Q Consensus 308 ~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~ 377 (395)
..... ....+.....++. .+...+++++.+||.+||++||.+|||+.|+|+||||+....+........
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~ 331 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWN-RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 331 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHH-HHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS
T ss_pred hhhhHHHHHHhcCCccCCCHH-HhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC
Confidence 21000 0001111111221 223457899999999999999999999999999999999876554433333
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=386.44 Aligned_cols=285 Identities=35% Similarity=0.621 Sum_probs=225.0
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (395)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... .+...
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 46999999999999999999999999999999985431 234579999999999999999999854322 12245
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|+||||++++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVN-EDCELKILDFGLARQ 177 (367)
T ss_dssp CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEc-CCCCEEEEeeecccc
Confidence 789999998887777664 568999999999999999999999 6999999999999999 688999999999987
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+..+.++...+.....
T Consensus 178 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 178 ADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 5432 34567899999999998756799999999999999999999999999999999999999999988776654321
Q ss_pred CCCCC---CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 310 NYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 310 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
..... ..+......+. .+...+++.+.+||.+||..||.+|||+.|+|+||||+.+.+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred HHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 10000 00111111221 123467999999999999999999999999999999999887654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=384.27 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=218.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++ .+...+++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCEEEE
Confidence 357999999999999999999999999999999986432 3345799999999999999999998 44456999
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC-CCcEEEeeccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVL 230 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~~ 230 (395)
||||++| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||+++..
T Consensus 79 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999986 55555432 23579999999999999999999999 699999999999999832 688999999999887
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
..........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+..........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------- 225 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE-------- 225 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH--------
T ss_pred CCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh--------
Confidence 766666677899999999999654 47999999999999999999999999988888777776632222211
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
....++.++.+||.+||..||.+|||+.|+|+||||+....
T Consensus 226 -----------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 226 -----------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp -----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred -----------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 22457999999999999999999999999999999987543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=383.15 Aligned_cols=255 Identities=20% Similarity=0.234 Sum_probs=185.6
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-ch--HHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YK--NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~--~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+|.+.+.||+|+||+||+|++ +|+.||||++..... .. +.|+..+..++|||||++++++..... ....+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEEEe
Confidence 588999999999999999997 689999999865432 22 235555567899999999999865332 234589999
Q ss_pred eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC--------CceeccCCCCceeecCCCCcEEEeecc
Q 016115 155 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP--------GVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 155 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--------~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
|||+ |+|.+.+.. ..+++..+..++.|++.||.|||+ + +|+||||||+|||++ .++.+||+|||
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DFG 153 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG 153 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeCC
Confidence 9999 566666654 568999999999999999999997 4 899999999999999 78999999999
Q ss_pred cccccccCCcc-----eeeeecccccCchhhcCCC-----CCCcccchHhHHHHHHHHHhCCCCCCCCChHH--------
Q 016115 226 SAKVLVKGEAN-----ISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-------- 287 (395)
Q Consensus 226 ~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-------- 287 (395)
+|+........ ...+||+.|||||++.+.. .++.++|||||||++|||+||..||......+
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 99876554332 2357999999999996532 25779999999999999999987764322100
Q ss_pred ---HHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 288 ---QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 288 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
....+.+.... ... ...++. .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~----------~~~-rp~~p~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 234 SDPSVEEMRKVVCE----------QKL-RPNIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTT----------SCC-CCCCCG-------GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhc----------ccC-CCCCCc-------cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00111111000 000 000000 00011234578899999999999999999999763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=375.08 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=213.0
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
..+|++.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++. ....++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECCEEE
Confidence 457999999999999999999999999999999985432 33457999999999999999999984 344589
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||+.| +|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQI 166 (297)
T ss_dssp EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEC-CCCCEEEeeCCCceec
Confidence 99999975 66555543 468999999999999999999999 6999999999999999 7889999999998876
Q ss_pred ccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.......
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------- 235 (297)
T 3fxz_A 167 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE---------- 235 (297)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC----------
T ss_pred CCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------
Confidence 54433 3456789999999999765 48999999999999999999999999888777666555421110
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
...+..++..+.+||.+||+.||.+|||+.|+++||||+....
T Consensus 236 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 236 ----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp ----------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred ----------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 0123457899999999999999999999999999999986543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=382.29 Aligned_cols=285 Identities=33% Similarity=0.577 Sum_probs=227.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
..+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GH 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----ee
Confidence 357999999999999999999999999999999986321 2345799999999999999999998 44
Q ss_pred ceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...+++||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLD-ENGVLKLADFGL 158 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECCCGG
T ss_pred CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEc-CCCCEEEEeccc
Confidence 455899999999987766653 23568889999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 227 AKVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 227 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
++...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+.
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 98764332 33456789999999999766668999999999999999999999999999999999999988887765554
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
..........+......++ ......++.++.+||.+||..||.+|||+.|+|+||||+....+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPL-HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp STTSSTTCCCCCCCCCCCH-HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred hhccCcccccccccCCCCh-HHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 3221111111111111111 1223567899999999999999999999999999999998766543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=393.25 Aligned_cols=252 Identities=28% Similarity=0.448 Sum_probs=212.4
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..++|.+.+.||+|+||+||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++ .+.
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~ 81 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTP 81 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence 345799999999999999999999999999999998543 23456899999999999999999998 445
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..+++||||++|++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~-~~~~~kl~DFG~s 155 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLD-DNLNVKIADFGLS 155 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEEC-TTCCEEECCSSCT
T ss_pred CEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEc-CCCCEEEEEeccc
Confidence 56899999999998887765 3579999999999999999999999 6999999999999999 7889999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.....+......+||+.|+|||++.+....+.++|||||||++|+|++|..||......+..
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------------ 217 (336)
T 3h4j_B 156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------------ 217 (336)
T ss_dssp BTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------------------
T ss_pred eeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------------------
Confidence 88776666667789999999999977654588999999999999999999999764321100
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.... .....++..+++++.+||++||..||.+|||++|+++||||+.-
T Consensus 218 ---------~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 218 ---------KKVN--SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ---------CCCC--SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ---------HHHH--cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 0000 00112345679999999999999999999999999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=379.75 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=215.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
.+.|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 346999999999999999999999999999999986432 2356899999999999999999998 4
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC----cEE
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QVK 220 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~----~~k 220 (395)
+...+++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++ .++ .+|
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~-~~~~~~~~~k 158 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLL-DRNVPKPRIK 158 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEES-CSSSSSCCEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEe-cCCCCCCCEE
Confidence 55568999999975 66555533 4679999999999999999999999 6999999999999998 455 799
Q ss_pred EeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
|+|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (326)
T 2y0a_A 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237 (326)
T ss_dssp ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred EEECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence 9999999887655555567899999999999654 589999999999999999999999998888777766655311111
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
......++..+.+||++||..||.+|||+.|+|+||||+...
T Consensus 238 -------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 238 -------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp -------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred -------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 112345789999999999999999999999999999998643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=389.27 Aligned_cols=255 Identities=25% Similarity=0.447 Sum_probs=209.4
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc-CCCceeeeceeeeecCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (395)
....+|.+.+.||+|+||+||+|++..+++.||+|++.+.. ....+|..+++.+ +||||+++++++ .
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----E
Confidence 34567999999999999999999999999999999986532 2245788888776 899999999998 5
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
+...+|+||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~-~~g~ikL~DF 197 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLD-SEGHIKLTDY 197 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEC-CCCCEEEeec
Confidence 55669999999986 55555544 3679999999999999999999999 6999999999999999 7889999999
Q ss_pred cccccc-ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh--------HH-HHHHHHH
Q 016115 225 GSAKVL-VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VD-QLVEIIK 294 (395)
Q Consensus 225 g~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~-~~~~~~~ 294 (395)
|+++.. .........+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... .+ ....+..
T Consensus 198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred ceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 999863 334445567899999999999764 589999999999999999999999964321 11 2222222
Q ss_pred HhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH------HHHhcCCCCcCCCC
Q 016115 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELRE 368 (395)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~ell~hp~~~~~~~ 368 (395)
. ...++..++.++.+||++||++||.+|+++ +|+++||||+.+++
T Consensus 277 ~-----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 277 K-----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp C-----------------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred c-----------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 0 011345679999999999999999999985 79999999999875
Q ss_pred C
Q 016115 369 P 369 (395)
Q Consensus 369 ~ 369 (395)
.
T Consensus 328 ~ 328 (396)
T 4dc2_A 328 D 328 (396)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=389.88 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=216.8
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
...+|.+.+.||+|+||+||+|++..+|+.||+|++.+. .....+|+.+++.++||||+++++++ .+.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence 456799999999999999999999999999999998542 23456899999999999999999998 556
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+|+||||++| +|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~-~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLD-KSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeEC-CCCCEEEeccce
Confidence 669999999975 66665543 468999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCc--ceeeeecccccCchhhcCCC---CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 227 AKVLVKGEA--NISYICSRYYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 227 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
++....... ....+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+.+.++.......
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-- 292 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-- 292 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc--
Confidence 987654432 23567999999999997543 27789999999999999999999999998888888776531100
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCC--CCCHHHHhcCCCCcCCCCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP 369 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~~~ 369 (395)
.++ ....+++++++||++||..+|.+ |++++|+++||||+.+++.
T Consensus 293 -------------~~p----------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 293 -------------TFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp -------------CCC----------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred -------------cCC----------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 000 01247999999999999999988 9999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=377.56 Aligned_cols=251 Identities=28% Similarity=0.481 Sum_probs=215.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..+|++.+.||+|+||+||+|++..+|+.||+|++.+. .....+|+.+++.++||||+++++++ .+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 45799999999999999999999999999999998643 22345789999999999999999998 5556
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~g~~kL~Dfg~a 153 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLD-KNGHIKITDFGFA 153 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEEC-TTSCEEECCCSSC
T ss_pred EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEc-CCCCEEEeecCcc
Confidence 69999999986 66666654 4678999999999999999999999 6999999999999999 7889999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
+.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+.+..+....
T Consensus 154 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------- 219 (318)
T 1fot_A 154 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----------- 219 (318)
T ss_dssp EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------
T ss_pred eecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 86543 23456799999999999654 58999999999999999999999999988877777766520
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~ 369 (395)
. .++..+++++.+||++||..||.+|+ +++++++||||+.+.+.
T Consensus 220 ------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 220 ------L------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp ------C------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ------C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 0 12345789999999999999999999 99999999999987653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=386.18 Aligned_cols=286 Identities=34% Similarity=0.593 Sum_probs=216.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (395)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... .....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 47999999999999999999999999999999986432 234479999999999999999998854321 22345
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++|+||++++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~-~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVN-EDCELKILDFGLARH 181 (367)
T ss_dssp CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECC------
T ss_pred EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEEC-CCCCEEEeecccccc
Confidence 789999998877666543 579999999999999999999999 6999999999999999 788999999999986
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..|.+....+.....
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 182 TADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred cccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 5432 34567899999999997756789999999999999999999999999999999999999999988776654321
Q ss_pred CCCC-C--CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 310 NYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 310 ~~~~-~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
.... + ..+......+.. ....+++.+.+||.+||.+||.+|||+.|+|+||||+.+..+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~ 324 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHH-HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGC
T ss_pred HHHHHHHhccCCCCCCCHHH-HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCC
Confidence 1000 0 011111112211 224578999999999999999999999999999999998876653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=393.14 Aligned_cols=264 Identities=26% Similarity=0.415 Sum_probs=219.7
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
...+|.+.+.||+|+||+||+|++..+++.||+|++.+. .....+|..+++.++||||+++++++ .+.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDD 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeC
Confidence 346799999999999999999999999999999998642 23356899999999999999999998 555
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+|+||||+.| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~-~~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMD-MNGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEc-CCCCEEEcchhh
Confidence 669999999975 66665543 24679999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCcc--eeeeecccccCchhhc----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 227 AKVLVKGEAN--ISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 227 a~~~~~~~~~--~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
++........ ...+||+.|+|||++. +...++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-- 299 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER-- 299 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc--
Confidence 9766444332 2357999999999986 2345899999999999999999999999999888888777642110
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCC--CCCHHHHhcCCCCcCCCCCCCC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
+.++. ....+++++++||++||+.+|++ |++++|+++||||+.+++...+
T Consensus 300 -------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~ 351 (437)
T 4aw2_A 300 -------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR 351 (437)
T ss_dssp -------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred -------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence 00110 11347999999999999998888 9999999999999999887653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=387.88 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=212.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+.
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~ 87 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDE 87 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 4467999999999999999999999999999999986432 3345799999999999999999998 455
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+|+||||+.| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~-~~g~vkL~DFG~ 161 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLD-EHGHVHITDFNI 161 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEC-CCCCEEEeccce
Confidence 569999999986 55444443 4679999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCcceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTPTR 301 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~~~~~ 301 (395)
++............||+.|+|||++.+ ...++.++|||||||++|+|++|..||..... .+....+...
T Consensus 162 a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------ 235 (384)
T 4fr4_A 162 AAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT------ 235 (384)
T ss_dssp CEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC------
T ss_pred eeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc------
Confidence 988766666677889999999999864 23488999999999999999999999975432 2222222210
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-HHHHhcCCCCcCCCCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDELREP 369 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~ell~hp~~~~~~~~ 369 (395)
...++..++.++.+||.+||+.||.+||+ ++++++||||+.+++.
T Consensus 236 -----------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 236 -----------------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp -----------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred -----------------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 01123457899999999999999999998 8999999999988763
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=389.35 Aligned_cols=280 Identities=31% Similarity=0.557 Sum_probs=226.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHc------CCCceeeeceeeeecCCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM------DHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~~ 146 (395)
..+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.+ +|+||+++++++ ..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~-----~~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF-----TF 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE-----EE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec-----cc
Confidence 347999999999999999999999999999999997553 3345688888877 577999999988 44
Q ss_pred ceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCc--EEEeec
Q 016115 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDF 224 (395)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~--~kl~Df 224 (395)
...+++||||+++++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++. +||+||
T Consensus 171 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~-~~~~~~vkL~DF 246 (429)
T 3kvw_A 171 RNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLK-QQGRSGIKVIDF 246 (429)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEES-STTSCCEEECCC
T ss_pred CCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEc-cCCCcceEEeec
Confidence 45699999999999888887632 2458999999999999999999999 6999999999999999 5655 999999
Q ss_pred ccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 225 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
|+++.... ......||+.|+|||++.+.. ++.++|||||||++|+|+||..||.+.+..+.+..+....+.+....+
T Consensus 247 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 247 GSSCYEHQ--RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp TTCEETTC--CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccceecCC--cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 99976432 334567899999999997654 899999999999999999999999999999999999999998887765
Q ss_pred hhcCC--------CCCCCC----------------------CCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH
Q 016115 305 RCMNP--------NYTDFR----------------------FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354 (395)
Q Consensus 305 ~~~~~--------~~~~~~----------------------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~ 354 (395)
..... .+..+. ........|...+....++.+.+||++||++||.+|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 43211 000000 000112233334445568899999999999999999999
Q ss_pred HHHhcCCCCcCCC
Q 016115 355 LEACAHPFFDELR 367 (395)
Q Consensus 355 ~ell~hp~~~~~~ 367 (395)
+|+|+||||++..
T Consensus 404 ~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 404 GQALRHPWLRRRL 416 (429)
T ss_dssp HHHHTSTTTC---
T ss_pred HHHhCChhhccCC
Confidence 9999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=382.55 Aligned_cols=259 Identities=27% Similarity=0.381 Sum_probs=211.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc---------ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
.+.|++.+.||+|+||+||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++ .+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----SS 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 45799999999999999999999999999999998532 23456899999999999999999998 44
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCcEEEee
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCD 223 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~~kl~D 223 (395)
...+|+||||++| +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.. ...+||+|
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEec
Confidence 5569999999985 6666666554555678999999999999999999999 699999999999999832 23499999
Q ss_pred cccccccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 224 FGSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 224 fg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+. ..+.+..+.........
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~- 253 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNP- 253 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCH-
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCc-
Confidence 999987654433 3356789999999999654 4899999999999999999999999875 33444444432111111
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
.....+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 254 ------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 254 ------------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp ------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred ------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 12245789999999999999999999999999999998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=384.00 Aligned_cols=253 Identities=28% Similarity=0.493 Sum_probs=213.4
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc-CCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (395)
...+|.+.+.||+|+||+||+|+++.+|+.||||++.+.. .....|..+++.+ +||||+++++++ .+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence 3457999999999999999999999999999999986532 2344688888876 899999999998 55
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~g~vkL~DFG 163 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLD-KDGHIKIADFG 163 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEEC-CCCCEEEeECh
Confidence 5569999999975 66666554 3578999999999999999999999 6999999999999999 68899999999
Q ss_pred ccccccc-CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 226 SAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 226 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+... .
T Consensus 164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~------ 234 (345)
T 1xjd_A 164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--N------ 234 (345)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C------
T ss_pred hhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--C------
Confidence 9986433 2334567899999999999764 4899999999999999999999999998887777666541 0
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHH-HHhcCCCCcCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELRE 368 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~-ell~hp~~~~~~~ 368 (395)
..++..+++++.+||.+||..||.+||++. ++++||||+.+++
T Consensus 235 ---------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 235 ---------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred ---------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 012345789999999999999999999998 9999999998864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=387.22 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=209.0
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-------chHHHHHH-HHHcCCCceeeeceeeeecCCCCc
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQL-MRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..+|++.+.||+|+||+||+|+++.+++.||||++.+... ...+|..+ ++.++||||+++++++ .+.
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EeC
Confidence 3479999999999999999999999999999999865432 12234444 4668899999999998 555
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+|+||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~-~~g~ikL~DFG~ 185 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLD-SQGHIVLTDFGL 185 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEECCCCB
T ss_pred CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEC-CCCCEEEeeCcc
Confidence 569999999986 56555544 3578999999999999999999999 6999999999999999 788999999999
Q ss_pred cccccc-CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 227 AKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 227 a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------- 255 (373)
T 2r5t_A 186 CKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--------- 255 (373)
T ss_dssp CGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC---------
T ss_pred ccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---------
Confidence 986433 3344567899999999999764 58999999999999999999999999988887777766520
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH----HHHhcCCCCcCCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 369 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~hp~~~~~~~~ 369 (395)
..++..++.++.+||.+||+.||.+|+++ .++++||||+.+++.
T Consensus 256 --------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 256 --------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp --------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred --------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 01234579999999999999999999997 699999999988754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=385.21 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=214.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 357999999999999999999999999999999986432 3345799999999999999999998 55566
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCcEEEeeccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGS 226 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~ 226 (395)
.|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 8999999986 55555543 4678999999999999999999999 699999999999999832 34699999999
Q ss_pred ccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......+.
T Consensus 178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----- 251 (362)
T 2bdw_A 178 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----- 251 (362)
T ss_dssp CBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----
T ss_pred ceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence 9877665555567899999999999654 5899999999999999999999999988877777666552111110
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.....+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 252 --------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 252 --------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp --------------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred --------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 1124579999999999999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=384.12 Aligned_cols=296 Identities=35% Similarity=0.623 Sum_probs=232.0
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCC-Ccee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~~ 149 (395)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++...... ....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 47999999999999999999999999999999986532 2345799999999999999999998543321 1123
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++||||+.+++.+.+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVN-EDCELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECSTTCC--
T ss_pred EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEEC-CCCCEEEEecCcccc
Confidence 4899999999876654 2458999999999999999999999 6999999999999999 788999999999986
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+.....
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 194 ADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred cccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 5332 33457899999999997756799999999999999999999999999999999999999988887765543321
Q ss_pred CCCCC---CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCCC
Q 016115 310 NYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLF 383 (395)
Q Consensus 310 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~ 383 (395)
..... ..+......+ ......+++.+.+||.+||+.||.+|||+.|+|+||||+.+..+.........+...+
T Consensus 272 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 347 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSL 347 (371)
T ss_dssp HHHHHHHHHSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTT
T ss_pred hhhhhhhhccCCCcchhH-HHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCcch
Confidence 10000 0000001111 1223467999999999999999999999999999999999887766555554444433
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=378.20 Aligned_cols=303 Identities=30% Similarity=0.596 Sum_probs=235.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++...........
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 457999999999999999999999999999999986332 233479999999999999999998755443445678
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||++|++.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 90 ~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLIN-SNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEc-CCCcEEEEeccccccc
Confidence 99999999988877764 568999999999999999999999 6999999999999999 6889999999999866
Q ss_pred ccCCc-----------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016115 231 VKGEA-----------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 231 ~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
..... .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 43221 1234689999999998765678999999999999999999999999999988888888877766
Q ss_pred ChhhhhhcCCCC--CCC--CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCC
Q 016115 300 TREEIRCMNPNY--TDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 375 (395)
Q Consensus 300 ~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~ 375 (395)
............ .++ ..+......+ ......+++++.+||.+||+.||.+|||+.|+++||||+....+......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~ 321 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEG 321 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCC
T ss_pred chhccccccccchhhHHhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccccc
Confidence 532111000000 000 0000000111 12234679999999999999999999999999999999999887765544
Q ss_pred CCCCCCCCCch
Q 016115 376 GRPFPPLFNFK 386 (395)
Q Consensus 376 ~~~~~~~~~~~ 386 (395)
....+..+.|+
T Consensus 322 ~~~~~~~~~~~ 332 (353)
T 2b9h_A 322 EPIPPSFFEFD 332 (353)
T ss_dssp CCCCGGGGGGG
T ss_pred CCCCcceeeec
Confidence 44444444443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=378.77 Aligned_cols=290 Identities=29% Similarity=0.484 Sum_probs=226.7
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC---C
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---K 145 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~ 145 (395)
...+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++..... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 3457999999999999999999999999999999885432 234579999999999999999998855321 1
Q ss_pred CceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
....+++||||++|++...+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg 169 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLIT-RDGVLKLADFG 169 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCT
T ss_pred CCceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEc-CCCCEEEccch
Confidence 24568999999999887777543 3569999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccC-----CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 226 SAKVLVKG-----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 226 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99865422 2223456899999999997766689999999999999999999999999999999999998888776
Q ss_pred hhhhhhcCCC--CCCCCCCCccCCCccccc-cccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 301 REEIRCMNPN--YTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 301 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
...+...... +................+ ....++.+.+||.+||+.||.+|||++|+|+||||+....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 5544322110 000000000000000000 11247889999999999999999999999999999875443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=387.11 Aligned_cols=285 Identities=32% Similarity=0.566 Sum_probs=216.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (395)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... .+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357999999999999999999999999999999986432 234579999999999999999998854321 2234
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+++||||++|++.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECCCCC--
T ss_pred ceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEc-CCCCEEEEEeeccc
Confidence 689999999998877764 358899999999999999999999 6999999999999999 78899999999998
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+....
T Consensus 176 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 176 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 76555455567899999999999764 58999999999999999999999999999999999999888887766554332
Q ss_pred C----------CCCCCCCCCcc---CCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 309 P----------NYTDFRFPQIK---AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 309 ~----------~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
+ .+....+.... ..+.........+.++.+||++||..||.+|||++|+|+||||+...++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 328 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 328 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCc
Confidence 1 11111100000 0000000111236789999999999999999999999999999876553
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=390.56 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=213.0
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence 457999999999999999999999999999999986432 3346899999999999999999998 55666
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC--CCCcEEEeeccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGS 226 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~--~~~~~kl~Dfg~ 226 (395)
.|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 9999999986 66666554 4679999999999999999999999 69999999999999984 357899999999
Q ss_pred ccccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 227 AKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 227 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......+.
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---- 234 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS---- 234 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----
T ss_pred eEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc----
Confidence 987654433 3456799999999999654 5899999999999999999999999998888877777653211111
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.....+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 235 ---------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 235 ---------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp ---------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ---------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 0123579999999999999999999999999999999754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=379.15 Aligned_cols=253 Identities=25% Similarity=0.448 Sum_probs=207.7
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc-CCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (395)
...+|.+.+.||+|+||.||+|++..+|+.||||++.+.. ....+|..+++.+ +||||+++++++ .+
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 81 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT 81 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----Ee
Confidence 4557999999999999999999999999999999996542 2244688888887 899999999998 55
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+|+||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~g~~kL~DFG 155 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLD-SEGHIKLTDYG 155 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCGG
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEC-CCCCEEEEecc
Confidence 5669999999985 66555544 3579999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccc-cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHH
Q 016115 226 SAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AVDQLVEIIKV 295 (395)
Q Consensus 226 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---------~~~~~~~~~~~ 295 (395)
+++... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .......+...
T Consensus 156 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~ 234 (345)
T 3a8x_A 156 MCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234 (345)
T ss_dssp GCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred ccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence 998643 23344566899999999999764 58999999999999999999999997531 11122222220
Q ss_pred hCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH------HHHhcCCCCcCCCC
Q 016115 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELRE 368 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~ell~hp~~~~~~~ 368 (395)
...++..++.++.+||++||++||.+||++ +|+++||||+.+++
T Consensus 235 -----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 235 -----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp -----------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred -----------------------------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 001334579999999999999999999995 89999999998875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=380.64 Aligned_cols=289 Identities=30% Similarity=0.585 Sum_probs=226.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---------------cchHHHHHHHHHcCCCceeeeceeee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRLMDHPNVISLKHCFF 140 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------------~~~~~e~~~l~~l~h~niv~~~~~~~ 140 (395)
..+|.+.+.||+|+||.||+|.+. +|..||||++.... ....+|+.+++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 347999999999999999999975 49999999885321 33457999999999999999999987
Q ss_pred ecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEE
Q 016115 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (395)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~k 220 (395)
.........+++||||++|++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~-~~~~~k 174 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLA-DNNDIT 174 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEE
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEc-CCCCEE
Confidence 766666677999999999988877763 34578999999999999999999999 6999999999999999 788999
Q ss_pred EeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
|+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999998766555556678899999999997756689999999999999999999999999999999999999888887
Q ss_pred hhhhhhcCCC----CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 301 REEIRCMNPN----YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 301 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
...+...... +............+ ......+++.+.+||.+||+.||.+|||+.|+++||||+.+..+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 328 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD 328 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence 6654321100 00000111111111 1233567899999999999999999999999999999999876544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=378.54 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=215.8
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
...++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence 34568999999999999999999999999999999985432 2345799999999999999999998 55
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~g~~kL~DFg 186 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLID-QQGYIQVTDFG 186 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEEC-CCCCEEEcccc
Confidence 5669999999974 66666654 2568999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 226 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+.+..+... .
T Consensus 187 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~------- 254 (350)
T 1rdq_E 187 FAKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--K------- 254 (350)
T ss_dssp TCEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C-------
T ss_pred cceeccCC--cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--C-------
Confidence 99876433 3456899999999999764 4899999999999999999999999998887777776652 0
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 368 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 368 (395)
..++..++.++.+||.+||+.||.+||+ ++++++||||+.+++
T Consensus 255 --------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 255 --------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 0123457999999999999999999998 999999999998765
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=375.36 Aligned_cols=256 Identities=25% Similarity=0.330 Sum_probs=207.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+|+.+++.++||||+++++++ .+....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence 35799999999999999999999999999999998533 24456899999999999999999988 555668
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++||||++|+ .+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~---~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 81 YLFLEYCSGG---ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVF 155 (323)
T ss_dssp EEEEECCTTE---EGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEEcCCCC---cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEe-CCCCEEEEEeecccee
Confidence 9999999864 223333445679999999999999999999999 6999999999999999 7889999999999765
Q ss_pred ccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 231 VKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 231 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
..... .....||+.|+|||++.+...++.++|||||||++|+|++|..||...................
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------- 227 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------- 227 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------
Confidence 43322 2346789999999999876655889999999999999999999998765432222221110000
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
......++..+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 228 ------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp ------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ------------------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 001245789999999999999999999999999999998643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=385.50 Aligned_cols=263 Identities=28% Similarity=0.447 Sum_probs=218.0
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
...+|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+|..++..++|+||+++++++ .+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence 456899999999999999999999999999999998642 23456799999999999999999998 556
Q ss_pred eeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+|+||||++ |+|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld-~~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLD-RCGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeec-CCCCEEEeechh
Confidence 67999999997 5666666542 3479999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCc--ceeeeecccccCchhhcC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016115 227 AKVLVKGEA--NISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (395)
Q Consensus 227 a~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~ 298 (395)
++....... ....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+.+.++......
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 987654433 224579999999999962 245899999999999999999999999998888877777642100
Q ss_pred CChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCC---CCHHHHhcCCCCcCCCCCCCC
Q 016115 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---pt~~ell~hp~~~~~~~~~~~ 372 (395)
. .++ .+...+|+++++||++||+ +|.+| ++++|+++||||+.+++...+
T Consensus 289 ~---------------~~p---------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 289 L---------------SLP---------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp C---------------CCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred c---------------CCC---------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 0 000 0124579999999999999 99998 599999999999999887664
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=367.30 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=207.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
++|.+.+.||+|+||.||+|.+..+|..||+|++.... ....+|+++++.++||||+++++++ .+....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCeEE
Confidence 46999999999999999999999999999999986543 3456899999999999999999998 4555689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC--CCCcEEEeeccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAK 228 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~--~~~~~kl~Dfg~a~ 228 (395)
+||||++| +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+||+++. .++.+||+|||++.
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999985 7777776655556789999999999999999999999 69999999999999952 35789999999998
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.......
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------- 244 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY--------- 244 (285)
T ss_dssp C----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred ecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc---------
Confidence 7766555566778999999999843 58999999999999999999999999887666554443310000
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
......+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 245 -----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 245 -----------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -----------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -----------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 0011236899999999999999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=382.38 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=215.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.+.|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++ .+...++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 35799999999999999999999999999999998643 23456799999999999999999998 4555699
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC-CCCcEEEeecccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKV 229 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~-~~~~~kl~Dfg~a~~ 229 (395)
+||||+.| +|.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||+++.
T Consensus 125 lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 125 LILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999986 5544433 223579999999999999999999999 69999999999999973 346799999999988
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~----------- 268 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE----------- 268 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred cCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 7666555667899999999999654 5899999999999999999999999998887777666542110
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
+ .......+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 269 ------~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 269 ------F--------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp ------C--------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred ------C--------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 0 01122457999999999999999999999999999999986543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=368.01 Aligned_cols=291 Identities=33% Similarity=0.550 Sum_probs=234.1
Q ss_pred ccccCceeeeeeecCCceEEEEEEEC-CCCcEEEEEEecccc------cchHHHHHHHHHc---CCCceeeeceeeeecC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFFSTT 143 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~ 143 (395)
....+|++.+.||+|+||.||+|++. .+|+.||+|++.... ....+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 44568999999999999999999985 678999999885332 2345788877766 8999999999986444
Q ss_pred CCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEee
Q 016115 144 SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~D 223 (395)
......+++||||++|++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~-~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVT-SSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECS
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEc-CCCCEEEec
Confidence 44667799999999999888876532 3458999999999999999999999 6999999999999999 688999999
Q ss_pred cccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 224 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
||+++............||..|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.+..+....+.+....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred CcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 9999876555555567789999999999764 489999999999999999999999999999999999998888776655
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
+...... ....+..... .....+...++..+.+||.+||..||.+|||+.|+++||||+.++....
T Consensus 243 ~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 308 (326)
T 1blx_A 243 WPRDVAL-PRQAFHSKSA-QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308 (326)
T ss_dssp SCTTCSS-CGGGSCCCCC-CCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred Ccccccc-chhhhcccCc-chhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence 4321110 0000100001 1112344568999999999999999999999999999999998876543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=381.60 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=213.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc-CCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (395)
...+|.+.+.||+|+||+||+|++..+|+.||||++.+.. .....|..+++.+ +||||+++++++ .+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 3457999999999999999999999999999999986432 2344688888877 799999999998 55
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~-~~g~vkL~DFG 166 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLD-SEGHIKIADFG 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEc-CCCcEEEEeCC
Confidence 5669999999986 66666554 3569999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccc-cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 226 SAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 226 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
+++... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------- 237 (353)
T 2i0e_A 167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-------- 237 (353)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred cccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------
Confidence 998643 23334567899999999999654 48999999999999999999999999988887777766510
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~~ 369 (395)
..++..+++++.+||++||..||.+||+ +.++++||||+.+++.
T Consensus 238 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 238 ---------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 0123457999999999999999999994 6999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=373.81 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=205.3
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------------------------------cchHHHHHHH
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------------------RYKNRELQLM 124 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~e~~~l 124 (395)
..++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4457999999999999999999999999999999985432 2345799999
Q ss_pred HHcCCCceeeeceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceecc
Q 016115 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRD 204 (395)
Q Consensus 125 ~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~D 204 (395)
+.++||||+++++++.. .....+++||||++++.+.. . .....+++..++.++.||+.||.|||+ +||+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~---~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~D 162 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVME---V-PTLKPLSEDQARFYFQDLIKGIEYLHY-QKIIHRD 162 (298)
T ss_dssp HTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCC---S-SCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred HhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHH---H-hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccC
Confidence 99999999999998843 22456899999998653222 1 224679999999999999999999999 6999999
Q ss_pred CCCCceeecCCCCcEEEeecccccccccCCc-ceeeeecccccCchhhcCCCC--CCcccchHhHHHHHHHHHhCCCCCC
Q 016115 205 VKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA-NISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFP 281 (395)
Q Consensus 205 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~ 281 (395)
|||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+... ++.++|||||||++|+|++|..||.
T Consensus 163 lkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEEC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEEC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999 688999999999987654432 334578999999999865432 4778999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCC
Q 016115 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (395)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp 361 (395)
..+.......+.... ..++ ....+++++.+||.+||+.||.+|||+.|+++||
T Consensus 242 ~~~~~~~~~~~~~~~-----------------~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 242 DERIMCLHSKIKSQA-----------------LEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp CSSHHHHHHHHHHCC-----------------CCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred CccHHHHHHHHhccc-----------------CCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 877665554443310 0000 1135789999999999999999999999999999
Q ss_pred CCcC
Q 016115 362 FFDE 365 (395)
Q Consensus 362 ~~~~ 365 (395)
||++
T Consensus 295 ~~~~ 298 (298)
T 2zv2_A 295 WVTR 298 (298)
T ss_dssp HHHC
T ss_pred cccC
Confidence 9963
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=387.98 Aligned_cols=290 Identities=31% Similarity=0.525 Sum_probs=211.2
Q ss_pred Ccee-eeeeecCCceEEEEEEEC--CCCcEEEEEEecccc--cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMA-ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.|.+ +++||+|+||+||+|++. .+++.||||++.... ....+|+.+++.++||||+++++++.. .....+++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeEEE
Confidence 4666 457999999999999965 578999999986542 345689999999999999999999854 23446899
Q ss_pred EEecccchHHHHHHhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec---CCCCcEEEeec
Q 016115 153 VMEYVPETMYRVLKHYSS-----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDF 224 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~---~~~~~~kl~Df 224 (395)
||||++|++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||+. ..++.+||+||
T Consensus 98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 999999998888764332 12358999999999999999999999 6999999999999993 25789999999
Q ss_pred ccccccccC----CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh---------HHHHHH
Q 016115 225 GSAKVLVKG----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVE 291 (395)
Q Consensus 225 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~ 291 (395)
|+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+... .+.+..
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 999876433 2233467899999999997766689999999999999999999999976654 478888
Q ss_pred HHHHhCCCChhhhhhcCCCCC---------CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 016115 292 IIKVLGTPTREEIRCMNPNYT---------DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (395)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 362 (395)
+...++.+....|........ ...+.......+........++.+.+||.+||++||.+|||++|+|+|||
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 888888877655543211000 00000000000001111234788999999999999999999999999999
Q ss_pred CcCCCCCCC
Q 016115 363 FDELREPNA 371 (395)
Q Consensus 363 ~~~~~~~~~ 371 (395)
|++...+..
T Consensus 337 f~~~~~~~~ 345 (405)
T 3rgf_A 337 FLEDPLPTS 345 (405)
T ss_dssp GTSSSCCCS
T ss_pred hccCCCCcc
Confidence 988665443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=376.98 Aligned_cols=282 Identities=33% Similarity=0.610 Sum_probs=226.0
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 97 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KKKK 97 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ecCC
Confidence 4557999999999999999999999999999999885432 2234799999999999999999998 4455
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
..++||||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 98 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVS-QSGVVKLCDFGFAR 172 (331)
T ss_dssp EEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEECCCTTC-
T ss_pred EEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEc-CCCcEEEEeCCCce
Confidence 6899999999987666543 24579999999999999999999999 6999999999999999 68899999999997
Q ss_pred ccccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh-
Q 016115 229 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC- 306 (395)
Q Consensus 229 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 306 (395)
...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...+..+.+..+....+.........
T Consensus 173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 654432 234457899999999997765689999999999999999999999999999999998888887766554332
Q ss_pred -cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 307 -MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 307 -~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
..+.+.....+..............+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 122223333333333333333445689999999999999999999999999999999763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=379.88 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=209.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
.++|.+.+.||+|+||+||+|.+..+|+.||||++........+|++++..+ +||||+++++++ .+...+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEEE
Confidence 4569999999999999999999999999999999988777778899998887 799999999998 5566799999
Q ss_pred ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC---cEEEeeccccccc
Q 016115 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QVKLCDFGSAKVL 230 (395)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~---~~kl~Dfg~a~~~ 230 (395)
||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+...++ .+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99985 66665543 4679999999999999999999999 69999999999999853333 5999999999876
Q ss_pred ccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCChhhhhh
Q 016115 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 231 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||... +..+.+..+... .
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--~-------- 239 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--K-------- 239 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC--C--------
T ss_pred cCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC--C--------
Confidence 5433 33456789999999999654 3889999999999999999999999863 333344443331 0
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
+. .....+..+++++.+||++||..||.+|||+.++++||||...
T Consensus 240 -------~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 240 -------FS--------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp -------CC--------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred -------cc--------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 00 0111234579999999999999999999999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=377.41 Aligned_cols=279 Identities=25% Similarity=0.437 Sum_probs=222.4
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcC-----CCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-----HPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~ 146 (395)
..++|.+.+.||+|+||+||+|++..+|+.||||++.... .....|+.+++.+. |+||+++++++. .
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~-----~ 107 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM-----Y 107 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE-----E
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceee-----E
Confidence 3457999999999999999999999999999999986432 33456899999986 999999999984 4
Q ss_pred ceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC------------
Q 016115 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------------ 214 (395)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~------------ 214 (395)
...+++||||++++|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 108 YDHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred CCeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhc
Confidence 44589999999888888876532 2458999999999999999999999 69999999999999972
Q ss_pred ------------CCCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 016115 215 ------------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (395)
Q Consensus 215 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 282 (395)
.++.+||+|||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 277899999999986433 23456789999999999765 489999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCChhhhhhcCCCCCC---------CCCCCccCC--------CccccccccCChhHHHHHHHhhc
Q 016115 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTD---------FRFPQIKAH--------PWHKVFHKRMPPEAIDLASRLLQ 345 (395)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~--------~~~~~~~~~~s~~~~~li~~~L~ 345 (395)
.+..+.+..+....+..+............. ..++..... .....+....++.+.+||++||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 9999999998888887776654432211100 001100000 00011122345788999999999
Q ss_pred cCCCCCCCHHHHhcCCCCc
Q 016115 346 YSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 346 ~dp~~Rpt~~ell~hp~~~ 364 (395)
.||.+|||+.|+|+||||+
T Consensus 342 ~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 342 IDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGC
T ss_pred CChhhCCCHHHHhcCcccC
Confidence 9999999999999999996
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=375.69 Aligned_cols=284 Identities=31% Similarity=0.520 Sum_probs=218.0
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.++|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++ |+||+++++++.. ......++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceEEE
Confidence 45799999999999999999999999999999998643 345678999999997 9999999998843 224558899
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
|||+.++.+..+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++..+||+|||+++.....
T Consensus 112 ~e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 112 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCCCCHHHHG------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeccCchhHHHHH------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999975433332 248899999999999999999999 699999999999999954558999999999877666
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChhhhh-hcCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKVLGTPTREEIR-CMNPNY 311 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 311 (395)
.......||..|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+....+........ ......
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 666667889999999999775678999999999999999999999985 455666666666655543221111 000000
Q ss_pred CCC---CCCCccCCCcc----ccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 312 TDF---RFPQIKAHPWH----KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 312 ~~~---~~~~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
... .........|. ......+++++.+||++||++||.+|||++|+|+||||+.+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence 000 00000000111 11223479999999999999999999999999999999987653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=392.16 Aligned_cols=252 Identities=30% Similarity=0.446 Sum_probs=214.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+.
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~ 88 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STP 88 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EEC
Confidence 4457999999999999999999999999999999986432 2356899999999999999999998 444
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+++||||++| +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~-~~~~vkL~DFG~ 162 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLD-AHMNAKIADFGL 162 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEC-TTCCEEECCCSS
T ss_pred CEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEe-cCCCeEEEeccc
Confidence 568999999975 5554443 35679999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
++...........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------- 233 (476)
T 2y94_A 163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--------- 233 (476)
T ss_dssp CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC---------
T ss_pred hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc---------
Confidence 98876666566778999999999997765557899999999999999999999998877766665544110
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
..+..+++++.+||++||..||.+|||+.|+++||||+..
T Consensus 234 --------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 --------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0223468999999999999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=382.13 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=195.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.++|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+...+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI-----LTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEE-----eeCCEEEE
Confidence 347999999999999999999999999999999986543 3455899999999999999999998 44556899
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC--cEEEeecccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKV 229 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~--~~kl~Dfg~a~~ 229 (395)
||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++ .+||+|||+++.
T Consensus 94 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~-~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 94 IMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLD-GSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEEC-SSSSCCEEECCCCCC--
T ss_pred EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEc-CCCCceEEEeecCcccc
Confidence 9999975 66666544 3579999999999999999999999 6999999999999998 444 499999999986
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
...........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.......
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~---------- 237 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV---------- 237 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT----------
T ss_pred ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC----------
Confidence 5555555567899999999999876644555999999999999999999998754433333222211100
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.+.++ ....+++++.+||++||++||.+|||+.|+++||||++.
T Consensus 238 ---~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 238 ---KYSIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ---CCCCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ---CCCCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 00011 112468999999999999999999999999999999654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=364.53 Aligned_cols=266 Identities=26% Similarity=0.397 Sum_probs=220.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence 457999999999999999999999999999999986432 3345799999999999999999998 45556
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCcEEEeeccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGS 226 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~ 226 (395)
.++||||+.| ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++.+ ++.+||+|||+
T Consensus 80 ~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 8999999986 55555544 3568999999999999999999999 699999999999999732 23499999999
Q ss_pred ccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+.............||+.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+.......+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 228 (284)
T 3kk8_A 155 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----- 228 (284)
T ss_dssp CEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----
T ss_pred eEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc-----
Confidence 9877666555667899999999999664 4899999999999999999999999988887777666552111110
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 377 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~ 377 (395)
.....+++++.+||.+||+.||.+|||+.|+++||||+..+..........
T Consensus 229 --------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~ 279 (284)
T 3kk8_A 229 --------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQD 279 (284)
T ss_dssp --------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSCCCCC
T ss_pred --------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHhhcCC
Confidence 011356899999999999999999999999999999998777666554443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=370.50 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=215.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
.++|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----E 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence 346999999999999999999999999999999986432 2356899999999999999999998 4
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC----cEE
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QVK 220 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~----~~k 220 (395)
+...+++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++ .+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~-~~~~~~~~~k 159 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLL-DKNIPIPHIK 159 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEES-CTTSSSCCEE
T ss_pred cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEe-cCCCCcCCEE
Confidence 55569999999975 66665543 4678999999999999999999999 6999999999999998 455 799
Q ss_pred EeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
|+|||++.............||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.+..+.......
T Consensus 160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~- 237 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF- 237 (321)
T ss_dssp ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC-
T ss_pred EccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc-
Confidence 9999999877665555567789999999999654 58999999999999999999999999888777766655421111
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
...+...++..+.+||.+||..||.+|||+.|+++||||+....
T Consensus 238 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~ 281 (321)
T 2a2a_A 238 ------------------------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281 (321)
T ss_dssp ------------------------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred ------------------------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence 11233467899999999999999999999999999999987653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=373.23 Aligned_cols=254 Identities=28% Similarity=0.454 Sum_probs=206.7
Q ss_pred cccCceeeeeeecCCceEEEEEEEC---CCCcEEEEEEecccc--------cchHHHHHHHHHcCCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (395)
...+|.+.+.||+|+||.||+|++. .+|+.||+|++.+.. ....+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 90 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF---- 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE----
Confidence 3457999999999999999999985 689999999986431 2345799999999999999999998
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEe
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~ 222 (395)
.....+|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+
T Consensus 91 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~-~~~~~kl~ 163 (327)
T 3a62_A 91 -QTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLN-HQGHVKLT 163 (327)
T ss_dssp -ECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEEC-TTSCEEEC
T ss_pred -EcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEEC-CCCcEEEE
Confidence 444558999999985 66666554 3568999999999999999999999 6999999999999999 68899999
Q ss_pred ecccccccccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 223 DFGSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 223 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
|||+++..... .......||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.+..+.+...
T Consensus 164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---- 238 (327)
T 3a62_A 164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL---- 238 (327)
T ss_dssp CCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----
T ss_pred eCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC----
Confidence 99999764332 223345789999999999664 489999999999999999999999999888777776665210
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~ 369 (395)
.++..++.++.+||.+||..||.+|| ++.|+++||||+.+.+.
T Consensus 239 -------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 239 -------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp -------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred -------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 12345789999999999999999999 89999999999987653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=374.22 Aligned_cols=259 Identities=26% Similarity=0.403 Sum_probs=197.5
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
...+.|.+.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.++||||+++++++ .+...++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeEE
Confidence 3456799999999999999999999999999999998654 33456799999999999999999998 4455689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC--CCCcEEEeeccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAK 228 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~--~~~~~kl~Dfg~a~ 228 (395)
+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||+++
T Consensus 125 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 99999985 65555543 4668999999999999999999999 69999999999999972 37889999999998
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhhhhhc
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 307 (395)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||......+. +..+......
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~--------- 269 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY--------- 269 (349)
T ss_dssp -------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC---------
T ss_pred ccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc---------
Confidence 76655555567789999999999764 489999999999999999999999987665543 3333221000
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
+ .......++.++.+||++||+.||++|||+.|+|+||||+....
T Consensus 270 --------~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 270 --------F--------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp --------C--------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred --------c--------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 0 01122457899999999999999999999999999999987544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=370.45 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=198.5
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccc------hHHHHHHH-HHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLM-RLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
++|++.+.||+|+||+||+|++..+|+.||||++...... ...|+..+ +..+|+||+++++++ .+...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCCE
Confidence 5799999999999999999999999999999988543221 12333333 344899999999998 45556
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++||||+++++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~-~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLG-PRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-GGGCEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEC-CCCCEEEccceeeee
Confidence 9999999999888877653 4579999999999999999999999 6999999999999999 788999999999987
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
...........||+.|+|||++.+ .++.++|||||||++|+|++|..+|....... .+.. +.
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~~----------- 268 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--GY----------- 268 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TC-----------
T ss_pred cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--cC-----------
Confidence 765555556678999999999865 58999999999999999999977765432221 1111 00
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
....+...+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 269 --------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 269 --------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 011234567999999999999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=366.50 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=199.4
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..++|++.+.||+|+||.||+|++..+|+.||||++..... ...++...++.++||||+++++++. +..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence 34579999999999999999999999999999999864321 1223444577789999999999984 444
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC-CceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..++||||++|++.+.+.........+++..++.++.||+.||.|||+ + ||+||||||+||+++ .++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLIN-ALGQVKMCDFGIS 157 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEEC-TTCCEEBCCC---
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEEC-CCCCEEEeecCCc
Confidence 589999999999888887766667889999999999999999999999 7 999999999999999 6889999999999
Q ss_pred cccccCCcceeeeecccccCchhh---cCCCCCCcccchHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCChhh
Q 016115 228 KVLVKGEANISYICSRYYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~ 303 (395)
.............||+.|+|||++ .....++.++||||||+++|+|++|..||... .....+...... ..+
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~---- 232 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSP---- 232 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-CCC----
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-CCC----
Confidence 877666555556789999999997 23455899999999999999999999999863 333444433331 000
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
......+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 233 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 233 ----------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ----------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ----------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 00123568999999999999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=370.91 Aligned_cols=289 Identities=35% Similarity=0.623 Sum_probs=226.0
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCC-Ccee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~~ 149 (395)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++...... ....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 47999999999999999999999999999999986432 2345799999999999999999988543221 1123
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++||||+.+++.+.+ ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVN-EDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEEC-TTCCEEECSTTCTTC
T ss_pred EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeEC-CCCcEEEeecccccC
Confidence 5899999998755433 2458999999999999999999999 6999999999999999 788999999999976
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+.....
T Consensus 176 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 176 ADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 5332 33457899999999997756689999999999999999999999999999999999999888887665543321
Q ss_pred CCCCC---CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCC
Q 016115 310 NYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 376 (395)
Q Consensus 310 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~ 376 (395)
..... ..+......+ ......+++++.+||.+||+.||.+|||+.++++||||+.+..+.......
T Consensus 254 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~ 322 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQ 322 (353)
T ss_dssp HHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCS
T ss_pred HHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCC
Confidence 10000 0000000111 112346799999999999999999999999999999999988765543333
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=379.06 Aligned_cols=287 Identities=21% Similarity=0.323 Sum_probs=208.1
Q ss_pred cccCceeeeeeecC--CceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
..++|++.+.||+| +||+||+|++..+|+.||||++.... ....+|+.+++.++|||||++++++. +
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~ 97 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----A 97 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----E
Confidence 45579999999999 99999999999999999999986442 33456999999999999999999984 4
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+++||||+.| ++.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~-~~~~~kl~dfg 173 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILIS-VDGKVYLSGLR 173 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCGG
T ss_pred CCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEcccc
Confidence 4569999999985 666655542 23568999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCc--------ceeeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016115 226 SAKVLVKGEA--------NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296 (395)
Q Consensus 226 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~ 296 (395)
.+........ .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 9865432211 1124678899999999763 458999999999999999999999998876655554433211
Q ss_pred CCCChhhhh----hc---------CCCCCCCCC---CC-ccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 297 GTPTREEIR----CM---------NPNYTDFRF---PQ-IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 297 ~~~~~~~~~----~~---------~~~~~~~~~---~~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
......... .. .....+... .. .........+...+++++.+||++||+.||.+|||+.|+|+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 100000000 00 000000000 00 00000111234568999999999999999999999999999
Q ss_pred CCCCcCCCCCC
Q 016115 360 HPFFDELREPN 370 (395)
Q Consensus 360 hp~~~~~~~~~ 370 (395)
||||+.+....
T Consensus 334 hp~f~~~~~~~ 344 (389)
T 3gni_B 334 HSFFKQIKRRA 344 (389)
T ss_dssp SGGGGGC---C
T ss_pred CHHHHHHhhcc
Confidence 99999887643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=390.52 Aligned_cols=256 Identities=29% Similarity=0.480 Sum_probs=214.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.+|.+.+.||+|+||+||+|++..+|+.||||++... .....+|+.+++.++||||+++++++ .+...+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~ 96 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSF 96 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCCEE
Confidence 4699999999999999999999999999999998532 23456899999999999999999998 555669
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC--CCCcEEEeecccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSA 227 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~--~~~~~kl~Dfg~a 227 (395)
++||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 999999985 66666554 3579999999999999999999999 69999999999999962 3557999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
+............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 172 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 243 (486)
T 3mwu_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL------ 243 (486)
T ss_dssp TTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS------
T ss_pred eECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC------
Confidence 87766655566789999999999965 4899999999999999999999999998888877776653111110
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
.....+|+++++||++||++||.+|||+.++|+||||+.....
T Consensus 244 -------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 244 -------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286 (486)
T ss_dssp -------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred -------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence 1124579999999999999999999999999999999986553
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=395.56 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=213.0
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
....+|.+.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++||||+++++++ .+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence 4556799999999999999999999999999999998543 12345799999999999999999998 45
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+|+||||++| +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld-~~g~vKL~DFG 331 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLD-DHGHIRISDLG 331 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTSCEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEe-CCCCeEEEecc
Confidence 5569999999975 555555432 23459999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChh
Q 016115 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 226 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~~~~~~ 302 (395)
+++...........+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+. ...+.......
T Consensus 332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------ 404 (576)
T 2acx_A 332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------ 404 (576)
T ss_dssp TCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------
T ss_pred cceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------
Confidence 99887666555667899999999999764 489999999999999999999999987542 22222222110
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
...++..+++++.+||++||+.||.+|| +++|+++||||+.+++
T Consensus 405 ----------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 405 ----------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp ----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred ----------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 0113346799999999999999999999 8999999999998765
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=361.94 Aligned_cols=255 Identities=30% Similarity=0.433 Sum_probs=216.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.++|.+.+.||+|+||.||+|.+..++..||+|++... .....+|+++++.++||||+++++++ .+....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeEE
Confidence 34699999999999999999999999999999998643 23456799999999999999999998 4555689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceee---cCCCCcEEEeecccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSA 227 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill---~~~~~~~kl~Dfg~a 227 (395)
+||||++| ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||++ + .++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDS-PDSPLKLIDFGLA 156 (277)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSS-TTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCC-CCCcEEEEecccc
Confidence 99999986 66565544 3568999999999999999999999 699999999999999 5 6788999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.............||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+.......+..
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 229 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK----- 229 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-----
T ss_pred eeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch-----
Confidence 87766666666789999999999854 38999999999999999999999999988877777766532222211
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
....+++.+.+||.+||+.||.+|||+.++|+||||++...
T Consensus 230 --------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 230 --------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp --------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred --------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 11356899999999999999999999999999999986443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=388.43 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=208.0
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
...+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+.
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-----~~~ 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTH 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-----EET
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-----eeC
Confidence 4467999999999999999999999999999999986431 2334688888999999999999998 444
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+++||||++| +|...+.. ...+++..++.++.||+.||.|||+.+||+||||||+|||++ .++.+||+|||+
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~-~~~~~kl~DFG~ 295 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGL 295 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC-SSSCEEECCCCC
T ss_pred CEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC-CCCCEEEccCCC
Confidence 558999999986 55555543 357899999999999999999999623999999999999999 688999999999
Q ss_pred cccccc-CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 227 AKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 227 a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 296 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 365 (446)
T 4ejn_A 296 CKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------- 365 (446)
T ss_dssp CCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred ceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC---------
Confidence 976433 2334456799999999999765 58999999999999999999999999888877776665410
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~ 369 (395)
..++..+++++.+||.+||++||.+|| +++|+++||||+.+...
T Consensus 366 --------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 366 --------------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred --------------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 012345789999999999999999999 99999999999988653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=388.71 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=215.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----------------cchHHHHHHHHHcCCCceeeecee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------------RYKNRELQLMRLMDHPNVISLKHC 138 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------------~~~~~e~~~l~~l~h~niv~~~~~ 138 (395)
..+|.+.+.||+|+||+||+|++..++..||||++.... ....+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 457999999999999999999999999999999986432 234579999999999999999999
Q ss_pred eeecCCCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCC-
Q 016115 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT- 216 (395)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~- 216 (395)
+ .+...+++|||||+| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+
T Consensus 115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 115 F-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp E-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTTC
T ss_pred E-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCCC
Confidence 8 556669999999986 66666654 3569999999999999999999999 6999999999999998433
Q ss_pred -CcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016115 217 -HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295 (395)
Q Consensus 217 -~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~ 295 (395)
..+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 2699999999988766666667789999999999853 5899999999999999999999999999888877777663
Q ss_pred hCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
....... ....+++++.+||++||.+||.+|||+.|+|+||||++....
T Consensus 263 ~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 263 KYYFDFN-------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp CCCCCHH-------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred CCCCCcc-------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence 2111111 124579999999999999999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=371.71 Aligned_cols=263 Identities=30% Similarity=0.477 Sum_probs=211.0
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc---------ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
..+|++.+.||+|+||.||+|.+..++..||+|++... .....+|+.+++.++||||+++++++ .+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence 34699999999999999999999999999999998543 13455799999999999999999998 55
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcc------------------------------------cCCCCCHHHHHHHHHHHHH
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSS------------------------------------MNQRMPLIYVKLYTYQIFR 189 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~------------------------------------~~~~~~~~~~~~i~~~i~~ 189 (395)
....++||||++| +|.+.+..+.. ....+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 5669999999975 55555432111 1223467889999999999
Q ss_pred HHHHHhcCCCceeccCCCCceeecCCCC--cEEEeecccccccccCCc-----ceeeeecccccCchhhcCC-CCCCccc
Q 016115 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEA-----NISYICSRYYRAPELIFGA-TEYTTSI 261 (395)
Q Consensus 190 al~~LH~~~~ivH~Dlkp~Nill~~~~~--~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~ 261 (395)
||.|||+ +||+||||||+|||++ .++ .+||+|||++........ .....||+.|+|||++.+. ..++.++
T Consensus 180 ~l~~LH~-~~ivH~Dlkp~NIll~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 180 ALHYLHN-QGICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHH-TTEECCCCCGGGEEES-CSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHH-CCccccCCChhhEEEe-cCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 6999999999999998 444 899999999986543221 2356789999999999642 4589999
Q ss_pred chHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHH
Q 016115 262 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341 (395)
Q Consensus 262 DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 341 (395)
||||||+++|+|++|..||.+.+..+....+........ ......+++++.+||.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~ 312 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE-------------------------NPNYNVLSPLARDLLS 312 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT-------------------------SGGGGGSCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC-------------------------CcccccCCHHHHHHHH
Confidence 999999999999999999999888887777665211111 0112346899999999
Q ss_pred HhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 342 RLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 342 ~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
+||+.||.+|||+.++|+||||+.+.+..
T Consensus 313 ~~l~~~p~~Rps~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 313 NLLNRNVDERFDAMRALQHPWISQFSDKI 341 (345)
T ss_dssp HHSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred HHcCCChhHCCCHHHHhcChhhccChHhh
Confidence 99999999999999999999999877643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=369.70 Aligned_cols=252 Identities=29% Similarity=0.432 Sum_probs=211.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
..|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+++++.++||||+++++++. +...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCe
Confidence 45999999999999999999999999999999986432 23457999999999999999999984 4445
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.++||||+.|++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 129 ~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEE-TTTEEEECCCTTCBS
T ss_pred EEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEC-CCCCEEEeeccCcee
Confidence 8999999999988777542 4678999999999999999999999 6999999999999999 789999999999976
Q ss_pred cccCCcceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 230 LVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.... ....||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+.+..+......
T Consensus 204 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--------- 271 (348)
T 1u5q_A 204 MAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--------- 271 (348)
T ss_dssp SSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---------
T ss_pred cCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------
Confidence 5432 34578999999999853 345899999999999999999999999988877766655441100
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
......+++.+.+||.+||+.||.+|||++++++||||.....
T Consensus 272 ------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 272 ------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 0012346889999999999999999999999999999976443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=368.05 Aligned_cols=288 Identities=29% Similarity=0.508 Sum_probs=218.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecC---------
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTT--------- 143 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------- 143 (395)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 47999999999999999999999999999999886432 33457999999999999999998874321
Q ss_pred CCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEee
Q 016115 144 SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~D 223 (395)
..+....++||||++|++.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++..++.+||+|
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccCceeEEeeccCCCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 133456899999999988776643 578999999999999999999999 69999999999999985678999999
Q ss_pred cccccccccCC----cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016115 224 FGSAKVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 224 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
||+++...... ......+|..|+|||++.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99998654321 12234568899999998775678999999999999999999999999999888888888766655
Q ss_pred ChhhhhhcCCCCCCCCCCCcc-CCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 300 TREEIRCMNPNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
..............+...... ...........++.++.+||++||+.||.+|||+.|+|+||||+....+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 544332211111000000000 00001123346899999999999999999999999999999999876654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=378.72 Aligned_cols=254 Identities=27% Similarity=0.381 Sum_probs=207.6
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 80 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
...+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++ .+...+++|||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E 166 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVME 166 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEe
Confidence 3367899999999999999999999999998653 34456899999999999999999998 44556899999
Q ss_pred cccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec-CCCCcEEEeecccccccccC
Q 016115 156 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD-PLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 156 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~-~~~~~~kl~Dfg~a~~~~~~ 233 (395)
|++| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ ..++.+||+|||+++.....
T Consensus 167 ~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 167 YVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp CCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 9985 55555543 23468999999999999999999999 6999999999999993 25678999999999887666
Q ss_pred CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 243 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~------------- 308 (373)
T 2x4f_A 243 EKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE------------- 308 (373)
T ss_dssp CBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC-------------
T ss_pred cccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-------------
Confidence 555566799999999999654 589999999999999999999999999988888777766311111
Q ss_pred CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
......+++++.+||.+||++||.+|||+.|+|+||||+....
T Consensus 309 ------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 309 ------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp ------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred ------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 1122457999999999999999999999999999999987643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=387.91 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=213.5
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
...++|.+.+.||+|+||.||+|++..+|+.||||++.+.. ....+|+.+++.++||||+++++++ .+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence 34567999999999999999999999999999999986432 2345799999999999999999988 45
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+|+||||++| +|...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~-~~g~vkL~DFG 334 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLD-DDGNVRISDLG 334 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTSCEEECCCT
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEe-CCCCEEEeecc
Confidence 5569999999985 6666665544445679999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCcc-eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCC
Q 016115 226 SAKVLVKGEAN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIKVLGTPT 300 (395)
Q Consensus 226 ~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~~~~~~~~~ 300 (395)
+++........ ...+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+ ..+....+...
T Consensus 335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~----- 408 (543)
T 3c4z_A 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ----- 408 (543)
T ss_dssp TCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----
T ss_pred eeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----
Confidence 99876554432 345899999999999764 58999999999999999999999998753 23333333321
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 368 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 368 (395)
...++..+++++.+||++||++||.+||+ ++++++||||+.+++
T Consensus 409 ------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 409 ------------------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp ------------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred ------------------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 01133467999999999999999999996 589999999998765
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=392.40 Aligned_cols=257 Identities=31% Similarity=0.521 Sum_probs=217.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.++|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++||||+++++++ .+..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 34799999999999999999999999999999998533 23356899999999999999999998 5566
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec--CCCCcEEEeecc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFG 225 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~--~~~~~~kl~Dfg 225 (395)
.+++||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ..++.+||+|||
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 79999999985 55555543 4679999999999999999999999 6999999999999994 256789999999
Q ss_pred cccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 226 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
+++............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 175 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----- 247 (484)
T 3nyv_A 175 LSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE----- 247 (484)
T ss_dssp HHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----
T ss_pred eeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 9988766665566789999999999965 489999999999999999999999999988887777765211111
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
......+++++.+||++||++||.+|||+.|+|+||||+.....
T Consensus 248 --------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~ 291 (484)
T 3nyv_A 248 --------------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE 291 (484)
T ss_dssp --------------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred --------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence 01124579999999999999999999999999999999876553
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=364.15 Aligned_cols=253 Identities=28% Similarity=0.430 Sum_probs=209.0
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.|...+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.. ....++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEEE
Confidence 4788889999999999999999999999999986432 334579999999999999999999843 4458999
Q ss_pred Eecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||++|+ +.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.....
T Consensus 121 ~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 121 MEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp ECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCcEEEeeeeeeeeccc
Confidence 9999864 444433 3568999999999999999999999 6999999999999999 788999999999987654
Q ss_pred CC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
.. ......||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+.......
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 260 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK------------ 260 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC------------
T ss_pred CccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC------------
Confidence 32 23456789999999999654 58999999999999999999999999887776665554311000
Q ss_pred CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
......+++.+.+||.+||+.||.+|||+.++++||||+....+
T Consensus 261 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 304 (321)
T 2c30_A 261 --------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP 304 (321)
T ss_dssp --------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred --------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence 00123568999999999999999999999999999999875543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=370.00 Aligned_cols=245 Identities=24% Similarity=0.408 Sum_probs=207.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHHcCCCceeeeceeeeecC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (395)
..+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 346999999999999999999999999999999986432 2345799999999999999999998
Q ss_pred CCCceeEEEEEecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEE
Q 016115 144 SKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl 221 (395)
.+...+++||||+.+ ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL 171 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIA-EDFTIKL 171 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTSCEEE
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEc-CCCcEEE
Confidence 555668999999864 55555543 4579999999999999999999999 6999999999999999 6889999
Q ss_pred eecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||...... .
T Consensus 172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~-------- 237 (335)
T 3dls_A 172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------V-------- 237 (335)
T ss_dssp CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------T--------
T ss_pred eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------H--------
Confidence 99999988776666667789999999999977654588999999999999999999999752210 0
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.. ....+..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 238 ------~~---------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 238 ------EA---------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ------TT---------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ------hh---------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 00 001123478999999999999999999999999999999763
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=372.36 Aligned_cols=284 Identities=31% Similarity=0.517 Sum_probs=218.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcC-CC-----ceeeeceeeeecCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-HP-----NVISLKHCFFSTTSK 145 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~ 145 (395)
...+|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++ |+ +|+++++++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~----- 126 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM----- 126 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE-----
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec-----
Confidence 3568999999999999999999999999999999997543 23346888888875 44 4888888883
Q ss_pred CceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-CCceeccCCCCceeecC-CCCcEEEee
Q 016115 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDP-LTHQVKLCD 223 (395)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~ivH~Dlkp~Nill~~-~~~~~kl~D 223 (395)
....+++||||++|+|.+.+.... ...+++..++.++.||+.||.|||++ .||+||||||+|||++. .++.+||+|
T Consensus 127 ~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 FRNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred cCCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 445689999999999888887632 24689999999999999999999942 59999999999999952 467899999
Q ss_pred cccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 224 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+....+.++...
T Consensus 205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999987643 23456789999999999765 489999999999999999999999999999999999999988877665
Q ss_pred hhhcCC------CCCCCCC------------CCccCCCcccccc-----------------ccCChhHHHHHHHhhccCC
Q 016115 304 IRCMNP------NYTDFRF------------PQIKAHPWHKVFH-----------------KRMPPEAIDLASRLLQYSP 348 (395)
Q Consensus 304 ~~~~~~------~~~~~~~------------~~~~~~~~~~~~~-----------------~~~s~~~~~li~~~L~~dp 348 (395)
+..... ...+..+ .......+...+. ...++++.+||.+||++||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 432110 0000000 0000000000000 0011478999999999999
Q ss_pred CCCCCHHHHhcCCCCcCCCC
Q 016115 349 SLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 349 ~~Rpt~~ell~hp~~~~~~~ 368 (395)
++|||++|+|+||||++..+
T Consensus 362 ~~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 362 KTRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp TTSCCHHHHTTSGGGCC---
T ss_pred hhCCCHHHHhcCcccccCCC
Confidence 99999999999999987543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=369.08 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=212.5
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHHc-CCCceeeeceeeeecC
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (395)
.+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---- 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE----
Confidence 46999999999999999999999999999999985432 2345789999998 799999999988
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEe
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~ 222 (395)
......++||||++| ++.+.+.. ...+++..++.++.||+.||.|||+ .||+|+||||+|||++ .++.+||+
T Consensus 170 -~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~-~~~~ikl~ 242 (365)
T 2y7j_A 170 -ESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLD-DNMQIRLS 242 (365)
T ss_dssp -EBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEEC
T ss_pred -eeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC-CCCCEEEE
Confidence 445569999999986 66665553 3578999999999999999999999 6999999999999999 78899999
Q ss_pred ecccccccccCCcceeeeecccccCchhhcC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 016115 223 DFGSAKVLVKGEANISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297 (395)
Q Consensus 223 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~ 297 (395)
|||++.............||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999988766665666789999999999853 22478899999999999999999999998877776666555221
Q ss_pred CCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
..... ....++..+.+||.+||+.||.+|||+.++|+||||++
T Consensus 323 ~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSSP-------------------------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCHH-------------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCc-------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 11111 12356889999999999999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=374.71 Aligned_cols=282 Identities=27% Similarity=0.414 Sum_probs=221.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcC--------CCceeeeceeeeecCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD--------HPNVISLKHCFFSTTS 144 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~--------h~niv~~~~~~~~~~~ 144 (395)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~- 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG- 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence 357999999999999999999999999999999997543 33457999999885 788999999884322
Q ss_pred CCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC-CceeccCCCCceeecCCCC------
Q 016115 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTH------ 217 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-~ivH~Dlkp~Nill~~~~~------ 217 (395)
.+...+++||||+++++++.+... ....+++..++.++.||+.||.|||+ + ||+||||||+|||++ .++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~-~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLS-VNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEEC-CCHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEe-ccchhhhhh
Confidence 245678999999999988877653 23569999999999999999999999 7 999999999999998 343
Q ss_pred -------------------------------------------cEEEeecccccccccCCcceeeeecccccCchhhcCC
Q 016115 218 -------------------------------------------QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254 (395)
Q Consensus 218 -------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 254 (395)
.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTS
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCC
Confidence 7999999999876433 3456789999999999765
Q ss_pred CCCCcccchHhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChhhhhhcCCCCCCC-------CCCCccC
Q 016115 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKA 321 (395)
Q Consensus 255 ~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 321 (395)
. ++.++|||||||++|+|+||..||...+ ..+.+..+....+..+...+........-+ .+.....
T Consensus 269 ~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 269 G-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp C-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred C-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 4 8999999999999999999999998655 566778888888887776553322110000 0000000
Q ss_pred CCccc------cccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 322 HPWHK------VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 322 ~~~~~------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
..... .+...++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00000 112334678999999999999999999999999999973
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=380.30 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=197.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHHcCCCceeeeceeeeecC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (395)
.++|.+.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~---- 209 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---- 209 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE----
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 357999999999999999999999999999999986432 2346899999999999999999987
Q ss_pred CCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC--CCCcEEE
Q 016115 144 SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKL 221 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~--~~~~~kl 221 (395)
... ..++||||+.|+ .+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++. .+..+||
T Consensus 210 -~~~-~~~lv~e~~~~g---~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 210 -DAE-DYYIVLELMEGG---ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -ESS-EEEEEEECCTTC---BGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -ecC-ceEEEEEcCCCC---cHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEEE
Confidence 222 268999999864 223333445789999999999999999999999 69999999999999973 2345999
Q ss_pred eecccccccccCCcceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016115 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
+|||+++............||+.|+|||++.+ ...++.++|||||||++|+|++|..||........+........
T Consensus 284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~-- 361 (419)
T 3i6u_A 284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-- 361 (419)
T ss_dssp CCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC--
T ss_pred eecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC--
Confidence 99999988766555566789999999999853 34578899999999999999999999986544332222222100
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
..+.......+++.+.+||++||+.||.+|||++|+|+||||+.
T Consensus 362 ----------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 362 ----------------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ----------------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ----------------------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 00111123457999999999999999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=366.64 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=198.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCC-------
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTS------- 144 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------- 144 (395)
.+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 4699999999999999999999999999999998632 2345679999999999999999998855432
Q ss_pred ---------------------------------------------CCceeEEEEEecccc-hHHHHHHhhcccCCCCCHH
Q 016115 145 ---------------------------------------------KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLI 178 (395)
Q Consensus 145 ---------------------------------------------~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~ 178 (395)
....++++|||||+| +|.+.+.. .......++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR-RCSLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT-CCSGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc-ccCccchhhH
Confidence 123358999999997 55555543 2333455677
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC-------------cceeeeecccc
Q 016115 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-------------ANISYICSRYY 245 (395)
Q Consensus 179 ~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~gt~~y 245 (395)
.++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...... ......||+.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 789999999999999999 6999999999999999 78899999999998765442 12335689999
Q ss_pred cCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCcc
Q 016115 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325 (395)
Q Consensus 246 ~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (395)
+|||++.+. .++.++|||||||++|+|++|..|+. +....+........
T Consensus 243 ~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~------------------------- 291 (332)
T 3qd2_B 243 MSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKF------------------------- 291 (332)
T ss_dssp SCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCC-------------------------
T ss_pred cChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCC-------------------------
Confidence 999999765 48999999999999999999876542 11111111111000
Q ss_pred ccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 326 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 326 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.......++++.+||.+||+.||.+|||+.|+++||||+++
T Consensus 292 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 00123357789999999999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=386.51 Aligned_cols=253 Identities=28% Similarity=0.473 Sum_probs=211.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.+|++.+.||+|+||+||+|++..++..||||++... .....+|+.+++.++||||+++++++ .+...+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCEE
Confidence 4699999999999999999999999999999998643 23346799999999999999999998 555669
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCcEEEeecccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSA 227 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a 227 (395)
|+|||||.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||++
T Consensus 112 ~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 999999986 66665554 3568999999999999999999999 699999999999999732 355999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 258 (494)
T 3lij_A 187 AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS------ 258 (494)
T ss_dssp EECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS------
T ss_pred eECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------
Confidence 88776666667789999999999853 5899999999999999999999999999888877777653211111
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.....+++.+.+||++||++||.+|||+.|+|+||||+..
T Consensus 259 -------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 259 -------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp -------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred -------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 1124579999999999999999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=367.10 Aligned_cols=255 Identities=26% Similarity=0.435 Sum_probs=186.9
Q ss_pred Cceee---eeeecCCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAE---RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~---~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+|.+. +.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.+. ||||+++++++ .+....|+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~l 83 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFL 83 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEEE
Confidence 45554 78999999999999999999999999987543 44567999999997 99999999998 55566899
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCC--CcEEEeecccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAKV 229 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~--~~~kl~Dfg~a~~ 229 (395)
||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 84 VMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999986 66666654 4679999999999999999999999 6999999999999998322 2799999999986
Q ss_pred cccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHhCCCCh
Q 016115 230 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-------DQLVEIIKVLGTPTR 301 (395)
Q Consensus 230 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------~~~~~~~~~~~~~~~ 301 (395)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.. +.+..+...
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~------ 231 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG------ 231 (325)
T ss_dssp CCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT------
T ss_pred cCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC------
Confidence 54432 23456789999999999654 5899999999999999999999999865432 222222110
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
.+ .+.......+++++.+||.+||..||.+|||+.|+++||||+....
T Consensus 232 -----------~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 232 -----------DF--------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp -----------CC--------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred -----------CC--------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 00 0111122457999999999999999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=358.94 Aligned_cols=255 Identities=28% Similarity=0.447 Sum_probs=211.0
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
...++|.+.+.||+|+||.||+|.+..++..||+|++... .....+|+.+++.++||||+++++++ .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ec
Confidence 4556899999999999999999999999999999998543 23345799999999999999999998 45
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
....++||||+++ ++.+.+... ..+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~-~~~~~~l~Dfg 154 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLG-SAGELKIADFG 154 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEEC-TTSCEEECSCC
T ss_pred CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEc-CCCCEEEEecc
Confidence 5568999999985 666666542 568999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 226 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
++...... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+.....
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 224 (279)
T 3fdn_A 155 WSVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-------- 224 (279)
T ss_dssp EESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------
T ss_pred ccccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC--------
Confidence 98654333 23456789999999999654 589999999999999999999999998887776666554211
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
.++..+++.+.+||.+||+.||.+|||+.|+++||||+......
T Consensus 225 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 225 ---------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred ---------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence 12344689999999999999999999999999999998765533
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=358.48 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=210.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----------ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
++|++.+.||+|+||.||+|++..+|+.||+|++... .....+|+.+++.++||||+++++++ .+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----EN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----cC
Confidence 4699999999999999999999999999999998643 23356799999999999999999998 44
Q ss_pred ceeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC----cEEE
Q 016115 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QVKL 221 (395)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~----~~kl 221 (395)
....++||||++ ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++ .+||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~~~~~kl 153 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLL-DKNVPNPRIKL 153 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEES-CSSSSSCCEEE
T ss_pred CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEe-cCCCCCCceEE
Confidence 556899999997 566666644 3578999999999999999999999 6999999999999998 444 7999
Q ss_pred eecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+|||++.............|++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+.+..+.......
T Consensus 154 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 230 (283)
T 3bhy_A 154 IDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF-- 230 (283)
T ss_dssp CCCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC--
T ss_pred EecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC--
Confidence 999999877655555566789999999999654 58999999999999999999999999888776665554321111
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
.......++..+.+||.+||..||.+|||+.++++||||+.++....
T Consensus 231 -----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 231 -----------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp -----------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred -----------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence 11123457899999999999999999999999999999998765443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=358.91 Aligned_cols=269 Identities=27% Similarity=0.413 Sum_probs=219.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
...+|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++ .+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 87 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN 87 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccC
Confidence 3457999999999999999999999999999999986432 2345799999999999999999998 455
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...++||||++| ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~kl~dfg~ 161 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLN-EDLEVKIGDFGL 161 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEc-CCCCEEEEeccC
Confidence 568999999995 55555443 3578999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 227 AKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 227 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
+...... .......||+.|+|||++.+. .++.++||||||+++|+|++|..||......+....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------- 230 (294)
T 2rku_A 162 ATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---------- 230 (294)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------
T ss_pred ceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc----------
Confidence 9876432 223445689999999999654 4899999999999999999999999988776655544321
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFN 384 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~ 384 (395)
. ..++..+++.+.+||.+||+.||.+|||+.|+++||||+....+..........++.+.
T Consensus 231 -------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (294)
T 2rku_A 231 -------E------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFS 290 (294)
T ss_dssp -------C------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCC
T ss_pred -------c------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCCccCCCCCCCcc
Confidence 0 01234568899999999999999999999999999999987666655444444555443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=356.35 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=214.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------------cchHHHHHHHHHcC-CCceeeeceeeee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRLMD-HPNVISLKHCFFS 141 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~-h~niv~~~~~~~~ 141 (395)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. ||||+++++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-- 93 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 93 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee--
Confidence 357999999999999999999999999999999985432 23347899999995 99999999998
Q ss_pred cCCCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEE
Q 016115 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (395)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~k 220 (395)
......++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+|+||||+||+++ .++.+|
T Consensus 94 ---~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~k 164 (298)
T 1phk_A 94 ---ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLD-DDMNIK 164 (298)
T ss_dssp ---ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEE
T ss_pred ---ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEc-CCCcEE
Confidence 555669999999985 66666654 3578999999999999999999999 6999999999999999 788999
Q ss_pred EeecccccccccCCcceeeeecccccCchhhc-----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016115 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~ 295 (395)
|+|||++.............|++.|+|||++. ....++.++||||||+++|+|++|..||...+..+....+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99999998776665556677899999999985 2345789999999999999999999999988877766665542
Q ss_pred hCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
..... ......++..+.+||.+||+.||.+|||+.|+++||||++....+.
T Consensus 245 ~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~ 295 (298)
T 1phk_A 245 NYQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295 (298)
T ss_dssp CCCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC----
T ss_pred CcccC-------------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhh
Confidence 11100 0012357899999999999999999999999999999998766543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=359.42 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=212.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
++|.+.+.||+|+||.||+|.+..++..||+|++... .....+|+.+++.++|+||+++++++.. .+..
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 81 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEKQ 81 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C---
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCCC
Confidence 4799999999999999999999999999999998643 2345679999999999999999998743 2334
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
..++||||+++++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++.
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~-~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLT-TGGTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEECCCTTCE
T ss_pred eEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEc-CCCcEEeecccccc
Confidence 589999999998777776533 4679999999999999999999999 6999999999999999 78899999999998
Q ss_pred ccccC---CcceeeeecccccCchhhcCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 229 VLVKG---EANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 229 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
..... .......||+.|+|||++.+.. .++.++||||||+++|+|++|..||...+..+....+.+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~------ 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--S------ 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--C------
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--C------
Confidence 65432 2223456899999999986532 2477999999999999999999999988776666555441 0
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
..++..+++.+.+||.+||..||.+|||+.|+++||||++.....
T Consensus 230 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 230 ---------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ---------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ---------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 012345689999999999999999999999999999998876644
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=398.78 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=215.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc-CCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (395)
...+|.+.+.||+|+||+||+|++..+++.||||++.+.. .....|..++..+ +|+||+++++++ .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 3457999999999999999999999999999999986431 2334678888876 699999999988 55
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+|+||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~-~~g~ikL~DFG 487 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLD-SEGHIKIADFG 487 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEEC-SSSCEEECCCT
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEc-CCCcEEEeecc
Confidence 6679999999985 56555554 3579999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccc-cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 226 SAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 226 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
+++... ........+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+..+.+..+....
T Consensus 488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------- 558 (674)
T 3pfq_A 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-------- 558 (674)
T ss_dssp TCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--------
T ss_pred eeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------
Confidence 998643 33344567899999999999654 58999999999999999999999999988888777766410
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCCCcCCCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN 370 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~hp~~~~~~~~~ 370 (395)
..++..+++++.+||++||++||.+|+++ +|+++||||+.+++..
T Consensus 559 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 559 ---------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred ---------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 11334679999999999999999999997 9999999999987643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=355.39 Aligned_cols=252 Identities=28% Similarity=0.422 Sum_probs=203.1
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++ .+.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STP 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecC
Confidence 4457999999999999999999999999999999985432 2345799999999999999999988 445
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+|+||||+||+++ .++.+||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~~l~dfg~ 157 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLD-AHMNAKIADFGL 157 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEEC-TTSCEEECCCCG
T ss_pred CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEEC-CCCCEEEeeccc
Confidence 568999999975 76666654 2568999999999999999999999 6999999999999999 688999999999
Q ss_pred ccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+.............||+.|+|||++.+....+.++||||||+++|+|++|..||...+.......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 227 (276)
T 2h6d_A 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV---------- 227 (276)
T ss_dssp GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc----------
Confidence 9877655545566789999999999765545789999999999999999999999877666555544310
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
..++..++..+.+||.+||+.||.+|||+.++++||||++.
T Consensus 228 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 228 -------------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 00223468899999999999999999999999999999763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=362.61 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=209.6
Q ss_pred cCceee-eeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcC-CCceeeeceeeeecCCCCce
Q 016115 77 ISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 148 (395)
..|.+. +.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.+. ||||+++++++ .+..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~~ 102 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENTS 102 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeCC
Confidence 357777 89999999999999999999999999986432 33457889999885 69999999998 5555
Q ss_pred eEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC--CCCcEEEeecc
Q 016115 149 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFG 225 (395)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~--~~~~~kl~Dfg 225 (395)
.+++||||+.|+ |.+.+.. .....+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 689999999874 3333321 224678999999999999999999999 69999999999999983 16789999999
Q ss_pred cccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 226 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
+++............||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+.........
T Consensus 180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 254 (327)
T 3lm5_A 180 MSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE---- 254 (327)
T ss_dssp GCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----
T ss_pred cccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc----
Confidence 99877665555567899999999999654 5899999999999999999999999998888777766653221111
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
.....+++.+.+||.+||+.||.+|||++++|+||||+........
T Consensus 255 ---------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 255 ---------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp ---------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-
T ss_pred ---------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccccc
Confidence 1224578999999999999999999999999999999988765543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=367.71 Aligned_cols=276 Identities=20% Similarity=0.292 Sum_probs=208.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.+|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+++++.++||||+++++++.. ......+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceEE
Confidence 47999999999999999999999999999999986432 334579999999999999999998843 2233588
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceee----cCCCCcEEEeeccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV----DPLTHQVKLCDFGS 226 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill----~~~~~~~kl~Dfg~ 226 (395)
+||||++| +|.+.+... .....+++..++.++.||+.||.|||+ +||+||||||+|||+ + .++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGED-GQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSG-GGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTT-SCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCC-CCceEEEccCCC
Confidence 99999985 666666543 223449999999999999999999999 699999999999998 5 567899999999
Q ss_pred ccccccCCcceeeeecccccCchhhcC-------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHH
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIFG-------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA----VDQLVEIIKV 295 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~~~~~ 295 (395)
++............||+.|+|||++.. ...++.++|||||||++|+|+||..||..... .+.+..+...
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 988766666666789999999999852 34589999999999999999999999975332 3344444432
Q ss_pred hCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 016115 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 362 (395)
........+........++ ....+....+...++..+.+||++||+.||++|||++|+|+||=
T Consensus 243 ~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDW----SGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTTCCEEE----ESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccCCcccc----CccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2111111111100000000 00011111233456778999999999999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=364.65 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=214.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..+|.+.+.||+|+||.||++.+..+++.||+|++.... ....+|+.+++.++|+||+++++++ .+..
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCC
Confidence 457999999999999999999999999999999986432 3345799999999999999999998 4555
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++||||+.| ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~-~~~~~kl~Dfg~~ 188 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLN-EDLEVKIGDFGLA 188 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred eEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEc-CCCCEEEeeccCc
Confidence 69999999995 55555543 3578999999999999999999999 6999999999999999 7889999999999
Q ss_pred cccccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 228 KVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 228 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
...... .......||+.|+|||++.+. .++.++||||||+++|+|++|..||......+....+....
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------- 257 (335)
T 2owb_A 189 TKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------- 257 (335)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC----------
T ss_pred eecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC----------
Confidence 876433 233446789999999999764 48999999999999999999999999887766665554310
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
+ .++..+++.+.+||.+||+.||.+|||+.|+++||||+....+...
T Consensus 258 -------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~ 304 (335)
T 2owb_A 258 -------Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 304 (335)
T ss_dssp -------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred -------C------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccC
Confidence 0 1224568899999999999999999999999999999876655433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=352.21 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=205.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++ .+....+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEE-----EcCCEEE
Confidence 46999999999999999999999999999999986432 3445799999999999999999988 4445689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||++| +|.+ +......+++..++.++.||+.||.|||+ +||+|+||||+||+++ .++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~----~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 82 LFLEYCSGGELFD----RIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEECCTTEEGGG----GSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHH----HHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEc-cCCCEEEeeCCCcccc
Confidence 99999986 4333 33445679999999999999999999999 6999999999999999 6889999999999765
Q ss_pred ccCC---cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 231 VKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 231 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.... ......||+.|+|||++.+...++.++||||||+++|+|++|..||............... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------- 226 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKT------- 226 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT--TCT-------
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh--ccc-------
Confidence 4332 1234568999999999976554578999999999999999999999876543222111110 000
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
.......+++.+.+||.+||+.||.+|||+.|+++||||+....
T Consensus 227 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 227 -----------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp -----------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred -----------------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 00012357899999999999999999999999999999987544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=369.26 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=199.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcC--CCceeeeceeeeecCCCCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD--HPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~ 148 (395)
..|.+.+.||+|+||+||+|.+.. ++.||||++.... ....+|+.+++.++ |+||+++++++ ....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~-----~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE-----ecCC
Confidence 359999999999999999999764 9999999986432 33457999999997 59999999988 4445
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+|+|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||+++
T Consensus 130 ~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~--~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIAN 202 (390)
T ss_dssp EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES--SSCEEECCCSSSC
T ss_pred EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE--CCeEEEEecCccc
Confidence 5999999877888877765 3578899999999999999999999 6999999999999997 5789999999998
Q ss_pred ccccCCc---ceeeeecccccCchhhcCC----------CCCCcccchHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q 016115 229 VLVKGEA---NISYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK 294 (395)
Q Consensus 229 ~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~ 294 (395)
....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+..
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 7644332 2345789999999998641 35899999999999999999999999865432 33332221
Q ss_pred HhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
. . . ...++...+.++.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus 283 ~---~------------~------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 283 P---N------------H------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp T---T------------S------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred c---c------------c------------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 0 0 0 001223457899999999999999999999999999999865543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=350.42 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=206.8
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++||||+++++++.... .+...++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEE
Confidence 5899999999999999999999999999999986432 23457999999999999999999875433 3456789
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC--ceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +| |+||||||+|||++..++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999975 66666654 3568999999999999999999999 68 99999999999997567899999999997
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.................
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------- 246 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV----------- 246 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-----------
T ss_pred ccccc-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC-----------
Confidence 54333 3345678999999999853 489999999999999999999999987655544433222100
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
....+....++++.+||.+||+.||.+|||+.++++||||++
T Consensus 247 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 247 ---------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ---------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ---------------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 011133456889999999999999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=360.20 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=196.2
Q ss_pred ccCceee-eeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHH-cCCCceeeeceeeeecCCCCcee
Q 016115 76 TISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 76 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.+.|.+. +.||+|+||+||+|++..+|+.||||++.... ....+|+.+++. ++||||+++++++ .+...
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCCE
Confidence 3468885 78999999999999999999999999986542 334579999988 4799999999998 44456
Q ss_pred EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCc---EEEeecc
Q 016115 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ---VKLCDFG 225 (395)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~---~kl~Dfg 225 (395)
+++||||++ |+|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++. +||+|||
T Consensus 86 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCE-HPNQVSPVKICDFD 159 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEES-CSSSSCSEEECCTT
T ss_pred EEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEc-cCCCcCceEEEEcc
Confidence 999999998 566666654 3578999999999999999999999 6999999999999998 4444 9999999
Q ss_pred cccccccCC--------cceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChH-------
Q 016115 226 SAKVLVKGE--------ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV------- 286 (395)
Q Consensus 226 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~------- 286 (395)
++....... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 987653221 1123458999999999854 134789999999999999999999999875421
Q ss_pred --------HHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHh
Q 016115 287 --------DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (395)
Q Consensus 287 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 358 (395)
.....+..... .++ ......++..+.+||++||+.||.+|||+.|++
T Consensus 240 ~~~~~~~~~~~~~i~~~~~-----------------~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKY-----------------EFP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCC-----------------CCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ccchhHHHHHHHHHhccCc-----------------ccC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 12222222100 000 011235789999999999999999999999999
Q ss_pred cCCCCcCCCC
Q 016115 359 AHPFFDELRE 368 (395)
Q Consensus 359 ~hp~~~~~~~ 368 (395)
+||||+....
T Consensus 295 ~hp~~~~~~~ 304 (316)
T 2ac3_A 295 QHPWVQGCAP 304 (316)
T ss_dssp HSTTCC----
T ss_pred cChhhcCCCC
Confidence 9999997654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=352.93 Aligned_cols=252 Identities=26% Similarity=0.460 Sum_probs=211.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..++|.+.+.||+|+||.||+|++..++..||||++... .....+|+++++.++||||+++++++ .+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 86 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDR 86 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcC
Confidence 446799999999999999999999999999999998543 23456799999999999999999998 445
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMG-YKGELKIADFGW 160 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEEC-TTCCEEECCCTT
T ss_pred CEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEc-CCCCEEEecccc
Confidence 568999999985 77666654 2568999999999999999999999 6999999999999999 688999999999
Q ss_pred ccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+...... ......|++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+...
T Consensus 161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------- 227 (284)
T 2vgo_A 161 SVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------- 227 (284)
T ss_dssp CEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred cccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-----------
Confidence 8765432 23456789999999999764 4899999999999999999999999988776665554431
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
+ ..++..++..+.+||.+||+.||.+|||+.++++||||+....
T Consensus 228 ------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 228 ------D------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp ------C------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred ------c------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 0 0123457899999999999999999999999999999986443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=359.96 Aligned_cols=282 Identities=26% Similarity=0.477 Sum_probs=220.8
Q ss_pred ccCceeeeeeecCCceEEEEEEE-CCCCcEEEEEEecccc---cchHHHHHHHHHcCCCc------eeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKC-LETGETVAIKKVLQDR---RYKNRELQLMRLMDHPN------VISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~ 145 (395)
..+|++.+.||+|+||.||+|.+ ..+|+.||||++.... ....+|+.+++.++|++ ++++++++ .
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~-----~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF-----E 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----E
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----c
Confidence 34799999999999999999998 5688999999986543 34457888998887654 89999988 4
Q ss_pred CceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC----------
Q 016115 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL---------- 215 (395)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~---------- 215 (395)
....+++||||+++++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++..
T Consensus 88 ~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 88 HHGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCcc
Confidence 455699999999989888876532 2468899999999999999999999 699999999999999832
Q ss_pred --------CCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH
Q 016115 216 --------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287 (395)
Q Consensus 216 --------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 287 (395)
++.+||+|||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 56799999999976433 23456789999999999764 48999999999999999999999999999998
Q ss_pred HHHHHHHHhCCCChhhhhhcCCCCC----CCCCCCcc---------CCCcc--ccccccCChhHHHHHHHhhccCCCCCC
Q 016115 288 QLVEIIKVLGTPTREEIRCMNPNYT----DFRFPQIK---------AHPWH--KVFHKRMPPEAIDLASRLLQYSPSLRC 352 (395)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------~~~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rp 352 (395)
....+.+..+..+...+........ ...+.... ..++. .......++++.+||.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 8888888888777665543221100 00000000 00000 001122357899999999999999999
Q ss_pred CHHHHhcCCCCcCCCC
Q 016115 353 TALEACAHPFFDELRE 368 (395)
Q Consensus 353 t~~ell~hp~~~~~~~ 368 (395)
|+.|+++||||+.++.
T Consensus 322 t~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 322 TLREALKHPFFDLLKK 337 (339)
T ss_dssp CHHHHTTSGGGGGGGC
T ss_pred CHHHHhcCHHHHHHhc
Confidence 9999999999998765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=354.65 Aligned_cols=252 Identities=27% Similarity=0.472 Sum_probs=184.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence 347999999999999999999999999999999986432 3456799999999999999999998 4555
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..++||||+++ ++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~-~~~~~kl~dfg~~ 159 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLT-RNMNIKIADFGLA 159 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEEC-TTCCEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEc-CCCCEEEEeecce
Confidence 68999999975 55555543 23678999999999999999999999 6999999999999999 7889999999999
Q ss_pred cccccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 228 KVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 228 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
....... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||......+.+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 226 (278)
T 3cok_A 160 TQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------ 226 (278)
T ss_dssp EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred eeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence 8654322 23345789999999998654 489999999999999999999999986543322211100
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
.+ ...+..++.++.+||.+||+.||.+|||+.++++||||....
T Consensus 227 -----~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 227 -----AD------------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp -----SC------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred -----cc------------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 00 012345789999999999999999999999999999998644
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=362.51 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=200.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCC--CceeeeceeeeecCCCCc
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDH--PNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~ 147 (395)
...|++.+.||+|+||.||+|.+ .+++.||||++.... ....+|+.+++.++| +||+++++++ .+.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeC
Confidence 34699999999999999999997 568999999986432 234579999999987 9999999988 455
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..+++|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~--~~~~kl~DFG~a 154 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIA 154 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSSS
T ss_pred CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE--CCcEEEeecccc
Confidence 56999999888888887765 4678999999999999999999999 6999999999999997 578999999999
Q ss_pred cccccCCc---ceeeeecccccCchhhcC----------CCCCCcccchHhHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 016115 228 KVLVKGEA---NISYICSRYYRAPELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEII 293 (395)
Q Consensus 228 ~~~~~~~~---~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~ 293 (395)
+....... .....||+.|+|||++.+ ...++.++|||||||++|+|++|..||...... ..+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 87644332 234578999999999853 245889999999999999999999999865432 2222222
Q ss_pred HHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
. .. ....++...+.++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 235 ~---~~------------------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 235 D---PN------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp C---TT------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred c---CC------------------------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 1 00 011123445789999999999999999999999999999986444
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=361.56 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=202.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHHcCCCceeeeceeeeecCC
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (395)
++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+++++.++||||+++++++.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---- 85 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---- 85 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc----
Confidence 46999999999999999999999999999999985431 23568999999999999999999873
Q ss_pred CCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCC--CcEEE
Q 016115 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKL 221 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~--~~~kl 221 (395)
... .++||||+.| +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++..+ ..+||
T Consensus 86 -~~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 86 -AED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp -SSS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred -CCc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 222 7899999986 5555443 24679999999999999999999999 6999999999999998322 24999
Q ss_pred eecccccccccCCcceeeeecccccCchhhc--CCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016115 222 CDFGSAKVLVKGEANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
+|||++.............||+.|+|||++. +...++.++|||||||++|+|++|..||........+...... +..
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~ 237 (322)
T 2ycf_A 159 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-GKY 237 (322)
T ss_dssp CCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH-TCC
T ss_pred ccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh-Ccc
Confidence 9999998765544444567899999999974 3445899999999999999999999999865433222222221 000
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.+.......++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 238 -----------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 238 -----------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp -----------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred -----------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 00111234578999999999999999999999999999999763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=355.88 Aligned_cols=251 Identities=19% Similarity=0.241 Sum_probs=202.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHc-CCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (395)
..+|++.+.||+|+||+||+|.+..+|+.||||++.... ....+|+..+..+ +||||+++++++ .+..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-----~~~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----AEDD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-----EETT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCC
Confidence 457999999999999999999999999999999986432 2334677888888 899999999998 4445
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC-------------
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------------- 214 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~------------- 214 (395)
..++||||++| +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC--------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 68999999975 8877777655555779999999999999999999999 69999999999999972
Q ss_pred -----CCCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHH
Q 016115 215 -----LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289 (395)
Q Consensus 215 -----~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~ 289 (395)
....+||+|||++....... ...||+.|+|||++.+...++.++||||||+++|+|++|..++..... .
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~ 237 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W 237 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred ccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence 23479999999998764432 345899999999997765677899999999999999999987755432 2
Q ss_pred HHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
..+... . ...++..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 238 ~~~~~~--~--------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 HEIRQG--R--------------------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHTT--C--------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHcC--C--------------------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 222110 0 011334579999999999999999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=354.84 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=210.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.+|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...+++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 83 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHYYL 83 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEEEE
Confidence 46999999999999999999999999999999986432 3356799999999999999999988 45556899
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceee---cCCCCcEEEeeccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAK 228 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill---~~~~~~~kl~Dfg~a~ 228 (395)
||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||++ + .++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 84 VMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPE-ENSKIMITDFGLSK 157 (304)
T ss_dssp EECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSS-TTCCEEBCSCSTTC
T ss_pred EEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCC-CCCCEEEccCCcce
Confidence 9999985 66666654 3568999999999999999999999 699999999999999 5 67889999999997
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+.......
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------- 226 (304)
T 2jam_A 158 MEQNG-IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF--------- 226 (304)
T ss_dssp CCCCB-TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC---------
T ss_pred ecCCC-ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 64332 23345689999999998654 58999999999999999999999999888777666665421110
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
.......+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus 227 ----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 227 ----------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ----------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ----------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 0112345789999999999999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=363.11 Aligned_cols=288 Identities=25% Similarity=0.425 Sum_probs=222.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCC-cEEEEEEecccc---cchHHHHHHHHHcCCCc------eeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR---RYKNRELQLMRLMDHPN------VISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~---~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~ 145 (395)
.++|++.+.||+|+||+||+|.+..++ ..||+|++.... ....+|+.+++.++|++ ++.+.+++ .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-----~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-----N 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----E
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----e
Confidence 357999999999999999999998877 689999986532 34457889999887665 88888877 4
Q ss_pred CceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC-----------
Q 016115 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----------- 214 (395)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~----------- 214 (395)
....+++||||+++++++.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 93 ~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 93 FHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eCCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecccccccccccc
Confidence 445689999999999888776532 2568999999999999999999999 69999999999999931
Q ss_pred -------CCCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH
Q 016115 215 -------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287 (395)
Q Consensus 215 -------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 287 (395)
.++.+||+|||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 468899999999976433 23456789999999999764 58999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChhhhhhcCCCCCC----CCCCCc---------cCCCccc--cccccCChhHHHHHHHhhccCCCCCC
Q 016115 288 QLVEIIKVLGTPTREEIRCMNPNYTD----FRFPQI---------KAHPWHK--VFHKRMPPEAIDLASRLLQYSPSLRC 352 (395)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rp 352 (395)
.+..+.+..+..+...+......... ..+... ...++.. ......+.++.+||++||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 88888888888776655432111000 000000 0000000 00112356899999999999999999
Q ss_pred CHHHHhcCCCCcCCCCCCCCCC
Q 016115 353 TALEACAHPFFDELREPNARLP 374 (395)
Q Consensus 353 t~~ell~hp~~~~~~~~~~~~~ 374 (395)
|+.|+|+||||+.+...+....
T Consensus 327 t~~e~l~hp~f~~~~~~~~~~~ 348 (355)
T 2eu9_A 327 TLAEALLHPFFAGLTPEERSFH 348 (355)
T ss_dssp CHHHHTTSGGGGGCCHHHHC--
T ss_pred CHHHHhcChhhcCCChhhcccc
Confidence 9999999999999876554433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=363.94 Aligned_cols=288 Identities=29% Similarity=0.481 Sum_probs=221.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcC-----------CCceeeeceeee
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-----------HPNVISLKHCFF 140 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----------h~niv~~~~~~~ 140 (395)
...+|.+.+.||+|+||+||+|++..+|+.||||++..+. ....+|+.+++.++ |+||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 4457999999999999999999999999999999987543 33457888888776 899999999885
Q ss_pred ecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC-CceeccCCCCceeecC-----
Q 016115 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDP----- 214 (395)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-~ivH~Dlkp~Nill~~----- 214 (395)
... .+...+++||||++++|.+.+.... ...+++..++.++.||+.||.|||+ + ||+||||||+|||++.
T Consensus 97 ~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETTT
T ss_pred ccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCCc
Confidence 433 2344789999999888888877643 3568999999999999999999999 7 9999999999999951
Q ss_pred CCCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC------hHHH
Q 016115 215 LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQ 288 (395)
Q Consensus 215 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~ 288 (395)
..+.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|+||..||...+ ..+.
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred CcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 3447999999999866433 3345789999999999765 48999999999999999999999998654 5567
Q ss_pred HHHHHHHhCCCChhhhhhcCCC-------CCCCCCCCccCCCccc------cccccCChhHHHHHHHhhccCCCCCCCHH
Q 016115 289 LVEIIKVLGTPTREEIRCMNPN-------YTDFRFPQIKAHPWHK------VFHKRMPPEAIDLASRLLQYSPSLRCTAL 355 (395)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 355 (395)
+..+...++..+...+...... ..-..+......+... .++..++.++.+||.+||+.||.+|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 7888888888776544322110 0000011111111111 12234577899999999999999999999
Q ss_pred HHhcCCCCcCCCCC
Q 016115 356 EACAHPFFDELREP 369 (395)
Q Consensus 356 ell~hp~~~~~~~~ 369 (395)
|+|+||||+.....
T Consensus 330 ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 330 GLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHTCGGGTTCTTC
T ss_pred HHhhChhhhcccCc
Confidence 99999999986543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=365.67 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=204.7
Q ss_pred ccccCceeeeeeecCCceEEEEEEEC---CCCcEEEEEEeccc--------ccchHHHHHHHHHc-CCCceeeeceeeee
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD--------RRYKNRELQLMRLM-DHPNVISLKHCFFS 141 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (395)
....+|.+.+.||+|+||.||+|++. .+|+.||||++... .....+|+++++.+ .|+||+++++++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 128 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-- 128 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE--
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE--
Confidence 34568999999999999999999984 58999999998642 23345699999999 699999999988
Q ss_pred cCCCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEE
Q 016115 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (395)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~k 220 (395)
.....+++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+|
T Consensus 129 ---~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~k 199 (355)
T 1vzo_A 129 ---QTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLD-SNGHVV 199 (355)
T ss_dssp ---EETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEE
T ss_pred ---eeCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCcEE
Confidence 444558999999985 66666654 3568999999999999999999999 6999999999999999 788999
Q ss_pred EeecccccccccCC--cceeeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 016115 221 LCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297 (395)
Q Consensus 221 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~ 297 (395)
|+|||+++...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+.....
T Consensus 200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence 99999997653322 22345789999999999753 3478999999999999999999999975432221111111100
Q ss_pred CCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
.. ...++..++..+.+||.+||..||.+|| |+.|+++||||+.+.+
T Consensus 280 ~~-------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 280 KS-------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp HC-------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred cc-------------------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 00 0012345789999999999999999999 9999999999998764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=380.83 Aligned_cols=255 Identities=20% Similarity=0.215 Sum_probs=194.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHH---HHHHcCCCceeeeceeee-----
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQ---LMRLMDHPNVISLKHCFF----- 140 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~---~l~~l~h~niv~~~~~~~----- 140 (395)
..+|.+.+.||+|+||.||+|++..+|+.||||++... .....+|+. +++.++|||||++++.+.
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45799999999999999999999899999999998632 133457884 455568999999984432
Q ss_pred --ecC---------CCCc---eeEEEEEecccchHHHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCceec
Q 016115 141 --STT---------SKDE---LFLNLVMEYVPETMYRVLKHYSSM---NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 203 (395)
Q Consensus 141 --~~~---------~~~~---~~~~lv~e~~~~~l~~~l~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~ 203 (395)
... .... ...|+||||++|+|.+.+...... ...+++..++.++.||+.||.|||+ +||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 111 0111 137899999999988888754221 2244568888899999999999999 699999
Q ss_pred cCCCCceeecCCCCcEEEeecccccccccCCcceeeeecccccCchhhcCC----------CCCCcccchHhHHHHHHHH
Q 016115 204 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAEL 273 (395)
Q Consensus 204 Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~l 273 (395)
||||+|||++ .++.+||+|||+++... .......| +.|+|||++.+. ..++.++|||||||++|+|
T Consensus 231 Dikp~NIll~-~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLD-QRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEEC-TTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEc-CCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 9999999999 68899999999998632 23345567 999999999765 2589999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC
Q 016115 274 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 353 (395)
Q Consensus 274 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt 353 (395)
++|+.||...+.......+ ......+++++.+||.+||+.||.+|||
T Consensus 307 ltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHSSCCC------CCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHCCCCCcccccccchhhh---------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 9999999764322111000 0011457899999999999999999999
Q ss_pred HHHHhcCCCCcCCCC
Q 016115 354 ALEACAHPFFDELRE 368 (395)
Q Consensus 354 ~~ell~hp~~~~~~~ 368 (395)
+.|+++||||+.+++
T Consensus 354 ~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 354 PLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHHTSHHHHHHHH
T ss_pred HHHHhhChHHHHHHH
Confidence 999999999987643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=351.49 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=206.7
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
...+|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++. ....+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCeE
Confidence 3457999999999999999999999999999999986432 33457999999999999999999984 34458
Q ss_pred EEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||++++ +.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++..
T Consensus 92 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMT-LEGDIRLADFGVSAK 166 (302)
T ss_dssp EEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEC-TTSCEEECCCHHHHH
T ss_pred EEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEC-CCCCEEEEECCCCcc
Confidence 9999999864 4444432 24668999999999999999999999 6999999999999999 688999999999764
Q ss_pred cccC-CcceeeeecccccCchhhc----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 230 LVKG-EANISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 230 ~~~~-~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
.... .......||+.|+|||++. ....++.++||||||+++|+|++|..||...+.......+......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------ 240 (302)
T 2j7t_A 167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP------ 240 (302)
T ss_dssp HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC------
T ss_pred ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc------
Confidence 3222 1223457899999999984 3445889999999999999999999999988877666555442100
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
....+..++..+.+||.+||..||.+|||+.++++||||+.+..
T Consensus 241 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 241 --------------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp --------------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred --------------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 00123457889999999999999999999999999999998664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=367.70 Aligned_cols=266 Identities=14% Similarity=0.115 Sum_probs=188.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHc--CCCceeeeceee-------
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM--DHPNVISLKHCF------- 139 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l--~h~niv~~~~~~------- 139 (395)
...|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.+ +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345999999999999999999999999999999997643 2234565545544 699988855333
Q ss_pred eecCC------------CCceeEEEEEecccchHHHHHHhhcccCCCCCHHHH------HHHHHHHHHHHHHHhcCCCce
Q 016115 140 FSTTS------------KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV------KLYTYQIFRGLAYIHTVPGVC 201 (395)
Q Consensus 140 ~~~~~------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~------~~i~~~i~~al~~LH~~~~iv 201 (395)
..... .....+|+||||++|+|.+.+..... .+++..+ ..++.||+.||.|||+ +||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence 21111 01145899999999999888876422 2333334 5677999999999999 6999
Q ss_pred eccCCCCceeecCCCCcEEEeecccccccccCCcceeeeecccccCchhhcC-CCCCCcccchHhHHHHHHHHHhCCCCC
Q 016115 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLF 280 (395)
Q Consensus 202 H~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf 280 (395)
||||||+|||++ .++.+||+|||+++..... .....+|+.|+|||++.+ ...++.++|||||||++|+|+||+.||
T Consensus 217 HrDikp~NIll~-~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 217 HGHFTPDNLFIM-PDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp ETTCSGGGEEEC-TTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCcCCHHHEEEC-CCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999 7889999999999865322 224567799999999964 135899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 281 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
....... ...+............+.......+++.+.+||.+||+.||++|||+.++|+|
T Consensus 294 ~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 8653210 00000000011111111111224679999999999999999999999999999
Q ss_pred CCCcCCCC
Q 016115 361 PFFDELRE 368 (395)
Q Consensus 361 p~~~~~~~ 368 (395)
|||+++.+
T Consensus 354 p~f~~~~~ 361 (371)
T 3q60_A 354 PEFLQLQN 361 (371)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99987654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=347.99 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=212.3
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCc
Confidence 3457999999999999999999999999999999986432 334579999999999999999998754 2344
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-----ceeccCCCCceeecCCCCcEEEe
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-----VCHRDVKPQNLLVDPLTHQVKLC 222 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~-----ivH~Dlkp~Nill~~~~~~~kl~ 222 (395)
.+++||||++| +|.+.+.........+++..++.++.||+.||.|||+ +| |+||||||+||+++ .++.+||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~ 158 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLD-GKQNVKLG 158 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEEC-SSSCEEEC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEc-CCCCEEEe
Confidence 58999999985 7877777655555679999999999999999999999 68 99999999999999 78899999
Q ss_pred ecccccccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 223 DFGSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 223 Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
|||++........ .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---- 233 (279)
T 2w5a_A 159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---- 233 (279)
T ss_dssp CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----
T ss_pred cCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc----
Confidence 9999987644322 2235689999999999765 489999999999999999999999998877666555544100
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
..++..++.++.+||.+||+.||.+|||+.|+++|+|+.+-
T Consensus 234 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 ------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 01234578999999999999999999999999999999763
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=351.33 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=211.7
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++ .+....
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 96 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSF 96 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCCeE
Confidence 36999999999999999999999999999999985432 3345799999999999999999998 445568
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCcEEEeecccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSA 227 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a 227 (395)
++||||+.+ ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++.. ++.+||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999975 66665554 2568999999999999999999999 699999999999999732 347999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.............||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+........
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 242 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD------- 242 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------
T ss_pred eeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 87765555555678999999999864 489999999999999999999999998887766665544211000
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
......+++++.+||++||..||.+|||+.++++||||++...
T Consensus 243 ------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 243 ------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp ------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred ------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 0012357899999999999999999999999999999987655
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=358.72 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=198.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHHc----CCCceeeeceeeeec
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLM----DHPNVISLKHCFFST 142 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l----~h~niv~~~~~~~~~ 142 (395)
.+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.+ +|+||+++++++
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~--- 107 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF--- 107 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE---
Confidence 36999999999999999999999999999999985432 2334699999998 899999999988
Q ss_pred CCCCceeEEEEEec-cc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEE
Q 016115 143 TSKDELFLNLVMEY-VP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (395)
Q Consensus 143 ~~~~~~~~~lv~e~-~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~k 220 (395)
.+....++|||| +. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++..++.+|
T Consensus 108 --~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 108 --ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp -------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTTEEE
T ss_pred --ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCCeEE
Confidence 444558899998 55 577666654 3568999999999999999999999 69999999999999985678999
Q ss_pred EeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
|+|||++...... ......||..|+|||++.+....+.++||||||+++|+|++|+.||..... +...
T Consensus 181 l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~----- 248 (312)
T 2iwi_A 181 LIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA----- 248 (312)
T ss_dssp ECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT-----
T ss_pred EEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh-----
Confidence 9999999876543 334567899999999987655445689999999999999999999975311 1110
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
...++..++..+.+||.+||+.||.+|||+.|+++||||+...+..
T Consensus 249 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~ 294 (312)
T 2iwi_A 249 ------------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294 (312)
T ss_dssp ------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred ------------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence 0012345789999999999999999999999999999999876644
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=357.45 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=206.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++..... ...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CCc
Confidence 357999999999999999999999999999999986542 123578888899999999999998854332 233
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEc-CCCCEEEeeccCc
Confidence 56899999975 66666554 3578999999999999999999999 6999999999999999 6889999999999
Q ss_pred cccccCCc----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 228 KVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 228 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
........ .....||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+...........+.
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--- 239 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--- 239 (311)
T ss_dssp ------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH---
T ss_pred ccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc---
Confidence 86644322 2235689999999999765 589999999999999999999999998887776666554211111
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
......++.++.+||.+||+.||.+||++.+++.|+|++....
T Consensus 240 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 240 ----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ----------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ----------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 1123457999999999999999999999999999999986544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=352.08 Aligned_cols=263 Identities=24% Similarity=0.389 Sum_probs=206.6
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc---ccchHHHHHHHHHc-CCCceeeeceeeeecCCC-Cce
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSK-DEL 148 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~~~ 148 (395)
...++|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.+ +||||+++++++...... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 4556899999999999999999999999999999998643 34456799999998 799999999998653321 145
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++||||+++ +|.+.+.... ...+++..++.++.||+.||.|||+ +||+|+||||+||+++ .++.+||+|||++
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~-~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVS 176 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEC-TTCCEEECCCTTT
T ss_pred eEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEc-CCCCEEEeeCcCc
Confidence 68999999986 7776665432 3578999999999999999999999 6999999999999999 7889999999998
Q ss_pred cccccCC-cceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 228 KVLVKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 228 ~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
....... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----- 251 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA----- 251 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----
Confidence 7654332 2334578999999999852 34588999999999999999999999988777665554433100
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
+ ......++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 252 --------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 252 --------------P--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp --------------C--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred --------------c--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 0 001235689999999999999999999999999999998743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=364.79 Aligned_cols=283 Identities=25% Similarity=0.408 Sum_probs=209.0
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
..++|++.+.||+|+||.||+|.+..+|..||+|++... .....+|+.+++.++||||+++++++. +...
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 105 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 105 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCE
Confidence 345799999999999999999999999999999998654 233457899999999999999999984 4455
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC-CceeccCCCCceeecCCCCcEEEeecccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
+++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ + ||+||||||+|||++ .++.+||+|||++
T Consensus 106 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVN-SRGEIKLCDFGVS 179 (360)
T ss_dssp EEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEEC-TTCCEEECCCCCC
T ss_pred EEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEEC-CCCCEEEEECCCC
Confidence 8999999986 76666654 3568999999999999999999998 5 899999999999999 6889999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh-h-
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-R- 305 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~- 305 (395)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+............ .
T Consensus 180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 180 GQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HHHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 765332 23346789999999999764 5899999999999999999999999987765543332211110000000 0
Q ss_pred -hcCCCCCCCCCCC------------ccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 306 -CMNPNYTDFRFPQ------------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 306 -~~~~~~~~~~~~~------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
........+.... .............++.++.+||++||+.||.+|||++|+|+||||+......
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 335 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence 0000000000000 0000000111234688999999999999999999999999999998765443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=350.39 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=206.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
..+|.+.+.||+|+||.||+|.+..+|+.||||.+.... ....+|+.+++.++||||+++++++. ....+++|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEEEE
Confidence 346999999999999999999999999999999986543 34568999999999999999999984 34458999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||++| +|.+.+.. ....+++..++.++.||+.||.|||+ .||+|+||||+||+++ .++.+||+|||++.....
T Consensus 103 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 103 MEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCCTTCEECBT
T ss_pred eecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEEC-CCCCEEEeecccchhhhh
Confidence 999986 66555542 24678999999999999999999999 6999999999999999 688999999999976644
Q ss_pred CCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 233 GEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 233 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+.... .+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~------------ 243 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PP------------ 243 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC------------
T ss_pred hccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-Cc------------
Confidence 322 3345789999999999654 48999999999999999999999999877665544433210 00
Q ss_pred CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
....+..++..+.+||.+||..||.+|||+.++++||||+....
T Consensus 244 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 244 -------------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp -------------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred -------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 00012346899999999999999999999999999999987553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=355.86 Aligned_cols=269 Identities=26% Similarity=0.398 Sum_probs=191.8
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
...+|.+.+.||+|+||.||+|.+..+|+.||||.+... .....+|+.+++.++||||+++++++. ....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SSSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecCC
Confidence 345799999999999999999999889999999988533 233457888899999999999999884 3345
Q ss_pred EEEEEecccc-hHHHHHHhhcc----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSS----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
.++||||++| +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLG-EDGSVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEC-TTCCEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEc-CCCCEEEEec
Confidence 8999999975 66666654322 24568999999999999999999999 6999999999999999 6889999999
Q ss_pred ccccccccCC------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016115 225 GSAKVLVKGE------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (395)
Q Consensus 225 g~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~ 298 (395)
|++....... ......||+.|+|||++.+...++.++||||||+++|+|++|..||............... .
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~ 243 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN--D 243 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--S
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--C
Confidence 9987654322 1234568999999999865445899999999999999999999999887665544333221 0
Q ss_pred CChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
.. ..............++.++.+||.+||+.||.+|||+.++++||||++....
T Consensus 244 ~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 244 PP-----------------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp CC-----------------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred CC-----------------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 00 0000000111234678999999999999999999999999999999986653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=349.02 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=208.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
..|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++|+||+++++++. +...++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 96 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLW 96 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEE
Confidence 46999999999999999999999999999999986432 34567999999999999999999884 344589
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||++| ++.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 97 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQL 169 (303)
T ss_dssp EEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEEC-CCCCEEEeecccceec
Confidence 99999986 5555443 3678999999999999999999999 6999999999999999 6889999999999776
Q ss_pred ccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+... .+
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------- 236 (303)
T 3a7i_A 170 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP---------- 236 (303)
T ss_dssp BTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC----------
T ss_pred CccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC----------
Confidence 5433 23345789999999999654 5899999999999999999999999987766655544331 00
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
..+...++..+.+||.+||+.||.+|||+.++++||||....
T Consensus 237 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 237 ----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp ----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred ----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 012345789999999999999999999999999999997643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=347.35 Aligned_cols=258 Identities=25% Similarity=0.438 Sum_probs=201.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.|.....||+|+||.||+|.+..++..||||.+.... ....+|+.+++.++||||+++++++ ......++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF-----SENGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEE-----EeCCcEEEE
Confidence 3445568999999999999999999999999986432 3345799999999999999999998 444568999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||+++ +|.+.+.. ......+++..++.++.||+.||.|||+ +||+|+||||+||+++..++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 98 MEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EECCSEEEHHHHHHH-TTCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEeCCCCCHHHHHHh-hccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999975 66555544 2223456789999999999999999999 69999999999999984488999999999986643
Q ss_pred CCc-ceeeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 233 GEA-NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 233 ~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
... .....||+.|+|||++.+. ..++.++||||||+++|+|++|..||..................
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 243 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------ 243 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC------------
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc------------
Confidence 322 3345789999999998643 23789999999999999999999999765433322111111110
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
...++..++.++.+||.+||+.||.+|||+.++++||||+....
T Consensus 244 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 244 --------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred --------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 01133457899999999999999999999999999999987554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=349.95 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=196.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
...+|++.+.||+|+||+||+|++ +|..||||++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 345799999999999999999987 68899999986432 2345799999999999999999998 4445
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC--ceeccCCCCceeecCCCCcEEEeecc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
.+++||||+.| +|.+.+... .....+++..++.++.||+.||.|||+ +| |+||||||+|||++ .++.+||+|||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg 184 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVD-KKYTVKVCDFG 184 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHST-THHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEEC-TTCCEEECCCC
T ss_pred ceEEEEecCCCCcHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEe-CCCcEEECCCC
Confidence 58999999986 666655532 112348999999999999999999999 69 99999999999999 78899999999
Q ss_pred cccccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 226 SAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 226 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
+++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+.....
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------- 256 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK------- 256 (309)
T ss_dssp -----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC-------
T ss_pred CCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------
Confidence 9976543322 3346789999999999765 489999999999999999999999998877766555432111
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc--CCCCcCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDEL 366 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~--hp~~~~~ 366 (395)
...++..+++++.+||.+||+.||.+|||+.++++ .+|++..
T Consensus 257 --------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 --------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred --------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 01133567999999999999999999999999987 5666543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=357.74 Aligned_cols=265 Identities=23% Similarity=0.359 Sum_probs=184.5
Q ss_pred cccCceeee-eeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 75 QTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 75 ~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
-.++|.+.+ .||+|+||+||+|++..+|+.||||++........+....++.++|+||+++++++.... .....+++|
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv 104 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLII 104 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEEE
Confidence 445799954 699999999999999999999999999776555555555678889999999999885422 235568999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCcEEEeeccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKVL 230 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~ 230 (395)
|||+.| +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||+++..
T Consensus 105 ~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 105 MECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999986 776666542 23579999999999999999999999 699999999999999732 456999999999765
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||..................
T Consensus 182 ~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 247 (336)
T 3fhr_A 182 TQN-ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL------------ 247 (336)
T ss_dssp -----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC------------------------------
T ss_pred ccc-ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc------------
Confidence 433 23456789999999998554 4899999999999999999999999776544322211111000
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
..+.++ ......+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 248 -~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 248 -GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000000 01124579999999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=347.59 Aligned_cols=258 Identities=26% Similarity=0.371 Sum_probs=205.1
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..+|++.+.||+|+||.||+|++..++..||+|.+.... ....+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence 457999999999999999999999999999999884321 2345799999999999999999988 5556
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILID-SNKTLKIFDFGIA 158 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEECCCSSS
T ss_pred eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEEeCCCc
Confidence 69999999986 66666654 3578999999999999999999999 6999999999999999 6889999999999
Q ss_pred cccccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 228 KVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 228 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
........ .....||+.|+|||++.+. .++.++||||||+++|+|+||..||.+.+..+........ ..+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~----- 230 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SVP----- 230 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--CCC-----
T ss_pred cccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--cCC-----
Confidence 87644322 2345689999999999765 4899999999999999999999999988776655443321 000
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
.........+++.+.++|.+||+.||.+||+..+.+.+.|..-+.+.
T Consensus 231 -----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 231 -----------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -----------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -----------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 01112335678999999999999999999977777777776655443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=352.34 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=206.2
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHHcC--CCceeeeceeeeec
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMD--HPNVISLKHCFFST 142 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~--h~niv~~~~~~~~~ 142 (395)
...+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++ |+||+++++++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~--- 117 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--- 117 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE---
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE---
Confidence 4457999999999999999999999999999999986432 33457999999996 59999999998
Q ss_pred CCCCceeEEEEEeccc--chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEE
Q 016115 143 TSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (395)
Q Consensus 143 ~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~k 220 (395)
......++|||++. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+++.+|
T Consensus 118 --~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 118 --ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp --ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEE
T ss_pred --ecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEE
Confidence 44556899999997 577776654 3578999999999999999999999 69999999999999985578999
Q ss_pred EeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
|+|||+++..... ......||+.|+|||++.+...++.++||||||+++|+|++|..||..... +.. +.
T Consensus 191 L~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~-- 259 (320)
T 3a99_A 191 LIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQ-- 259 (320)
T ss_dssp ECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CC--
T ss_pred EeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--cc--
Confidence 9999999876443 334567899999999997665457889999999999999999999975321 111 00
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
..+...+++++.+||.+||+.||.+|||++++++||||+....
T Consensus 260 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 260 -------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp -------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred -------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 0123457899999999999999999999999999999987654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=348.92 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=190.3
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
....+|.+.+.||+|+||.||+|.+..+|+.||||++..... ...++..+++.++||||+++++++ .+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-----~~~ 96 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF-----ITN 96 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE-----ecC
Confidence 345679999999999999999999999999999999864321 122344567888999999999998 444
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC-CceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+++||||+++.+...... ....+++..++.++.||+.||.|||+ + ||+||||||+||+++ .++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~ 171 (318)
T 2dyl_A 97 TDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLD-ERGQIKLCDFGI 171 (318)
T ss_dssp SEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEEC-TTSCEEECCCTT
T ss_pred CcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEEC-CCCCEEEEECCC
Confidence 56899999996654444332 24678999999999999999999998 5 999999999999999 788999999999
Q ss_pred ccccccCCcceeeeecccccCchhhc----CCCCCCcccchHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~ 301 (395)
+.............||+.|+|||++. ....++.++||||||+++|+|++|..||... ...+.+..+... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~- 248 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE--EPP- 248 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS--CCC-
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc--CCC-
Confidence 98766555555667899999999985 2345889999999999999999999999874 444444444331 000
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
.++ ....++.++.+||.+||+.||.+|||+.++++||||+....
T Consensus 249 -------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 249 -------------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp -------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred -------------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 000 11246899999999999999999999999999999987543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=343.15 Aligned_cols=257 Identities=25% Similarity=0.356 Sum_probs=197.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCC--------C
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTS--------K 145 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--------~ 145 (395)
.+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++..... .
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 46999999999999999999999999999999986443 334579999999999999999998754321 3
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
....+++||||++| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~-~~~~~kl~df 160 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFID-ESRNVKIGDF 160 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECCC
T ss_pred cCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEc-CCCCEEEeeC
Confidence 35678999999985 77666654 23567889999999999999999999 6999999999999999 7889999999
Q ss_pred ccccccccC---------------CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH-H
Q 016115 225 GSAKVLVKG---------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-Q 288 (395)
Q Consensus 225 g~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~ 288 (395)
|++...... .......||+.|+|||++.+...++.++||||||+++|+|++ ||....... .
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 999765422 122345689999999999766568999999999999999998 554332222 2
Q ss_pred HHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 289 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
...+... . .. +...+....+..+.+||++||+.||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~-~----------------~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 238 LKKLRSV-S----------------IE--------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHST-T----------------CC--------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHhcccc-c----------------cc--------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 2221110 0 00 1111334567889999999999999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=353.95 Aligned_cols=273 Identities=21% Similarity=0.324 Sum_probs=207.3
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---------------------cchHHHHHHHHHcCCCcee
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------------RYKNRELQLMRLMDHPNVI 133 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------------------~~~~~e~~~l~~l~h~niv 133 (395)
...+|.+.+.||+|+||.||+|.+ +|+.||||.+.... ....+|+.+++.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 345899999999999999999998 89999999985331 4456899999999999999
Q ss_pred eeceeeeecCCCCceeEEEEEecccc-hHHHHHHhh--ccc--CCCCCHHHHHHHHHHHHHHHHHHhc-CCCceeccCCC
Q 016115 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY--SSM--NQRMPLIYVKLYTYQIFRGLAYIHT-VPGVCHRDVKP 207 (395)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~--~~~~~~~~~~~i~~~i~~al~~LH~-~~~ivH~Dlkp 207 (395)
++++++ .+...+++||||++| +|.+.+... ... ...+++..++.++.||+.||.|||+ . ||+||||||
T Consensus 107 ~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p 180 (348)
T 2pml_X 107 TCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKP 180 (348)
T ss_dssp CCSEEE-----ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCCCG
T ss_pred eEEEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCCCh
Confidence 999998 444568999999997 433331100 222 5779999999999999999999997 5 999999999
Q ss_pred CceeecCCCCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCc-ccchHhHHHHHHHHHhCCCCCCCCCh-
Q 016115 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT-SIDIWSAGCVLAELLLGQPLFPGENA- 285 (395)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~~lltg~~pf~~~~~- 285 (395)
+||+++ .++.+||+|||++...... ......||..|+|||++.+...++. ++||||||+++|+|++|..||.....
T Consensus 181 ~Nil~~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 181 SNILMD-KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp GGEEEC-TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred HhEEEc-CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999 7889999999999876443 3345678999999999976534555 99999999999999999999988766
Q ss_pred HHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
.+....+.......+.. ...+ ..... ..........++.++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 259 ~~~~~~i~~~~~~~~~~--------~~~~-~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLD--------RNHF-LYPLT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHHHTSCCCCCCCS--------SSSS-TTTTC-C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhccCcCCccc--------hhhh-hcccc-ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 44444332210000000 0000 00000 00011122567999999999999999999999999999999987
Q ss_pred CC
Q 016115 366 LR 367 (395)
Q Consensus 366 ~~ 367 (395)
..
T Consensus 329 ~~ 330 (348)
T 2pml_X 329 TN 330 (348)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=351.21 Aligned_cols=264 Identities=26% Similarity=0.358 Sum_probs=187.4
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-----chHHHHH-HHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
...+|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+|+. +++.++||||+++++++. +..
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~ 94 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REG 94 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCC
Confidence 44579999999999999999999999999999999865321 1223444 667789999999999984 445
Q ss_pred eEEEEEecccchHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcCC-CceeccCCCCceeecCCCCcEEEeeccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..++||||++|++.+.+..... ....+++..++.++.|++.||.|||+ + ||+||||||+|||++ .++.+||+|||+
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~ 172 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLD-RSGNIKLCDFGI 172 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEE-TTTEEEECCCSS
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEc-CCCCEEEccCCC
Confidence 6899999999988877764322 35778999999999999999999999 7 999999999999999 788999999999
Q ss_pred ccccccCCcceeeeecccccCchhhc---CCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTRE 302 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~ 302 (395)
++............||+.|+|||++. ....++.++||||||+++|+|++|..||....... .+..+
T Consensus 173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---------- 242 (327)
T 3aln_A 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV---------- 242 (327)
T ss_dssp SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC----------
T ss_pred ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH----------
Confidence 98776555555567899999999983 23458999999999999999999999998643211 00000
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
.....+ .+.......+++.+.+||.+||+.||.+|||+.++++||||....+.
T Consensus 243 ---------~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 243 ---------VKGDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295 (327)
T ss_dssp ---------CCSCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred ---------hcCCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence 000000 01111224578999999999999999999999999999999876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=353.61 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=202.4
Q ss_pred ccccCceeeeeeecCCceEEEEEEEC-------CCCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeee
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFF 140 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~ 140 (395)
...++|.+.+.||+|+||.||+|++. .++..||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~- 156 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 156 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE-
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-
Confidence 34568999999999999999999874 345679999986542 2345799999999 899999999998
Q ss_pred ecCCCCceeEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCC
Q 016115 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (395)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp 207 (395)
.+...+|+||||+.| +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||
T Consensus 157 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp 231 (370)
T 2psq_A 157 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAA 231 (370)
T ss_dssp ----CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCG
T ss_pred ----ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccch
Confidence 444558999999986 77777665321 13468999999999999999999999 6999999999
Q ss_pred CceeecCCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCC
Q 016115 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 283 (395)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~ 283 (395)
+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+.
T Consensus 232 ~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 232 RNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp GGEEEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hhEEEC-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999 788999999999986544322 2234567889999999765 48999999999999999999 99999987
Q ss_pred ChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+....+.... ....+..++.++.+||.+||+.||.+|||+.|++++
T Consensus 310 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PVEELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CGGGHHHHHHTTC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7665554433210 011234578999999999999999999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=347.07 Aligned_cols=247 Identities=19% Similarity=0.228 Sum_probs=199.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.+|.+.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.+ +|+||+++++++ .+....++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG-----PCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEE-----EETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEE-----ecCCccEEE
Confidence 4799999999999999999999999999999998643 34567899999999 999999999988 444568999
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCc-----EEEeeccccc
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAK 228 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~-----~kl~Dfg~a~ 228 (395)
|||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++. +||+|||+++
T Consensus 84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~-~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 84 LELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIG-RPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-CGGGTCTTSEEECCCTTCE
T ss_pred EEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeec-cCCCCCCceEEEEEcccce
Confidence 999987888777653 4679999999999999999999999 6999999999999998 5665 9999999998
Q ss_pred ccccCCc--------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Q 016115 229 VLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLG 297 (395)
Q Consensus 229 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~ 297 (395)
....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+. .+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 7644332 2356789999999999764 489999999999999999999999987433 333333332211
Q ss_pred CCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+.. .....++ ++.+||.+||+.||.+||+++++++
T Consensus 238 ~~~~~------------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIE------------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHH------------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHH------------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11110 0112234 8999999999999999999988875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=344.89 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=199.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.++|.+.+.||+|+||+||+|.+..+|+.||+|++... .....+|+++++.++||||+++++++. +....+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeE
Confidence 45799999999999999999999999999999988542 234557999999999999999999984 445589
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||+.| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVR-ENKNVVVADFGLARLM 158 (310)
T ss_dssp EEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEEC-CCCCEEEeecccceec
Confidence 99999986 66655543 24678999999999999999999999 6999999999999999 7889999999999866
Q ss_pred ccCCcc---------------eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016115 231 VKGEAN---------------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295 (395)
Q Consensus 231 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~ 295 (395)
...... ....||+.|+|||++.+. .++.++||||||+++|+|++|..||.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------ 231 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------ 231 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT------
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH------
Confidence 433221 145789999999999764 5899999999999999999999998753211000
Q ss_pred hCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
.............+..+++.+.+||.+||+.||.+|||+.++++ |++.++
T Consensus 232 --------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~ 281 (310)
T 3s95_A 232 --------------------FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR 281 (310)
T ss_dssp --------------------SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred --------------------HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence 00000000011124567889999999999999999999999986 555443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=342.28 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=197.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcC--CCceeeeceeeeecCCCCc
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD--HPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~ 147 (395)
..+|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+|+.+++.++ |+||+++++++ .+.
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~ 100 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITD 100 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE-----ECS
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe-----ecC
Confidence 346999999999999999999974 58999999985432 33457999999997 59999999988 445
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..+++|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||++
T Consensus 101 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~--~~~~kL~Dfg~~ 173 (313)
T 3cek_A 101 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIA 173 (313)
T ss_dssp SEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSSS
T ss_pred CEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE--CCeEEEeecccc
Confidence 56899999888888887765 3578999999999999999999999 6999999999999997 478999999999
Q ss_pred cccccCCc---ceeeeecccccCchhhcCC----------CCCCcccchHhHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 016115 228 KVLVKGEA---NISYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEII 293 (395)
Q Consensus 228 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~ 293 (395)
........ .....||+.|+|||++.+. ..++.++||||||+++|+|++|..||...... ..+..+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence 87644332 2245689999999998641 35888999999999999999999999865432 2222221
Q ss_pred HHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
. .. ....++...+.++.+||.+||+.||.+|||+.|+++||||+....+.
T Consensus 254 ~---~~------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~ 303 (313)
T 3cek_A 254 D---PN------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303 (313)
T ss_dssp C---TT------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC----
T ss_pred h---cc------------------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCch
Confidence 1 00 00112334578999999999999999999999999999998755433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=356.64 Aligned_cols=256 Identities=18% Similarity=0.207 Sum_probs=205.1
Q ss_pred cccCceeeeeeecCCceEEEEEE-----ECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (395)
...+|.+.+.||+|+||+||+|. +..++..||||++... .....+|+.+++.++||||+++++++
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~----- 143 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS----- 143 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence 44679999999999999999999 4457789999998542 22345799999999999999999998
Q ss_pred CCceeEEEEEecccc-hHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCc
Q 016115 145 KDELFLNLVMEYVPE-TMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQ 218 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~ 218 (395)
.+....++||||+.| +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. +..
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCce
Confidence 444457899999975 77777765432 23568999999999999999999999 699999999999999831 235
Q ss_pred EEEeecccccccccC---CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016115 219 VKLCDFGSAKVLVKG---EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (395)
Q Consensus 219 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~ 294 (395)
+||+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999755322 222335678899999999764 48999999999999999998 9999998887776665544
Q ss_pred HhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
... ...+..++..+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 302 ~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 302 GGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 210 0122456889999999999999999999999999987643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=336.11 Aligned_cols=249 Identities=18% Similarity=0.230 Sum_probs=202.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+ +|+|++++++++ .+....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeEE
Confidence 34799999999999999999999999999999988643 34567899999999 799999999988 45556899
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCc-----EEEeecccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSA 227 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~-----~kl~Dfg~a 227 (395)
||||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++. +||+|||++
T Consensus 84 v~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~-~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 84 VIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIG-RPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEEC-CSSSTTTTCEEECCCTTC
T ss_pred EEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEec-cCCCCCCCeEEEEECccc
Confidence 9999988888777643 3469999999999999999999999 6999999999999998 4444 999999999
Q ss_pred cccccCCc--------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHh
Q 016115 228 KVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVL 296 (395)
Q Consensus 228 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~---~~~~~~~~~~~~~ 296 (395)
+....... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||... ...+.+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 87654422 2345689999999999664 4899999999999999999999999874 3334444433321
Q ss_pred CCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..... ......+++++.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~------------------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 238 QSTPL------------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHSCH------------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCccH------------------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 11111 1122357899999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=345.93 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=199.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCc---EEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
...+|.+.+.||+|+||.||+|++..+|+ .||||++... .....+|+.+++.++||||+++++++ .+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TR 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 44579999999999999999999986655 4999998643 23345799999999999999999998 55
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
....++||||++| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~-~~~~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVD-SNLVCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEC-CCCCEEECCCC
Confidence 5568999999976 66555543 23579999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 226 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 226 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
+++........ ....+|..|+|||++.+. .++.++||||||+++|+|++ |..||......+....+......
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-- 273 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-- 273 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC--
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC--
Confidence 99876443221 123457789999999654 48999999999999999999 99999988887766665442110
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+..+++.+.+||.+||..||.+|||+.++++
T Consensus 274 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 --------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 122457899999999999999999999999985
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=335.45 Aligned_cols=246 Identities=18% Similarity=0.297 Sum_probs=202.1
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
...+|++.+.||+|+||.||+|.+. ++..||+|++.... ....+|+.+++.++||||+++++++ .+....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence 3457999999999999999999986 57789999987543 3456899999999999999999998 4455589
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||+++ ++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-GGGCEEECCTTGGGGB
T ss_pred EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEc-CCCCEEeccccccccc
Confidence 99999986 55555543 23568999999999999999999999 6999999999999998 6889999999999865
Q ss_pred ccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 231 VKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 231 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
..... .....+|..|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------- 225 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------- 225 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred cccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----------
Confidence 43321 2234457789999999654 48999999999999999999 9999998887776665543210
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 226 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 226 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 01223468999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=340.45 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=207.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecC-----------CC
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTT-----------SK 145 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----------~~ 145 (395)
.+|.+.+.||+|+||.||+|++..+|+.||+|++........+|+++++.++||||+++++++.... ..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 4699999999999999999999999999999999877777889999999999999999999874311 12
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
....+++||||+++ +|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~Df 166 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLV-DTKQVKIGDF 166 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEE-ETTEEEECCC
T ss_pred CcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEc-CCCCEEECcc
Confidence 24568999999996 7777765432 3578999999999999999999999 6999999999999999 7889999999
Q ss_pred ccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 225 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
|++.............||+.|+|||++.+. .++.++||||||+++|+|++|..||... ......+..
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~---------- 233 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD---------- 233 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT----------
T ss_pred hhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc----------
Confidence 999877665555566789999999999764 4899999999999999999999887421 111111110
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
..+...++..+.+||.+||..||.+|||+.|+++|.|.-.
T Consensus 234 ---------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 ---------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ---------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ---------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0022346889999999999999999999999999987643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=362.17 Aligned_cols=273 Identities=22% Similarity=0.333 Sum_probs=203.0
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
..+|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+++++.++||||+++++++... +....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence 347999999999999999999999999999999986432 3345799999999999999999988432 23357
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceee----cCCCCcEEEeecc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV----DPLTHQVKLCDFG 225 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill----~~~~~~~kl~Dfg 225 (395)
++||||+.| +|.+.+... .....+++..++.++.||+.||.|||+ +||+||||||+|||+ + .++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGED-GQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSG-GGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTT-SCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCC-CceeEEEecCC
Confidence 899999985 555555432 223449999999999999999999999 699999999999998 5 56789999999
Q ss_pred cccccccCCcceeeeecccccCchhhcCC-------CCCCcccchHhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHH
Q 016115 226 SAKVLVKGEANISYICSRYYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQPLFPGE----NAVDQLVEIIK 294 (395)
Q Consensus 226 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~lltg~~pf~~~----~~~~~~~~~~~ 294 (395)
+++............||+.|+|||++.+. ..++.++|||||||++|+|++|..||... ...+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 99887666555667899999999998541 34788999999999999999999999753 23334444333
Q ss_pred HhCCCChhhhhhcCC-CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 295 VLGTPTREEIRCMNP-NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 295 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+.+ ...+..... ....+.+. ...+....+...++..+.+||.+||+.||++|||+.++++
T Consensus 242 --~~p-~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 242 --GKP-SGAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp --SCC-TTCCEEEECSTTCCEEEE--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred --CCC-cccchhheeccCCCcccC--ccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 221 111110000 00000000 0011111223445678999999999999999999999854
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=345.27 Aligned_cols=265 Identities=20% Similarity=0.252 Sum_probs=189.1
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCc---EEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (395)
....+|.+.+.||+|+||.||+|.+..++. .||||++... .....+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 344579999999999999999999877765 8999998643 2334579999999999999999998854332
Q ss_pred CC-ceeEEEEEecccc-hHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEE
Q 016115 145 KD-ELFLNLVMEYVPE-TMYRVLKHYSS--MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (395)
Q Consensus 145 ~~-~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~k 220 (395)
.. ....++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+|
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~-~~~~~k 177 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLA-EDMTVC 177 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-TTSCEE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEc-CCCCEE
Confidence 11 1234899999986 66666654322 22368999999999999999999999 6999999999999999 788999
Q ss_pred EeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 016115 221 LCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL 296 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~ 296 (395)
|+|||+++........ ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 9999999876444322 234457789999999764 48999999999999999999 999999887766655544311
Q ss_pred CCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-------HHHHhcCCCCcCCCCC
Q 016115 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-------ALEACAHPFFDELREP 369 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-------~~ell~hp~~~~~~~~ 369 (395)
. ...+..+++++.+||.+||+.||.+||| +++++.|||+......
T Consensus 257 ~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 257 R----------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp C----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred C----------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 0 0122457899999999999999999999 7888899999875543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=348.73 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=201.0
Q ss_pred cccCceeeeeeecCCceEEEEEE-----ECCCCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (395)
..++|.+.+.||+|+||.||+|+ +..+++.||||++.... ....+|+++++.+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 34579999999999999999998 55677899999986532 2356799999999 789999999988432
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhccc---------------------------------------------------
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSM--------------------------------------------------- 171 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------------------------------------- 171 (395)
...+++||||+.| +|.+.+......
T Consensus 99 ---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 99 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 2347899999985 666666543211
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCc---ce
Q 016115 172 -----------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NI 237 (395)
Q Consensus 172 -----------~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~ 237 (395)
...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++....... ..
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEc-CCCcEEEEeccceeeecccccchhcc
Confidence 1228999999999999999999999 6999999999999999 788999999999986543322 23
Q ss_pred eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCC
Q 016115 238 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316 (395)
Q Consensus 238 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
...||+.|+|||++.+. .++.++|||||||++|+|+| |..||.+....+.+..........
T Consensus 254 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 315 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------------- 315 (359)
T ss_dssp -CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------
T ss_pred ccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-----------------
Confidence 45678899999999754 58999999999999999998 999998876555544444321110
Q ss_pred CCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 317 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 316 ----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1224578999999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=357.99 Aligned_cols=257 Identities=29% Similarity=0.405 Sum_probs=190.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEEEEe
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVME 155 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (395)
.|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +||||+++++++ .+...+++|||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEEe
Confidence 57778999999999998654 5689999999986543 3346799999876 899999999988 55566999999
Q ss_pred cccchHHHHHHhhcccCCC---CCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC------------CCCcEE
Q 016115 156 YVPETMYRVLKHYSSMNQR---MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------------LTHQVK 220 (395)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~---~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~------------~~~~~k 220 (395)
||+|+|.+.+......... .++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+|
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 9999988887653322111 1333467899999999999999 69999999999999973 235899
Q ss_pred EeecccccccccCCc-----ceeeeecccccCchhhcC------CCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHH
Q 016115 221 LCDFGSAKVLVKGEA-----NISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 288 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~ 288 (395)
|+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++|+|+| |..||......+
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 999999987654432 123578999999999965 2458999999999999999999 999997654433
Q ss_pred HHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 289 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
..+..... ..+... ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 248 -~~i~~~~~-----------------~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 -SNIIRGIF-----------------SLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp -HHHHHTCC-----------------CCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred -HHHhcCCC-----------------Cccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 22222100 000000 0011235688999999999999999999999999999964
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=333.10 Aligned_cols=244 Identities=26% Similarity=0.399 Sum_probs=189.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc--------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..+|.+.+.||+|+||.||+|.+ +|..||||++.... ....+|+.+++.++||||+++++++ .+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence 45799999999999999999997 58899999885431 2345799999999999999999998 455
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC---ceeccCCCCceeecC-------CCC
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG---VCHRDVKPQNLLVDP-------LTH 217 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~---ivH~Dlkp~Nill~~-------~~~ 217 (395)
...++||||++|+.+..+.. ...+++..++.++.||+.||.|||+ +| |+||||||+||+++. .++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred CceEEEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCc
Confidence 56899999998643333322 4679999999999999999999999 68 899999999999983 267
Q ss_pred cEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 016115 218 QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297 (395)
Q Consensus 218 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~ 297 (395)
.+||+|||++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+....
T Consensus 154 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~- 230 (271)
T 3dtc_A 154 ILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK- 230 (271)
T ss_dssp CEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC-
T ss_pred ceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC-
Confidence 89999999998654433 2345789999999999754 48999999999999999999999999887666554433210
Q ss_pred CCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.....+..+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 231 --------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 231 --------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp --------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0011234678999999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=358.00 Aligned_cols=255 Identities=27% Similarity=0.389 Sum_probs=191.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHHc-CCCceeeeceeeeecCCCCceeEEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
.+|.+.+.||+|+||+||. ....+|+.||||++... .....+|+.+++.+ +|||||++++++ .+...+|+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEE
Confidence 3699999999999999763 33568999999998644 34567899999999 799999999988 5555689999
Q ss_pred ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC----CCCcEEEeeccccccc
Q 016115 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVL 230 (395)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~----~~~~~kl~Dfg~a~~~ 230 (395)
|||+|+|.+.+.... ....+..++.++.||+.||.|||+ +||+||||||+|||++. ....+||+|||+++..
T Consensus 98 E~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCAATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCSEEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCCCCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 999999888776432 234444567899999999999999 69999999999999952 2236889999999876
Q ss_pred ccCC----cceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 231 VKGE----ANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 231 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
.... ......||+.|+|||++.+ ...++.++|||||||++|+|+| |..||.......... + .+....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~---~~~~~~-- 247 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-L---LGACSL-- 247 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-H---TTCCCC--
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-H---hccCCc--
Confidence 5432 2234578999999999964 3446789999999999999999 999997654332211 1 111000
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
... ......+..+.+||.+||+.||.+|||+.++++||||..+.
T Consensus 248 -------------~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 248 -------------DCL-------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp -------------TTS-------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred -------------ccc-------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 000 00112356789999999999999999999999999997643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=344.85 Aligned_cols=249 Identities=25% Similarity=0.311 Sum_probs=202.3
Q ss_pred cccCceeeeeeecCCceEEEEEEEC-----CCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (395)
...+|.+.+.||+|+||.||+|++. .+++.||||++.... ....+|+.+++.++||||+++++++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 119 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC----- 119 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----
Confidence 3457999999999999999999986 355899999986542 3346799999999999999999998
Q ss_pred CCceeEEEEEecccc-hHHHHHHhhccc--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCceec
Q 016115 145 KDELFLNLVMEYVPE-TMYRVLKHYSSM--------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 203 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~ 203 (395)
.+...+++||||++| +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~ 198 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHR 198 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 444558999999986 777776653221 2678999999999999999999999 699999
Q ss_pred cCCCCceeecCCCCcEEEeecccccccccCC---cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCC
Q 016115 204 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 279 (395)
Q Consensus 204 Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~p 279 (395)
||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++||||||+++|+|+| |..|
T Consensus 199 Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 199 DLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCcceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCc
Confidence 9999999999 78899999999997654332 12345678899999998754 48999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 280 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
|.+.+..+....+... .. ...+..++..+.+||++||+.||.+|||+.++++
T Consensus 277 ~~~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 277 YYGMAHEEVIYYVRDG--NI--------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TTTSCHHHHHHHHHTT--CC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCChHHHHHHHhCC--Cc--------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 9988776665554431 00 0123457899999999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=338.05 Aligned_cols=248 Identities=29% Similarity=0.471 Sum_probs=188.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.+|++.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++|+||+++++++. ....
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 106 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 106 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCc
Confidence 4699999999999999999999999999999998642 223457999999999999999999984 3445
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.++||||+.+ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~-~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFIT-ATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEECCC----
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEc-CCCCEEEEecccee
Confidence 8999999986 7777777665566789999999999999999999999 6999999999999999 78899999999987
Q ss_pred ccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChhhhh
Q 016115 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 229 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 305 (395)
....... .....|++.|+|||++.+. .++.++||||||+++|+|++|..||.+... ......+... .
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-------- 254 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-D-------- 254 (310)
T ss_dssp --------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-C--------
T ss_pred eecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-c--------
Confidence 6544322 2345689999999999654 589999999999999999999999975432 1222221110 0
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
++ ......+++++.+||.+||..||.+|||+.++++
T Consensus 255 ----------~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 255 ----------YP--------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp ----------SC--------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------CC--------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 0012356899999999999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=331.05 Aligned_cols=246 Identities=19% Similarity=0.278 Sum_probs=202.0
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
...+|++.+.||+|+||.||+|.+. ++..||+|++.... ....+|+.+++.++||||+++++++ .+....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 4567999999999999999999875 57789999987543 3456799999999999999999998 5555689
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||++| ++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVD-RDLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEEC-TTCCEEECCTTCEEEC
T ss_pred EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEEC-CCCCEEEccCccceec
Confidence 99999975 566666542 3468999999999999999999999 6999999999999999 7889999999999866
Q ss_pred ccCCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 231 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
...... ....+|..|+|||++.+. .++.++||||||+++|+|+| |..||...+..+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR---------- 223 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred chhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC----------
Confidence 444322 223456779999999654 48999999999999999999 9999998887766655543110
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 224 ------------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123468899999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.66 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=203.8
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCC-------CcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeee
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFF 140 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~ 140 (395)
...++|.+.+.||+|+||.||+|++..+ +..||||++.... ....+|+++++.+ +||||+++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~- 144 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC- 144 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee-
Confidence 3456899999999999999999997543 3579999986542 3345799999999 899999999998
Q ss_pred ecCCCCceeEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCC
Q 016115 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (395)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp 207 (395)
.....+++||||++| +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||
T Consensus 145 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp 219 (382)
T 3tt0_A 145 ----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAA 219 (382)
T ss_dssp ----CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCG
T ss_pred ----ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCc
Confidence 444558999999986 77777765432 12469999999999999999999999 6999999999
Q ss_pred CceeecCCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCC
Q 016115 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 283 (395)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~ 283 (395)
+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...
T Consensus 220 ~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999 788999999999986644322 2234568899999999764 58999999999999999999 99999988
Q ss_pred ChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
+..+....+..... ...+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 298 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77665554443100 11234578999999999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=343.02 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=185.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcC-CCceeeeceeeeecCC---CCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMD-HPNVISLKHCFFSTTS---KDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~---~~~~ 148 (395)
.+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.+. ||||+++++++..... ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47999999999999999999999999999999885432 33457889999996 9999999998854322 4456
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC--ceeccCCCCceeecCCCCcEEEeeccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
.+++||||++|+|.+.+..... ...+++..++.++.||+.||.|||+ +| |+||||||+|||++ .++.+||+|||+
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLS-NQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEEC-TTSCEEBCCCTT
T ss_pred eEEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEEC-CCCCEEEecCcc
Confidence 6899999999998888765433 4579999999999999999999999 68 99999999999999 688999999999
Q ss_pred ccccccCCcc-------------eeeeecccccCchhhc--CCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 016115 227 AKVLVKGEAN-------------ISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291 (395)
Q Consensus 227 a~~~~~~~~~-------------~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~ 291 (395)
+......... ....||+.|+|||++. ....++.++||||||+++|+|++|..||...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9876443221 1445899999999983 234578999999999999999999999976443221110
Q ss_pred HHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 016115 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (395)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~ 362 (395)
. +. .......+..+.+||.+||+.||.+|||+.|+++|-+
T Consensus 265 ~---------------------~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 K---------------------YS----------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----------------------CC----------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred c---------------------cc----------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0 00 0012345778999999999999999999999998743
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=332.86 Aligned_cols=244 Identities=22% Similarity=0.343 Sum_probs=195.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----------cchHHHHHHHHHcCCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (395)
...+|++.+.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---- 92 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM---- 92 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee----
Confidence 3457999999999999999999999999999999985321 3445799999999999999999988
Q ss_pred CCCceeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC--ceeccCCCCceeecCCCCc--
Q 016115 144 SKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQ-- 218 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~--ivH~Dlkp~Nill~~~~~~-- 218 (395)
.+.. ++||||+. |++.+.+.. ....+++..++.++.||+.||.|||+ +| |+||||||+|||++ .++.
T Consensus 93 -~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~-~~~~~~ 164 (287)
T 4f0f_A 93 -HNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQ-SLDENA 164 (287)
T ss_dssp -TTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEES-CCCTTC
T ss_pred -cCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEe-ccCCCC
Confidence 3332 59999998 566555543 34679999999999999999999999 69 99999999999998 4554
Q ss_pred ---EEEeecccccccccCCcceeeeecccccCchhhcC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHH--HHHH
Q 016115 219 ---VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ--LVEI 292 (395)
Q Consensus 219 ---~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~ 292 (395)
+||+|||+++.... ......||+.|+|||++.+ ...++.++||||||+++|+|++|..||........ ...+
T Consensus 165 ~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 165 PVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp SCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred ceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 99999999975433 3445678999999999843 33478899999999999999999999986554332 2222
Q ss_pred HHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.. .+. ...++..+++.+.+||.+||+.||.+|||+.++++
T Consensus 243 ~~-~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 RE-EGL--------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HH-SCC--------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc-cCC--------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 21 110 11133467899999999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=350.33 Aligned_cols=248 Identities=21% Similarity=0.287 Sum_probs=202.1
Q ss_pred CccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.....+|.+.+.||+|+||.||+|++..+|+.||||.+... ...+.+|+++++.++||||+++++++ .+.
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 184 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQK 184 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecC
Confidence 34556899999999999999999999999999999998643 23455799999999999999999998 444
Q ss_pred eeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+++||||++ |+|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~-~~~~~kl~DfG~ 259 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVT-EKNVLKISDFGM 259 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEECCGGG
T ss_pred CCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEc-CCCcEEECcCCC
Confidence 45899999998 5666666542 3468999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 227 AKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 227 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
++........ ....++..|+|||++.+. .++.++|||||||++|+|+| |..||...+..+....+.....
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----- 333 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR----- 333 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-----
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 9865433221 112357789999999754 48999999999999999998 9999998877665544332100
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 334 -----------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 334 -----------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0123456889999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=343.47 Aligned_cols=268 Identities=22% Similarity=0.288 Sum_probs=203.5
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
..++|.+.+.||+|+||.||+|++ .+|+.||||++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~ 101 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-----MTPTE 101 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE-----CCSSC
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE-----ecCCc
Confidence 445799999999999999999984 478999999986432 2456899999999999999999998 44445
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC---CceeccCCCCceeecCCCCcEEEeecc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP---GVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
.++||||+.| +|.+.+.........+++..++.++.||+.||.|||+ + ||+||||||+|||++ .++.+||+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg 179 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLD-EEFEAVVGDFG 179 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEEC-TTCCEEECCCS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEEC-CCCCEEeccCc
Confidence 7899999986 7777776655556679999999999999999999999 7 999999999999999 78899999999
Q ss_pred cccccccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCC
Q 016115 226 SAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIKVLGTP 299 (395)
Q Consensus 226 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~~~~~~~~ 299 (395)
++........ .....||+.|+|||++.+. .++.++||||||+++|+|+||..||.... ..........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 253 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK----- 253 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT-----
T ss_pred cccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH-----
Confidence 9987643333 2334589999999999655 48999999999999999999999995211 0000111110
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
...................+....+..+.+||.+||+.||.+|||+.|+++|-+-..
T Consensus 254 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 254 ---------GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp ---------TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred ---------HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 001111111111111122233345678999999999999999999999998765433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=344.40 Aligned_cols=268 Identities=22% Similarity=0.220 Sum_probs=195.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
...+|++.+.||+|+||+||+|++ .++.||||++.... ....+|+.+++.++||||+++++++..... ....++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEE
T ss_pred chhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEE
Confidence 445799999999999999999987 48999999986443 223457888899999999999999855332 244578
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC----------CceeccCCCCceeecCCCCcEE
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP----------GVCHRDVKPQNLLVDPLTHQVK 220 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~----------~ivH~Dlkp~Nill~~~~~~~k 220 (395)
+||||+++ +|.+.+.. ..+++..++.++.||+.||.|||+ . ||+||||||+|||++ .++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~-~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLK-NNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEEC-TTCCEE
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEEC-CCCeEE
Confidence 99999986 77666654 458999999999999999999999 7 999999999999999 788999
Q ss_pred EeecccccccccCCc---ceeeeecccccCchhhcCC----CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016115 221 LCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~ 293 (395)
|+|||+++....... .....||+.|+|||++.+. ..++.++|||||||++|+|+||+.||.+...........
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999977654332 2235789999999999753 235568899999999999999999997653321111111
Q ss_pred HHhCCCChhhhhhc-CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 294 KVLGTPTREEIRCM-NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 294 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.....+....+... .........+. .......+.++.+||.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRD-------YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCG-------GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccc-------cccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111111111110 00000000000 0001123456999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=338.52 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=202.0
Q ss_pred ccccCceeeeeeecCCceEEEEEEEC-----CCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (395)
....+|.+.+.||+|+||.||+|.+. .++..||||++.... ....+|+.+++.++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 95 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC---- 95 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE----
Confidence 34567999999999999999999973 456899999986432 3345799999999999999999998
Q ss_pred CCCceeEEEEEeccc-chHHHHHHhhcc--------------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCcee
Q 016115 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS--------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 202 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH 202 (395)
.+...+++||||+. |+|.+.+..... ....+++..++.++.||+.||.|||+ +||+|
T Consensus 96 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH 173 (314)
T 2ivs_A 96 -SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVH 173 (314)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred -ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCcc
Confidence 44555899999998 577777665332 12458999999999999999999999 69999
Q ss_pred ccCCCCceeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCC
Q 016115 203 RDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 278 (395)
Q Consensus 203 ~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~ 278 (395)
|||||+||+++ .++.+||+|||++......... ....+|+.|+|||++.+. .++.++||||||+++|+|++ |..
T Consensus 174 ~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 174 RDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccchheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 7889999999999866443322 234567889999999764 48999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHh
Q 016115 279 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (395)
Q Consensus 279 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 358 (395)
||.+.........+.... ....+..+++++.+||.+||+.||.+|||+.+++
T Consensus 252 p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~ 303 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGH----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303 (314)
T ss_dssp SSTTCCGGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHhhcCC----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 998877655444333210 0012345789999999999999999999999998
Q ss_pred cC
Q 016115 359 AH 360 (395)
Q Consensus 359 ~h 360 (395)
++
T Consensus 304 ~~ 305 (314)
T 2ivs_A 304 KD 305 (314)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=333.05 Aligned_cols=247 Identities=18% Similarity=0.250 Sum_probs=199.7
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
....+|++.+.||+|+||.||+|.+. ++..||+|++.... ....+|+++++.++|+||+++++++ .+...+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence 34557999999999999999999875 67789999997542 3456899999999999999999998 455568
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||+.| +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||+++.
T Consensus 95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~-~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVN-DQGVVKVSDFGLSRY 169 (283)
T ss_dssp EEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEEC-TTSCEEECSTTGGGG
T ss_pred EEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEc-CCCCEEEcccccccc
Confidence 999999975 666655432 3568999999999999999999999 6999999999999999 788999999999986
Q ss_pred cccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 230 LVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 230 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
...... .....+|+.|+|||++.+. .++.++||||||+++|+|+| |..||...+..+....+.....
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------- 239 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------- 239 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---------
T ss_pred ccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC---------
Confidence 543321 1223457789999999754 48999999999999999998 9999998887776665544211
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 240 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 240 -------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 01223468899999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=335.62 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=202.5
Q ss_pred cccCceeeeeeecCCceEEEEEEE-----CCCCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (395)
...+|.+.+.||+|+||.||+|++ ..+++.||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 96 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE----
Confidence 345799999999999999999985 4577899999986432 3445799999999 899999999998
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhcc--------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCC
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS--------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~ 208 (395)
.+....++||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~ 174 (313)
T 1t46_A 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR 174 (313)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred -ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccc
Confidence 444458999999985 77777665321 12358999999999999999999999 69999999999
Q ss_pred ceeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 016115 209 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (395)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~ 284 (395)
||+++ .++.+||+|||++......... ....+|+.|+|||++.+. .++.++||||||+++|+|+| |..||....
T Consensus 175 Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 175 NILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eEEEc-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999 7889999999999876544332 234568889999998754 58999999999999999999 999998876
Q ss_pred hHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.............. ...+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhccCCC---------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 55555444442111 01123568999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=331.96 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=205.0
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
....+|.+.+.||+|+||.||+|.+..++..||+|.+..+. ....+|+.+++.++||||+++++++ .+...+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence 45567999999999999999999999999999999987543 3455799999999999999999998 455558
Q ss_pred EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||+. ++|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++..
T Consensus 85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVG-ENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEEC-GGGCEEECCCCGGGT
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEc-CCCCEEEccCcccee
Confidence 99999998 5777666542 23568999999999999999999999 6999999999999999 688999999999987
Q ss_pred cccCCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 230 LVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 230 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
....... ....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||...+.......+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~---------- 229 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------- 229 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------
T ss_pred ccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC----------
Confidence 6544322 234568889999999754 48999999999999999999 999998877655544433210
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 230 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 ------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 01123457899999999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.22 Aligned_cols=259 Identities=15% Similarity=0.132 Sum_probs=194.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCC-----CcEEEEEEecccccchHHHHH---------------HHHHcCCCceeee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYKNRELQ---------------LMRLMDHPNVISL 135 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~e~~---------------~l~~l~h~niv~~ 135 (395)
..+|.+.+.||+|+||.||+|.+..+ ++.||||++........+|++ .++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34799999999999999999998764 588999998765443434443 4455679999999
Q ss_pred ceeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC-
Q 016115 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP- 214 (395)
Q Consensus 136 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~- 214 (395)
++++.... .+..+.++||||++++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESS
T ss_pred Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecC
Confidence 99885532 23466899999997777777654 24679999999999999999999999 69999999999999972
Q ss_pred CCCcEEEeecccccccccCCcc--------eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChH
Q 016115 215 LTHQVKLCDFGSAKVLVKGEAN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286 (395)
Q Consensus 215 ~~~~~kl~Dfg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~ 286 (395)
.++.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|+|+||..||.+....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 3678999999999765433221 234589999999999765 4899999999999999999999999864333
Q ss_pred HHHHHHHH-HhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 287 DQLVEIIK-VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 287 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
........ ............. + ....+++++.+||..||..||.+||++.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~----------------~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKC----------------F---PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHH----------------S---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHh----------------c---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 22222221 1111111100000 0 01356899999999999999999999998874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=341.00 Aligned_cols=246 Identities=21% Similarity=0.304 Sum_probs=195.5
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcE----EEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
...+|++.+.||+|+||+||+|++..+|+. ||+|.+... .....+|+.+++.++||||+++++++ .
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~ 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-----P 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----c
Confidence 345799999999999999999999888876 677766432 23445799999999999999999987 2
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
+ ...++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 86 ~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~-~~~~~kl~Df 159 (325)
T 3kex_A 86 G-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLK-SPSQVQVADF 159 (325)
T ss_dssp B-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEES-SSSCEEECSC
T ss_pred C-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEEC-CCCeEEECCC
Confidence 2 237899999984 66655543 23578889999999999999999999 6999999999999999 6889999999
Q ss_pred ccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 225 GSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 225 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
|+++....... .....+|..|+|||++.+. .++.++||||||+++|+|+| |..||.+....+....+....
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---- 234 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---- 234 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC----
T ss_pred CcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----
Confidence 99987644332 2344567899999999754 48999999999999999999 999998876655544433210
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
....+..++.++.+||.+||..||.+|||+.++++|
T Consensus 235 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 235 ------------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ------------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ------------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001223457889999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=334.77 Aligned_cols=250 Identities=23% Similarity=0.263 Sum_probs=198.1
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.++|.+.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++|++++..+..+.. .....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEEE
Confidence 35799999999999999999999999999999986533 3456789999999999988887766643 33457899
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceee---cCCCCcEEEeeccccccc
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill---~~~~~~~kl~Dfg~a~~~ 230 (395)
|||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||+ + .++.+||+|||+++..
T Consensus 84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGG-GTTCEEECCCTTCEEC
T ss_pred EEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccC-CCCeEEEecCccceec
Confidence 999988887776632 3569999999999999999999999 699999999999999 5 6788999999999876
Q ss_pred ccCCc--------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCC
Q 016115 231 VKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLGTP 299 (395)
Q Consensus 231 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~~~~~~~~~ 299 (395)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.. ..+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 54432 2245789999999999765 4899999999999999999999999864322 2222222211101
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+. ......+++++.+||.+||+.||.+|||+.++++
T Consensus 238 ~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PI------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CH------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hh------------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 10 1122456899999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=341.88 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=201.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEE--EEEEeccc-----ccchHHHHHHHHHc-CCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETV--AIKKVLQD-----RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v--aiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (395)
...+|.+.+.||+|+||.||+|++..+|..+ |+|.+... .....+|+++++.+ +||||+++++++ .+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~ 97 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 97 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-----ee
Confidence 3457999999999999999999998888865 99988642 23456799999999 899999999998 44
Q ss_pred ceeEEEEEecccc-hHHHHHHhhc------------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~ 213 (395)
...+++||||+++ +|.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 176 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEc
Confidence 5568999999975 7777765432 234579999999999999999999999 6999999999999999
Q ss_pred CCCCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 016115 214 PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 292 (395)
Q Consensus 214 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~ 292 (395)
.++.+||+|||+++............+++.|+|||++.+. .++.++||||||+++|+|+| |..||.+.+..+....+
T Consensus 177 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 177 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp -GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred -CCCeEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 6889999999999754433333445668899999999654 48999999999999999998 99999988776654443
Q ss_pred HHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.... ....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 255 ~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 255 PQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2210 001223568999999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=330.60 Aligned_cols=251 Identities=23% Similarity=0.257 Sum_probs=200.1
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.++|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++|++++..+..+.. .....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEE
Confidence 35799999999999999999999999999999988643 3445689999999999988777665533 33457899
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec--CCCCcEEEeecccccccc
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~--~~~~~~kl~Dfg~a~~~~ 231 (395)
|||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ..++.+||+|||++....
T Consensus 84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 999988887777532 3579999999999999999999999 6999999999999994 257889999999998765
Q ss_pred cCCc--------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCC
Q 016115 232 KGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTPT 300 (395)
Q Consensus 232 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~~~~ 300 (395)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .+.+..+.......+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 4432 2345789999999999764 489999999999999999999999986432 222222222111111
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
. ......+++++.+||.+||+.||.+|||+.++++
T Consensus 239 ~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 I------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp H------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred h------------------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0 1122457899999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=340.63 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=201.5
Q ss_pred cccCceeeeeeecCCceEEEEEEE-----CCCCcEEEEEEeccc-----ccchHHHHHHHHHc-CCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQD-----RRYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (395)
...+|.+.+.||+|+||.||+|.+ ..++..||||++... .....+|+.+++.+ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC---- 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 446799999999999999999997 346678999998643 23456899999999 899999999998
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhccc-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCceec
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSM-------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 203 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------------------~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~ 203 (395)
.....+++||||++| +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||
T Consensus 119 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~ 196 (344)
T 1rjb_A 119 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHR 196 (344)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred -eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 444458999999975 777776543211 1347999999999999999999999 699999
Q ss_pred cCCCCceeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCC
Q 016115 204 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 279 (395)
Q Consensus 204 Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~p 279 (395)
||||+|||++ .++.+||+|||++......... ....||+.|+|||++.+. .++.++||||||+++|+|+| |..|
T Consensus 197 Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 197 DLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCChhhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999 7889999999999866444322 234568899999998654 48999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 280 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
|.+......+..+...... ...+..+++++.+||.+||..||.+|||+.++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp STTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCcHHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9887655554444431000 0122356899999999999999999999999998
Q ss_pred CCC
Q 016115 360 HPF 362 (395)
Q Consensus 360 hp~ 362 (395)
|-.
T Consensus 328 ~l~ 330 (344)
T 1rjb_A 328 FLG 330 (344)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=337.45 Aligned_cols=260 Identities=23% Similarity=0.280 Sum_probs=209.3
Q ss_pred CccccCceeeeeeecCCceEEEEEEEC-----CCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeec
Q 016115 73 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFST 142 (395)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~ 142 (395)
.....+|.+.+.||+|+||.||+|.+. .++..||||.+.... ....+|+.+++.++|+||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--- 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--- 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE---
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE---
Confidence 345568999999999999999999876 357889999986432 2345799999999999999999998
Q ss_pred CCCCceeEEEEEecccc-hHHHHHHhhcc------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC
Q 016115 143 TSKDELFLNLVMEYVPE-TMYRVLKHYSS------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (395)
Q Consensus 143 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~ 215 (395)
.+....++||||++| +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .
T Consensus 98 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~-~ 173 (322)
T 1p4o_A 98 --SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVA-E 173 (322)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEEC-T
T ss_pred --ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEc-C
Confidence 444558999999985 77776654321 12467899999999999999999999 6999999999999999 7
Q ss_pred CCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 016115 216 THQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 291 (395)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~ 291 (395)
++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 88999999999976544322 2234568899999998754 48999999999999999999 8999998877666555
Q ss_pred HHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC------CCCcC
Q 016115 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH------PFFDE 365 (395)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h------p~~~~ 365 (395)
+..... ...+..++..+.+||.+||+.||.+|||+.|+++| +||+.
T Consensus 253 ~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~ 304 (322)
T 1p4o_A 253 VMEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304 (322)
T ss_dssp HHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcc
Confidence 443100 01224578999999999999999999999999976 77766
Q ss_pred CCC
Q 016115 366 LRE 368 (395)
Q Consensus 366 ~~~ 368 (395)
+..
T Consensus 305 ~~~ 307 (322)
T 1p4o_A 305 VSF 307 (322)
T ss_dssp HCS
T ss_pred ccc
Confidence 554
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=334.08 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=193.1
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHH--cCCCceeeeceeeeecCCCCceeEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRL--MDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ....+|.+++.. ++||||+++++++.... .....+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEE
Confidence 45799999999999999999987 79999999986543 333457777776 79999999999875433 34556899
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCceeccCCCCceeecCCCCcEEEee
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--------TVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--------~~~~ivH~Dlkp~Nill~~~~~~~kl~D 223 (395)
||||+++ +|.+.+. ...+++..++.++.||+.||.||| + +||+||||||+|||++ .++.+||+|
T Consensus 84 v~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~-~~~~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVK-KNGQCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEEC-TTSCEEECC
T ss_pred ehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEc-CCCCEEEee
Confidence 9999986 6666553 357999999999999999999999 8 6999999999999999 788999999
Q ss_pred cccccccccCCcc-----eeeeecccccCchhhcCCCC-----CCcccchHhHHHHHHHHHhC----------CCCCCCC
Q 016115 224 FGSAKVLVKGEAN-----ISYICSRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG----------QPLFPGE 283 (395)
Q Consensus 224 fg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~lltg----------~~pf~~~ 283 (395)
||+++........ ....||+.|+|||++.+... ++.++|||||||++|+|+|| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9999766544332 23478999999999966432 34689999999999999999 8888653
Q ss_pred Ch----HHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 284 NA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 284 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.. ...........+.. +.. ....+...+++++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~-----------------~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQR-----------------PNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCC-----------------CCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCC-----------------CCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 21 12222221110000 000 011122345678999999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=339.87 Aligned_cols=255 Identities=15% Similarity=0.137 Sum_probs=190.5
Q ss_pred cCceeeeeeecCCceEEEEEEECC---CCcEEEEEEecccccc---------------hHHHHHHHHHcCCCceeeecee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRY---------------KNRELQLMRLMDHPNVISLKHC 138 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~---------------~~~e~~~l~~l~h~niv~~~~~ 138 (395)
.+|.+.+.||+|+||.||+|.+.. ++..||||++...... ..+|+.+++.++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 469999999999999999999987 7889999998654322 2246667778899999999998
Q ss_pred eeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC-
Q 016115 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH- 217 (395)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~- 217 (395)
+.... .+...+++||||++++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++
T Consensus 117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~ 189 (345)
T 2v62_A 117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLG-YKNP 189 (345)
T ss_dssp EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEE-SSST
T ss_pred ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEc-cCCC
Confidence 85533 33567999999996676665543 3479999999999999999999999 6999999999999998 455
Q ss_pred -cEEEeecccccccccCCc--------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC--ChH
Q 016115 218 -QVKLCDFGSAKVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--NAV 286 (395)
Q Consensus 218 -~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~--~~~ 286 (395)
.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||... +..
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 899999999976543221 1345789999999999765 5899999999999999999999999652 222
Q ss_pred HHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.............+....... ....+++++.+||.+||..||.+|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 222222222111111111000 01257899999999999999999999999876
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=336.35 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=201.0
Q ss_pred ccccCceeeeeeecCCceEEEEEEEC-------CCCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeee
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFF 140 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~ 140 (395)
...++|.+.+.||+|+||.||+|++. .++..||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~- 110 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 110 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-
Confidence 44568999999999999999999975 467789999986532 2345799999999 899999999998
Q ss_pred ecCCCCceeEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCC
Q 016115 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (395)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp 207 (395)
.+...+++||||++| +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||
T Consensus 111 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp 185 (334)
T 2pvf_A 111 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAA 185 (334)
T ss_dssp ----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSG
T ss_pred ----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCcc
Confidence 444558999999985 77776664322 12358999999999999999999999 6999999999
Q ss_pred CceeecCCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCC
Q 016115 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 283 (395)
Q Consensus 208 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~ 283 (395)
+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.
T Consensus 186 ~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 186 RNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999 788999999999987654332 2233467889999998654 48999999999999999999 99999988
Q ss_pred ChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+....+..... ...+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77666555444210 01224578999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=334.50 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=193.4
Q ss_pred cccCceeeeeeecCCceEEEEEE----ECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
...+|++.+.||+|+||+||+|+ +..+|+.||||++.... ....+|+.+++.++||||+++++++.. .+
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~ 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AG 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---HH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence 44579999999999999999998 56789999999986543 345679999999999999999998743 22
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+++||||+++ +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~-~~~~~kl~Dfg 159 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVE-NENRVKIGDFG 159 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEE-ETTEEEECCCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEc-CCCeEEEccCc
Confidence 2347899999975 766666542 2458999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCc----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 226 SAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 226 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
++........ .....++..|+|||++.+. .++.++||||||+++|+|+||..||...... .. ...+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~---~~~~~~~~ 233 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FM---RMIGNDKQ 233 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HH---HHHCTTCC
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH--HH---hhhcCccc
Confidence 9987644322 1223467789999999765 4899999999999999999999998653221 11 11111100
Q ss_pred hh------hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 302 EE------IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 302 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.. ....... .....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 234 GQMIVFHLIELLKNN-------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp THHHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cchhHHHHHHHHhcc-------------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 0000000 001123467899999999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=332.78 Aligned_cols=246 Identities=25% Similarity=0.302 Sum_probs=189.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++ ....
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-----eeCC
Confidence 357999999999999999999999999999999986442 3345799999999999999999998 4445
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~-~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVS-ADDFAYLVDFGIA 181 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECSCCC-
T ss_pred eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEc-CCCCEEEecCccC
Confidence 68999999986 66666654 2568999999999999999999999 6999999999999999 6889999999998
Q ss_pred cccccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 228 KVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 228 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
........ .....|++.|+|||++.+. .++.++||||||+++|+|++|..||...+.. .+........ +
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~-~------ 252 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAI-P------ 252 (309)
T ss_dssp ---------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCC-C------
T ss_pred ccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCC-C------
Confidence 76544322 2345689999999999654 5899999999999999999999999876544 2222222100 0
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-CHHHHhc
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACA 359 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-t~~ell~ 359 (395)
........++.++.+||.+||+.||.+|| +++++++
T Consensus 253 ------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 253 ------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 01123356789999999999999999999 7777664
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=340.89 Aligned_cols=265 Identities=22% Similarity=0.253 Sum_probs=199.7
Q ss_pred CccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.....+|.+.+.||+|+||.||+|++ .+|+.||||++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 108 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DERN 108 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCTT
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCC
Confidence 34566899999999999999999995 478999999886432 3446799999999999999999988 4445
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..++||||++| +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLD-ENFVPKITDFGIS 186 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEEC-TTCCEEECCCTTC
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEEC-CCCCEEEeecccc
Confidence 58999999986 5444443322233468999999999999999999999 6999999999999999 7889999999999
Q ss_pred cccccCC---cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCCh
Q 016115 228 KVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI---IKVLGTPTR 301 (395)
Q Consensus 228 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~---~~~~~~~~~ 301 (395)
+...... ......||+.|+|||++.+. .++.++||||||+++|+|+||+.||......+..... .....
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---- 261 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN---- 261 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT----
T ss_pred cccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc----
Confidence 7643322 22345689999999998765 4899999999999999999999999765432211000 00000
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp 361 (395)
... +...........+...++..+.+|+.+||+.||++|||+.|+++|-
T Consensus 262 ------~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 262 ------NGQ-----LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp ------TTC-----CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------ccc-----HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 000 0111111111122334567899999999999999999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=332.21 Aligned_cols=256 Identities=20% Similarity=0.239 Sum_probs=193.9
Q ss_pred ccccCceeeeeeecCCceEEEEEEECC---CCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (395)
....+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345679999999999999999998765 55689999986432 234579999999999999999999865544
Q ss_pred CCceeEEEEEecccc-hHHHHHHhhc--ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEE
Q 016115 145 KDELFLNLVMEYVPE-TMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl 221 (395)
......++||||+.+ +|.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~-~~~~~kl 188 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLR-DDMTVCV 188 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEEC-TTSCEEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEc-CCCcEEE
Confidence 434457899999986 6666654322 334679999999999999999999999 6999999999999999 6889999
Q ss_pred eecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016115 222 CDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 297 (395)
Q Consensus 222 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~ 297 (395)
+|||++........ .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+.....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 99999986644322 2234567889999999764 58999999999999999999 9999988776665554433100
Q ss_pred CCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 268 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 ----------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ----------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11234578999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=339.88 Aligned_cols=246 Identities=23% Similarity=0.324 Sum_probs=191.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEE----EEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v----aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
...+|++.+.||+|+||+||+|++..+|+.+ |+|.+... .....+|+.+++.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 88 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---- 88 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES----
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec----
Confidence 3457999999999999999999998887754 77766432 2345679999999999999999998843
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
.. .++|+||+.+ ++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 89 -~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~-~~~~~kl~Df 161 (327)
T 3poz_A 89 -ST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVK-TPQHVKITDF 161 (327)
T ss_dssp -SS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE-ETTEEEECCT
T ss_pred -CC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEEC-CCCCEEEccC
Confidence 22 6688888884 66665544 24678999999999999999999999 6999999999999999 7889999999
Q ss_pred ccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 225 GSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 225 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
|+++........ ....+|..|+|||++.+. .++.++|||||||++|+|+| |..||...+..+....+.....
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--- 237 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--- 237 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred cceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC---
Confidence 999876544332 233457789999999764 58999999999999999999 9999988766554443332100
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 238 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 238 -------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00123468899999999999999999999999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=332.33 Aligned_cols=243 Identities=17% Similarity=0.199 Sum_probs=193.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCC-------cEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (395)
...+|.+.+.||+|+||+||+|.+..++ ..||+|++.... ....+|+.+++.++||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC---- 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE----
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE----
Confidence 3457999999999999999999998877 479999986433 3345799999999999999999998
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCc----
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ---- 218 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~---- 218 (395)
.+....++||||+.| +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.
T Consensus 82 -~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~-~~~~~~~~ 155 (289)
T 4fvq_A 82 -VCGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLI-REEDRKTG 155 (289)
T ss_dssp -CCTTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-ECCBGGGT
T ss_pred -EeCCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEe-cCCccccc
Confidence 344457899999984 766666542 2348999999999999999999999 6999999999999998 4555
Q ss_pred ----EEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCC-CCCCCCChHHHHHHHH
Q 016115 219 ----VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEII 293 (395)
Q Consensus 219 ----~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~~~ 293 (395)
+||+|||++...... ....||..|+|||++.+...++.++||||||+++|+|++|. .||...+..... ...
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~ 231 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFY 231 (289)
T ss_dssp BCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHH
T ss_pred ccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHh
Confidence 999999998754322 23457889999999987556899999999999999999954 555554443332 222
Q ss_pred HHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
... ..++...++++.+||.+||+.||.+|||+.++++|
T Consensus 232 ~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 EDR-----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HTT-----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcc-----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 210 01223457889999999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=337.02 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=201.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCc-----EEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (395)
...+|.+.+.||+|+||.||+|.+..++. .||+|.+.... ....+|+.+++.+ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC---- 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 34579999999999999999999877664 79999986532 3355799999999 899999999998
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhcc----------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceee
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill 212 (395)
.....+++||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 120 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 120 -THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLL 197 (333)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEE
T ss_pred -ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEE
Confidence 444458999999985 77777654321 13568999999999999999999999 699999999999999
Q ss_pred cCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHH
Q 016115 213 DPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 288 (395)
Q Consensus 213 ~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~ 288 (395)
+ .++.+||+|||++......... ....+|+.|+|||++.+. .++.++||||||+++|+|+| |..||.+......
T Consensus 198 ~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 198 T-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp E-GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred C-CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9 7889999999999866443322 234568889999998754 48999999999999999999 9999988765555
Q ss_pred HHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 289 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
+..+....... ..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 276 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 276 FYKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 55444421110 012346889999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=339.85 Aligned_cols=256 Identities=18% Similarity=0.207 Sum_probs=200.1
Q ss_pred cccCceeeeeeecCCceEEEEEE-----ECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (395)
...+|.+.+.||+|+||.||+|+ +..++..||||.+... .....+|+.+++.++||||+++++++
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 102 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS----- 102 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-----
Confidence 34579999999999999999999 5567889999998532 23345799999999999999999998
Q ss_pred CCceeEEEEEeccc-chHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC--CCCc
Q 016115 145 KDELFLNLVMEYVP-ETMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQ 218 (395)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~--~~~~ 218 (395)
.+....++||||++ ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .+..
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcce
Confidence 44445789999996 577777765432 12458999999999999999999999 69999999999999982 2346
Q ss_pred EEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016115 219 VKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (395)
Q Consensus 219 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~ 294 (395)
+||+|||++........ .....||+.|+|||++.+. .++.++||||||+++|+|+| |..||...+..+....+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 99999999976543322 2234568899999998654 48999999999999999998 9999998877665554443
Q ss_pred HhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
... ...+..++..+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 261 ~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 261 GGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 100 0122457899999999999999999999999999988743
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=329.46 Aligned_cols=246 Identities=27% Similarity=0.349 Sum_probs=188.8
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCC---CcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
....+|++.+.||+|+||.||+|.+..+ +..||+|.+... .....+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 86 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-----
Confidence 4456899999999999999999998654 457999988643 233457999999999999999999872
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
+ ...++||||+++ +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 87 ~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~Df 160 (281)
T 1mp8_A 87 E-NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVS-SNDCVKLGDF 160 (281)
T ss_dssp S-SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEE-ETTEEEECC-
T ss_pred c-CccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEEC-CCCCEEECcc
Confidence 1 237899999996 666665432 3468999999999999999999999 6999999999999999 6889999999
Q ss_pred ccccccccCCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 225 GSAKVLVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 225 g~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
|+++........ ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~---- 235 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---- 235 (281)
T ss_dssp ------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred ccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC----
Confidence 999876543322 233457889999999654 48999999999999999997 9999998777665554433100
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..+++.+.+||.+||..||.+|||+.++++
T Consensus 236 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 236 ------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0123457899999999999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=340.92 Aligned_cols=254 Identities=13% Similarity=0.106 Sum_probs=196.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCC--------CcEEEEEEecccccchHHHHHHHHHcCCCceeeec------------
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLET--------GETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLK------------ 136 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~--------~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~------------ 136 (395)
.+|.+.+.||+|+||.||+|++..+ ++.||||.+... ....+|+++++.++||||++++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 4799999999999999999999874 889999998765 4567899999999999999843
Q ss_pred ---eeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec
Q 016115 137 ---HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (395)
Q Consensus 137 ---~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~ 213 (395)
+++. ......++||||++++|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 121 ~~~~~~~----~~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 121 TCMGFGV----HQDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVD 193 (352)
T ss_dssp CCCEEEE----ETTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEE
T ss_pred chhhccc----cCCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEc
Confidence 3332 1245689999999778888776532 3679999999999999999999999 6999999999999999
Q ss_pred CCCC--cEEEeecccccccccCCc--------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 016115 214 PLTH--QVKLCDFGSAKVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (395)
Q Consensus 214 ~~~~--~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 283 (395)
.++ .+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 194 -~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 -PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp -TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred -CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 566 899999999976543322 1234789999999999764 5899999999999999999999999875
Q ss_pred C-hHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 284 N-AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 284 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
. ..+.+............ .+.. .......++.++.+||.+||+.||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~--------~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPG--------PFVG-----------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCC--------CEEC-----------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChh--------hhhh-----------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 3 33333332221110000 0000 00012356899999999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=337.15 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=198.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
..+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++||||+++++++.... ......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence 34799999999999999999999999999999988532 234557999999999999999999885432 2345688
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||+.+ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~-~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTSCEEECCCSSCEES
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEc-CCCCEEEEecCcchhc
Confidence 99999996 7777777665667789999999999999999999999 6999999999999999 6889999999998754
Q ss_pred ccCCc----------ceeeeecccccCchhhcCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhC
Q 016115 231 VKGEA----------NISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLG 297 (395)
Q Consensus 231 ~~~~~----------~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~ 297 (395)
..... .....||+.|+|||++.+.. .++.++||||||+++|+|++|..||...... +....... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~ 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--N 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--C
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--c
Confidence 32111 11235689999999986432 2688999999999999999999999531100 00011111 0
Q ss_pred CCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.... .....++..+.+||.+||+.||.+|||+.+++++
T Consensus 263 ---------------~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 ---------------QLSI----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ---------------C--C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------cCCC----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0000 0123568899999999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=354.97 Aligned_cols=255 Identities=20% Similarity=0.187 Sum_probs=193.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCC-Cceeeece---------e
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDH-PNVISLKH---------C 138 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h-~niv~~~~---------~ 138 (395)
...|...+.||+|+||+||+|.+..+|+.||||++... .....+|+.+++.++| .|...+.. .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34588999999999999999999999999999998632 2334578888888877 32211111 1
Q ss_pred ------------eeecCCCCceeEEEEEecccchHHHHHHhh---cccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceec
Q 016115 139 ------------FFSTTSKDELFLNLVMEYVPETMYRVLKHY---SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 203 (395)
Q Consensus 139 ------------~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~ 203 (395)
+..........++++|+++.++|.+.+... ......+++..++.++.||+.||.|||+ +||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 100000112347789999999888777533 2334567888899999999999999999 699999
Q ss_pred cCCCCceeecCCCCcEEEeecccccccccCCcceeeeecccccCchhhc---------CCCCCCcccchHhHHHHHHHHH
Q 016115 204 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF---------GATEYTTSIDIWSAGCVLAELL 274 (395)
Q Consensus 204 Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~ll 274 (395)
||||+|||++ .++.+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++|+|+
T Consensus 236 DiKp~NILl~-~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 236 YLRPVDIVLD-QRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCCGGGEEEC-TTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEe-cCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999 6888999999998765333 344567 9999999983 3344788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCH
Q 016115 275 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354 (395)
Q Consensus 275 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~ 354 (395)
||+.||...+..+.... .+. ....+++++.+||.+||+.||.+|||+
T Consensus 312 tg~~Pf~~~~~~~~~~~-----------------------~~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEW-----------------------IFR----------SCKNIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HSSCCCCTTGGGSCSGG-----------------------GGS----------SCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCcchhhhHHH-----------------------HHh----------hcccCCHHHHHHHHHHccCChhhCcCH
Confidence 99999976543211000 000 113578999999999999999999999
Q ss_pred HHHhcCCCCcCCCC
Q 016115 355 LEACAHPFFDELRE 368 (395)
Q Consensus 355 ~ell~hp~~~~~~~ 368 (395)
.++++||||+.+.+
T Consensus 359 ~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 359 LQAMETPEYEQLRT 372 (413)
T ss_dssp HHHTTSHHHHHHHH
T ss_pred HHHHhCHHHHHHHH
Confidence 99999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=328.69 Aligned_cols=254 Identities=28% Similarity=0.393 Sum_probs=190.1
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
..+|++.+.||+|+||+||+|++ .++.||||.+.... ....+|+++++.++||||+++++++. +. .++|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence 45799999999999999999997 57899999986442 34567999999999999999999773 22 6799
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC--CCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
|||++| +|.+.+... .....+++..++.++.||+.||.|||+. +||+||||||+|||++.++..+||+|||++...
T Consensus 78 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999985 666665532 2223478899999999999999999983 389999999999999843445899999999765
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||................+..
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 222 (307)
T 2eva_A 157 QTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR----------- 222 (307)
T ss_dssp ----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC-----------
T ss_pred ccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC-----------
Confidence 332 2345689999999999654 58999999999999999999999998643322111111110100
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc-----CCCCcCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFDELRE 368 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~-----hp~~~~~~~ 368 (395)
......++..+.+||.+||+.||.+|||+.++++ ..++....+
T Consensus 223 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 223 ---------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp ---------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred ---------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 0123457899999999999999999999999987 455555444
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=328.40 Aligned_cols=249 Identities=23% Similarity=0.310 Sum_probs=186.8
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
...++|++.+.||+|+||.||+|++. ..||+|++.... ....+|+.+++.++|+||++++++. ..
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~ 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TA 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CS
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cC
Confidence 34457999999999999999999863 359999986432 3345799999999999999999854 12
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...++||||+.| ++.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~-~~~~~kl~Dfg~ 166 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLH-EDNTVKIGDFGL 166 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE-TTTEEEECCCC-
T ss_pred CccEEEEEecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEEC-CCCCEEEcccee
Confidence 237899999985 5544443 234678999999999999999999999 6999999999999999 688999999999
Q ss_pred ccccccCC---cceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 227 AKVLVKGE---ANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 227 a~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+....... ......||+.|+|||++.. ...++.++||||||+++|+|++|..||......+.+............
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 97654322 2234568999999999852 345788999999999999999999999987776666555543111110
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 -----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01123457899999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=371.25 Aligned_cols=283 Identities=25% Similarity=0.333 Sum_probs=206.2
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecC-CCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTT-SKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~ 150 (395)
++|++.+.||+|+||.||+|.+..+|+.||||++... .....+|+++++.++||||+++++++.... .......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 4799999999999999999999999999999988643 233457999999999999999998873311 1224567
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC---cEEEeeccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QVKLCDFGS 226 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~---~~kl~Dfg~ 226 (395)
++||||++| +|.+.+... .....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++ .+||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~-~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQP-GPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEEC-CSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeec-CCCceeEEEccccc
Confidence 899999975 666655542 223468899999999999999999999 69999999999999983 44 399999999
Q ss_pred ccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+.............||+.|+|||++.+. .++.++||||||+++|+|++|..||............. ..........
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i---~~~~~~~~~~ 246 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV---REKSNEHIVV 246 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC---C------CCS
T ss_pred ccccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh---hcccchhhhh
Confidence 9887666666667899999999998654 58999999999999999999999998764432211000 0000000000
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
.........+. ...+....+...+++.+.+||.+||.+||.+|||+.++++||||+.+..
T Consensus 247 ~~~l~g~~~~~--~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 247 YDDLTGAVKFS--SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp CCCCSSSCCCC--SSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhhccccccc--cccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 00000011111 1111122234457889999999999999999999999999999988654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=343.39 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=188.4
Q ss_pred cccCceeeeeeecCCceEEEEEEEC---CCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
...+|.+.+.||+|+||.||+|++. .++..||||.+... ...+.+|+.+++.++||||+++++++ .+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TK 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ee
Confidence 3457999999999999999999976 46778999998643 23455799999999999999999998 44
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+++||||++| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~kl~Dfg 192 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILIN-SNLVCKVSDFG 192 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECCC-
T ss_pred CCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEc-CCCCEEECcCc
Confidence 4558999999974 66666543 23578999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 226 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 226 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
+++........ ....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+......
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~-- 269 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL-- 269 (373)
T ss_dssp ---------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC--
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence 99876443221 122346789999999754 58999999999999999998 99999988776665544331100
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+..++..+.+||.+||+.||.+||++.++++
T Consensus 270 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 --------------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --------------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 012346889999999999999999999998875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=354.12 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=202.9
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
...+|.+.+.||+|+||.||+|.+..++..||||.+..+. ..+.+|+.+++.++||||+++++++ .+...++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCcEE
Confidence 4457999999999999999999999889999999987543 3456899999999999999999998 4445589
Q ss_pred EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||+. |+|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 293 lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVG-ENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-GGGCEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEEC-CCCcEEEeecccceec
Confidence 9999998 5777776542 23568999999999999999999999 6999999999999999 6889999999999876
Q ss_pred ccCCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 231 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
...... ....++..|+|||++.+. .++.++|||||||++|+|+| |..||.+.+..+....+....
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~----------- 436 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------- 436 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------
T ss_pred cCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 433221 123456789999999754 48999999999999999999 999999877655544333210
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 437 -----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 437 -----------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 00123457899999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=332.05 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=199.9
Q ss_pred cccCceeeeeeecCCceEEEEEEE-----CCCCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (395)
..++|.+.+.||+|+||.||+|++ ..+++.||||++.... ....+|+.+++.+ +||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec--
Confidence 345799999999999999999985 3577899999986532 2345799999999 68999999998743
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhccc------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCce
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSM------------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Ni 210 (395)
....+++||||++| +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 103 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Ni 179 (316)
T 2xir_A 103 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI 179 (316)
T ss_dssp --TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred --CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceE
Confidence 22347899999985 666666543221 2238999999999999999999999 6999999999999
Q ss_pred eecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChH
Q 016115 211 LVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 286 (395)
Q Consensus 211 ll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~ 286 (395)
+++ .++.+||+|||+++........ ....||+.|+|||++.+. .++.++||||||+++|+|+| |..||......
T Consensus 180 l~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 180 LLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp EEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred EEC-CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 999 6889999999999866443322 235678899999999764 48999999999999999998 99999876654
Q ss_pred HHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
+.+......... ...+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 258 ~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 258 EEFCRRLKEGTR---------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHHTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhccCcc---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444433332110 01223468899999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=346.35 Aligned_cols=245 Identities=21% Similarity=0.294 Sum_probs=198.4
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
....+|.+.+.||+|+||.||+|.+ +|+.||||++.... ..+.+|+.+++.++||||+++++++... ...++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~ 263 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY 263 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceE
Confidence 3456799999999999999999997 47899999997543 3456899999999999999999987432 22488
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 264 iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEC-CCCCEEEeeCCCcccc
Confidence 99999985 777777653 22347899999999999999999999 6999999999999999 7889999999999854
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
... .....++..|+|||++.+. .++.++|||||||++|+|+| |..||...+..+....+.+..
T Consensus 340 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------- 403 (450)
T 1k9a_A 340 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------- 403 (450)
T ss_dssp C--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-------------
T ss_pred ccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 322 2233568899999999765 48999999999999999998 999998876655554443210
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 404 ---------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 404 ---------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01123457899999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=324.12 Aligned_cols=246 Identities=18% Similarity=0.293 Sum_probs=201.0
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
...+|.+.+.||+|+||.||+|.+. ++..||+|++.... ....+|+++++.++||||+++++++ .+....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 79 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSCE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCeE
Confidence 3457999999999999999999986 67889999997543 3456899999999999999999998 4445589
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||++| +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFV 154 (267)
T ss_dssp EEECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEEC-GGGCEEECCTTGGGGB
T ss_pred EEEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEC-CCCCEEEccccccccc
Confidence 99999985 666665432 3568999999999999999999999 6999999999999999 6889999999999765
Q ss_pred ccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 231 VKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 231 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~---------- 223 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------- 223 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred ccccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc----------
Confidence 33221 1234467789999999654 48999999999999999999 8999998877766655543100
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123468899999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=323.39 Aligned_cols=245 Identities=16% Similarity=0.227 Sum_probs=197.8
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
...+|.+.+.||+|+||.||+|++ +|..||||++.... ....+|+.+++.++||||+++++++... ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence 445799999999999999999998 48899999986432 2345788899999999999999988432 224
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC--ceeccCCCCceeecCCCCcEEEeecc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
..++||||++| +|.+.+.. .....+++..++.++.||+.||.|||+ +| |+||||||+||+++ .++.++|+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~-~~~~~~l~~~~ 158 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMID-EDMTARISMAD 158 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEEC-TTSCEEEEGGG
T ss_pred CeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEc-CCcceeEEecc
Confidence 58899999985 77666654 222358999999999999999999999 69 99999999999999 78889999999
Q ss_pred cccccccCCcceeeeecccccCchhhcCCCC--CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 226 SAKVLVKGEANISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 226 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
++..... ....||+.|+|||++.+... ++.++||||||+++|+|++|..||...+..+....+.....
T Consensus 159 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------ 228 (271)
T 3kmu_A 159 VKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL------ 228 (271)
T ss_dssp SCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC------
T ss_pred ceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC------
Confidence 8754322 23567999999999976432 23379999999999999999999998887776665544111
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...++..+++++.+||.+||+.||.+|||+.++++
T Consensus 229 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 229 ---------------------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01133457999999999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=325.72 Aligned_cols=247 Identities=25% Similarity=0.332 Sum_probs=195.7
Q ss_pred ccccCceeeeeeecCCceEEEEEEECC---CCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
....+|.+.+.||+|+||.||+|++.. ++..||+|.+... .....+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----- 83 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE----- 83 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-----
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-----
Confidence 455689999999999999999998654 3446999998653 234457999999999999999999872
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
+. ..++||||+.+ +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+||
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~Df 157 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVA-SPECVKLGDF 157 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEE-ETTEEEECCC
T ss_pred CC-CCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEC-CCCcEEeCcc
Confidence 22 25799999985 666665442 3568999999999999999999999 6999999999999999 6889999999
Q ss_pred ccccccccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 225 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
|++........ .....++..|+|||++.+. .++.++||||||+++|+|+| |..||......+....+......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~--- 233 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL--- 233 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---
T ss_pred CCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---
Confidence 99987644332 2234567889999999654 48999999999999999998 99999877666555444331100
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 -------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0123468999999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=331.28 Aligned_cols=247 Identities=21% Similarity=0.283 Sum_probs=193.1
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCC----cEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
...+|.+.+.||+|+||.||+|.+..++ ..||||.+.... ....+|+.+++.++||||+++++++ .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 116 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----S 116 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----e
Confidence 4457999999999999999999986553 359999986432 2345799999999999999999998 4
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
+....++||||++| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~-~~~~~kl~Df 191 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVN-SNLVCKVSDF 191 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEEC-CCCcEEECCC
Confidence 45568999999986 66655543 24578999999999999999999999 6999999999999999 7889999999
Q ss_pred ccccccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016115 225 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 225 g~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
|+++........ ....+|..|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+......
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~- 269 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL- 269 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-
T ss_pred CcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-
Confidence 999876443221 123457789999999754 48999999999999999999 99999988776665554431000
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+..++..+.+||.+||+.||.+||++.+++++
T Consensus 270 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 ---------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ---------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0123468899999999999999999999998863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=334.12 Aligned_cols=263 Identities=24% Similarity=0.303 Sum_probs=198.6
Q ss_pred ccccCceeeeeeecCCceEEEEEE----ECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
....+|++.+.||+|+||.||+|+ +..+++.||||++.... ....+|+++++.++|+||+++++++.. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---P 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---S
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---C
Confidence 345689999999999999999999 56789999999986542 335689999999999999999998753 3
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
+...+++||||++| +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~-~~~~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVE-SEAHVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEE-ETTEEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEEC-CCCCEEEccc
Confidence 45568899999964 666666542 2468999999999999999999999 6999999999999999 7889999999
Q ss_pred ccccccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 225 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 225 g~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
|++......... ....||..|+|||++.+. .++.++||||||+++|+|++|..||............... ....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~ 249 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER-DVPA 249 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc-cccc
Confidence 999876444322 234568889999999764 4899999999999999999999999754322111000000 0000
Q ss_pred h-hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 301 R-EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 301 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
. ........+ .....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 250 LSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 000000000 001123467899999999999999999999999954
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=324.74 Aligned_cols=244 Identities=23% Similarity=0.278 Sum_probs=196.0
Q ss_pred cccCceeee-eeecCCceEEEEEEE--CCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 75 QTISYMAER-VVGTGSFGIVFQAKC--LETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 75 ~~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
...+|.+.+ .||+|+||.||+|.+ ..+++.||||++... .....+|+.+++.++||||+++++++ ..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~--- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA--- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES---
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC---
Confidence 345799988 999999999999954 567889999998644 23455799999999999999999987 21
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
...++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+||
T Consensus 90 --~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~-~~~~~kl~Df 161 (291)
T 1xbb_A 90 --ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLV-TQHYAKISDF 161 (291)
T ss_dssp --SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEE-ETTEEEECCC
T ss_pred --CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEe-CCCcEEEccC
Confidence 237899999985 66666554 4568999999999999999999999 6999999999999999 6889999999
Q ss_pred ccccccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016115 225 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 225 g~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
|++......... ....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+... ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~~ 238 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ER 238 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CC
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CC
Confidence 999876444322 123456889999999654 48899999999999999999 99999988776655444321 00
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 239 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 --------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0123457899999999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=347.75 Aligned_cols=251 Identities=21% Similarity=0.249 Sum_probs=199.0
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.++|.+.+.||+|+||.||+|++..+|+.||||++... .....+|+++++.++|.+++..+..+. ......++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEEEE
Confidence 45799999999999999999999999999999987543 345678999999999865555544443 234458899
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeec--CCCCcEEEeecccccccc
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~--~~~~~~kl~Dfg~a~~~~ 231 (395)
|||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||||+ ..++.+||+|||+++...
T Consensus 82 me~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 82 MDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 999988888777642 3579999999999999999999999 6999999999999993 257889999999998765
Q ss_pred cCCcc--------eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCC
Q 016115 232 KGEAN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTPT 300 (395)
Q Consensus 232 ~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~~~~ 300 (395)
..... ....||..|+|||++.+. .++.++|||||||++|+|++|..||.+... .+.+..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 54322 256789999999999765 489999999999999999999999987543 333333332211111
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
. ..+...++.++.+||.+||+.||.+||++.+|++
T Consensus 237 ~------------------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 I------------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp H------------------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred H------------------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1 1123457899999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=345.84 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=201.0
Q ss_pred CccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.....+|.+.+.||+|+||.||+|.+. ++..||||++.... ..+.+|+.+++.++||||+++++++. ...
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~ 256 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEP 256 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCc
Confidence 345567999999999999999999975 57789999997543 34568999999999999999999872 223
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+++||||+.+ +|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~-~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVS-ASLVCKIADFGLAR 332 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEEC-TTCCEEECSTTGGG
T ss_pred cEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEC-CCCcEEEeeCCCce
Confidence 7899999985 7777665422 2357888999999999999999999 6999999999999999 78899999999998
Q ss_pred ccccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 229 VLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 229 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
....... .....++..|+|||++... .++.++|||||||++|+|+| |..||.+.+..+....+......
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------- 404 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM------- 404 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC-------
T ss_pred EcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 7643221 1223457789999999654 48999999999999999999 99999988887776665542110
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+..+++++.+||.+||..||.+|||+.++++
T Consensus 405 ---------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 405 ---------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 012357899999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=335.15 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=189.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEE----EEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v----aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
..+|++.+.||+|+||.||+|.+..+++.+ |+|.+... .....+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 457999999999999999999998888765 66655322 2345579999999999999999998843
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
.. .++|++|+.+ ++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~-~~~~~kL~DfG 162 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVK-TPQHVKITDFG 162 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE-ETTEEEECCTT
T ss_pred CC-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEc-CCCCEEEccCc
Confidence 22 6788888885 666665542 4568999999999999999999999 6999999999999999 68899999999
Q ss_pred cccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 226 SAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 226 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
+++........ ....+|..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---- 237 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---- 237 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----
Confidence 99876443322 233457789999999764 58999999999999999999 9999998776655444332100
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..++.++.+||.+||..||.+|||+.|+++
T Consensus 238 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 238 ------------------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0012346889999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=331.65 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=195.2
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.|...+.||+|+||.||+|.+ ++..||||++... .....+|+.+++.++||||+++++++ .+...
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 104 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-----SDGDD 104 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----ecCCc
Confidence 355668999999999999986 6889999998542 23345799999999999999999988 44445
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.++||||++| +|.+.+... .....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~-~~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLD-EAFTAKISDFGLAR 181 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEc-CCCcEEEeeccccc
Confidence 8999999974 666666542 335678999999999999999999999 6999999999999999 78899999999997
Q ss_pred ccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 229 VLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 229 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||........+..+.............
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 259 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred ccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence 6544322 223468999999999854 47999999999999999999999998765433333332221111100000
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...... .......+..+.+||.+||+.||.+|||+.+++++
T Consensus 260 ~~~~~~--------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 260 YIDKKM--------------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HSCSSC--------------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hccccc--------------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000000 01122346789999999999999999999999863
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=325.09 Aligned_cols=245 Identities=25% Similarity=0.345 Sum_probs=187.6
Q ss_pred ccCceee-eeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHH-HHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 76 TISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 76 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.++|.+. +.||+|+||.||+|.+..+|+.||||++.... ...+|+.++ +.++||||+++++++.... .+...+++|
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv 93 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV 93 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH-HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH-HHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEEE
Confidence 3468777 78999999999999999999999999986543 455688877 6779999999999884321 235668999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--CCcEEEeeccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKVL 230 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~ 230 (395)
|||++| +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||++...
T Consensus 94 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 94 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp ECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 999986 777776652 23569999999999999999999999 699999999999999932 678999999998643
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
. ...++.++|||||||++|+|++|..||...+.......+. ..
T Consensus 171 ~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~---------------~~ 213 (299)
T 3m2w_A 171 T----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---------------TR 213 (299)
T ss_dssp T----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---------------CS
T ss_pred c----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---------------HH
Confidence 2 1247889999999999999999999997654322110000 00
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
. ......+.......+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 214 ---~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 214 ---I---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp ---S---CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred ---H---hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 0 000011111122467999999999999999999999999999999987543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=326.94 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=194.3
Q ss_pred ccCceeeeeeecCCceEEEEEE----ECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
...|++.+.||+|+||.||+|+ +..+|+.||+|++.... ....+|+.+++.++|+||+++++++... +
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 4469999999999999999999 56789999999986432 3456799999999999999999988542 2
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...+++||||+++ +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~-~~~~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVE-SEHQVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEE-ETTEEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEc-CCCCEEECccc
Confidence 2458899999986 666666432 3568999999999999999999999 6999999999999999 68899999999
Q ss_pred cccccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 226 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 226 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
++......... ....||..|+|||++.+. .++.++||||||+++|+|+||..|+.... .. .....+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~---~~~~~~~~~~ 245 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPM--AL---FLKMIGPTHG 245 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HH---HHHHHCSCCG
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchh--hH---HhhccCCccc
Confidence 99876544322 234567889999999764 48899999999999999999998864321 11 1111111110
Q ss_pred hhh-----hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 302 EEI-----RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 302 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
... ...... .....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 246 QMTVTRLVNTLKEG-------------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GGHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccCHHHHHHHHhcc-------------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 000 000000 001123467899999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=324.74 Aligned_cols=246 Identities=20% Similarity=0.310 Sum_probs=192.5
Q ss_pred CccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.....+|++.+.||+|+||.||+|.+ +|+.||||++.... ....+|+.+++.++||||+++++++.. ....+
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 90 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGL 90 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CC
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCce
Confidence 34456899999999999999999987 58899999987543 345679999999999999999998643 22357
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||+++ +|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVS-EDNVAKVSDFGLTKE 166 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-TTSCEEECCCCC---
T ss_pred EEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEe-CCCcEEEeecccccc
Confidence 899999986 7777665432 1347889999999999999999999 6999999999999999 788999999999876
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.... .....++..|+|||++.+. .++.++||||||+++|+|+| |..||...+..+....+...
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~------------- 230 (278)
T 1byg_A 167 ASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------------- 230 (278)
T ss_dssp -----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-------------
T ss_pred cccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-------------
Confidence 5432 2234568899999999654 58999999999999999998 99999877665544433221
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 231 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 ---------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 001123457899999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=356.29 Aligned_cols=248 Identities=25% Similarity=0.295 Sum_probs=194.4
Q ss_pred cCceeee-eeecCCceEEEEEEEC--CCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 77 ISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.++.+.+ .||+|+||.||+|.+. .++..||||++... ...+.+|+++++.++|||||++++++.. .
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~ 408 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 408 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------S
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------C
Confidence 4455555 8999999999999875 35667999998653 2345689999999999999999998732 2
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++||||+.| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~-~~~~vkL~DFGla 483 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLV-NRHYAKISDFGLS 483 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEE-ETTEEEECCCSTT
T ss_pred CeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEc-CCCcEEEeeccCc
Confidence 38899999986 45554432 24679999999999999999999999 6999999999999999 7889999999999
Q ss_pred cccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 228 KVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 228 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
+........ ....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+.....
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----- 557 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----- 557 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-----
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 876433221 123346789999999654 58999999999999999998 9999998887776655543100
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHh---cCCCCc
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFFD 364 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell---~hp~~~ 364 (395)
...+..+++++.+||.+||..||.+||++.+++ ++-|+.
T Consensus 558 -----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 558 -----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 012345789999999999999999999999875 444443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=323.24 Aligned_cols=247 Identities=25% Similarity=0.291 Sum_probs=198.0
Q ss_pred cccCceeee-eeecCCceEEEEEEEC--CCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
..++|.+.. .||+|+||.||+|.+. .++..||||++... .....+|+++++.++||||+++++++. .
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 81 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----A 81 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----S
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-----C
Confidence 345677776 9999999999999864 46788999998753 233457999999999999999999872 1
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
...++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~-~~~~~kl~Dfg 155 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLV-NRHYAKISDFG 155 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEE-ETTEEEECCCT
T ss_pred -CCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEc-CCCCEEECccc
Confidence 127899999986 55554432 34669999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 226 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 226 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
++......... ....+|+.|+|||++.+. .++.++||||||+++|+|+| |..||...+..+....+... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~--~~- 231 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--KR- 231 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--CC-
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC--Cc-
Confidence 99876443322 223457889999999654 48999999999999999998 99999988776655544331 00
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp 361 (395)
..++..+++++.+||.+||..||.+||++.++++|.
T Consensus 232 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 232 -------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 012345789999999999999999999999999764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=330.86 Aligned_cols=279 Identities=22% Similarity=0.297 Sum_probs=193.2
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-chHHHHHH--HHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQL--MRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
..++|++.+.||+|+||.||+|++ +++.||||++..... ....|.++ ++.++|+||+++++.+......+...++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 445799999999999999999987 789999999864432 22334444 4458999999999877655556666789
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC---------CceeccCCCCceeecCCCCcEEE
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP---------GVCHRDVKPQNLLVDPLTHQVKL 221 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---------~ivH~Dlkp~Nill~~~~~~~kl 221 (395)
+||||++| +|.+.+.. ...++..++.++.||+.||.|||+ + ||+||||||+|||++ .++.+||
T Consensus 89 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~-~~~~~kL 161 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVI 161 (336)
T ss_dssp EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEEC-TTSCEEE
T ss_pred EEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEc-CCCcEEE
Confidence 99999975 77666654 445888999999999999999999 7 999999999999999 6889999
Q ss_pred eecccccccccCC---------cceeeeecccccCchhhcCC------CCCCcccchHhHHHHHHHHHhCCCCCCCCCh-
Q 016115 222 CDFGSAKVLVKGE---------ANISYICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLGQPLFPGENA- 285 (395)
Q Consensus 222 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~lltg~~pf~~~~~- 285 (395)
+|||+++...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.....
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998664322 12234689999999999652 2356789999999999999999766643221
Q ss_pred HHHHHHHHHHh-CCCChhhhhhc-CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHH------
Q 016115 286 VDQLVEIIKVL-GTPTREEIRCM-NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA------ 357 (395)
Q Consensus 286 ~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el------ 357 (395)
.+......... ..+....+... ........++.. + .....+++++.+||.+||+.||.+|||+.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA----W--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT----C--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc----c--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 11000000000 11111111100 000000000000 0 0011235689999999999999999999999
Q ss_pred hcCCCCcCCCC
Q 016115 358 CAHPFFDELRE 368 (395)
Q Consensus 358 l~hp~~~~~~~ 368 (395)
+.++|-++-..
T Consensus 316 ll~~~~~~~~~ 326 (336)
T 3g2f_A 316 LMMIWERNKSV 326 (336)
T ss_dssp HHHCCCC----
T ss_pred HHHHHHhcccC
Confidence 55888776444
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=339.91 Aligned_cols=245 Identities=14% Similarity=0.189 Sum_probs=190.6
Q ss_pred cccCceeeeeeecCCceEEEEE-----EECCCCcEEEEEEecccc-cchHHHHHHHHHcC---CCceeeeceeeeecCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQDR-RYKNRELQLMRLMD---HPNVISLKHCFFSTTSK 145 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~-----~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~ 145 (395)
...+|.+.+.||+|+||+||+| .+..+++.||||++.... ....+|.++++.++ |+||+++++++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~----- 137 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHL----- 137 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE-----
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeee-----
Confidence 3457999999999999999999 467789999999986543 34567888888887 999999999984
Q ss_pred CceeEEEEEeccc-chHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC--------
Q 016115 146 DELFLNLVMEYVP-ETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-------- 215 (395)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~-------- 215 (395)
.....++||||++ |+|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~-~~~~~~~~~ 215 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILG-NGFLEQDDE 215 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEEC-GGGTCC---
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEec-ccccCcccc
Confidence 3444899999998 577777765433 35679999999999999999999999 6999999999999998 5
Q ss_pred ---CCcEEEeecccccccc---cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHH
Q 016115 216 ---THQVKLCDFGSAKVLV---KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289 (395)
Q Consensus 216 ---~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~ 289 (395)
++.+||+|||+|+... .........||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 7899999999997543 223334567899999999997654 8999999999999999999999996432100
Q ss_pred HHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
+..... + . ....++.+.+++.+||+.+|.+|++..+.+.+
T Consensus 293 ------------------------~~~~~~----~-~--~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 ------------------------CKPEGL----F-R--RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ------------------------EEECSC----C-T--TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ------------------------eeechh----c-c--ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 000000 0 0 00236789999999999999999766555543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=320.82 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=197.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
...+|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+|+++++.++||||+++++++. + ...+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----Q-EPIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-----C-CCcE
Confidence 4467999999999999999999974 56789999986542 34567999999999999999999872 2 2378
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||+.| +|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVS-DTLSCKIADFGLARLI 159 (279)
T ss_dssp EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEc-CCCCEEECCCcccccc
Confidence 99999975 6655554311 1368999999999999999999999 6999999999999999 7889999999999876
Q ss_pred ccCCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 231 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
...... ....++..|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---------- 228 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---------- 228 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred cCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC----------
Confidence 543321 223457789999999654 48999999999999999999 9999998877666555433100
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..++.++.+||.+||..||.+|||+.++++
T Consensus 229 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 ------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0122457899999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=343.69 Aligned_cols=252 Identities=25% Similarity=0.321 Sum_probs=199.2
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
....+|.+.+.||+|+||.||+|.+.. +..||||++.... ..+.+|+.+++.++||||+++++++. + ..+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~-~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C-Cce
Confidence 445679999999999999999999864 4679999987543 34568999999999999999999873 2 237
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||+.+ +|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVG-ENLVCKVADFGLARL 329 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCCCTTC-
T ss_pred EEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEC-CCCCEEECCCcccee
Confidence 899999985 7776665321 2468999999999999999999999 6999999999999999 788999999999987
Q ss_pred cccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 230 LVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 230 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
...... .....++..|+|||++.+. .++.++||||||+++|+|+| |..||.+....+....+.....
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------- 399 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 399 (452)
T ss_dssp -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred cCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 644322 1233457889999999754 58999999999999999999 9999998887776665543110
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc--CCCCcC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE 365 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~--hp~~~~ 365 (395)
...+..+++.+.+||.+||+.||.+|||++++++ ..++..
T Consensus 400 -------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 400 -------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 0122457899999999999999999999999986 355544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=354.51 Aligned_cols=237 Identities=23% Similarity=0.293 Sum_probs=190.6
Q ss_pred eeeeecCCceEEEEEEE--CCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 82 ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.+.||+|+||.||+|.+ ..+++.||||+++... ....+|+++++.++|||||++++++. +. .+++|
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~-~~~lv 447 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE-SWMLV 447 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS-SEEEE
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC-CEEEE
Confidence 35899999999999954 4567899999986532 34567999999999999999999872 22 27899
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 448 ~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC
T ss_pred EEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEe-CCCCEEEEEcCCcccccc
Confidence 999985 56665543 4678999999999999999999999 6999999999999999 788999999999987644
Q ss_pred CCc----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 233 GEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 233 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
... .....+|..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---------- 590 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---------- 590 (635)
T ss_dssp -------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred CccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 332 1233457889999999654 58999999999999999998 9999999888776665544210
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..+++++.+||.+||+.||++|||+.++++
T Consensus 591 ------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 ------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0123457899999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=322.46 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=192.8
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCc---EEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
....|.+.+.||+|+||+||+|.+..++. .||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 94 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP---- 94 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----
Confidence 34468888999999999999999765554 79999986432 3345799999999999999999988432
Q ss_pred ceeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
....++||||+. |++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~-~~~~~kl~Dfg 169 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLD-ESFTVKVADFG 169 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-TTCCEEECCTT
T ss_pred CCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEc-CCCcEEeCcCC
Confidence 223479999997 566655543 34678999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCC-----cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCC
Q 016115 226 SAKVLVKGE-----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 226 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
+++...... ......+++.|+|||.+.+. .++.++||||||+++|+|++| .+||...+..+....+.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-- 246 (298)
T 3pls_A 170 LARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-- 246 (298)
T ss_dssp SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC--
T ss_pred CcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC--
Confidence 997653322 12234568899999999654 589999999999999999995 555555555444433332100
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 247 --------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0122456889999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=330.96 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=186.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHH--cCCCceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRL--MDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
++|++.+.||+|+||.||+|++ +|+.||||++..... ...+|.+++.. ++|+||+++++++.... .....+++|
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv 113 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYLI 113 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEEE
Confidence 4799999999999999999997 489999999864432 23345555554 48999999999885432 222568999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC--------CceeccCCCCceeecCCCCcEEEeec
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP--------GVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--------~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
|||+.| +|.+.+.. ..+++..++.++.|++.||.|||+ + ||+||||||+|||++ .++.+||+||
T Consensus 114 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~-~~~~~kl~Df 186 (337)
T 3mdy_A 114 TDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADL 186 (337)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCC
T ss_pred EeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEEC-CCCCEEEEeC
Confidence 999986 77776654 468999999999999999999998 7 999999999999999 7889999999
Q ss_pred ccccccccCCcc-----eeeeecccccCchhhcCCCCCCcc------cchHhHHHHHHHHHhC----------CCCCCCC
Q 016115 225 GSAKVLVKGEAN-----ISYICSRYYRAPELIFGATEYTTS------IDIWSAGCVLAELLLG----------QPLFPGE 283 (395)
Q Consensus 225 g~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~------~DiwslG~il~~lltg----------~~pf~~~ 283 (395)
|+++........ ....||+.|+|||++.+.. +... +|||||||++|+|+|| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999765443322 2357899999999996644 4443 9999999999999999 6666543
Q ss_pred Ch----HHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 284 NA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 284 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.. ............. .+ .++ .......+++++.+||.+||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~---------~~-----~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKL---------RP-----SFP-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCC---------CC-----CCC-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCCchhhhHHHHhhhcc---------Cc-----ccc-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 21 1112211110000 00 000 00112245678999999999999999999999987
Q ss_pred C
Q 016115 360 H 360 (395)
Q Consensus 360 h 360 (395)
|
T Consensus 325 ~ 325 (337)
T 3mdy_A 325 T 325 (337)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=323.29 Aligned_cols=246 Identities=22% Similarity=0.330 Sum_probs=193.1
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCC---cEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..+|.+.+.||+|+||.||+|.+..++ ..+|+|.+.... ....+|+.+++.++||||+++++++.. ..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CC
Confidence 346999999999999999999975433 358999886432 334579999999999999999998643 33
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...++||||++| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||+
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~-~~~~~kl~Dfg~ 174 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLD-EKFTVKVADFGL 174 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-TTCCEEECSCGG
T ss_pred CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEC-CCCCEEECcccc
Confidence 457899999987 66665543 24568999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCc-----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 227 AKVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 227 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
++....... .....+|+.|+|||++.+. .++.++||||||+++|+|++ |.+||...+..+....+.....
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~--- 250 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--- 250 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC---
T ss_pred cccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC---
Confidence 976543322 2234567889999999654 48999999999999999999 6677777665555444433100
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..++..+.+||.+||..||.+|||+.++++
T Consensus 251 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 -------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122456889999999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=326.28 Aligned_cols=246 Identities=28% Similarity=0.368 Sum_probs=190.9
Q ss_pred ceeeeeeecCCceEEEEEEE----CCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 79 YMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
|++.+.||+|+||+||++.+ ..+|+.||||++.... ....+|+++++.++||||+++++++... +...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence 49999999999999988754 4578999999997542 3346799999999999999999988542 2346
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+++||||+++ +|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLD-NDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEc-CCCCEEECCccccc
Confidence 8899999986 65555543 458999999999999999999999 6999999999999999 78899999999998
Q ss_pred ccccCCc----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH-----------HHHHHH
Q 016115 229 VLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-----------QLVEII 293 (395)
Q Consensus 229 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-----------~~~~~~ 293 (395)
....... .....+|..|+|||++.+. .++.++||||||+++|+|+||..||....... ....+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 7655432 2234568889999999764 48899999999999999999999997542211 000111
Q ss_pred HHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.... .. .....+..++.++.+||++||+.||.+|||+.++++
T Consensus 262 ~~~~-----------~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLE-----------RG-------------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHH-----------TT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHh-----------cc-------------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1000 00 001123457899999999999999999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=341.99 Aligned_cols=246 Identities=17% Similarity=0.171 Sum_probs=184.2
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHHcC---------CCceeee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMD---------HPNVISL 135 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~---------h~niv~~ 135 (395)
.+|.+.+.||+|+||+||+|++ +|+.||||++.... ....+|+.+++.++ |+||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 4699999999999999999998 78999999986542 34568999998886 6666666
Q ss_pred ceeeeecC-------------------------CCCceeEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHH
Q 016115 136 KHCFFSTT-------------------------SKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189 (395)
Q Consensus 136 ~~~~~~~~-------------------------~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~ 189 (395)
.+++.... ..+...+|+||||+.++ +++.+. ...+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 55432210 01245699999999764 444442 256899999999999999
Q ss_pred HHHHHh-cCCCceeccCCCCceeecCCCC--------------------cEEEeecccccccccCCcceeeeecccccCc
Q 016115 190 GLAYIH-TVPGVCHRDVKPQNLLVDPLTH--------------------QVKLCDFGSAKVLVKGEANISYICSRYYRAP 248 (395)
Q Consensus 190 al~~LH-~~~~ivH~Dlkp~Nill~~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP 248 (395)
||.||| + +||+||||||+|||++ .++ .+||+|||+|+..... ..+||+.|+||
T Consensus 173 aL~~lH~~-~~ivHrDlKp~NILl~-~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP 246 (336)
T 2vuw_A 173 SLAVAEAS-LRFEHRDLHWGNVLLK-KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHH-HCCBCSCCCGGGEEEE-ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred HHHHHHHh-CCEeECCCCHHHEEEe-ccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence 999999 8 6999999999999999 454 8999999999876543 45799999999
Q ss_pred hhhcCCCCCCcccchHhHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccc
Q 016115 249 ELIFGATEYTTSIDIWSAGCV-LAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 326 (395)
Q Consensus 249 E~~~~~~~~~~~~DiwslG~i-l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (395)
|++.+.. +.++||||||++ .+++++|..||....... ....+...... .. ....
T Consensus 247 E~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~----~~~~ 302 (336)
T 2vuw_A 247 DLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF------------------KT----KCNT 302 (336)
T ss_dssp GGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC------------------SS----CCCS
T ss_pred hhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc------------------Cc----ccch
Confidence 9997543 889999998777 778888999985422111 11122211000 00 0001
Q ss_pred cccccCChhHHHHHHHhhccCCCCCCCHHHHh-cCCCCc
Q 016115 327 VFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFD 364 (395)
Q Consensus 327 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell-~hp~~~ 364 (395)
.....+++++.+||++||++| |++|+| +||||+
T Consensus 303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 303 PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 123457889999999999987 999999 999995
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=347.87 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=202.3
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
...+|++.+.||+|+||.||+|.+.. +..||||++.... ..+.+|+++++.++|+||+++++++. + ..++
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~-~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----e-ccce
Confidence 34579999999999999999999864 4679999997543 34568999999999999999999873 2 2378
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
|||||+.+ +|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVG-ENLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEc-CCCcEEEcccccceec
Confidence 99999985 7777665322 2458899999999999999999999 6999999999999999 6889999999999865
Q ss_pred ccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 231 VKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 231 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
..... .....++..|+|||++.+. .++.++|||||||++|+|+| |..||.+....+.+..+.....
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---------- 482 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---------- 482 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred CCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 43221 1223457789999999754 58999999999999999999 9999998887776665543110
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC--CCCcC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH--PFFDE 365 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h--p~~~~ 365 (395)
...+..++..+.+||.+||..||++|||+.++++. .+|..
T Consensus 483 ------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 483 ------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 01224578999999999999999999999999863 55543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=335.92 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=186.1
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCC---cEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
....|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ..+.+|+.+++.++||||+++++++.. .
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~ 162 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----S 162 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----C
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----C
Confidence 3446889999999999999999975433 468999885432 334578899999999999999998643 2
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
....++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~~~~kL~DFG 237 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLD-EKFTVKVADFG 237 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECCC-
T ss_pred CCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEEC-CCCCEEEeecc
Confidence 3347899999986 66665543 23568899999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCc-----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016115 226 SAKVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 226 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|+| |.+||...+..+....+... ..
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--~~ 314 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RR 314 (373)
T ss_dssp --------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--CC
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--CC
Confidence 9986543321 1234567889999999754 58999999999999999999 78888876655444433321 00
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...+..++..+.+||.+||+.||.+|||+.++++
T Consensus 315 --------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 315 --------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122457899999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=322.40 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=189.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECC-CCc--EEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~--~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
..+|++.+.||+|+||.||+|++.. ++. .||||++... .....+|+.+++.++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 3479999999999999999998643 333 6899988643 1234579999999999999999998842
Q ss_pred CceeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
.. .++||||+. +++.+.+... ...+++..++.++.||+.||.|||+ +||+|+||||+||+++ .++.+||+||
T Consensus 93 -~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~-~~~~~kl~Df 165 (291)
T 1u46_A 93 -PP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLA-TRDLVKIGDF 165 (291)
T ss_dssp -SS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEE-ETTEEEECCC
T ss_pred -CC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEc-CCCCEEEccc
Confidence 22 679999998 4666666542 3568999999999999999999999 6999999999999999 6889999999
Q ss_pred ccccccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016115 225 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 225 g~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
|++......... ....+|..|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~- 243 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER- 243 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC-
Confidence 999876544322 223467789999999654 48899999999999999999 99999988877666554431000
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
......++.++.++|.+||..||.+|||+.++++
T Consensus 244 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 244 --------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0012357899999999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=323.44 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=192.4
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHH--cCCCceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRL--MDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.+|.+.+.||+|+||.||+|++ +|+.||||++.... ....+|.++++. ++||||+++++++.... .....+++|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence 4699999999999999999998 68999999986543 334578888887 78999999999885433 122358999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--------TVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--------~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
|||+++ +|.+.+.. ..+++..++.++.||+.||.||| + +||+||||||+|||++ .++.+||+||
T Consensus 119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~-~~~~~kL~Df 191 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVK-KNGTCCIADL 191 (342)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEEC-TTSCEEECCC
T ss_pred EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEEC-CCCCEEEEEC
Confidence 999996 77776654 46899999999999999999999 8 6999999999999999 6889999999
Q ss_pred ccccccccCCc-----ceeeeecccccCchhhcCCCC-----CCcccchHhHHHHHHHHHhC----------CCCCCCCC
Q 016115 225 GSAKVLVKGEA-----NISYICSRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG----------QPLFPGEN 284 (395)
Q Consensus 225 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~lltg----------~~pf~~~~ 284 (395)
|++........ .....||+.|+|||++.+... ++.++||||||+++|+|+|| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 99987655442 234568999999999965432 23689999999999999999 78886542
Q ss_pred h----HHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 285 A----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 285 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
. .+.+......... .+ .++. ......++..+.+||.+||+.||.+|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~---------~~-----~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKL---------RP-----NIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCC---------CC-----CCCG-------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHh---------CC-----CCcc-------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1 1222211110000 00 0000 00112345689999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=323.12 Aligned_cols=259 Identities=26% Similarity=0.388 Sum_probs=195.5
Q ss_pred ccccCceeeeeeecCCceEEEEEE----ECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
....+|++.+.||+|+||.||+|+ +..+|+.||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--- 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---
Confidence 344579999999999999999998 46689999999986542 3456799999999999999999987432
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
+...+++||||+++ +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~-~~~~~kL~Df 189 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVE-NENRVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEE-ETTEEEECCC
T ss_pred CCCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEc-CCCcEEEecC
Confidence 22357899999985 766666542 3568999999999999999999999 6999999999999999 6889999999
Q ss_pred ccccccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 225 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 225 g~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
|++......... ....++..|+|||++.+. .++.++||||||+++|+|+||..||..... .+ .+..+...
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~---~~~~~~~~ 263 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPA--EF---MRMIGNDK 263 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HH---HHHHCTTC
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HH---HHhhcccc
Confidence 999876544321 223457789999999754 489999999999999999999998864311 11 11111111
Q ss_pred hh------hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 301 RE------EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 301 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.. ......... ....+..++.++.+||.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 264 QGQMIVFHLIELLKNNG-------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CTHHHHHHHHHHHHTTC-------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred chhhhHHHHHHHhhcCC-------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 000000000 00123457899999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=321.75 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=193.8
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
...+|.+.+.||+|+||.||+|.+.. .+|+|++... .....+|+.+++.++|+||+++++++. +..
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-----SPP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-----CSS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 34579999999999999999999743 4999988632 233457999999999999999999984 444
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++||||+.| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++ ++.+||+|||++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~--~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD--NGKVVITDFGLF 176 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSCC
T ss_pred ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe--CCCEEEeecCCc
Confidence 58999999985 55544432 23468999999999999999999999 6999999999999998 568999999998
Q ss_pred cccccC------CcceeeeecccccCchhhcC--------CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016115 228 KVLVKG------EANISYICSRYYRAPELIFG--------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293 (395)
Q Consensus 228 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~ 293 (395)
...... .......||+.|+|||++.+ ...++.++||||||+++|+|++|..||...........+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 654321 12233458999999999864 2347889999999999999999999999887766655543
Q ss_pred HHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
..... ......++.++.+||.+||..||.+|||+.++++ .|+.+.....+
T Consensus 257 ~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~~~~ 306 (319)
T 2y4i_B 257 TGMKP---------------------------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRR 306 (319)
T ss_dssp TTCCC---------------------------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC------
T ss_pred cCCCC---------------------------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHhhcc
Confidence 31000 0011246889999999999999999999999986 45555444333
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=345.18 Aligned_cols=246 Identities=27% Similarity=0.344 Sum_probs=197.5
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCC---CcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
....+|.+.+.||+|+||.||+|.+..+ +..||||.+.... ....+|+.+++.++||||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----- 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 3456799999999999999999998653 4679999886432 34557999999999999999999872
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
+ ..+++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~-~~~~vkL~DF 535 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVS-SNDCVKLGDF 535 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEE-ETTEEEECCC
T ss_pred c-CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEe-CCCCEEEEec
Confidence 2 237899999985 66665543 23468999999999999999999999 6999999999999999 7889999999
Q ss_pred ccccccccCCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 225 GSAKVLVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 225 g~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
|+++........ ....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+......
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--- 611 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--- 611 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---
Confidence 999876443322 234457889999999654 58999999999999999997 99999998887776666542110
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.++..+++.+.+||.+||..||.+|||+.++++
T Consensus 612 -------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 -------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 123457899999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=353.85 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=194.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECC-CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
.++|++.+.||+|+||+||+|.+.. +|+.||||++.... ....+|+.+++.++||||+++++++..........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999999976 78999999885432 23457899999999999999999986655444455
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.|+||||++|+.+..+. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ . +.+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~-----~~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~-~-~~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLT-E-EQLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-S-SCEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEe-C-CcEEEEecccchh
Confidence 79999999975332222 1378999999999999999999999 6999999999999998 3 4899999999987
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....
T Consensus 231 ~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------------- 282 (681)
T 2pzi_A 231 INSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------------- 282 (681)
T ss_dssp TTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------------
T ss_pred cccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc-----------------------
Confidence 6443 445789999999998653 589999999999999999999888642100
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
..+. .......++.+.+||.+||++||.+||+..+.+.|+|+..+
T Consensus 283 -----~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 283 -----GLPE-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -----SCCT-------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----cccc-------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000 00111246789999999999999999999999999998643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=300.17 Aligned_cols=219 Identities=16% Similarity=0.058 Sum_probs=172.3
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTRAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----EECCc
Confidence 46999999999999999999999999999999986542 3346789999999999999999998 44455
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.|+||||++| +|.+.+.. . ....++..++.||+.||.|||+ +||+||||||+|||++ .++.+||+++|
T Consensus 106 ~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~-~~g~~kl~~~~--- 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVS-IDGDVVLAYPA--- 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEE-TTSCEEECSCC---
T ss_pred EEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEc-CCCCEEEEecc---
Confidence 8999999986 55555432 2 3555688899999999999999 6999999999999999 78889998443
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
|++ .++.++|||||||++|+|+||+.||.+.+..+.+.
T Consensus 175 ----------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------------ 212 (286)
T 3uqc_A 175 ----------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------------ 212 (286)
T ss_dssp ----------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------------
T ss_pred ----------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------------
Confidence 333 27899999999999999999999998754321000
Q ss_pred CCCCCCCCCCc-cCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 309 PNYTDFRFPQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 309 ~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
...... ............+++++.+||.+||+.||.+| |+.|+++
T Consensus 213 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 213 -----PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp -----ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred -----HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 000000 00111122345689999999999999999999 9999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-34 Score=283.05 Aligned_cols=178 Identities=19% Similarity=0.112 Sum_probs=123.2
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeccc--------------ccchHHHHHHHHHc-CCCceeeeceeeeecCCCCce
Q 016115 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--------------RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 84 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (395)
.++.|+.|.+..++....|+.||+|.+.++ .+.+.+|+++|+++ .|+||+++++++ +++.
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 467788888877777778999999998543 13355799999999 699999999999 6777
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+|||||||+| +|.+.+.. .+.+++. +|+.||+.||+|||+ +|||||||||+|||++ .++.+||+|||+|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~-~dg~vKL~DFGlA 386 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVD-ARQHARLIDFGSI 386 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEEC-TTSCEEECCCTTE
T ss_pred EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEEC-CCCCEEEeecccC
Confidence 79999999997 55555543 4566654 478899999999999 6999999999999999 7889999999999
Q ss_pred cccccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCC
Q 016115 228 KVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277 (395)
Q Consensus 228 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~ 277 (395)
+..... ....+.+||+.|||||++.+ .+..++|+||+|+++++|.++.
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence 876443 23445789999999999965 4678899999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-28 Score=239.95 Aligned_cols=179 Identities=17% Similarity=0.208 Sum_probs=132.3
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 80 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
...+.||+|+||.||+|.. .+..+++|...... ....+|+++++.++||||+++..++....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---- 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD---- 412 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT----
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC----
Confidence 3456899999999999954 67889999864221 22468999999999999995544443222
Q ss_pred eeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..|+||||++ ++|.+.+.. +..++.||+.||.|||+ +||+||||||+|||++ . .+||+|||+
T Consensus 413 -~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~-~--~~kL~DFGl 475 (540)
T 3en9_A 413 -NKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFD-K--DLYIIDFGL 475 (540)
T ss_dssp -TTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEES-S--SEEECCCTT
T ss_pred -ccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEEC-C--eEEEEECcc
Confidence 2589999998 455554432 55789999999999999 6999999999999999 4 899999999
Q ss_pred ccccccCCcc--------eeeeecccccCchhhcCC-CCCCcccchHhHHHHHHHHHhCCCCCC
Q 016115 227 AKVLVKGEAN--------ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFP 281 (395)
Q Consensus 227 a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~ 281 (395)
++........ ....||+.|||||++... ..|+..+|+||..+-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9877543221 256789999999999541 237888999999998888887776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-25 Score=201.31 Aligned_cols=138 Identities=17% Similarity=0.206 Sum_probs=109.1
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----------------------cchHHHHHHHHHcCCCceeeec
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRLMDHPNVISLK 136 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------------~~~~~e~~~l~~l~h~niv~~~ 136 (395)
|.+.+.||+|+||.||+|.+ .+|+.||||.+.... ....+|+.+++.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 45569999999999999999 889999999985321 22458999999999 5 6777
Q ss_pred eeeeecCCCCceeEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC
Q 016115 137 HCFFSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (395)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~ 215 (395)
+++.. ...++||||++|+ |.+ +. ......++.||+.||.|||+ .||+||||||+|||++
T Consensus 168 ~~~~~------~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-- 227 (282)
T 1zar_A 168 KVYAW------EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-- 227 (282)
T ss_dssp CEEEE------ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE--
T ss_pred eEEec------cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE--
Confidence 75521 2368999999874 333 21 12345789999999999999 6999999999999999
Q ss_pred CCcEEEeecccccccccCCcceeeeecccccCchhhc
Q 016115 216 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252 (395)
Q Consensus 216 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 252 (395)
++.+||+|||+|+. +..|+|||.+.
T Consensus 228 ~~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 78899999999863 45578999873
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-21 Score=174.54 Aligned_cols=132 Identities=19% Similarity=0.228 Sum_probs=101.8
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcE--EEEEEecccc----------------------------cchHHHHHHHHHcC
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR----------------------------RYKNRELQLMRLMD 128 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~e~~~l~~l~ 128 (395)
|.+.+.||+|+||.||+|.+..+|+. ||||++.... ....+|+.+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78899999999999999998778999 9999864321 13457999999998
Q ss_pred CCce--eeeceeeeecCCCCceeEEEEEecccc------hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh-cCCC
Q 016115 129 HPNV--ISLKHCFFSTTSKDELFLNLVMEYVPE------TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH-TVPG 199 (395)
Q Consensus 129 h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH-~~~~ 199 (395)
|+++ ..++.. ...++||||+++ .+.+.... .++..+..++.||+.||.||| + .|
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~-~g 191 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE-AE 191 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT-SC
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH-CC
Confidence 8764 222221 125799999953 33332211 234457789999999999999 8 69
Q ss_pred ceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 200 ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
|+||||||+|||++ . .++|+|||+|...
T Consensus 192 ivHrDlkp~NILl~-~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYI-D--KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEES-S--SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEc-C--cEEEEECcccccC
Confidence 99999999999999 4 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=5.7e-19 Score=165.32 Aligned_cols=140 Identities=16% Similarity=0.127 Sum_probs=92.7
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc----------c--------hHHHHHHHHHcCCCceeeeceeee
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----------Y--------KNRELQLMRLMDHPNVISLKHCFF 140 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------~--------~~~e~~~l~~l~h~niv~~~~~~~ 140 (395)
|.+.+.||+|++|.||+|.+ .+|+.||||+++.... . ...+.++.....|+|+++++....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999996 4799999998743210 0 011222222334555554433221
Q ss_pred ecCC-CCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC--
Q 016115 141 STTS-KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-- 217 (395)
Q Consensus 141 ~~~~-~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~-- 217 (395)
.... -.....+|||||++|..+ ..... ......++.||+.+|.+||+ .|||||||||.|||++ +++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L---~~l~~------~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~-~dgd~ 244 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPM---RQVSS------VPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIR-EEKDA 244 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEG---GGCCC------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-EEECS
T ss_pred CCCeeeeccCceEEEEecCCccH---hhhcc------cHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEe-CCCCc
Confidence 1000 000113699999998532 22111 12345778899999999999 6999999999999998 444
Q ss_pred --------cEEEeeccccccc
Q 016115 218 --------QVKLCDFGSAKVL 230 (395)
Q Consensus 218 --------~~kl~Dfg~a~~~ 230 (395)
.+.|+||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.4e-12 Score=117.09 Aligned_cols=136 Identities=15% Similarity=0.123 Sum_probs=101.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecc----cccchHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.|.+...++.|+.+.||++.. .|..+++|.... ......+|+.+++.+. +.++.+++++. .+....|+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~l 87 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL 87 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE-----ecCCceEE
Confidence 588888999999999999975 468999999863 3345678999999885 56677787766 33445889
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV----------------------------------- 197 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~----------------------------------- 197 (395)
||||++|..+... .. +......++.++..+|..||+.
T Consensus 88 v~e~i~G~~l~~~--~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEE--YE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHH--CC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhc--cC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999998533322 10 1112346677899999999971
Q ss_pred -----------------------CCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 198 -----------------------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 198 -----------------------~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
..++|+|++|.|||++ ++..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-CCcEEEEEEchhccc
Confidence 2489999999999998 455567999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=4.5e-11 Score=106.72 Aligned_cols=134 Identities=16% Similarity=0.087 Sum_probs=92.0
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHHcCCCc--eeeeceeeeecCCCCceeEEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
.|.+....+.|..+.||++. ..+|..+++|..... .....+|+.+++.+.+.+ +.+++++. .+....++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~-----~~~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEE
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEec-----cCCCCCEEEE
Confidence 35555444566779999996 456788999987653 234568999999886544 44566655 2223478999
Q ss_pred ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 016115 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP------------------------------------ 198 (395)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~------------------------------------ 198 (395)
||++|..+. .. ... ...++.+++..|..||+..
T Consensus 95 e~i~G~~l~----~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL----SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT----TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC----cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999985332 11 111 1245567777777887631
Q ss_pred ---------------------CceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 199 ---------------------GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 199 ---------------------~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++|+|++|.|||++ +++.+.|+|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE-NGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-TTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE-CCcEEEEEcchhccc
Confidence 299999999999998 555567999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.15 E-value=8.2e-11 Score=110.49 Aligned_cols=141 Identities=16% Similarity=0.150 Sum_probs=99.4
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEec--cc-----ccchHHHHHHHHHcCC--CceeeeceeeeecCCCCceeEE
Q 016115 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVL--QD-----RRYKNRELQLMRLMDH--PNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 81 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~--~~-----~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~ 151 (395)
..+.|+.|.++.||++.. .+..+++|+.. .. .....+|..+++.+.. ..+.+++..+... ......|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence 356789999999999885 35688899775 22 3456789999999974 4466776655221 1123467
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------- 197 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---------------------------------- 197 (395)
+||||++|..+. . .....++......++.+++.+|..||+.
T Consensus 118 ~vme~v~G~~l~---~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 118 YIMEFVSGRVLW---D--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEECCCCBCCC---C--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEecCCeecC---C--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 999999985221 0 1123466777888899999999999962
Q ss_pred -----------------------CCceeccCCCCceeecCCCC-cEEEeeccccccc
Q 016115 198 -----------------------PGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKVL 230 (395)
Q Consensus 198 -----------------------~~ivH~Dlkp~Nill~~~~~-~~kl~Dfg~a~~~ 230 (395)
.+++|+|+++.|||++.++. .+.|+||+.+...
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36999999999999984332 3689999998653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=6.7e-11 Score=108.45 Aligned_cols=186 Identities=15% Similarity=0.152 Sum_probs=110.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcCC-Cce--eeeceeeeecCCCCceeEEEEEecc
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDH-PNV--ISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h-~ni--v~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
+.++.|....||++. ..+++|+.... .....+|..+++.+.. ..+ .+++... .........|+||+++
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceEEEccc
Confidence 458999999999863 46899986543 3445689999988843 222 2232221 1111122357899999
Q ss_pred cchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 016115 158 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------------- 197 (395)
Q Consensus 158 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---------------------------------------- 197 (395)
+|..+..... ..++..+...++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9842221110 2345555566666676666666641
Q ss_pred -----------------CCceeccCCCCceeecCC-CCcEEEeecccccccccCCcceeeeecccccCchhhc---C-CC
Q 016115 198 -----------------PGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF---G-AT 255 (395)
Q Consensus 198 -----------------~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~-~~ 255 (395)
..++|+|++|.||+++.+ +..+.|+||+.+.................-..|+... . ..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 247999999999999933 4568899999986542221111100000001222110 0 00
Q ss_pred ---------CCCcccchHhHHHHHHHHHhCCCCC
Q 016115 256 ---------EYTTSIDIWSAGCVLAELLLGQPLF 280 (395)
Q Consensus 256 ---------~~~~~~DiwslG~il~~lltg~~pf 280 (395)
......+.|++|.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0122358999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=3.6e-07 Score=83.57 Aligned_cols=70 Identities=11% Similarity=-0.033 Sum_probs=46.9
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcCCCc---eeeeceeeeecCCCCceeEEEEEec
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPN---VISLKHCFFSTTSKDELFLNLVMEY 156 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~ 156 (395)
.+.++.|....||+. |..+++|+.... .....+|..+++.+.+.. +.+++.+.. ......++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEec
Confidence 356889999999987 567899986432 234568999999997532 333333321 122346799999
Q ss_pred ccch
Q 016115 157 VPET 160 (395)
Q Consensus 157 ~~~~ 160 (395)
++|.
T Consensus 95 i~G~ 98 (306)
T 3tdw_A 95 VQGQ 98 (306)
T ss_dssp CCSE
T ss_pred cCCe
Confidence 9984
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=1.2e-06 Score=78.38 Aligned_cols=133 Identities=14% Similarity=0.081 Sum_probs=84.1
Q ss_pred eeecCCce-EEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHcCC-CceeeeceeeeecCCCCceeEEEEEecccch
Q 016115 84 VVGTGSFG-IVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLVMEYVPET 160 (395)
Q Consensus 84 ~lg~G~~g-~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~ 160 (395)
.+..|..| .||+......+..+++|.-.... ....+|..+|+.+.. -.+.+++.+. .+....++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEEEeeCCc
Confidence 34555554 69998877677889999865432 345678999988852 2244555554 3334578999999984
Q ss_pred HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 016115 161 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV------------------------------------------- 197 (395)
Q Consensus 161 l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~------------------------------------------- 197 (395)
......... ......++.++...|..||..
T Consensus 106 ~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 106 TAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 322221100 011223444555555555531
Q ss_pred --------------CCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 198 --------------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 198 --------------~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
..++|+|+.+.|||++ .++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECccccc
Confidence 0179999999999999 566677999998854
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.32 E-value=1.9e-06 Score=79.76 Aligned_cols=75 Identities=15% Similarity=0.217 Sum_probs=40.2
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCC--ceeeeceeeeec-CCCCceeEEEEEecccc
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHP--NVISLKHCFFST-TSKDELFLNLVMEYVPE 159 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~-~~~~~~~~~lv~e~~~~ 159 (395)
+.|+.|..+.||++.. .+..+++|+..........|..+++.+... .+.+++...... ........+++|+|++|
T Consensus 38 ~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G 115 (346)
T 2q83_A 38 DVIQGNQMALVWKVHT--DSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG 115 (346)
T ss_dssp EECC----CEEEEEEE--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred eeccccccCcEEEEEe--CCCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence 4567778899999875 334599999876443344566666655421 233333210000 00123347899999987
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=3.1e-06 Score=79.00 Aligned_cols=77 Identities=13% Similarity=0.091 Sum_probs=49.7
Q ss_pred eeeee-ecCCceEEEEEEEC--C----CCcEEEEEEecccc-------cchHHHHHHHHHcCC---CceeeeceeeeecC
Q 016115 81 AERVV-GTGSFGIVFQAKCL--E----TGETVAIKKVLQDR-------RYKNRELQLMRLMDH---PNVISLKHCFFSTT 143 (395)
Q Consensus 81 ~~~~l-g~G~~g~Vy~~~~~--~----~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h---~niv~~~~~~~~~~ 143 (395)
..+.| +.|..+.+|+.... . ++..+++|+..... ....+|..+++.+.. -.+.+++.+....
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~- 102 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG- 102 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS-
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC-
Confidence 34668 88999999988752 0 26789999875432 345789998888753 2355565544211
Q ss_pred CCCceeEEEEEecccc
Q 016115 144 SKDELFLNLVMEYVPE 159 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~ 159 (395)
......++||||++|
T Consensus 103 -~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 -DVLGTPFFLMDYVEG 117 (357)
T ss_dssp -TTTSSCEEEEECCCC
T ss_pred -CccCCceEEEEecCC
Confidence 111235789999987
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=7.9e-06 Score=77.41 Aligned_cols=71 Identities=18% Similarity=0.184 Sum_probs=44.5
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEecccc-----------cchHHHHHHHHHcCC--Cc-eeeeceeeeecCCCCc
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDH--PN-VISLKHCFFSTTSKDE 147 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~~~ 147 (395)
.+.||.|..+.||++....++..++||...... .....|.++++.+.. +. +.+++.+ + .+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CCc
Confidence 467999999999999765567889999754221 123568888887743 33 3344432 1 111
Q ss_pred eeEEEEEecccc
Q 016115 148 LFLNLVMEYVPE 159 (395)
Q Consensus 148 ~~~~lv~e~~~~ 159 (395)
.++|||+++|
T Consensus 110 --~~lvmE~l~g 119 (397)
T 2olc_A 110 --AVTVMEDLSH 119 (397)
T ss_dssp --TEEEECCCTT
T ss_pred --cEEEEEeCCC
Confidence 4699999986
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00011 Score=66.76 Aligned_cols=65 Identities=15% Similarity=0.098 Sum_probs=41.8
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCcee-eeceeeeecCCCCceeEEEEEecc
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
.+.|+.|....+|++ ..+++|+..... ....+|..+++.+...++. +++... .+. -++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence 577999999999998 468999875432 2335688888877533333 444332 211 24889999
Q ss_pred -cc
Q 016115 158 -PE 159 (395)
Q Consensus 158 -~~ 159 (395)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 65
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00045 Score=62.13 Aligned_cols=71 Identities=18% Similarity=0.155 Sum_probs=49.2
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCc---eeeeceeeeecCCCCceeEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPN---VISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~ 151 (395)
..-++.+|.|..+.||+.. ..+|+.|++|+..... ..+..|...|+.|.... +.+++... . -+
T Consensus 17 v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~----~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----D----RT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----T----TE
T ss_pred eEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----C----ce
Confidence 3456789999999999998 4679999999865332 23568999999885322 33333321 1 35
Q ss_pred EEEecccc
Q 016115 152 LVMEYVPE 159 (395)
Q Consensus 152 lv~e~~~~ 159 (395)
+||||+.+
T Consensus 87 lv~e~l~~ 94 (288)
T 3f7w_A 87 LAMEWVDE 94 (288)
T ss_dssp EEEECCCC
T ss_pred EEEEeecc
Confidence 89999874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00053 Score=58.15 Aligned_cols=98 Identities=18% Similarity=0.086 Sum_probs=61.8
Q ss_pred hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcceee
Q 016115 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239 (395)
Q Consensus 160 ~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 239 (395)
+|.+.|..+ +.++++.++|.++.|.+.+|.-+-..+.-..+=+.|..|++. .+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW-RDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE-TTSCEEECC-C--------------
T ss_pred cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe-cCCceeccc-cccc-----------
Confidence 566777654 579999999999999999987762101111223456888888 677776553 1110
Q ss_pred eecccccCchhhcCCCCCCcccchHhHHHHHHHHHh
Q 016115 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL 275 (395)
Q Consensus 240 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt 275 (395)
.....+.|||... ...+.+.=|||||+++|..+-
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 1133467888763 235788899999999999985
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00032 Score=66.81 Aligned_cols=79 Identities=11% Similarity=-0.054 Sum_probs=48.1
Q ss_pred hcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcceeeee--cccccCchhhcCCCC--CCcccchHhHHHHH
Q 016115 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIFGATE--YTTSIDIWSAGCVL 270 (395)
Q Consensus 195 H~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~--~~~~~DiwslG~il 270 (395)
+. ..++|+|+++.|||++ .++ ++|+||+.+.......+...... ...|++|+....... .....++.++...+
T Consensus 230 ~~-~~liHGDl~~~Nil~~-~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RA-QALIHGDLHTGSVMVT-QDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BC-CEEECSCCSGGGEEEC-SSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CC-CeEEecCCCCCcEEEe-CCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45 5899999999999998 444 99999999875432222211111 234667665421110 11224455777777
Q ss_pred HHHHhC
Q 016115 271 AELLLG 276 (395)
Q Consensus 271 ~~lltg 276 (395)
|..+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00028 Score=64.27 Aligned_cols=71 Identities=15% Similarity=0.093 Sum_probs=51.2
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHHcCC---CceeeeceeeeecCCCCceeEEEEEecc
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMDH---PNVISLKHCFFSTTSKDELFLNLVMEYV 157 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (395)
.+.|+.|....+|+... ++..+++|+.... ......|...|+.|.. ..+.+++... ......++||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~-----~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIG-----NSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEE-----ECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEe-----ecCCceEEEEEec
Confidence 46789999999999975 5678999987543 2345678888888742 4466666554 2234578999999
Q ss_pred cc
Q 016115 158 PE 159 (395)
Q Consensus 158 ~~ 159 (395)
+|
T Consensus 114 ~G 115 (312)
T 3jr1_A 114 NK 115 (312)
T ss_dssp CC
T ss_pred cC
Confidence 86
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00052 Score=62.68 Aligned_cols=142 Identities=12% Similarity=0.029 Sum_probs=75.2
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEecc--cccchHHHHHHHHHcCCCce--eeeceeeeecCC----CCceeEEEE
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--DRRYKNRELQLMRLMDHPNV--ISLKHCFFSTTS----KDELFLNLV 153 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~----~~~~~~~lv 153 (395)
.+.|+.|....+|++... +..+++|+... .......|..+++.+...++ .+++... .+ ......+++
T Consensus 27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~---~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK---DGELLGELSGRPAAL 101 (322)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT---TCCSCEEETTEEEEE
T ss_pred eeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC---CCCEEEEECCEEEEE
Confidence 456888888999998753 33688998865 33445678888877753232 2332210 00 011336789
Q ss_pred EecccchH------------HHH---HHhhccc-CCC----CC---HHHHH-H-----------HHHHHHHHHHHHhc--
Q 016115 154 MEYVPETM------------YRV---LKHYSSM-NQR----MP---LIYVK-L-----------YTYQIFRGLAYIHT-- 196 (395)
Q Consensus 154 ~e~~~~~l------------~~~---l~~~~~~-~~~----~~---~~~~~-~-----------i~~~i~~al~~LH~-- 196 (395)
|+|++|.. ... +...... ... .. +.... . +...+...+..+..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99998731 011 1111100 000 01 11000 0 00113334444442
Q ss_pred ----CCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 197 ----VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 197 ----~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
..+++|+|+++.|||++ +++.+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~-~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFL-GDELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEE-TTEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEe-CCceEEEecchhccC
Confidence 13799999999999998 455558999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00063 Score=62.52 Aligned_cols=33 Identities=39% Similarity=0.406 Sum_probs=27.4
Q ss_pred CCceeccCCCCceeecCC---CCcEEEeeccccccc
Q 016115 198 PGVCHRDVKPQNLLVDPL---THQVKLCDFGSAKVL 230 (395)
Q Consensus 198 ~~ivH~Dlkp~Nill~~~---~~~~kl~Dfg~a~~~ 230 (395)
..++|||+.+.|||++.+ ++.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999832 167999999998654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00073 Score=64.51 Aligned_cols=69 Identities=16% Similarity=0.254 Sum_probs=46.9
Q ss_pred eeeeecCCceEEEEEEECC-------CCcEEEEEEecc-cc-cchHHHHHHHHHcCCCce-eeeceeeeecCCCCceeEE
Q 016115 82 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQ-DR-RYKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~-~~-~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~ 151 (395)
.+.|+.|....||++.... ++..+++|+... .. ....+|..+++.+...++ .++++.+ .+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence 4678899999999998642 257899998844 22 334468888888764444 4555544 22 2
Q ss_pred EEEecccc
Q 016115 152 LVMEYVPE 159 (395)
Q Consensus 152 lv~e~~~~ 159 (395)
+|+||++|
T Consensus 149 ~v~e~l~G 156 (429)
T 1nw1_A 149 RLEEYIPS 156 (429)
T ss_dssp EEECCCCE
T ss_pred EEEEEeCC
Confidence 78999886
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0021 Score=61.71 Aligned_cols=70 Identities=13% Similarity=0.221 Sum_probs=46.7
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHHcCCCce-eeeceeeeecCCCCceeEEEEEec
Q 016115 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELFLNLVMEY 156 (395)
Q Consensus 81 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 156 (395)
-.+.|+.|-...+|++.....+..+++|+...... ...+|..+++.|...++ .++++++ .+ .+||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence 35678889999999998754457899998743322 23589999999976555 3555544 22 258999
Q ss_pred ccc
Q 016115 157 VPE 159 (395)
Q Consensus 157 ~~~ 159 (395)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00075 Score=62.98 Aligned_cols=69 Identities=13% Similarity=0.130 Sum_probs=41.8
Q ss_pred eeeeecCCceEEEEEEECC--------CCcEEEEEEeccccc---chHHHHHHHHHcCCCce-eeeceeeeecCCCCcee
Q 016115 82 ERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRR---YKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELF 149 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~ 149 (395)
.+.|+.|....+|++.... .+..+++|+...... ....|..+++.+...++ .++++.+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~---- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N---- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence 4567888889999998642 136899998754322 23578888888764443 3554432 1
Q ss_pred EEEEEecccc
Q 016115 150 LNLVMEYVPE 159 (395)
Q Consensus 150 ~~lv~e~~~~ 159 (395)
-++||||++|
T Consensus 109 ~~~v~e~i~G 118 (369)
T 3c5i_A 109 GGRIEEWLYG 118 (369)
T ss_dssp TEEEEECCCS
T ss_pred CcEEEEEecC
Confidence 1478999886
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0014 Score=59.88 Aligned_cols=139 Identities=15% Similarity=0.051 Sum_probs=76.1
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeccc---ccchHHHHHHHHHcCCCc--eeeeceeeeecCC--CCceeEEEEEe
Q 016115 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRLMDHPN--VISLKHCFFSTTS--KDELFLNLVME 155 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~--~~~~~~~lv~e 155 (395)
..|+ |....||++.. .+|+.+++|..... ......|..+++.+.... +++++.. .... ......+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence 3466 88889998763 35678999998632 334456888887775322 3333332 0000 11234678999
Q ss_pred cccchH--------H----HHH---Hhhccc-----CCCCCHHH----------------------HHHHHHHHHHHHHH
Q 016115 156 YVPETM--------Y----RVL---KHYSSM-----NQRMPLIY----------------------VKLYTYQIFRGLAY 193 (395)
Q Consensus 156 ~~~~~l--------~----~~l---~~~~~~-----~~~~~~~~----------------------~~~i~~~i~~al~~ 193 (395)
+++|.. . ..+ ...... ........ ....+..++..+.-
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998721 1 111 111000 01111111 11122222222332
Q ss_pred H----hcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 194 I----HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 194 L----H~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+ .. ..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~-~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFT-VLRLHGDCHAGNILWR-D--GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSC-CEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred HhhhcCC-eeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence 2 22 4689999999999998 4 799999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0013 Score=61.57 Aligned_cols=138 Identities=15% Similarity=0.220 Sum_probs=77.0
Q ss_pred eeeecCCceEEEEEEECC-------CCcEEEEEEeccc---ccchHHHHHHHHHcCCCce-eeeceeeeecCCCCceeEE
Q 016115 83 RVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQD---RRYKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~ 151 (395)
+.|..|-...+|++.... ++..|++|+.-.. .....+|..+++.+...++ .++++.+ .+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----c
Confidence 567788889999988532 3578999986332 2334478888887753333 4455444 22 2
Q ss_pred EEEecccchH---------------HHHHHhhccc----CCCC--CHHHHHHHHHHHHH-------------------HH
Q 016115 152 LVMEYVPETM---------------YRVLKHYSSM----NQRM--PLIYVKLYTYQIFR-------------------GL 191 (395)
Q Consensus 152 lv~e~~~~~l---------------~~~l~~~~~~----~~~~--~~~~~~~i~~~i~~-------------------al 191 (395)
+||||++|.. .+.|...-.. .+.. -+..+.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999998621 1111111111 1111 23445555544322 12
Q ss_pred HHH----hcC---CCceeccCCCCceeecCC---CCcEEEeecccccc
Q 016115 192 AYI----HTV---PGVCHRDVKPQNLLVDPL---THQVKLCDFGSAKV 229 (395)
Q Consensus 192 ~~L----H~~---~~ivH~Dlkp~Nill~~~---~~~~kl~Dfg~a~~ 229 (395)
..| ... ..++|+|+.+.|||++.+ .+.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 221 258999999999999843 26899999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0013 Score=60.74 Aligned_cols=32 Identities=22% Similarity=0.436 Sum_probs=27.2
Q ss_pred CCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 198 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
..++|+|+.+.||+++ .++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~-~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVG-NEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEEC-GGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEe-CCCeEEEEECCCCeeC
Confidence 3699999999999998 5677999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.032 Score=52.82 Aligned_cols=70 Identities=11% Similarity=0.155 Sum_probs=46.1
Q ss_pred eeeeeecCCceEEEEEEECCC-------CcEEEEEEecccc---cchHHHHHHHHHcCCCce-eeeceeeeecCCCCcee
Q 016115 81 AERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR---RYKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELF 149 (395)
Q Consensus 81 ~~~~lg~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~ 149 (395)
-++.|..|-...+|++..... +..|++|+..... -...+|..+++.+...++ .++++.+ .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~---- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P---- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence 345678888999999986421 5789999874432 233578999888863333 3444322 2
Q ss_pred EEEEEecccc
Q 016115 150 LNLVMEYVPE 159 (395)
Q Consensus 150 ~~lv~e~~~~ 159 (395)
-++||||++|
T Consensus 145 ~~~I~efI~G 154 (424)
T 3mes_A 145 EGRIEEFIDG 154 (424)
T ss_dssp TEEEEECCCS
T ss_pred CCEEEEEeCC
Confidence 1578999987
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.13 E-value=0.43 Score=44.66 Aligned_cols=30 Identities=27% Similarity=0.487 Sum_probs=25.2
Q ss_pred ceeccCCCCceeec-----CCCCcEEEeecccccc
Q 016115 200 VCHRDVKPQNLLVD-----PLTHQVKLCDFGSAKV 229 (395)
Q Consensus 200 ivH~Dlkp~Nill~-----~~~~~~kl~Dfg~a~~ 229 (395)
++|+|+.+.|||+. .++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 67999999999993 2467799999999864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 395 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-117 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-71 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-71 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-68 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-66 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-65 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-65 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-64 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-64 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-64 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-63 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-62 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-61 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-59 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-58 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-58 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-58 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-55 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 342 bits (878), Expect = e-117
Identities = 223/328 (67%), Positives = 272/328 (82%), Gaps = 3/328 (0%)
Query: 62 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL 121
+ T G P Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQD+R+KNREL
Sbjct: 6 VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 122 QLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
Q+MR +DH N++ L++ F+S+ KDE++LNLV++YVPET+YRV +HYS Q +P+IYV
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLY YQ+FR LAYIH+ G+CHRD+KPQNLL+DP T +KLCDFGSAK LV+GE N+SYI
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
RE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+ R T LEACAH
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQE 388
FFDELR+PN +LPNGR P LFNF +
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQ 331
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 1e-71
Identities = 73/305 (23%), Positives = 128/305 (41%), Gaps = 31/305 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ +G G+ G+VF+ +G +A K + + + RELQ++ + P ++
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F+ + +++ ME++ L R+P + + + +GL Y
Sbjct: 68 GFYGAFY-----SDGEISICMEHMDGGS---LDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
+ + HRDVKP N+LV+ ++KLCDFG + L+ AN S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYT 312
T Y+ DIWS G L E+ +G+ P +A +L+ +V G R P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 313 DFRF--------------PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358
+ I P K+ E D ++ L +P+ R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 359 AHPFF 363
H F
Sbjct: 297 VHAFI 301
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 4e-71
Identities = 101/321 (31%), Positives = 169/321 (52%), Gaps = 20/321 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKN---RELQLMRLMDHPNVI 133
Y +G G++G+V A VAIKK+ + + Y RE++++ H N+I
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ + T + + LV + +Y++LK Q + ++ + YQI RGL Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPE 249
IH+ V HRD+KP NLL++ T +K+CDFG A+V + Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 307
++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P++E++ C+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 308 -NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
P PW+++F +A+DL ++L ++P R +A AHP+ ++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
Query: 367 REPNARLPNGRPFPPLFNFKQ 387
+P+ PF
Sbjct: 302 YDPSDEPIAEAPFKFDMELDD 322
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (552), Expect = 1e-68
Identities = 96/304 (31%), Positives = 148/304 (48%), Gaps = 23/304 (7%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVI 133
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L F + ++LV +++ + + + ++K Y +GL Y
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H + HRD+KP NLL+D +KL DFG AK ++ +R+YRAPEL+F
Sbjct: 116 LHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
GA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT E+ M
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR--EPN 370
F P H +F + +DL L ++P R TA +A +F P
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 371 ARLP 374
+LP
Sbjct: 293 CQLP 296
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 212 bits (539), Expect = 2e-66
Identities = 94/300 (31%), Positives = 149/300 (49%), Gaps = 21/300 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLM-RLMDHPNVISLK 136
Y R +G G + VF+A + E V +K + ++ K RE++++ L PN+I+L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
S+ LV E+V T ++ + Q + ++ Y Y+I + L Y H+
Sbjct: 97 DIVKDPVSR---TPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ G+ HRDVKP N+++D +++L D+G A+ G+ + SRY++ PEL+
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 257 YTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y S+D+WS GC+LA ++ + P F G + DQLV I KVLGT + D R
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 316 FPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367
F I W + H + PEA+D +LL+Y R TA EA HP+F +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-65
Identities = 102/316 (32%), Positives = 168/316 (53%), Gaps = 21/316 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y + VG+G++G V A TG VAIKK+ + + + REL+L++ M H NV
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 133 ISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I L F + D+ LVM ++ + +++KH +++ ++ YQ+ +GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
YIH G+ HRD+KP NL V+ ++K+ DFG A+ Y+ +R+YRAPE+I
Sbjct: 135 RYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E ++ + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 312 TDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
P+++ + + P A++L ++L R TA EA AHP+F+ L +
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
Query: 369 PNARLPNGRPFPPLFN 384
P + + F+
Sbjct: 310 TE-DEPQVQKYDDSFD 324
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-65
Identities = 100/307 (32%), Positives = 166/307 (54%), Gaps = 21/307 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
+ +G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ L E L LV E++ + + + + S +PL +K Y +Q+ +GLA
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
+ H+ V HRD+KPQNLL++ +KL DFG A+ V + + +YRAPE++
Sbjct: 117 FCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 310
G Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370
FP+ + KV + + L S++L Y P+ R +A A AHPFF ++ +P
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292
Query: 371 ARLPNGR 377
+P+ R
Sbjct: 293 --VPHLR 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-65
Identities = 83/309 (26%), Positives = 146/309 (47%), Gaps = 22/309 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G+FG VF+A+ +TG+ VA+KKVL + + RE+++++L+ H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 133 ISLKHCFFSTTS---KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
++L + S + + + LV ++ + S++ + L +K +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL---AGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-----SYICSRY 244
GL YIH + HRD+K N+L+ +KL DFG A+ + + + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
YR PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 305 RCMNPNYTDFRFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
++ + +K ++ P A+DL +LL P+ R + +A H
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 362 FFDELREPN 370
FF P+
Sbjct: 307 FFWSDPMPS 315
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 207 bits (528), Expect = 2e-64
Identities = 68/318 (21%), Positives = 127/318 (39%), Gaps = 41/318 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVIS 134
Y +GTG+FG+V + TG A K V+ D+ +E+Q M ++ HP +++
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L F +D+ + ++ E++ + + + + +M Y Q+ +GL ++
Sbjct: 88 LHDAF-----EDDNEMVMIYEFMSGGE--LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 195 HTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
H H D+KP+N++ ++++KL DFG L ++ + + APE+ G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
D+WS G + LL G F GEN + L +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP--NA 371
+ + D +LL P+ R T +A HP+ P ++
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 372 RLPNGRPFPPLFNFKQEV 389
++P+ R + K +
Sbjct: 294 QIPSSRYTKIRDSIKTKY 311
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-64
Identities = 96/299 (32%), Positives = 155/299 (51%), Gaps = 17/299 (5%)
Query: 79 YMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDRRYKN------RELQLMRLM---D 128
Y +G G++G VF+A+ L+ G VA+K+V + RE+ ++R + +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
HPNV+ L + + E L LV E+V + + L +P +K +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLL 126
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
RGL ++H+ V HRD+KPQN+LV + Q+KL DFG A++ A S + + +YRAP
Sbjct: 127 RGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E++ + Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW-PRD 242
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367
F A P K + DL + L ++P+ R +A A +HP+F +L
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 3e-64
Identities = 100/318 (31%), Positives = 160/318 (50%), Gaps = 19/318 (5%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y VG+G++G V A +TG VA+KK+ + + REL+L++ M H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I L F S +E ++ ++ + Q++ +V+ YQI RGL
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLK 135
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
YIH+ + HRD+KP NL V+ K+ DFG A+ + Y+ +R+YRAPE++
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 313 DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
Q+ + VF P A+DL ++L R TA +A AH +F + +P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 370 NARLPNGRPFPPLFNFKQ 387
+ P P+ F +
Sbjct: 311 D-DEPVADPYDQSFESRD 327
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 6e-63
Identities = 100/299 (33%), Positives = 156/299 (52%), Gaps = 18/299 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ L + L LV E+ + K++ S N + VK + +Q+ +GL
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
+ H+ V HRD+KPQNLL++ ++KL +FG A+ + + + + +YR P+++
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 252 FGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
FGA Y+TSID+WSAGC+ AEL +PLFPG + DQL I ++LGTPT E+ M
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
+P A ++ DL LL+ +P R +A EA HP+F + P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 200 bits (509), Expect = 2e-62
Identities = 92/295 (31%), Positives = 156/295 (52%), Gaps = 20/295 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ L + L LV E++ + + ++L + + K + Q+ G+A
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIA 114
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
Y H V HRD+KPQNLL++ ++K+ DFG A+ + I + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 310
G+ +Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
D F + PW K + IDL S++L+ P+ R TA +A H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 4e-61
Identities = 74/313 (23%), Positives = 126/313 (40%), Gaps = 32/313 (10%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFF 140
+V+G G G V Q T E A+ K+LQD RE++L R P+++ + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 141 STTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+ + + L +VME + ++ ++ +Q I + Y+H++
Sbjct: 76 NLYAGRK-CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-N 131
Query: 200 VCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 257
+ HRDVKP+NLL +KL DFG AK + + + YY APE++ +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 317
S D+WS G ++ LL G P F + + + + IR + + +
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRMGQYEFPNPEWS 242
Query: 318 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPNARLPNG 376
++ E L LL+ P+ R T E HP+ + P L
Sbjct: 243 EV-------------SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
Query: 377 RPFPPLFNFKQEV 389
R ++V
Sbjct: 290 RVLKEDKERWEDV 302
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 198 bits (505), Expect = 5e-61
Identities = 70/316 (22%), Positives = 125/316 (39%), Gaps = 40/316 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVIS 134
Y +G+G+FG+V + TG K + D+ E+ +M + HP +I+
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L F +D+ + L++E++ + ++ + +M V Y Q GL ++
Sbjct: 91 LHDAF-----EDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 195 HTVPGVCHRDVKPQNLLVD-PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
H + H D+KP+N++ + VK+ DFG A L E + + APE++
Sbjct: 144 HE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
D+W+ G + LL G F GE+ ++ L + + +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPNAR 372
+ PEA D LLQ P R T +A HP+ + +R
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
Query: 373 LPNGRPFPPLFNFKQE 388
+P+ R K++
Sbjct: 297 IPSSRYNKIRQKIKEK 312
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-60
Identities = 67/301 (22%), Positives = 116/301 (38%), Gaps = 44/301 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ + +G G++G V A T E VA+K V R +E+ + ++++H NV+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L +EY + MP + + +Q+ G+ Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPEL 250
+H G+ HRD+KP+NLL+D +K+ DFG A V + Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ + +D+WS G VL +L G+ + + Q K T
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370
+PW K+ + L ++L +PS R T + ++++ +
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 270
Query: 371 A 371
A
Sbjct: 271 A 271
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-60
Identities = 63/294 (21%), Positives = 110/294 (37%), Gaps = 44/294 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVIS 134
+ +G G+FG V++A+ ET A K + ++ E+ ++ DHPN++
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L F E L +++E+ + + + +++ Q L Y+
Sbjct: 74 LLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFG 253
H + HRD+K N+L +KL DFG + + S+I + Y+ APE++
Sbjct: 127 HD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 254 AT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
T Y D+WS G L E+ +P N + L++I
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
K+ P R D + L+ + R T + HPF
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-60
Identities = 61/289 (21%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
+ +G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ + +T K + + LV E + LK Y + M + ++ + QI +GL ++H
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 196 T-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
T P + HRD+K N+ + T VK+ D G A L + + I + + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
+Y S+D+++ G + E+ + + Q+ + P
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 233
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
F K PE ++ ++ + R + + H FF
Sbjct: 234 -------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (495), Expect = 6e-60
Identities = 76/305 (24%), Positives = 120/305 (39%), Gaps = 49/305 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPN 131
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I + C+ E LVMEY + + + + + T+ +GL
Sbjct: 77 TIQYRGCYL-----REHTAWLVMEYCLGSA---SDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
AY+H+ + HRDVK N+L+ VKL DFGSA ++ S++ + Y+ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 183
Query: 252 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
E Y +D+WS G EL +P NA+ L I +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
+ + + LQ P R T+ H F R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276
Query: 370 NARLP 374
+
Sbjct: 277 TVIMD 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 7e-60
Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 45/296 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRLMDHPNV 132
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 66 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 192 AYIH----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYR 246
H V HRD+KP N+ +D VKL DFG A++L + +++ + YY
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
+PE + Y DIWS GC+L EL P F + + +I +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----------- 229
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
+F +I E ++ +R+L R + E +P
Sbjct: 230 --------KFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-59
Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 48/292 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDHPN 131
+ R +G G FG V+ A+ ++ +A+K + RE+++ + HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++ L F D + L++EY P + + Y ++ L
Sbjct: 68 ILRLYGYF-----HDATRVYLILEYAPLGT---VYRELQKLSKFDEQRTATYITELANAL 119
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
+Y H+ V HRD+KP+NLL+ ++K+ DFG + + + Y PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G + +D+WS G + E L+G+P F + I +V
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+F FP + A DL SRLL+++PS R E HP+
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-58
Identities = 95/342 (27%), Positives = 168/342 (49%), Gaps = 32/342 (9%)
Query: 69 KNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RE 120
+ G+ T+ Y + +G+G+ GIV A VAIKK+ + + + RE
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
L LM+ ++H N+ISL + F + +E + LVME + + +V++ +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------ 120
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
+ YQ+ G+ ++H+ + HRD+KP N++V +K+ DFG A+ Y
Sbjct: 121 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPY 178
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
+ +RYYRAPE+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP
Sbjct: 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 300 TREEIRCMNPNYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQY 346
E ++ + P ++ P+ + K+F +K +A DL S++L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 347 SPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQE 388
P+ R + +A HP+ + +P A + P +
Sbjct: 298 DPAKRISVDDALQHPYINVWYDP-AEVEAPPPQIYDKQLDER 338
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-58
Identities = 65/296 (21%), Positives = 117/296 (39%), Gaps = 40/296 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRLMDHPNVISL 135
YM +G G FGIV + + +T K V D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F + L ++ E++ ++ + + + + Y +Q+ L ++
Sbjct: 67 HESF-----ESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
H+ + H D++P+N++ +K+ +FG A+ L G+ + Y APE+
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
+T+ D+WS G ++ LL G F E + I+ T E
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
K + EA+D RLL R TA EA HP+ + E
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 191 bits (486), Expect = 4e-58
Identities = 97/357 (27%), Positives = 159/357 (44%), Gaps = 49/357 (13%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM 127
GEP + Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 128 DHPNVISLKH----------CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 177
+ + F+ + + + +V E + E + ++K Y ++ +PL
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 124
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-----QVKLCDFGSAKVLVK 232
IYVK + Q+ GL Y+H G+ H D+KP+N+L++ + Q+K+ D G+A
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD- 183
Query: 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------V 286
E + I +R YR+PE++ GA + DIWS C++ EL+ G LF +
Sbjct: 184 -EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 287 DQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKAHPWHKV------FHKRMP 333
D + +II++LG +R T F ++K P V F K
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 334 PEAIDLASRLLQYSPSLRCTALEACAHPFF------DELREPNARL-PNGRPFPPLF 383
E D S +LQ P R A HP+ +E+R P+ L +G P F
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-58
Identities = 71/309 (22%), Positives = 125/309 (40%), Gaps = 45/309 (14%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRL 126
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+PN+++ + L +VMEY + M + +
Sbjct: 74 NKNPNIVNYLDSYL-----VGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRE 124
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+ L ++H+ V HRD+K N+L+ VKL DFG + ++ S + + Y+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE++ Y +DIWS G + E++ G+P + EN + L I GTP
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP------ 234
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
+ + P +++ D +R L R +A E H F
Sbjct: 235 -------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
Query: 366 LREPNARLP 374
+ ++ P
Sbjct: 276 AKPLSSLTP 284
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 187 bits (475), Expect = 2e-57
Identities = 76/306 (24%), Positives = 120/306 (39%), Gaps = 54/306 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------------LQDRRYKNRELQLMR 125
Y + ++G G +V + T + A+K + + R +E+ ++R
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 126 -LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 184
+ HPN+I LK + + F LV + + L Y + + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
+ + +H + HRD+KP+N+L+D + +KL DFG + L GE +
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 245 YRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
Y APE+I + Y +D+WS G ++ LL G P F + L I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
M+ NY F P+ DL SR L P R TA EA A
Sbjct: 228 -------MSGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
Query: 360 HPFFDE 365
HPFF +
Sbjct: 270 HPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (472), Expect = 1e-56
Identities = 67/303 (22%), Positives = 115/303 (37%), Gaps = 42/303 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
Y V+GTG+F V A+ T + VAIK + + E+ ++ + HPN++
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+L + + L L+M+ V L +Q+ + Y
Sbjct: 71 ALDDIY-----ESGGHLYLIMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
+H + + HRD+KP+NLL L ++ + DFG +K+ G + + Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
Y+ ++D WS G + LL G P F EN +I+K
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371
+ + A D L++ P R T +A HP+ +
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275
Query: 372 RLP 374
+
Sbjct: 276 NIH 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-55
Identities = 83/320 (25%), Positives = 130/320 (40%), Gaps = 59/320 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDHPN 131
+ +++G GSF V A+ L T AIK + Y RE +M +DHP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ L F +D+ L + Y L Y + YT +I L
Sbjct: 70 FVKLYFTF-----QDDEKLYFGLSYAKNGE---LLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAP 248
Y+H G+ HRD+KP+N+L++ +++ DFG+AKVL S++ + Y +P
Sbjct: 122 EYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
EL+ S D+W+ GC++ +L+ G P F N +IIK+
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC------AHPF 362
++ FP+ + P+A DL +LL + R E AHPF
Sbjct: 226 ----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 363 FDELREPNARLPNGRPFPPL 382
F+ + L P P L
Sbjct: 270 FESVT--WENLHQQTP-PKL 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-52
Identities = 63/305 (20%), Positives = 119/305 (39%), Gaps = 50/305 (16%)
Query: 74 KQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------REL 121
++ + Y +G+G F +V + + TG A K + + R + RE+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 122 QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK 181
+++ + HPNVI+L + +++ + L++E V L + + + +
Sbjct: 65 SILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGE---LFDFLAEKESLTEEEAT 116
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDFGSAKVLVKGEANIS 238
+ QI G+ Y+H+ + H D+KP+N+++ ++K+ DFG A + G +
Sbjct: 117 EFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 239 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298
+ + APE++ D+WS G + LL G F G+ + L + V
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358
E + A D RLL P R T ++
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
Query: 359 AHPFF 363
HP+
Sbjct: 270 QHPWI 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-52
Identities = 82/313 (26%), Positives = 133/313 (42%), Gaps = 52/313 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHP 130
++ +++G GSFG VF A+ +T + AIK + +D + +++ L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+ + F + + L VMEY+ L ++ + L Y +I G
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L ++H+ G+ +RD+K N+L+D H K+ DFG K + G+A + C + Y APE
Sbjct: 116 LQFLHS-KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
++ G +Y S+D WS G +L E+L+GQ F G++ + IR NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFDELRE 368
Y + + EA DL +L P R HP F E+
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263
Query: 369 PNARLPNGRPFPP 381
L PP
Sbjct: 264 --EELERKEIDPP 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-52
Identities = 66/303 (21%), Positives = 111/303 (36%), Gaps = 56/303 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMD 128
Y ++G+G FG V+ + VAIK V +DR E+ L++ +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 129 --HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
VI L F L++E + L + + + + + +Q
Sbjct: 66 SGFSGVIRLLDWFE-----RPDSFVLILERPE--PVQDLFDFITERGALQEELARSFFWQ 118
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 246
+ + + H GV HRD+K +N+L+D ++KL DFGS L+K + +R Y
Sbjct: 119 VLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
PE I + S +WS G +L +++ G F + + +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR------------------ 218
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
F +R+ E L L PS R T E HP+ ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 367 REP 369
P
Sbjct: 262 LLP 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 173 bits (439), Expect = 4e-51
Identities = 69/303 (22%), Positives = 115/303 (37%), Gaps = 52/303 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMD 128
+ R++G G FG V+ + +TG+ A+K + + R + L L+ D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P ++ + + F L+ +++ + L ++ S + ++ Y +I
Sbjct: 66 CPFIVCMSYAF-----HTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEII 117
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
GL ++H V +RD+KP N+L+D H V++ D G A K + + S + Y AP
Sbjct: 118 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E++ Y +S D +S GC+L +LL G F D+ L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFF 363
PE L LLQ + R A E PFF
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 364 DEL 366
L
Sbjct: 269 RSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (433), Expect = 9e-51
Identities = 75/300 (25%), Positives = 125/300 (41%), Gaps = 54/300 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
+ R +GTGSFG V + G A+K + L+ + N E ++ ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I + F +D + ++M+Y+ L +QR P K Y ++ L
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGE---LFSLLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
Y+H+ + +RD+KP+N+L+D H +K+ DFG AK + + + + Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
Y SID WS G ++ E+L G F N + +I+
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDEL 366
+ RFP + DL SRL+ S R + HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-49
Identities = 60/299 (20%), Positives = 111/299 (37%), Gaps = 51/299 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISL 135
+ +G+GSFG V++ K VA+K + Q + E+ ++R H N++
Sbjct: 13 GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L +V ++ ++Y L + + +I + Q +G+ Y+
Sbjct: 70 MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELI 251
H + HRD+K N+ + VK+ DFG A V + + + S + APE+I
Sbjct: 121 HA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 252 FG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
Y+ D+++ G VL EL+ GQ + N DQ++ ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------------- 223
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
+ P + P L + L+ R + A + L
Sbjct: 224 --RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS--IELLAR 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (414), Expect = 2e-48
Identities = 62/295 (21%), Positives = 107/295 (36%), Gaps = 43/295 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPN 131
Y ++G G V A+ L VA+K + D RE Q ++HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++++ + + +VMEYV L+ M + L
Sbjct: 69 IVAV-YDTGEAETPAGPLPYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRA 247
+ H G+ HRDVKP N+++ T+ VK+ DFG A+ + ++ + I + Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE G D++S GCVL E+L G+P F G++ V + ++ P
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
H+ + + + + L +P R
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 8e-47
Identities = 68/311 (21%), Positives = 119/311 (38%), Gaps = 53/311 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
+++G G+FG V + TG A+K + ++ E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
K+ F + L VMEY L + S + + Y +I L Y+H
Sbjct: 71 KYAF-----QTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ V +RD+K +NL++D +K+ DFG K + A + C +
Sbjct: 123 S-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
+Y ++D W G V+ E++ G+ F ++ I+ + R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELREPN 370
FP + + PEA L + LL+ P R A E H FF +
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--W 269
Query: 371 ARLPNGRPFPP 381
+ + PP
Sbjct: 270 QDVVQKKLLPP 280
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-45
Identities = 51/282 (18%), Positives = 102/282 (36%), Gaps = 45/282 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCFF 140
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+++ L +V EY+ + ++ L+ S + + ++ + + Y+
Sbjct: 71 ----EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG-NN 123
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 259
HRD+ +N+LV + K+ DFG K + + APE + +++T
Sbjct: 124 FVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179
Query: 260 SIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 318
D+WS G +L E+ G+ +P D + + K ++
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------GYKMD- 220
Query: 319 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
PP ++ ++R + L+
Sbjct: 221 ---------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 2e-44
Identities = 57/302 (18%), Positives = 103/302 (34%), Gaps = 45/302 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLK 136
Y R +G+GSFG ++ + GE VAIK ++ E ++ ++M I
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ + + +VME + ++ ++ +++ L V L Q+ + YIH+
Sbjct: 69 RWCGA----EGDYNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 197 VPGVCHRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANI--------SYICSRYYR 246
HRDVKP N L+ + V + DFG AK + + + Y
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
+ G E + D+ S G VL LG + G A + + ++ I
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 363
+ Y P E + + + + F
Sbjct: 240 LCKGY---------------------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
Query: 364 DE 365
+
Sbjct: 279 RQ 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (387), Expect = 2e-44
Identities = 48/267 (17%), Positives = 95/267 (35%), Gaps = 24/267 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLK 136
Y R +G GSFG++F+ L + VAIK + E + +L+ I
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ F + L LV++ + ++ +L ++ + V + Q+ + IH
Sbjct: 67 YYFGQ----EGLHNVLVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 197 VPGVCHRDVKPQNLLVD----PLTHQVKLCDFGSAKVLVKGEANI--------SYICSRY 244
+ +RD+KP N L+ + + + DFG K + +
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
Y + G E + D+ + G V L G + G A + ++ +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKR 331
R + + + F + + + F
Sbjct: 238 RELCAGFPE-EFYKYMHYARNLAFDAT 263
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-41
Identities = 73/322 (22%), Positives = 125/322 (38%), Gaps = 55/322 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKV--------LQDRRYKNRELQLMRLM 127
+ +V+GTG++G VF + + +TG+ A+K + + + E Q++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
+ H F + E L+L+++Y L + S +R V++Y +I
Sbjct: 86 RQSPFLVTLHYAF----QTETKLHLILDY---INGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC---SRY 244
L ++H G+ +RD+K +N+L+D V L DFG +K V E +Y Y
Sbjct: 139 VLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
+ G + + ++D WS G ++ ELL G F + + EI +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 246
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACA 359
P + + M A DL RLL P R A E
Sbjct: 247 -----RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
Query: 360 HPFFDELREPNARLPNGRPFPP 381
H FF ++ L + P
Sbjct: 292 HLFFQKINW--DDLAAKKVPAP 311
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-41
Identities = 58/300 (19%), Positives = 112/300 (37%), Gaps = 37/300 (12%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRLMDHPNVIS 134
+ + + +G G FG V++ K GE VA+K + ++ E+ ++ H N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ + L LV +Y +++ L Y + + + GLA+
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115
Query: 194 IHTV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-----YIC 241
+H P + HRD+K +N+LV + D G A I +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 242 SRYYRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296
++ Y APE++ + E DI++ G V E+ + G + QL V
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
P+ EE+R + +++ + ++ + + + R TAL
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (366), Expect = 1e-40
Identities = 58/295 (19%), Positives = 109/295 (36%), Gaps = 54/295 (18%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISL 135
+ +GTGSFG V K E+G A+K + L+ + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ F + + + + + R + + Y QI Y+H
Sbjct: 107 EFSFKDN--------SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
++ + +RD+KP+NLL+D +++ DFG AK + + APE+I
Sbjct: 159 SL-DLIYRDLKPENLLIDQ-QGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y ++D W+ G ++ E+ G P F + + +I
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP-----SLRCTALEACAHPFFDE 365
F + DL LLQ +L+ + H +F
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-40
Identities = 57/293 (19%), Positives = 102/293 (34%), Gaps = 47/293 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISL 135
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 15 LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+++ +++ + EY+ S ++ + + QI G+A+I
Sbjct: 74 YAVV----TQEPIYI--ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIFG 253
HRD++ N+LV K+ DFG A+++ E + APE I
Sbjct: 127 E-RNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 254 ATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
+T D+WS G +L E++ G+ +PG + + + +
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFF 363
+ V P E L + P R T + FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 5e-40
Identities = 47/291 (16%), Positives = 100/291 (34%), Gaps = 45/291 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCF 139
+ +G+G FG+V + VAIK + + + E ++M + HP ++ L
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
++ + LV E++ + + + + + G+AY+
Sbjct: 70 L-----EQAPICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIFGATEY 257
V HRD+ +N LV +K+ DFG + ++ + S + +PE+ + Y
Sbjct: 122 VIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 317
++ D+WS G ++ E+ + + ++VE I
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216
Query: 318 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
+ + + + + P R E+ E
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ--LAEIAE 261
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-39
Identities = 57/288 (19%), Positives = 102/288 (35%), Gaps = 51/288 (17%)
Query: 83 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN-------RELQLMRLMDHPNV 132
+G GSFG+V + + +VA+K + D + RE+ M +DH N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I L + + +V E P + +L L + Y Q+ G+
Sbjct: 74 IRLYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPE 249
Y+ + HRD+ +NLL+ VK+ DFG + L + + + + +
Sbjct: 126 YLES-KRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
++ + D W G L E+ GQ + G N L +I K
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------- 229
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
R P+ + P + ++ + + P R T +
Sbjct: 230 ---EGERLPRP----------EDCPQDIYNVMVQCWAHKPEDRPTFVA 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-39
Identities = 64/296 (21%), Positives = 105/296 (35%), Gaps = 47/296 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
S++ +++ V EY+ + + + L + QI G+AY+
Sbjct: 81 V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATE 256
HRD++ N+LV K+ DFG A+++ E A + APE
Sbjct: 133 NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190
Query: 257 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
+T D+WS G +L EL G+ +PG + L ++ + P E
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDELREP 369
P DL + + P R T A +F
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 3e-39
Identities = 55/294 (18%), Positives = 112/294 (38%), Gaps = 43/294 (14%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
E ++ E++ Q + + + QI + Y+
Sbjct: 82 CT-----REPPFYIITEFMTYGNLLDY-LRECNRQEVSAVVLLYMATQISSAMEYLEK-K 134
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATE 256
HRD+ +N LV H VK+ DFG ++++ A+ + APE + +
Sbjct: 135 NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
++ D+W+ G +L E+ + Q+ E+++ D+R
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370
+ P + +L Q++PS R + E H F+ + + +
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETMFQES 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-39
Identities = 59/303 (19%), Positives = 108/303 (35%), Gaps = 56/303 (18%)
Query: 82 ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVI 133
++ +G+G+FG V + + +TVA+K + + E +M+ +D+P ++
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ + + LVME L Y N+ + + +Q+ G+ Y
Sbjct: 72 RMIGICEAES------WMLVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE----ANISYICSRYYRAPE 249
+ HRD+ +N+L+ H K+ DFG +K L E A + APE
Sbjct: 123 LEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
I ++++ D+WS G ++ E GQ + G + + K
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDE 365
R P E DL + Y R + ++D
Sbjct: 226 ----GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
Query: 366 LRE 368
+ E
Sbjct: 272 VNE 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 5e-39
Identities = 64/309 (20%), Positives = 112/309 (36%), Gaps = 54/309 (17%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRLMDH 129
E+V+G G FG V G+ VAIK + + RR E +M DH
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
PNVI L+ + ++ E++ + + + +I + I
Sbjct: 87 PNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAA 139
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------ 243
G+ Y+ HRD+ +N+LV+ K+ DFG ++ L ++ +Y +
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE 302
+ APE I ++T++ D+WS G V+ E++ G+ + D + I +
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------- 248
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
D+R P P L Q + R +
Sbjct: 249 ----------DYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287
Query: 363 FDELREPNA 371
+R PN+
Sbjct: 288 DKMIRNPNS 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 5e-39
Identities = 59/314 (18%), Positives = 108/314 (34%), Gaps = 70/314 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKN-----RELQLM-RLMDHP 130
+V+G+G+FG V A +T VA+K + + EL++M +L H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLK-------------------HYSS 170
N+++L + L+ EY + L+
Sbjct: 102 NIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
+ + + YQ+ +G+ ++ HRD+ +N+LV VK+CDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTH-GKVVKICDFGLARDI 214
Query: 231 VKGEANISYICSR---YYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 286
+ + +R + APE +F YT D+WS G +L E+ LG +PG
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 346
++I+ F+ E + +
Sbjct: 274 ANFYKLIQ-----------------NGFKMD----------QPFYATEEIYIIMQSCWAF 306
Query: 347 SPSLRCTALEACAH 360
R + +
Sbjct: 307 DSRKRPSFPNLTSF 320
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 9e-39
Identities = 67/312 (21%), Positives = 115/312 (36%), Gaps = 53/312 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L ++T + L+ + +P +L + + Y+ + QI +G+ Y
Sbjct: 75 RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR---YYRAPEL 250
+ + HRD+ +N+LV H VK+ DFG AK+L E + + A E
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
I YT D+WS G + EL+ G + G A ++ I++
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILE--------------- 227
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
R P + + + R E F R+P
Sbjct: 228 --KGERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274
Query: 370 NARLPNGRPFPP 381
L
Sbjct: 275 QRYLVIQGDERM 286
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-38
Identities = 48/284 (16%), Positives = 101/284 (35%), Gaps = 45/284 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCF 139
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+ + ++ EY+ +L + M R + + + Y+ +
Sbjct: 69 T-----KQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--YICSRYYRAPELIFGATEY 257
HRD+ +N LV+ VK+ DFG ++ ++ E S + PE++ +++
Sbjct: 121 FLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 258 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
++ DIW+ G ++ E+ LG+ + + I + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------------R 222
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
P + + + R T ++
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 7e-38
Identities = 63/303 (20%), Positives = 107/303 (35%), Gaps = 54/303 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKN-----RELQLMRLMDHPNVIS 134
+ +G G+FG V Q + VAIK + Q + RE Q+M +D+P ++
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + L LVME + K + +P+ V +Q+ G+ Y+
Sbjct: 74 LIGVCQAEA------LMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR----YYRAPEL 250
HRD+ +N+L+ H K+ DFG +K L ++ + + + APE
Sbjct: 126 EE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
I ++++ D+WS G + E L GQ + + + I + E
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDEL 366
PPE L S Y R L ++
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
Query: 367 REP 369
+
Sbjct: 275 SKV 277
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-37
Identities = 58/293 (19%), Positives = 109/293 (37%), Gaps = 51/293 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLE---TGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
SL + E +V+ Y+ R + + + Q+ +G+ +
Sbjct: 92 SLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKF 145
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAP 248
+ + HRD+ +N ++D VK+ DFG A+ + E + + + + A
Sbjct: 146 LAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
E + ++TT D+WS G +L EL+ G P +P N D V +++ R +
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GRRLL 254
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
P Y P ++ + +R + E +
Sbjct: 255 QPEY--------------------CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-36
Identities = 64/305 (20%), Positives = 113/305 (37%), Gaps = 65/305 (21%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHP 130
+ +G G+FG V +A + TVA+K + L +R EL+++ L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHY--------------SSMNQRM 175
N+++L ++ EY + L+ +
Sbjct: 88 NIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
L + ++YQ+ +G+A++ + HRD+ +N+L+ K+CDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200
Query: 236 NISYICSR---YYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 291
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 351
+IK + + + P E D+ P R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 352 CTALE 356
T +
Sbjct: 293 PTFKQ 297
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-36
Identities = 60/300 (20%), Positives = 107/300 (35%), Gaps = 56/300 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RLMDHPNVI 133
+ V+G G+FG V +A+ + G AIK++ D R EL+++ +L HPN+I
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLK------------HYSSMNQRMPLIYV 180
+L +L L +EY P + L+ +S + +
Sbjct: 75 NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ + RG+ Y+ HRD+ +N+LV + K+ DFG ++
Sbjct: 130 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ A E + + YTT+ D+WS G +L E++ +L E +
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
+R E DL + + P R + +
Sbjct: 241 -----------QGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 8e-36
Identities = 68/293 (23%), Positives = 100/293 (34%), Gaps = 50/293 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRLMDHP 130
R +G G FG V Q + VAIK R +E MR DHP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+++ L E + ++ME R + L + LY YQ+
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAP 248
LAY+ + HRD+ +N+LV VKL DFG ++ + + + AP
Sbjct: 121 LAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
E I +T++ D+W G + E+L+ G F G D + I P
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
PP L ++ Y PS R E A
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-35
Identities = 55/292 (18%), Positives = 96/292 (32%), Gaps = 50/292 (17%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMD 128
++V+G G FG V++ + VAIK + K E +M
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
H N+I L+ + ++ EY+ K + ++ + I
Sbjct: 68 HHNIIRLEGVIS-----KYKPMMIITEYMENGAL--DKFLREKDGEFSVLQLVGMLRGIA 120
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC----SRY 244
G+ Y+ HRD+ +N+LV+ K+ DFG ++VL
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
+ APE I + S D+WS G V+ E++ E + ++++ I
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
FR P P L + Q + R +
Sbjct: 228 -------DGFRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFAD 262
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-34
Identities = 67/321 (20%), Positives = 114/321 (35%), Gaps = 64/321 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQD------RRYKNRELQLMRLM 127
+ +G G+FG V +A T TVA+K + + R + L+ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY------------SSMNQR 174
H NV++L L +++E+ + L+
Sbjct: 75 HHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234
+ L ++ Y++Q+ +G+ ++ + HRD+ +N+L+ + VK+CDFG A+ + K
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP 188
Query: 235 ANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLV 290
+ + APE IF YT D+WS G +L E+ +PG ++
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 350
+K T R P PE PS
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280
Query: 351 RCTALEACAHPFFDELREPNA 371
R T E H L + NA
Sbjct: 281 RPTFSELVEH--LGNLLQANA 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (314), Expect = 9e-34
Identities = 65/321 (20%), Positives = 106/321 (33%), Gaps = 73/321 (22%)
Query: 83 RVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
R +G G+FG VFQA+ E VA+K + ++ RE LM D+PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP---------------------ETMYRVLKHYSSM 171
+ + L + EY+ + + S
Sbjct: 79 V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 172 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231
+ Q+ G+AY+ HRD+ +N LV VK+ DFG ++ +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIY 191
Query: 232 KGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 287
+ A+ + + PE IF YTT D+W+ G VL E+ G + G +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 347
+ + I A P + P E +L
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282
Query: 348 PSLRCTALEACAHPFFDELRE 368
P+ R + H + E
Sbjct: 283 PADRPSFCS--IHRILQRMCE 301
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-32
Identities = 59/309 (19%), Positives = 112/309 (36%), Gaps = 66/309 (21%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQD------RRYKNRELQLMR 125
+ + +G G+FG V A+ + + VA+K + D + +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY------------SSMN 172
+ H N+I+L + L +++EY + + L+ +
Sbjct: 75 IGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 173 QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232
+++ + YQ+ RG+ Y+ + HRD+ +N+LV + +K+ DFG A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHH 187
Query: 233 GEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 288
+ + + APE +F YT D+WS G +L E+ LG +PG V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245
Query: 289 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 348
L +++K R E + P
Sbjct: 246 LFKLLK-----------------EGHRMD----------KPSNCTNELYMMMRDCWHAVP 278
Query: 349 SLRCTALEA 357
S R T +
Sbjct: 279 SQRPTFKQL 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 5e-30
Identities = 59/312 (18%), Positives = 108/312 (34%), Gaps = 63/312 (20%)
Query: 82 ERVVGTGSFGIVFQAKC-----LETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
R +G GSFG+V++ E VAIK V +++R E +M+ + +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-------TMYRVLKHYSSMNQRMPLIYVKLYT 184
V+ L ++ME + R + + L +
Sbjct: 85 VVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--- 241
+I G+AY++ HRD+ +N +V VK+ DFG + + + +
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPT 300
+ +PE + +TT D+WS G VL E+ L + + G + L +++
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------ 354
P +L QY+P +R +
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 355 LEACAHPFFDEL 366
++ P F E+
Sbjct: 289 IKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 2e-19
Identities = 32/204 (15%), Positives = 55/204 (26%), Gaps = 32/204 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------------RELQLMRLMD 128
+++G G VF E +K +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
+ L+ ++ME + R+ + I
Sbjct: 65 FRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEVLDMIL 113
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
+A + G+ H D+ N+LV + + DF + + GE I R R
Sbjct: 114 EEVAKFYH-RGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEV--GEEGWREILERDVRNI 168
Query: 249 ELIFGATEYTTSIDIWSAGCVLAE 272
F Y T DI SA + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 395 | |||
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.7 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-64 Score=470.53 Aligned_cols=312 Identities=71% Similarity=1.235 Sum_probs=281.3
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHcCCCceeeeceeeeecCC-CCceeEEEEEec
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFLNLVMEY 156 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e~ 156 (395)
+|...++||+|+||+||+|++..+|+.||||++..+.....+|+++++.++|+||++++++|..... .+..++++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 6999999999999999999999999999999998887777899999999999999999999866443 456678999999
Q ss_pred ccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCCcc
Q 016115 157 VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (395)
Q Consensus 157 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 236 (395)
|++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++........
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~ 179 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCC
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCccc
Confidence 9999888888777777889999999999999999999999 699999999999999955568999999999988777777
Q ss_pred eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCC
Q 016115 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316 (395)
Q Consensus 237 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
.+..||+.|+|||++.+...++.++|||||||++|+|++|..||...+..+.+..+.+..|.+....+....+.+.+..+
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~ 259 (350)
T d1q5ka_ 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259 (350)
T ss_dssp CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCC
T ss_pred ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccc
Confidence 77889999999999887777999999999999999999999999999999999999999999999999988888888888
Q ss_pred CCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCCCCCCCCCCCCCCch-hhhh
Q 016115 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QEVC 390 (395)
Q Consensus 317 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 390 (395)
+.....++.......+++++.+||.+||++||++|||+.|+|+||||+++.++...+++.+..+...+|. +++.
T Consensus 260 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 334 (350)
T d1q5ka_ 260 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS 334 (350)
T ss_dssp CCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHT
T ss_pred cccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhcc
Confidence 8888888877777889999999999999999999999999999999999999999999999999988887 4444
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-61 Score=437.38 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=208.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.++|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+++++.++|||||++++++ .+...+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCcee
Confidence 35799999999999999999999999999999998543 23456899999999999999999999 455569
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|+|||||+| +|.+ +......+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+.
T Consensus 79 ~ivmEy~~gg~L~~----~l~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~-~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 79 YLFLEYCSGGELFD----RIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLD-ERDNLKISDFGLATV 152 (271)
T ss_dssp EEEEECCTTEEGGG----GSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEeccCCCcHHH----HHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEEC-CCCCEEEccchhhee
Confidence 999999996 4433 33446789999999999999999999999 6999999999999999 688999999999987
Q ss_pred cccCC---cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 230 LVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 230 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
..... .....+||+.|||||++.+...++.++|||||||++|+|+||+.||...................
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------- 225 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------- 225 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-------
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence 64432 23456799999999999876656788999999999999999999998765443333322210000
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
......+|+++.+||.+||+.||++|||++|+|+||||++
T Consensus 226 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 -------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp -------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0012457999999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-61 Score=431.16 Aligned_cols=248 Identities=29% Similarity=0.492 Sum_probs=213.2
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+. .....+|+++++.++|||||++++++ .+..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECC
Confidence 45799999999999999999999999999999998532 23345799999999999999999999 5556
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~-~~~~~kl~DFG~a 153 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLG-SAGELKIADFGWS 153 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEECCCCSC
T ss_pred EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceec-CCCCEeeccccee
Confidence 69999999995 66565554 3679999999999999999999999 6999999999999999 6889999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
+..... ......||+.|||||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+.+.
T Consensus 154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------ 219 (263)
T d2j4za1 154 VHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 219 (263)
T ss_dssp SCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred eecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence 876443 33456799999999999765 4899999999999999999999999988887777665541
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
++ .++..+|+++.+||.+||++||++|||++|+|+||||++
T Consensus 220 -----~~------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -----EF------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----CC------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 00 123457999999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-60 Score=436.14 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=212.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+++++.++|||||++++++ .+...+|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCEEEE
Confidence 36999999999999999999999999999999986432 3356899999999999999999999 44556999
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||||+|+.+..+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+....
T Consensus 95 vmEy~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EEECCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCS
T ss_pred EEEecCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEEC-CCCcEeeccchhheeecc
Confidence 999999643333332 2579999999999999999999999 6999999999999999 688999999999987654
Q ss_pred CC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCCC
Q 016115 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (395)
Q Consensus 233 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (395)
.. .....+||+.|||||++.+. .++.++|||||||++|+|+||..||.+.+..+.+..+...... .
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~----------- 235 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-E----------- 235 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-C-----------
T ss_pred ccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-C-----------
Confidence 43 34566799999999999764 5899999999999999999999999998888777766653111 0
Q ss_pred CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
...+..+|+++++||.+||++||.+|||++|+|+||||+.
T Consensus 236 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 236 --------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp --------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred --------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0123467999999999999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-60 Score=433.36 Aligned_cols=280 Identities=34% Similarity=0.593 Sum_probs=228.4
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 81 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
..++||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++|||||++++++ .+...+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 3578999999999999999999999999985332 2345799999999999999999999 5555699
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+||||+.|+++..+. .....+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+...
T Consensus 77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEec-CCCccccccCccccccC
Confidence 999999998655543 345678999999999999999999999 6999999999999999 78999999999998765
Q ss_pred cCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
... .....+||+.|+|||++.+...|+.++|||||||++|+|+||..||.+.+..+++..+.+..+.+....+......
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 433 3345678999999999977667899999999999999999999999999999999999999998877655433222
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
.....+......++.. ....+++++.+||++||++||++|||++|+|+||||++...+..
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~ 291 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291 (299)
T ss_dssp TTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred chhhhhccCCCCChHH-hcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCC
Confidence 2222222222222222 23467999999999999999999999999999999997655443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=435.00 Aligned_cols=254 Identities=30% Similarity=0.524 Sum_probs=214.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
++|++.+.||+|+||+||+|++..+|+.||||++.+. .....+|+++++.++|||||++++++ .+...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 4699999999999999999999999999999998532 13356899999999999999999998 55566
Q ss_pred EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
+|+|||||+| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++ +++.+||+|||+|+
T Consensus 83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~-~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLN-EDMHIQITDFGTAK 156 (288)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccC-CCceEEecccccce
Confidence 9999999996 55555544 3679999999999999999999999 6999999999999999 78899999999998
Q ss_pred ccccCC---cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 229 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 229 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
...... .....+||+.|||||++.+. .|+.++|||||||++|+|+||..||.+.+..+.+.++.+.
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~---------- 225 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 225 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT----------
T ss_pred ecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC----------
Confidence 764332 23346799999999999765 4899999999999999999999999998888777766541
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHH------HhcCCCCcCCCCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPNA 371 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e------ll~hp~~~~~~~~~~ 371 (395)
. ..++..+++++++||++||++||.+|||++| +++||||+.+++...
T Consensus 226 -------~------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 226 -------E------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp -------C------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred -------C------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 0 0133467999999999999999999999987 588999999887554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-59 Score=430.37 Aligned_cols=284 Identities=33% Similarity=0.625 Sum_probs=232.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
++|++.+.||+|+||+||+|++..+|+.||||++... .....+|+++++.++|||||++++++ .+...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence 4799999999999999999999999999999998543 23345799999999999999999999 455569
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
|+||||+.+++...+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+..
T Consensus 77 ~iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECSTTHHHHH
T ss_pred eEEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeec-ccCcceeccCCcceec
Confidence 999999999877766542 34679999999999999999999999 6999999999999999 6889999999999876
Q ss_pred ccC-CcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
... .......||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+.....
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 543 3344567899999999987777678999999999999999999999999999999999998888776554432211
Q ss_pred CCC-CCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 310 NYT-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 310 ~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
... ...++......+ ......+|+++++||++||++||++|||++|+|+||||+++..+.
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~ 293 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293 (298)
T ss_dssp STTCCTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred ccccccccccccccch-hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCC
Confidence 000 001111111111 122346789999999999999999999999999999999887763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-60 Score=427.37 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=203.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
++|++.+.||+|+||+||+|+++.+|+.||||.+.... ....+|+++++.++|||||++++++.+ .....+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEE
Confidence 47999999999999999999999999999999986432 234579999999999999999998853 233458
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-----ceeccCCCCceeecCCCCcEEEeec
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-----VCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~-----ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
|+|||||+| +|.+.+.........+++..++.++.||+.||.|||+ +| |+||||||+|||++ .++.+||+||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DF 158 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLD-GKQNVKLGDF 158 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEEC-TTSCEEECCH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcC-CCCcEEEeec
Confidence 999999985 7777776665567789999999999999999999998 45 99999999999999 6889999999
Q ss_pred ccccccccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 225 GSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 225 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
|+|+....... .....||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+....+... ..
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~--~~---- 231 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KF---- 231 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CC----
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CC----
Confidence 99987655433 3457889999999999654 5899999999999999999999999998887777666542 00
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~ 363 (395)
..++..+|+++.+||++||+.||++|||++|+|+|||+
T Consensus 232 ----------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 ----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 01234579999999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-60 Score=429.63 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=212.0
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+.|++.+.||+|+||+||+|++..+|+.||||++... .+...+|+++++.++|||||++++++ .+...+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCeEEE
Confidence 4699999999999999999999999999999998542 34566899999999999999999999 44556999
Q ss_pred EEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
|||||+|+ |.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+...
T Consensus 87 vmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNT 161 (288)
T ss_dssp EEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTTCEECH
T ss_pred EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeEC-CCCCEEEEechhhhccC
Confidence 99999964 4444333 24679999999999999999999999 6999999999999999 68899999999997654
Q ss_pred cCC-cceeeeecccccCchhhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 232 KGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 232 ~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
... ......||+.|||||++.. ...|+.++|||||||++|+|+||+.||.+.+..+.+.++.+....
T Consensus 162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~-------- 233 (288)
T d2jfla1 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP-------- 233 (288)
T ss_dssp HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC--------
T ss_pred CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 332 2335679999999999842 344789999999999999999999999998888777776652100
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
....+..+|+++.+||++||++||.+|||++|+|+||||+.
T Consensus 234 ------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 234 ------------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ------------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ------------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00123467999999999999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-59 Score=439.27 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=221.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++|||||++++++ .+...+|+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence 47999999999999999999999999999999986432 3345799999999999999999999 45556999
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC-CCCcEEEeeccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKVL 230 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~-~~~~~kl~Dfg~a~~~ 230 (395)
|||||+| +|.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||+|+..
T Consensus 101 vmE~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 101 IYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EECCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999986 5555543 234679999999999999999999999 69999999999999963 3578999999999988
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
..........||+.|||||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+........
T Consensus 177 ~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---------- 245 (350)
T d1koaa2 177 DPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---------- 245 (350)
T ss_dssp CTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC----------
T ss_pred ccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence 777777778899999999999765 489999999999999999999999999988888887766322111
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
......+|+++++||.+||++||++|||++|+|+||||+....+.
T Consensus 246 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 246 ---------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp ---------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred ---------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence 112346799999999999999999999999999999999876543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-59 Score=432.73 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=201.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.+.|++.+.||+|+||+||+|+++.+|+.||||++.... ....+|+.+++.++|||||++++++ .+...+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 346999999999999999999999999999999986432 2345799999999999999999998 556679
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC--CCCcEEEeecccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSA 227 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~--~~~~~kl~Dfg~a 227 (395)
|+|||||+| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+.. .++.+||+|||+|
T Consensus 83 ~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEecccee
Confidence 999999984 66666653 5689999999999999999999999 69999999999999952 4678999999999
Q ss_pred cccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
+...........+||+.|||||++.+. .|+.++|||||||++|+|+||..||.+.+..+....+.+......
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~------- 229 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD------- 229 (307)
T ss_dssp ---------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC-------
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-------
Confidence 887666666678899999999999765 589999999999999999999999999888777776665211110
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
......+|+++.+||.+||++||++|||++|+++||||+.
T Consensus 230 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 230 ------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 1123467999999999999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-59 Score=420.77 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=206.4
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
|++.+.||+|+||+||+|++..++..||+|.+.... ..+.+|+++++.++|||||++++++.... .+...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 477889999999999999999999999999986432 23457999999999999999999885433 34566899
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCC--ceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|||||+| +|.+.+.. ...+++..++.++.||+.||.|||+ +| |+||||||+|||++..++.+||+|||+|+.
T Consensus 90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999986 55555554 3679999999999999999999999 58 999999999999974578999999999986
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
... ......+||+.|||||++.+ .++.++|||||||++|+|++|+.||........+.+.+.. +..
T Consensus 165 ~~~-~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~---------- 230 (270)
T d1t4ha_ 165 KRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVK---------- 230 (270)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCC----------
T ss_pred ccC-CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCC----------
Confidence 433 33456789999999999864 4899999999999999999999999876555444333221 110
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
...+...+++++.+||.+||++||++|||++|+|+||||+
T Consensus 231 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 231 ---------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ---------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0113345789999999999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.7e-59 Score=435.92 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=218.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
+.|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++|||||+++++| .+...+|+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence 46999999999999999999999999999999986432 3345799999999999999999999 55666999
Q ss_pred EEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC-CCCcEEEeeccccccc
Q 016115 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKVL 230 (395)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~-~~~~~kl~Dfg~a~~~ 230 (395)
|||||+|+ |.+.+ ......+++.+++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||+|+..
T Consensus 104 vmE~~~gg~L~~~~---~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 104 ILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEECCCCCBHHHHT---TCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEcCCCChHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccceec
Confidence 99999964 43332 2334579999999999999999999999 69999999999999973 4678999999999988
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
..........||+.|||||++.+. .++.++|||||||++|+|+||..||.+.+..+.+..+.+.....+
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------- 248 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------- 248 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred CCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence 777777778899999999999764 589999999999999999999999999998888877766321111
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
......+|+++.+||.+||++||.+|||+.|+|+||||+...
T Consensus 249 ---------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 249 ---------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp ---------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ---------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 112346799999999999999999999999999999998643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-59 Score=426.33 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=217.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc----------ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+++.++|||||++++++ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 35799999999999999999999999999999998532 12346899999999999999999999 5
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC----cEE
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QVK 220 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~----~~k 220 (395)
+...+|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++ .+|
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~-~~~~~~~~vk 157 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLL-DRNVPKPRIK 157 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEES-CSSSSSCCEE
T ss_pred ECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEe-cCCCcccceE
Confidence 56679999999985 66666654 3579999999999999999999999 6999999999999998 343 599
Q ss_pred EeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 221 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
|+|||+|+............||+.|+|||++.+. .++.++|||||||++|+|+||..||.+.+..+.+..+.......
T Consensus 158 l~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~- 235 (293)
T d1jksa_ 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF- 235 (293)
T ss_dssp ECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC-
T ss_pred ecchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-
Confidence 9999999888766666677899999999999754 58999999999999999999999999988888777765531111
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~ 370 (395)
.......+|+++++||++||+.||++|||++|+|+||||+......
T Consensus 236 ------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 281 (293)
T d1jksa_ 236 ------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281 (293)
T ss_dssp ------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred ------------------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence 1223356799999999999999999999999999999998765533
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=423.54 Aligned_cols=286 Identities=33% Similarity=0.556 Sum_probs=235.1
Q ss_pred ccCceeeeeeecCCceEEEEEEECCC-CcEEEEEEeccc------ccchHHHHHHHHHc---CCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQD------RRYKNRELQLMRLM---DHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~------~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~ 145 (395)
.++|++++.||+|+||+||+|++..+ ++.||||++... .....+|+.+++.+ +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 45899999999999999999999766 567999998532 22345788887766 799999999998766656
Q ss_pred CceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
....++++|||++++++..... .....+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~-~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVT-SSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEc-CCCCeeecchh
Confidence 6778999999999987665544 335778999999999999999999999 6999999999999999 78899999999
Q ss_pred cccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhh
Q 016115 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 226 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (395)
+++............||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+....+.+....+.
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 99887666666778899999999999764 59999999999999999999999999999999999999999888776554
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
....... ..+...... ....+...+++.+.+||++||++||++|||++|+|+||||++++.
T Consensus 241 ~~~~~~~-~~~~~~~~~-~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 241 RDVALPR-QAFHSKSAQ-PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp TTCSSCG-GGSCCCCCC-CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccchh-hhhcccccc-chhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 3211110 011111111 122345678999999999999999999999999999999998865
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-59 Score=428.07 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=211.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++|||||++++++ .+...+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-----EECCEE
Confidence 5999999999999999999999999999999986432 2345799999999999999999998 444559
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
|+|||||.|+++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+..
T Consensus 91 ~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEE-TTTEEEECCCTTCBSS
T ss_pred EEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEC-CCCCEEEeeccccccc
Confidence 99999999876654432 24679999999999999999999999 6999999999999999 7899999999999865
Q ss_pred ccCCcceeeeecccccCchhhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 231 VKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
.. .....||+.|||||++.+ ...|+.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--------- 233 (309)
T d1u5ra_ 166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------- 233 (309)
T ss_dssp SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence 43 345679999999999864 2358999999999999999999999999888877777665521100
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.....+|+++.+||.+||++||.+|||++|+|+||||+.-
T Consensus 234 ------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 234 ------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp ------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 0123568999999999999999999999999999999763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=430.50 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=216.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+++.++||||+++++++ .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 45799999999999999999999999999999998643 23345799999999999999999999 6666
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~-~~g~vkl~DFG~a 152 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLD-KDGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCCTTC
T ss_pred ccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEec-CCCCEEEeecccc
Confidence 79999999996 44444443 4679999999999999999999999 6999999999999999 6889999999999
Q ss_pred ccccc-CCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 228 KVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 228 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+.... .......+||+.|||||++.+. .|+.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~----------- 220 (337)
T d1o6la_ 153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------- 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-----------
Confidence 87644 3344567899999999999765 4899999999999999999999999999887777666552
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 368 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 368 (395)
. ..++..+|+++++||++||++||.+|++ ++|+++||||+.+++
T Consensus 221 ------~------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 221 ------E------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ------C------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 0 1134567999999999999999999994 999999999988753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-58 Score=426.17 Aligned_cols=251 Identities=28% Similarity=0.442 Sum_probs=214.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (395)
++|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+++.++|||||++++++ .+...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 4799999999999999999999999999999998643 23345799999999999999999999 55566
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|+|||||.|+.+..+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+.
T Consensus 79 ~~ivmE~~~gg~l~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~-~~g~vkL~DFG~a~~ 153 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLD-KNGHIKITDFGFAKY 153 (316)
T ss_dssp EEEEECCCCSCBHHHHH---HHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEEC-TTSCEEECCCSSCEE
T ss_pred eeeEeeecCCccccccc---cccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEc-CCCCEEEecCccceE
Confidence 99999999975333322 235678899999999999999999999 6999999999999999 788999999999987
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... ....+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+....
T Consensus 154 ~~~~--~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------- 217 (316)
T d1fota_ 154 VPDV--TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------- 217 (316)
T ss_dssp CSSC--BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-------------
T ss_pred eccc--cccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 6433 3457899999999999664 48999999999999999999999999998888877776521
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCCC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~~ 369 (395)
..++..+++++.++|.+||.+||.+|+ |++++++||||+++.+.
T Consensus 218 ----------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 218 ----------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 012345799999999999999999996 99999999999998653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-59 Score=434.40 Aligned_cols=281 Identities=26% Similarity=0.422 Sum_probs=207.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
.++|++.+.||+|+||+||+|++..+|+.||+|++.... ....+|+.+++.++|||||+++++| .+...+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 457999999999999999999999999999999986432 2345799999999999999999999 455569
Q ss_pred EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
|+|||||.| +|.+.+.. .+.+++..++.++.||+.||.|||+..||+||||||+|||++ .++.+||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~-~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC-TTCCEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC-CCCCEEEeeCCCccc
Confidence 999999996 66665554 357999999999999999999999612899999999999999 788999999999987
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhhhhhcC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 308 (395)
.... ...+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+..+. ........+...........
T Consensus 155 ~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 155 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred cCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 6443 23457899999999999875 599999999999999999999999987654432 22122211211110000000
Q ss_pred C--CCCCCCC---CC---------ccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 309 P--NYTDFRF---PQ---------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 309 ~--~~~~~~~---~~---------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
. ....... +. .............+|.++.+||.+||++||++|||++|+|+||||++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 0 0000000 00 00000001112246899999999999999999999999999999987544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.2e-58 Score=414.33 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=218.0
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------------cchHHHHHHHHHcC-CCceeeeceeeeec
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRLMD-HPNVISLKHCFFST 142 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 142 (395)
++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++ |||||++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 47999999999999999999999999999999985431 12457999999997 99999999999
Q ss_pred CCCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEE
Q 016115 143 TSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (395)
Q Consensus 143 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl 221 (395)
.+...+|||||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~-~~~~~kl 151 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLD-DDMNIKL 151 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEE
T ss_pred --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEc-CCCCeEE
Confidence 566679999999985 77777654 3679999999999999999999999 6999999999999999 7889999
Q ss_pred eecccccccccCCcceeeeecccccCchhhcC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016115 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296 (395)
Q Consensus 222 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~ 296 (395)
+|||+++............||+.|+|||.+.+ ...++.++||||+||++|+|+||+.||.+.+..+....+....
T Consensus 152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 99999998877666667789999999999853 3347889999999999999999999999998888777776531
Q ss_pred CCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
.... ......+|+++++||++||++||++|||++|+|+||||+++
T Consensus 232 ~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 232 YQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1111 11224689999999999999999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-58 Score=423.40 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=218.3
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.++|++.+.||+|+||+||+|.++.+|+.||||++.... ....+|+++++.++|||||+++++| .+...+|+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence 357999999999999999999999999999999997543 2345899999999999999999999 55556999
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCC-CCcEEEeeccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVL 230 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~~ 230 (395)
|||||+| +|.+.+.. ....+++.+++.++.||+.||.|||+ +||+||||||+|||++.+ ...+||+|||+++..
T Consensus 79 vmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999996 55555532 23479999999999999999999999 699999999999999732 357999999999987
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
..........+|+.|+|||.+.+. .|+.++|||||||++|+|++|..||.+.+..+.+..+.+.....+.
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 224 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE--------- 224 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH---------
T ss_pred ccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh---------
Confidence 766666777899999999998654 4899999999999999999999999999998888888763222221
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
.....+|+++++||++||.+||.+|||++|+|+||||++
T Consensus 225 ----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 225 ----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ----------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 123457999999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.5e-57 Score=413.24 Aligned_cols=277 Identities=33% Similarity=0.597 Sum_probs=224.4
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
++|++.+.||+|+||+||+|++. +|+.||||++... .....+|+.+++.++|||||++++++ .+....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence 47999999999999999999985 8899999998543 22345899999999999999999999 445558
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+++|||+.++++..+.. ....+++..++.++.||+.||+|||+ .||+||||||+|||++ .++.+||+|||+|...
T Consensus 76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLIN-REGELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEc-CCCCEEecccccceec
Confidence 99999999987666643 35789999999999999999999999 6999999999999999 6889999999999876
Q ss_pred ccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 231 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
..... .....|++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 54333 34456899999999998777789999999999999999999999999999999999999888877665543221
Q ss_pred CCCC-CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 310 NYTD-FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 310 ~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
.... .........+ ...+...+++++.|||++||++||++|||+.|+|+||||++
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCC-GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhcccccccccCcc-hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1100 0111111111 22344668999999999999999999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-57 Score=425.11 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=215.5
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++|||||++++++ .+.
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~ 113 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccc
Confidence 3468999999999999999999999999999999985321 2345799999999999999999998 555
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+++||||+.| ++...+.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~-~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLID-QQGYIQVTDFGF 187 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred cccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccC-CCCCEEeeecee
Confidence 668999999996 55555543 3579999999999999999999999 6999999999999999 688999999999
Q ss_pred ccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 227 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
|+..... .....||+.|||||++.+. .++.++|||||||++|+|+||..||.+.+....+..+.....
T Consensus 188 a~~~~~~--~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--------- 255 (350)
T d1rdqe_ 188 AKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--------- 255 (350)
T ss_dssp CEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred eeecccc--cccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC---------
Confidence 9876433 3457899999999999764 489999999999999999999999999888877777765210
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
.++..+++++.+||++||++||.+|+ |++++++||||+..++
T Consensus 256 --------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 256 --------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred --------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 12345799999999999999999995 9999999999998765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.7e-58 Score=430.29 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=207.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHH---HHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRE---LQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
.++|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+| +.+++.++|||||++++++ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 357999999999999999999999999999999985321 112233 5566667899999999998 5
Q ss_pred CceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeec
Q 016115 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (395)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Df 224 (395)
+...+|+|||||+| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~-~~g~iKl~DF 151 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLD-EHGHVRISDL 151 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-SSSCEEECCC
T ss_pred ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEc-CCCcEEEeee
Confidence 55569999999995 66666554 3678999999999999999999999 6999999999999999 7889999999
Q ss_pred ccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 225 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
|+|+...... .....||+.|||||++.+...|+.++|||||||++|+|+||+.||.+.+..+... +.+.....
T Consensus 152 Gla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~----- 224 (364)
T d1omwa3 152 GLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTM----- 224 (364)
T ss_dssp TTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSC-----
T ss_pred ceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccC-----
Confidence 9998765443 3456799999999999766668999999999999999999999998765433322 22111100
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCCCcCCCC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 368 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~hp~~~~~~~ 368 (395)
...++..+|+++.+||.+||++||.+||| ++|+++||||+.+++
T Consensus 225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 01134568999999999999999999999 799999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=418.38 Aligned_cols=251 Identities=29% Similarity=0.509 Sum_probs=211.8
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHH-HHcCCCceeeeceeeeecCCCCce
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM-RLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
++|++.+.||+|+||+||+|+++.+|+.||||++.++. ....+|..++ +.++|||||++++++ .+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 47999999999999999999999999999999996432 1233455554 578999999999999 5566
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+|+|||||+| +|.+.+.. ...+++.+++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~-~~~~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLD-KDGHIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeec-CCCceeccccchh
Confidence 69999999996 55555544 4678999999999999999999999 6999999999999999 7889999999999
Q ss_pred cccccCC-cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 228 KVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 228 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
+...... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+... .+
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~------- 220 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP------- 220 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence 8664433 33456789999999999765 5899999999999999999999999998888777766541 11
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHH-HHhcCCCCcCCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELRE 368 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~-ell~hp~~~~~~~ 368 (395)
.++..+|+++.+||++||++||.+|||+. ++++||||++++.
T Consensus 221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 13345799999999999999999999995 8999999998754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-56 Score=416.66 Aligned_cols=286 Identities=35% Similarity=0.619 Sum_probs=226.6
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (395)
..+|++++.||+|+||+||+|.++.+|+.||||++.... ....+|+++|+.++|||||+++++|..... ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 457999999999999999999999999999999986432 234579999999999999999999855432 2344
Q ss_pred eEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccc
Q 016115 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (395)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 228 (395)
.+|+|||||++++...... ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+
T Consensus 97 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~-~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVN-EDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred eEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhcc-ccccccccccccee
Confidence 5799999998777666543 679999999999999999999999 6999999999999999 78999999999998
Q ss_pred ccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... .....||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+....+.++...+....
T Consensus 170 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 170 QADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp ECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 76433 3456789999999999877778999999999999999999999999999999999999999988877665432
Q ss_pred CCCCCC---CCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 309 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 309 ~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
...... ..+......+. .....+++++.+||++||.+||.+|||+.|+|+||||+.+.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~ 312 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred chhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence 110000 01111111221 123467999999999999999999999999999999999876544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-57 Score=410.89 Aligned_cols=245 Identities=27% Similarity=0.420 Sum_probs=205.2
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHHcC--CCceeeeceeeeecCC
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMD--HPNVISLKHCFFSTTS 144 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 144 (395)
++|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+|+.+++.++ |||||++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----- 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----- 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence 46999999999999999999999999999999986432 22457999999997 89999999998
Q ss_pred CCceeEEEEEecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEe
Q 016115 145 KDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~ 222 (395)
.+...+++||||+.+ ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEEC
Confidence 555568999999974 45555443 3679999999999999999999999 7999999999999998556899999
Q ss_pred ecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 223 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
|||+|+.... .......||+.|+|||++.+...++.++|||||||++|+|+||+.||...+ .+.+.
T Consensus 154 DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~------- 219 (273)
T d1xwsa_ 154 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG------- 219 (273)
T ss_dssp CCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------
T ss_pred ccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-------
Confidence 9999986543 334567899999999999776656788999999999999999999997532 12210
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~ 367 (395)
...++..+|+++++||++||++||++|||++|+|+||||+++.
T Consensus 220 ----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 220 ----------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ----------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ----------------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 0113346799999999999999999999999999999998754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.6e-56 Score=413.75 Aligned_cols=282 Identities=31% Similarity=0.525 Sum_probs=221.9
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
++|++++.||+|+||+||+|++..+|+.||||++.... ....+|+++++.++ ||||++++++|.. .....+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCceeEEE
Confidence 57999999999999999999999999999999987543 44568999999996 9999999998843 2344589999
Q ss_pred ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccCC
Q 016115 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (395)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 234 (395)
|||+++.+.. ..+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+++.+||+|||+|+......
T Consensus 112 e~~~~~~L~~------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQ------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGG------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHH------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999763322 13579999999999999999999999 6999999999999998556679999999999877776
Q ss_pred cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCChhhhhhcCCCCCC
Q 016115 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (395)
Q Consensus 235 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (395)
......+|+.|+|||++.+...++.++||||+||++|+|++|..||... +..++...+...++.+....+.........
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 6777889999999999987777899999999999999999999999754 455566666666654333222111100000
Q ss_pred CCC----CCccCCCc----cccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 314 FRF----PQIKAHPW----HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 314 ~~~----~~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
..+ .......+ .......+++++.|||++||++||.+|||++|+|+||||+.+.+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 000 00000111 11123457899999999999999999999999999999998765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=416.90 Aligned_cols=263 Identities=25% Similarity=0.358 Sum_probs=208.3
Q ss_pred ccCceeee-eeecCCceEEEEEEECCCCcEEEEEEecccccchHHHHHHHH-HcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 76 TISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-LMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 76 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.++|.+.. .||+|+||+||+|++..+|+.||||++... ....+|+.++. .++|||||+++++|.+.. .....+|+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEE
Confidence 35798864 699999999999999999999999998654 34567888865 558999999999884322 235678999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC--CCCcEEEeeccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAKVL 230 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~--~~~~~kl~Dfg~a~~~ 230 (395)
||||+| +|.+.+.. .....+++.+++.++.||+.||+|||+ +||+||||||+|||++. ..+.+||+|||+|+..
T Consensus 88 mEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 88 MECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeec
Confidence 999985 77776654 223579999999999999999999999 69999999999999983 2457999999999987
Q ss_pred ccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
..........||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~------------- 230 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR------------- 230 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC-------------
T ss_pred cCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh-------------
Confidence 777767778899999999998654 589999999999999999999999987654443333222100
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
...+.++ ......+|+++.+||++||++||++|||+.|+++||||++
T Consensus 231 ~~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 231 MGQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp SCSSSCC--------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred cCCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 0011111 1122457999999999999999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=410.91 Aligned_cols=288 Identities=34% Similarity=0.644 Sum_probs=229.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
.+|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+++|+.++||||+++++++..........++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 46999999999999999999999999999999986432 2345799999999999999999998665555556678
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+++++++|+|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+...
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEEC-CCCCEEEcccCceeecc
Confidence 8888888888887764 479999999999999999999999 6999999999999999 78899999999997654
Q ss_pred cCCc----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 232 KGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 232 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
.... ....+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+...........+........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 4322 344678999999999877667899999999999999999999999999998888888887777765543221
Q ss_pred CCCC---CCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCCC
Q 016115 308 NPNY---TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (395)
Q Consensus 308 ~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~ 372 (395)
.... .....+.....++.. ....+++++++||.+||++||.+|||++|+|+||||+....+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~ 307 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 307 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred hhhhhhcccccCCccCCCCHHH-hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccC
Confidence 1000 000111111222222 234678999999999999999999999999999999987775543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=401.56 Aligned_cols=283 Identities=34% Similarity=0.565 Sum_probs=227.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
++|++.+.||+|+||+||+|++..+|+.||||+++... ....+|+.+++.++||||+++++++ .+....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 47999999999999999999999999999999985432 2345899999999999999999999 555568
Q ss_pred EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
++|++++.|+.+..+.. ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++ .++.+||+|||.++..
T Consensus 77 ~iv~~~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLIN-RNGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred eEEeeeccccccccccc---cccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccc-cCCceeeeecchhhcc
Confidence 99999999876555443 35788999999999999999999999 6999999999999999 6889999999999876
Q ss_pred ccCCc-ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 231 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
..... .....+++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+.+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 54433 334456888999999977766899999999999999999999875 5667777788888877776655443322
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~ 369 (395)
.......................+++.+.+||++||++||.+|||++|+|+||||+++..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~ 292 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence 1111111111111122223445678999999999999999999999999999999987653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-55 Score=404.85 Aligned_cols=285 Identities=28% Similarity=0.469 Sum_probs=221.5
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC---CC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---KD 146 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 146 (395)
.++|++++.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 458999999999999999999999999999999985332 234589999999999999999998854321 22
Q ss_pred ceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
...+|+||||+.++++.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~-~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLIT-RDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeec-CCCcEEeeecce
Confidence 45689999999988665443 345689999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCC-----cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 227 AKVLVKGE-----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 227 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
++...... .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 97654322 2234578999999999987767899999999999999999999999999999999999998888776
Q ss_pred hhhhhcCCCCCCCCCCC--ccCCCccccc-cccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcC
Q 016115 302 EEIRCMNPNYTDFRFPQ--IKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~ 365 (395)
..+...........+.. .........+ ....++++.|||.+||++||++|||+.|+|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 54433221111111110 0001111111 1235788999999999999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-55 Score=409.47 Aligned_cols=283 Identities=32% Similarity=0.565 Sum_probs=219.4
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (395)
.+|++++.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++|||||+++++|..... ++...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 47999999999999999999999999999999996432 234579999999999999999999854432 34567
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+|+|||||.|++++.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~-~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCccccccc-cccceeeechhhhhc
Confidence 99999999998777653 568999999999999999999999 6999999999999999 688899999999988
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
...........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+......++....+.+..+.+.....
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 7777777778899999999999764 589999999999999999999999999999999999999888887776654332
Q ss_pred CCCC----------CCCCCc---cCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCC
Q 016115 310 NYTD----------FRFPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (395)
Q Consensus 310 ~~~~----------~~~~~~---~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~ 368 (395)
.... ...+.. ...+.........++++.+||++||.+||++|||++|+|+||||+...+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 1110 000000 0001111122335788999999999999999999999999999998654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=404.36 Aligned_cols=285 Identities=34% Similarity=0.585 Sum_probs=224.2
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCC-CCcee
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (395)
++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+++++.++|+|||++++++..... ++...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 47999999999999999999999999999999986432 234579999999999999999998855433 23334
Q ss_pred EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
+++++++++|+|.+.+. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+|++|||++..
T Consensus 98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~-~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVN-EDCELKILDFGLARH 170 (348)
T ss_dssp CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECCC----C
T ss_pred EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCcccccc-ccccccccccchhcc
Confidence 55655555567666553 3579999999999999999999999 6999999999999999 788999999999976
Q ss_pred cccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.. .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.+..+.+..........
T Consensus 171 ~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 171 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp CT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred cC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 53 3334567899999999987777789999999999999999999999999999999999999888877665433211
Q ss_pred CCCC---CCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCCCCCCC
Q 016115 310 NYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (395)
Q Consensus 310 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~ 371 (395)
.... ..........+.. ....+++++++||++||++||.+|||+.|+|+||||+++..+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~ 312 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred hhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence 0000 0011111111211 23467999999999999999999999999999999998876544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-54 Score=392.90 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=204.2
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
...+|++.+.||+|+||+||+|++..+|+.||||++..+. +.+.+|+++++.++|||||++++++ .+...++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 89 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY 89 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCeeE
Confidence 3457999999999999999999999999999999986543 3456899999999999999999998 4445589
Q ss_pred EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+|||||++ ++...+.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVG-ENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEEC-CCCcEEEccccceeec
Confidence 99999995 66666544 234678999999999999999999999 6999999999999999 7889999999999876
Q ss_pred ccCCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 231 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
...... ....|++.|+|||++.+. .|+.++|||||||++|||++|..||........+.+++.. +.
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-~~---------- 233 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DY---------- 233 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-TC----------
T ss_pred CCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-CC----------
Confidence 544332 234578999999999765 4899999999999999999976665544444444433331 00
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCcCC
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~~~ 366 (395)
....+..+++++.+||.+||+.||++|||++|+++ +|+.+
T Consensus 234 ----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 234 ----------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred ----------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 01133567999999999999999999999999965 45443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-54 Score=392.48 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=201.9
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
.++|++.+.||+|+||+||+|++..+|+.||||++..+. ..+.+|+++++.++|||||++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 346999999999999999999999999999999986432 23457999999999999999999886543 2345
Q ss_pred eEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+|+|||||+|+ |.+.+.. .+.+++.+++.++.||+.||+|||+ +||+||||||+|||++ .++.++|+|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~-~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEE-TTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccC-ccccceeehhhhh
Confidence 688999999964 4444433 4679999999999999999999999 6999999999999999 7889999999998
Q ss_pred cccccCC----cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 228 KVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 228 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
....... .....+||+.|||||++.+. .++.++|||||||++|+|+||..||.+.+..+.+.++......+
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~---- 233 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---- 233 (277)
T ss_dssp EECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC----
T ss_pred hhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC----
Confidence 7653332 23356799999999999764 58999999999999999999999999988887777666521111
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~hp~~~ 364 (395)
.......+|+++.+||++||++||.+||+..+.+.|+|.+
T Consensus 234 ---------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 ---------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ---------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1112346799999999999999999999555555677764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=386.82 Aligned_cols=249 Identities=23% Similarity=0.289 Sum_probs=196.6
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHcCCCceeeeceeeeecCCCCce
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (395)
..++|.+.+.||+|+||+||+|++. ..||||++... ...+.+|+.+++.++|||||++++++. + .
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-----~-~ 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----A-P 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-S
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-----c-c
Confidence 3457999999999999999999853 36999998532 234457999999999999999998752 1 2
Q ss_pred eEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
.+++|||||+| +|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~-~~~~~Kl~DFGla 151 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLH-EDLTVKIGDFGLA 151 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE-TTSSEEECCCCCS
T ss_pred EEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEc-CCCCEEEccccce
Confidence 37899999995 66655543 24579999999999999999999999 6999999999999999 7889999999999
Q ss_pred cccccCCc---ceeeeecccccCchhhcCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 228 KVLVKGEA---NISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 228 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
+....... .....||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..........+
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p-- 229 (276)
T d1uwha_ 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP-- 229 (276)
T ss_dssp CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC--
T ss_pred eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC--
Confidence 87643322 2345789999999998643 3478999999999999999999999998777666655554311111
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.....+..+++++.+||.+||+.||++|||+.|++++
T Consensus 230 ---------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 ---------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0112335678999999999999999999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-53 Score=390.87 Aligned_cols=247 Identities=23% Similarity=0.294 Sum_probs=189.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCc---EEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..+|++.+.||+|+||+||+|++..+|+ .||||.+... .+.+.+|+++++.++|||||++++++ .+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeC
Confidence 3469999999999999999999887765 5889987532 23456899999999999999999998 444
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
..+++|||||+|+.+..+.. .....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~--~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~-~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVN-SNLVCKVSDFGLS 175 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHH--TTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECCC---
T ss_pred CEEEEEEEecCCCcceeeec--cccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEEC-CCCcEEECCcccc
Confidence 45899999999754433322 224578999999999999999999999 6999999999999999 7899999999999
Q ss_pred cccccCCcc------eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 228 KVLVKGEAN------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 228 ~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
+........ ....||+.|||||++.+. .++.++|||||||++|||+| |..||.+.+..+.+..+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-- 252 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL-- 252 (299)
T ss_dssp --------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence 876543322 123568899999999764 58999999999999999998 89999988887766655431110
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+..+++++.+||.+||+.||++|||+.|++++
T Consensus 253 --------------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 --------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0224578999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=383.90 Aligned_cols=244 Identities=18% Similarity=0.297 Sum_probs=191.5
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.+|++.+.||+|+||+||+|++. ++..||||++..+. ..+.+|+++++.++|||||++++++ .....+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~-----~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCccccccee-----ccCCceEEE
Confidence 36999999999999999999975 57789999986543 3456899999999999999999998 444458999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++....
T Consensus 79 ~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEEC-GGGCEEECSCC-------
T ss_pred EEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeec-CCCCeEecccchheeccC
Confidence 999985 55554433 34678899999999999999999999 6999999999999999 788999999999987654
Q ss_pred CCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 233 GEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 233 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+.+..+.....
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------------ 220 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------ 220 (263)
T ss_dssp -----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC------------
T ss_pred CCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC------------
Confidence 4332 235689999999999765 59999999999999999999 5677777776666665544211
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..+++++.+||.+||+.||++|||++|+++|
T Consensus 221 ----------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 221 ----------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01224568899999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=394.91 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=202.0
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCc-----EEEEEEeccc-----ccchHHHHHHHHHc-CCCceeeeceeeeecCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQD-----RRYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 144 (395)
.++|++.+.||+|+||+||+|++..+++ .||+|.+... .....+|+.+++.+ +|||||++++++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~----- 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC----- 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----
Confidence 4579999999999999999999876554 6999988533 23345799999888 899999999999
Q ss_pred CCceeEEEEEecccc-hHHHHHHhhcc-------------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceecc
Q 016115 145 KDELFLNLVMEYVPE-TMYRVLKHYSS-------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRD 204 (395)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~-------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~D 204 (395)
.+...+++|||||+| +|.+.+..... ....+++..++.++.||+.||.|||+ +||+|||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRD 189 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 189 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecc
Confidence 455558999999985 66666654321 12458999999999999999999999 6999999
Q ss_pred CCCCceeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCC
Q 016115 205 VKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 280 (395)
Q Consensus 205 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf 280 (395)
|||+|||++ .++.+||+|||+|+........ ....||+.|||||++.+. .++.++|||||||++|||+| |..||
T Consensus 190 lKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 190 LAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp CSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred Cchhccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCC
Confidence 999999999 7899999999999876554432 245679999999999764 58999999999999999998 89999
Q ss_pred CCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 281 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.+.+..+.+.+++..... ...+..+|+++.+||.+||+.||++|||++||++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCC---------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 987766666655542100 11234578999999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=385.15 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=201.4
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
...+|++.+.||+|+||+||+|++. ++..||||++.... ..+.+|+++++.++|||||++++++. +. .++
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~-~~~ 83 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PIY 83 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SCE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-----cC-CeE
Confidence 3457999999999999999999975 67889999996543 34568999999999999999999762 22 268
Q ss_pred EEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccc
Q 016115 152 LVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (395)
Q Consensus 152 lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 230 (395)
+||||++++ |.+.+.. .....+++..++.++.||+.||.|||+ +||+||||||+||||+ +++.+||+|||+|+..
T Consensus 84 iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVS-DTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeee-cccceeeccccceEEc
Confidence 999999964 4443322 122468999999999999999999999 6999999999999999 7899999999999876
Q ss_pred ccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhhhhhc
Q 016115 231 VKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (395)
Q Consensus 231 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (395)
..... .....||+.|||||++.+. .++.++|||||||++|||+|| .+||...+..+.+..+....
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~----------- 227 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY----------- 227 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred cCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----------
Confidence 54432 2235678999999999754 489999999999999999995 55566666655555443310
Q ss_pred CCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc--CCCCcC
Q 016115 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE 365 (395)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~--hp~~~~ 365 (395)
....+..+++++.+||.+||+.||++|||++++++ |+||..
T Consensus 228 -----------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 -----------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 01123457899999999999999999999999998 888853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=380.46 Aligned_cols=244 Identities=18% Similarity=0.261 Sum_probs=203.2
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc---ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
.+|++.+.||+|+||+||+|+++ ++..||||+++.. ...+.+|+.+++.++|||||++++++ .+...+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEE-----eeCCceEEE
Confidence 36899999999999999999974 7889999998754 34456899999999999999999998 444559999
Q ss_pred Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccccccccc
Q 016115 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 232 (395)
|||+++ ++...+. .....+++..++.++.||++||.|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 78 ~Ey~~~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EECCTTEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSS
T ss_pred EEccCCCcHHHhhh---ccccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEc-CCCcEEECcchhheeccC
Confidence 999985 4444433 224678899999999999999999999 6999999999999999 788999999999986654
Q ss_pred CCcc--eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCC
Q 016115 233 GEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (395)
Q Consensus 233 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (395)
.... ....||+.|+|||++.+. .++.++|||||||++|||+| |+.||...+..+....+.+...
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~------------ 219 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------------ 219 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC------------
T ss_pred CCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 4332 235689999999999764 48999999999999999998 8999999888777666554211
Q ss_pred CCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..+++++.+||++||+.||++|||+.++++|
T Consensus 220 ----------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 220 ----------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01234568899999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=383.95 Aligned_cols=249 Identities=25% Similarity=0.314 Sum_probs=200.9
Q ss_pred ccCceeeee-eecCCceEEEEEEECC--CCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 76 TISYMAERV-VGTGSFGIVFQAKCLE--TGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 76 ~~~y~~~~~-lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.++|.+... ||+|+||+||+|.++. ++..||||++... .+.+.+|+++++.++|||||++++++. ++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-----~~ 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----AE 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cC
Confidence 456888874 9999999999998754 4557999998643 234567999999999999999999873 22
Q ss_pred eeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
.+|+|||||+| +|.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 82 -~~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~-~~~~~Kl~DFGl 155 (285)
T d1u59a_ 82 -ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLV-NRHYAKISDFGL 155 (285)
T ss_dssp -SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEE-ETTEEEECCCTT
T ss_pred -eEEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeec-cCCceeeccchh
Confidence 27899999996 4444432 234679999999999999999999999 7999999999999999 788999999999
Q ss_pred ccccccCCcc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 016115 227 AKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (395)
Q Consensus 227 a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 301 (395)
|+........ ....||+.|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+....+.+. ..
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~--~~-- 230 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--KR-- 230 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--CC--
T ss_pred hhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CC--
Confidence 9876544322 234578999999999755 48999999999999999998 99999988877666555431 10
Q ss_pred hhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHH---hcCCCCc
Q 016115 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFD 364 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el---l~hp~~~ 364 (395)
...+..+|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 231 ------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01234679999999999999999999999877 6788874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=384.57 Aligned_cols=241 Identities=23% Similarity=0.307 Sum_probs=194.0
Q ss_pred eeeecCCceEEEEEEEC--CCCcEEEEEEecccc------cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 83 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 83 ~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+.||+|+||+||+|.+. .+++.||||++.... ..+.+|++++++++|||||++++++. +. ..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-----~~-~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE-SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----SS-SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-----cC-CEEEEE
Confidence 57999999999999864 456789999985432 23568999999999999999999872 22 267999
Q ss_pred ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccccC
Q 016115 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (395)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 233 (395)
|||+| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.....
T Consensus 87 E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 87 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEE-ETTEEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhccc-ccCcccccchhhhhhcccc
Confidence 99996 55555443 4679999999999999999999999 6999999999999999 7899999999999876544
Q ss_pred Ccc----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcC
Q 016115 234 EAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (395)
Q Consensus 234 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (395)
... ....||+.|||||++.+. .++.++|||||||++|||+| |..||.+.+..+....+.+. ..
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~~--------- 228 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ER--------- 228 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CC---------
T ss_pred ccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--CC---------
Confidence 322 234678999999999764 48999999999999999998 89999988877665555431 10
Q ss_pred CCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHH---hcCCCCc
Q 016115 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFD 364 (395)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el---l~hp~~~ 364 (395)
...+..+|+++.+||.+||+.||++|||++++ |+|+|+.
T Consensus 229 -----------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 -----------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 11234679999999999999999999999998 5676654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=392.03 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=207.3
Q ss_pred ccCceeeeeeecCCceEEEEEEEC---CCCcEEEEEEeccc--------ccchHHHHHHHHHcCC-CceeeeceeeeecC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD--------RRYKNRELQLMRLMDH-PNVISLKHCFFSTT 143 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~ 143 (395)
.++|++++.||+|+||+||+|++. .+|+.||||++.+. .....+|++++++++| |||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~---- 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence 467999999999999999999873 47899999998532 1234579999999987 7999999998
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEe
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~ 222 (395)
.+...++++|||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+
T Consensus 99 -~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~-~~~~vkL~ 171 (322)
T d1vzoa_ 99 -QTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLD-SNGHVVLT 171 (322)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEES
T ss_pred -ccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeec-CCCCEEEe
Confidence 555569999999995 55555544 3567899999999999999999999 6999999999999999 68899999
Q ss_pred ecccccccccCCc--ceeeeecccccCchhhcCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016115 223 DFGSAKVLVKGEA--NISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299 (395)
Q Consensus 223 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 299 (395)
|||+++....... .....|++.|+|||.+.+.. .++.++|||||||+||+|+||..||.+.+..+....+.+.....
T Consensus 172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 9999986543322 34567899999999996543 46889999999999999999999998776555444444321100
Q ss_pred ChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCCCcCCCC
Q 016115 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~hp~~~~~~~ 368 (395)
...++..+|+++.+||++||++||++|| |++|+++||||+.++.
T Consensus 252 -------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 252 -------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp -------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred -------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 0112345799999999999999999999 5899999999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=379.14 Aligned_cols=254 Identities=25% Similarity=0.311 Sum_probs=197.9
Q ss_pred ccccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeE
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (395)
...++|++.+.||+|+||+||+|++..+ ..||||++.... ..+.+|+.+++.++|+|||++++++. +. .+
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-----~~-~~ 86 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----EE-PI 86 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-----cC-Ce
Confidence 3456899999999999999999998654 679999986443 34568999999999999999999872 22 26
Q ss_pred EEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
++||||++++ +...+... ....+++.+++.++.||+.||+|||+ +||+||||||+||||+ .++.+||+|||+|+.
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~-~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVG-ENLVCKVADFGLARL 162 (285)
T ss_dssp EEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCCCTTC-
T ss_pred EEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEEC-CCCcEEEcccchhhh
Confidence 8999999965 44443322 23568999999999999999999999 6999999999999999 789999999999987
Q ss_pred cccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCChhhhhh
Q 016115 230 LVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (395)
Q Consensus 230 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (395)
...... .....||+.|+|||++.+. .++.++|||||||++|||+||. +||......+.+..+.+...
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--------- 232 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 232 (285)
T ss_dssp -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred ccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 644332 2345689999999999764 5899999999999999999965 55555665555555443110
Q ss_pred cCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc--CCCCcCCC
Q 016115 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDELR 367 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~--hp~~~~~~ 367 (395)
...+..+++++.+||.+||+.||++|||++++++ ++||+...
T Consensus 233 -------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 233 -------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -------------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 0123457899999999999999999999999988 89997653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=374.92 Aligned_cols=245 Identities=20% Similarity=0.253 Sum_probs=187.4
Q ss_pred cCceeeeeeecCCceEEEEEEECCCC----cEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
..|.+.++||+|+||+||+|.+..++ ..||||++.... ..+.+|+++++.++|||||++++++ .+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----ecC
Confidence 36999999999999999999987655 469999985432 2345799999999999999999998 444
Q ss_pred eeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccc
Q 016115 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (395)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 227 (395)
...++||||+.++++..+.. .....+++..+..++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+|
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~-~~~~~Kl~DFGla 157 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVN-SNLVCKVSDFGLS 157 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHH--HTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECCCCC-
T ss_pred CceEEEEEecccCcchhhhh--cccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEEC-CCCeEEEcccchh
Confidence 45899999999754433322 234679999999999999999999999 6999999999999999 7899999999999
Q ss_pred cccccCCc----ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChh
Q 016115 228 KVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 228 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
+....... .....||+.|||||++.+. .++.++|||||||++|||+||..| |...+..+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------ 230 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------ 230 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC------
Confidence 87654332 2234578999999999765 599999999999999999996544 55555544444333210
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....+..++..+.+||.+||+.||++|||+.|+++
T Consensus 231 ----------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 231 ----------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ----------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 01123456889999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=376.66 Aligned_cols=245 Identities=27% Similarity=0.355 Sum_probs=189.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCC---cEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.++|++.+.||+|+||+||+|++..++ ..||||.+... ...+.+|+.+++.++|||||++++++. +
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----~- 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----E- 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c-
Confidence 457999999999999999999986543 56899988532 233557999999999999999999872 2
Q ss_pred eeEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
..+++||||++++ +...+. .....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~-~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVS-SNDCVKLGDFGL 154 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEE-ETTEEEECC---
T ss_pred CeEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeec-CCCcEEEccchh
Confidence 2378999999964 444333 234678999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCc--ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhh
Q 016115 227 AKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (395)
Q Consensus 227 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 303 (395)
|+....... .....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+.+..+... ..
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~--~~---- 227 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--ER---- 227 (273)
T ss_dssp ----------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--CC----
T ss_pred heeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CC----
Confidence 987654332 2345678999999999754 58999999999999999998 89999988877776665441 10
Q ss_pred hhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..++..+|+++.+||.+||+.||.+|||+.|+++|
T Consensus 228 ----------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 ----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01234679999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=378.79 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=194.4
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCc----EEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCc
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (395)
.+|++.+.||+|+||+||+|++..+|+ .||+|.+... .+.+.+|+.+++.++|||||++++++.. .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence 369999999999999999999988886 5788877532 2345689999999999999999998842 2
Q ss_pred eeEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
. .++++||+. |++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~-~~~~~kl~DFGl 157 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVK-TPQHVKITDFGL 157 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE-ETTEEEECCCSH
T ss_pred C-eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeC-CCCCeEeecccc
Confidence 2 456677766 566665443 35679999999999999999999999 6999999999999999 788999999999
Q ss_pred ccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 016115 227 AKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (395)
Q Consensus 227 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 302 (395)
|+........ ....||+.|||||++.+. .++.++|||||||++|||+| |..||.+.+..+....+.+....
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~---- 232 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---- 232 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC----
T ss_pred ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 9876544332 234579999999999765 58999999999999999999 89999887766655544431100
Q ss_pred hhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
..+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1234578999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=366.30 Aligned_cols=245 Identities=20% Similarity=0.315 Sum_probs=194.2
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEE
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
..++|++.+.||+|+||.||+|++ +|..||||+++.+. +.+.+|+++++.++||||+++++++.. +...+++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~l 78 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI 78 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEEE
Confidence 445799999999999999999998 58899999997543 445689999999999999999998743 2234789
Q ss_pred EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
||||+++ +|.+.+.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++...
T Consensus 79 v~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-TTSCEEECCCCC-----
T ss_pred EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheec-CCCCEeecccccceecC
Confidence 9999985 6666665421 2458899999999999999999999 6999999999999999 78899999999998654
Q ss_pred cCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhhhhcCCC
Q 016115 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (395)
Q Consensus 232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (395)
.. .....+|..|+|||++.+. .++.++|||||||++|||+| |.+||...+..+....+.+.
T Consensus 155 ~~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~--------------- 216 (262)
T d1byga_ 155 ST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------- 216 (262)
T ss_dssp ---------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---------------
T ss_pred CC--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------------
Confidence 32 3345678999999999765 58999999999999999998 78889887766665554321
Q ss_pred CCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
....++..+++++.+||++||+.||.+|||+.+++++
T Consensus 217 -------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 217 -------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp -------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0111344578999999999999999999999999873
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=371.00 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=188.8
Q ss_pred ccCceeeeeeecCCceEEEEEEECC-----CCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 144 (395)
.++|++.+.||+|+||+||+|++.. +++.||||++.... +...+|..++.++ +|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--- 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc---
Confidence 3579999999999999999999754 45689999986432 2233456666555 68999999887743
Q ss_pred CCceeEEEEEeccc-chHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCcee
Q 016115 145 KDELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL 211 (395)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nil 211 (395)
....+++|||||+ |+|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 89 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NIL 166 (299)
T d1ywna1 89 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 166 (299)
T ss_dssp -TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEE
T ss_pred -CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCcccee
Confidence 2334889999999 466666654321 23468999999999999999999999 69999999999999
Q ss_pred ecCCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhC-CCCCCCCChHH
Q 016115 212 VDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVD 287 (395)
Q Consensus 212 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~ 287 (395)
++ .++.+||+|||+|+....... .....||+.|||||++.+. .++.++|||||||++|||+|| ..||.+.+..+
T Consensus 167 l~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 167 LS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EC-CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99 788999999999986544332 2345789999999999764 589999999999999999996 56888766555
Q ss_pred HHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
.+......... ...+..+++++.+||.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLKEGTR---------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCC---------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55544442111 11234578999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=374.65 Aligned_cols=249 Identities=23% Similarity=0.294 Sum_probs=201.7
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcE--EEEEEecc-----cccchHHHHHHHHHc-CCCceeeeceeeeecCCCCc
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQ-----DRRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~-----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (395)
-++|++.+.||+|+||+||+|+++.+|.. ||||.+.. ..+.+.+|+++++.+ +|||||++++++. +.
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~ 83 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR 83 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ET
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----cC
Confidence 35799999999999999999999888875 67777642 233456899999998 7999999999994 44
Q ss_pred eeEEEEEeccc-chHHHHHHhh------------cccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC
Q 016115 148 LFLNLVMEYVP-ETMYRVLKHY------------SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (395)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~------------~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~ 214 (395)
..+++||||++ |+|.+.+... ......+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~- 161 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG- 161 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEc-
Confidence 55999999999 4666666432 2335779999999999999999999999 6999999999999999
Q ss_pred CCCcEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCC-CCCCCCChHHHHHHHH
Q 016115 215 LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEII 293 (395)
Q Consensus 215 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~~~ 293 (395)
.++.+||+|||+++............||..|+|||.+.+. .++.++|||||||++|||++|. +||.+.+..+....+.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 7889999999999876555555566789999999999765 4899999999999999999965 6788777666655543
Q ss_pred HHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
+. . ....+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 241 ~~--~--------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QG--Y--------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GT--C--------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hc--C--------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 31 0 011234578999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=367.29 Aligned_cols=243 Identities=24% Similarity=0.323 Sum_probs=190.0
Q ss_pred cCceeeeeeecCCceEEEEEEECCC-C--cEEEEEEeccc-------ccchHHHHHHHHHcCCCceeeeceeeeecCCCC
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~--~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (395)
.+|++.+.||+|+||.||+|++..+ + ..||||++..+ .+.+.+|+.+++.++|||||++++++. +
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-----~ 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-----T 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----e
Confidence 4699999999999999999986533 3 36899988542 124468999999999999999999883 2
Q ss_pred ceeEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecc
Q 016115 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (395)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 225 (395)
. .+++||||+++ ++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 83 ~-~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~-~~~~vkl~DfG 156 (273)
T d1u46a_ 83 P-PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLA-TRDLVKIGDFG 156 (273)
T ss_dssp S-SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEE-ETTEEEECCCT
T ss_pred c-chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhccc-cccceeeccch
Confidence 2 36799999985 55544443 23569999999999999999999999 6999999999999999 68899999999
Q ss_pred cccccccCCcce----eeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016115 226 SAKVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (395)
Q Consensus 226 ~a~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 300 (395)
+++......... ...|+..|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+.+..+.+...
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~--- 232 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE--- 232 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC---
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC---
Confidence 998765443322 23467889999999764 58999999999999999998 8999999988887776654200
Q ss_pred hhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHh
Q 016115 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 358 (395)
....+..+|+++.+||.+||+.||++|||+.|++
T Consensus 233 ------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 233 ------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp ------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------------------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 0112346789999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-50 Score=369.31 Aligned_cols=248 Identities=24% Similarity=0.295 Sum_probs=200.4
Q ss_pred ccCceeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCC
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (395)
.++|++.+.||+|+||+||+|++. .+++.||||++... ...+.+|+++++.++||||+++++++ .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~ 86 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-----A 86 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee-----c
Confidence 457999999999999999999975 35678999998643 23456899999999999999999998 3
Q ss_pred CceeEEEEEeccc-chHHHHHHhhc--------------------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceecc
Q 016115 146 DELFLNLVMEYVP-ETMYRVLKHYS--------------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRD 204 (395)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~D 204 (395)
.....+++|||+. |+|.+.+.... .....+++..++.++.||+.||+|||+ +||+|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD 165 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 165 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence 4445889999998 46666664321 123458999999999999999999999 6999999
Q ss_pred CCCCceeecCCCCcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCC-CCC
Q 016115 205 VKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLF 280 (395)
Q Consensus 205 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf 280 (395)
|||+|||++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|. +||
T Consensus 166 lKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999 788999999999986644322 2345678999999999764 5999999999999999999985 688
Q ss_pred CCCChHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 281 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
.+.+..+....+.+. .. ...+..+++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~e~~~~v~~~--~~--------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDG--NI--------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHHTT--CC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcC--CC--------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888887776665431 10 0123467899999999999999999999999954
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-50 Score=367.01 Aligned_cols=259 Identities=22% Similarity=0.257 Sum_probs=200.1
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
++|++.+.||+|+||+||+|++..+|+.||||++... .....+|+++++.++|+|++..+..+. .+....++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEEEE
Confidence 3699999999999999999999999999999987643 345678999999999887666655443 3334588999
Q ss_pred ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC--CCCcEEEeeccccccccc
Q 016115 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAKVLVK 232 (395)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~--~~~~~kl~Dfg~a~~~~~ 232 (395)
||+++++...+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. .+..+||+|||+|+....
T Consensus 83 e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9999987766543 34679999999999999999999999 69999999999999863 345799999999987754
Q ss_pred CCc--------ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhh
Q 016115 233 GEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (395)
Q Consensus 233 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 304 (395)
... .....||+.|||||++.+. .++.++|||||||++|+|+||..||......+....+.........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~--- 234 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--- 234 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH---
T ss_pred cccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC---
Confidence 432 2345799999999999765 4899999999999999999999999876655544333221100000
Q ss_pred hhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHH---HHhcCCCCcC
Q 016115 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFFDE 365 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~---ell~hp~~~~ 365 (395)
.........+|+++.+||.+||+.||++||+++ ++|+|+|.+.
T Consensus 235 ------------------~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 235 ------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ------------------SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------------CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 001112346799999999999999999999987 5578887654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=364.98 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=195.0
Q ss_pred cccCceeeeeeecCCceEEEEEEECCCC-------cEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeee
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFS 141 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (395)
..++|++++.||+|+||.||+|++..++ ..||||++..+. ....+|...+.++ +|||||++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~-- 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-- 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc--
Confidence 4468999999999999999999976554 479999986543 2334577777777 899999999999
Q ss_pred cCCCCceeEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCC
Q 016115 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (395)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~ 208 (395)
.+...+++|||||.+ ++.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+
T Consensus 89 ---~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~ 164 (299)
T d1fgka_ 89 ---TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAAR 164 (299)
T ss_dssp ---CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred ---ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeeccc
Confidence 445568999999995 56666643321 23568999999999999999999999 69999999999
Q ss_pred ceeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 016115 209 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (395)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~ 284 (395)
|||++ .++.+||+|||+++........ ....||+.|+|||++.+. .|+.++|||||||++|+|+| |.+||.+.+
T Consensus 165 NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 165 NVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999 7889999999999876554332 235689999999999764 59999999999999999998 789998877
Q ss_pred hHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+....+... .. ...+..+++++.+||.+||++||.+|||+.|+++
T Consensus 243 ~~~~~~~i~~~--~~--------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEG--HR--------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTT--CC--------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcC--CC--------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 76655444321 10 1123457899999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=364.72 Aligned_cols=257 Identities=23% Similarity=0.278 Sum_probs=207.3
Q ss_pred ccccCceeeeeeecCCceEEEEEEECC-----CCcEEEEEEecccc-----cchHHHHHHHHHcCCCceeeeceeeeecC
Q 016115 74 KQTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (395)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (395)
...++|.+.+.||+|+||+||+|.+.. ++..||||++.... ..+.+|+++++.++|||||++++++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~---- 92 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 92 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE----
Confidence 344689999999999999999998753 35789999986432 2245899999999999999999998
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhc------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCC
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYS------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~ 216 (395)
.....+++||||+.+ ++.+.+.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++ .+
T Consensus 93 -~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld-~~ 169 (308)
T d1p4oa_ 93 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVA-ED 169 (308)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEEC-TT
T ss_pred -ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeec-CC
Confidence 444458999999985 5555554321 123457889999999999999999999 6999999999999999 78
Q ss_pred CcEEEeecccccccccCCc---ceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 016115 217 HQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEI 292 (395)
Q Consensus 217 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~ 292 (395)
+.+||+|||+|+....... .....||+.|+|||.+.+. .++.++||||||+++|||+|| ..||.+.+..+.+..+
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999986644332 2334689999999999765 489999999999999999998 5888888887777666
Q ss_pred HHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc------CCCCcCC
Q 016115 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDEL 366 (395)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~------hp~~~~~ 366 (395)
.+... ...+..+++.+.+||.+||+.||++|||+.++++ +|+|+++
T Consensus 249 ~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 249 MEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp HTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HhCCC----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 54210 0123457899999999999999999999999997 7887653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-49 Score=361.61 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=200.9
Q ss_pred cccCceeeeeeecCCceEEEEEEEC-----CCCcEEEEEEecccc-----cchHHHHHHHHHc-CCCceeeeceeeeecC
Q 016115 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (395)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (395)
..++|++.+.||+|+||.||+|++. .+++.||||++.... ..+.+|+.+++.+ +|||||++++++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~---- 96 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence 3457999999999999999999863 467789999986542 2345788999998 699999999998
Q ss_pred CCCceeEEEEEecccc-hHHHHHHhhc--------------ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCC
Q 016115 144 SKDELFLNLVMEYVPE-TMYRVLKHYS--------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (395)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~--------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~ 208 (395)
.+...+++|||||++ ++.+.+.... .....+++..++.++.||+.||+|||+ +||+||||||+
T Consensus 97 -~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~ 174 (311)
T d1t46a_ 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR 174 (311)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred -eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccccc
Confidence 444558999999985 5555554422 123468999999999999999999999 69999999999
Q ss_pred ceeecCCCCcEEEeecccccccccCCcc---eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 016115 209 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (395)
Q Consensus 209 Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~ 284 (395)
|||++ .++.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+
T Consensus 175 NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 175 NILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 99999 6889999999999876544332 235789999999999754 58999999999999999999 677777776
Q ss_pred hHHHHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
..+.+.++.+.... ...+..+++++.+||.+||+.||.+|||++++++
T Consensus 253 ~~~~~~~~i~~~~~---------------------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCC---------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66666665543111 1122456899999999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-48 Score=368.50 Aligned_cols=284 Identities=29% Similarity=0.470 Sum_probs=208.4
Q ss_pred ccCceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcC-----------CCceeeeceeeee
Q 016115 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-----------HPNVISLKHCFFS 141 (395)
Q Consensus 76 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 141 (395)
.++|++++.||+|+||+||+|++..+|+.||||++..+. ....+|+.+++.++ |+||+++++++..
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 346999999999999999999999999999999997653 33457888888775 5789999888744
Q ss_pred cCCCCceeEEEEEecc--cchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCC--
Q 016115 142 TTSKDELFLNLVMEYV--PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-- 217 (395)
Q Consensus 142 ~~~~~~~~~~lv~e~~--~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~-- 217 (395)
.. ....+++|+++ .++...... ......+++..++.++.||+.||.|||+..||+||||||+|||++..+.
T Consensus 92 ~~---~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KG---PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EE---TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred cc---ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 22 22344455444 444333333 3345788999999999999999999997359999999999999973222
Q ss_pred ---cEEEeecccccccccCCcceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC------hHHH
Q 016115 218 ---QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQ 288 (395)
Q Consensus 218 ---~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~ 288 (395)
.++++|||.+..... .....+||+.|+|||++.+. .++.++||||+||++++|++|+.||...+ ..+.
T Consensus 167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ccceeeEeeccccccccc--ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 499999999976533 33456799999999999865 48999999999999999999999997543 3456
Q ss_pred HHHHHHHhCCCChhhhhhcCCC-------CCCCCCCCccCCCccc------cccccCChhHHHHHHHhhccCCCCCCCHH
Q 016115 289 LVEIIKVLGTPTREEIRCMNPN-------YTDFRFPQIKAHPWHK------VFHKRMPPEAIDLASRLLQYSPSLRCTAL 355 (395)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 355 (395)
+......+|..+...+...... .....+......++.. .+....++++.|||.+||++||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 6777788888776655432210 0001111111111111 12234578899999999999999999999
Q ss_pred HHhcCCCCcCCC
Q 016115 356 EACAHPFFDELR 367 (395)
Q Consensus 356 ell~hp~~~~~~ 367 (395)
|+|+||||++..
T Consensus 324 e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 324 GLVNHPWLKDTL 335 (362)
T ss_dssp HHHTCGGGTTCT
T ss_pred HHhcCcccCCCC
Confidence 999999998653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-49 Score=360.26 Aligned_cols=244 Identities=21% Similarity=0.268 Sum_probs=188.6
Q ss_pred eeeeeeecCCceEEEEEEECCCC---cEEEEEEeccc-----ccchHHHHHHHHHcCCCceeeeceeeeecCCCCceeEE
Q 016115 80 MAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 80 ~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (395)
...++||+|+||+||+|++..++ ..||||++... ...+.+|++++++++|||||++++++... ...++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~ 105 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPL 105 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceE
Confidence 34678999999999999986543 36899998532 23456899999999999999999987432 33588
Q ss_pred EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCCCcEEEeecccccccc
Q 016115 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (395)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 231 (395)
+|||||+++.+..+.. .....+++..+..++.|++.||.|||+ +||+||||||+|||++ +++.+||+|||+++...
T Consensus 106 lv~E~~~~g~l~~~~~--~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLD-EKFTVKVADFGLARDMY 181 (311)
T ss_dssp EEEECCTTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-TTCCEEECSSGGGCCTT
T ss_pred EEEEEeecCchhhhhc--cccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeEC-CCCCEEEecccchhhcc
Confidence 9999999754444333 234567888899999999999999999 6999999999999999 78999999999998764
Q ss_pred cCCcc-----eeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhhh
Q 016115 232 KGEAN-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIR 305 (395)
Q Consensus 232 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 305 (395)
..... ....||..|+|||.+.+. .++.++||||||+++|||+||..||....... ....+.. +..
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~~------ 252 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GRR------ 252 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TCC------
T ss_pred ccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CCC------
Confidence 43222 234679999999998754 58999999999999999999887776543332 2222221 110
Q ss_pred hcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 016115 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 360 (395)
...+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 253 --------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 --------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01234578999999999999999999999999988
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-48 Score=353.68 Aligned_cols=249 Identities=18% Similarity=0.231 Sum_probs=199.6
Q ss_pred cCceeeeeeecCCceEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHcCC-CceeeeceeeeecCCCCceeEEEE
Q 016115 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLV 153 (395)
Q Consensus 77 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv 153 (395)
++|++++.||+|+||+||+|++..+|+.||||++... .....+|+++++.++| +|++.+++++ ......++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccEEE
Confidence 3699999999999999999999999999999987543 3456789999999986 8999998887 455568999
Q ss_pred EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecC----CCCcEEEeecccccc
Q 016115 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKV 229 (395)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~----~~~~~kl~Dfg~a~~ 229 (395)
|||+++++.+.+... ...+++..+..++.|++.||+|||+ +||+||||||+|||++. .++.+||+|||+|+.
T Consensus 80 me~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 999999887776542 3578999999999999999999999 69999999999999962 256799999999987
Q ss_pred cccCC--------cceeeeecccccCchhhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Q 016115 230 LVKGE--------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGT 298 (395)
Q Consensus 230 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~~ 298 (395)
..... ......||+.|||||++.+. .++.++|||||||++|+|+||..||.+... ......+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 64432 12345799999999999764 599999999999999999999999976433 3333333221111
Q ss_pred CChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
... ..+...+|+++.+|+..|+..+|++||+.+.+.+
T Consensus 235 ~~~------------------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPL------------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCH------------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCh------------------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111 1123457899999999999999999999876643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=351.48 Aligned_cols=255 Identities=21% Similarity=0.252 Sum_probs=185.9
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEeccccc-chHHH--HHHHHHcCCCceeeeceeeeecCCCCceeEEEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRE--LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~e--~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (395)
+|.+.+.||+|+||.||+|++ +|+.||||++..+.. ...+| +..++.++|||||++++++.... .....+++||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence 588999999999999999986 789999999864432 22234 44456789999999999986544 3345689999
Q ss_pred ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCceeccCCCCceeecCCCCcEEEeeccc
Q 016115 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (395)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-------~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 226 (395)
||+++ +|.+.+.. ..+++..++.++.|++.||.|||+. +||+||||||+||||+ .++.+||+|||+
T Consensus 81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFGl 154 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCTT
T ss_pred ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEecCc
Confidence 99985 66666654 4689999999999999999999962 5999999999999999 789999999999
Q ss_pred ccccccCCc-----ceeeeecccccCchhhcCCC-----CCCcccchHhHHHHHHHHHhCCCCCCCCChHH---------
Q 016115 227 AKVLVKGEA-----NISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD--------- 287 (395)
Q Consensus 227 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--------- 287 (395)
++....... .....||+.|+|||++.+.. .++.++|||||||++|||+||..||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 987755432 22457899999999986532 25678999999999999999998874322110
Q ss_pred --HHHHHHHHhCCCChhhhhhcCCCCCCCCCCCccCCCccccccccCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 016115 288 --QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (395)
Q Consensus 288 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 359 (395)
....+...... .... +.+. ...........+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~----------~~~~----p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 235 DPSVEEMRKVVCE----------QKLR----PNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHHHHHHTT----------SCCC----CCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHhc----------cccC----CCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 00001110000 0000 0000 00011123356899999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=3.4e-26 Score=194.41 Aligned_cols=165 Identities=17% Similarity=0.126 Sum_probs=116.6
Q ss_pred ceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----------------------cchHHHHHHHHHcCCCceeeec
Q 016115 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRLMDHPNVISLK 136 (395)
Q Consensus 79 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------------~~~~~e~~~l~~l~h~niv~~~ 136 (395)
+.+++.||+|+||+||+|++ .+|+.||||++.... ....+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56789999999999999997 479999999864211 0112477788889999998876
Q ss_pred eeeeecCCCCceeEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcCCCceeccCCCCceeecCCC
Q 016115 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (395)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~ivH~Dlkp~Nill~~~~ 216 (395)
++. . .+++|||+++... ..++...+..++.|++.+|.|||+ +||+||||||+|||++ +
T Consensus 81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~-~- 138 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-E- 138 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-T-
T ss_pred Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeee-C-
Confidence 543 2 2599999997521 123445567889999999999999 6999999999999998 3
Q ss_pred CcEEEeecccccccccCCcceeeee-cccccCchhhcCCCCCCcccchHhHHHHH
Q 016115 217 HQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVL 270 (395)
Q Consensus 217 ~~~kl~Dfg~a~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il 270 (395)
+.++|+|||+|.......... ... +.. .-.+.+ ...|+.++|+||+.--+
T Consensus 139 ~~~~liDFG~a~~~~~~~~~~-~l~rd~~-~~~~~f--~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 139 EGIWIIDFPQSVEVGEEGWRE-ILERDVR-NIITYF--SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TEEEECCCTTCEETTSTTHHH-HHHHHHH-HHHHHH--HHHHCCCCCHHHHHHHH
T ss_pred CCEEEEECCCcccCCCCCcHH-HHHHHHH-HHHHHH--cCCCCCcccHHHHHHHH
Confidence 459999999997654332211 000 000 001222 23488999999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=6.6e-07 Score=77.52 Aligned_cols=136 Identities=15% Similarity=0.110 Sum_probs=83.5
Q ss_pred CceeeeeeecCCceEEEEEEECCCCcEEEEEEecccc----cchHHHHHHHHHcC-CCceeeeceeeeecCCCCceeEEE
Q 016115 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (395)
Q Consensus 78 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 152 (395)
.|++++..+.++.+.||+... ++..+++|+..... ....+|..+++.+. +--+.+++... .+....++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l 87 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL 87 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence 477777666566678998863 66778889875432 24567888888775 22244555444 33345789
Q ss_pred EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 016115 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV----------------------------------- 197 (395)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~----------------------------------- 197 (395)
||++++|........ . . . ....++.++...+..||+.
T Consensus 88 v~~~l~G~~~~~~~~--~--~-~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYE--D--E-Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTT--T--C-S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccc--c--c-c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 999999843321110 0 0 0 1112233444444444421
Q ss_pred -----------------------CCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 198 -----------------------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 198 -----------------------~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
..++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec-CCceEEEeechhccc
Confidence 1279999999999998 555567999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.15 E-value=6.2e-06 Score=70.72 Aligned_cols=69 Identities=13% Similarity=0.097 Sum_probs=44.7
Q ss_pred eecCC-ceEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHcCCCc--eeeeceeeeecCCCCceeEEEEEecccc
Q 016115 85 VGTGS-FGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNLVMEYVPE 159 (395)
Q Consensus 85 lg~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~ 159 (395)
+..|. -+.||+... ..+..+++|...... .....|...++.+.... +.+++.+. .+....++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEeeec
Confidence 34444 467899874 457778899775443 34567888888775433 34455444 233447899999986
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.90 E-value=4.9e-05 Score=69.55 Aligned_cols=71 Identities=18% Similarity=0.118 Sum_probs=43.1
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeccc-----------ccchHHHHHHHHHcC-C--CceeeeceeeeecCCCCc
Q 016115 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----------RRYKNRELQLMRLMD-H--PNVISLKHCFFSTTSKDE 147 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~~ 147 (395)
.+.||.|....||++.+..+|+.++||.-... ......|.+.++.+. + ..+.+++.+. .+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-----~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-----TEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-----TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-----CCC
Confidence 35689999999999997777889999965321 111245888887663 2 2344444322 222
Q ss_pred eeEEEEEecccc
Q 016115 148 LFLNLVMEYVPE 159 (395)
Q Consensus 148 ~~~~lv~e~~~~ 159 (395)
.++|||++++
T Consensus 106 --~~lvmE~L~~ 115 (392)
T d2pula1 106 --AVTVMEDLSH 115 (392)
T ss_dssp --TEEEECCCTT
T ss_pred --CEEEEeccCC
Confidence 4589999975
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.07 E-value=0.0012 Score=59.91 Aligned_cols=69 Identities=16% Similarity=0.240 Sum_probs=46.3
Q ss_pred eeeeecCCceEEEEEEECC-------CCcEEEEEEecccc--cchHHHHHHHHHcCCCce-eeeceeeeecCCCCceeEE
Q 016115 82 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR--RYKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELFLN 151 (395)
Q Consensus 82 ~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~ 151 (395)
++.|+.|-.-.+|++.... .++.|.+++.-... ....+|..+++.+.-.++ .++++++ .+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence 4678889999999998643 34568888764322 234578888888764444 3566655 32 4
Q ss_pred EEEecccc
Q 016115 152 LVMEYVPE 159 (395)
Q Consensus 152 lv~e~~~~ 159 (395)
+|+||++|
T Consensus 118 ~I~efi~g 125 (395)
T d1nw1a_ 118 RLEEYIPS 125 (395)
T ss_dssp EEECCCCE
T ss_pred eEEEEecc
Confidence 78999886
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.0026 Score=56.02 Aligned_cols=69 Identities=17% Similarity=0.002 Sum_probs=40.1
Q ss_pred ceEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHcCCCcee--eeceeeeecCCCCceeEEEEEecccc
Q 016115 90 FGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI--SLKHCFFSTTSKDELFLNLVMEYVPE 159 (395)
Q Consensus 90 ~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~lv~e~~~~ 159 (395)
--.||++.. .+|..|++|+..... .....|...+..|...++. ..+..--..........+.++++++|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 468999984 578899999986543 3345677887776532221 11111000011223456788888875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.70 E-value=0.0028 Score=55.38 Aligned_cols=31 Identities=29% Similarity=0.214 Sum_probs=26.5
Q ss_pred CCceeccCCCCceeecCCCCcEEEeecccccc
Q 016115 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (395)
Q Consensus 198 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 229 (395)
.|+||+|+.++||+++ ++...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~-~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFL-GDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEE-TTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcc-cccceeEeccccccc
Confidence 4799999999999999 566668999998853
|